Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,protein targeting to ER (GO:0045047),-0.7541807282558296,-2.950055287925933,0.0,0.0,0.0,71/99,15.24%,RPL37A;RPL41;RPL13;RPL11;RPS21;RPL27A;RPLP1;RPL17;RPL23;RPS24;RPL19;RPL21;RPS9;RPL38;RPL6;RPS15;RPL37;RPL4;RPS8;RPS7;RPL8;RPS23;RPSA;RPS3;RPS19;RPS11;RPL34;RPL18A;RPL28;RPL26;RPL24;RPS29;RPS14;RPS12;RPS6;RPL23A;RPL18;RPS20;SRP9;RPS18;RPS25;RPL3;RPL32;RPL36;RPS27A;RPL5;RPL14;RPS2;RPL27;RPS27;RPL29;RPL31;RPLP0;RPL35A;RPLP2;RPL7A;RPL7;RPS28;RPS10;RPS17;RPL30;RPS4X;SRPRB;SEC62;RPS26;RPS16;SEC61G;RPS5;RPL13A;UBA52;ZFAND2B
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.7693571175001477,-2.9323239770615803,0.0,0.0,0.0,68/87,15.24%,RPL37A;RPL41;RPL13;RPL11;RPS21;RPL27A;RPLP1;RPL17;RPL23;RPS24;RPL19;RPL21;RPS9;RPL38;RPL6;RPS15;RPL37;RPL4;RPS8;RPS7;RPL8;RPS23;RPSA;RPS3;RPS19;RPS11;RPL34;RPL18A;RPL28;RPL26;RPL24;RPS29;RPS14;RPS12;RPS6;RPL23A;RPL18;RPS20;SRP9;RPS18;RPS25;RPL3;RPL32;RPL36;RPS27A;RPL5;RPL14;RPS2;RPL27;RPS27;RPL29;RPL31;RPLP0;RPL35A;RPLP2;RPL7A;RPL7;RPS28;RPS10;RPS17;RPL30;RPS4X;RPS26;RPS16;RPS5;RPL13A;UBA52;ZFAND2B
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.7585094021675535,-2.9217442675904044,0.0,0.0,0.0,69/91,15.15%,RPL37A;RPL41;RPL13;RPL11;RPS21;RPL27A;RPLP1;RPL17;RPL23;RPS24;RPL19;RPL21;RPS9;RPL38;RPL6;RPS15;RPL37;RPL4;RPS8;RPS7;RPL8;RPS23;RPSA;RPS3;RPS19;RPS11;RPL34;RPL18A;RPL28;RPL26;RPL24;RPS29;RPS14;RPS12;RPS6;RPL23A;RPL18;RPS20;SRP9;RPS18;RPS25;RPL3;RPL32;RPL36;RPS27A;RPL5;RPL14;RPS2;RPL27;RPS27;RPL29;RPL31;SIL1;RPLP0;RPL35A;RPLP2;RPL7A;RPL7;RPS28;RPS10;RPS17;RPL30;RPS4X;SEC62;RPS26;RPS16;RPS5;RPL13A;UBA52
prerank,cytoplasmic translation (GO:0002181),-0.7517762072123917,-2.9099209385602807,0.0,0.0,0.0,67/91,15.15%,RPL37A;RPL41;RPL13;RPL11;RPS21;RPL27A;RPLP1;RPL17;RPL23;RPS24;RPL19;RPL21;RPS9;RPL38;RPL6;RPS15;RPL37;RPL4;RPS8;RPS7;RPL8;RPS23;RPSA;RPS3;RPS19;RPS11;RPL34;RPL18A;RPL28;RPL26;RPL24;RPS29;RPS14;RPS12;RPS6;RPL23A;RPL18;RPS20;RPS18;RPS25;RPL3;RPL32;RPL36;RPS27A;RPL5;RPL14;RPS2;RPL27;EIF3I;RPS27;RPL29;RPL31;RPLP0;RPL35A;RPL7A;RPL7;RPS28;RPS10;RPS17;RPL30;RPS4X;GSPT2;RPS26;RPS16;RPS5;RPL13A;UBA52
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.7133738453054432,-2.82845316556283,0.0,0.0,0.0,72/110,15.15%,RPL37A;RPL41;RPL13;RPL11;RPS21;RPL27A;RPLP1;RPL17;RPL23;RPS24;RPL19;RPL21;RPS9;RPL38;RPL6;RPS15;RPL37;RPL4;RPS8;RPS7;RPL8;RPS23;RPSA;RPS3;RPS19;RPS11;RPL34;RPL18A;RPL28;RPL26;RPL24;RPS29;RPS14;RPS12;RPS6;RPL23A;RPL18;RPS20;PABPC1;RPS18;RPS25;RPL3;RPL32;RPL36;RPS27A;RPL5;RPL14;RPS2;RPL27;RPS27;RPL29;RPL31;PYM1;RPLP0;RPL35A;RPLP2;EIF4G1;RPL7A;RPL7;RPS28;RPS10;RPS17;RPL30;RPS4X;RBM8A;GSPT2;RNPS1;RPS26;RPS16;RPS5;RPL13A;UBA52
prerank,peptide biosynthetic process (GO:0043043),-0.6276911284465251,-2.6080294216602793,0.0,0.0,0.0,87/153,19.63%,EEF1A1;RPL37A;RPL41;RPL13;RPL11;RPS21;RPL27A;RPLP1;RPL17;RPL23;RPS24;RPL19;RPL21;RPS9;RPL38;RPL6;RPS15;RPL37;RPL4;RPS8;RPS7;RPL8;RPS23;RPSA;RPS3;RPS19;RPS11;RPL34;RPL18A;RPL28;RPL26;RPL24;RPS29;RPS14;RPS12;RPS6;RPL23A;RPL18;RPS20;WARS1;MRRF;RPS18;RPS25;RPL3;RPL32;SARS1;RPL36;RPS27A;RPL5;RPL14;RPS2;RPL27;RPS27;MRPL32;RPL29;RPL31;RPLP0;RPL35A;RPLP2;FURIN;EIF4G1;RPL7A;MRPS14;RPL7;RPS28;RPS10;RPS17;RPL30;RPS4X;GSPT2;MRPS16;RSL24D1;RPS26;RPS16;RPS5;MRPL23;MRPS5;RPL13A;RRBP1;MRPL24;RPL36A;PCSK1;RPL12;RPL9;MRPL13;MRPL35;RPL35
prerank,translation (GO:0006412),-0.584042616892173,-2.504585645033093,0.0,0.0,0.0,100/208,19.63%,EEF1A1;RPL37A;RPL41;RPL13;RPL11;RPS21;RPL27A;RPLP1;RPL17;RPL23;RPS24;RPL19;RPL21;RPS9;RPL38;RPL6;RPS15;EEF2;RPL37;RPL4;RPS8;RPS7;RPL8;RPS23;RPSA;RPS3;RPS19;WARS2;RPS11;RPL34;RPL18A;RPL28;RPL26;RPL24;RPS29;RPS14;RPS12;RPS6;RPL23A;RPL18;LARS2;RPS20;WARS1;EEF1D;MRRF;RPS18;RPS25;RPL3;RPL32;SARS1;RPL36;RPS27A;RPL5;RPL14;RPS2;RPL27;NDUFA7;RPS27;MRPL32;RPL29;RPL31;RPLP0;APEH;RPL35A;RPLP2;EIF4G1;RPL7A;MRPS14;RPL7;RPS28;RPS10;RPS17;RPL30;RPS4X;GSPT2;EEF1G;MRPS16;RSL24D1;YARS1;RPS26;RPS16;IARS1;RPS5;MRPL23;MRPS5;RPL13A;UBA52;RRBP1;EEF1B2;NARS1;MRPL24;RPL36A;EEFSEC;RPL12;EEF1E1;MRPS28;RPL9;MRPL13;MRPL35;RPL35
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.573780366897097,-2.421715650462944,0.0,0.0,0.0,86/168,18.15%,RPL37A;RPL41;RPL13;RPL11;RPS21;RPL27A;RPLP1;RPL17;RPL23;RPS24;RPL19;RPL21;RPS9;RPL38;RPL6;RPS15;RPL37;RPL4;RPS8;RPS7;RPL8;RPS23;RPSA;RPS3;RPS19;RPS11;RPL34;PAN2;RPL18A;RPL28;RPL26;RPL24;RPS29;RPS14;RPS12;RPS6;RPL23A;RPL18;RPS20;PABPC1;RPS18;RPS25;RPL3;RPL32;RPL36;RPS27A;RPL5;RPL14;RPS2;RPL27;RPS27;RPL29;CNOT6L;DDX5;RPL31;PATL1;PYM1;RPLP0;RPL35A;RPLP2;EIF4G1;RPL7A;RPL7;RPS28;RPS10;RPS17;RPL30;RPS4X;RBM8A;ZFP36L1;GSPT2;RNPS1;RPS26;RPS16;RPS5;RPL13A;UBA52;POLR2G;DCPS;TNKS1BP1;RPL36A;ZC3H12A;PPP2R2A;RPL12;PELO;SMG5
prerank,rRNA metabolic process (GO:0016072),-0.5393925492675,-2.265780088222738,0.0,0.0,0.0,79/160,19.98%,RPL37A;RPL41;RPL13;RPL11;RPL27A;RPLP1;RPL17;RPL23;RPS24;RPL19;RPL21;RPS9;RPL38;RPL6;RPS15;RPL37;RPL4;RPS7;RPL8;RPS19;RPL34;RPL18A;RPL28;RPL26;RPL24;RPS14;RPS6;RPL23A;RPL18;RPS25;RPL3;RPL32;RPL36;RPL5;RPL14;DCAF13;RPS2;RPL27;RPS27;RPL29;RPL31;DDX52;RPLP0;IMP3;RPL35A;TEX10;PDCD11;TRIR;RPLP2;RPL7A;BMS1;RPL7;RPS28;POP5;RPS17;PIH1D1;RPL30;DDX54;DHX37;WDR3;FBL;POP4;RPS16;RPF1;RPL13A;UBA52;RPL36A;UTP18;UTP15;TBL3;RPL12;MRM2;RPL9;EBNA1BP2;EXOSC10;NOP53;NOLC1;RPL35;MTREX
prerank,negative regulation of cell-substrate adhesion (GO:0010812),-0.6669107602757876,-2.1713767560265334,0.0,0.00011181937175828817,0.001,22/39,14.48%,EFNA5;ACTN4;ACER2;THBS1;JAG1;ADAM15;CORO2B;NOTCH1;FZD4;SEMA3E;KANK1;CORO1C;AP1AR;NEXMIF;MYOC;AJAP1;RHOA;GCNT2;SPRY4;SPOCK1;CASK;RCC2
prerank,ncRNA processing (GO:0034470),-0.4911564134560491,-2.1260659398871034,0.0,0.0010165397432571651,0.007,90/200,20.47%,RPL37A;RPL41;RPL13;RPL11;RPL27A;RPLP1;RPL17;RPL23;RPS24;RPL19;RPL21;RPS9;RPL38;RPL6;RPS15;RPL37;RPL4;RPS7;RPL8;RPS19;RPL34;RPL18A;RPL28;RPL26;RPL24;RPS14;RPS6;RPL23A;RPL18;RPS25;RPL3;RPL32;SARS1;RPL36;RPL5;RPL14;DCAF13;RPS2;RPL27;RPS27;RPL29;RPL31;DDX52;RPLP0;ADAR;IMP3;RPL35A;TEX10;PDCD11;RPLP2;RPL7A;SSB;BMS1;RPL7;RPS28;POP5;RPS17;PIH1D1;RPL30;DDX54;DGCR8;INTS11;DHX37;WDR3;FBL;RPP21;POP4;RPS16;RPF1;INTS6;RPL13A;UBA52;LIN28B;RPL36A;RPP30;UTP18;UTP15;TBL3;INTS1;RPL12;MRM2;RPL9;EBNA1BP2;EXOSC10;NOP53;NOLC1;RPL35;MTREX;AGO3;METTL3
prerank,ribosome biogenesis (GO:0042254),-0.49332402830697847,-2.1076680581774676,0.0,0.001397742146978602,0.012,86/187,21.79%,RPL37A;RPL41;RPL13;RPL11;RPL27A;RPLP1;RPL17;RPL23;RPS24;RPL19;RPL21;RPS9;RPL38;RPL6;RPS15;RPL37;RPL4;RPS7;RPL8;RPS19;RPL34;RPL18A;RPL28;RPL26;RPL24;RPS14;RPS6;RPL23A;RPL18;RPS25;RPL3;RPL32;RPL36;RPL5;RPL14;DCAF13;RPS2;RPL27;RPS27;RPL29;RPL31;DDX52;RPLP0;IMP3;RPL35A;TEX10;PDCD11;RPLP2;RPL7A;BMS1;RPL7;RPS28;POP5;RPS17;PIH1D1;RPL30;DDX54;DHX37;RBIS;WDR3;FBL;POP4;RPS16;RPF1;RPL13A;UBA52;DHX29;EIF2A;RPL36A;UTP18;UTP15;TBL3;RPL12;MRM2;HEATR3;RPL9;EBNA1BP2;EXOSC10;NOP53;NOLC1;RPL35;MTREX;NOC2L;PWP2;EIF6;RPL22
prerank,rRNA processing (GO:0006364),-0.4929127366398417,-2.0971979819270596,0.0,0.0015482682243455287,0.015,87/172,21.79%,RPL37A;RPL41;RPL13;RPL11;RPL27A;RPLP1;RPL17;RPL23;RPS24;RPL19;RPL21;RPS9;RPL38;RPL6;RPS15;RPL37;RPL4;RPS7;RPL8;RPS19;RPL34;RPL18A;RPL28;RPL26;RPL24;RPS14;RPS6;RPL23A;RPL18;RPS25;RPL3;RPL32;RPL36;RPL5;RPL14;DCAF13;RPS2;RPL27;RPS27;RPL29;RPL31;DDX52;RPLP0;MAK16;IMP3;RPL35A;TEX10;PDCD11;RPLP2;RPL7A;BMS1;RPL7;RPS28;POP5;RPS17;RSL1D1;PIH1D1;RPL30;DDX54;DHX37;WDR3;FBL;POP4;RPS16;RPF1;RPL13A;UBA52;TSR3;RPL36A;UTP18;UTP15;TBL3;RPL12;MRM2;RPL9;EBNA1BP2;EXOSC10;NOP53;THUMPD1;NOLC1;RPL35;MTREX;RRP15;PWP2;NHP2;EIF6;RPL22
prerank,response to copper ion (GO:0046688),-0.7406021380129032,-2.048099603834368,0.0,0.0035143231124033425,0.033,10/20,6.61%,MT1E;MT1F;MT1G;MT1B;MT1M;MT1A;MT1H;MT1X;ATP5F1D;MT2A
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.7091149062108133,-2.047948626632526,0.0,0.0032800349049097862,0.033,11/22,10.13%,SLIT2;TMSB4X;KANK3;GSN;TMSB10;KANK1;HIP1R;CYRIB;SSH2;KANK4;SSH1
prerank,cellular response to copper ion (GO:0071280),-0.7946128996020096,-2.046494435833352,0.0,0.003144919830701855,0.034,9/16,6.61%,MT1E;MT1F;MT1G;MT1B;MT1M;MT1A;MT1H;MT1X;MT2A
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.784717770145405,2.04373824496697,0.0,0.12523819668254318,0.116,6/23,2.69%,TGFBR3;ADAMTS9;FGFR2;TPM1;TNNC1;TNNT2
prerank,regulation of glucose import (GO:0046324),0.7302400715640295,2.0405732089123467,0.0,0.06757456655532906,0.126,7/30,3.89%,IGF1;PRKAG2;OSBPL8;APPL2;PID1;SORBS1;GRB10
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.8089281279741043,2.040230033871483,0.0,0.04504971103688604,0.126,4/18,3.59%,IGF1;IGFBP2;IL18;IGF2
prerank,retinoid metabolic process (GO:0001523),0.6166912338671525,2.0375401759293394,0.0016611295681063123,0.03536402316395554,0.13,12/71,6.35%,CYP26B1;ALDH1A1;ALDH1A2;RBP4;ABCA4;SDC2;GPC6;RBP1;GPC3;LRP2;SCPEP1;NAPEPLD
prerank,retinoic acid metabolic process (GO:0042573),0.8448925979330922,2.0280860673701615,0.0,0.035859569985361286,0.159,3/14,6.13%,CYP26B1;ALDH1A2;SCPEP1
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.44688810621595615,-2.0261946570089275,0.0,0.0043412226682629515,0.052,126/306,21.79%,ST3GAL4;EEF1A1;PTMA;RPL37A;RPL41;RPL13;RPL11;RPS21;RPL27A;RPLP1;RPL17;RPL23;RPS24;RPL19;RPL21;RPS9;RPL38;RPL6;RPS15;EEF2;RPL37;RPL4;RPS8;RPS7;RPL8;RPS23;RPSA;RPS3;PTMS;RPS19;RPS11;RPL34;RPL18A;RPL28;RPL26;RPL24;RPS29;RPS14;RPS12;RPS6;RPL23A;RPL18;RPS20;WARS1;B4GALT5;EEF1D;EXT1;MRRF;RPS18;RPS25;RPL3;RPL32;SARS1;RPL36;RPS27A;RPL5;RPL14;RPS2;RPL27;RPS27;MRPL32;RPL29;RPL31;SET;RPLP0;ING4;RPL35A;RPLP2;EIF4G1;RPL7A;MRPS14;RPL7;RPS28;RPS10;RPS17;KIN;RPL30;RPA1;RPS4X;BCL3;GSPT2;EEF1G;DONSON;POLR2C;XAB2;RAD17;MRPS16;MCM4;RNPS1;RSL24D1;RPS26;TOPBP1;RPS16;RPS5;MRPL23;MRPS5;RPL13A;POLR2G;RRBP1;NR4A2;TOP3A;FAM111A;EEF1B2;MCM8;MRPL24;POLA1;RPL36A;EEFSEC;RPL12;CDK2;RAD9A;RPL9;MRPL13;MRPL35;INHA;RPL35;POLE;ATR;POLD3;GTPBP2;FUT9;MRPL34;RBBP8;PAX8;DHPS;RPL22
prerank,epithelial tube morphogenesis (GO:0060562),-0.6342494989860434,-2.0106969634521916,0.0,0.005218237348720115,0.07,14/32,8.65%,MEF2C;SLIT2;PODXL;COL4A1;ACVRL1;RASIP1;HES1;PKD1;SOX17;RHOB;CTNNB1;MET;RYR2;PAK1
prerank,branching morphogenesis of an epithelial tube (GO:0048754),-0.6212108031549661,-2.0041575126486024,0.0,0.005590968587914408,0.08,18/39,10.71%,SLIT2;TIE1;COL4A1;KDR;RASIP1;ENG;PKD1;SEMA3E;TGFBR2;CTNNB1;LRP5;MET;SIX1;NOTCH4;VEGFA;NPNT;PAK1;BMP2
prerank,cellular response to zinc ion (GO:0071294),-0.7774450468721082,-1.982677574101223,0.0,0.008274633510113323,0.126,11/15,15.83%,MT1E;MT1F;MT1G;MT1B;MT1M;MT1A;MT1H;MT1X;MT2A;MT3;ATP13A2
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.7854717993452907,-1.9781319865869726,0.0,0.008466323861698962,0.133,8/14,9.72%,THBS1;KLF4;MEOX2;NOTCH1;HDAC5;CARD10;PDCD10;RHOA
prerank,skeletal system morphogenesis (GO:0048705),0.6535591570127128,1.95255155078021,0.0,0.12043289417194201,0.476,11/42,5.94%,CYP26B1;FGFR2;HOXC4;WWOX;FBN2;HOXB4;LTF;HOXB3;HOXA3;PDGFRA;ANKRD11
prerank,response to progesterone (GO:0032570),-0.7209581689314518,-1.9388442107761608,0.0,0.0169253867252318,0.263,7/18,8.93%,ABHD2;CAV1;THBS1;TGFB2;UBE3A;TGFB1;WBP2
prerank,response to zinc ion (GO:0010043),-0.6635654127033835,-1.9371030573788623,0.0,0.016918757118210555,0.274,11/25,6.61%,MT1E;MT1F;MT1G;MT1B;MT1M;MT1A;MT1H;MT1X;SLC30A5;CRIP1;MT2A
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.5943673621755102,-1.9363296293663155,0.0,0.01644676592944822,0.278,18/39,15.87%,RPS24;RPS15;RPS7;RPSA;RPS19;RPS14;RPS6;RPS25;RPS27;DDX52;RPS28;RPS17;ERAL1;WDR3;RPS27L;RPS16;RPS5;TSR3
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.5695797377777072,-1.935138561700925,0.0,0.01596780628708355,0.281,20/47,14.48%,EFNA5;ACTN4;LIMS2;RAC1;CARMIL1;PTK2;DOCK1;FLNA;LIMS1;KANK1;CORO1C;AP1AR;FERMT2;CALR;MYOC;CRK;S100A10;SPRY4;NEDD9;RCC2
prerank,ribosome assembly (GO:0042255),-0.5688549407494647,-1.9327792043896783,0.0,0.016385838707656843,0.298,27/47,23.86%,RPL11;RPL6;RPS15;RPSA;RPS19;RPL24;RPS14;RPL23A;RPL3;RPL5;RPS27;RPLP0;RPS28;ERAL1;DHX37;RPS27L;RSL24D1;RPS5;DHX29;EIF2A;NOP53;NLE1;PWP2;EIF6;PPAN;MRPS11;MRPS2
prerank,regulation of activated T cell proliferation (GO:0046006),0.6893342173439876,1.9167792316990986,0.0019120458891013384,0.18135726528849266,0.669,4/30,3.59%,IGF1;IGFBP2;IL18;IGF2
prerank,organic anion transport (GO:0015711),-0.5135303707142724,-1.9149424374166721,0.0,0.021038607723411255,0.365,24/76,15.86%,ABCC4;SLC4A10;ABCG2;SLC26A7;LRRC8C;SLCO1C1;LRRC8D;SLCO2A1;SLCO2B1;CA4;SLC39A8;SLC4A8;SLCO3A1;LRRC8A;CA2;SLC4A2;SLC26A6;SLC52A3;CYB5R1;SLC25A42;SLC35B2;SLC16A2;CFTR;SLC17A9
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.7895356943097299,-1.8925444550024022,0.0,0.029552262536119017,0.47,4/12,2.39%,PODXL;PROM1;IQGAP1;JAG1
prerank,cellular zinc ion homeostasis (GO:0006882),-0.6394366266467397,-1.892511370910346,0.0,0.028533219000390776,0.47,14/26,9.85%,SLC39A10;MT1E;MT1F;MT1G;MT1B;MT1M;MT1A;MT1H;MT1X;SLC30A5;MT2A;SLC39A8;SLC39A7;SLC30A1
prerank,energy reserve metabolic process (GO:0006112),0.7373142567145943,1.890954994234865,0.003816793893129771,0.23696148005402057,0.815,4/19,1.73%,PRKAG2;LEPR;PID1;PHKB
prerank,positive regulation of focal adhesion assembly (GO:0051894),-0.6776326117289602,-1.8870550659927297,0.0,0.030489415366093238,0.508,10/19,12.15%,TEK;PTPRJ;KDR;RAC1;LIMS1;FERMT2;MYOC;VEGFA;COL16A1;S100A10
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.6104535955884889,1.8855721088843207,0.0,0.22795153784664335,0.836,4/49,1.24%,IL31RA;IGF1;IL18;KIT
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.724980403849582,1.884825852735112,0.0,0.18904496922387815,0.839,4/21,2.14%,EYA4;EYA1;EYA2;BCL2
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.724980403849582,1.884825852735112,0.0,0.18904496922387815,0.839,4/21,2.14%,EYA4;EYA1;EYA2;BCL2
prerank,branched-chain amino acid catabolic process (GO:0009083),0.7419804288756717,1.8821987682588408,0.0019723865877712033,0.1683473047824557,0.853,10/20,13.67%,ACADSB;MCCC2;IVD;DBT;HSD17B10;BCKDHA;ALDH6A1;BCKDHB;AUH;HIBCH
prerank,branched-chain amino acid metabolic process (GO:0009081),0.7419804288756717,1.8821987682588408,0.0019723865877712033,0.1683473047824557,0.853,10/20,13.67%,ACADSB;MCCC2;IVD;DBT;HSD17B10;BCKDHA;ALDH6A1;BCKDHB;AUH;HIBCH
prerank,regulation of smoothened signaling pathway (GO:0008589),0.6079480558770439,1.874832038548276,0.0,0.173698814412222,0.882,18/50,12.04%,DCDC2;RORA;ZIC1;FGFR2;TULP3;INTU;MGRN1;TEDC2;TTC23;GLI3;GPC3;SUFU;ARMC9;HERC4;FBXL17;WDR11;IFT122;GAS1
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.5087516079707064,-1.871064360330991,0.002688172043010753,0.03837929404865116,0.601,30/70,22.16%,ELMO1;ACTB;ACTG1;MYO10;RAC1;HSP90AA1;HSP90AB1;PTK2;PLCG2;DOCK1;FYN;NCKAP1;WIPF1;ARPC1B;ARPC3;NCK1;WIPF3;PAK1;CRK;ACTR2;PRKCE;ARPC4;CYFIP2;YES1;ARPC1A;PRKCD;NCKAP1L;MAPK3;ACTR3;ABI1
prerank,Fc-gamma receptor signaling pathway (GO:0038094),-0.5070073174337878,-1.8693311784856677,0.0,0.03815836061251584,0.608,30/71,22.16%,ELMO1;ACTB;ACTG1;MYO10;RAC1;HSP90AA1;HSP90AB1;PTK2;PLCG2;DOCK1;FYN;NCKAP1;WIPF1;ARPC1B;ARPC3;NCK1;WIPF3;PAK1;CRK;ACTR2;PRKCE;ARPC4;CYFIP2;YES1;ARPC1A;PRKCD;NCKAP1L;MAPK3;ACTR3;ABI1
prerank,branching involved in blood vessel morphogenesis (GO:0001569),-0.7694899211581021,-1.8635605984393957,0.0,0.0401872045167666,0.636,8/13,7.98%,COL4A1;KDR;ENG;SEMA3E;TGFBR2;CTNNB1;NOTCH4;VEGFA
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.6004175589573987,-1.8627748758482434,0.0,0.039630100873158006,0.637,19/33,27.17%,MEF2C;THBS1;ACVRL1;KLF4;MEOX2;NOTCH1;TGFB1;HDAC5;CARD10;PDCD10;RHOA;JUP;CSNK2B;ATP2B4;DLL4;GADD45A;RGCC;ANGPT4;VASH1
prerank,neuron projection organization (GO:0106027),-0.7259830262785392,-1.8612243889183033,0.0,0.03961600599436495,0.65,11/15,22.20%,LGMN;GSK3B;ARF1;APP;ATP1A3;PICK1;ABCD2;INSR;PSEN1;DCTN1;MAP1A
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.8386779402940849,1.8478697505878896,0.004024144869215292,0.23726181146093317,0.943,4/10,6.08%,APPL2;PID1;GRB10;PRKCB
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.8033342323284296,-1.8445652374970236,0.0,0.049449011066442984,0.737,6/10,9.35%,CST3;FAP;NOTCH1;TGFB1;TNFRSF1B;DPP4
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.4972951439753126,-1.8391159676910498,0.0027247956403269754,0.05234355456360949,0.76,30/73,22.16%,ELMO1;ACTB;ACTG1;MYO10;RAC1;HSP90AA1;HSP90AB1;PTK2;PLCG2;DOCK1;FYN;NCKAP1;WIPF1;ARPC1B;ARPC3;NCK1;WIPF3;PAK1;CRK;ACTR2;PRKCE;ARPC4;CYFIP2;YES1;ARPC1A;PRKCD;NCKAP1L;MAPK3;ACTR3;ABI1
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.7516803519330625,1.8378692755014743,0.0,0.2526725667781346,0.959,4/15,8.32%,IGF1;ROCK2;PRKCA;CAMK2D
prerank,negative regulation of growth (GO:0045926),-0.45519672651436915,-1.8323937425987362,0.0,0.05573312897636784,0.794,33/121,10.67%,APBB2;SLIT2;PTPRJ;ACVRL1;TGFB2;ADAM15;MT1E;MT1F;MT1G;MT1B;MT1M;MT1A;MT1H;MT1X;NOTCH1;NDRG3;FHL1;SH3BP4;RACK1;BMPR2;SOX17;CCDC85B;CCN3;RERG;OSGIN2;TGFB1;MT2A;APBB1;SESN2;RTN4;ING4;CDKN1B;NDUFA13
prerank,modulation by symbiont of host process (GO:0044003),-0.7859709542150884,-1.8213849496430237,0.0018832391713747645,0.06376571353600843,0.84,7/10,15.15%,B2M;UBB;UBC;RPS27A;HGS;MRC1;UBA52
prerank,entry into host (GO:0044409),-0.7309844221046048,-1.8205592379111344,0.005649717514124294,0.06281453208521838,0.847,5/13,6.64%,CDH1;CBL;PPIA;CTNNB1;MET
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.6759170051183943,1.820109585078356,0.001976284584980237,0.30130306734670254,0.983,4/26,2.14%,EYA4;EYA1;EYA2;BCL2
prerank,hemidesmosome assembly (GO:0031581),-0.7633224790232879,-1.8169077991712235,0.0,0.06390068000723638,0.857,4/11,5.96%,ITGA6;ITGB4;PLEC;LAMA3
prerank,vasodilation (GO:0042311),-0.7378709771108314,-1.8162045687873862,0.005791505791505791,0.06275196648435362,0.859,7/13,12.59%,NOS3;KLF2;KCNMA1;SOD1;NOS1;GPER1;ADRB2
prerank,gene expression (GO:0010467),-0.3979822695585997,-1.8152600942944956,0.0,0.062124762588500096,0.861,128/348,20.10%,EEF1A1;PTMA;RPL37A;RPL41;RPL13;RPL11;RPS21;RPL27A;RPLP1;RPL17;RPL23;RPS24;RPL19;RPL21;HNRNPK;RPS9;ADARB1;RPL38;RPL6;RPS15;RPL37;RPL4;RPS8;RPS7;RPL8;RPS23;RPSA;RPS3;RPS19;ADARB2;RPS11;RPL34;RPL18A;RPL28;RPL26;RPL24;RPS29;RPS14;RPS12;RPS6;RPL23A;RPL18;SRSF2;RPS20;WARS1;MRRF;RPS18;RPS25;RPL3;RPL32;SARS1;SRSF1;RPL36;RPS27A;GALNT2;RPL5;RPL14;HNRNPU;RPS2;RPL27;RPS27;MRPL32;RPL29;RPL31;TSPAN17;RPLP0;DDX20;SRSF5;ADAR;DDX39B;RPL35A;RPLP2;EIF4G1;RPL7A;MRPS14;RPL7;RPS28;HHEX;RPS10;RPS17;CPSF3;SRSF9;RPL30;DDX54;RPS4X;BCL3;RBM8A;GSPT2;POLR2C;XAB2;DNAJB11;HSPD1;MRPS16;RNPS1;SRSF6;RSL24D1;NUP37;RPS26;RPS16;BICD1;RPS5;MRPL23;SYMPK;MRPS5;RPL13A;CLP1;AGFG1;PRPF4;POLR2G;RRBP1;NR4A2;CPSF2;NXT1;MRPL24;RPL36A;NUP54;RPL12;NUP85;SMG5;YTHDC1;RPL9;MRPL13;MRPL35;NUP133;RPL35;HNRNPUL1;MAGOH;THOC3
prerank,regulation of dendritic spine development (GO:0060998),-0.6662187922994339,-1.8143944559235066,0.00425531914893617,0.06119569254408134,0.863,12/19,26.97%,MEF2C;SHANK3;PPFIA2;GRIN3A;LLPH;KIF1A;CAMK2B;PSEN1;FMR1;SHANK1;FOXO6;CPEB3
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.5709225481728087,1.8137234018164814,0.0,0.3071389188025919,0.988,4/57,1.24%,IL31RA;IGF1;IL18;KIT
prerank,sodium ion transport (GO:0006814),0.5387350980182525,1.8112129437992557,0.0015600624024961,0.3007423867325592,0.989,12/85,3.87%,SCN7A;ATP1A2;SLC6A13;SLC24A3;SLC8A3;SLC5A5;SLC6A12;SLC6A9;NALCN;ATP1B3;SLC8A1;SLC6A1
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.491970808438603,-1.8079558161141123,0.0027548209366391185,0.06599827808666964,0.891,32/69,22.34%,COX4I1;COX6C;NDUFC2;NDUFA7;NDUFA5;NDUFA6;NDUFB5;NDUFA12;NDUFV1;NDUFB7;NDUFA4;UQCRH;COX6A1;NDUFA13;NDUFS1;COX7C;UQCR11;NDUFB11;SDHAF2;COX8A;NDUFB10;COX5A;NDUFA1;UQCRQ;UQCC3;COA6;UQCRC2;NDUFB4;NDUFS7;UQCRC1;CYCS;UQCR10
prerank,positive regulation of cell-substrate adhesion (GO:0010811),-0.49449931162515354,-1.8053819841994139,0.0,0.06701869737773923,0.894,24/67,14.01%,UTRN;FN1;LIMS2;VIT;RAC1;CARMIL1;DOCK1;PTK2B;FLNA;LIMS1;FERMT2;CALR;GSK3B;MYOC;ECM2;FBLN2;NPNT;EMP2;CRK;CDK6;CDH13;S100A10;NEDD9;JUP
prerank,neurotransmitter biosynthetic process (GO:0042136),0.7642966104102217,1.8019878103644114,0.0020920502092050207,0.3197628489398171,0.993,2/14,0.72%,MOXD1;SLC22A2
prerank,sodium ion transmembrane transport (GO:0035725),0.529166484407568,1.8008324981341157,0.003125,0.3092126356598454,0.993,11/84,3.87%,SCN7A;ATP1A2;SLC6A13;SLC24A3;SLC8A3;SLC6A12;SLC6A9;NALCN;ATP1B3;SLC8A1;SLC6A1
prerank,bone development (GO:0060348),0.5982596661392381,1.8000219398528887,0.0035211267605633804,0.29802431565038157,0.993,10/39,5.22%,CYP26B1;RANBP3L;FGFR2;GNAS;LTF;SH3PXD2B;LRRC17;SULF1;AKAP13;GJA1
prerank,stress-activated protein kinase signaling cascade (GO:0031098),-0.5998788835991212,-1.7977922734995515,0.0,0.07230192995179525,0.918,15/27,23.62%,MAP3K5;UBB;IKBKB;UBC;RPS27A;MAPK8;CHUK;MAP2K7;MAP3K8;CUL1;CCDC88C;UBA52;SKP1;MAPK3;MAPK11
prerank,cell projection organization (GO:0030030),-0.5826687181361876,-1.7951696294719015,0.006787330316742082,0.0732183927992291,0.93,7/30,4.23%,PARVB;RHOJ;RAC1;GSN;ITGB1;PACSIN2;NCKAP1
prerank,positive regulation of cell-substrate junction organization (GO:0150117),-0.6118203322533351,-1.7893920925103302,0.0,0.07756613155233091,0.944,12/24,12.15%,TEK;PTPRJ;KDR;RAC1;IQSEC1;LIMS1;FERMT2;MYOC;VEGFA;COL16A1;DUSP3;S100A10
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.5946054119188035,-1.7875101901542185,0.006263048016701462,0.07793810211552685,0.947,14/28,23.02%,OCLN;RAC1;RPS3;CLIP1;MET;PAK1;NAV3;GIT1;TOGARAM1;CKAP5;MAPRE1;DCTN1;NUMA1;HSPA1B
prerank,thyroid hormone generation (GO:0006590),0.7798255091364612,1.783152203344385,0.006382978723404255,0.34700029596933607,0.999,3/10,2.68%,CPQ;SLC5A5;DUOX2
prerank,positive regulation of biomineral tissue development (GO:0070169),0.6060262265100306,1.7825533218788554,0.0,0.3346818115781992,0.999,10/40,5.46%,BMP6;ADGRV1;OSR1;WNT4;WNT6;BMP7;FBN2;SLC8A1;KL;PTN
prerank,regulation of small molecule metabolic process (GO:0062012),0.6572669569861496,1.7798390285684131,0.0018450184501845018,0.3319623106886058,0.999,6/28,5.73%,RORA;PPARA;PRKN;PDK1;ACADL;EPHX2
prerank,aerobic electron transport chain (GO:0019646),-0.4867366537750434,-1.7780046050689209,0.00273224043715847,0.0862543938229619,0.96,31/68,22.34%,COX4I1;COX6C;NDUFC2;NDUFA7;NDUFA5;NDUFA6;NDUFB5;NDUFA12;NDUFV1;NDUFB7;NDUFA4;UQCRH;COX6A1;NDUFA13;NDUFS1;COX7C;UQCR11;NDUFB11;SDHAF2;COX8A;NDUFB10;COX5A;NDUFA1;UQCRQ;UQCC3;UQCRC2;NDUFB4;NDUFS7;UQCRC1;CYCS;UQCR10
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.7715885177917741,1.7752848096367528,0.008350730688935281,0.3358629225919227,0.999,3/13,3.59%,IGF1;SORBS1;IGF2
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.7229746060156594,-1.7739747711713258,0.0019646365422396855,0.0889609117238535,0.966,6/12,10.47%,ACTB;ACTG1;LAMA5;LAMA3;ZDHHC7;VANGL2
prerank,embryonic organ morphogenesis (GO:0048562),0.5934939489738086,1.7687976188693915,0.007220216606498195,0.3489517246760869,1.0,10/42,3.77%,EFEMP1;FBN1;FGFR2;HOXC4;RBP4;FBN2;HOXB4;HOXB3;HOXA3;PDGFRA
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.6720001682315558,1.768246517977231,0.005802707930367505,0.3389025404574884,1.0,4/24,3.59%,IGF1;SORBS1;PPP1R3G;IGF2
prerank,negative regulation of vascular permeability (GO:0043116),-0.729071723472141,-1.7672652316787252,0.001976284584980237,0.09504646599454493,0.972,10/12,7.98%,SLIT2;PTPRJ;CLDN5;PDE3A;RAMP2;FERMT2;CEACAM1;PDE2A;DDAH1;VEGFA
prerank,maintenance of blood-brain barrier (GO:0035633),-0.5821745679373288,-1.7665005792969777,0.0021141649048625794,0.09417675976975826,0.973,17/30,7.94%,SLC12A2;PECAM1;ACTB;CLDN5;ESAM;ACTG1;OCLN;TJP2;JAM2;LSR;ITGB1;MBP;F11R;SLC1A1;TJP1;WNK3;MFSD2A
prerank,positive regulation of dendritic spine development (GO:0060999),-0.628951100561453,-1.762749096570546,0.0019342359767891683,0.09675425276321697,0.979,12/20,26.97%,SHANK3;LRP8;LLPH;RELN;DBNL;CAMK2B;PSEN1;FMR1;DBN1;SHANK1;FOXO6;CPEB3
prerank,neurotransmitter uptake (GO:0001504),0.780392367577891,1.7599347980732718,0.0021008403361344537,0.3594345565418859,1.0,3/12,2.01%,ATP1A2;SLC22A2;SLC1A3
prerank,mesoderm development (GO:0007498),-0.6362178010957323,-1.7595752812063292,0.006024096385542169,0.0987804343014735,0.979,7/18,11.84%,TIE1;TBX1;BMX;TBX3;VEGFA;IKZF1;MESD
prerank,alpha-amino acid catabolic process (GO:1901606),0.6281974979843905,1.758959275821428,0.009523809523809525,0.35084714955526847,1.0,11/29,15.78%,DDO;ALDH4A1;ACADSB;CBS;FAH;HSD17B10;HOGA1;THNSL2;PRODH;AADAT;GSTZ1
prerank,regulation of protein localization to cell periphery (GO:1904375),-0.6564963682577369,-1.7584959604153554,0.004149377593360996,0.09828334254544277,0.979,8/18,9.08%,SPTBN1;ACTB;STX7;VAMP8;VTI1B;ZDHHC2;ZDHHC7;APPL1
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.5902105024912319,-1.7583984561294674,0.004201680672268907,0.09674303577294656,0.979,12/26,21.39%,OCLN;RAC1;RPS3;CLIP1;MET;STMN2;PAK1;NAV3;TOGARAM1;MAPRE1;DCTN1;NUMA1
prerank,glycerolipid catabolic process (GO:0046503),-0.6390807127395299,-1.7561988826386776,0.006097560975609756,0.09792723625001269,0.982,12/19,24.67%,GPCPD1;ABHD2;MGLL;SMPD4;GDPD1;GDPD3;LYPLA2;PNPLA6;PLA2G4A;ABHD6;PLA2G4F;PRDX6
prerank,leukocyte cell-cell adhesion (GO:0007159),-0.590668923403318,-1.755383407077673,0.004056795131845842,0.09711512437207327,0.983,8/24,14.53%,PECAM1;MSN;ITGB1;F11R;SEMA4D;ITGA4;GFUS;NT5E
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.7845087479327096,1.7545159585662369,0.008421052631578947,0.35807254191899096,1.0,3/12,3.59%,IGF1;SORBS1;IGF2
prerank,regulation of fatty acid oxidation (GO:0046320),0.723499335936415,1.7541411682334827,0.001996007984031936,0.3483750466621193,1.0,4/16,5.29%,PRKAG2;APPL2;PPARA;ACADL
prerank,endocardial cushion morphogenesis (GO:0003203),-0.6479118330837027,-1.7535622622017797,0.006237006237006237,0.09742950178611502,0.984,11/18,18.81%,NOS3;ACVRL1;TGFB2;ENG;NOTCH1;TGFBR2;TBX2;BMP2;HEYL;ACVR1;BMP4
prerank,chloride transport (GO:0006821),-0.4748608759839143,-1.7531555213834504,0.0,0.09643519045025271,0.984,20/74,11.51%,SLC4A10;SLC12A2;SLC12A7;SLC26A7;ANO1;ANO4;CLIC4;SLC12A6;SLC1A1;GABRB3;CLIC5;GABRB1;TTYH3;SLC12A8;SLC4A8;ANO3;LRRC8A;GABRG3;SLC12A4;SLC26A6
prerank,regulation of plasminogen activation (GO:0010755),-0.7163533977548154,-1.7495871509803786,0.0019455252918287938,0.09893352034614257,0.986,5/12,7.14%,THBS1;RUNX1;SERPINE2;PLGRKT;CLEC3B
prerank,sterol metabolic process (GO:0016125),0.5459812351469755,1.7493930772496742,0.0,0.3558654143362258,1.0,12/60,11.91%,PRKAG2;CYP26B1;CYP27A1;LIPA;INSIG2;ABCA1;FDXR;ABCA5;PMVK;SOAT2;RXRA;GBA2
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.7166257798688527,1.7369460066170204,0.007984031936127744,0.3929394795617331,1.0,3/16,1.96%,RORA;PRKN;PDK1
prerank,endocardial cushion development (GO:0003197),-0.6167817139380524,-1.735775230808601,0.002178649237472767,0.11464979960591985,0.992,13/21,24.13%,NOS3;ACVRL1;TGFB2;ENG;NOTCH1;BMPR2;TBX2;BMP2;HEYL;ACVR1;BMP4;HEY1;FOXF1
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.5509932549932376,-1.735420162448246,0.004347826086956522,0.1134020459431747,0.992,12/34,13.39%,LIMS2;RAC1;CARMIL1;DOCK1;FLNA;LIMS1;FERMT2;CALR;MYOC;CRK;S100A10;NEDD9
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.6970049176039559,-1.7349817243385437,0.005952380952380952,0.11229375697180818,0.992,7/13,20.64%,NOS3;HSP90AA1;CALM1;GCH1;QDPR;MTHFD1L;AKT1
prerank,establishment of endothelial barrier (GO:0061028),-0.5761536899297239,-1.7320134950412542,0.0043859649122807015,0.11467326915689521,0.994,12/29,11.74%,PECAM1;RAP1A;TJP2;PDE4D;MSN;F11R;PPP1R16B;ROBO4;TJP1;PDE2A;SOX18;RAB1A
prerank,bicarbonate transport (GO:0015701),-0.5924637577717844,-1.731705267282939,0.0041753653444676405,0.11333222208207676,0.994,10/25,15.12%,SLC4A10;SLC26A7;CA4;SLC39A8;SLC4A8;CA2;SLC4A2;SLC26A6;CYB5R1;CFTR
prerank,cellular amino acid catabolic process (GO:0009063),0.504757897985929,1.7300758353676493,0.0031847133757961785,0.41183158695320166,1.0,27/87,15.78%,DDO;ALDH4A1;ABAT;ACADSB;CBS;AASS;MCCC2;FAH;ALDH7A1;IVD;DBT;HSD17B10;BCKDHA;HOGA1;HMGCL;GCDH;ALDH6A1;BCKDHB;AUH;PIPOX;PRODH;SHMT1;HIBCH;AADAT;HMGCLL1;ASPA;GSTZ1
prerank,cellular protein metabolic process (GO:0044267),-0.3676658560043275,-1.7293189190426619,0.0,0.11520636432314066,0.994,139/396,16.13%,FN1;ST3GAL6;EEF1A1;ST8SIA4;IGFBP6;STK38;RPL37A;RPL41;ADAM10;RPL13;RPL11;RPS21;GAS6;RPL27A;RPLP1;CST3;RPL17;RPL23;SPARCL1;RPS24;RPL19;RPL21;RPS9;CDH2;RPL38;RPL6;RPS15;RPL37;RPL4;DAB2IP;RPS8;RPS7;SFTPA2;SFTPA1;RPL8;RPS23;RPSA;RPS3;RPS19;RPS11;RPL34;RPL18A;RPL28;MSLN;RPL26;DENND3;RPL24;RPS29;LGMN;RPS14;RPS12;RPS6;RPL23A;RPL18;RPS20;CKAP4;WARS1;SPP1;LAMB2;MRRF;RPS18;CHRM3;PDIA6;RPS25;FBXW2;RPL3;HSP90B1;RPL32;SARS1;IGFBP5;ADPRH;NEDD8;RPL36;RPS27A;LGALS1;RPL5;FAM20C;RPL14;PCMT1;APP;RPS2;RPL27;RPS27;PRSS23;MRPL32;RPL29;RPL31;CHEK2;ZDHHC2;MSRB3;NUCB1;RPLP0;RPL35A;MAN2B1;RPLP2;FURIN;EIF4G1;RPL7A;MRPS14;RPL7;RPS28;SCG2;MEN1;RPS10;RPS17;RPN1;RPL30;CHGB;FUCA2;RPS4X;LTBP1;CDKL3;GSPT2;STOML2;MMP15;IDE;PLOD2;ERO1A;CALU;CCN1;MRPS16;RSL24D1;RPS26;RPS16;VCAN;RPS5;MRPL23;MRPS5;RPL13A;UBA52;FBXL2;ST8SIA2;UBE2G1;WFS1;VGF;QPCT;RRBP1;ABCA3;DUSP12
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.5692149570965589,1.7289007380009616,0.0017667844522968198,0.4052221507767899,1.0,9/46,6.29%,ALDH1A1;NPR3;LGR4;RBPJ;ADAMTS5;NOVA1;MAP2K6;TLE3;NRDC
prerank,triglyceride homeostasis (GO:0070328),0.6367220202417055,1.7276650821762927,0.007285974499089253,0.39906738620134513,1.0,5/26,7.68%,RORA;C1QTNF3;IL18;APOC4;LIPC
prerank,response to cadmium ion (GO:0046686),-0.5969821758715816,-1.727654770750541,0.002197802197802198,0.11600461110124123,0.994,12/26,10.32%,MT1E;MT1F;MT1G;MT1B;MT1M;MT1A;MT1H;MT1X;MT2A;JUN;MAPK8;CHUK
prerank,positive regulation of bone mineralization (GO:0030501),0.6078065006942092,1.7272958088556898,0.003616636528028933,0.38982226271444387,1.0,10/35,5.46%,BMP6;ADGRV1;OSR1;WNT4;BMP7;FBN2;LTF;SLC8A1;KL;PTN
prerank,positive regulation of protein polymerization (GO:0032273),-0.4813165236948802,-1.721701407037413,0.0,0.12323754704346548,0.996,28/65,21.39%,OCLN;RAC1;HSP90AA1;CARMIL1;PTK2B;RPS3;CDC42EP3;CLIP1;NCKAP1;NCK1;MET;BAIAP2L1;PAK1;NAV3;NCK2;BIN1;TOGARAM1;CDC42EP5;TPPP;PRKCE;TPPP3;CDC42EP2;PINK1;EVL;NCKAP1L;MAPRE1;DCTN1;NUMA1
prerank,negative regulation of protein polymerization (GO:0032272),-0.568608976755578,-1.7211911714032546,0.004140786749482402,0.12214713317763007,0.996,13/27,20.56%,SLIT2;KANK3;KANK1;HIP1R;STMN2;CYRIB;SSH2;KANK4;SSH1;STMN1;TUBB4A;PRKCD;MAPRE1
prerank,neutrophil degranulation (GO:0043312),-0.36694483925119825,-1.71890224788327,0.0,0.12341488743240107,0.997,155/425,26.19%,PTPRB;PECAM1;PTPRJ;FTH1;EEF1A1;B2M;RAP1A;ATP8A1;ADGRE5;HSPA8;ADAM10;RAC1;HSP90AA1;CST3;IQGAP1;GSN;HSP90AB1;FTL;PRG2;MAGT1;OSTF1;EEF2;RAB31;PSAP;PPIA;PKM;PTPRN2;CD55;CTSD;RAB27A;PLEKHO2;ATG7;NRAS;CD93;CKAP4;AP2A2;ATP6V0A1;VAT1;PGLYRP1;ACTR10;CD44;DOCK2;CTSB;PTPRC;VAMP8;STOM;CEACAM1;NDUFC2;TNFRSF1B;PPIE;LAMP1;GOLGA7;TMC6;ATP11B;GRN;ERP44;PSMD13;HEXB;CPNE3;HMOX2;CD63;TMEM30A;APEH;PDAP1;MAN2B1;RHOA;SCAMP1;ATP6V0C;LAMTOR1;TUBB4B;ARL8A;HRNR;CAP1;TMBIM1;TOLLIP;FUCA2;IMPDH1;DBNL;STK10;SNAP25;ATP11A;PSMC3;DGAT1;LRG1;TCIRG1;SVIP;CD47;ALDOA;PSMD12;GDI2;JUP;CSNK2B;IMPDH2;LPCAT1;ACTR2;LAMTOR2;RHOG;CDA;GM2A;CYBB;CTSZ;QPCT;RNASE3;CYB5R3;MIF;ALDOC;BRI3;PRCP;DSP;S100A11;BST2;RAB37;ACLY;TIMP2;PLAUR;TYROBP;IRAG2;DDOST;PSEN1;PADI2;PRKCD;NCKAP1L;CD300A;SLC11A1;ENPP4;GCA;CTSC;CPPED1;ADGRG3;GHDC;VCP;MANBA;VAPA;HUWE1;HPSE;HSPA1B;SLC2A3;PYGL;RAB3A;RAB14;PRDX6;NPC2;ARSB;CD68;LCN2;SRP14;LTA4H;FABP5;RAB5B;RAB7A;CAT;PTAFR;C3;NAPRT;TRPM2
prerank,cellular response to cadmium ion (GO:0071276),-0.609474995795739,-1.7187935542101604,0.0,0.12183778303879425,0.997,12/24,10.32%,MT1E;MT1F;MT1G;MT1B;MT1M;MT1A;MT1H;MT1X;MT2A;JUN;MAPK8;CHUK
prerank,glycolipid metabolic process (GO:0006664),-0.5039556647789987,-1.717885231351279,0.009324009324009324,0.12124201748511991,0.997,12/47,10.76%,ST3GAL4;ST6GALNAC3;ST3GAL6;ESYT2;PSAP;SUMF1;SMPD4;HEXB;HEXA;ST8SIA6;CERK;GLTP
prerank,negative regulation of complement activation (GO:0045916),-0.7593380533386382,-1.717332724442752,0.0018975332068311196,0.12032352924201062,0.997,4/10,15.70%,CD55;SUSD4;A2M;CR2
prerank,positive regulation of tissue remodeling (GO:0034105),0.7682410349923892,1.714028954183805,0.004228329809725159,0.433724756413589,1.0,2/10,1.22%,ROCK2;IL18
prerank,positive regulation of stem cell differentiation (GO:2000738),0.7129489109121971,1.7134328292936403,0.02131782945736434,0.4259450178537575,1.0,4/16,5.46%,SOX5;HOXB4;SOX6;PTN
prerank,positive regulation of cell junction assembly (GO:1901890),-0.47594033304069283,-1.7121586174226675,0.0,0.12574596624091133,0.997,19/56,12.15%,TEK;CAV1;PTPRJ;CLDN5;KDR;RAC1;LIMS1;FERMT2;CLSTN2;MYOC;VEGFA;NRXN1;IL1RAP;SYNDIG1;COL16A1;EPHB1;ACE2;CLSTN3;S100A10
prerank,substantia nigra development (GO:0021762),-0.5286340267622485,-1.7120815551261699,0.0066815144766146995,0.12426286082062075,0.997,21/37,29.61%,ACTB;GNB4;CALM1;PLP1;MBP;NDRG2;RHOA;S100A1;INA;HSPA5;CKB;CALM2;YWHAQ;YWHAH;PADI2;CALM3;CNP;SYNGR3;SEC16A;ATP5PF;GLUD1
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.6988947515528883,1.7099389910186837,0.018255578093306288,0.4300159734486761,1.0,6/17,6.79%,BMP6;SASH1;LTF;TRIM5;CACTIN;PRKCA
prerank,acylglycerol homeostasis (GO:0055090),0.6536541085245352,1.7097446911136507,0.023985239852398525,0.42072139659781377,1.0,4/20,7.68%,RORA;IL18;APOC4;LIPC
prerank,neutrophil activation involved in immune response (GO:0002283),-0.3655469404871046,-1.7096198175935262,0.0,0.12605864871890057,0.997,155/428,26.19%,PTPRB;PECAM1;PTPRJ;FTH1;EEF1A1;B2M;RAP1A;ATP8A1;ADGRE5;HSPA8;ADAM10;RAC1;HSP90AA1;CST3;IQGAP1;GSN;HSP90AB1;FTL;PRG2;MAGT1;OSTF1;EEF2;RAB31;PSAP;PPIA;PKM;PTPRN2;CD55;CTSD;RAB27A;PLEKHO2;ATG7;NRAS;CD93;CKAP4;AP2A2;ATP6V0A1;VAT1;PGLYRP1;ACTR10;CD44;DOCK2;CTSB;PTPRC;VAMP8;STOM;CEACAM1;NDUFC2;TNFRSF1B;PPIE;LAMP1;GOLGA7;TMC6;ATP11B;GRN;ERP44;PSMD13;HEXB;CPNE3;HMOX2;CD63;TMEM30A;APEH;PDAP1;MAN2B1;RHOA;SCAMP1;ATP6V0C;LAMTOR1;TUBB4B;ARL8A;HRNR;CAP1;TMBIM1;TOLLIP;FUCA2;IMPDH1;DBNL;STK10;SNAP25;ATP11A;PSMC3;DGAT1;LRG1;TCIRG1;SVIP;CD47;ALDOA;PSMD12;GDI2;JUP;CSNK2B;IMPDH2;LPCAT1;ACTR2;LAMTOR2;RHOG;CDA;GM2A;CYBB;CTSZ;QPCT;RNASE3;CYB5R3;MIF;ALDOC;BRI3;PRCP;DSP;S100A11;BST2;RAB37;ACLY;TIMP2;PLAUR;TYROBP;IRAG2;DDOST;PSEN1;PADI2;PRKCD;NCKAP1L;CD300A;SLC11A1;ENPP4;GCA;CTSC;CPPED1;ADGRG3;GHDC;VCP;MANBA;VAPA;HUWE1;HPSE;HSPA1B;SLC2A3;PYGL;RAB3A;RAB14;PRDX6;NPC2;ARSB;CD68;LCN2;SRP14;LTA4H;FABP5;RAB5B;RAB7A;CAT;PTAFR;C3;NAPRT;TRPM2
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.6099876199734331,1.708537793699927,0.01444043321299639,0.41607074979509123,1.0,7/31,3.77%,OSR1;FGFR2;HOXC4;HOXB4;HOXB3;HOXA3;PDGFRA
prerank,regulation of Rac protein signal transduction (GO:0035020),0.7026445716813189,1.707393790723448,0.013779527559055118,0.4113857703322911,1.0,3/16,3.27%,ARHGAP24;AUTS2;ALS2
prerank,regulation of transforming growth factor beta production (GO:0071634),-0.6361095146382584,-1.706992775545312,0.005780346820809248,0.12824284198528674,0.997,7/18,11.96%,FN1;CD200;CD34;TGFB2;ITGB8;PTGS2;LTBP1
prerank,carnitine shuttle (GO:0006853),0.7683300434162407,1.705258049236973,0.012578616352201259,0.4109534751253715,1.0,3/11,5.67%,PRKAG2;PRKAA2;CPT2
prerank,regulation of cell-substrate adhesion (GO:0010810),-0.5151590198599426,-1.7037185260813532,0.004651162790697674,0.13158793229629664,0.998,17/42,13.62%,VIT;RAC1;ATXN3;PTK2;CORO2B;NOTCH1;MINK1;FZD4;LIMS1;CORO1C;ECM2;FBLN2;NPNT;EMP2;RHOA;GCNT2;SPOCK1
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.6436808827757641,1.703435696435291,0.013513513513513514,0.4086596395972132,1.0,4/22,8.32%,IGF1;ROCK2;PRKCA;CAMK2D
prerank,neuromuscular junction development (GO:0007528),0.6228562610801758,1.7018915369428353,0.019230769230769232,0.4056966104994125,1.0,9/24,8.75%,UNC13C;PDZRN3;LRP4;NEDD4;PPFIBP2;CACNB4;LRRK2;DNAJA3;MUSK
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.48043288600554057,-1.7001919854821743,0.0,0.1351787112487696,0.998,24/57,23.59%,RPL11;RPS24;RPL38;RPS15;RPS7;RPS19;RPL26;RPS6;RPS25;RPL5;RPL14;RPL35A;RPL7;RPS28;RPS17;DHX37;RBIS;RPS16;HEATR3;EBNA1BP2;NOC2L;WDR74;NOP16;NIP7
prerank,positive regulation of T cell proliferation (GO:0042102),0.5300500980702809,1.6983314868149046,0.006700167504187605,0.410496721110692,1.0,8/55,7.72%,IGF1;IGFBP2;IL18;ANXA1;IGF2;IL6;PDCD1LG2;CCL19
prerank,sphingolipid metabolic process (GO:0006665),-0.4250611840438452,-1.6963193908624628,0.002777777777777778,0.13918143730540664,0.998,31/108,15.59%,ST6GALNAC3;CERT1;ELOVL7;SGMS1;SGMS2;ACER3;ESYT2;ELOVL5;ACER2;SPTLC2;PLPP1;SERINC1;DEGS2;PSAP;KDSR;SUMF1;PRKD3;PPM1L;SPNS2;SMPD4;SGPL1;HEXB;HEXA;ELOVL6;CERK;GLTP;ELOVL1;CERS4;ORMDL2;PRKD1;GM2A
prerank,arachidonate transport (GO:1903963),0.7611091186681432,1.6948653705844559,0.018518518518518517,0.4074656263864268,1.0,3/10,5.50%,BDKRB2;ANXA1;ACE
prerank,arachidonic acid secretion (GO:0050482),0.7611091186681432,1.6948653705844559,0.018518518518518517,0.4074656263864268,1.0,3/10,5.50%,BDKRB2;ANXA1;ACE
prerank,macrophage differentiation (GO:0030225),0.7258934157055228,1.6935337389802998,0.007984031936127744,0.40440507268445425,1.0,3/13,7.99%,IL31RA;MMP9;CSF1
prerank,regulation of lipid biosynthetic process (GO:0046890),0.5989150620326333,1.6910006979970553,0.017013232514177693,0.4062964131169003,1.0,6/32,5.55%,PRKAG2;PPARA;SORBS1;ZBTB20;AVIL;PRKAA2
prerank,negative regulation of metabolic process (GO:0009892),0.5338174030151173,1.6904817017507259,0.005136986301369863,0.40070442975488335,1.0,9/54,6.29%,ALDH1A1;NPR3;LGR4;RBPJ;ADAMTS5;NOVA1;MAP2K6;TLE3;NRDC
prerank,diterpenoid metabolic process (GO:0016101),0.5329418880468747,1.687404598999271,0.0050335570469798654,0.40419601846983866,1.0,9/55,6.35%,ALDH1A1;RBP4;ABCA4;SDC2;GPC6;RBP1;GPC3;LRP2;NAPEPLD
prerank,negative regulation of signaling receptor activity (GO:2000272),0.625109692933315,1.6868387925116666,0.009689922480620155,0.3986981335329936,1.0,5/25,3.99%,ERRFI1;PPARA;SLC6A9;SNX6;CRHBP
prerank,ethanol metabolic process (GO:0006067),0.7348044554204894,1.6867934062386691,0.022222222222222223,0.3917072374657241,1.0,1/12,0.14%,ALDH1A1
prerank,embryonic heart tube morphogenesis (GO:0003143),-0.5002284979737678,-1.685051494528337,0.004914004914004914,0.15478995890540176,1.0,13/43,11.44%,MEF2C;MICAL2;ENG;NOTCH1;HES1;SOX17;TGFBR2;TBX2;TBX3;RYR2;VANGL2;SOX18;NDRG4
prerank,neutrophil mediated immunity (GO:0002446),-0.3598947245464856,-1.6847967530358963,0.0,0.1534687989331988,1.0,156/432,26.19%,PTPRB;PECAM1;PTPRJ;FTH1;EEF1A1;B2M;RAP1A;ATP8A1;ADGRE5;HSPA8;ADAM10;RAC1;HSP90AA1;CST3;IQGAP1;GSN;HSP90AB1;FTL;PRG2;MAGT1;OSTF1;EEF2;RAB31;PSAP;PPIA;PKM;PTPRN2;CD55;CTSD;RAB27A;PLEKHO2;ATG7;NRAS;CD93;CKAP4;AP2A2;ATP6V0A1;VAT1;PGLYRP1;ACTR10;CD44;DOCK2;CTSB;PTPRC;VAMP8;STOM;CEACAM1;NDUFC2;TNFRSF1B;PPIE;LAMP1;GOLGA7;TMC6;ATP11B;GRN;ERP44;PSMD13;HEXB;CPNE3;HMOX2;CD63;TMEM30A;APEH;PDAP1;MAN2B1;RHOA;SCAMP1;ATP6V0C;LAMTOR1;TUBB4B;ARL8A;HRNR;CAP1;TMBIM1;KMT2E;TOLLIP;FUCA2;IMPDH1;DBNL;STK10;SNAP25;ATP11A;PSMC3;DGAT1;LRG1;TCIRG1;SVIP;CD47;ALDOA;PSMD12;GDI2;JUP;CSNK2B;IMPDH2;LPCAT1;ACTR2;LAMTOR2;RHOG;CDA;GM2A;CYBB;CTSZ;QPCT;RNASE3;CYB5R3;MIF;ALDOC;BRI3;PRCP;DSP;S100A11;BST2;RAB37;ACLY;TIMP2;PLAUR;TYROBP;IRAG2;DDOST;PSEN1;PADI2;PRKCD;NCKAP1L;CD300A;SLC11A1;ENPP4;GCA;CTSC;CPPED1;ADGRG3;GHDC;VCP;MANBA;VAPA;HUWE1;HPSE;HSPA1B;SLC2A3;PYGL;RAB3A;RAB14;PRDX6;NPC2;ARSB;CD68;LCN2;SRP14;LTA4H;FABP5;RAB5B;RAB7A;CAT;PTAFR;C3;NAPRT;TRPM2
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.677600953874943,1.6840920331679434,0.018108651911468814,0.39473031018004145,1.0,4/16,8.32%,IGF1;ROCK2;PRKCA;CAMK2D
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.6804717603536875,-1.6829980843696775,0.0039447731755424065,0.15438874654161786,1.0,6/12,11.44%,PTPRJ;APOD;F3;CBL;HGS;NDRG4
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.5147029920346856,-1.682624891017064,0.009259259259259259,0.1531154225007456,1.0,16/38,19.18%,NDUFC2;NDUFA7;NDUFA5;NDUFA6;NDUFB5;NDUFA12;NDUFV1;NDUFB7;NDUFA4;NDUFA13;NDUFS1;NDUFB11;NDUFB10;NDUFA1;NDUFB4;NDUFS7
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.5238364169423774,-1.681838277660943,0.0070921985815602835,0.15236660076745834,1.0,17/35,11.12%,SEMA6A;SEMA7A;NRP2;SEMA6D;RAC1;SEMA3C;PLXND1;SEMA4D;PLXNA4;SEMA3E;FLNA;ARHGDIA;MET;SEMA4B;SEMA5B;SEMA6C;SEMA3G
prerank,macrophage activation involved in immune response (GO:0002281),-0.6798758234607557,-1.6814578126577748,0.005494505494505495,0.15121999533514116,1.0,8/13,19.60%,PLCG2;LBP;SBNO2;GRN;DYSF;IFI35;CX3CR1;TYROBP
prerank,positive regulation of regulated secretory pathway (GO:1903307),-0.6329785595111385,-1.6782496714367838,0.007633587786259542,0.15439770364891636,1.0,9/17,15.43%,RAB27A;KCNB1;STX1A;CACNA1G;SLC4A8;CACNA1H;SYT10;SYT4;CACNA1I
prerank,negative regulation of axon extension (GO:0030517),-0.5497537005778133,-1.6782451001801164,0.009280742459396751,0.15270102558684034,1.0,13/30,13.88%,SEMA6A;SEMA7A;SEMA6D;SEMA3C;SEMA4D;SEMA3E;SEMA4B;SEMA5B;RTN4;SEMA6C;SEMA3G;CDKL3;MT3
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.7041185305291181,-1.6771626189194986,0.017077798861480076,0.15271852240683595,1.0,4/11,4.37%,NOS3;HSP90AA1;CALM1;GCH1
prerank,positive regulation of supramolecular fiber organization (GO:1902905),-0.439426322936834,-1.6748911757622391,0.0,0.1547556057957986,1.0,32/86,21.39%,OCLN;RAC1;CARMIL1;PTK2B;RPS3;CDC42EP3;CLIP1;NCKAP1;WDR1;NCK1;MET;BAIAP2L1;STMN2;APP;PAK1;COLGALT1;EDN1;NAV3;NCK2;BIN1;CLU;TOGARAM1;CDC42EP5;PRKCE;CFL2;CDC42EP2;EVL;PSEN1;NCKAP1L;MAPRE1;DCTN1;NUMA1
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.6662885954038515,1.6746258803589615,0.01383399209486166,0.42292358033766286,1.0,5/17,9.58%,IGF1;PDGFRB;CCN4;VTN;FGF9
prerank,secretion (GO:0046903),0.7181081067786124,1.6727721907991802,0.021526418786692758,0.423131319800013,1.0,3/14,1.78%,SLC22A4;SLC22A2;FBLN5
prerank,acylglycerol metabolic process (GO:0006639),-0.510829717028829,-1.67104297570928,0.008888888888888889,0.15912848255432135,1.0,10/37,12.43%,ABHD2;CAV1;DGKH;MGLL;DGKB;DGKI;LYPLA2;DGKZ;DGKG;DGAT1
prerank,regulation of axon extension involved in axon guidance (GO:0048841),-0.570728673882605,-1.6703165137691756,0.011086474501108648,0.15846570547177194,1.0,11/24,11.12%,SEMA6A;SEMA7A;SEMA6D;SEMA3C;SEMA4D;SEMA3E;VEGFA;SEMA4B;SEMA5B;SEMA6C;SEMA3G
prerank,regulation of cell junction assembly (GO:1901888),-0.5546614795142473,-1.670057286602216,0.0020964360587002098,0.15721104798141824,1.0,8/27,2.98%,MEF2C;PRKCH;CLDN5;RAP1A;OCLN;CBFB;RUNX1;F11R
prerank,cellular glucan metabolic process (GO:0006073),0.731673716544932,1.6691908771616246,0.030864197530864196,0.4296991604401647,1.0,2/11,1.73%,PRKAG2;PHKB
prerank,zinc ion homeostasis (GO:0055069),-0.55533352481605,-1.6683347495518663,0.008438818565400843,0.15834545262596353,1.0,14/28,9.85%,SLC39A10;MT1E;MT1F;MT1G;MT1B;MT1M;MT1A;MT1H;MT1X;SLC30A5;MT2A;SLC39A8;SLC39A7;SLC30A1
prerank,mesenchyme morphogenesis (GO:0072132),-0.630216489973052,-1.6678395190298907,0.010330578512396695,0.1576310837592603,1.0,8/17,12.27%,NOS3;ACVRL1;TGFB2;ENG;NOTCH1;TBX2;BMP2;HEYL
prerank,membrane lipid biosynthetic process (GO:0046467),-0.4679367015249561,-1.6676865686109512,0.002347417840375587,0.15624215853862627,1.0,18/58,9.60%,ST3GAL4;CERT1;ELOVL7;SGMS1;SGMS2;ACER3;ELOVL5;ACER2;SPTLC2;PLPP1;DEGS2;KDSR;PRKD3;PPM1L;SPNS2;SGPL1;ST8SIA6;ELOVL6
prerank,negative regulation of response to stimulus (GO:0048585),-0.46280278673216,-1.6675303846181158,0.005037783375314861,0.1549033756967566,1.0,27/60,22.02%,SLIT2;KLF7;CD34;KLF4;MCTP1;HHIP;VPS13C;UBASH3B;SOCS5;KIF26A;DDAH1;AQP11;YBX1;LPCAT3;CDK6;TLE5;PTPN1;MAP3K3;CLU;NR1H2;CASK;WFS1;ACVR1;SH2B3;COL3A1;THY1;NR1H3
prerank,limb development (GO:0060173),0.593339622192667,1.6657919540491999,0.01092896174863388,0.4352540606016255,1.0,7/28,6.50%,LRP4;DKK1;INTU;SMOC1;GLI3;ZNRF3;SALL1
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.6940750569070152,1.6650682400253443,0.010121457489878543,0.4309658808096427,1.0,4/16,0.99%,IGF1;TGFBR3;RBPJ;FGFR2
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.731098360725234,1.6647151735113646,0.015968063872255488,0.425526699108415,1.0,6/12,9.77%,DPYD;DPYSL3;CTPS1;CTPS2;DPYS;ALDH6A1
prerank,positive regulation of nuclear division (GO:0051785),0.6147831550964327,1.663561089292418,0.022770398481973434,0.4234532057120297,1.0,4/25,3.59%,IGF1;DMRT1;PDGFRB;IGF2
prerank,body fluid secretion (GO:0007589),0.6908831476955489,1.6613338685627266,0.026052104208416832,0.42478412145396083,1.0,2/15,0.72%,SLC22A4;SLC22A2
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),0.7404973352680374,1.6597665735804847,0.021052631578947368,0.42391778085709764,1.0,4/11,10.32%,IGF1;PLCB1;IGF1R;PIK3R1
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.6421913748251968,1.6573219378005184,0.03275529865125241,0.4263585338580513,1.0,2/20,6.39%,IGF1;NIBAN2
prerank,regulation of catabolic process (GO:0009894),-0.6217013777841665,-1.6571904362787464,0.014256619144602852,0.17068507469282462,1.0,9/18,11.24%,NEDD4L;FAP;ITGB1;FAF1;CHEK2;ZDHHC2;ZDHHC7;FURIN;HGS
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.6794718116526456,-1.656054699899588,0.009380863039399626,0.1712261536757552,1.0,7/13,15.43%,KCNB1;STX1A;CACNA1G;CACNA1H;SYT10;SYT4;CACNA1I
prerank,myoblast differentiation (GO:0045445),0.6936266147865129,1.6521869464831411,0.03024193548387097,0.4392479325246498,1.0,3/14,1.07%,IGF1;TCF7L2;EPAS1
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.5977437834047596,-1.651584305745735,0.006493506493506494,0.17729341361015571,1.0,10/20,11.12%,SEMA6A;SEMA7A;SEMA6D;SEMA3C;SEMA4D;SEMA3E;SEMA4B;SEMA5B;SEMA6C;SEMA3G
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.6426250782278141,1.6510595527126841,0.015779092702169626,0.4306494948206095,1.0,5/20,7.98%,IGF1;ZBTB20;PRKAA2;PRKAA1;ARNT
prerank,positive regulation of glycolytic process (GO:0045821),0.6426250782278141,1.6510595527126841,0.015779092702169626,0.4306494948206095,1.0,5/20,7.98%,IGF1;ZBTB20;PRKAA2;PRKAA1;ARNT
prerank,dicarboxylic acid transport (GO:0006835),0.5934585404495979,1.6502830592103426,0.02495201535508637,0.42736313199696085,1.0,12/28,10.50%,SLC13A3;SLC1A3;PDPN;SLC25A18;GJA1;SLC13A5;FOLR1;FOLR2;ABCC2;SLC25A22;SLC19A1;SLC22A6
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.7124913167355744,-1.6488431659895693,0.01556420233463035,0.180685052153657,1.0,5/10,11.44%,PTPRJ;APOD;PTPN12;HGS;NDRG4
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.449721656432983,-1.64867742450258,0.00273224043715847,0.17929437551643235,1.0,23/73,16.59%,NTRK3;CAV1;FNIP2;TFRC;BCAR3;GAS6;HSP90AA1;HSP90AB1;NGF;MTCP1;TGFB1;CD44;APP;VEGFA;PDCD10;PAK1;EIF4G1;NOS1;TERF2IP;PRKD1;RAF1;MIF;TNKS1BP1
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.7727502642482833,1.646121521436272,0.020491803278688523,0.43779559461818285,1.0,5/10,8.32%,ATP1A2;OSR1;NEDD4;PCSK9;CAMK2D
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.5339247208537107,-1.6458225855670698,0.0044742729306487695,0.18253984989673758,1.0,16/32,12.68%,RHOJ;KDR;THBS1;KLF4;MEOX2;NOTCH1;GATA2;HDAC5;JCAD;CARD10;VEGFA;PDCD10;PTGS2;RHOA;PIK3C2A;MAP3K3
prerank,primary alcohol metabolic process (GO:0034308),0.6058598722853564,1.6439153485204152,0.025896414342629483,0.4404504076883055,1.0,3/25,6.35%,IGF1;RBP4;NAPEPLD
prerank,ketone body metabolic process (GO:1902224),0.7536525480086743,1.6432003792990206,0.017316017316017316,0.43731093819238803,1.0,7/10,16.96%,ACSS3;HMGCL;BDH1;BDH2;HMGCLL1;OXCT1;HMGCS2
prerank,membrane organization (GO:0061024),-0.37162125893238734,-1.6423551038603343,0.0,0.1873967265766003,1.0,87/227,24.47%,DNM3;SPTBN1;CERT1;HIP1;SGIP1;ACTB;ACTG1;HSPA8;SH3KBP1;TFRC;FNBP1L;CBL;REEP3;STON2;REEP1;UBB;REPS2;SH3GLB1;FNBP1;FZD4;PACSIN2;CHMP5;SYNJ1;CHMP2B;CORO1C;AP2A2;ARPC3;CCDC88A;ATP2C1;VAMP8;VTI1B;ARRB1;UBC;RPS27A;HIP1R;CHP1;DNM2;LEMD2;DYSF;AP2M1;AMPH;TOR1B;PIK3C2A;LPCAT3;GLTP;NECAP1;HGS;NSFL1C;TMEM43;EPN2;BIN1;ADRB2;DNM1;PICK1;PIP5K1C;ACTR2;M6PR;CFTR;UBA52;AGFG1;SGCZ;TLCD2;DVL2;CHMP1B;ARPC4;SH3GL2;SYT2;AP2B1;ARRB2;SUN1;ANK3;ARPC1A;CTDNEP1;CHMP1A;ACTR3;GCA;CHRNB1;AP2A1;VAPA;MFN2;HUWE1;CHMP3;TIMM50;CHMP7;SYP;PDCD6IP;OTOF
prerank,chloride transmembrane transport (GO:1902476),-0.48376145130302073,-1.6414032867621353,0.009111617312072893,0.18744239873259713,1.0,17/48,15.81%,SLC12A2;SLC12A7;ANO1;ANO4;SLC12A6;SLC1A1;GABRB3;GABRB1;SLC12A8;SLC4A8;ANO3;LRRC8A;GABRG3;SLC12A4;ANO2;CFTR;GLRA3
prerank,monocarboxylic acid metabolic process (GO:0032787),0.46415041426259473,1.6394925186234357,0.0030303030303030303,0.4451031583007106,1.0,14/117,7.04%,IGF1;CYP26B1;ALDH1A2;PCCA;PPARA;ALDH4A1;ABAT;ACADSB;MCCC2;ACOT4;SCPEP1;ECHDC3;PTGR1;HOGA1
prerank,embryonic skeletal system development (GO:0048706),0.5640976201075696,1.6391773376176957,0.01845018450184502,0.4403253598242161,1.0,9/35,6.15%,OSR1;HOXC4;RBP4;HOXB4;HOXB3;HOXA3;PDGFRA;SULF1;SLC2A10
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.4344229230400526,-1.6386572306773954,0.0,0.19066741683482052,1.0,33/91,9.95%,ABCG2;FTH1;SLC39A10;TFRC;SCARA5;FTL;MT1E;MT1F;MT1G;MT1B;MT1M;MT1A;MT1H;MT1X;ATOX1;IREB2;SLC40A1;SLC30A5;SOD1;NEDD8;MT2A;SLC31A1;SLC22A17;ARF1;SLC39A8;APP;ISCU;HMOX2;FBXL5;ATP6V1A;SLC39A7;SLC30A1;FRRS1
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.42022720057345364,1.6385779096277624,0.0,0.4367598738085216,1.0,44/248,10.34%,BICC1;IGFBP2;RNF220;WLS;LRRK1;TCF7L2;PTK7;LGR4;FGFR2;MCC;ZEB2;PRKN;LRP4;DAB2;DKK3;RBMS3;DKK1;TBL1XR1;IGFBP4;PRICKLE1;LYPD6;INVS;LRRK2;GLI3;TMEM64;TLE3;ZNRF3;GPC3;FRAT1;PSME4;GNAQ;PSMA2;PSMA3;FOLR1;SIAH2;TLE1;AMFR;USP34;AXIN2;SMURF2;PSMD8;HDAC1;LATS1;DVL3
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.6727672327938184,-1.637771284048662,0.011764705882352941,0.18875311429144553,1.0,7/12,14.48%,EFNA5;ACTN4;KANK1;CORO1C;AP1AR;SPRY4;RCC2
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.6727672327938184,-1.637771284048662,0.011764705882352941,0.18875311429144553,1.0,7/12,14.48%,EFNA5;ACTN4;KANK1;CORO1C;AP1AR;SPRY4;RCC2
prerank,cardiac myofibril assembly (GO:0055003),0.6881280603553492,1.637507039303151,0.0234375,0.434972286873072,1.0,5/15,4.14%,CSRP3;PDGFRB;OBSL1;PDGFRA;NEBL
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.5080229192695881,-1.6369173843215956,0.002380952380952381,0.188545431754935,1.0,16/37,22.20%,RPL11;HSP90AB1;RPL23;RPS7;UCHL5;UBXN1;PDCL3;BAG6;RPL5;CAMLG;OGT;RYBP;N4BP1;NOP53;TLK2;MAP1A
prerank,monocarboxylic acid catabolic process (GO:0072329),0.6129759994760253,1.6369078006763709,0.028089887640449437,0.4316332566840478,1.0,4/21,7.04%,CYP26B1;CEL;FAH;HOGA1
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.7162439179961048,1.6366556838539263,0.023206751054852322,0.4217876525451066,1.0,2/12,4.92%,IGF1;CAMTA1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.7162439179961048,1.6366556838539263,0.023206751054852322,0.4217876525451066,1.0,2/12,4.92%,IGF1;CAMTA1
prerank,aspartate family amino acid catabolic process (GO:0009068),0.6445076535684972,1.634794615029892,0.03155818540433925,0.4228629583547705,1.0,7/19,15.41%,DDO;AASS;ALDH7A1;GCDH;PIPOX;AADAT;ASPA
prerank,positive regulation of ossification (GO:0045778),0.556686058971798,1.6325149711368103,0.01391304347826087,0.42646336091448317,1.0,9/39,5.46%,BMP6;ADGRV1;OSR1;WNT4;BMP7;FBN2;SLC8A1;KL;PTN
prerank,regulation of chondrocyte differentiation (GO:0032330),0.623695129131388,1.6315162745490497,0.02033271719038817,0.424883131807888,1.0,5/24,5.39%,SOX5;ADAMTS12;EFEMP1;SOX6;ADAMTS7
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.5989859917700983,-1.6306702780127222,0.013565891472868217,0.19881088477838652,1.0,10/18,27.64%,JAM2;ITGB1;ITGA4;ADD2;SLC39A8;CX3CR1;PODXL2;SELPLG;SELP;ITGB7
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.6482102971189481,-1.6306340696420245,0.007766990291262136,0.19714539938331876,1.0,5/14,9.89%,GAB1;KDR;FLT4;VEGFA;PIK3CD
prerank,mesonephros development (GO:0001823),0.7365742271344454,1.6303749984333586,0.024390243902439025,0.423954880619128,1.0,3/11,5.81%,OSR1;BMP7;FGF1
prerank,regulation of Wnt signaling pathway (GO:0030111),0.4637134739617968,1.6292425056961668,0.0030257186081694403,0.42336251697687555,1.0,23/108,8.15%,DCDC2;WLS;PTK7;TRABD2B;FGFR2;RNF43;WWOX;PRKN;DKK1;GRB10;MACF1;VGLL4;CBY1;SULF1;LRRK2;ITGA3;GPC3;APCDD1;TCF7L1;GNAQ;SALL1;FOLR1;TLE1
prerank,regulation of macrophage cytokine production (GO:0010935),-0.6500706894507304,-1.6290231586847916,0.015503875968992248,0.1987370555971871,1.0,7/13,16.01%,SEMA7A;TGFB2;PLCG2;TGFB1;CD74;IRAK3;LAPTM5
prerank,regulation of urine volume (GO:0035809),0.7483212244834442,1.628800210419635,0.02813852813852814,0.41979081307590244,1.0,4/10,11.32%,NPR3;ADM;NPR1;TFAP2B
prerank,regulation of sequestering of triglyceride (GO:0010889),0.6751556246128557,1.6284424028750317,0.03024193548387097,0.4162900456928976,1.0,3/15,5.08%,OSBPL8;PPARA;APOC4
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.6131400359841167,1.6263329274691949,0.01730769230769231,0.41858774201194693,1.0,5/23,7.98%,IGF1;ZBTB20;PRKAA2;PRKAA1;ARNT
prerank,cardiac muscle contraction (GO:0060048),0.5722767193701052,1.625349172120128,0.017889087656529516,0.416839970700858,1.0,7/34,3.10%,ATP1A2;TPM1;DMD;CSRP3;TNNC1;TNNT2;SLC8A1
prerank,modified amino acid transport (GO:0072337),0.6801031737641849,1.6251674419497169,0.025,0.41294248312426507,1.0,6/15,10.46%,SLC6A13;SLC16A12;PDPN;FOLR1;FOLR2;SLC19A1
prerank,neurotransmitter secretion (GO:0007269),-0.48846143389946106,-1.6248083511972227,0.004338394793926247,0.2050825115653087,1.0,24/44,31.96%,HSPA8;LIN7A;PTPRN2;STX1A;NRXN1;PCLO;SYT10;GAD1;SNAP25;CPLX2;SYN2;PIP5K1C;CDK5;PPFIA3;RAB3A;OTOF;CPLX1;SNAPIN;RIMS2;SNPH;SLC32A1;SYT1;GRM4;SYN1
prerank,negative regulation of cell development (GO:0010721),0.6107325997326768,1.6246484538036112,0.013409961685823755,0.41001113092831976,1.0,4/25,2.80%,IGF1;FBN1;APPL2;LTF
prerank,cellular response to sterol (GO:0036315),0.6806326228282337,1.6242146159648994,0.0465587044534413,0.40707500179524253,1.0,3/13,3.73%,RORA;INSIG2;GRAMD1C
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.587079911430822,1.6238094485663723,0.02486678507992895,0.40411507809067077,1.0,5/29,2.69%,TGFBR3;FGFR2;TPM1;TNNC1;TNNT2
prerank,cell junction assembly (GO:0034329),-0.4211396541015076,-1.622970879600431,0.0,0.20692318102040147,1.0,25/100,8.05%,DNM3;FN1;SHANK3;SPOCK2;ACTB;ADGRL3;CLDN5;ACTG1;ITGA6;LIMS2;PKP4;CDH1;CTNND2;PLXND1;CDH11;CDH2;GJC1;KIRREL3;FLNA;LIMS1;NRCAM;FERMT2;TJP1;VMP1;NRXN1
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.6692998018227494,-1.6225867555546671,0.019011406844106463,0.20587083486854324,1.0,4/12,3.16%,CAV1;PDE4D;CALM1;GJD3
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.5806363596963104,1.6201583814771565,0.014545454545454545,0.41196301017036185,1.0,7/31,5.93%,TGFBR3;RBPJ;FGFR2;TPM1;TNNC1;TNNT2;LRP2
prerank,regulation of receptor binding (GO:1900120),-0.7094459770058134,-1.6186221979311752,0.0225140712945591,0.21257896195695405,1.0,4/10,8.02%,B2M;ADAM15;ATP2A3;ATP2A2
prerank,retina homeostasis (GO:0001895),-0.5541600777739545,-1.6185564938707826,0.020703933747412008,0.2109286082600509,1.0,6/23,6.04%,ACTB;POTEF;B2M;ACTG1;HSPB1;SOD1
prerank,cellular response to fluid shear stress (GO:0071498),-0.6756527290443676,-1.6180142145138143,0.01727447216890595,0.21039600304305342,1.0,4/12,2.99%,MEF2C;KLF2;KLF4;SREBF2
prerank,positive regulation of protein secretion (GO:0050714),0.4862894477991528,1.6179745438790434,0.01867572156196944,0.41492660936265247,1.0,8/69,2.26%,IGF1;BMP6;WLS;TCF7L2;C1QTNF3;RBP4;FRMD4A;NLGN2
prerank,regulation of bone mineralization (GO:0030500),0.5128736212005413,1.6169547130498592,0.009900990099009901,0.41392789132716545,1.0,13/55,7.11%,BMP6;ADGRV1;OSR1;WNT4;BMP7;FBN2;BMP2K;SLC8A1;KL;ECM1;PTN;BCOR;DDR2
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.6775836317253816,1.6152599592636139,0.018,0.4155238244945105,1.0,3/16,3.66%,IGF1;IGFBP2;IGFBP4
prerank,regulation of cell-matrix adhesion (GO:0001952),-0.4388361717441915,-1.6149857687138012,0.012594458438287154,0.21456487646405953,1.0,25/64,11.67%,UTRN;LIMCH1;EFNA5;ACTG1;ACER2;THBS1;JAG1;ADAM15;PTK2;SLK;PTK2B;MINK1;SEMA3E;CORO1C;NEXMIF;GSK3B;MYOC;EMP2;GPM6B;AJAP1;RHOA;PEAK1;CDK6;DUSP3;CDH13
prerank,regulation of B cell receptor signaling pathway (GO:0050855),-0.5646464862839214,-1.614875543286979,0.027837259100642397,0.21309317674912803,1.0,5/21,2.60%,PRKCH;FOXP1;SLC39A10;CBFB;RUNX1
prerank,positive regulation of DNA metabolic process (GO:0051054),0.5080122485665727,1.6132486032306157,0.014218009478672985,0.4182251355533457,1.0,18/61,16.58%,EYA4;EYA1;EYA2;FGFR4;SMOC2;PDGFRB;USP7;STPG4;CEBPG;NPAS2;PRKD2;RTEL1;MRE11;BABAM2;WRN;RAD51;PML;HGF
prerank,ganglion development (GO:0061548),-0.6841696638983851,-1.6129207584894714,0.02390438247011952,0.2153875560037672,1.0,4/11,6.03%,NRP2;UNC5C;TUBB3;CTNNB1
prerank,T cell migration (GO:0072678),-0.6416515104663423,-1.61266689116549,0.024299065420560748,0.2141564607914735,1.0,4/13,9.89%,SLC12A2;MSN;S1PR1;PIK3CD
prerank,cardiac muscle tissue development (GO:0048738),0.5237769942794755,1.6122303415816253,0.023529411764705882,0.4173765628145418,1.0,13/50,9.06%,ADAMTS9;GJB6;NOTCH2;BMP7;RBP4;CSRP3;CBY1;AKAP13;SIK1;GJA1;MAML1;NDUFV2;KDM6B
prerank,skeletal system development (GO:0001501),0.43599505129046756,1.611291264099259,0.0014925373134328358,0.41640206173856764,1.0,25/148,7.97%,IGF1;SOX5;BMP6;NPR3;FBN1;FGFR2;BMP7;RBP4;WWOX;GNAS;COL9A2;SOX6;COL1A2;IGF2;SH3PXD2B;COL13A1;SULF1;AKAP13;PRELP;GJA1;ANKRD11;SUFU;EN1;EXTL1;DYM
prerank,heart looping (GO:0001947),-0.49173183373752943,-1.6109484485978927,0.011933174224343675,0.21575814017361125,1.0,11/39,11.44%,MEF2C;MICAL2;ENG;NOTCH1;SOX17;TGFBR2;TBX2;TBX3;VANGL2;SOX18;NDRG4
prerank,regulation of mitotic nuclear division (GO:0007088),0.5165710285833202,1.6109421607412429,0.013333333333333334,0.4136093469786572,1.0,11/55,10.39%,IGF1;BMP7;DMRT1;PDGFRB;IGF2;OBSL1;TOM1L2;CCDC8;CUL9;CUL7;PHIP
prerank,lipid phosphorylation (GO:0046834),-0.6947380943986996,-1.6107595234190226,0.016853932584269662,0.21448188157731496,1.0,7/10,23.52%,DGKH;DGKB;DGKI;DGKZ;DGKG;DGKQ;DGKE
prerank,cellular response to organonitrogen compound (GO:0071417),-0.4065885575924125,-1.6100338606278422,0.0,0.2143699659044245,1.0,42/99,25.22%,MEF2C;SLIT2;ACTB;RAP1A;PDE3A;CDH1;SH3BP4;GABRB3;GABRB1;CTNNB1;HSP90B1;IGFBP5;CAPN2;PDE2A;KCNQ1;AHR;MTOR;SESN2;SSH1;LAMTOR1;XBP1;CPEB1;SLC26A6;SPAAR;ZFP36L1;HCN1;JUP;HRH1;LAMTOR2;CFTR;RRAGB;HCN2;NR1H4;CTNNA1;TSHR;NSMF;LAMTOR4;RELA;GABRG2;P2RY12;EZR;GLRA1
prerank,positive regulation of glucose import (GO:0046326),0.6233790614212129,1.609537299528028,0.03792415169660679,0.41438736140570204,1.0,3/21,2.20%,IGF1;OSBPL8;SORBS1
prerank,regulation of osteoblast differentiation (GO:0045667),0.481332886045453,1.6094289546490037,0.006299212598425197,0.410775394002683,1.0,15/82,7.11%,IGF1;RANBP3L;BMP6;WNT4;FGFR2;BMP7;FBN2;SMAD6;LTF;CCN4;SMOC1;TMEM64;SUFU;IL6;DDR2
prerank,regulation of epithelial cell proliferation (GO:0050678),0.47061454378187495,1.6093925101595319,0.007587253414264037,0.40699196085323897,1.0,8/85,1.29%,IGF1;TGFBR3;BMP6;TCF7L2;OSR1;FGFR2;MCC;ANGPT1
prerank,lipid oxidation (GO:0034440),-0.6660753789246902,-1.6083315155321536,0.0186219739292365,0.21591540551373645,1.0,3/12,12.65%,ADIPOR2;PPARGC1A;ALOX12
prerank,myotube differentiation (GO:0014902),0.6383985274357906,1.6082797272649227,0.02636916835699797,0.4068243904995169,1.0,4/17,2.19%,IGF1;ADAM12;ADAMTS5;ADAMTS15
prerank,mesenchymal cell differentiation (GO:0048762),0.5133904452188492,1.6063253827850406,0.00859106529209622,0.408874545573472,1.0,8/51,2.93%,RANBP3L;TGFBR3;ROCK2;WNT4;RBPJ;FGFR2;BMP7;LOXL3
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.6874284141844771,-1.6059614657955728,0.023076923076923078,0.219105758215298,1.0,4/11,9.45%,CD200;CD34;THBS1;PTGS2
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.5738511267227733,-1.6057816835653125,0.015717092337917484,0.21774048505207425,1.0,8/19,6.57%,PRKCH;CLDN5;OCLN;CBFB;RUNX1;F11R;IKBKB;TJP1
prerank,smooth muscle cell differentiation (GO:0051145),-0.6652972883240844,-1.6040981845716926,0.007905138339920948,0.21934386310131485,1.0,7/12,22.63%,MEF2C;MRTFB;HEY2;TMEM204;APLNR;BMP4;HEY1
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.7205471570554035,1.6040545325330973,0.03469387755102041,0.4118127566507047,1.0,2/10,2.82%,SOX5;SOX6
prerank,maturation of SSU-rRNA (GO:0030490),-0.4933646248459902,-1.6039715959319245,0.019823788546255508,0.21792166285525033,1.0,14/34,23.20%,RPS8;RPS19;RPS14;DCAF13;DDX52;BMS1;RPS28;DHX37;WDR3;RPS16;TSR3;PWP2;TSR1;MRPS11
prerank,liver development (GO:0001889),0.5605377266256408,1.6024484335067783,0.023593466424682397,0.4130769192011571,1.0,10/32,11.59%,TGFBR3;WNT4;ARID5B;ANXA1;PRKCSH;PCSK9;IL6;CEBPG;COBL;PKD2
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.6856202655744781,1.601549213117979,0.03680981595092025,0.4119509394343902,1.0,9/13,21.82%,SORBS1;IGF2;PRKCZ;ECHDC3;GKAP1;PTPN11;C1QTNF12;IRS1;SNX5
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.724677400311917,1.6014866578271203,0.06339468302658487,0.4084182451408933,1.0,5/10,9.57%,IVD;ACADL;ACAD11;ACADS;GCDH
prerank,receptor internalization (GO:0031623),-0.480670472615105,-1.6011970134662241,0.004796163069544364,0.22191138456478784,1.0,15/44,12.71%,DNM3;CAV1;TFRC;CD9;ITGB1;RAMP2;RAB31;ACKR3;ARRB1;CEACAM1;DNM2;RAMP1;AP2M1;DNM1;CD81
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.6570338202240995,1.6002351409793283,0.03747534516765286,0.4088583060247672,1.0,6/16,8.32%,ATP1A2;DMD;GSTM2;SLC8A1;ANK2;CAMK2D
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.4602063008899846,-1.5992858174768965,0.006864988558352402,0.22411915266931565,1.0,31/54,30.13%,CAV1;RPL11;DNAJA1;RPS3;IVNS1ABP;UBXN1;SOX4;PINX1;CTNNB1;ARRB1;RPL5;CHP1;ISG15;CAMLG;OGT;COPS9;NXN;SPOPL;PRMT3;N4BP1;PRKCG;ARRB2;AKT1;SIRT7;HSPA1B;TNFAIP3;SPRY2;PER2;SMAD7;VPS28;MINAR1
prerank,response to prostaglandin E (GO:0034695),0.7344727803871371,1.5990530431966508,0.0288659793814433,0.40892380181198895,1.0,5/10,16.83%,TGFBR3;CCL19;PTGER4;GNG2;SFRP1
prerank,signal release from synapse (GO:0099643),-0.4844452141473196,-1.5978902550952925,0.0021691973969631237,0.2250364856635549,1.0,23/43,31.96%,HSPA8;LIN7A;PTPRN2;STX1A;NRXN1;PCLO;SYT10;GAD1;SNAP25;CPLX2;SYN2;PIP5K1C;CDK5;PPFIA3;RAB3A;OTOF;CPLX1;SNAPIN;SNPH;SLC32A1;SYT1;GRM4;SYN1
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.4319864703701066,-1.5976482645359122,0.0025380710659898475,0.22390808944854887,1.0,22/67,11.14%,ELMO1;NRP2;KDR;RAC1;HSP90AA1;PTK2;DOCK1;CLEC14A;FYN;PTK2B;DAB2IP;NCKAP1;HSPB1;PXN;BCAR1;NCK1;FLT4;VEGFA;PAK2;RHOA;CRK;NCK2
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.4217783200193081,1.5965787232137252,0.005502063273727648,0.4135168300282306,1.0,37/186,10.34%,BICC1;IGFBP2;TCF7L2;TRABD2B;MCC;RNF43;WWOX;PRKN;LRP4;DAB2;DKK3;RBMS3;DKK1;IGFBP4;RNF213;GRB10;PRICKLE1;VGLL4;CBY1;INVS;GLI3;TMEM64;TLE3;ZNRF3;APCDD1;PSME4;PSMA2;PSMA3;SIAH2;TLE1;AMFR;WIF1;AXIN2;PSMD8;HDAC1;LATS1;DVL3
prerank,striated muscle contraction (GO:0006941),0.5126655708456884,1.595781521069038,0.01020408163265306,0.41241247639489464,1.0,13/53,12.29%,ATP1A2;TPM1;DMD;CSRP3;TNNC1;TNNT2;SLC8A1;ARHGEF11;RCSD1;DTNA;SCN3B;SCN2B;CCDC78
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.6203577086278103,1.5954055604890736,0.031746031746031744,0.40993683605254677,1.0,1/19,0.03%,IGF1
prerank,endothelial cell differentiation (GO:0045446),-0.6675633290467167,-1.5945281722139764,0.015904572564612324,0.22845994106702425,1.0,6/12,10.93%,TIE1;KDR;ACVRL1;JAG1;BMPR2;SOX18
prerank,positive regulation of dendrite extension (GO:1903861),-0.5955402002323944,-1.594432373982467,0.03219315895372234,0.22696919099196708,1.0,13/17,31.25%,NEDD4L;ITSN2;RNF157;SYT4;CPNE9;SYT2;RASAL1;PLAA;RIMS2;CPNE5;SYT17;SYT1;SMURF1
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.6600235124823296,-1.5942360129133917,0.021484375,0.22566746640419097,1.0,9/12,19.35%,CAV1;CTNNA3;RYR2;CACNA1C;BIN1;JUP;DSG2;DSP;TRPM4
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.6980481475626448,-1.593115606462645,0.020036429872495445,0.2262875144504251,1.0,7/10,20.25%,PRKG1;CD9;SERPINE2;CEACAM1;ALOX12;SH2B3;PRKCD
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.6585722715115381,1.5913426201516467,0.026476578411405296,0.41930114807648,1.0,2/15,1.41%,IGF1;PRKN
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.5684422738073203,1.590596669742334,0.019963702359346643,0.41816058049746846,1.0,6/29,11.59%,IL31RA;FER;STAT5B;PIAS1;JAK2;PKD2
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.613324435560688,-1.5895137111758042,0.019230769230769232,0.23207244402031768,1.0,6/15,11.67%,NTRK3;KDR;F3;VEGFA;SCG2;CDH13
prerank,neural crest cell migration (GO:0001755),-0.496697731479841,-1.589074940714288,0.008695652173913044,0.231380084638304,1.0,13/36,11.12%,FN1;SEMA6A;SEMA7A;SEMA6D;SEMA3C;SEMA4D;TBX1;SEMA3E;CORO1C;SEMA4B;SEMA5B;SEMA6C;SEMA3G
prerank,embryonic eye morphogenesis (GO:0048048),0.7124884885818343,1.5877886778897452,0.03578528827037773,0.42325528510655513,1.0,4/11,4.90%,EFEMP1;FBN1;FBN2;KDM2B
prerank,ear morphogenesis (GO:0042471),0.6246416186211541,1.5870292001805677,0.02574257425742574,0.42227346640425134,1.0,3/20,0.99%,OSR1;ZIC1;FGFR2
prerank,lipoprotein catabolic process (GO:0042159),-0.6505947682650075,-1.5841416672529676,0.026515151515151516,0.2397438391434298,1.0,4/11,10.46%,CTSD;ABHD17B;ABHD17A;LYPLA2
prerank,bone morphogenesis (GO:0060349),0.6611652038426796,1.58270085474865,0.026156941649899398,0.4321495916920195,1.0,3/14,2.80%,CYP26B1;FGFR2;LTF
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),-0.40800813943483427,-1.5825279723056505,0.005698005698005698,0.24174577006060807,1.0,32/93,16.59%,NTRK3;CAV1;FNIP2;PDE4D;TFRC;RASSF2;BCAR3;GAS6;HSP90AA1;HSP90AB1;NGF;RACK1;MTCP1;TGFB1;CD44;NCK1;APP;VEGFA;PDCD10;PAK1;DDIT4;CNKSR3;EIF4G1;NOS1;NCK2;SPTBN4;NLRP2B;TERF2IP;PRKD1;RAF1;MIF;TNKS1BP1
prerank,presynapse assembly (GO:0099054),0.6519528036765389,1.5819884434426135,0.03155818540433925,0.43089679346854964,1.0,6/16,7.47%,LRP4;CEL;NLGN2;IL1RAPL1;PTPRD;PTEN
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.6224528047122532,-1.5818883282864782,0.027944111776447105,0.2414302778038711,1.0,4/14,13.99%,ENTPD1;ENTPD7;ENTPD2;NUDT1
prerank,endothelial cell migration (GO:0043542),-0.4933057058115421,-1.5814703008571194,0.004576659038901602,0.24067027911976052,1.0,15/37,11.67%,NOS3;ID1;PLXND1;FAP;PXN;CCN3;MYH9;VEGFA;NR4A1;EMP2;DPP4;RHOA;SCG2;SOX18;CDH13
prerank,regulation of phospholipase activity (GO:0010517),0.7083957499578779,1.5802945703341018,0.0486815415821501,0.4327629070484863,1.0,2/10,1.95%,FGFR2;PDPK1
prerank,regulation of cellular biosynthetic process (GO:0031326),0.5631444392694334,1.5802777235631187,0.03717472118959108,0.42932374618152397,1.0,9/28,10.25%,PRKAG2;FGFR4;NOS1AP;AVIL;PRKAA2;MITF;SIRPA;MED1;JAK2
prerank,metal ion homeostasis (GO:0055065),-0.4750078590511888,-1.5796981918594546,0.013856812933025405,0.24280669933757476,1.0,16/40,21.17%,TMTC2;SLC12A2;SLC12A7;CAV1;SLC12A6;SLC12A8;KCNA1;GRIN1;SLC12A4;MT3;WFS1;COX11;LETM1;JPH2;ANK3;KCNH2
prerank,determination of heart left/right asymmetry (GO:0061371),-0.4755714211359654,-1.5790944609029718,0.022277227722772276,0.24252796222232206,1.0,11/42,11.44%,MEF2C;MICAL2;ENG;NOTCH1;SOX17;TGFBR2;TBX2;TBX3;VANGL2;SOX18;NDRG4
prerank,leukocyte tethering or rolling (GO:0050901),-0.5857986737700229,-1.5784750136561483,0.02529182879377432,0.2422529416019394,1.0,9/17,27.64%,JAM2;ITGB1;ITGA4;ADD2;CX3CR1;PODXL2;SELPLG;SELP;ITGB7
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.506099080876519,-1.578421031647581,0.013513513513513514,0.24080412786993477,1.0,11/34,8.17%,GAB1;SEMA6A;KDR;RAMP2;MT1G;DAB2IP;NOTCH1;HSPB1;FLT4;VEGFA;NR4A1
prerank,negative regulation of potassium ion transport (GO:0043267),-0.6325889355518967,-1.5777194381995978,0.023391812865497075,0.2406544150216369,1.0,5/13,12.40%,CAV1;NEDD4L;PTK2B;NOS1;BIN1
prerank,thymus development (GO:0048538),-0.6377798346694834,-1.5768104628048545,0.019305019305019305,0.2409524749999348,1.0,4/13,6.82%,TBX1;HES1;SOD1;SIX1
prerank,receptor signaling pathway via STAT (GO:0097696),0.5850871960997976,1.5756726459403718,0.0380952380952381,0.44053571826438415,1.0,5/25,11.59%,IL31RA;STAT5B;PIAS1;JAK2;PKD2
prerank,proteoglycan metabolic process (GO:0006029),0.5819689308617991,1.5753391530909175,0.03225806451612903,0.4382693316588485,1.0,4/26,4.47%,IGF1;ADAMTS12;GAL3ST3;SULF1
prerank,positive regulation of ATP metabolic process (GO:1903580),0.5614782355298986,1.5752141246725198,0.02394106813996317,0.43523696415778296,1.0,8/32,8.78%,IGF1;PPARA;PID1;ZBTB20;PRKAA2;PRKAA1;ARNT;NUPR1
prerank,regulation of acrosome reaction (GO:0060046),0.7086850849331918,1.5740446944771969,0.05702647657841141,0.4353209889633094,1.0,3/10,3.95%,PLA2G10;PLCB1;SPINK13
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.529595706661399,1.5738977461947565,0.02040816326530612,0.4324562726001353,1.0,10/43,8.57%,IGF1;BMP6;WNT4;BMP7;FBN2;LTF;CCN4;IL6;DDR2;ATRAID
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.6164436162155988,1.5733266317360626,0.03937007874015748,0.4309801894027264,1.0,3/20,5.04%,WNT4;C1QTNF3;SIK1
prerank,maturation of 5.8S rRNA (GO:0000460),0.6308799068261781,1.5728121454242416,0.042,0.4293959632755525,1.0,5/17,10.40%,NSA2;MPHOSPH6;FTSJ3;NOL9;PRKDC
prerank,negative regulation of response to cytokine stimulus (GO:0060761),-0.6833331822949353,-1.570392341080778,0.0367504835589942,0.2532781380306888,1.0,6/10,18.50%,KLF4;PTPRC;TLE5;IRAK3;SIGIRR;SH2B3
prerank,regulation of dendrite extension (GO:1903859),-0.5832112587697326,-1.5695830620324878,0.030612244897959183,0.2535197653115976,1.0,13/18,31.25%,NEDD4L;ITSN2;RNF157;SYT4;CPNE9;SYT2;RASAL1;PLAA;RIMS2;CPNE5;SYT17;SYT1;SMURF1
prerank,response to muramyl dipeptide (GO:0032495),-0.6430851361422594,-1.5694141111704076,0.03207547169811321,0.2522458661247384,1.0,6/12,18.36%,VIM;NOD1;CHMP5;ARHGEF2;ERBIN;IRF5
prerank,cAMP biosynthetic process (GO:0006171),0.7149513839487374,1.5691570106731392,0.04208416833667335,0.43827908267855337,1.0,2/10,0.72%,ADCY5;ADCY1
prerank,cell projection assembly (GO:0030031),-0.5534728102592977,-1.5686388683091441,0.023554603854389723,0.2522630782361025,1.0,5/22,4.23%,PARVB;RHOJ;RAC1;GSN;NCKAP1
prerank,positive regulation of cell-matrix adhesion (GO:0001954),-0.46439686829229876,-1.567747785822149,0.02843601895734597,0.25247823338461584,1.0,18/42,14.52%,UTRN;TEK;PTPRJ;KDR;RAC1;PTK2B;LIMS1;FERMT2;GSK3B;MYOC;VEGFA;EMP2;COL16A1;CDK6;CDH13;S100A10;JUP;GFUS
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.6626704283473083,1.5659689470210696,0.038306451612903226,0.44561954767012985,1.0,2/15,5.19%,MOXD1;AANAT
prerank,steroid metabolic process (GO:0008202),0.47688057844434106,1.5658226206945136,0.01669449081803005,0.44279831646778056,1.0,8/72,5.93%,CYP26B1;CYP27A1;LIPA;HSD17B1;NR1I2;FDXR;HSD17B10;LRP2
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.49362328097185937,-1.563853807607256,0.02102803738317757,0.25923809319207664,1.0,17/33,12.21%,SEMA6A;BMPER;RHOJ;KLF2;THBS1;KLF4;PKM;PPP1R16B;ITGA5;CREB3L1;TJP1;CEMIP2;CEACAM1;VEGFA;S100A1;SYNJ2BP;EPN2
prerank,toxin transport (GO:1901998),0.7076371967056031,1.563068338102856,0.05321507760532151,0.44810780717608917,1.0,3/10,2.46%,SLC22A2;ANTXR1;ANTXR2
prerank,heart contraction (GO:0060047),0.5273904306894657,1.5626315908506072,0.02054794520547945,0.4461776380753237,1.0,8/41,5.50%,ATP1A2;TPM1;DMD;CSRP3;TNNC1;TNNT2;SLC8A1;ACE
prerank,myeloid cell activation involved in immune response (GO:0002275),-0.5768098026043019,-1.5620597849930897,0.028735632183908046,0.26171323960027343,1.0,6/18,11.17%,PLCG2;LBP;DOCK2;SBNO2;DYSF;IFI35
prerank,male meiosis I (GO:0007141),0.6422780671845556,1.5616466564632812,0.054945054945054944,0.44607105846698825,1.0,3/16,6.49%,MYBL1;SLC25A31;HSF2BP
prerank,monovalent inorganic cation homeostasis (GO:0055067),-0.5453335199275535,-1.5602054855279033,0.03177966101694915,0.2642895995974,1.0,9/23,21.58%,SLC12A2;SLC12A7;SLC12A6;SLC12A8;SLC12A4;PDK2;ATP6V0A4;KCNH2;CLCN3
prerank,stem cell differentiation (GO:0048863),0.5381974637808361,1.5588803836967555,0.019784172661870502,0.45113041790082825,1.0,11/39,9.44%,OSR1;FGFR2;KIT;HOXB4;JARID2;EPOP;UFL1;ACE;SETD6;MTF2;FBXL17
prerank,regulation of focal adhesion assembly (GO:0051893),-0.4426776401498071,-1.5587835996844208,0.007246376811594203,0.26572976382410973,1.0,24/54,12.15%,TEK;LIMCH1;EFNA5;PTPRJ;APOD;ACTG1;KDR;THBS1;ACVRL1;RAC1;PTK2;SLK;LIMS1;CORO1C;FAM107A;FERMT2;MYOC;VEGFA;GPM6B;RHOA;COL16A1;PEAK1;DUSP3;S100A10
prerank,regulation of glycolytic process (GO:0006110),0.4762178167391155,1.5585238297911064,0.018272425249169437,0.4489868107038828,1.0,10/68,10.11%,IGF1;PRKAG2;PPARA;ZBTB20;PRKAA2;NDC1;PRKAA1;ARNT;NUPR1;NUP107
prerank,negative regulation of cell adhesion (GO:0007162),-0.4216041163181736,-1.5583364654658705,0.005277044854881266,0.26524515392847925,1.0,20/72,6.18%,PODXL;SEMA6A;ACER2;ADAM10;ACVRL1;CDH1;PLXND1;JAG1;PTK2;CORO2B;NOTCH1;SEMA4D;TGFBI;ARHGDIB;FZD4;PLXNA4;ARHGDIA;NEXMIF;TGFB1;PTPRC
prerank,regulation of intracellular pH (GO:0051453),-0.5063236604762971,-1.557321040739156,0.015765765765765764,0.2656664634871915,1.0,12/34,18.17%,SLC4A10;SLC9A2;SLC9A8;CHP1;SLC4A8;CA2;SLC4A2;SLC26A6;SLC9B1;CFTR;TMEM165;ATP5F1B
prerank,glycoprotein catabolic process (GO:0006516),0.6264430055082748,1.555941205727085,0.050100200400801605,0.4541268299438324,1.0,6/17,13.19%,ADAMTS12;ADAMTS9;FBXO44;FBXO6;EDEM1;NGLY1
prerank,endoplasmic reticulum organization (GO:0007029),-0.4195283033123734,-1.5556422443626725,0.0024390243902439024,0.2676481374679899,1.0,39/72,33.25%,REEP3;REEP1;CAV2;RTN3;REEP5;SHTN1;STX1A;APP;SMPD4;CCDC47;RTN4;TOR1B;LMAN2;LPCAT3;BNIP1;SEC61G;LMAN2L;ATL2;GET4;SPTSSB;SEC16B;VAPA;TLE6;OTOF;REEP2;RNF112;ATL3;SEC16A;TMEM33;ZBED3;STX5;WDR83OS;SEC61B;RAB18;UBE2J2;TRDN;SEC31A;SEC31B;DOP1B
prerank,receptor metabolic process (GO:0043112),-0.4463929340765164,-1.555448137259374,0.004694835680751174,0.26652753508193905,1.0,20/53,14.99%,DNM3;CAV1;TFRC;CD9;ITGB1;RAMP2;RAB31;ACKR3;SH3GLB1;LGMN;TGFB1;DNM2;RAMP1;AP2M1;LMTK2;DNM1;CD81;EHD3;MVB12A;CALCRL
prerank,negative regulation of platelet activation (GO:0010544),-0.5998087012725744,-1.5549757640844966,0.031683168316831684,0.2660564513063222,1.0,9/16,20.25%,PRKG1;NOS3;CD9;SERPINE2;CEACAM1;THBD;ALOX12;SH2B3;PRKCD
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.5485840853759126,-1.5544818194259666,0.015217391304347827,0.26567750256570416,1.0,11/24,23.62%,MEF2C;CDH2;CDON;CTNNB1;OLFM2;BNIP2;BOC;TCF3;CTNNA1;SPAG9;MAPK11
prerank,hepaticobiliary system development (GO:0061008),0.608300906150683,1.5541351741862346,0.03861003861003861,0.4567273895548127,1.0,8/20,11.59%,TGFBR3;WNT4;ARID5B;PRKCSH;PCSK9;CEBPG;COBL;PKD2
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.541674088130663,1.553913515410852,0.034420289855072464,0.45413915743015226,1.0,4/34,3.59%,IGF1;DMRT1;PDGFRB;IGF2
prerank,activation of protein kinase B activity (GO:0032148),0.5551365371015289,1.5535535877160453,0.039399624765478425,0.4521604843148377,1.0,6/29,5.81%,IGF1;OSBPL8;IL18;PDPK1;RICTOR;FGF1
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.5037719674044673,-1.5533404515050095,0.03375527426160337,0.26656017929148845,1.0,18/29,34.27%,RPS21;RPS8;RPS19;RPS14;DCAF13;BMS1;DHX37;RPS16;TBL3;KRI1;PWP2;TSR1;MRPS11;ABT1;UTP20;UTP4;RPP40;HELB
prerank,manganese ion transport (GO:0006828),-0.6077497765235444,-1.553122662443709,0.03386454183266932,0.2655052318249001,1.0,11/14,29.49%,TRPC3;TRPC6;ATP2C1;SLC39A8;TRPC4;TRPC1;TMEM165;SLC39A14;SLC11A1;TRPC7;ATP2C2
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.46323836757563697,1.5498826227907676,0.00641025641025641,0.46065832296940246,1.0,6/74,2.14%,IGF1;EYA4;EYA1;TCF7L2;EYA2;BCL2
prerank,atrioventricular valve development (GO:0003171),-0.611865750793957,-1.549687065742346,0.029473684210526315,0.27170145593899847,1.0,12/14,31.51%,TGFB2;NOTCH1;BMPR2;TGFBR2;BMP2;HEYL;APLNR;ACVR1;GJA5;SLIT3;ZFPM1;TBX20
prerank,peptidyl-lysine dimethylation (GO:0018027),0.6084108221666658,1.548028072424159,0.05154639175257732,0.4634527858877441,1.0,5/18,11.04%,KMT2A;SETD7;SETD1A;ASH1L;KMT2B
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.5705182329648121,1.5461724866908817,0.05353728489483748,0.46614108536591603,1.0,3/26,2.20%,IGF1;OSBPL8;SORBS1
prerank,positive regulation of embryonic development (GO:0040019),0.6134863582765192,1.5461508403735165,0.0497131931166348,0.46301909127339896,1.0,5/19,6.39%,OSR1;WNT4;SCX;PLCB1;NIBAN2
prerank,regulation of endothelial cell proliferation (GO:0001936),-0.4035185572767145,-1.545548955910356,0.0028089887640449437,0.27950942263813033,1.0,25/88,11.79%,TEK;CAV1;PTPRM;NRP2;TIE1;KDR;THBS1;ACVRL1;F3;CAV2;BMPR2;PPP1R16B;NRAS;ATP5F1A;PDCL3;EMC10;FLT4;VEGFA;NR4A1;PIK3CD;BMP2;SCG2;SYNJ2BP;CDH13;XDH
prerank,nucleoside catabolic process (GO:0009164),0.6934695227829143,1.5436710795130657,0.050505050505050504,0.4681578146550775,1.0,6/11,12.28%,DPYD;UPB1;NT5M;DPYS;DERA;UPP2
prerank,cristae formation (GO:0042407),-0.5143040101846593,-1.5421722129523987,0.023454157782515993,0.2858116069236846,1.0,18/27,29.63%,ATP5MG;ATP5MC3;ATP5F1A;ATP5F1D;CHCHD3;ATP5F1E;ATP5PD;IMMT;UQCC3;APOO;LETM1;ATP5F1B;ATP5MC2;SPG7;ATP5MF;ATP5MC1;ATP5PF;MICOS13
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.6769420256535525,-1.541924137386127,0.029143897996357013,0.2846831235356556,1.0,3/10,1.87%,IL33;KDR;NAMPT
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.6502514261378968,-1.5414279962396014,0.026465028355387523,0.2842831810798857,1.0,3/11,2.60%,MECOM;CD34;RUNX1
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.5389485025820596,-1.5409259381305345,0.028688524590163935,0.28391319691833083,1.0,5/21,6.18%,PRKCH;FOXP1;SLC39A10;RPS3;PTPRC
prerank,kidney development (GO:0001822),0.47450311438156223,1.540656602061058,0.014150943396226415,0.475011409502221,1.0,13/65,7.16%,OSR1;GREB1L;WNT4;BMP7;LRP4;CTSH;PCSK9;PYGO1;ARL3;SULF1;ACE;SALL1;KANK2
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.5577142449679787,-1.540244650946884,0.03682170542635659,0.28388853721481333,1.0,5/19,9.14%,SLCO1C1;KLF2;KLF4;APP;MAPK8
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.5708980758467861,1.5398107193552766,0.04331450094161959,0.47461372234394006,1.0,3/26,4.92%,IGF1;FHL2;CAMTA1
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.593528308401486,-1.53864045027378,0.033268101761252444,0.28601887618847527,1.0,13/17,28.21%,ATP5MG;ATP5MC3;ATP5F1A;ATP5F1D;ATP5F1E;STOML2;ATP5PD;ATP5F1B;VPS9D1;ATP5MC2;ATP5MF;ATP5MC1;ATP5PF
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.5864610266063629,1.5377338666147646,0.045627376425855515,0.477956550129357,1.0,7/22,12.80%,SH3D19;TIMP3;SNX33;SNX9;NRDC;PTPN3;PACSIN3
prerank,endoderm formation (GO:0001706),-0.4786077571636593,-1.5365883832905485,0.013363028953229399,0.2892311124250694,1.0,11/35,13.08%,COL8A1;FN1;COL12A1;COL6A1;SOX17;ITGA5;ITGA4;LAMA3;SOX7;MMP15;ITGA7
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.6730182785827934,1.5344350643562195,0.06804123711340206,0.48521502583505005,1.0,8/12,21.82%,SORBS1;IGF2;PRKCZ;GKAP1;PTPN11;C1QTNF12;IRS1;SNX5
prerank,negative regulation of cartilage development (GO:0061037),0.6699813720696491,1.5321916664068902,0.060784313725490195,0.4894106385429444,1.0,3/13,5.39%,ADAMTS12;EFEMP1;ADAMTS7
prerank,inner mitochondrial membrane organization (GO:0007007),-0.4502327963674815,-1.5312903452255167,0.01405152224824356,0.30040895441596105,1.0,26/47,26.12%,ATP5MG;ATP5MC3;ATP5F1A;ATP5F1D;GHITM;CHCHD3;ATP5F1E;NDUFA13;TIMM9;ATP5PD;ROMO1;MTX3;TIMM10B;TIMM13;IMMT;UQCC3;APOO;LETM1;ATP5F1B;HSPA9;TIMM29;TIMM22;ATP5MC2;SPG7;ATP5MF;ATP5MC1
prerank,regulation of amyloid-beta formation (GO:1902003),0.5294774027176065,1.5297615241902494,0.03867403314917127,0.4942245831337547,1.0,3/34,3.90%,IGF1;ROCK2;EPHA4
prerank,purine ribonucleotide transport (GO:0015868),-0.5890068624158405,-1.529031235569516,0.032454361054766734,0.30428460423108983,1.0,7/16,15.86%,ABCC4;LRRC8C;LRRC8D;LRRC8A;SLC25A42;SLC35B2;SLC17A9
prerank,nucleoside diphosphate metabolic process (GO:0009132),-0.5969606524114635,-1.528644291446736,0.034552845528455285,0.3035957382452776,1.0,4/15,9.11%,ENTPD1;CMPK1;ENTPD7;ENTPD2
prerank,platelet degranulation (GO:0002576),-0.38726711945017267,-1.528234601389627,0.0,0.3028594077158226,1.0,31/118,9.23%,PCDH7;ABCC4;VWF;FN1;PECAM1;TMSB4X;ACTN4;THBS1;TGFB2;GAS6;CD9;CALM1;PSAP;LHFPL2;TAGLN2;FLNA;ACTN1;WDR1;ENDOD1;TGFB1;CD109;FAM3C;SOD1;VTI1B;CLEC3B;APP;VEGFA;SRGN;CYRIB;A2M;CD63
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.6286761547915052,1.5277354662719431,0.05747126436781609,0.4980056636984693,1.0,6/16,12.28%,DPYD;UPB1;DPYSL3;NT5M;DPYS;UPP2
prerank,inorganic anion transmembrane transport (GO:0098661),-0.4176894323412308,-1.527362259195783,0.014319809069212411,0.30344982010905447,1.0,23/63,16.11%,SLC12A2;SLC12A7;SLC26A2;ANO1;ANO4;SLC5A6;SLC12A6;SLC1A1;GABRB3;GABRB1;SLC12A8;SLC4A8;ANO3;LRRC8A;GABRG3;SLC12A4;SLC37A3;SLC25A30;XPR1;ANO2;CFTR;GLRA3;SLC25A3
prerank,positive regulation of behavior (GO:0048520),-0.6645557263827911,-1.5268619825993748,0.042435424354243544,0.30308489607824873,1.0,3/10,4.49%,MEF2C;SGIP1;STRA6
prerank,fatty-acyl-CoA metabolic process (GO:0035337),-0.5439331539259342,-1.5265148646428932,0.016985138004246284,0.30228503498657233,1.0,10/20,21.71%,FAR2;ACSL4;ACACA;FAR1;DGAT1;FASN;ACSL3;ACLY;SCD5;SCD
prerank,cell-substrate junction assembly (GO:0007044),-0.4764397342436112,-1.52636007942703,0.0407725321888412,0.3009854586873495,1.0,12/33,14.48%,FN1;THSD1;ITGA6;ITGB4;PLEC;ACTN1;FERMT2;LAMA3;BCR;PEAK1;WHAMM;RCC2
prerank,regulation of cardiac conduction (GO:1903779),0.49061979870945793,1.5260928855784874,0.025597269624573378,0.5004041043521594,1.0,11/54,6.09%,ATP1A2;ITPR1;SLC8A3;STIM1;CORIN;ATP1B3;SLC8A1;DMPK;ANK2;NPR2;TMEM65
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.3760829792964314,-1.5253044838230716,0.008645533141210375,0.302025312686921,1.0,28/114,15.39%,TMSB4X;ACTN4;TNFRSF11B;PTK2B;NFKBIA;LIMS1;IKBKB;EDA;ST18;TNFRSF11A;TNFRSF1B;CARD14;AIM2;PSMD13;BIRC3;PSMF1;COMMD7;PSMB10;CHUK;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;TRAF1;PSME1;PSMB3
prerank,regulation of centrosome cycle (GO:0046605),-0.5489497967142161,-1.5248543848790752,0.027426160337552744,0.3015869034591926,1.0,15/21,37.26%,CHMP5;CHMP2B;CHMP1B;CHMP1A;GEN1;CHMP3;PDCD6IP;CHMP4C;CEP131;VPS4B;AURKA;ATF5;NPM1;PKHD1;XRCC3
prerank,ribosomal large subunit assembly (GO:0000027),-0.5166240951490764,-1.523740977500531,0.026845637583892617,0.3026008756682054,1.0,11/24,22.07%,RPL11;RPL6;RPL24;RPL23A;RPL3;RPL5;RPLP0;RSL24D1;NOP53;NLE1;PPAN
prerank,peptidyl-tyrosine modification (GO:0018212),0.4935465132108556,1.5236286579592588,0.018487394957983194,0.5054003696669355,1.0,11/56,4.21%,EFEMP1;EPHA3;FGFR2;FGFR4;KIT;PDGFRB;TPST1;FER;PDGFRA;EPHA4;ABI2
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.4167930231959456,1.5234203996291231,0.0058823529411764705,0.5028060976272598,1.0,30/138,11.64%,IL31RA;EPHA7;EPHA3;FGFR2;FGFR4;BDKRB2;KIT;PDGFRB;FER;EPHA8;PDGFRA;EPHA4;DDR1;NPR2;PTN;FRS2;IGF1R;CLNK;PTPRD;DDR2;RYK;CSF1;MTSS1;MUSK;FRK;JAK2;AXL;EPHA2;NPR1;ERBB2
prerank,carnitine metabolic process (GO:0009437),0.6580324294754963,1.5231268364782955,0.065439672801636,0.5005674558684736,1.0,6/12,13.90%,ACADL;CPT2;BBOX1;TMLHE;SHMT1;CPT1C
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.5850017559886985,1.52291743799783,0.06336633663366337,0.49819349192916346,1.0,4/23,4.56%,PRKAG2;CEMIP;BMP7;SPHK1
prerank,regulation of striated muscle contraction (GO:0006942),0.568274293848002,1.522618447899927,0.03522504892367906,0.4960448865339803,1.0,4/27,4.09%,ATP1A2;SLC8A3;DMD;ANK2
prerank,negative regulation of TOR signaling (GO:0032007),0.5299889370867814,1.5225928192993878,0.030534351145038167,0.49308299153051927,1.0,14/36,11.89%,NPRL3;FNIP1;DEPTOR;SZT2;NPRL2;SESN1;PRKAA2;PDCD6;UBR2;RNF152;PRKAA1;EPM2A;FLCN;AKT1S1
prerank,negative regulation of cell growth (GO:0030308),-0.37800184662036296,-1.5222548992225242,0.008403361344537815,0.3043711590425865,1.0,43/121,25.74%,APBB2;SLIT2;PTPRJ;ACVRL1;TGFB2;ADAM15;NDRG3;FHL1;SH3BP4;RACK1;BMPR2;SOX17;CCDC85B;CCN3;RERG;OSGIN2;TGFB1;DCC;APBB1;SESN2;RTN4;CDKN1B;NDUFA13;SEMA3G;CDKL3;MT3;JADE1;CDA;BST2;WFDC1;RTN4R;ESR2;CDKN1A;OSGIN1;HYAL2;CDKN2D;BTG1;SIPA1;HSPA1B;ULK2;DACT3;SPHK2;CRLF3
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.5878230145786042,-1.5215779001156902,0.03468208092485549,0.3045388941985753,1.0,12/16,28.21%,ATP5MG;ATP5MC3;ATP5F1A;ATP5F1D;ATP5F1E;STOML2;ATP5PD;ATP5F1B;ATP5MC2;ATP5MF;ATP5MC1;ATP5PF
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.6697348262086993,-1.5203230210347012,0.05252918287937743,0.3043273716219514,1.0,2/10,2.95%,KLF4;MBP
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.6697348262086993,-1.5203230210347012,0.05252918287937743,0.3043273716219514,1.0,2/10,2.95%,KLF4;MBP
prerank,ceramide metabolic process (GO:0006672),-0.44155614357309264,-1.5200110999397476,0.014634146341463415,0.3035924614871308,1.0,11/49,9.62%,ST6GALNAC3;SGMS1;SGMS2;ACER3;ACER2;SPTLC2;PLPP1;DEGS2;SMPD4;SGPL1;CERK
prerank,protein localization to membrane (GO:0072657),-0.3561678650483292,-1.5197436365917438,0.0034965034965034965,0.30263684763581183,1.0,52/187,13.34%,SPTBN1;BSG;SHANK3;CAV1;RAP1A;DLG2;EFR3B;LIN7A;GAS6;CDH1;SLMAP;KCNB2;AGRN;EHD4;RAMP2;F11R;RAB3C;ATP1B1;SH3GLB1;KCNB1;FLNA;MAP7;IKBKB;ZDHHC15;RFTN1;ITGA4;FERMT2;EHD1;NKD2;WNK3;RAMP1;PTCH1;NRXN1;TMED2;EMP2;ZDHHC2;C2CD5;TSPAN17;RAB38;TTC7A;ABHD17A;RAB3B;HGS;SYNJ2BP;CACNB2;S100A10;TM9SF3;SPTBN4;CD81;EHD3;MYO5A;PICK1
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.5738835206920773,1.5190421460351107,0.048507462686567165,0.5020085529642888,1.0,6/23,8.32%,ATP1A2;NOS1AP;CACNG1;ANK2;CACNA2D1;CAMK2D
prerank,regulation of neuroinflammatory response (GO:0150077),0.6056578917652374,1.5183933431927448,0.05421686746987952,0.5012055046213553,1.0,6/19,8.78%,IGF1;IL18;SPHK1;IL6;MMP9;NUPR1
prerank,extracellular structure organization (GO:0043062),0.39977912113398206,1.5182300188027256,0.011396011396011397,0.49864296518246326,1.0,33/204,5.41%,COL22A1;ADAMTS12;NID2;ADAMTS9;LAMC3;COL4A5;ADAM12;ITGA9;FBN1;COL4A6;LAMA2;SMOC2;ADAMTS5;FBN2;THSD4;ADAMTS10;FBLN5;ADAMTS15;TNC;PXDN;LOXL1;NID1;COL9A2;MMP2;NDNF;COL1A2;SMOC1;ITGAX;COL13A1;DDR1;COL18A1;ADAMTS7;ITGA3
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.5800458527628516,-1.517749928159545,0.05702647657841141,0.30568691705800044,1.0,4/15,6.99%,RPL11;RPL23;RPS7;RPL5
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.6440100823398627,-1.5167970257438612,0.0392156862745098,0.3066787456546505,1.0,8/11,22.34%,UQCRH;UQCR11;UQCRQ;UQCC3;UQCRC2;UQCRC1;CYCS;UQCR10
prerank,endothelial cell proliferation (GO:0001935),-0.5678397527159948,-1.516747073399831,0.04054054054054054,0.3052556467723118,1.0,5/17,3.97%,TEK;BMPER;CD34;ACVRL1;BMPR2
prerank,negative regulation of reproductive process (GO:2000242),0.6321523998929894,1.5148772197692841,0.05,0.5067169786724828,1.0,4/17,5.22%,IGF1;SPINK13;SULF1;GJA1
prerank,embryonic heart tube development (GO:0035050),-0.5981437669266351,-1.5144839227662912,0.041407867494824016,0.30889542351368315,1.0,9/14,26.76%,HES1;SOX17;TBX2;RYR2;SOX18;NDRG4;ACVR1;CITED2;MEGF8
prerank,adenine nucleotide transport (GO:0051503),-0.577802451261205,-1.5144839223645503,0.03861788617886179,0.3073586303618738,1.0,7/17,15.86%,ABCC4;LRRC8C;LRRC8D;LRRC8A;SLC25A42;SLC35B2;SLC17A9
prerank,external encapsulating structure organization (GO:0045229),0.3986651311838304,1.5143162859825565,0.011299435028248588,0.5054847337087338,1.0,33/205,5.41%,COL22A1;ADAMTS12;NID2;ADAMTS9;LAMC3;COL4A5;ADAM12;ITGA9;FBN1;COL4A6;LAMA2;SMOC2;ADAMTS5;FBN2;THSD4;ADAMTS10;FBLN5;ADAMTS15;TNC;PXDN;LOXL1;NID1;COL9A2;MMP2;NDNF;COL1A2;SMOC1;ITGAX;COL13A1;DDR1;COL18A1;ADAMTS7;ITGA3
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.467453641891897,1.5139811750409855,0.034653465346534656,0.5037523044874649,1.0,8/61,4.77%,IGF1;ROBO1;AUTS2;NOTCH2;LPAR1;ALS2;AKAP13;MAPRE2
prerank,metanephric mesenchyme development (GO:0072075),0.6842088370678326,1.5138540298760153,0.06720977596741344,0.5011767024536697,1.0,2/10,0.73%,OSR1;WNT4
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.5845615873096754,1.5137430377971495,0.0670391061452514,0.4985943018582417,1.0,6/21,7.01%,SNTA1;KCNA5;NOS1AP;ANK2;CACNA1D;CACNA2D1
prerank,microtubule bundle formation (GO:0001578),-0.45463005990069777,-1.5135218955502099,0.035211267605633804,0.30822843756798235,1.0,22/42,35.55%,NAV1;CLIP1;RP1;CHP1;MTCL1;TOGARAM1;CCDC66;TPPP;LRGUK;TPPP3;GAS2L1;NUMA1;SPEF1;FOXJ1;CFAP46;NCKAP5L;DCX;PLK1;CFAP206;CLASP1;PSRC1;CCDC40
prerank,protein localization to cell periphery (GO:1990778),-0.37078281171894506,-1.5113685038157,0.009287925696594427,0.31181079690253294,1.0,37/133,13.07%,SPTBN1;BSG;CAV1;RAP1A;EFR3B;LIN7A;GAS6;CDH1;SLMAP;KCNB2;EHD4;RAMP2;F11R;RAB3C;ATP1B1;KCNB1;FLNA;MAP7;IKBKB;EHD1;NKD2;WNK3;RAMP1;PTCH1;TMED2;EMP2;ZDHHC2;C2CD5;TSPAN17;TTC7A;RAB3B;CACNB2;S100A10;SPTBN4;CD81;EHD3;MYO5A
prerank,regulation of multicellular organism growth (GO:0040014),0.610486123330006,1.5083929376063103,0.05405405405405406,0.5136352024571651,1.0,2/15,3.69%,IGF1;STAT5B
prerank,regulation of cellular pH (GO:0030641),-0.5015279067834892,-1.5065006667237568,0.039301310043668124,0.3218205369937556,1.0,9/29,11.79%,SLC4A10;SLC9A2;SLC9A8;CHP1;SLC4A8;CA2;SLC4A2;SLC26A6;SLC9B1
prerank,eye development (GO:0001654),0.4780665697504617,1.5063488538946859,0.024475524475524476,0.5176578481832692,1.0,9/54,3.84%,EFEMP1;FBN1;RBP4;FBN2;MEIS1;SLC39A5;SHROOM2;SMOC1;SH3PXD2B
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.6078051611908233,-1.5062486866764642,0.044061302681992334,0.32073614042727333,1.0,4/13,9.07%,IL33;KDR;NAMPT;EDN1
prerank,endoplasmic reticulum tubular network organization (GO:0071786),-0.572027619357709,-1.5056640540336705,0.046153846153846156,0.3206067657054142,1.0,9/15,30.49%,REEP3;REEP1;RTN3;RTN4;ARL6IP1;ATL2;REEP2;TMEM33;RAB18
prerank,integrin-mediated signaling pathway (GO:0007229),-0.4088111792993596,-1.5054449541765413,0.01891891891891892,0.3196359442661676,1.0,31/73,21.26%,FN1;SEMA7A;ADAM10;ITGB4;ITGB1;ADAM15;PTK2;DOCK1;ITGB8;PTK2B;BCAR1;ITGA5;LAMA5;FERMT2;LAMA3;CEACAM1;CUL3;MYH9;COL16A1;ISG15;NEDD9;CD47;ERBIN;RCC2;PRKD1;ADAM9;TXK;COL3A1;THY1;FYB2;ITGA11
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.6839777749994448,1.5053928528727067,0.06438631790744467,0.5179779318607601,1.0,5/10,12.28%,DPYD;UPB1;NT5M;DPYS;UPP2
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.6553989357109815,1.5053336736409242,0.062,0.5151512128983499,1.0,3/14,5.39%,ADAMTS12;EFEMP1;ADAMTS7
prerank,ribosomal small subunit assembly (GO:0000028),-0.5731181547974188,-1.505150610815195,0.04339250493096647,0.3188088559318155,1.0,12/16,25.30%,RPS15;RPSA;RPS19;RPS14;RPS27;RPS28;ERAL1;RPS27L;RPS5;PWP2;MRPS11;ABT1
prerank,regulation of microtubule depolymerization (GO:0031114),-0.5132513221631271,-1.504733769947528,0.036016949152542374,0.31811808733856733,1.0,14/25,29.11%,MAP1B;STMN2;APC;NAV3;ARHGEF2;APC2;TTBK2;MAP1A;CLASP2;CAMSAP3;SPEF1;CAMSAP1;TRPV4;FGF13
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.6319061146453302,1.5032269182379132,0.07047619047619047,0.5194720793701361,1.0,5/14,12.28%,DPYD;UPB1;NT5M;DPYS;UPP2
prerank,sensory perception of sound (GO:0007605),0.435563213100014,1.5023528375294584,0.02465331278890601,0.5196279396691,1.0,16/88,11.15%,DCDC2;EYA1;ADGRV1;CEMIP;KIT;ALDH7A1;CCDC50;RIPOR2;CACNA1D;TMC2;LRP2;BIRC5;WHRN;EML2;GSDME;TFAP2A
prerank,negative regulation of transforming growth factor beta production (GO:0071635),-0.6498993104432599,-1.5022344046528693,0.04059040590405904,0.3229236961739592,1.0,3/10,9.96%,FN1;HSP90AB1;FURIN
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),-0.46463772184009916,-1.5021454511996364,0.032327586206896554,0.3215946329753535,1.0,11/35,8.11%,TEK;NTRK3;ESAM;F11R;PTK2B;ARHGDIB;SEMA3E;ARHGDIA;TJP1;BAIAP2L1;ABI3
prerank,macrophage activation (GO:0042116),-0.4793894030055575,-1.5020838148376565,0.02914798206278027,0.32024118661813517,1.0,11/34,14.80%,FOXP1;PLCG2;LBP;CD93;SBNO2;APP;DYSF;IFI35;CLU;C1QA;IFNGR1
prerank,response to iron ion (GO:0010039),0.661209642962318,1.5018763084352873,0.07142857142857142,0.5181531227294539,1.0,3/12,3.76%,BMP6;BCL2;TFR2
prerank,negative regulation of leukocyte activation (GO:0002695),0.6187694988116076,1.5008673189960415,0.08421052631578947,0.5186740269931096,1.0,1/15,0.01%,IL31RA
prerank,actin filament bundle organization (GO:0061572),0.5179339776064298,1.500856453696207,0.06319702602230483,0.5158267416032452,1.0,9/33,6.80%,PAWR;RHOD;DPYSL3;SHROOM2;CALD1;BAIAP2;ESPN;BAIAP2L2;LIMA1
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.6298764561001657,-1.5003233493222712,0.05252918287937743,0.3229847431012639,1.0,4/11,13.48%,RAC1;BCAR1;PAK1;STMN1
prerank,platelet aggregation (GO:0070527),-0.47466535436290236,-1.4999782682407659,0.03981264637002342,0.322311501286834,1.0,9/33,7.85%,FN1;ACTB;ACTG1;PPIA;FLNA;HSPB1;ACTN1;UBASH3B;MYH9
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.6407819781441789,1.49926323137804,0.08086785009861933,0.5183870249014476,1.0,5/13,9.94%,IGF1;PLCB1;SLC2A10;CCL19;GOLGA2
prerank,regulation of protein dephosphorylation (GO:0035304),-0.46222892915234526,-1.4987721352665266,0.03260869565217391,0.32406294115754314,1.0,19/37,24.75%,CALM1;PPIA;PPP1R16B;TIPRL;TGFB1;YWHAB;HSP90B1;PPP1R2;PPP6R1;SYMPK;PPP1R16A;CALM2;PPP2R5A;PTBP1;PRKCD;CDCA2;NSMF;PPP1R15A;CALM3
prerank,negative regulation of cilium assembly (GO:1902018),-0.6175222447730826,-1.4985549883276852,0.06,0.32307515521718744,1.0,4/12,13.29%,TBC1D30;MAP4;LIMK2;ODF2L
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.5260348636175443,-1.498539734795421,0.052083333333333336,0.32160694148287006,1.0,8/22,8.31%,RPL23;RPS15;RPL37;RPS7;UBB;RPS20;SPRED2;DDX5
prerank,adherens junction organization (GO:0034332),-0.44790970031581806,-1.4970859643504797,0.029748283752860413,0.3236503999635077,1.0,16/48,14.03%,ACTB;CADM1;CDH1;CDH11;CDH2;RAMP2;FERMT2;CTNNB1;TJP1;CSK;PVR;PAK2;CADM3;CDH13;JUP;PIP5K1C
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.6068215456431696,-1.4969349968130086,0.05273833671399594,0.32245847506954023,1.0,10/13,28.08%,CSPG4;BGN;HEXB;HEXA;IDS;VCAN;ARSB;DCN;IDUA;NCAN
prerank,purine ribonucleotide catabolic process (GO:0009154),-0.525128872322193,-1.4967030520893578,0.03870967741935484,0.32162809206785076,1.0,9/21,14.53%,PDE4D;NT5C2;NUDT3;HPRT1;PDE2A;NUDT4;XDH;HINT1;NT5E
prerank,vascular transport (GO:0010232),0.4435780262082999,1.4961239750893882,0.024429967426710098,0.525428966748777,1.0,16/81,7.55%,ATP1A2;SLC6A13;LEPR;SLC24A3;SLC13A3;SLC22A2;SLC16A12;SLC38A3;SLC5A5;SLC6A9;SLC1A3;SLC6A1;LRP2;SLC2A10;ABCC2;SLC1A5
prerank,regulation of DNA repair (GO:0006282),0.4999811372611681,1.4959656964583399,0.050761421319796954,0.5230172441028542,1.0,3/44,1.02%,EYA4;EYA1;EYA2
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.5097343074416752,-1.495686720119051,0.03624733475479744,0.3225761188723033,1.0,11/24,21.70%,UBE3A;PTK2B;UBB;PKD1;UCHL5;TMF1;PSME3;PSME1;ATP5IF1;PINK1;CTSC
prerank,negative regulation of chemotaxis (GO:0050922),-0.4809817504701387,-1.4956769876874914,0.03111111111111111,0.32114825783498624,1.0,14/31,11.18%,SLIT2;SEMA6A;SEMA7A;SEMA6D;THBS1;SEMA3C;NOTCH1;SEMA4D;SEMA3E;SEMA4B;SEMA5B;SEMA6C;SEMA3G;DUSP3
prerank,diacylglycerol metabolic process (GO:0046339),-0.5283014679882722,-1.4947645325541752,0.05636743215031315,0.32191443262378217,1.0,11/23,23.52%,DGKH;DGKB;DGKI;LIPE;DGKZ;DGKG;DGAT1;ANG;GPAM;DGKQ;DGKE
prerank,positive regulation of interleukin-2 production (GO:0032743),-0.514968373628111,-1.4943416055230105,0.03532008830022075,0.32151563735875294,1.0,6/25,6.18%,SPTBN1;PDE4D;RUNX1;PLCG2;RPS3;PTPRC
prerank,positive regulation of ERAD pathway (GO:1904294),-0.611211786550091,-1.493555942556673,0.043137254901960784,0.32204973016358174,1.0,5/13,14.75%,CAV1;ATXN3;BAG6;HERPUD1;BCAP31
prerank,nuclear migration (GO:0007097),0.6417283575375187,1.4930077026825006,0.07520325203252033,0.5299421526957667,1.0,7/13,19.10%,SYNE2;CLMN;SYNE3;PAFAH1B1;SUN2;CEP120;TMEM201
prerank,monocyte differentiation (GO:0030224),0.6817667237965099,1.4919269675455402,0.08032128514056225,0.5305386947828754,1.0,1/10,0.01%,IL31RA
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.6605429182258492,-1.4916029019023307,0.04961832061068702,0.3254092150960555,1.0,8/10,26.12%,ATP5MG;ATP5MC3;ATP5F1A;ATP5F1D;ATP5PD;VPS9D1;ATP5MC2;ATP5MC1
prerank,dopamine metabolic process (GO:0042417),0.603795395514436,1.4911998583322903,0.072,0.5300816863746718,1.0,3/18,2.63%,MOXD1;PRKN;SNCAIP
prerank,ceramide catabolic process (GO:0046514),-0.5942676436988296,-1.4904965067765998,0.05,0.3267933454544755,1.0,5/14,15.59%,ACER3;ACER2;HEXB;HEXA;GM2A
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.6093232818421335,1.4883957455718133,0.0682261208576998,0.5366970682077192,1.0,4/18,8.84%,FBN1;LTF;LRRC17;FSTL3
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.6015922126234664,-1.4869949966680898,0.05010438413361169,0.33396228595967686,1.0,7/13,29.39%,TMSB4X;HEY2;PSEN1;HEY1;SOX11;PER2;SIN3A
prerank,positive regulation of protein processing (GO:0010954),-0.5330861973930965,-1.48630899518161,0.053497942386831275,0.3341641356453472,1.0,6/19,10.49%,GSN;PLGRKT;NKD2;CLEC3B;MYH9;LPCAT3
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.6412794198957823,1.4862603263433891,0.07554671968190854,0.5407073499136323,1.0,5/13,11.87%,BMP6;DAB2;RBPMS;JAK2;BMPR1A
prerank,response to amyloid-beta (GO:1904645),0.48588173795973033,1.4861552521895365,0.04247787610619469,0.538185893649914,1.0,8/44,7.38%,IGF1;SNX6;MMP2;EPHA4;GJA1;IGF1R;CACNA2D1;MMP9
prerank,transport across blood-brain barrier (GO:0150104),0.43933408876055796,1.4861293783124845,0.021103896103896104,0.535400322386526,1.0,16/83,7.55%,ATP1A2;SLC6A13;LEPR;SLC24A3;SLC13A3;SLC22A2;SLC16A12;SLC38A3;SLC5A5;SLC6A9;SLC1A3;SLC6A1;LRP2;SLC2A10;ABCC2;SLC1A5
prerank,regulation of cAMP-mediated signaling (GO:0043949),-0.5148758610201504,-1.485373857387638,0.03146067415730337,0.334991390940569,1.0,10/24,15.63%,PDE4D;PDE3A;GNAI1;PEX5L;PDE2A;RNF157;UBE2B;PRKAR1A;PDE11A;APLNR
prerank,regulation of glucose metabolic process (GO:0010906),0.5202715830407015,1.485010296355918,0.06537102473498234,0.5362101132100936,1.0,4/34,4.01%,RORA;PRKN;PDK1;SLC45A3
prerank,basement membrane organization (GO:0071711),0.6321178790329304,1.4825776229015006,0.06589147286821706,0.5417333890248198,1.0,5/14,4.99%,NID2;FLRT2;PXDN;NID1;NTNG2
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.48084998162417236,-1.4824889069004406,0.03571428571428571,0.3408893419031242,1.0,11/30,19.29%,NOS3;BMP5;TNFSF10;BCL2L1;GSK3B;TMBIM1;ARHGEF2;RNF34;FAS;CASP8;TNFRSF10B
prerank,detection of mechanical stimulus (GO:0050982),-0.536286736842922,-1.481524457583872,0.05128205128205128,0.34183471134539106,1.0,6/19,7.15%,PIEZO2;PTK2;CDH2;PKD1;CTNNB1;PIEZO1
prerank,ganglioside biosynthetic process (GO:0001574),-0.5801647937517789,-1.4804419711572188,0.058333333333333334,0.34305031467922553,1.0,8/15,19.14%,ST6GALNAC3;ST8SIA4;ST6GALNAC5;B4GALT5;ST8SIA6;ST8SIA2;B4GALT6;ST3GAL1
prerank,steroid biosynthetic process (GO:0006694),0.47026735352095356,1.4800453696640927,0.04745166959578207,0.5473633744546315,1.0,6/56,5.83%,PRKAG2;CYP27A1;INSIG2;HSD17B1;FDXR;HSD17B10
prerank,protein localization to cilium (GO:0061512),0.5141819793485322,1.4795789235640042,0.06851851851851852,0.5460958650438192,1.0,14/32,18.97%,TULP3;TULP1;ARL3;INVS;WDR19;WDR35;ARL6;TCTN1;IFT122;IFT140;ATP6V1D;TULP2;BBS1;RAB29
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.5049151082962976,-1.4791667634000538,0.05032822757111598,0.34493886884616554,1.0,7/25,9.38%,RPL11;HSP90AB1;RPL23;RPS7;PDCL3;RPL5;PSMF1
prerank,ceramide biosynthetic process (GO:0046513),-0.4588859787889224,-1.4788222274847027,0.03365384615384615,0.34446076426919137,1.0,13/40,17.27%,ST6GALNAC3;SGMS1;SGMS2;ST8SIA4;SPTLC2;DEGS2;ST6GALNAC5;SMPD4;ST8SIA6;CERS4;ST8SIA2;B4GALT6;CLN8
prerank,blood vessel morphogenesis (GO:0048514),-0.43352636803141875,-1.4788094593347298,0.01647058823529412,0.34305330395827704,1.0,21/54,9.08%,CAV1;ID1;COL4A1;KDR;CDH2;RAMP2;RASIP1;ITGB8;LAMA1;ENG;TBX1;HES1;SOX17;SLC1A1;STRA6;TGFBR2;TGFB1;LRP5;FLT4;VEGFA;HEY2
prerank,negative regulation of anoikis (GO:2000811),-0.5880254762703372,-1.478722598999742,0.047109207708779445,0.34179926445811937,1.0,5/14,5.04%,CAV1;ITGB1;PTK2;NOTCH1;ITGA5
prerank,regulation of GTPase activity (GO:0043087),-0.35442132878799165,-1.4786419957972516,0.0038461538461538464,0.34062153920605603,1.0,34/177,6.04%,DOCK9;PRKG1;CHN2;FGD5;EFNA5;LRCH1;FGD6;RAP1A;SIPA1L1;RGS6;ITGA6;BCAR3;PKP4;TBC1D30;PLXND1;AGRN;ITGB1;PTK2;F11R;RASIP1;ARHGAP27;CAV2;DAB2IP;CHN1;SH3BP4;SEMA4D;RACK1;NET1;DOCK10;PLXNA4;TGM2;LIMS1;FERMT2;SOD1
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.5974090292440294,1.4781996593287463,0.0872093023255814,0.5479113051109928,1.0,1/17,0.03%,IGF1
prerank,purine nucleotide catabolic process (GO:0006195),-0.5933848667491584,-1.4769888087474947,0.06274509803921569,0.3434632594204055,1.0,6/13,14.53%,NT5C2;NT5C;GDA;XDH;HINT1;NT5E
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),-0.43353772146088093,-1.4756393895050504,0.027227722772277228,0.34524696944420463,1.0,22/54,21.72%,MEF2C;TMSB4X;NOS3;KDR;THBS1;ACVRL1;ETS1;HSPB1;ATP5F1A;GATA2;TGFB1;VEGFA;JUP;CSNK2B;PRKD1;NF1;PRCP;ATP5F1B;ATP2B4;CD40;AKT1;GADD45A
prerank,myotube cell development (GO:0014904),0.6723887064216414,1.4745775874371732,0.08733624454148471,0.5573642659147207,1.0,1/10,0.03%,IGF1
prerank,regulation of microtubule polymerization (GO:0031113),-0.451726581400029,-1.472709827834627,0.04439252336448598,0.3513680167586475,1.0,15/40,21.39%,OCLN;RAC1;RPS3;CLIP1;MET;PRUNE1;STMN2;PAK1;NAV3;STMN1;TOGARAM1;TUBB4A;MAPRE1;DCTN1;NUMA1
prerank,sphingolipid biosynthetic process (GO:0030148),-0.3994432326357835,-1.4726816388801653,0.014457831325301205,0.34999001296824533,1.0,19/71,9.60%,CERT1;ELOVL7;SGMS1;SGMS2;ACER3;ELOVL5;ACER2;SPTLC2;PLPP1;DEGS2;ST6GALNAC5;KDSR;PRKD3;PPM1L;SPNS2;ST8SIA1;SMPD4;SGPL1;ELOVL6
prerank,anterior/posterior pattern specification (GO:0009952),0.4741896379388729,1.47232265417499,0.036521739130434785,0.5621422462824167,1.0,8/53,4.38%,WLS;HOXC6;HOXC4;HOXB4;HOXB3;HOXA3;HOXC5;HOXA7
prerank,regulation of smooth muscle cell migration (GO:0014910),0.5717621894420701,1.4717416403047705,0.07210626185958255,0.5612142073009352,1.0,5/20,7.35%,IGF1;PDGFRB;CCN4;ACE;VTN
prerank,regulation of blood circulation (GO:1903522),0.5123183966519678,1.4712684359913033,0.06445993031358885,0.5599724586643559,1.0,7/34,8.32%,CELF2;BDKRB2;TPM1;TNNT2;DMPK;ACE;CAMK2D
prerank,positive regulation of kinase activity (GO:0033674),0.42358589902397126,1.4710634634146262,0.021875,0.5577561711189941,1.0,22/107,8.75%,PRKAG2;EPHA7;EPHA3;FGFR2;FGFR4;KIT;LMO4;PDGFRB;ALS2;EPHA8;PDGFRA;EPHA4;DDR1;MRNIP;SNX9;IGF1R;DDR2;XRCC5;CCL19;RYK;CSF1;MUSK
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.5337256475480563,-1.4706679767884445,0.043568464730290454,0.3538093767798873,1.0,12/21,32.10%,CAV1;PLTP;NFKBIA;PTCH1;NR1H2;ABCA3;ZDHHC8;NR1H3;GPS2;TREM2;ABCA7;PPARG
prerank,urogenital system development (GO:0001655),0.6643422008325994,1.4703714999188313,0.08928571428571429,0.5573775498038726,1.0,2/11,3.35%,OSR1;ANXA1
prerank,carbohydrate homeostasis (GO:0033500),0.4488867474986087,1.4695879978780662,0.032467532467532464,0.5571775156391938,1.0,11/67,8.15%,LEPR;TCF7L2;APPL2;FGFR4;RBP4;PRKAA2;IGF1R;IL6;PRKAA1;MCU;SLC30A8
prerank,odontogenesis (GO:0042476),0.5092965314932052,1.4693482240239752,0.056776556776556776,0.5553157449596349,1.0,10/35,13.89%,OSR1;FGFR2;WNT6;COL1A2;ANKRD11;BCOR;AXIN2;HDAC1;GLI2;LAMB1
prerank,regulation of heart contraction (GO:0008016),0.433762495108002,1.4676089251714017,0.028616852146263912,0.5583367979612959,1.0,14/90,6.09%,CELF2;ATP1A2;ITPR1;SLC8A3;TPM1;STIM1;CORIN;ATP1B3;TNNT2;SLC8A1;DMPK;ANK2;NPR2;TMEM65
prerank,response to amino acid (GO:0043200),-0.475465157139039,-1.4675972495438605,0.05138339920948617,0.3601317012398901,1.0,19/31,28.92%,SH3BP4;CAPN2;MTOR;SESN2;LAMTOR1;XBP1;GRIN1;CPEB1;SPAAR;LAMTOR2;GLRA3;RRAGB;TMBIM6;NSMF;LAMTOR4;GLRA1;MEAK7;CPEB3;RPTOR
prerank,epithelial cell morphogenesis (GO:0003382),0.5895089826875326,1.467566210276168,0.07216494845360824,0.555710268831674,1.0,2/17,4.88%,COL22A1;COL18A1
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.5663691554360203,1.464469235299439,0.07269155206286837,0.5635169463994482,1.0,4/21,6.20%,DCDC2;TEDC2;TTC23;ARMC9
prerank,positive regulation of DNA repair (GO:0045739),0.48414328657380795,1.4642742239858348,0.0415944540727903,0.5614331172367805,1.0,6/46,9.12%,EYA4;EYA1;EYA2;SPIRE2;SLF1;CEBPG
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.5860630351504467,1.4638334211597612,0.07692307692307693,0.560226889619092,1.0,5/19,4.24%,TGFBR3;RBPJ;FGFR2;RBP4;VGLL4
prerank,regulation of amyloid fibril formation (GO:1905906),-0.562381380177214,-1.4631554574807903,0.05731225296442688,0.37067893535073015,1.0,9/15,28.80%,APP;CRYAB;CLU;IAPP;PFDN6;PFDN5;PSEN1;PFDN4;TREM2
prerank,regulated exocytosis (GO:0045055),-0.34706413200383623,-1.4630735750672885,0.0035211267605633804,0.36938574904737925,1.0,49/173,14.40%,PCDH7;ABCC4;VWF;FN1;PECAM1;TMSB4X;ACTN4;THBS1;TGFB2;GAS6;CD9;CALM1;RAB31;PSAP;LHFPL2;TAGLN2;FLNA;ACTN1;WDR1;STX1A;ENDOD1;TGFB1;CD109;FAM3C;SOD1;VTI1B;RAB11FIP1;CLEC3B;APP;MYH9;VEGFA;SRGN;CYRIB;A2M;CD63;PCLO;SYT10;CYB5R1;SNAP25;CDC37L1;SYT4;CPLX2;SDF4;CLU;RAB11FIP5;ALDOA;MAGED2;PIP5K1C;TMED10
prerank,regulation of protein-containing complex assembly (GO:0043254),-0.36890060742946523,-1.4623279695724902,0.014577259475218658,0.36983691321544915,1.0,41/110,22.44%,FNIP2;HSPA8;TFRC;HSP90AA1;GSN;DAB2IP;RACK1;RPS3;SH3GLB1;WARS1;TGFB1;HJURP;MPP7;FAF1;GFAP;GSK3B;CRYAB;VEGFA;NAPB;SPIDR;RALB;HSPA5;TAL1;PIH1D1;SVIP;CLU;RAF1;TPPP;IAPP;PREB;CDC42EP2;PINK1;NOP53;MMP1;TIRAP;PEX5;BIK;HDAC6;BMF;VCP;MTLN
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.6019414398059157,-1.461428187018949,0.045275590551181105,0.37080746505651685,1.0,3/12,2.95%,FOXP1;KLF4;MBP
prerank,cellular response to glucose starvation (GO:0042149),0.49310126346588773,1.4611152323152699,0.05319148936170213,0.5666950429231362,1.0,11/41,8.65%,PRKAG2;PRKAG3;SZT2;CPEB4;SIK1;SESN1;MTMR3;PRKAA2;PRKAA1;ATG14;PIK3R4
prerank,NADH dehydrogenase complex assembly (GO:0010257),-0.422420986877022,-1.460990492113408,0.030534351145038167,0.36882948858240805,1.0,27/56,33.59%,NDUFC2;NDUFA7;NDUFA5;NDUFA6;NDUFB5;NDUFAF4;NDUFA12;NDUFV1;NDUFB7;NDUFA13;NDUFS1;NDUFB11;NDUFB10;NDUFA1;NDUFB4;NDUFAF8;NDUFS7;BCS1L;DMAC2;NDUFAF3;NDUFC1;ACAD9;NDUFS2;NDUFS5;TMEM126A;NDUFAB1;NDUFA3
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.422420986877022,-1.460990492113408,0.030534351145038167,0.36882948858240805,1.0,27/56,33.59%,NDUFC2;NDUFA7;NDUFA5;NDUFA6;NDUFB5;NDUFAF4;NDUFA12;NDUFV1;NDUFB7;NDUFA13;NDUFS1;NDUFB11;NDUFB10;NDUFA1;NDUFB4;NDUFAF8;NDUFS7;BCS1L;DMAC2;NDUFAF3;NDUFC1;ACAD9;NDUFS2;NDUFS5;TMEM126A;NDUFAB1;NDUFA3
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.6190285520640755,-1.4606791692034535,0.043912175648702596,0.3681753051630266,1.0,5/11,19.19%,NOTCH1;FOXO1;LMNA;GLRX3;ATP2B4
prerank,modification-dependent macromolecule catabolic process (GO:0043632),-0.6367889000069316,-1.4602949736213813,0.06826568265682657,0.36767274380522846,1.0,6/10,15.15%,UBB;NEDD8;UBC;RPS27A;ISG15;UBA52
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.6156194144056237,-1.4601999137427593,0.064030131826742,0.36640512085002397,1.0,7/11,20.27%,NDUFA13;TIMM9;ROMO1;TIMM10B;TIMM13;TIMM29;TIMM22
prerank,peptide catabolic process (GO:0043171),0.5544259196479043,1.4599889752500097,0.08555133079847908,0.5677255115388166,1.0,5/23,7.04%,CPQ;CTSH;ACE;TPP1;NPEPPS
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.5718378745035022,1.4594685043577695,0.09215686274509804,0.5668798209961528,1.0,5/20,4.09%,ATP1A2;DMD;GSTM2;SLC8A1;ANK2
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.48487948640678097,1.4594084717400255,0.06371681415929203,0.5644237729720945,1.0,5/44,5.83%,PRKAG2;CYP27A1;INSIG2;HSD17B1;HSD17B10
prerank,synaptic vesicle cycle (GO:0099504),-0.47939627765349174,-1.458951382488597,0.06430155210643015,0.36815867800795765,1.0,15/30,29.38%,STX1A;SLC17A6;SYNDIG1;PCLO;SYT10;SNAP25;CPLX2;PIP5K1C;SYT7;CDK5;RAB3A;OTOF;CPLX1;SNAPIN;SLC32A1
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.6705600165458576,1.4587028166249096,0.10736842105263159,0.5640648819092065,1.0,1/10,0.21%,ATP1A2
prerank,prostanoid biosynthetic process (GO:0046457),-0.578767469764498,-1.4585771747197975,0.045548654244306416,0.3675831630200103,1.0,7/15,16.37%,PTGIS;PTGDS;EDN1;PTGS2;CD74;PLA2G4A;MIF
prerank,muscle cell development (GO:0055001),0.5207589564697556,1.457861696570384,0.06941838649155722,0.564216963093334,1.0,6/30,4.14%,IGF1;DMD;SLC8A1;MEGF10;ANK2;NEBL
prerank,negative regulation of stress fiber assembly (GO:0051497),0.5570575732399379,1.4573217814582413,0.0694980694980695,0.563403474936727,1.0,7/24,10.32%,ARHGAP28;ARHGAP6;CGNL1;PHLDB2;ARHGEF18;RHPN2;PIK3R1
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),-0.4827988775900849,-1.4569444020276368,0.04878048780487805,0.3702182152925386,1.0,16/30,29.30%,TPT1;ACKR3;RPS3;CD44;BCL2L1;DDX39B;CD74;CLU;MIF;CXCL12;CDKN2D;PTTG1IP;PSMD10;YJU2;SNAI2;TMEM161A
prerank,positive regulation of neuron migration (GO:2001224),-0.6198556631384846,-1.4567921665670862,0.0745697896749522,0.3691388062001917,1.0,7/11,22.93%,SEMA6A;DAB2IP;SHTN1;ARHGEF2;NSMF;PLAA;SEMA3A
prerank,negative regulation of nuclear division (GO:0051784),0.6514723277903705,1.4566499564246729,0.09494949494949495,0.563041765215987,1.0,3/11,4.91%,BMP7;DMRT1;TOM1L2
prerank,regulation of actomyosin structure organization (GO:0110020),0.6298238655316184,1.4564770522837391,0.09349593495934959,0.5610065543040661,1.0,5/13,6.05%,ROCK2;FHOD1;ALMS1;AKAP13;ASAP3
prerank,filopodium assembly (GO:0046847),-0.5595457928277401,-1.456176349969429,0.05952380952380952,0.3694416693041954,1.0,4/16,4.94%,DNM3;FGD5;FGD6;SPATA13
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.6071595472004091,1.4560601645405735,0.06952965235173825,0.5598786391758397,1.0,4/15,6.29%,SH3D19;SNX33;SNX9;NRDC
prerank,positive regulation of blood coagulation (GO:0030194),-0.5455722848627877,-1.4546710509495326,0.05870020964360587,0.37202175463474646,1.0,3/17,2.37%,ST3GAL4;THBS1;F3
prerank,actin filament bundle assembly (GO:0051017),0.5041890334787017,1.4541129766701257,0.08614232209737828,0.56396865316865,1.0,9/33,6.80%,PAWR;RHOD;DPYSL3;SHROOM2;CALD1;BAIAP2;ESPN;BAIAP2L2;LIMA1
prerank,intestinal absorption (GO:0050892),-0.5942422155859688,-1.453832469041767,0.06412825651302605,0.37260365042395427,1.0,4/13,11.51%,TJP2;F11R;KCNQ1;SLC26A6
prerank,amino acid import across plasma membrane (GO:0089718),0.5401520421561505,1.4537069293360685,0.07076350093109869,0.5626030077244867,1.0,5/24,2.01%,SLC22A4;SLC6A13;SLC22A2;SLC6A9;SLC1A3
prerank,regulation of cell growth (GO:0001558),-0.33480275127921955,-1.4536035890469874,0.0,0.3718058374969839,1.0,63/204,23.02%,APBB2;SLIT2;PTPRJ;LTBP4;TFRC;ADAM10;ACVRL1;TGFB2;ADAM15;NDRG3;FHL1;SH3BP4;RACK1;NET1;BMPR2;SOX17;CDK11B;CCDC85B;SOCS2;CCN3;RERG;BCAR1;OSGIN2;FAM107A;TGFB1;CEACAM1;KIF26A;APBB1;MTOR;MFSD2A;H3-3A;SESN2;RTN4;EIF4G1;LAMTOR1;CDKN1B;NDUFA13;RPS6KA1;EGLN2;SPOCK1;MT3;NRG3;JADE1;LAMTOR2;CDA;CISH;SGK1;AGTR1;BST2;SUPV3L1;WFDC1;PAK5;AKT1;ESR2;CDKN1A;OSGIN1;PTCH2;PAPPA2;HYAL2;CDKN2D;BTG1;SIPA1;HSPA1B
prerank,nucleoside phosphate catabolic process (GO:1901292),-0.5850415735737402,-1.4534052604045187,0.06525911708253358,0.3709500960207394,1.0,3/13,9.11%,ENTPD1;ENTPD7;ENTPD2
prerank,negative regulation of cell-cell adhesion (GO:0022408),-0.44660408185629563,-1.4526133787546254,0.04708520179372197,0.3715889525829228,1.0,14/39,11.53%,PODXL;FXYD5;CDH1;JAG1;KLF4;PTK2;MBP;NOTCH1;NEXMIF;TGFB1;NOTCH4;VEGFA;BMP2;SPINT2
prerank,clathrin coat assembly (GO:0048268),-0.5610763609254683,-1.4521363121397541,0.06237816764132553,0.3714012663635325,1.0,5/15,11.59%,HIP1;SGIP1;HIP1R;PIK3C2A;NSG2
prerank,positive regulation of cartilage development (GO:0061036),0.6031112320411357,1.4518102470134027,0.09631147540983606,0.5664263985798724,1.0,3/17,2.82%,SOX5;SCX;SOX6
prerank,lung development (GO:0030324),0.5143352956224644,1.4515805375377455,0.058823529411764705,0.5646013015453641,1.0,7/33,5.81%,ERRFI1;FGFR2;RBP4;LOXL3;PDPN;ITGA3;FGF1
prerank,lamellipodium assembly (GO:0030032),-0.4829646595097719,-1.4512774440632776,0.060215053763440864,0.37232475116362534,1.0,9/26,5.95%,PARVB;ABLIM1;RAC1;CARMIL1;ITGB1;S1PR1;SPATA13;ARHGEF6;CCDC88A
prerank,regulation of osteoblast proliferation (GO:0033688),0.5819106966607679,1.4511307511611102,0.09330628803245436,0.5634623046932465,1.0,3/17,2.80%,NPR3;FGFR2;LTF
prerank,regulation of hydrolase activity (GO:0051336),-0.3891967991720938,-1.4510110514256824,0.018134715025906734,0.3715513906852653,1.0,14/71,4.15%,PRKG1;CHN2;FGD5;CAV1;EFNA5;FGD6;SIPA1L1;PLXND1;PTK2;RASIP1;ARHGAP27;DAB2IP;CHN1;PLXNA4
prerank,regulation of proteolysis (GO:0030162),-0.4196648210116587,-1.4509508941723435,0.03217821782178218,0.3702980161609019,1.0,19/48,21.60%,CAV1;LTBP4;CST3;SERPINE2;PERP;NEDD8;BAG6;DNAJC1;OGT;TBC1D10A;CASP8;SPOPL;CLN8;CYFIP2;CAMK2N1;PLAUR;CDK5;AKT1;HDAC6
prerank,negative regulation of macrophage activation (GO:0043031),0.5909405459844771,1.4499176373089795,0.09829867674858223,0.5649354974010361,1.0,2/16,4.23%,IL31RA;SYT11
prerank,regulation of muscle contraction (GO:0006937),0.5340845428184452,1.4489494046677067,0.07547169811320754,0.5654663863123706,1.0,3/26,2.25%,ATP1A2;TPM1;TNNC1
prerank,ganglioside metabolic process (GO:0001573),-0.5256757078578324,-1.4485549560384452,0.057203389830508475,0.3750580278628463,1.0,8/20,15.59%,ST6GALNAC3;ST8SIA4;ST6GALNAC5;HEXB;HEXA;ST8SIA6;ST8SIA2;GM2A
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.570452001895974,-1.447701550048976,0.07495069033530571,0.375787912479285,1.0,4/14,6.22%,PRKG1;MEF2C;SLIT2;IGFBP5
prerank,T cell homeostasis (GO:0043029),-0.6206791725796109,-1.447669613234191,0.06958250497017893,0.3744789345602938,1.0,8/10,30.32%,ZC3H8;FAS;PPP2R3C;JAK3;NCKAP1L;AKT1;FADD;PMAIP1
prerank,regulation of monooxygenase activity (GO:0032768),-0.50836574783894,-1.4471610474570717,0.06832298136645963,0.37423591807133655,1.0,7/23,7.40%,CAV1;NOS3;NOSTRIN;HSP90AA1;CALM1;DDAH1;DNM2
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.5132072109025768,-1.4465805393458224,0.05870020964360587,0.37438112306190385,1.0,12/22,34.61%,PTPRJ;CEACAM1;DGKZ;DUSP3;LAPTM5;CD300A;THY1;FCGR2B;EZR;GPS2;PTPN22;PHPT1
prerank,positive regulation of T cell mediated immunity (GO:0002711),-0.5038412530566291,-1.4454658215012113,0.05172413793103448,0.3758072959045677,1.0,5/22,12.87%,B2M;STX7;CD55;CYRIB;HSPD1
prerank,endodermal cell differentiation (GO:0035987),-0.46358732642773937,-1.4452664465303195,0.04121475054229935,0.37490505131193075,1.0,7/31,5.96%,COL8A1;FN1;COL12A1;COL6A1;ITGA5;ITGA4;LAMA3
prerank,response to unfolded protein (GO:0006986),-0.4276695035124229,-1.4444649118503845,0.05357142857142857,0.375538244272008,1.0,16/48,12.87%,HSPA8;HSP90AA1;HSP90AB1;DAB2IP;DNAJA1;STT3B;HSPB1;HSPA14;DERL1;ERP44;TOR1B;HSPA5;PTPN1;HSPB8;HERPUD1;HSPD1
prerank,protein localization to cell-cell junction (GO:0150105),-0.5554016378006497,-1.4444433579480316,0.06224899598393574,0.37424647271014894,1.0,8/15,9.48%,ACTB;ACTG1;TJP2;LSR;F11R;MPP7;TJP1;PAK2
prerank,aminoglycan biosynthetic process (GO:0006023),0.46427474353440823,1.4441952744125008,0.04909090909090909,0.5789708774085418,1.0,14/49,12.47%,B3GALT1;HS3ST3A1;PXYLP1;SDC2;HS3ST3B1;GPC6;GPC3;HAS1;XYLT2;NDST2;B3GALT6;UGDH;HS6ST1;GPC4
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.4021125006388749,1.4438125346254154,0.023703703703703703,0.5778044043990269,1.0,19/129,9.85%,RNF220;WLS;LRRK1;PTK7;LGR4;FGFR2;ZEB2;TBL1XR1;LYPD6;LRRK2;GPC3;FRAT1;PSME4;PSMA2;PSMA3;USP34;AXIN2;SMURF2;PSMD8
prerank,membrane depolarization during action potential (GO:0086010),0.5299266283151038,1.4437717397187475,0.07421150278293136,0.5754296834611093,1.0,4/26,4.86%,SCN7A;ATP1A2;SLC8A1;CACNA1D
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),0.5882704537596422,1.4436366577692046,0.07615230460921844,0.573320800608988,1.0,3/15,5.37%,DAB2;BMP2K;WASL
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.5458032802951512,1.4432385464002455,0.07155963302752294,0.5721313301684527,1.0,9/23,10.36%,TGFBR3;DKK3;ITGA3;SMAD3;FOLR1;NREP;SMURF2;LATS1;BCL9
prerank,cellular response to BMP stimulus (GO:0071773),0.44285926924540303,1.443217899279153,0.048013245033112585,0.5697221499695235,1.0,10/66,7.51%,ADAMTS12;TGFBR3;BMP6;BMP7;SMAD6;SLC39A5;SCX;ADAMTS7;SMAD3;RGMB
prerank,positive regulation of DNA binding (GO:0043388),0.5153606091852564,1.4428839800115194,0.07913669064748201,0.568262125549527,1.0,5/31,9.12%,IGF1;PRKN;NIBAN2;MMP9;CEBPG
prerank,lymphocyte mediated immunity (GO:0002449),-0.6004741827068142,-1.4427683686227752,0.07003891050583658,0.3773479932797654,1.0,4/12,17.18%,JAG1;CD55;MSH2;BTN3A3
prerank,positive regulation of tumor necrosis factor production (GO:0032760),-0.3893423893124335,-1.4424533593929527,0.014634146341463415,0.3768031268685136,1.0,34/69,33.94%,PTPRJ;IL33;THBS1;PLCG2;LBP;HSPB1;PTPRC;APP;STAT3;OAS2;ARHGEF2;CLU;IFNGR1;IFIH1;MIF;TYROBP;PSEN1;FRMD8;TIRAP;AGER;CCR2;DDT;SPHK2;TLR4;RASGRP1;FADD;C1QTNF4;MAVS;DHX9;NOD2;TLR1;LPL;SYK;IL1A
prerank,histone H3-K36 demethylation (GO:0070544),0.6295190477504324,1.442082268351268,0.12200435729847495,0.5685234696897228,1.0,4/10,7.85%,KDM7A;KDM2B;PHF8;KDM2A
prerank,granulocyte differentiation (GO:0030851),-0.5403229706966244,-1.4420430956734325,0.06275303643724696,0.3764866066257461,1.0,8/18,22.47%,LEF1;CBFA2T3;LBR;TAL1;CDK2;SPI1;CDKN1A;CEBPA
prerank,positive regulation of interleukin-6 production (GO:0032755),-0.3947037667602445,-1.4419716075445859,0.02040816326530612,0.37534168905165105,1.0,34/68,35.55%,IL33;PLCG2;MBP;LBP;APP;XBP1;STAT3;CD74;ARHGEF2;HSPD1;IFIH1;TYROBP;MYD88;TIRAP;HYAL2;AGER;RAB7B;SPHK2;TLR4;TLR7;C1QTNF4;MAVS;TLR6;DHX9;NOD2;TLR1;NOS2;LPL;SYK;IL1A;F2R;IL16;TSLP;TLR8
prerank,regulation of stress fiber assembly (GO:0051492),0.43424558293525106,1.4419368572922293,0.03858520900321544,0.5665706877245864,1.0,17/74,10.32%,ARHGAP28;ROCK2;ARHGAP6;CGNL1;TPM1;LPAR1;FHOD1;CCN2;ALMS1;PPM1E;PHLDB2;ASAP3;ARHGEF10L;ARHGEF18;RHPN2;ABL1;PIK3R1
prerank,retrograde axonal transport (GO:0008090),-0.5439045381679866,-1.4415119584133673,0.06097560975609756,0.3751917959512527,1.0,8/16,25.08%,DLG2;ACTR10;SOD1;KIF1A;TMEM108;NEFL;MAP1A;HAP1
prerank,renal system development (GO:0072001),0.46230568028438757,1.4411972142996163,0.05237315875613748,0.5665174431007792,1.0,14/52,12.27%,GREB1L;WNT4;RBP4;LRP4;PCSK9;PYGO1;ARL3;SULF1;ACE;SALL1;IFT27;TFAP2A;TFAP2B;GLI2
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.5481654832459886,1.440371177120099,0.08224299065420561,0.5667905431493563,1.0,6/21,11.87%,IGF1;MMP2;GJA1;MMP9;FGF9;BMPR1A
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),-0.6204155505965393,-1.4402346997570425,0.06896551724137931,0.3770731616083125,1.0,7/10,15.63%,PDE4D;PDE3A;PDE2A;RNF157;UBE2B;PDE11A;APLNR
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.4939610164625292,1.4393820342578652,0.05871886120996441,0.5676378123811293,1.0,5/38,7.94%,BMP6;SASH1;DDX60;PRKCA;POLR3G
prerank,positive regulation of macrophage activation (GO:0043032),-0.5399545918213567,-1.439362546233012,0.07578947368421053,0.3780956714813552,1.0,9/17,30.74%,IL33;THBS1;LBP;HSPD1;CEBPA;TLR4;KARS1;TREM2;TLR6
prerank,regulation of water loss via skin (GO:0033561),-0.5650015869617083,-1.4391389242208719,0.05622489959839357,0.37599558015229023,1.0,9/15,32.34%,LSR;MET;HRNR;ALOX12;STMN1;SFN;UGCG;ALOXE3;TMEM79
prerank,establishment of skin barrier (GO:0061436),-0.5650015869617083,-1.4391389242208719,0.05622489959839357,0.37599558015229023,1.0,9/15,32.34%,LSR;MET;HRNR;ALOX12;STMN1;SFN;UGCG;ALOXE3;TMEM79
prerank,angiogenesis involved in wound healing (GO:0060055),-0.6224154519743144,-1.4387822208344738,0.07421150278293136,0.37544331509906076,1.0,6/11,7.98%,ADIPOR2;CD34;KDR;GATA2;MCAM;VEGFA
prerank,alcohol catabolic process (GO:0046164),0.6532194926610919,1.437379655402611,0.1054945054945055,0.5717549654939673,1.0,2/10,2.08%,CYP27A1;CEL
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.41261972359642124,-1.4363121426611292,0.022573363431151242,0.38060664767678243,1.0,28/54,23.59%,RPL11;RPL6;RPL26;RPL24;RPL23A;RPL3;RPL5;RPL14;RPLP0;MAK16;RPL35A;RPL7A;RPL7;RSL1D1;RSL24D1;RPF1;HEATR3;EBNA1BP2;NOP53;NLE1;RRP15;NOC2L;NHP2;EIF6;PPAN;WDR74;NOP16;NIP7
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.5325363228220014,1.4357486565855409,0.08867924528301886,0.5748608126606874,1.0,4/27,1.41%,ARHGAP28;ARHGAP6;CGNL1;PRKN
prerank,extracellular matrix organization (GO:0030198),0.36812441683969466,1.434372544196388,0.010568031704095112,0.5769755877987789,1.0,39/276,5.41%,COL22A1;ADAMTS12;NID2;COL26A1;ADAMTS9;LAMC3;COL4A5;ADAM12;ITGA9;FBN1;COL4A6;LAMA2;SMOC2;ADAMTS5;FBN2;THSD4;ADAMTS10;FBLN5;KLK2;FLRT2;ADAMTS15;TNC;PXDN;LOXL1;NID1;COL9A2;SCX;LOXL3;MMP2;NDNF;COL1A2;SMOC1;SH3PXD2B;ITGAX;COL13A1;DDR1;COL18A1;ADAMTS7;ITGA3
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.5569924668048585,1.4340181656059612,0.10325047801147227,0.5757090280532987,1.0,5/21,4.09%,ATP1A2;DMD;GSTM2;SLC8A1;ANK2
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.44398966402476475,1.4338609822996282,0.048465266558966075,0.5738062073920647,1.0,13/67,7.11%,EFEMP1;EPHA3;FGFR2;FGFR4;KIT;PDGFRB;FER;PDGFRA;EPHA4;ABI2;DDR1;IGF1R;DDR2
prerank,regulation of T cell migration (GO:2000404),-0.53786324498981,-1.4331096652254645,0.05473684210526316,0.3877414368060141,1.0,5/18,9.72%,LRCH1;APOD;CD200;APP;RHOA
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.4639064008247566,-1.4328407071330822,0.047109207708779445,0.3870807470395386,1.0,13/30,23.49%,CAV1;SEMA4D;PTPRC;SRCIN1;CADM4;SAMSN1;INPP5F;SH2B3;PRKCD;CD300A;THY1;HYAL2;SOCS1
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.4620876181720377,-1.432770042117643,0.04504504504504504,0.38590793113987976,1.0,19/31,30.32%,PPP1R13B;YWHAB;NMT1;GSK3B;HIP1R;MAPK8;YWHAG;BBC3;CASP8;YWHAQ;YWHAH;PPP3R1;CHCHD10;BAX;PPP3CC;YWHAZ;BID;SFN;PMAIP1
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.511254829042215,1.431628395844299,0.08743169398907104,0.5788627250076832,1.0,12/30,11.62%,TGFBR3;DKK3;ITGA3;SMAD3;FOLR1;NREP;FSTL3;SMURF2;LATS1;BCL9;TFAP2B;FSTL1
prerank,DNA synthesis involved in DNA repair (GO:0000731),-0.4410823796395777,-1.4307658860595935,0.05301204819277108,0.38987687619723144,1.0,21/42,24.53%,UBB;TRIM25;UBC;RPS27A;WRNIP1;ISG15;RPA1;UBA52;USP43;POLK;FAAP20;POLA1;SPRTN;POLN;POLE;POLD3;CDKN2D;VCP;POLD1;POLI;DTL
prerank,organic cation transport (GO:0015695),0.5586509819291715,1.430681542198472,0.09568480300187618,0.5795691672334727,1.0,2/20,0.72%,SLC22A4;SLC22A2
prerank,regulation of response to cytokine stimulus (GO:0060759),-0.5091120216917606,-1.4305491251226725,0.06289308176100629,0.3891505608715412,1.0,8/19,18.50%,LIFR;CBFB;KLF4;RUNX1;TLE5;IFIH1;IRAK1;SH2B3
prerank,activation of protein kinase A activity (GO:0034199),0.5812504044001876,1.4293407413088077,0.111328125,0.5816656214715051,1.0,2/16,0.72%,ADCY5;ADCY1
prerank,embryonic limb morphogenesis (GO:0030326),0.49081027390470106,1.4289749457093763,0.08392857142857142,0.5806080308982504,1.0,7/34,6.93%,CYP26B1;OSR1;INTU;FBXW4;GLI3;SALL1;WDPCP
prerank,cellular response to acid chemical (GO:0071229),-0.4869566742931941,-1.4283537767774455,0.05973025048169557,0.39370341397025677,1.0,17/27,28.92%,KLF2;SH3BP4;CAPN2;MTOR;VEGFA;SESN2;LAMTOR1;XBP1;CPEB1;SPAAR;LAMTOR2;RRAGB;NSMF;LAMTOR4;GLRA1;CPEB3;RPTOR
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.6642369741748269,1.4282772098283072,0.11740890688259109,0.5805113089369401,1.0,4/10,8.32%,OSR1;NEDD4;PCSK9;CAMK2D
prerank,regulation of anatomical structure morphogenesis (GO:0022603),-0.35096212829756335,-1.4277412506106135,0.024096385542168676,0.3940834144681385,1.0,33/118,9.86%,FMNL2;MEF2C;SHANK3;EFNA5;SIPA1L1;BMPER;PLXND1;NEDD4L;ETS1;CDH2;PHLDB1;CHN1;SEMA4D;TBX1;WARS1;ZDHHC15;TGFB1;INF2;FERMT2;CTNNB1;PPFIA2;CEACAM1;GSK3B;FLT4;ZRANB1;ABI3;EMP2;LFNG;SRCIN1;CYRIB;PAK1;PAK2;KIF1A
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.6569276397142102,1.4277393704492396,0.09933774834437085,0.5800068221626743,1.0,2/10,8.96%,ADGRV1;WHRN
prerank,carboxylic acid transmembrane transport (GO:1905039),0.4778199547595367,1.4276927460375242,0.06951871657754011,0.5777952414189773,1.0,10/40,12.73%,SLC7A11;SLC13A3;SLC38A3;SLC38A9;SLC25A11;SLC27A1;SLC19A1;SLC36A2;SLC38A7;SLC38A2
prerank,sodium ion export across plasma membrane (GO:0036376),0.6088981880502395,1.4274430146314288,0.09297520661157024,0.5763178776118003,1.0,2/13,2.41%,ATP1A2;ATP1B3
prerank,amino acid transmembrane transport (GO:0003333),0.4680048679530231,1.4269457808664703,0.06914893617021277,0.5756668314906275,1.0,8/45,6.79%,SLC7A11;SLC22A4;SLC6A13;SLC22A2;SLC38A3;SLC25A18;SLC38A9;LRRC8E
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.47302972984296615,1.4267886907257468,0.07155635062611806,0.5738722950969698,1.0,8/46,7.14%,IGF1;TCF7L2;IL18;OGN;PDGFRB;CCN4;IL6;XRCC5
prerank,positive regulation of cell migration (GO:0030335),-0.3223475079765292,-1.4254555903011117,0.0,0.3988578038182247,1.0,70/253,13.52%,LEF1;GAB1;NTRK3;FN1;PECAM1;PODXL;CAV1;ACTG1;SEMA6A;ACTN4;SEMA7A;ITGA6;TIAM1;SEMA6D;KDR;THBS1;ADAM10;TGFB2;CARMIL1;SEMA3C;F3;ITGB1;PTK2;PLCG2;DOCK1;PTK2B;DAB2IP;NOTCH1;SEMA4D;RACK1;BMPR2;SHTN1;ROR2;SEMA3E;BCAR1;FAM107A;TGFB1;FERMT2;PTPRC;TJP1;PDGFC;MYOC;MTOR;VEGFA;PDCD10;GRN;PAK1;CPNE3;SEMA4B;EDN1;SEMA5B;RTN4;APC;SEMA6C;PIK3CD;HSPA5;XBP1;BMP2;SEMA3G;STAT3;GCNT2;CDH13;GPER1;TWIST2;RIPOR1;ARHGEF2;CCN1;PPP3CA;NEDD9;RET
prerank,positive regulation of GTPase activity (GO:0043547),-0.3348346563521591,-1.4251487214404017,0.0,0.39835273420742323,1.0,48/188,12.15%,DOCK9;NTRK3;RAP1A;SIPA1L1;RGS6;ITGA6;TIAM1;BCAR3;PKP4;TBC1D30;AGRN;ARHGAP42;ITGB1;TBC1D8;F11R;SIPA1L2;ARHGAP27;CAV2;SEMA4D;RACK1;NET1;DOCK10;ARHGEF15;CCDC125;SIPA1L3;TGM2;RABGAP1L;LIMS1;CORO1C;FERMT2;ADPRH;ABR;GRTP1;SGSM1;BCR;GSK3B;TBC1D8B;TBC1D1;ARHGEF19;TBC1D13;ARHGEF26;ARHGAP25;ARHGEF5;ARHGEF10;EVI5;RANGAP1;TBC1D10A;S100A10
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.5617245952952398,1.4249918368363916,0.12546125461254612,0.5775086925017445,1.0,3/17,1.28%,ATP1A2;TFPI;BMP7
prerank,positive regulation of chemotaxis (GO:0050921),-0.43025793741018226,-1.4249789504271357,0.05236907730673317,0.39743691991745506,1.0,11/43,7.98%,NTRK3;TMSB4X;KDR;THBS1;STX3;F3;LGMN;HSPB1;TGFB1;MET;VEGFA
prerank,protein N-linked glycosylation via asparagine (GO:0018279),-0.4607172264413624,-1.424187454687051,0.06079664570230608,0.398099477426974,1.0,14/30,26.35%,ST6GAL1;FUT8;MAGT1;STT3B;MCFD2;RPN1;MGAT1;DDOST;MGAT2;ALG5;DPM1;ALG8;MGAT5;UBE2J1
prerank,positive regulation of cell differentiation (GO:0045597),0.36474938324789075,1.4241532447118632,0.013550135501355014,0.5777723374635062,1.0,32/237,7.36%,IGF1;RANBP3L;SOX5;BMP6;TCF4;RIN2;WNT4;IL18;BMP7;FBN2;MEDAG;DAB2;HOXB4;ZEB1;CCN2;PLA2G10;LTF;SOX6;PLCB1;CCN4;PDPN;RIPOR2;MAPK9;GLIPR2;GJA1;TMEM64;PTN;IL6;SMAD3;DDR2;NBL1;LMO3
prerank,positive regulation of cell aging (GO:0090343),-0.603421327755321,-1.4233875186310299,0.08704061895551257,0.39895581136462954,1.0,5/11,18.10%,B2M;YPEL3;ABI3;LMNA;EEF1E1
prerank,negative regulation of cell-matrix adhesion (GO:0001953),-0.4570956395640235,-1.42298367012878,0.047325102880658436,0.39870315194135225,1.0,12/32,9.10%,APOD;ACER2;THBS1;ACVRL1;JAG1;ADAM15;SEMA3E;CORO1C;FAM107A;NEXMIF;MYOC;AJAP1
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.49408155452486535,-1.4227493383536103,0.06597938144329897,0.39793579614632263,1.0,10/23,18.15%,UBB;COPS7A;UBC;RPS27A;RBX1;DDB1;UBA52;COPS8;CETN2;COPS6
prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.3688960215614368,-1.4227393748028239,0.03089887640449438,0.3966329384599783,1.0,40/94,23.64%,RPS6KA5;UBB;NFKBIA;NOD1;IKBKB;ST18;UBC;RPS27A;IL1R1;IL1RAP;PSMD13;RBX1;PSMF1;PSMB10;CHUK;PSMB6;TOLLIP;PSME3;PSMB5;PSMC3;MAP3K3;TAB3;MAP3K8;PSMD12;PSMB8;IRAK3;PSME1;CUL1;UBA52;PSMB3;RPS6KA4;IRAK1;PSMD5;MYD88;SKP1;MAPK3;PELI1;PSMD9;PSMB4;RELA
prerank,protein mono-ADP-ribosylation (GO:0140289),0.6403738743417958,1.4226537192251534,0.112,0.5802580142617997,1.0,6/11,19.51%,PARP4;PARP10;PARP12;PARP9;TIPARP;PARP14
prerank,negative regulation of ossification (GO:0030279),0.5263272549742073,1.4225236915962554,0.0916030534351145,0.5784206231602689,1.0,7/23,6.54%,RBPJ;LRP4;SMAD6;DKK1;ECM1;CHSY1;BCOR
prerank,cell junction organization (GO:0034330),-0.38977763903095275,-1.4204748581300712,0.034229828850855744,0.4009407203071768,1.0,19/71,7.59%,APBB2;ACTB;ACTG1;OCLN;TJP2;LIMS2;TGFB2;CTNND2;AGRN;CXADR;SEMA3E;FLNA;LIMS1;TGFB1;FERMT2;PPFIA2;TJP1;VMP1;APP
prerank,protein O-linked mannosylation (GO:0035269),0.5599521488892407,1.420318867417603,0.08583690987124463,0.5835310187659897,1.0,4/18,4.32%,TMTC4;LARGE1;TMTC1;CRPPA
prerank,regulation of intracellular protein transport (GO:0033157),-0.4528735959347327,-1.4195576210404428,0.05806451612903226,0.4020311024279322,1.0,11/32,21.56%,PRR5L;PTPN14;TGFB1;PDCD10;OAZ1;PTPN1;RIPOR1;ATP13A2;BMP4;UHMK1;SIRT7
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.38323101963512396,1.4189513856396865,0.02401129943502825,0.5856637725499608,1.0,28/161,10.34%,BICC1;IGFBP2;TCF7L2;MCC;PRKN;LRP4;DAB2;DKK3;RBMS3;DKK1;IGFBP4;PRICKLE1;INVS;GLI3;TMEM64;TLE3;ZNRF3;PSME4;PSMA2;PSMA3;SIAH2;TLE1;AMFR;AXIN2;PSMD8;HDAC1;LATS1;DVL3
prerank,cellular response to nerve growth factor stimulus (GO:1990090),-0.4955024884746876,-1.4186102743540114,0.05652173913043478,0.4033599704989712,1.0,9/22,21.53%,NTRK3;RAP1A;NGF;EHD1;STMN2;TMEM108;SH3GL2;AKT1;KIDINS220
prerank,intraciliary retrograde transport (GO:0035721),0.6271612192341384,1.4184669994264887,0.10845986984815618,0.584972243926796,1.0,6/12,17.07%,DYNC2H1;WDR19;WDR35;IFT122;IFT140;DYNC2I1
prerank,negative regulation of receptor binding (GO:1900121),-0.6232735048892167,-1.4183399106785335,0.07543520309477757,0.40282015118964504,1.0,4/10,8.02%,B2M;ADAM15;ATP2A3;ATP2A2
prerank,negative regulation of gluconeogenesis (GO:0045721),0.6379260898243265,1.4181846983603033,0.10897435897435898,0.5836807541562875,1.0,5/11,18.42%,C1QTNF3;SIK1;CRY1;GCK;C1QTNF12
prerank,regulation of macrophage migration (GO:1905521),-0.6142759916953328,-1.4181427038744514,0.09622641509433963,0.40213451330115846,1.0,5/10,15.51%,MTUS1;CD200;PTK2B;CD81;CX3CR1
prerank,regulation of histone methylation (GO:0031060),0.6144410319407303,1.4181271567293618,0.11316872427983539,0.5815883041238114,1.0,5/13,9.70%,AASS;JARID2;MTHFR;TET1;NSD1
prerank,protein localization to plasma membrane (GO:0072659),-0.3474539406020333,-1.4174589778316753,0.008955223880597015,0.4025896738197511,1.0,36/129,13.07%,SPTBN1;BSG;RAP1A;EFR3B;GAS6;CDH1;SLMAP;KCNB2;EHD4;RAMP2;F11R;RAB3C;ATP1B1;KCNB1;FLNA;MAP7;IKBKB;CCDC88A;EHD1;NKD2;WNK3;RAMP1;PTCH1;TMED2;EMP2;ZDHHC2;C2CD5;TSPAN17;TTC7A;RAB3B;CACNB2;S100A10;SPTBN4;CD81;EHD3;MYO5A
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.49246706651909006,1.4165160671852055,0.06928838951310862,0.5841963677220094,1.0,5/37,4.56%,PRKAG2;CEMIP;BMP7;PARD3;SPHK1
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.5839806777940925,1.4158313263686992,0.10693069306930693,0.5841950237804677,1.0,5/14,11.86%,IL18;ANXA1;PRKCZ;CCL19;MYB
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.46096905790558723,-1.415788949926904,0.06950672645739911,0.40551349449391627,1.0,13/30,22.20%,RPL11;HSP90AB1;UCHL5;UBXN1;BAG6;CAMLG;OGT;RYBP;SVIP;N4BP1;NOP53;TLK2;MAP1A
prerank,aorta development (GO:0035904),0.6011107954112511,1.4151159386567669,0.11244979919678715,0.5841491542230076,1.0,3/14,2.84%,ADAMTS9;ROBO1;PDGFRB
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.5079298631132534,1.414264608137836,0.09266409266409266,0.5845950835553244,1.0,2/29,1.18%,IGF1;NOTCH2
prerank,long-chain fatty acid transport (GO:0015909),0.5092430731202735,1.4140726753706274,0.09041591320072333,0.5828956611226249,1.0,6/30,10.49%,PRKAG2;ACSL1;PRKAA2;CPT2;SLC27A1;RPS6KB1
prerank,cellular response to glucagon stimulus (GO:0071377),0.5709191571100134,1.4137001881489215,0.11960784313725491,0.5819982330444263,1.0,2/17,0.72%,ADCY5;ADCY1
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.3932417536585659,1.4136005986235092,0.022727272727272728,0.5801829114818616,1.0,13/121,7.35%,IL31RA;IGF1;BMP6;IL34;IL18;KIT;ANGPT1;IGF2;EPHA4;ACE;ENPP2;IL6;VTN
prerank,regulation of protein localization to membrane (GO:1905475),-0.46366494751313264,-1.4131310555416463,0.07079646017699115,0.41119950779681724,1.0,10/28,9.08%,SPTBN1;ACTB;GSN;FYN;STX7;VAMP8;VTI1B;ZDHHC2;ZDHHC7;APPL1
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.32273768078250453,1.4130829289236515,0.0,0.579675475807764,1.0,297/1668,13.52%,IGF1;GLIS3;CREB5;RORA;PRDM6;SOX5;BMP6;MAF;VGLL3;TCF7L2;TCF4;OSR1;AUTS2;AEBP1;RBPJ;ARNT2;ZIC1;ZNF462;HOXC6;FHL2;FGFR2;PPARA;EPAS1;HLF;NR2F2;KDM7A;PID1;IKZF2;NPAS3;IL18;KIT;HOXC4;CDK8;ATXN1;ZEB2;WWOX;PRKN;BRD8;KMT2A;KCNIP3;ZKSCAN2;PRRX1;MEIS1;DAB2;HOXB4;ARID5B;ESRRG;FHOD1;MXI1;CSRP3;FNIP1;ZEB1;AASS;SMAD6;CUX1;MYBL1;PRDM5;SATB1;ZIC2;EBF1;ZBTB20;DKK1;DMRT1;SCX;NR1I2;ASCL2;SOX6;SP100;TBL1XR1;CITED4;HOXB3;TSHZ3;RNASEL;PPARGC1B;PAX5;HIF3A;NFYB;EPOP;CDK7;MIDEAS;ZIC5;BBX;HOXA3;PKNOX2;SSBP2;IGF2;STAT5B;MAML3;HOXC5;VSX2;TFR2;JAZF1;NCOA2;NFAT5;ZHX2;ELOA;ZFP90;HDAC8;ELF4;TEAD1;SSU72;HOXA7;FOXD1;ZNF367;RNF2;BAZ1B;MGA;NFIB;ARID1B;ARID4A;TNRC6B;TEF;KDM2B;CAMTA1;GMEB1;IKZF4;FIZ1;ZNF250;SOX1;SP110;GLI3;SALL4;ZFHX2;SIX5;WASL;DPF2;IRF8;TNRC6A;ZMIZ1;FGF1;BAZ1A;HIVEP2;ZNF569;SUFU;PRKCB;TET1;CXXC5;ZBTB32;MYNN;MXD1;MAML1;ZFP37;TCF7L1;DLG1;PHF8;SALL1;CBX8;BCOR;WWC1;THAP1;IL6;ZNF23;SMAD3;WWC2;NCOA3;TEAD3;KANK2;RFXAP;EN1;SSBP3;PTEN;CHD4;PHF14;PHF21A;GABPB1;GABPB2;NCOA7;PBX4;NR6A1;TCF12;KDM2A;MTF2;ZKSCAN5;ARNT;CCNT2;PIAS1;RSF1;CCNT1;LYAR;PER3;ABRA;GTF2F1;CAMK2D;MITF;RPRD1B;WWP2;NFIA;DNAJA3;CBX2;KDM5B;FSTL3;KAT8;KDM3B;CDK1;KAT6B;PCGF5;KDM6B;CEBPG;MDM2;CREB3L2;EBF4;NSD1;SMURF2;AKAP8L;FRK;IER5;IRF3;BBS7;ASXL2;MED13;MED1;ZSCAN29;NFYC;BATF2;HDAC1;ABL1;AGO2;HOXB6;PIK3R1;DVL3;BCL9;PHIP;PRKDC;IRX1;ZIC4;FLCN;PARP9;ZNF8;NEUROD2;TADA2A;ATOH8;ZBTB38;TSHZ1;SNAI1;SMARCA5;TFAP2A;SMARCE1;CBX7;HOXC8;TFAP2B;ZNF568;ARID3A;NPAS2;PRKD2;PKD2;ERBB2;ZNF177;CDC73;RXRA;ZBTB37;RNF14;MYB;BMPR1A;BCLAF3;TAF3;CNOT2;E2F6;INO80;ZBTB39;CRY1;CGGBP1;CRTC3;HIVEP1;CRTC1;MAML2;GLI2;ORC2;TGFA;SERPINE1;MLXIP;SMARCB1;FOXK2;GMEB2;EPC2;BATF;AR;IFI27;HSF1;PHF6;SOX13;EZH1;SRCAP;SEBOX;NFATC4;PPIL4;METTL23;KLF5;TBK1;HOXA6;DICER1;CLOCK;GDNF;NR1I3;TRAK1;CREBBP;ZMIZ2;HOXD4
prerank,negative regulation of stem cell differentiation (GO:2000737),-0.5764465484860049,-1.4124368312829825,0.0823045267489712,0.4115851750252901,1.0,5/12,12.25%,JAG1;NOTCH1;HES1;HNRNPU;REST
prerank,regulation of fibroblast migration (GO:0010762),-0.511887874646634,-1.412251775837407,0.06100217864923747,0.41068173046187445,1.0,9/20,9.08%,PRR5L;THBS1;RAC1;ITGB1;PTK2;CORO1C;TGFB1;GNA12;APPL1
prerank,keratan sulfate catabolic process (GO:0042340),0.6213825880012392,1.4122381937865858,0.10882956878850103,0.5800962530566101,1.0,4/11,5.12%,FMOD;OGN;OMD;PRELP
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.6046564585619433,1.4121928182037145,0.11065573770491803,0.5780912400878511,1.0,1/12,0.09%,CYP26B1
prerank,response to ATP (GO:0033198),-0.5220061492993948,-1.4120179868190212,0.08492569002123142,0.40999126393279317,1.0,13/18,43.73%,ABCC9;TRPC3;HSP90B1;SSH1;DGKQ;P2RY12;P2RY1;P2RX3;P2RX7;P2RY2;CIB2;KCNJ11;PDXP
prerank,neural crest cell development (GO:0014032),-0.4227964967780565,-1.4118749566545576,0.052060737527114966,0.40907728318438974,1.0,13/44,11.12%,SEMA6A;SEMA7A;SEMA6D;SEMA3C;CDH2;SEMA4D;TBX1;SEMA3E;CORO1C;SEMA4B;SEMA5B;SEMA6C;SEMA3G
prerank,negative regulation of protein ubiquitination (GO:0031397),-0.413914696574104,-1.4117540470545067,0.05442176870748299,0.4080413119206333,1.0,27/50,30.13%,CAV1;DNAJA1;RPS3;IVNS1ABP;UBXN1;SOX4;PINX1;ARRB1;CHP1;ISG15;CAMLG;OGT;NXN;SPOPL;PRMT3;N4BP1;PRKCG;ARRB2;AKT1;SIRT7;HSPA1B;TNFAIP3;SPRY2;PER2;SMAD7;VPS28;MINAR1
prerank,positive regulation of histone methylation (GO:0031062),0.5301568328121673,1.410590816864874,0.09345794392523364,0.5809018938374789,1.0,8/24,15.71%,AUTS2;KMT2A;JARID2;TET1;MTF2;MYB;PHF1;SMAD4
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.5384885652978388,1.4104104604542718,0.11450381679389313,0.5793094716255801,1.0,8/21,15.71%,BMP6;DAB2;RBPMS;SLC2A10;JAK2;BMPR1A;VEPH1;SMAD4
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.6054519859156268,1.4101694457331508,0.1125,0.5779729410501587,1.0,4/12,15.20%,ROCK2;PICALM;FLOT2;RANBP9
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.5944403623475514,1.4100408667323168,0.11904761904761904,0.57629431806427,1.0,5/13,11.62%,FBN1;FBN2;NBL1;CHRDL1;FSTL1
prerank,heart morphogenesis (GO:0003007),-0.4124293867429239,-1.4099147187667267,0.05141388174807198,0.41178545226303775,1.0,16/50,12.27%,NOS3;ACVRL1;TGFB2;PTK2;ENG;NOTCH1;TBX1;HES1;SOX17;TBX2;TBX3;VEGFA;RYR2;HEY2;BMP2;HEYL
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.5426788963862521,-1.4088828149979367,0.08518518518518518,0.41330132965852073,1.0,9/15,21.25%,ARPC1B;ARPC3;WHAMM;ACTR2;ARPC4;ARPC5L;ARPC1A;TRIM27;ACTR3
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.600678146240689,1.4086836790007993,0.12087912087912088,0.5783924209169247,1.0,2/13,3.83%,B3GALT1;GAL3ST3
prerank,response to ketone (GO:1901654),-0.4802228372050059,-1.4067560190037012,0.07053941908713693,0.4176242555225349,1.0,8/24,8.93%,ABHD2;SLIT2;CAV1;THBS1;TGFB2;UBE3A;TGFB1;WBP2
prerank,regulation of interleukin-2 production (GO:0032663),-0.42559503228561735,-1.406422975017219,0.06220095693779904,0.41722646903679517,1.0,16/43,25.59%,SPTBN1;PDE4D;CD34;RUNX1;PLCG2;RPS3;PTPRC;NAV3;STOML2;LAPTM5;HDAC7;TRIM27;CCR2;CD80;EZR;TNFAIP3
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.45975423815000804,1.40629025496827,0.08702791461412152,0.5837006182782153,1.0,4/53,2.44%,EYA4;EYA1;EYA2;PLA2R1
prerank,positive regulation of signal transduction (GO:0009967),0.36064792000270973,1.406182617096863,0.02063273727647868,0.5819414333083263,1.0,38/238,8.09%,IGF1;DCDC2;ROBO1;BMP6;SASH1;WLS;RBPJ;FGFR2;SMOC2;SORBS1;NLGN2;BMP2K;LOXL3;CCBE1;IGF2;MAML3;GRB10;MACF1;TEDC2;SULF1;TTC23;LRRK2;ZMIZ1;PRKCZ;FGF1;PRKCB;PDE6G;ARMC9;MAML1;SALL1;PRKCA;IL6;VTN;LMO3;PTEN;RWDD3;ARNT;GKAP1
prerank,negative regulation of locomotion (GO:0040013),-0.5862624011138715,-1.405527806457421,0.06374501992031872,0.4181730011776907,1.0,5/12,11.53%,FRMD5;CCDC125;CRK;DUSP3;SPINT2
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.3835792727021978,1.4049981282080994,0.033527696793002916,0.5836886876905777,1.0,23/152,9.85%,RNF220;WLS;LRRK1;PTK7;LGR4;FGFR2;ZEB2;TBL1XR1;MACF1;SULF1;LYPD6;LRRK2;GPC3;FRAT1;PSME4;PSMA2;SALL1;PSMA3;WNT5B;USP34;AXIN2;SMURF2;PSMD8
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.4322663458032094,-1.4046952754498792,0.06986899563318777,0.41903003265346545,1.0,15/36,22.20%,RPL11;HSP90AB1;UCHL5;UBXN1;BAG6;AQP11;PSMF1;CAMLG;OGT;RYBP;N4BP1;PRKCG;NOP53;TLK2;MAP1A
prerank,cellular copper ion homeostasis (GO:0006878),-0.5535537649041169,-1.4046015741100752,0.09146341463414634,0.41801692720596834,1.0,5/14,7.59%,ATOX1;MT2A;SLC31A1;ARF1;APP
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.5536592706544794,1.403839145256872,0.1017274472168906,0.5851198561749298,1.0,1/19,0.03%,IGF1
prerank,B cell receptor signaling pathway (GO:0050853),-0.4585995370255299,-1.4038284880334075,0.07205240174672489,0.4187479686845442,1.0,10/32,9.89%,MEF2C;PLCG2;BMX;BCAR1;NFATC2;CD38;RFTN1;PTPRC;PLEKHA1;PIK3CD
prerank,cellular response to decreased oxygen levels (GO:0036294),0.43904456291632415,1.403447654471726,0.0695364238410596,0.5842915343119093,1.0,11/65,9.22%,RORA;SLC8A3;EPAS1;BMP7;NDNF;CPEB2;CPEB4;BNIP3;NPEPPS;ACAA2;MDM2
prerank,regulation of steroid metabolic process (GO:0019218),0.5350513429606654,1.4033835251498148,0.1038961038961039,0.5823821434200488,1.0,3/23,5.73%,RORA;ACADL;EPHX2
prerank,proteasome assembly (GO:0043248),-0.5958242112461293,-1.4028769950853577,0.06679764243614932,0.4201785454576565,1.0,7/11,32.98%,PSMD13;POMP;PSMD5;OTUD6B;PSMD9;PSMD10;PSMG1
prerank,acidic amino acid transport (GO:0015800),0.55065458660558,1.402773124461851,0.10912698412698413,0.5822116023898268,1.0,7/17,9.18%,SLC6A13;SLC1A3;SLC6A1;SLC25A18;GJA1;LRRC8E;SLC25A22
prerank,regulation of kinase activity (GO:0043549),0.40820541691814766,1.4023810646487436,0.04285714285714286,0.5814309913655371,1.0,18/89,8.75%,EPHA7;EPHA3;FGFR2;FGFR4;KIT;LMO4;PDGFRB;SLAMF8;EPHA8;PDGFRA;EPHA4;DDR1;NPRL2;IGF1R;DDR2;RBL2;RYK;MUSK
prerank,regulation of steroid biosynthetic process (GO:0050810),0.6270480486290335,1.402179832611415,0.13709677419354838,0.5799579243323961,1.0,2/11,1.02%,WNT4;FGFR4
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.5209239568012778,1.402073281044086,0.11071428571428571,0.5782707364023918,1.0,7/28,11.91%,ARHGAP28;NAA80;ARHGAP40;COTL1;ARHGAP35;LATS1;GBA2
prerank,transcription by RNA polymerase II (GO:0006366),0.3539621443437716,1.4016778270715293,0.008928571428571428,0.5774364849506985,1.0,48/305,13.47%,GLIS3;RORA;SOX5;MAF;RBPJ;PPARA;NOTCH2;POLR2D;PRRX1;PHAX;ESRRG;CCN2;NR1I2;TBL1XR1;PAX5;CDK7;MAML3;ELOA;TEAD1;SSU72;MAML1;HSF2BP;TEAD3;INTS8;NR6A1;NRBP1;CCNT2;CCNT1;POLR2A;GTF2F1;RPRD1B;SNAPC5;MED1;HDAC1;TAF8;TAF1A;RPRD2;DTX1;CDC73;RXRA;TAF3;ICE2;MAML2;GMEB2;AR;GTF2I;NR1I3;CREBBP
prerank,post-Golgi vesicle-mediated transport (GO:0006892),-0.3663267272406904,-1.4006321042115857,0.04644808743169399,0.42470717691824894,1.0,26/88,14.86%,STXBP6;FTH1;HSPA8;EXOC6;FTL;MON2;CLINT1;EXOC4;VPS13A;VPS13C;CLVS2;CLVS1;GOPC;VAMP8;ARRB1;ARF1;DNM2;APP;GOLGA7;EXOC5;SCAMP1;HGS;SCAMP2;MYO5A;AP1S2;SORCS1
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),-0.5295714402800975,-1.4004939004998773,0.09980430528375733,0.4237919889218337,1.0,7/17,25.01%,PTPRJ;CEACAM1;DGKZ;DUSP3;LAPTM5;THY1;EZR
prerank,positive regulation of programmed cell death (GO:0043068),-0.309083438191464,-1.3999545801725923,0.008733624454148471,0.4240108507810612,1.0,78/272,20.17%,UNC13B;SLIT2;MAP3K5;MCF2L;ITGA6;TIAM1;RASSF2;TRIO;ARHGEF3;ITGB1;KCNMA1;RASGRF2;DAB2IP;NGF;UBB;DNAJA1;RACK1;NET1;TNFSF10;CTSD;ARHGEF12;PREX1;ATG7;TGM2;SFRP4;RPS6;ARHGEF17;RHOB;ARHGEF6;SOX4;CTNNB1;SOD1;FAF1;ABR;UBC;RPS27A;HIP1R;APBB1;DNM2;JUN;FOXO1;ARHGEF19;MAPK8;DDX20;ARHGEF26;ING4;APC;ARHGEF5;BMP2;ATF4;GPER1;REST;BIN1;RYBP;ARHGEF2;HSPD1;CLU;GADD45G;RNPS1;NLRP2B;FAS;UBA52;PLEKHN1;NF1;CASP8;LAPTM5;TOP2A;IAPP;GNA13;EEF1E1;IRF5;BMP4;FOXL2;TNFRSF10B;TFAP4;PLEKHG5;PSEN1;CTNNBL1
prerank,catecholamine metabolic process (GO:0006584),0.5997232867526877,1.3989985798433509,0.11728395061728394,0.5835554345909773,1.0,7/14,22.55%,PRKN;SNCAIP;RNF180;LRTOMT;DRD2;ATP7A;COMT
prerank,negative regulation of histone methylation (GO:0031061),0.6442895160603634,1.3983761948403897,0.11825726141078838,0.5835658227962179,1.0,4/10,7.92%,AASS;JARID2;BCOR;MTF2
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.6047723983559847,-1.3977637209726228,0.09345794392523364,0.4284659232111333,1.0,4/10,13.14%,SEMA6A;DAB2IP;XDH;CADM4
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.531331737417945,1.3970757176685626,0.10037878787878787,0.5856244200900889,1.0,5/24,7.98%,RORA;CCBE1;SULF1;IL6;ARNT
prerank,carboxylic acid transport (GO:0046942),0.43762610873545355,1.3966729007591567,0.07032590051457976,0.5848539899405939,1.0,7/55,4.07%,SLC6A13;SLC13A3;SLC16A12;SLC38A3;SLC6A12;SLC6A9;LLGL2
prerank,positive regulation of cell motility (GO:2000147),-0.32066955144731685,-1.3961937595018643,0.014545454545454545,0.4312659046515935,1.0,60/205,13.52%,LEF1;NTRK3;PECAM1;PODXL;CAV1;SPOCK2;ACTG1;SEMA6A;ACTN4;SEMA7A;ITGA6;TIAM1;SEMA6D;KDR;THBS1;ADAM10;CAVIN1;CARMIL1;SEMA3C;F3;ITGB1;PTK2;PTK2B;NOTCH1;SEMA4D;RACK1;ROR2;SEMA3E;BCAR1;FAM107A;TGFB1;FERMT2;TJP1;PDGFC;MYOC;VEGFA;PDCD10;GRN;PAK1;CPNE3;SEMA4B;EDN1;SEMA5B;APC;SEMA6C;PIK3CD;HSPA5;XBP1;BMP2;SEMA3G;STAT3;GCNT2;CDH13;GPER1;TWIST2;RIPOR1;CCN1;PPP3CA;NEDD9;RET
prerank,positive regulation of phospholipase activity (GO:0010518),0.5265890506992241,1.3952575679133912,0.11252268602540835,0.5870054753108033,1.0,5/22,3.77%,FGFR2;KIT;PDPK1;PDGFRB;PDGFRA
prerank,Rac protein signal transduction (GO:0016601),-0.5101589501684634,-1.395058871354672,0.10351966873706005,0.4330832037514718,1.0,8/18,15.45%,ELMO1;TIAM1;RAC1;NCKAP1;EPS8;CDH13;DBNL;RHOG
prerank,response to metal ion (GO:0010038),-0.383691135959332,-1.3950059964371337,0.04568527918781726,0.43190316797357653,1.0,21/67,16.18%,CAV1;THBS1;TRPC3;CALM1;NEDD4L;MT1A;MT1X;KCNMA1;HOMER1;SLC30A5;CRIP1;ATP5F1D;MT2A;GPHN;PPP1CA;PPP3CA;ITPR3;MT3;TRPC1;AHCYL1;CALM2
prerank,connective tissue development (GO:0061448),0.48387461842921575,1.3946067070188215,0.11475409836065574,0.5869977348106251,1.0,6/35,4.47%,SOX5;ARID5B;SCX;SOX6;SH3PXD2B;SULF1
prerank,cholesterol homeostasis (GO:0042632),0.42240547141511137,1.3935183150190262,0.06969205834683954,0.5883369258793325,1.0,10/64,8.58%,RORA;FGFR4;IL18;PLA2G10;ABCA1;PCSK9;EPHX2;LIMA1;LIPC;ABCA5
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.5296266518838186,-1.3926242631602224,0.08134920634920635,0.4370015562128353,1.0,9/16,21.25%,ESR1;RBFOX2;DDX5;DDX54;EGLN2;NCOA4;PADI2;DDX17;ESR2
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.39849832791574746,1.392624084355609,0.04874213836477988,0.5889989226546446,1.0,26/95,12.47%,CEMIP;HS3ST3A1;PXYLP1;ST3GAL3;ANGPT1;FMOD;UST;SDC2;HS3ST3B1;OGN;GPC6;OMD;B4GALT1;PRELP;CHSY1;GPC3;CHST3;HAS1;XYLT2;NDST2;B3GALT6;CHST15;UGDH;B4GALT2;HS6ST1;GPC4
prerank,negative regulation of interleukin-1 production (GO:0032692),0.5150390887034678,1.3917661482988128,0.1087378640776699,0.589738895194056,1.0,1/23,0.03%,IGF1
prerank,membrane fusion (GO:0061025),-0.43131543649619947,-1.391563627249773,0.060810810810810814,0.43845618103888767,1.0,8/33,12.68%,DNM3;NSF;VTI1B;CHP1;DNM2;DYSF;NSFL1C;DNM1
prerank,regulation of cell migration (GO:0030334),-0.29979691654644647,-1.3905745348183367,0.0,0.4398317899436187,1.0,101/382,12.39%,LEF1;FRMD5;NTRK3;LIMCH1;SLIT2;PECAM1;PODXL;CAV1;PTPRJ;TMSB4X;CLDN5;TMEFF2;ACTG1;SEMA6A;ACTN4;SEMA7A;PRR5L;ITGA6;TIAM1;CLIC4;SEMA6D;KDR;THBS1;ADAM10;ACVRL1;DACH1;RAC1;CDH1;CARMIL1;SEMA3C;PLXND1;F3;JAG1;ITGB1;ADAM15;PTK2;ADARB1;ENG;SLK;PTK2B;NOTCH1;SEMA4D;RACK1;MCTP1;SERPINE2;DOCK10;TMSB10;MINK1;PLXNA4;ROR2;SEMA3E;FLNA;SRGAP1;KANK1;SPATA13;BCAR1;CORO1C;RHOB;FAM107A;TGFB1;ROBO4;FERMT2;IGFBP5;TJP1;GNA12;CEACAM1;PDGFC;MYOC;VEGFA;PDCD10;ABI3;SRCIN1;CYRIB;GRN;PAK1;CPNE3;SEMA4B;EDN1;APPL1;SEMA5B;PODN;APC;NAV3;FGF7;RHOA;SEMA6C;PIK3CD;HSPA5;XBP1;BMP2;SEMA3G;DUSP3;STAT3;GCNT2;CDH13;GPER1;TWIST2;YTHDF3;LMNA;CD74;RIPOR1
prerank,glycoprotein biosynthetic process (GO:0009101),0.4173208961157883,1.390188909820464,0.06535947712418301,0.5925011049156717,1.0,9/79,3.96%,IGF1;B3GALT1;ST3GAL3;GALNTL5;LARGE1;B3GNT5;GAL3ST2;GAL3ST3;ST3GAL5
prerank,cation transmembrane transport (GO:0098655),0.45619036237120103,1.3894361333694125,0.07692307692307693,0.5929391394615168,1.0,3/44,1.68%,TRPM3;ATP1A2;SLC6A9
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.45670050413639635,1.3877429505982528,0.0823327615780446,0.5963977047175835,1.0,8/43,7.38%,IGF1;IL18;PDGFRB;MMP2;CCN4;GJA1;IL6;MMP9
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.5939320929292803,1.3874621310389785,0.11363636363636363,0.5952980310682239,1.0,2/13,1.88%,ERRFI1;SNX6
prerank,cellular response to amyloid-beta (GO:1904646),0.47779111777715516,1.387288596407742,0.09461966604823747,0.5938843339711304,1.0,6/35,7.01%,IGF1;SNX6;EPHA4;GJA1;IGF1R;CACNA2D1
prerank,sterol homeostasis (GO:0055092),0.41966952487932124,1.386787051561345,0.07467532467532467,0.5937282514396244,1.0,10/65,8.58%,RORA;FGFR4;IL18;PLA2G10;ABCA1;PCSK9;EPHX2;LIMA1;LIPC;ABCA5
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.4248681859273684,-1.386722879492855,0.06293706293706294,0.44905658330620246,1.0,12/40,12.92%,RPL11;RPL23;UBE3A;PTK2;PTK2B;RPS7;PDCL3;GNA12;RPL5;FOXF2;UBQLN4;CLU
prerank,heart process (GO:0003015),-0.5483292367605238,-1.3862558585240383,0.10438413361169102,0.44893480986457013,1.0,3/14,6.04%,SGCD;FYN;SOD1
prerank,pore complex assembly (GO:0046931),0.5499411085725385,1.3849991753077824,0.11834319526627218,0.5973890025948286,1.0,5/19,10.11%,PLEKHA7;AFDN;NDC1;GSDMD;NUP107
prerank,regulation of establishment of protein localization (GO:0070201),-0.5723106734108664,-1.3847119797819352,0.09636363636363636,0.4520057542365818,1.0,4/13,9.13%,CORO2B;DNAJA1;CTSD;SPIDR
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.4416219259740012,-1.3846504308300673,0.06264501160092807,0.4508471054392826,1.0,12/32,16.86%,PPP1R13B;BAG6;DDX5;DDIT4;MSH2;BCL3;HINT1;MYBBP1A;PDK2;AEN;RPS27L;USP28
prerank,phosphatidylcholine catabolic process (GO:0034638),0.6275568107060198,1.384591063090893,0.1431451612903226,0.5966692981866959,1.0,3/10,7.68%,PLA2G10;ENPP2;LIPC
prerank,fat cell differentiation (GO:0045444),0.43551694267821767,1.3843321281685799,0.07279029462738301,0.595527541939846,1.0,11/57,11.32%,TCF7L2;OSBPL8;C1QTNF3;PID1;SMAD6;CBY1;WNT5B;TMEM120B;BBS7;MED1;TFAP2B
prerank,ERK1 and ERK2 cascade (GO:0070371),0.5302041288509194,1.3841198171998828,0.12167300380228137,0.5942101196956452,1.0,2/21,3.29%,IGF1;CTSH
prerank,positive regulation of hydrolase activity (GO:0051345),-0.34034895109004754,-1.3835176917389442,0.012012012012012012,0.45271672432015614,1.0,29/137,11.25%,DOCK9;RAP1A;RGS6;ITGA6;CD200;BCAR3;PKP4;TBC1D30;CALM1;AGRN;ITGB1;F11R;ARHGAP27;CAV2;PSAP;SEMA4D;RACK1;RPS3;NET1;DOCK10;TGM2;LIMS1;FERMT2;GSK3B;MAPK8;RHOA;NDUFA13;BMP2;EVI5
prerank,regulation of protein kinase A signaling (GO:0010738),0.5348399710529874,1.3829546307613683,0.11553030303030302,0.5956955679088579,1.0,3/20,5.17%,ADGRV1;AKAP7;LRRK2
prerank,T-helper cell differentiation (GO:0042093),-0.538494780350854,-1.382591084275959,0.07587548638132295,0.4539603388982363,1.0,2/14,0.83%,LEF1;FOXP1
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.598944132254531,-1.3825445525840274,0.10294117647058823,0.45273401004212016,1.0,2/10,6.50%,CAV1;KCNAB1
prerank,regulation of membrane repolarization (GO:0060306),-0.567006789915815,-1.3824889377217648,0.11,0.4515573571393398,1.0,4/13,7.36%,CAV1;KCNJ2;NEDD4L;KCNQ1
prerank,prostaglandin biosynthetic process (GO:0001516),-0.5249446681588145,-1.3823976189380045,0.07462686567164178,0.4504592860662748,1.0,10/18,29.35%,PTGIS;PTGDS;EDN1;PTGS2;CD74;PLA2G4A;MIF;HPGDS;PRXL2B;CBR1
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.3712041264644962,-1.3817966038684621,0.019753086419753086,0.4507588401480691,1.0,34/73,33.94%,PTPRJ;IL33;THBS1;PLCG2;LBP;HSPB1;PTPRC;APP;STAT3;OAS2;ARHGEF2;CLU;IFNGR1;IFIH1;MIF;TYROBP;PSEN1;FRMD8;TIRAP;AGER;CCR2;DDT;SPHK2;TLR4;RASGRP1;FADD;C1QTNF4;MAVS;DHX9;NOD2;TLR1;LPL;SYK;IL1A
prerank,diol metabolic process (GO:0034311),-0.5081821347657203,-1.3817452311554699,0.10136452241715399,0.44956573272768463,1.0,6/19,4.37%,NOS3;PLPP1;HSP90AA1;CALM1;DEGS2;GCH1
prerank,negative regulation of multicellular organismal process (GO:0051241),0.36233661543188783,1.3816986948476948,0.023842917251051893,0.5976614563124182,1.0,28/199,7.47%,ALDH1A1;ROBO1;ROCK2;NPR3;LGR4;RBPJ;MCC;LRP4;ADAMTS5;NOVA1;SMAD6;DKK1;ADM;SLAMF8;CRHBP;SYT11;MAP2K6;HOXA7;DUSP10;NFIB;GJA1;TLE3;CHSY1;SFMBT1;NRDC;WWC1;WWC2;PTEN
prerank,circulatory system development (GO:0072359),-0.3428806494665859,-1.3815228430956665,0.024390243902439025,0.448873983265771,1.0,29/118,11.65%,MEF2C;TEK;NTRK3;FN1;HEG1;MICAL2;ACVRL1;TGFB2;RAMP2;NOTCH1;TBX1;CXADR;PKD1;SOX17;STRA6;TGFBR2;SOX4;TGFB1;CRIP1;PDLIM7;FLT4;NOTCH4;LDB3;HEY2;ECE1;CDKN1B;BMP2;SOX18;CACNA1C
prerank,negative regulation of Rho protein signal transduction (GO:0035024),-0.5137924102148457,-1.3807435585232246,0.08823529411764706,0.4498328980361591,1.0,9/18,13.48%,HEG1;RASIP1;CCDC125;KANK1;MET;CUL3;MYOC;KCTD13;STMN1
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.4781105273919789,-1.3806747816275027,0.10344827586206896,0.4487266403855374,1.0,11/23,20.01%,ELOVL7;FAR2;ELOVL5;ACSL4;FAR1;ELOVL6;DGAT1;ELOVL1;ACSL3;TECR;ACSL5
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.5177843540555922,1.3805230453921995,0.11152416356877323,0.5994390608521755,1.0,7/25,8.60%,WNK4;DMD;SLC6A9;ATP1B3;ANK2;TCAF1;COX17
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.5256299852043954,-1.3804437972875532,0.08757637474541752,0.4481361572804656,1.0,2/16,2.50%,CLDN5;CLDN11
prerank,nitric oxide biosynthetic process (GO:0006809),-0.5642165557902563,-1.3797993419422558,0.11342155009451796,0.4486384885294107,1.0,7/13,22.45%,NOS3;GCH1;NOS1;CYB5R3;AKT1;CYP1B1;DDAH2
prerank,embryonic digit morphogenesis (GO:0042733),0.5484653037938052,1.3796990219437075,0.11741682974559686,0.6001117202726571,1.0,7/18,13.47%,OSR1;INTU;GLI3;SALL1;WDPCP;HDAC1;CREBBP
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.6017042470415205,1.3793464643777937,0.1290983606557377,0.5993093848720605,1.0,3/13,0.99%,TGFBR3;RBPJ;FGFR2
prerank,glial cell development (GO:0021782),-0.476409392515241,-1.3790127185013035,0.0949367088607595,0.4495043172570571,1.0,13/25,22.99%,SOX4;APP;CDK6;NRROS;PICK1;MT3;EIF2B5;NF1;EIF2B2;TPPP;SOX10;DLL1;SOX11
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.5976237080132365,-1.3785667498684437,0.10634328358208955,0.4494249272407835,1.0,5/10,23.49%,CD55;TGFBR2;CD81;NCKAP1L;SOCS1
prerank,cytoplasmic translational initiation (GO:0002183),-0.5178388257980757,-1.3784209232973805,0.09278350515463918,0.44859524506860443,1.0,9/17,24.58%,EIF3I;EIF4G1;EIF3D;EIF4H;DHX29;EIF2D;EIF4B;EIF3A;EIF5
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.43355757413894447,-1.377916098224645,0.06941431670281996,0.448724189639517,1.0,16/35,21.25%,ESR1;PLPP1;UBE3A;RBFOX2;KDM3A;DDX5;WBP2;TMF1;DDX54;GPER1;EGLN2;NCOA4;NR3C2;PADI2;DDX17;ESR2
prerank,protein-containing complex disassembly (GO:0032984),-0.3995661056524523,-1.3772071361071647,0.037825059101654845,0.44932803382229763,1.0,12/54,12.65%,CAV1;HSPA8;RPL23;CTNNB1;VAMP8;VTI1B;GSK3B;MAP1LC3B;PYM1;APC;PPP1CA;SNX14
prerank,intestinal lipid absorption (GO:0098856),0.620285159065631,1.3769913188941774,0.14967462039045554,0.6047786095044443,1.0,3/11,10.61%,CEL;LIMA1;SOAT2
prerank,regulation of blood coagulation (GO:0030193),-0.47429677550766036,-1.3762618489887266,0.07659574468085106,0.4506289271923126,1.0,6/27,3.73%,ST3GAL4;CAV1;CD34;THBS1;FAP;SERPINE2
prerank,positive regulation of B cell proliferation (GO:0030890),-0.45005720810961114,-1.3750156992640405,0.07142857142857142,0.45272750683313645,1.0,11/29,20.71%,MEF2C;TFRC;NFATC2;CD38;PTPRC;CD74;CD81;MIF;CD40;NCKAP1L;TIRAP
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.3873141007134703,-1.3749636766299984,0.0675,0.4516034599349747,1.0,29/57,30.46%,MAP3K5;FYN;TNFSF10;CTSD;NOD1;LGMN;PERP;AIM2;SOX7;NDUFA13;GRIN1;USP50;GPER1;TBC1D10A;REST;BCAP31;CASP8;CYFIP2;FOXL2;ACVR1C;CYCS;CASP1;ARL6IP5;PPM1F;FIS1;NLRC4;FADD;PMAIP1;GRIN2B
prerank,peptidyl-asparagine modification (GO:0018196),-0.4437730949226463,-1.3745475941037444,0.08085106382978724,0.45138583665290705,1.0,14/31,26.35%,ST6GAL1;FUT8;MAGT1;STT3B;MCFD2;RPN1;MGAT1;DDOST;MGAT2;ALG5;DPM1;ALG8;MGAT5;UBE2J1
prerank,histone monoubiquitination (GO:0010390),0.5029511958401036,1.3731687669652486,0.11275415896487985,0.6148217069798814,1.0,11/24,18.25%,RNF2;DDB2;KDM2B;BCOR;CDC73;CUL4B;RNF20;PCGF1;UBE2E1;DTX3L;CTR9
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.5225119662695179,-1.3729079685003258,0.1016597510373444,0.4547818093155978,1.0,9/17,19.65%,EMC10;BAG6;EMC7;CAMLG;EMC1;EMC3;EMC6;EMC9;GET4
prerank,nitric oxide metabolic process (GO:0046209),-0.5515984540792941,-1.3719478524670632,0.11411992263056092,0.45608055225578575,1.0,7/14,22.45%,NOS3;GCH1;NOS1;CYB5R3;AKT1;CYP1B1;DDAH2
prerank,cation transport (GO:0006812),0.36626535987676556,1.3717023611687829,0.03656821378340366,0.6173882986618663,1.0,12/167,3.10%,TRPM3;SCN7A;ATP1A2;SLC22A4;SLC22A2;SLC8A3;SLC5A5;KCNQ4;SLC6A9;KCNA5;SLC41A1;SLC8A1
prerank,midbody abscission (GO:0061952),-0.5200564432174093,-1.3714706987321184,0.10980392156862745,0.4561705249141502,1.0,10/17,31.27%,CHMP5;CHMP2B;CHMP1B;CHMP1A;CHMP3;CHMP7;PDCD6IP;CHMP4C;CEP55;VPS4B
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.4206320450934513,1.370908771514437,0.0698051948051948,0.617981606133956,1.0,13/72,10.36%,FGFR2;FGFR4;FGFBP1;POLR2D;FLRT2;KL;HNRNPH1;FRS2;FGF1;POLR2A;GTF2F1;FGF9;FGF20
prerank,activation of adenylate cyclase activity (GO:0007190),0.4717158016347407,1.3708625602052513,0.0963855421686747,0.6161742159174033,1.0,3/35,0.82%,ADCY5;ADCY1;LGR4
prerank,negative regulation of signal transduction (GO:0009968),0.3536950091181139,1.37018885454474,0.013368983957219251,0.6163883943908922,1.0,44/249,9.68%,CYP26B1;ADAMTS12;LEPROT;TRABD2B;LGR4;RNF43;PID1;WWOX;TULP3;DKK3;BCL2;DKK1;LTF;MGRN1;NEDD4;GRB10;CRHBP;VGLL4;CBY1;SULF1;LRRK2;CACTIN;GLI3;GPC3;PRKCZ;APCDD1;SUFU;PRKCB;SLC2A10;NIBAN2;PDCD6;KANK2;HERC4;PTEN;NTN1;SIAH2;TLE1;WWP2;YTHDF2;FSTL3;RPGRIP1L;WIF1;APLN;PTGIR
prerank,regulation of keratinocyte proliferation (GO:0010837),0.5229975512149608,1.3700316916447346,0.13568773234200743,0.6149527148045237,1.0,3/22,1.30%,FGFR2;NOTCH2;STXBP4
prerank,response to ethanol (GO:0045471),-0.5436580605125911,-1.3685200478284303,0.10236220472440945,0.46285518849270263,1.0,5/14,12.80%,SOD1;GRIN3A;ADCY7;GRIN1;SDF4
prerank,metal ion export (GO:0070839),0.4871737968442689,1.368299888283095,0.11720226843100189,0.6185211992758071,1.0,5/31,4.29%,ATP1A2;KCNA5;KCNT2;ATP1B3;KCND3
prerank,positive regulation of protein binding (GO:0032092),-0.39189712473649135,-1.3674554133792778,0.05025125628140704,0.4646094896556873,1.0,15/56,10.76%,CAV1;CLDN5;B2M;EPB41;TIAM1;RPL11;PKD1;GSK3B;HIP1R;ADD2;APP;DERL1;RALB;BMP2;MEN1
prerank,positive regulation of phosphorylation (GO:0042327),0.3498417018345361,1.3670551333500136,0.024161073825503355,0.6205788344578386,1.0,43/240,10.91%,IGF1;EPHA7;LEPR;ROCK2;IL34;EPHA3;FGFR2;FGFR4;KIT;ANGPT1;PELI2;DAB2;LMO4;FNIP1;ZBTB20;PDGFRB;IGF2;EPHA8;FAM20A;PDGFRA;EPHA4;DDR1;LRRK2;PRKAA2;FGF1;IGF1R;DDR2;MMP9;PRKAA1;ATG14;RYK;ARNT;MUSK;VEGFB;AXIN2;FGF9;ABL1;DVL3;FGF20;AXL;FLCN;RAP2A;EPHA2
prerank,regulation of spindle assembly (GO:0090169),-0.46607702865136885,-1.3670404287334292,0.09812108559498957,0.4644731619284752,1.0,16/25,35.93%,CHMP5;CHMP2B;HNRNPU;CHMP1B;CHMP1A;NUMA1;SPAG5;HSPA1B;CHMP3;PDCD6IP;CHMP4C;DRG1;VPS4B;HSPA1A;PLK1;DYNC1H1
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),-0.34607567654966254,-1.3662553838274998,0.01881720430107527,0.4653732831786265,1.0,43/107,19.46%,CAV1;SLC39A10;TPT1;MT1E;MT1F;MT1G;MT1B;MT1M;MT1A;MT1H;MT1X;ATP1B1;SLC30A5;SLC10A7;CALR;ATP2C1;MT2A;ATP2A3;SLC39A8;SLC24A2;ATP2A2;RYR2;HTR2A;ATP13A4;EDN1;SLC39A7;SLC30A1;RMDN3;STIM2;STOML2;ATP2B1;ATP13A5;MT3;ATP13A2;SLC24A5;CCL13;TMEM165;CXCL12;SLC39A14;ATP2B2;ATP2B4;NPTN;CD40
prerank,T cell mediated immunity (GO:0002456),-0.5487416584039879,-1.3662485204566313,0.10588235294117647,0.46412961088043037,1.0,4/13,8.32%,CADM1;JAG1;CD55;EMP2
prerank,negative regulation of mRNA processing (GO:0050686),-0.5367177677385786,-1.366240272872547,0.10441767068273092,0.46288965910092666,1.0,7/15,28.55%,SRSF9;RNPS1;SRSF6;PTBP1;PCBP4;SRSF7;BARD1
prerank,smooth muscle contraction (GO:0006939),0.5721217498893987,1.3651806154384964,0.1346153846153846,0.6246114279194851,1.0,4/14,3.10%,ROCK2;BDKRB2;MYLK;SLC8A1
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.5044169056403961,1.3651722006618974,0.12035398230088495,0.6226936662817527,1.0,1/25,0.03%,IGF1
prerank,myelination (GO:0042552),-0.40147475482350076,-1.3651026663352162,0.0776255707762557,0.4647473699108364,1.0,20/46,17.19%,ADGRG6;ACER3;MAL;PLP1;MBP;MARVELD1;B4GALT5;CMTM8;SCN8A;TNFRSF21;MYOC;PLLP;ARHGEF10;GPC1;ABCD2;EIF2B5;NF1;EIF2B2;TPPP;B4GALT6
prerank,response to glucagon (GO:0033762),0.5481749060714558,1.3647781761760738,0.13211382113821138,0.6219294486357484,1.0,2/19,0.72%,ADCY5;ADCY1
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.5061457545630605,1.3644588783521874,0.09444444444444444,0.6209747010821292,1.0,5/26,5.55%,PRKAG2;LPGAT1;SLC45A3;ACADL;PRKAA2
prerank,ureteric bud development (GO:0001657),0.5621501383197403,1.3643798678760093,0.1442125237191651,0.6192861419000871,1.0,5/17,6.50%,OSR1;FGFR2;BMP7;GPC3;SALL1
prerank,melanocyte differentiation (GO:0030318),0.6049299313929051,1.3643413631150365,0.15918367346938775,0.6174915376752546,1.0,2/11,1.24%,LRMDA;KIT
prerank,regulation of fatty acid metabolic process (GO:0019217),0.5440873732094684,1.364300720384463,0.13562753036437247,0.6157494000815898,1.0,3/17,5.55%,PRKAG2;PPARA;PRKAA2
prerank,sodium-independent organic anion transport (GO:0043252),-0.5943772571518174,-1.3634443172498634,0.10789980732177264,0.46810006734165555,1.0,6/10,18.27%,SLCO1C1;SLCO2A1;SLCO2B1;SLCO3A1;SLC16A2;SLCO4A1
prerank,striated muscle tissue development (GO:0014706),-0.4505106388309149,-1.3633215876753801,0.08565310492505353,0.4671970080021695,1.0,9/29,6.82%,MEF2C;PGM5;CAV1;SGCD;BMP5;MYL6;BMPR2;TBX2;SIX1
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.3876989993816989,1.3630380347214763,0.05637982195845697,0.6178285446973062,1.0,13/113,6.79%,IGF1;BMP6;TCF7L2;OSR1;FGFR2;NOTCH2;STXBP4;JAML;ECM1;PTN;FGF1;PDCD6;PRKCA
prerank,transepithelial transport (GO:0070633),-0.52975237675836,-1.3613707546859397,0.11673151750972763,0.4714869821982401,1.0,4/15,4.20%,ABCG2;SLC12A2;CXADR;SLC1A1
prerank,sphingosine biosynthetic process (GO:0046512),-0.5790609658411179,-1.3613095531607504,0.11753371868978806,0.4691599999181503,1.0,3/11,1.83%,ACER3;ACER2;SPTLC2
prerank,sphingoid biosynthetic process (GO:0046520),-0.5790609658411179,-1.3613095531607504,0.11753371868978806,0.4691599999181503,1.0,3/11,1.83%,ACER3;ACER2;SPTLC2
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.5947398358758252,1.3611637234659901,0.14915966386554622,0.6217327101802241,1.0,8/12,18.80%,SZT2;EPHA4;NFIB;PAFAH1B1;MYCBP2;GLI2;CHRNB2;EPHB2
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),-0.5164806593420647,-1.360151455296492,0.1217564870259481,0.4710935222927113,1.0,6/15,7.98%,TMSB4X;KDR;LGMN;HSPB1;MET;VEGFA
prerank,renal water homeostasis (GO:0003091),0.5101892299882582,1.3600039844997962,0.13825757575757575,0.6234578763236697,1.0,2/23,0.72%,ADCY5;ADCY1
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.5582698485087395,-1.3599964909589384,0.10816326530612246,0.4702748062301431,1.0,10/12,42.32%,CRYAB;CLU;IAPP;PFDN6;PFDN5;PFDN4;TREM2;VBP1;LDLR;PFDN1
prerank,bile acid and bile salt transport (GO:0015721),-0.47165062282233267,-1.3599529619755386,0.11181434599156118,0.4691638303807497,1.0,5/24,6.85%,ABCC4;ATP8B1;SLCO1C1;SLCO2B1;CEACAM1
prerank,neuron development (GO:0048666),-0.3255769513335822,-1.3594212640302588,0.02727272727272727,0.4693307520188151,1.0,23/141,8.42%,FRY;MEF2C;PTPRM;PBX3;STX3;TGFB2;RUNX1;PLP1;MAP4;TENM2;VSX1;BLOC1S2;B4GALT5;EHD1;RP1;ETV1;ATP8A2;GSK3B;STMN2;MYOC;APP;TENM4;GPM6B
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.4276934412059209,-1.358723318039647,0.08163265306122448,0.4700721167483119,1.0,11/36,11.87%,CAV1;NOS3;NOSTRIN;HSP90AA1;CALM1;SCARB1;GCH1;DDAH1;DNM2;S100A1;CYGB
prerank,lysine metabolic process (GO:0006553),0.5963178684210588,1.35858098190064,0.1306122448979592,0.6241685099806672,1.0,5/12,13.74%,AASS;ALDH7A1;GCDH;PIPOX;AADAT
prerank,lysine catabolic process (GO:0006554),0.5963178684210588,1.35858098190064,0.1306122448979592,0.6241685099806672,1.0,5/12,13.74%,AASS;ALDH7A1;GCDH;PIPOX;AADAT
prerank,actin polymerization or depolymerization (GO:0008154),0.4369840759217309,1.3584947170619646,0.08450704225352113,0.6225490127975652,1.0,13/50,11.21%,MICAL3;ARHGAP6;GAS7;AVIL;ABI2;WASF1;WASL;SPIRE2;WASF3;CORO7;PSTPIP2;JAK2;COBL
prerank,regulation of mitotic spindle assembly (GO:1901673),-0.5037739425183025,-1.3581487482181522,0.09591836734693877,0.4704594083676735,1.0,13/19,33.32%,CHMP5;CHMP2B;HNRNPU;CHMP1B;CHMP1A;HSPA1B;CHMP3;PDCD6IP;CHMP4C;DRG1;VPS4B;HSPA1A;PLK1
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.5265630795906323,1.357682372272947,0.1423076923076923,0.6232580172407048,1.0,3/22,5.93%,ALDH1A2;RBP1;LRP2
prerank,protein targeting to mitochondrion (GO:0006626),-0.3918305572218358,-1.3569083550898635,0.05336426914153132,0.472643755539895,1.0,23/52,30.65%,HSP90AA1;FBXO7;TOMM20;NDUFA13;TOMM22;HSPD1;TIMM9;ROMO1;BCAP31;TIMM10B;TIMM13;TIMM29;TIMM22;MFN2;TOMM7;TIMM50;TSPO;TIMM44;FIS1;CHCHD4;AIP;TOMM34;DNLZ
prerank,negative regulation of supramolecular fiber organization (GO:1902904),-0.36331395994810917,-1.3566498529353863,0.05181347150259067,0.47209436226264917,1.0,35/72,29.11%,SLIT2;SHANK3;KANK3;HSPA8;KANK1;HIP1R;STMN2;CRYAB;CYRIB;SSH2;KANK4;APC;NAV3;SSH1;ARHGEF2;CLU;STMN1;APC2;IAPP;TUBB4A;PFDN6;PFDN5;PRKCD;TTBK2;MAPRE1;SHANK1;CLASP2;CAMSAP3;SPEF1;PFDN4;CAMSAP1;SSH3;EMILIN1;TREM2;FGF13
prerank,microvillus organization (GO:0032528),-0.5569460410538104,-1.3566366238376573,0.13168724279835392,0.47090261382866355,1.0,3/13,3.98%,RAP1A;FXYD5;MINK1
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.5726141650916083,-1.3564709552899565,0.103515625,0.47005777206609767,1.0,4/11,9.08%,TGFB2;JAG1;SOX4;HEY2
prerank,peptide metabolic process (GO:0006518),0.4076148483377369,1.3561614341085333,0.06732348111658457,0.6260291281634817,1.0,10/75,7.29%,CPQ;AEBP1;DMD;GSTM2;GSTT4;GSTT1;ACE;TPP1;NPEPPS;CPXM1
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.5125365927194614,1.3554060659943137,0.12406015037593984,0.6264518683064818,1.0,4/23,6.39%,IGF1;EFNB2;MAML1;NIBAN2
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.5706752042062166,-1.3553564521976058,0.09898989898989899,0.4718864620177754,1.0,3/11,12.40%,CAV1;NEDD4L;BIN1
prerank,activation of protein kinase activity (GO:0032147),0.38815168955291,1.3546534806744763,0.06962962962962962,0.6268667290782692,1.0,8/106,1.95%,IGF1;ADCY5;OSBPL8;ADCY1;NRK;IL18;ANGPT1;PDPK1
prerank,camera-type eye development (GO:0043010),0.507274440265681,1.3542397954883212,0.13382899628252787,0.6263487242406789,1.0,4/25,2.96%,EFEMP1;FBN1;FBN2;SHROOM2
prerank,amino sugar metabolic process (GO:0006040),-0.5897817241220976,-1.3540866411402128,0.09701492537313433,0.4742184237521185,1.0,2/10,0.61%,CSGALNACT1;ST6GAL1
prerank,regulation of ERAD pathway (GO:1904292),-0.5757213108976453,-1.353433198328295,0.10795454545454546,0.47467467780865885,1.0,5/11,12.81%,ATXN3;UBXN1;BAG6;AQP11;HERPUD1
prerank,membrane repolarization during action potential (GO:0086011),-0.5453123802032802,-1.3532882968890403,0.104,0.4737769489743243,1.0,4/13,7.36%,KCNJ2;ATP1A1;ATP1B1;KCNQ1
prerank,negative regulation of viral transcription (GO:0032897),-0.5468695674541068,-1.3527214645708763,0.11439842209072978,0.47420899587642773,1.0,7/13,22.66%,TRIM14;LARP7;TRIM13;MID2;IFITM3;TRIM27;UBP1
prerank,response to endoplasmic reticulum stress (GO:0034976),-0.3450552292382437,-1.3526113672057887,0.046242774566473986,0.47326832305850863,1.0,45/107,25.19%,MAP3K5;THBS1;NIBAN1;RASGRF2;DAB2IP;CREB3L1;TMEM117;NCK1;HSP90B1;BAG6;GSK3B;ATP2A3;JUN;ATP2A2;TMX1;DERL1;ERP44;CCDC47;UBXN6;HSPA5;ATF4;SELENOK;ERO1A;HERPUD1;BBC3;BCAP31;ERLEC1;EIF2B5;CFTR;WFS1;DNAJC10;RNF5;DNAJB9;TNFRSF10B;ATF3;MBTPS1;VCP;THBS4;CEBPB;BRSK2;PPP1R15B;TRIB3;PPP1R15A;ERN1;BAX
prerank,catecholamine biosynthetic process (GO:0042423),0.6134843881419327,1.3520711450120493,0.13507625272331156,0.6312424155082721,1.0,1/11,0.10%,MOXD1
prerank,positive regulation of developmental growth (GO:0048639),-0.39739590575346356,-1.3519264405872478,0.08037825059101655,0.474099837102743,1.0,19/49,22.15%,SEMA7A;AGRN;NEDD4L;NGF;SEMA4D;SHTN1;ITSN2;RNF157;PPIB;DBNL;SYT4;CPNE9;SYT2;INSR;RASAL1;L1CAM;DLL1;PLAA;DBN1
prerank,cognition (GO:0050890),-0.409202866115009,-1.3513345141715098,0.060674157303370786,0.47445358791940806,1.0,12/42,15.79%,ST3GAL4;SHROOM4;MAGT1;STRA6;CHMP2B;FAM107A;APP;MFSD2A;SLC1A4;DGCR2;PTCHD1;NF1
prerank,epithelial to mesenchymal transition (GO:0001837),0.44453758767705254,1.351298004809443,0.0944055944055944,0.6317431277405068,1.0,6/47,2.93%,TGFBR3;ROCK2;WNT4;RBPJ;BMP7;LOXL3
prerank,receptor-mediated endocytosis (GO:0006898),-0.33660696861892825,-1.3512657708821654,0.027210884353741496,0.47341135292627934,1.0,44/132,19.75%,DNM3;CAV1;SGIP1;TFRC;FNBP1L;HSP90AA1;CD9;SCARB1;ITGB1;RAMP2;ARHGAP27;CAV2;RAB31;ACKR3;SCARF1;AP2A2;STAB1;CALR;HSP90B1;HIP1R;PDLIM7;DNM2;RAMP1;AP2M1;LRP3;LMBR1L;ADRB2;DNM1;CD81;CANX;MRC1;PIP5K1C;M6PR;CALCRL;PI4KB;TMEM108;INPP5F;SNX1;CUBN;SPARC;SNAP91;AP2B1;ARRB2;INSR
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.49114861347128547,-1.3509938124854368,0.10782241014799154,0.47299310448243814,1.0,7/19,16.86%,BAG6;DDIT4;MSH2;BCL3;AEN;RPS27L;USP28
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.4177179814700648,1.350308294188745,0.09013605442176871,0.6330623893373422,1.0,15/63,13.64%,IGF1;TCF7L2;WWOX;DEPTOR;SP100;SH3RF1;NOL3;SIAH2;BIRC6;FEM1B;PHIP;CFLAR;CYLD;AR;BCL2L12
prerank,negative regulation of interleukin-2 production (GO:0032703),-0.5032791588781139,-1.3498345072885427,0.1245136186770428,0.4750653086326301,1.0,9/18,29.87%,CD34;PTPRC;NAV3;LAPTM5;HDAC7;TRIM27;EZR;TNFAIP3;ZFP36
prerank,response to acidic pH (GO:0010447),-0.5399325719062464,-1.3496696297712196,0.14092664092664092,0.4743569763049199,1.0,4/13,13.42%,GPR4;LGMN;CHP1;RAB11FIP5
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.4209515435647377,-1.3487667810969042,0.07399577167019028,0.47558440608027597,1.0,9/37,7.75%,CAV1;RPS7;UBB;RACK1;RPS3;NCK1;SOD1;BCL2L1;SFPQ
prerank,diol biosynthetic process (GO:0034312),-0.5292695985191517,-1.3486933003718014,0.10588235294117647,0.47459456621922896,1.0,4/15,4.37%,ACER3;ACER2;SPTLC2;GCH1
prerank,nerve growth factor signaling pathway (GO:0038180),-0.5762632728641977,-1.3486431203812388,0.13909774436090225,0.47355924313213077,1.0,2/10,3.34%,RAP1A;NGF
prerank,protein insertion into ER membrane (GO:0045048),-0.42805512335563484,-1.3476650730699167,0.08647450110864745,0.4751288970538483,1.0,20/37,32.12%,STX1A;EMC10;BAG6;APP;CCDC47;EMC7;CAMLG;EMC1;EMC3;SEC61G;EMC6;EMC9;GET4;VAPA;OTOF;STX5;WDR83OS;SEC61B;UBE2J2;EMC4
prerank,positive regulation of apoptotic process (GO:0043065),-0.2964062519425929,-1.3471780406793288,0.014492753623188406,0.4753215623890904,1.0,88/293,20.17%,UNC13B;SLIT2;MAP3K5;MCF2L;ITGA6;TIAM1;RASSF2;TRIO;TGFB2;ARHGEF3;FAP;ITGB1;KCNMA1;RASGRF2;DAB2IP;NGF;UBB;DNAJA1;RACK1;RPS3;NET1;TNFSF10;CTSD;ARHGEF12;PREX1;ATG7;TGM2;SFRP4;RPS6;TPD52L1;ARHGEF17;RHOB;ARHGEF6;SOX4;CTNNB1;SOD1;FAF1;ABR;UBC;RPS27A;HIP1R;APBB1;DNM2;JUN;FOXO1;GRN;ARHGEF19;PTGIS;MAPK8;DDX20;ARHGEF26;ING4;APC;ARHGEF5;BMP2;TLE5;ATF4;GPER1;MYBBP1A;REST;BIN1;RYBP;ARHGEF2;HSPD1;CLU;GADD45G;RNPS1;NLRP2B;FAS;UBA52;PLEKHN1;BRMS1;NF1;CASP8;TOP2A;IAPP;ZC3H12A;GNA13;EEF1E1;IRF5;BMP4;FOXL2;TNFRSF10B;CDK5;TFAP4;PLEKHG5;PSEN1;CTNNBL1
prerank,regulation of cartilage development (GO:0061035),0.5439184192815384,1.3467324242949565,0.15264187866927592,0.6421605114776391,1.0,3/18,2.82%,SOX5;SCX;SOX6
prerank,cardiac ventricle morphogenesis (GO:0003208),0.4562957199888837,1.345730214046935,0.11663807890222985,0.6434152530477546,1.0,6/41,2.69%,TGFBR3;RBPJ;FGFR2;TPM1;TNNC1;TNNT2
prerank,protein polymerization (GO:0051258),0.42121911592628514,1.345534915128268,0.08375209380234507,0.6421724669082504,1.0,13/55,11.21%,ARHGAP6;PRKN;GAS7;WASF1;WASL;SPIRE2;ARL6;WASF3;RNF135;CORO7;PSTPIP2;JAK2;COBL
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.40980818519920725,-1.3453182911930897,0.09113300492610837,0.4791487895606767,1.0,12/39,17.15%,EFR3B;SOCS2;SOCS5;PIK3C2B;TTC7A;PIK3CD;PIK3C2A;PIK3C3;ITPKB;PI4KB;CISH;PIK3R3
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.5458529457312429,1.3452316385631196,0.14694656488549618,0.6412616832561022,1.0,4/17,7.01%,SNTA1;NOS1AP;ANK2;CACNA2D1
prerank,ribonucleoprotein complex assembly (GO:0022618),-0.3312575618448443,-1.3450241762196982,0.021148036253776436,0.4788199837613964,1.0,51/132,22.51%,RPL11;HSP90AA1;HSP90AB1;RPL38;RPL6;RPS15;RPSA;RPS19;RPL24;RPS14;LUC7L2;RPL23A;RPL3;SRSF1;RPL5;RPS27;SF3B1;CPSF7;KHDC4;RPLP0;DDX20;SRSF5;DDX39B;RPS28;CLNS1A;SRSF9;CPSF6;USP39;ERAL1;STRAP;XAB2;SNRPC;EIF4H;PRPF18;SRSF6;SRPK1;RPS27L;RSL24D1;RPS5;CLP1;DHX29;YTHDC1;NOP53;NLE1;EIF2D;PWP2;EIF4B;EIF3A;EIF6;PPAN;SNRPG
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.5118530893444327,1.3446430328744445,0.13346613545816732,0.641285901081887,1.0,10/23,19.24%,C1QTNF3;PPARA;SIK1;NUPR1;CRY1;PFKFB1;GCK;NCOR1;C1QTNF12;HDAC4
prerank,genitalia development (GO:0048806),-0.5553543952638555,-1.3441834971088673,0.1392156862745098,0.4798268883172484,1.0,4/12,10.96%,PKD1;STRA6;TBX3;FOXF2
prerank,proteoglycan biosynthetic process (GO:0030166),0.48302882365108896,1.3438150357086585,0.118491921005386,0.6420989998707701,1.0,4/31,3.83%,IGF1;PXYLP1;HS3ST3B1;GAL3ST3
prerank,tight junction assembly (GO:0120192),-0.39241498779962913,-1.3437294057221911,0.07159904534606205,0.4798762851158714,1.0,12/49,9.51%,PECAM1;CLDN5;ESAM;ACTG1;OCLN;LSR;CLDN11;RAMP2;F11R;MPP7;PAK2;APC
prerank,positive regulation of cellular catabolic process (GO:0031331),0.36579504076249464,1.3434722706802789,0.0725925925925926,0.6414092172102485,1.0,22/132,9.63%,IGF1;SH3D19;PPARA;DAPK1;ZBTB20;TRIM5;VGLL4;NPRL2;LRRK2;SNX33;UFL1;SNX9;PRKAA2;NRDC;BNIP3;OPTN;RNF152;PRKAA1;DAGLB;ARNT;PLEKHF1;ITCH
prerank,response to interleukin-4 (GO:0070670),-0.5903133560918716,-1.3433084405854407,0.11591355599214145,0.479776713307729,1.0,4/10,19.01%,LEF1;XBP1;TCF7;JAK3
prerank,negative regulation of cell motility (GO:2000146),-0.3388542077656915,-1.342386049317893,0.029585798816568046,0.4811392501024623,1.0,20/108,6.22%,FRMD5;LIMCH1;SLIT2;PTPRJ;CLDN5;TMEFF2;CLIC4;ACVRL1;DACH1;CDH1;JAG1;ADAM15;ADARB1;ENG;MCTP1;CCDC125;SRGAP1;KANK1;RHOB;IGFBP5
prerank,cardiac cell development (GO:0055006),-0.5770040146568025,-1.341466986200239,0.13861386138613863,0.4826650293895992,1.0,5/11,7.98%,JAG1;NOTCH1;CXADR;MYH11;VEGFA
prerank,pattern recognition receptor signaling pathway (GO:0002221),-0.38522613580738707,-1.3414111857924056,0.06295399515738499,0.48168176513110617,1.0,11/56,6.52%,PLCG2;SFTPA2;SFTPA1;UBB;LBP;NOD1;LGMN;CTSB;HSP90B1;UBC;RPS27A
prerank,positive regulation of endothelial cell migration (GO:0010595),-0.3489958013985295,-1.3406793583299474,0.043478260869565216,0.48248149802476203,1.0,27/84,9.89%,TEK;TMSB4X;FOXP1;NOS3;NRP2;KDR;THBS1;RAC1;SCARB1;ETS1;PTK2B;BMPR2;LGMN;HSPB1;ATP5F1A;BCAR1;GATA2;RHOB;TGFB1;CALR;EMC10;MET;FLT4;VEGFA;GRN;EDN1;PIK3CD
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.5212323354792809,-1.3403722549015005,0.12698412698412698,0.48215370422462456,1.0,9/16,23.77%,TRIB2;TNFRSF21;CD274;JAK3;TYROBP;DLL1;VSIR;AGER;FCGR2B
prerank,xenobiotic transport (GO:0042908),0.5335642517487832,1.3402248903392784,0.14068441064638784,0.6496919160036249,1.0,5/17,7.41%,SLC22A4;SLC22A2;NR1I2;GJA1;ABCC2
prerank,lamellipodium organization (GO:0097581),-0.4329019650293835,-1.340210733704592,0.08733624454148471,0.4813878235442732,1.0,19/29,26.90%,PARVB;ABLIM1;RAC1;CARMIL1;ITGB1;S1PR1;SPATA13;ARHGEF6;CCDC88A;CDH13;WHAMM;SNX1;ARFIP2;SNX2;ABLIM2;SPEF1;P2RY12;ABLIM3;CTTN
prerank,negative regulation of lipid storage (GO:0010888),0.5173663400541944,1.3398421952461008,0.14041745730550284,0.6491159939575611,1.0,4/19,6.85%,OSBPL8;PPARA;ABCA1;IL6
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.5392516091204507,1.339824579137222,0.1402805611222445,0.6473257335620208,1.0,7/17,11.92%,ATP1A2;SLC8A1;ANK2;CACNA1D;CACNA2D1;SCN3B;SCN2B
prerank,visual perception (GO:0007601),0.3989923081074256,1.3395934747792113,0.07108239095315025,0.6462567151036184,1.0,7/84,4.88%,EYA4;ADGRV1;EFEMP1;ZIC2;CRYGS;TULP1;COL18A1
prerank,toll-like receptor signaling pathway (GO:0002224),-0.35586960055743916,-1.3395583354815501,0.043010752688172046,0.4820118870401037,1.0,30/84,22.17%,PLCG2;SFTPA2;SFTPA1;UBB;LBP;LGMN;IKBKB;RFTN1;CTSB;HSP90B1;UBC;RPS27A;BIRC3;MAP3K1;S100A1;CHUK;HSPD1;TAB3;PIK3C3;IRAK3;PIK3AP1;UBA52;CASP8;IRAK1;UBE2D1;NR1H4;MYD88;TIRAP;TRIL;CTSL
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.45949085513130894,-1.3393295625743382,0.10020876826722339,0.4814877325087681,1.0,17/24,35.62%,UBB;UBC;RPS27A;RPA1;UBA52;POLK;LIG4;POLE;POLD3;POLB;POLD1;RFC5;LIG3;RPA3;RPA2;XRCC1;RFC2
prerank,positive regulation of protein-containing complex assembly (GO:0031334),-0.3369129238448193,-1.3390124933834127,0.04371584699453552,0.4811924372095761,1.0,30/113,12.92%,UNC13B;FNIP2;ESR1;TFRC;HSP90AA1;RASIP1;DAB2IP;RACK1;RPS3;SH3GLB1;WARS1;TGFB1;FERMT2;MPP7;FAF1;GSK3B;PIEZO1;VEGFA;SPIDR;RBX1;DDB1;EIF4G1;GBP5;ISG15;USP50;TAL1;PIH1D1;RPA1;PSMC3;CLU
prerank,positive regulation of coagulation (GO:0050820),-0.588327303258317,-1.3387536648348555,0.12867647058823528,0.47961125165333107,1.0,2/10,1.79%,ST3GAL4;THBS1
prerank,positive regulation of hemostasis (GO:1900048),-0.588327303258317,-1.3387536648348555,0.12867647058823528,0.47961125165333107,1.0,2/10,1.79%,ST3GAL4;THBS1
prerank,positive regulation of MAP kinase activity (GO:0043406),0.4124984446201805,1.338429185339096,0.08414239482200647,0.6481885525406136,1.0,9/66,5.81%,ROBO1;SASH1;IL34;KIT;DKK1;PDGFRB;LRRK2;PDGFD;FGF1
prerank,cellular modified amino acid catabolic process (GO:0042219),0.5712941076742387,1.3374802079459298,0.14227642276422764,0.6492161076769509,1.0,6/15,18.10%,ALDH4A1;GGACT;HOGA1;PRODH;ABHD16A;ABHD12
prerank,positive regulation of cellular senescence (GO:2000774),-0.5835092895034916,-1.3373014942452404,0.177734375,0.4824096355810378,1.0,3/10,8.11%,B2M;YPEL3;ABI3
prerank,amino acid import (GO:0043090),0.5138975107651154,1.3369999345591659,0.1569767441860465,0.6489270889885635,1.0,5/21,3.87%,SLC22A4;SLC6A13;SLC22A2;SLC1A3;SLC6A1
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.42650477744661097,-1.3361094997421612,0.10657596371882086,0.4845648441263937,1.0,14/35,19.95%,MEF2C;CAV1;PTPRM;THBS1;CAV2;ATP5F1A;PDCD10;SCG2;SYNJ2BP;XDH;NF1;ATP5IF1;SPARC;DLL4
prerank,protein K11-linked ubiquitination (GO:0070979),0.4979862538687608,1.3356457863404005,0.14732965009208104,0.6514010555101464,1.0,10/27,20.09%,PRKN;UBE2E2;ANAPC13;UBE2L3;CDC26;UBE2A;UBE2H;ANAPC2;CDC23;ANAPC5
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.30894519052325475,1.3355501087593384,0.001088139281828074,0.6498395508244384,1.0,180/1082,13.64%,IL31RA;IGF1;GLIS3;CREB5;RORA;BMP6;TCF7L2;TCF4;OSR1;AUTS2;WNT4;RBPJ;ARNT2;ZIC1;ZNF462;FGFR2;PPARA;EPAS1;HLF;NR2F2;PID1;NPAS3;IL18;HOXC4;CDK8;BMP7;ZEB2;WWOX;PRKN;BRD8;KMT2A;MEIS1;DAB2;HOXB4;ESRRG;FHOD1;CSRP3;MYBL1;ZIC2;DMRT1;SCX;NR1I2;ASCL2;SP100;TBL1XR1;CITED4;PLCB1;HOXB3;RNASEL;PPARGC1B;NFYB;CDK7;TP53INP2;SSBP2;IGF2;STAT5B;MAML3;TFR2;NCOA2;NFAT5;MYRFL;ZFP90;HDAC8;ELF4;TEAD1;HOXA7;NFIB;ARID1B;FIZ1;SOX1;GLI3;NDP;WASL;DPF2;IRF8;ZMIZ1;MSANTD1;FGF1;TET1;MAML1;NIBAN2;PHF8;SALL1;ARHGEF11;IL6;SMAD3;NCOA3;RFXAP;NEK4;BLM;SSBP3;RGMB;TRIM56;GABPB1;GABPB2;NCOA7;PBX4;TCF12;MTF2;ARNT;CCNT2;RSF1;CCNT1;LYAR;ABRA;GTF2F1;MITF;RPRD1B;NFIA;FSTL3;KAT8;KAT6B;PCGF5;KDM6B;MAP3K2;CEBPG;RASL11A;BRCA2;PICALM;CREB3L2;NSD1;AKAP8L;IER5;IRF3;ASXL2;MED13;MED1;HDAC1;ABL1;AGO2;PIK3R1;DVL3;BCL9;PHIP;PRKDC;FLCN;PARP9;ATOH8;ZBTB38;SNAI1;KMT2B;SMARCA5;TFAP2A;TFAP2B;NPAS2;PRKD2;PKD2;ERBB2;RXRA;TRIM45;RNF14;MYB;BMPR1A;BCLAF3;INO80;CRTC3;HIVEP1;ICE2;CRTC1;MAML2;GLI2;SERPINE1;MLXIP;SMARCB1;RNF20;FOXK2;AR;HSF1;FZD2;METTL23;KLF5;TBK1;CLOCK;GDNF;NR1I3;CREBBP;ZMIZ2;HOXD4;MEIS2;BCL2L12
prerank,organic hydroxy compound transport (GO:0015850),-0.4277865953971156,-1.3354284405444807,0.10810810810810811,0.48529074869898214,1.0,7/36,6.85%,ABCC4;ATP8B1;SLCO1C1;SLCO2B1;SLC16A1;STRA6;CEACAM1
prerank,histone lysine demethylation (GO:0070076),0.48630004067511784,1.335376527112249,0.1392156862745098,0.6485341258110101,1.0,12/25,17.42%,KDM7A;KDM2B;PHF8;KDM2A;KDM5B;KDM3B;KDM6B;KDM5C;PHF2;KDM6A;RIOX2;KDM4D
prerank,cellular response to ketone (GO:1901655),0.46004760214935303,1.335307894986301,0.12222222222222222,0.6469339844387503,1.0,3/35,0.72%,ROCK2;ADCY5;ADCY1
prerank,glucose homeostasis (GO:0042593),0.3927182375978218,1.335238911999016,0.07836990595611286,0.6453377380366939,1.0,12/83,8.15%,LEPR;TCF7L2;APPL2;FGFR4;RBP4;HK2;PRKAA2;IGF1R;IL6;PRKAA1;MCU;SLC30A8
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.5142233583668353,-1.3348382649734676,0.12596899224806202,0.4857157280803248,1.0,9/16,29.30%,TPT1;ACKR3;RPS3;BCL2L1;CLU;CXCL12;CDKN2D;SNAI2;TMEM161A
prerank,epithelial cell-cell adhesion (GO:0090136),0.585553296218715,1.3337785056533917,0.1749502982107356,0.6481502147814737,1.0,2/11,1.24%,PLEKHA7;KIT
prerank,cellular defense response (GO:0006968),0.43998035105514055,1.3331832243745523,0.0922242314647378,0.6482066898424318,1.0,2/40,1.54%,DCDC2;CCR9
prerank,actin filament polymerization (GO:0030041),0.47806638023844783,1.3331367326829755,0.1219047619047619,0.6466002447664432,1.0,10/29,11.21%,ARHGAP6;GAS7;WASF1;WASL;SPIRE2;WASF3;CORO7;PSTPIP2;JAK2;COBL
prerank,regulation of protein localization to nucleus (GO:1900180),-0.39069382292901744,-1.332649377165099,0.09285714285714286,0.49046838181182795,1.0,24/43,35.75%,TFRC;LIMK2;TGFB1;FERMT2;GSK3B;CARD10;SESN2;WWTR1;ATP13A2;SUMO3;BMP4;CTNNA1;AKT1;OTUD7B;BYSL;SIN3A;MFHAS1;SHH;PLK1;NGFR;TESK1;PARK7;CDK5RAP3;LIF
prerank,positive regulation of angiogenesis (GO:0045766),-0.33095048262558474,-1.332610436178634,0.03763440860215054,0.48943576932159666,1.0,30/108,10.63%,GAB1;TEK;NOS3;BMPER;TIE1;CD34;KDR;THBS1;F3;KLF4;RUNX1;ITGB1;ETS1;RAMP2;ITGB8;PKM;PIK3R6;HSPB1;ITGA5;GATA2;RHOB;PDCL3;EMC10;TJP1;VEGFA;GRN;PTGIS;PIK3CD;S100A1;XBP1
prerank,phosphatidylcholine biosynthetic process (GO:0006656),-0.42500958648560183,-1.3321577984398585,0.09267241379310345,0.48949721161990817,1.0,15/32,33.09%,CEPT1;MFSD2A;LPCAT3;GPAT4;CSNK2B;LPCAT1;LPIN3;LPIN1;LCAT;SLC44A5;CHPT1;SLC44A2;PEMT;STARD10;ACHE
prerank,positive regulation of lipid metabolic process (GO:0045834),0.5098109118600871,1.3319282437933546,0.14972273567467653,0.6486289662101512,1.0,3/22,2.63%,PPARA;SORBS1;ZBTB20
prerank,cellular glucose homeostasis (GO:0001678),-0.4083812664046724,-1.3317426346571077,0.0851528384279476,0.4896162477469026,1.0,13/41,13.27%,UNC13B;LRRC8D;GAS6;PPARGC1A;RACK1;KCNB1;SOX4;HK1;FOXO1;LRRC8A;XBP1;GPER1;FOXK1
prerank,eye morphogenesis (GO:0048592),0.5271751286891686,1.3315750490943103,0.14849624060150377,0.6480598953363911,1.0,4/19,2.96%,EFEMP1;FBN1;FBN2;SHROOM2
prerank,carbohydrate transport (GO:0008643),-0.5486372728081083,-1.3310240774496487,0.137524557956778,0.4904171906680697,1.0,3/11,11.51%,AQP11;SLC50A1;SLC26A6
prerank,histone modification (GO:0016570),0.37972822991623556,1.3309235585603891,0.08945686900958466,0.6482887923553023,1.0,14/109,10.21%,EYA4;EYA1;EYA2;BRD8;PRDM5;TBL1XR1;MIDEAS;BAZ1B;UFL1;PRMT7;KAT8;KAT6B;NSD1;HDAC1
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.4108477031053918,-1.3308211328797614,0.08470588235294117,0.4898264601556039,1.0,12/38,15.98%,NOS3;THBS1;BMP5;TNFSF10;BCL2L1;GSK3B;TMBIM1;ARHGEF2;RNF34;MADD;FAS;CASP8
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.5119161431813742,-1.3306865967129886,0.12684989429175475,0.48901380628171937,1.0,13/16,33.58%,SRSF1;SFPQ;DDX5;SRSF9;SRSF6;RBM17;DDX17;HNRNPM;PUF60;SCNM1;CELF4;DHX9;PQBP1
prerank,regulation of MAPK cascade (GO:0043408),0.3595180221776927,1.3304028744967349,0.06433566433566433,0.6482185688967628,1.0,18/157,6.85%,IGF1;EPHA7;TGFBR3;ROCK2;KSR1;FGFR2;NRK;KIT;PELI2;LPAR1;TRIM5;IGF2;EPHA8;GFRAL;IGF1R;WWC1;ADRA1D;IL6
prerank,fatty acid beta-oxidation (GO:0006635),0.4350548673762318,1.33009877166833,0.11965811965811966,0.6473041994844991,1.0,16/51,14.43%,IVD;EHHADH;ACADL;ECI2;CPT2;HSD17B10;ACAD11;ECHDC1;ACADS;ACAA2;GCDH;ACAT2;AUH;AMACR;ACOX1;BDH2
prerank,chondrocyte differentiation (GO:0002062),0.47997167448827266,1.329371719110953,0.1274131274131274,0.6479201239264314,1.0,8/32,9.45%,SOX5;OSR1;SCX;SOX6;SULF1;NFIB;WNT5B;CREB3L2
prerank,lipid translocation (GO:0034204),-0.47611875335278164,-1.329079107435557,0.11587982832618025,0.49250047304728556,1.0,8/21,12.33%,ATP10A;ATP8B1;ATP8A1;ATP8A2;ATP11B;ATP11C;TMEM30A;ATP11A
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.5103305867694408,-1.3285163333780892,0.1454183266932271,0.49291279296306423,1.0,4/15,12.43%,GRM3;GRM7;HOMER1;GRM8
prerank,anterior/posterior axis specification (GO:0009948),0.5509891373050869,1.3284994999437987,0.14867617107942974,0.6488525751814607,1.0,1/15,0.45%,WLS
prerank,negative regulation of myotube differentiation (GO:0010832),-0.5427422876991773,-1.3281664180373625,0.11663479923518165,0.4927057283205686,1.0,4/12,10.63%,NOTCH1;CCN3;HDAC5;XBP1
prerank,regulation of actin filament bundle assembly (GO:0032231),0.49443984579846123,1.32799279716998,0.13686131386861314,0.6488327246679034,1.0,5/26,6.05%,ROCK2;PRKN;FHOD1;ALMS1;ASAP3
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.36600787165204446,1.327642460842593,0.05730659025787966,0.6481329855269081,1.0,27/138,13.47%,RORA;RBPJ;PPARA;NOTCH2;POLR2D;ESRRG;CCN2;NR1I2;TBL1XR1;CDK7;MAML3;TEAD1;MAML1;TEAD3;NR6A1;NRBP1;POLR2A;GTF2F1;MED1;HDAC1;TAF8;RXRA;TAF3;MAML2;AR;NR1I3;CREBBP
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.579324276713493,1.3275757334162888,0.1884920634920635,0.6465941428629701,1.0,3/12,2.41%,WNK4;DMD;ATP1B3
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.6010643812349826,1.3271927442115128,0.1771058315334773,0.6459959475302188,1.0,2/10,3.26%,OXSR1;CXCL13
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.5198306243447951,1.3271256606877684,0.14616755793226383,0.6444638207504048,1.0,5/20,8.32%,OSR1;NEDD4;PCSK9;MMP9;CAMK2D
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.44947604590843304,-1.326494571916138,0.1148936170212766,0.49605868796270586,1.0,13/24,28.67%,ABCG2;ABCB10;SUCLA2;RSAD1;ATP5IF1;UROD;UROS;FECH;FLVCR1;COX15;HMBS;TSPO;ABCB6
prerank,activation of GTPase activity (GO:0090630),-0.3459029600636024,-1.326393416048207,0.03826530612244898,0.49519712357695855,1.0,28/89,12.13%,NTRK3;SIPA1L1;TIAM1;TBC1D30;ARHGAP42;TBC1D8;SIPA1L2;ARHGEF15;CCDC125;SIPA1L3;RABGAP1L;CORO1C;ADPRH;ABR;GRTP1;SGSM1;BCR;TBC1D8B;TBC1D1;ARHGEF19;TBC1D13;ARHGEF26;ARHGAP25;ARHGEF5;ARHGEF10;EVI5;RANGAP1;TBC1D10A
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.5686711160371862,-1.3262841195896957,0.136986301369863,0.4943034587689194,1.0,5/11,22.49%,CREB3L1;HSPA5;ATF4;ATF3;CEBPB
prerank,regulation of protein metabolic process (GO:0051246),-0.4023494775812489,-1.3261439408035405,0.082039911308204,0.493503872374056,1.0,14/44,11.24%,LTBP4;KLF2;HSP90AB1;KLF4;NEDD4L;FAF1;NEDD8;APP;CHEK2;ZDHHC2;MAPK8;FURIN;SSH1;HGS
prerank,stress-activated MAPK cascade (GO:0051403),-0.37885468092535945,-1.3261010300822345,0.07672634271099744,0.49251303930546203,1.0,17/61,15.15%,MAP3K5;UBB;MINK1;NOD1;IKBKB;ARHGEF6;UBC;RPS27A;MAPK8;CHUK;MAP2K7;ZFP36L1;MAP3K12;TAB3;MAP3K8;CUL1;UBA52
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.31682682872033374,1.325943406537891,0.005931198102016607,0.6463468247934325,1.0,108/572,13.60%,GLIS3;PRDM6;BMP6;TCF7L2;OSR1;AEBP1;RBPJ;FHL2;FGFR2;PPARA;NR2F2;ATXN1;ZEB2;WWOX;PRKN;KCNIP3;DAB2;ARID5B;MXI1;FNIP1;ZEB1;AASS;CUX1;PRDM5;SATB1;DKK1;DMRT1;NR1I2;ASCL2;SP100;TBL1XR1;NEDD4;IGF2;VSX2;JAZF1;ZHX2;ZFP90;HDAC8;HOXA7;RNF2;NFIB;KDM2B;SOX1;GLI3;DPF2;IRF8;SUFU;CXXC5;ZBTB32;MXD1;ZFP37;DLG1;SALL1;CBX8;BCOR;WWC1;THAP1;SMAD3;WWC2;KANK2;EN1;PHF21A;NR6A1;MTF2;LYAR;PER3;MITF;WWP2;DNAJA3;CBX2;MDM2;NSD1;SMURF2;FRK;MED1;HDAC1;IRX1;FLCN;PARP9;ZNF8;SNAI1;TFAP2A;CBX7;TFAP2B;ZNF568;ZNF177;CDC73;RXRA;MYB;TAF3;CNOT2;E2F6;CRY1;CGGBP1;HIVEP1;GLI2;ORC2;AR;IFI27;HSF1;PHF6;SOX13;EZH1;NFATC4;DICER1;NR1I3;CREBBP;MEIS2
prerank,regulation of macrophage activation (GO:0043030),0.47998112887584055,1.3250462745103022,0.15384615384615385,0.6473571588163763,1.0,5/30,6.85%,IL31RA;PLA2G10;SPHK1;MYO18A;IL6
prerank,positive regulation of cytoskeleton organization (GO:0051495),-0.35431581650315697,-1.3244571271787897,0.053475935828877004,0.4957820181784641,1.0,23/76,22.17%,TEK;NTRK3;CARMIL1;PTK2B;CDC42EP3;NCKAP1;WDR1;NCK1;BAIAP2L1;EDN1;SORBS3;NCK2;NES;BIN1;CDC42EP5;PRKCE;CFL2;CDC42EP2;EVL;CDK5;NCKAP1L;NUMA1;SPAG5
prerank,cyclooxygenase pathway (GO:0019371),-0.5709288359862086,-1.3233142923445131,0.1350844277673546,0.49783618197153484,1.0,5/10,29.35%,PTGIS;PTGDS;PTGS2;HPGDS;CBR1
prerank,sensory perception of mechanical stimulus (GO:0050954),0.38633974476910016,1.3232836505072123,0.07776049766718507,0.6512419686163573,1.0,14/85,11.15%,DCDC2;EYA1;ADGRV1;CEMIP;ALDH7A1;CCDC50;RIPOR2;CACNA1D;LRP2;BIRC5;WHRN;EML2;GSDME;TFAP2A
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.3666304921736847,-1.322580788460603,0.0825242718446602,0.49881883071262784,1.0,17/65,11.70%,HIP1;PTPRJ;SH3KBP1;BCAR3;CBL;DAB2IP;MVB12B;PTPN12;CCDC88A;CEACAM1;RHBDF2;HIP1R;SHKBP1;DUSP3;HGS;CDH13;GPER1
prerank,positive regulation of leukocyte activation (GO:0002696),-0.48327176871335176,-1.322506169703589,0.14613778705636743,0.4978732114044199,1.0,9/18,30.74%,IL33;THBS1;LBP;HSPD1;CEBPA;CRLF2;TLR4;KARS1;TLR6
prerank,anion transmembrane transport (GO:0098656),0.4094325016480432,1.3223080578970916,0.09693877551020408,0.6525033516738897,1.0,15/67,11.66%,SLC6A13;SLC13A3;SLC13A4;SLC16A12;SLC6A9;SLC1A3;SLC25A18;SLC13A5;LRRC8E;SLC25A22;SLC25A11;SLC27A1;SLC19A1;SLC13A1;SLC35A1
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.48800020756651313,1.3221313121640221,0.15454545454545454,0.6513142206812019,1.0,5/26,7.98%,RORA;CCBE1;SULF1;IL6;ARNT
prerank,oligodendrocyte development (GO:0014003),-0.5102154208613287,-1.3214958537609904,0.1550695825049702,0.4994826808003045,1.0,7/15,18.83%,PLP1;B4GALT5;EIF2B5;EIF2B2;TPPP;B4GALT6;SOX10
prerank,protein hydroxylation (GO:0018126),-0.5119251997401068,-1.3214799155162806,0.14682539682539683,0.498382987686754,1.0,8/15,28.92%,P3H2;EGLN3;PLOD2;PLOD3;JMJD7;PLOD1;VPS33B;HIF1AN
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.4418345639374803,1.3208009966041705,0.12369337979094076,0.6536381126212946,1.0,15/42,15.54%,RBBP4;HNRNPC;ARID1B;CECR2;NASP;CHD4;HDAC1;SMARCA5;SMARCE1;INO80;SMARCB1;SRCAP;SMARCC1;SMARCA2;ACTR6
prerank,positive regulation of interleukin-13 production (GO:0032736),0.5997271175443999,1.3207888912348973,0.17647058823529413,0.6519674584941889,1.0,2/10,5.73%,IL18;PRKCZ
prerank,positive regulation of phospholipase C activity (GO:0010863),0.45271478924419106,1.320436101680022,0.11051693404634581,0.6513291938960212,1.0,7/40,6.41%,ARHGAP6;KIT;LPAR1;PDGFRB;PDGFRA;LPAR2;GNAQ
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.4469005288080285,-1.3201938604301606,0.12320328542094455,0.5008397233471679,1.0,11/25,22.45%,KLF2;HSP90AA1;HSP90AB1;KLF4;DDAH1;EDN1;PTGS2;CLU;INSR;AKT1;DDAH2
prerank,negative regulation of cellular protein localization (GO:1903828),0.45628246304452225,1.3200538579721206,0.1413237924865832,0.6507342541828377,1.0,8/34,10.64%,LEPROT;ROCK2;RIPOR2;SNX33;UBXN2B;PICALM;LATS1;FLCN
prerank,negative regulation of cell migration (GO:0030336),-0.31830537456868363,-1.320002904775831,0.015105740181268883,0.5002380629048878,1.0,25/137,6.22%,LIMCH1;SLIT2;PTPRG;PTPRJ;CLDN5;TMEFF2;CLIC4;ACVRL1;DACH1;RAC1;CDH1;JAG1;ADAM15;ADARB1;ENG;DAB2IP;MCTP1;ARHGDIB;SRGAP1;KANK1;CORO1C;RHOB;NEXMIF;CALR;IGFBP5
prerank,cardiac muscle cell action potential (GO:0086001),0.4740050447786828,1.3190135287486608,0.1285444234404537,0.6522259622494497,1.0,7/30,7.01%,ATP1A2;DMD;SLC8A1;ANK2;KCND3;CACNA1D;CACNA2D1
prerank,negative regulation of mitochondrion organization (GO:0010823),0.45819897338657734,1.3185510123028088,0.1282051282051282,0.6518424058893554,1.0,6/33,10.64%,IGF1;PRKN;BNIP3;NOL3;ACAA2;FLCN
prerank,hematopoietic stem cell differentiation (GO:0060218),0.599770594379807,1.318225054766007,0.17697228144989338,0.651148056490767,1.0,5/10,16.83%,HOXB4;UFL1;ACE;BATF;SFRP1
prerank,negative regulation of secretion by cell (GO:1903531),-0.4031812214983084,-1.317890054800818,0.13333333333333333,0.5049034118091712,1.0,11/38,13.59%,STXBP6;GRM7;NOTCH1;VAMP8;RHBDF2;TNFRSF1B;SLC30A1;RSAD2;CHGA;SYT4;CYP51A1
prerank,intracellular pH reduction (GO:0051452),-0.4177880657864732,-1.3175411351209128,0.08991228070175439,0.5046488476597201,1.0,20/33,28.50%,DMXL1;ATP6V0A1;RAB38;ATP6V1A;ATP6V0C;ATP6V1E1;TCIRG1;DMXL2;ATP6V0A4;ATP6V0A2;RAB39A;SLC11A1;ATP6V0D2;CLCN3;ATP6V0E2;ATP6V1B2;RAB7A;TMEM9;ATP6V1H;RAB20
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.5321937720698695,1.3174074052765312,0.1811320754716981,0.6520730318673444,1.0,2/19,1.05%,BMP6;AFDN
prerank,regulation of interleukin-4 production (GO:0032673),-0.4594358591194003,-1.3172291458456866,0.13263157894736843,0.504447955090511,1.0,2/21,1.60%,LEF1;SLC7A5
prerank,cellular response to lipid (GO:0071396),0.34757322294787324,1.3160820486709657,0.05738880918220947,0.6545188919147249,1.0,19/191,7.40%,RORA;ATP1A2;ROCK2;ADCY5;PTK7;ADCY1;TFPI;EPHA3;PID1;WNT6;CXCL13;CRHBP;CACTIN;SSTR2;UBE2L3;IL6;NCOA3;PDCD1LG2;WNT5B
prerank,protein oxidation (GO:0018158),0.5845564920109753,1.3159299383892227,0.16565656565656567,0.6532972439918767,1.0,2/11,2.93%,LOXL1;LOXL3
prerank,positive regulation of metabolic process (GO:0009893),0.37527221689111234,1.3151508223318742,0.07981927710843373,0.654124114497177,1.0,16/103,6.98%,LEPR;APPL2;EPAS1;IL18;ACSL1;ESRRG;CAMK1D;GNAS;ALMS1;PPARGC1B;GRB10;GJA1;ACADL;CPT2;IGF1R;PTH2R
prerank,monosaccharide transmembrane transport (GO:0015749),0.5468973291550944,1.3150678156667612,0.1731958762886598,0.6526862047683228,1.0,3/16,6.15%,SLC2A12;SLC45A3;SLC2A10
prerank,regulation of execution phase of apoptosis (GO:1900117),-0.5565421708656264,-1.3149459570010091,0.14149139579349904,0.5099187989308706,1.0,4/11,17.53%,FAP;BCL2L1;PTGIS;ZC3H12A
prerank,protein prenylation (GO:0018342),-0.5667750983171956,-1.3148113689816268,0.1556420233463035,0.5091218179657488,1.0,5/10,20.95%,PGGT1B;RABGGTB;RCE1;PTAR1;RABGGTA
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.4518868619866196,1.3145197562316036,0.1266294227188082,0.6526553901922418,1.0,7/37,7.11%,ALCAM;ADGRL1;JAML;FAT4;IL1RAPL1;AMIGO3;PTPRD
prerank,regulation of angiogenesis (GO:0045765),-0.3033934778745694,-1.3144891525062548,0.013559322033898305,0.5088253541238424,1.0,41/192,8.86%,GAB1;TEK;CLDN5;PTPRM;SEMA6A;NOS3;BMPER;RHOJ;TIE1;CD34;KDR;THBS1;TGFB2;PLXND1;F3;KLF4;RUNX1;ITGB1;ETS1;RAMP2;ITGB8;DAB2IP;PPP1R16B;SEMA3E;PIK3R6;HSPB1;STAB1;GATA2;WARS1;RHOB;PDCL3;CTNNB1;SARS1;EMC10;CEMIP2;CEACAM1;SERPINF1;VEGFA;EMP2;GRN;PTGIS
prerank,potassium ion homeostasis (GO:0055075),-0.4600723489677585,-1.3144447735726754,0.14736842105263157,0.5078409414442326,1.0,10/23,11.43%,SLC12A2;SLC12A7;KCNJ2;ATP1A1;KCNMA1;ATP1B1;SLC12A6;SLC12A8;SLC12A4;ATP1A3
prerank,positive regulation of histone acetylation (GO:0035066),-0.4646208517451776,-1.3144167045053838,0.13179916317991633,0.5067792465360365,1.0,7/23,11.23%,RPS6KA5;PPARGC1A;ARRB1;WBP2;GLYR1;NOS1;PIH1D1
prerank,positive regulation of dephosphorylation (GO:0035306),-0.4442504409460309,-1.3144150026608261,0.11814345991561181,0.5056704022277236,1.0,13/27,21.65%,CALM1;PPIA;PPP1R16B;TGFB1;BMP2;MTMR9;SYMPK;CALM2;PPP2R5A;PTBP1;PRKCD;CDCA2;NSMF
prerank,regulation of macromolecule metabolic process (GO:0060255),0.348073847423729,1.3140393079880042,0.05401459854014599,0.652420690485134,1.0,18/170,9.06%,IGF1;PRDM6;ROCK2;AFF2;ZNF462;IGF2BP1;NOVA1;PRDM5;DKK1;SLC8A1;TRIM5;CACTIN;MTMR3;ZUP1;FUBP1;ATRAID;SIRPA;KDM6B
prerank,histone H3-K4 methylation (GO:0051568),0.4796977946449247,1.3130875176478631,0.13894324853228962,0.6537353371913602,1.0,12/26,23.05%,KMT2A;ASH2L;SETD1A;KMT2B;KDM6A;CTR9;DYDC2;WDR82;SETD4;BEND3;TET3;DPY30
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.5288805224443136,-1.3128728456708014,0.11871227364185111,0.5089751800407544,1.0,6/14,27.75%,SRSF9;RNPS1;SRSF6;PTBP1;PCBP4;SRSF7
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.5709001243045372,1.312393677751327,0.16041666666666668,0.654181110204292,1.0,2/14,1.51%,AUTS2;KMT2A
prerank,regulation of T cell receptor signaling pathway (GO:0050856),-0.4219802591402878,-1.3120236474904339,0.12581344902386118,0.510132261804361,1.0,20/33,39.23%,PTPRJ;RPS3;CEACAM1;DGKZ;DUSP3;CD81;LAPTM5;CD300A;THY1;RELA;EZR;CARD11;KCNN4;PTPN22;RC3H1;PHPT1;TRAT1;CD226;TESPA1;LCK
prerank,nucleus organization (GO:0006997),-0.38829129816987995,-1.3119347615015828,0.10829493087557604,0.5092293424739727,1.0,21/47,26.38%,SYNE1;REEP3;RPS19;CHMP5;CHMP2B;LEMD2;BIN1;CHMP1B;NUP54;PITPNB;NUP133;SUN1;IRAG2;CTDNEP1;CHMP1A;NUMA1;CHMP3;CHMP7;PDCD6IP;CHMP4C;CEP55
prerank,positive regulation of MAPK cascade (GO:0043410),0.3362993032416221,1.3117512677430514,0.03708609271523179,0.6544517137556028,1.0,30/245,6.85%,IGF1;ROBO1;ROCK2;IL34;KSR1;FGFR2;FGFR4;NOTCH2;KIT;ANGPT1;PELI2;MTURN;LPAR1;CCN2;PDGFRB;TRIM5;IGF2;EPHA8;PDGFRA;GFRAL;GLIPR2;LRRK2;PDGFD;PRKCZ;FGF1;IGF1R;WWC1;ADRA1D;PRKCA;IL6
prerank,"transcription, DNA-templated (GO:0006351)",0.33723414676518815,1.3111932262006953,0.05241935483870968,0.6545552800645548,1.0,28/207,12.85%,GLIS3;SOX5;MAF;POLR2D;SCX;PAX5;CDK7;ELOA;GTF3C5;HSF2BP;THAP1;POLR3GL;POLR3G;CCNT2;RSF1;CCNT1;POLR2A;GTF2F1;SMN1;TAF1A;SMARCA5;DTX1;CDC73;GTF3C3;TAF3;HIPK3;GMEB2;HSF1
prerank,regulation of cellular senescence (GO:2000772),-0.43261834082932465,-1.3109981187922917,0.11982570806100218,0.5106572941809631,1.0,7/28,12.68%,B2M;YPEL3;ABI3;YBX1;CDK6;RSL1D1;MAP3K3
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.2990989830840892,1.3102449664467084,0.0,0.6557585349631063,1.0,314/1646,15.76%,IL31RA;IGF1;GLIS3;CREB5;RORA;SOX5;MAF;VGLL3;TCF7L2;TCF4;OSR1;EFEMP1;WNT4;RBPJ;ARNT2;ZIC1;DENND4A;HOXC6;PPARA;EPAS1;HLF;NR2F2;KDM7A;IKZF2;NPAS3;KIT;HOXC4;BMP7;ATXN1;ZEB2;KMT2A;TULP3;ZKSCAN2;PRRX1;MEIS1;SNX6;DKK3;HOXB4;ARID5B;ESRRG;RUNX1T1;MXI1;ZEB1;SMAD6;CUX1;MYBL1;PRDM5;SATB1;ZIC2;EBF1;ZBTB20;DMRT1;SCX;NR1I2;ASCL2;SOX6;SP100;TBL1XR1;PLCB1;HOXB3;LOXL3;TSHZ3;PPARGC1B;JARID2;PAX5;HIF3A;NFYB;EPOP;MIDEAS;ZIC5;BBX;HOXA3;PKNOX2;TP53INP2;SSBP2;IGF2;STAT5B;HOXC5;VSX2;NCOA2;NFAT5;ZHX2;PRICKLE1;ELOA;MYRFL;ZFP90;VGLL4;ELF4;TEAD1;HOXA7;FOXD1;CBY1;BEND5;ZNF367;BAZ1B;MGA;NFIB;ARID1B;ARID4A;L3MBTL2;TEF;KDM2B;CAMTA1;GMEB1;IKZF4;ZNF250;SOX1;SP110;GLI3;SALL4;ZFHX2;NDP;SIX5;DPF2;PERM1;IRF8;SFMBT1;ZMIZ1;MSANTD1;BAZ1A;HIVEP2;ZNF569;SUFU;PRKCB;METTL4;ZBTB32;MYNN;MXD1;ZFP37;TCF7L1;NIBAN2;PHF8;SALL1;BCOR;ARHGEF11;TYMS;WWC1;THAP1;UBE2L3;IL6;ZNF23;GPBP1;SMAD3;WWC2;XRCC5;TEAD3;RFXAP;NEK4;BLM;EN1;GPBP1L1;RGMB;CHD4;PHF14;TRIM56;NCOA7;PBX4;NR6A1;TCF12;KDM2A;MTF2;ZKSCAN5;POLR3G;ARNT;CCNT2;PIAS1;RSF1;CCNT1;TLE1;BIRC5;POLR2A;ZMYND15;CAMK2D;MITF;WWP2;NFIA;KDM5B;ZNF628;FSTL3;KAT8;KDM3B;KAT6B;PCGF5;MAP3K2;CEBPG;MDM2;BRCA2;PICALM;CREB3L2;EBF4;NSD1;SMURF2;MBTD1;IRF3;BBS7;MED13;SCMH1;MED1;NUP107;ZSCAN29;NFYC;BATF2;HDAC1;ABL1;HOXB6;DVL3;PHIP;IRX1;ZIC4;L3MBTL3;ASCC2;ZBTB11;PARP9;ZNF8;NEUROD2;TADA2A;ATOH8;ZBTB38;TSHZ1;SNAI1;KMT2B;SMARCA5;TFAP2A;SMARCE1;HOXC8;TFAP2B;ZNF568;ARID3A;NPAS2;ERBB2;ZNF177;RXRA;TRIM45;ZBTB37;RNF14;MYB;CNOT2;E2F6;ZBTB39;CRY1;HIVEP1;GLI2;CBFA2T2;NONO;TGFA;MLXIP;SMARCB1;RNF20;FOXK2;GMEB2;CCNE1;EPC2;BATF;AR;HSF1;PHF6;SOX13;PSPC1;FZD2;SRCAP;SEBOX;NFATC4;KLF5;HOXA6;CLOCK;TRAK1;CREBBP;ZMIZ2;HOXD4;MEIS2;HOXB9;RRP8;ZFX;ZNF697;ZNF148;SCML4;KDM5C;POLR3C;DMRTA2;NLK;MTDH;MNAT1;SRF;CDKN1C;TFDP2;SMARCC1;CDK15;UBE2V1;PCGF1;CIR1;HOXD8;KLF9;NKRF;JMY;CCNL1;BRIP1;BACH1;ATF7IP;PATZ1;MYPOP;AXIN1;KLF13;SOX12;ZNF18;PHF1;PHF2;NIPBL;SMARCA2;SMARCD3;BARX2;SMAD4;BCL7A;PSIP1;ZNHIT3
prerank,postreplication repair (GO:0006301),-0.39609772517601616,-1.3100221673726244,0.10602409638554217,0.5123768697528687,1.0,21/45,24.53%,UBB;TRIM25;UBC;RPS27A;UBE2B;ISG15;RPA1;MSH2;UBA52;USP43;POLK;FAAP20;UBE2V2;SPRTN;POLN;POLD3;NSMCE1;VCP;POLD1;POLI;DTL
prerank,neutrophil activation (GO:0042119),-0.5441331331568771,-1.3094707729207202,0.14340344168260039,0.5127734306000716,1.0,5/12,20.25%,PREX1;KMT2E;IL15;TYROBP;PRKCD
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.5007444012768671,-1.3092132315507319,0.15555555555555556,0.512315036846044,1.0,7/15,10.15%,BMPER;KLF4;PKM;ITGA5;TJP1;VEGFA;S100A1
prerank,fatty acid catabolic process (GO:0009062),0.4012280036374976,1.3088205689108439,0.10801963993453355,0.6586380660136691,1.0,17/67,14.50%,PCCA;CEL;EHHADH;ACADL;ECI2;CPT2;HSD17B10;ACAD11;ECHDC1;ACADS;PHYH;ACAA2;ACAT2;AUH;ACOX1;BDH2;HACL1
prerank,homeostasis of number of cells (GO:0048872),-0.5343548747583052,-1.3084322197390401,0.14555765595463138,0.5131927023809072,1.0,5/12,15.51%,NOS3;NOTCH1;CCN3;LPCAT3;CX3CR1
prerank,regulation of endothelial cell chemotaxis (GO:2001026),-0.5025439617891416,-1.3083739116191047,0.15195071868583163,0.5122513189563398,1.0,6/15,6.64%,TMSB4X;THBS1;NOTCH1;LGMN;HSPB1;MET
prerank,regulation of cellular component biogenesis (GO:0044087),-0.40568189408294286,-1.3083536987594468,0.13333333333333333,0.5112367186157606,1.0,10/39,6.69%,RAP1A;MSN;TIE1;HSPA8;HSP90AA1;DAB2IP;NOTCH1;HJURP;TJP1;GFAP
prerank,cAMP metabolic process (GO:0046058),0.5579421045810447,1.3080869242534925,0.19047619047619047,0.6591493520073017,1.0,2/13,0.72%,ADCY5;ADCY1
prerank,copper ion homeostasis (GO:0055070),-0.4905516202045447,-1.3074359762808752,0.14989733059548255,0.5127327878160592,1.0,5/17,7.59%,ATOX1;MT2A;SLC31A1;ARF1;APP
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.5931800269916161,1.3072938001498176,0.18101545253863136,0.659873787310669,1.0,3/10,9.02%,IGF2;PRMT7;PCGF5
prerank,intracellular lipid transport (GO:0032365),0.5092298765012371,1.3064568556986629,0.16792452830188678,0.6608658132361818,1.0,4/21,6.78%,PRKAG2;PRKAA2;CPT2;SGPP1
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.45362900467093964,-1.3064064317008586,0.12258064516129032,0.5145518686312144,1.0,12/26,22.45%,NOS3;ACER3;ACER2;SPTLC2;GCH1;NOS1;CYB5R3;ABCA2;AKT1;CYP1B1;SPTLC1;DDAH2
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.4770611708110655,1.3062008237301348,0.140625,0.6599995060082391,1.0,7/27,8.58%,PPARA;IL18;PLA2G10;ABCA1;MAPK9;CSF1;ABCA5
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.4370175126554108,-1.3060981429232477,0.13786008230452676,0.514287525138774,1.0,8/26,12.92%,KLF2;HSP90AA1;HSP90AB1;KLF4;DDAH1;EDN1;PTGS2;CLU
prerank,inorganic cation transmembrane transport (GO:0098662),0.33015192452423275,1.3060791705748445,0.036939313984168866,0.6587784278518733,1.0,19/268,4.86%,TRPM3;SCN7A;ATP1A2;SLC6A13;SLC24A3;KCNK2;SLC8A3;SLC6A12;KCNQ4;SLC6A9;NALCN;KCNA5;SLC1A3;SLC41A1;ATP1B3;SLC8A1;SLC6A1;KCND3;CACNA1D
prerank,negative regulation of microtubule depolymerization (GO:0007026),-0.46945765587293375,-1.3057017746153134,0.13429752066115702,0.5142853054197842,1.0,11/21,29.11%,STMN2;APC;NAV3;ARHGEF2;APC2;TTBK2;CLASP2;CAMSAP3;SPEF1;CAMSAP1;FGF13
prerank,cardiac conduction system development (GO:0003161),0.487141101570563,1.3056896223274215,0.16605839416058393,0.6583820608795673,1.0,4/24,6.22%,GJB6;NOTCH2;GJA1;MAML1
prerank,positive regulation of vasoconstriction (GO:0045907),-0.5381335011858592,-1.305675349698627,0.15139442231075698,0.5132556949761734,1.0,3/13,7.56%,CAV1;ADRA1B;ADRA1A
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.3859403465619257,1.305602355616396,0.09162717219589257,0.6570045419224284,1.0,15/90,6.98%,LEPR;APPL2;EPAS1;IL18;ACSL1;ESRRG;GNAS;ALMS1;PPARGC1B;GRB10;GJA1;ACADL;CPT2;IGF1R;PTH2R
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.49041731255748144,-1.305433913468484,0.14556962025316456,0.5128241430753459,1.0,3/18,3.24%,MTUS1;SLIT2;PTK2B
prerank,regulation of Rho protein signal transduction (GO:0035023),-0.35649377366351753,-1.3048809112550765,0.08717948717948718,0.5132104710658641,1.0,25/72,13.48%,ARHGEF28;HEG1;ARHGEF3;RAC1;PRAG1;F11R;RASIP1;NET1;ARHGDIB;CCDC125;GPR4;EPS8L2;KANK1;ARHGDIA;ARRB1;MET;BCR;CUL3;MYOC;PDCD10;EPS8;KCTD13;LPAR6;ARHGEF2;STMN1
prerank,positive regulation of telomerase activity (GO:0051973),-0.4149760051003147,-1.304741786397365,0.10021321961620469,0.5125481874100236,1.0,7/33,10.79%,NEK7;HSP90AA1;HSP90AB1;KLF4;CTNNB1;PARM1;MAP2K7
prerank,protein mannosylation (GO:0035268),0.4889672386284269,1.3035400490943119,0.16182572614107885,0.6616573922835735,1.0,4/22,4.32%,TMTC4;LARGE1;TMTC1;CRPPA
prerank,aorta morphogenesis (GO:0035909),0.5267049697104541,1.3034686870196261,0.16024340770791076,0.6602785980972931,1.0,4/17,2.84%,ADAMTS9;RBPJ;MYLK;PDGFRB
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.4459626842049235,-1.3033642265880974,0.1350210970464135,0.5139672222826518,1.0,15/23,30.32%,PPP1R13B;YWHAB;NMT1;MAPK8;YWHAG;BBC3;CASP8;YWHAQ;YWHAH;PPP3R1;PPP3CC;YWHAZ;BID;SFN;PMAIP1
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.4459626842049235,-1.3033642265880974,0.1350210970464135,0.5139672222826518,1.0,15/23,30.32%,PPP1R13B;YWHAB;NMT1;MAPK8;YWHAG;BBC3;CASP8;YWHAQ;YWHAH;PPP3R1;PPP3CC;YWHAZ;BID;SFN;PMAIP1
prerank,central nervous system myelination (GO:0022010),-0.5416546317819192,-1.3029117028110127,0.1705150976909414,0.5140907411879678,1.0,7/11,19.88%,PLP1;B4GALT5;TENM4;CLU;B4GALT6;SOX10;ABCA2
prerank,regulation of T cell cytokine production (GO:0002724),-0.5102001773063793,-1.3027718410499842,0.15320910973084886,0.513427473273319,1.0,3/15,7.16%,B2M;CD55;TNFRSF1B
prerank,positive regulation of myoblast differentiation (GO:0045663),0.5271989953525896,1.3025940594079888,0.1527777777777778,0.6613033229832258,1.0,3/16,3.68%,RANBP3L;PLCB1;RIPOR2
prerank,negative regulation of cell differentiation (GO:0045596),0.34683949296443667,1.302540651804168,0.06484149855907781,0.6598288335025508,1.0,24/181,9.06%,RORA;RANBP3L;ADAMTS12;ADGRV1;OSR1;EFEMP1;PPARA;BMP7;MEIS1;RUNX1T1;SMAD6;ABCA1;IGF2;ANKRD26;TMEM64;ADAMTS7;SUFU;IL6;SMAD3;PTEN;IQCB1;ABCA5;YTHDF2;USF3
prerank,negative regulation of developmental process (GO:0051093),-0.35282608002286836,-1.3025304224465515,0.08130081300813008,0.5130160017239918,1.0,18/69,10.71%,KLF7;NOS3;TFRC;GAS6;CST3;NOTCH1;TBX1;ARHGEF15;KANK1;TBX2;TGFB1;VAT1;DCC;GRIN3A;NOTCH4;HEY2;CDK6;BMP2
prerank,respiratory tube development (GO:0030323),0.4685222558118757,1.302514627816914,0.16785714285714284,0.6583110985520081,1.0,6/28,5.81%,FGFR2;RBP4;LOXL3;PDPN;ITGA3;FGF1
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.5090936080900488,-1.3024943886879248,0.1326530612244898,0.512043642231014,1.0,4/14,6.14%,TMSB4X;NFKBIA;PKD1;FAF1
prerank,cellular response to interleukin-4 (GO:0071353),-0.5764331096556695,-1.3022112529154901,0.13562753036437247,0.5116742164424029,1.0,4/10,19.01%,LEF1;XBP1;TCF7;JAK3
prerank,regulation of organelle assembly (GO:1902115),0.3956966326561773,1.3015407222260438,0.10792580101180438,0.6596655429681341,1.0,9/72,6.64%,DCDC2;NPRL3;SPICE1;ODAD3;ALMS1;NPRL2;MTMR3;TBC1D9B;SDCCAG8
prerank,myoblast fusion (GO:0007520),0.5609031097356361,1.3014348441069479,0.17227722772277226,0.6583409878461586,1.0,3/12,2.19%,ADAM12;ADAMTS5;ADAMTS15
prerank,sensory perception of light stimulus (GO:0050953),0.386778620124139,1.3012350547251814,0.0929853181076672,0.6573579839807954,1.0,11/87,10.16%,EYA4;ADGRV1;EFEMP1;ZIC2;CRYGS;TULP1;COL18A1;GPR143;WHRN;EML2;DHRS3
prerank,dicarboxylic acid catabolic process (GO:0043649),0.5495706009962037,1.3011675763714172,0.18354430379746836,0.6559737273165233,1.0,5/13,17.66%,DDO;ACOT4;ASPA;MTHFS;QPRT
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.6006107938686913,1.301152255857796,0.19246031746031747,0.654459677088362,1.0,3/10,10.64%,PRKAA2;PRKAA1;FLCN
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.5168280861431597,-1.300875206930772,0.14770459081836326,0.5143434313179932,1.0,7/14,27.05%,THBS1;ITGA4;PDCD4;GPER1;CD40;RGCC;CCL2
prerank,negative regulation of interferon-beta production (GO:0032688),0.5819455136688685,1.3007696529802355,0.1953781512605042,0.6539446303320828,1.0,3/10,8.77%,CACTIN;NLRC3;SIRPA
prerank,calcium-mediated signaling (GO:0019722),0.3776922491814144,1.3004642759781198,0.10648148148148148,0.6532790082261393,1.0,16/93,8.37%,RCAN2;ADGRL1;ACKR2;CCR9;CXCR5;PDPK1;SLC8A1;DMPK;ANK2;CXCR6;SPHK1;LRRK2;PPP1R9A;PRKAA1;MCU;GPR143
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.5512456815184265,1.3003024418139995,0.1811320754716981,0.6522553054880427,1.0,2/14,4.23%,IGF1;SYT11
prerank,atrioventricular valve morphogenesis (GO:0003181),-0.4684936163335036,-1.2998179734974398,0.13304721030042918,0.5162071410114024,1.0,8/19,12.27%,TGFB2;NOTCH1;BMPR2;TGFBR2;SOX4;HEY2;BMP2;HEYL
prerank,mononuclear cell differentiation (GO:1903131),0.4953650394225239,1.2994497233035056,0.16605166051660517,0.653328071251602,1.0,1/24,0.01%,IL31RA
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.40830311541920467,-1.299432837736228,0.12222222222222222,0.5161870466518467,1.0,8/35,7.29%,HIP1;SGIP1;B2M;RAC1;CBL;HNRNPK;HIP1R;ARF1
prerank,JNK cascade (GO:0007254),-0.40248546725916223,-1.2993521383434774,0.1278538812785388,0.5153388299510917,1.0,12/40,15.15%,MAP3K5;UBB;MINK1;NOD1;ARHGEF6;UBC;RPS27A;MAPK8;MAP2K7;MAP3K12;TAB3;UBA52
prerank,positive regulation of response to stimulus (GO:0048584),-0.3954019029368701,-1.2993046616871056,0.11136890951276102,0.5144061517019586,1.0,25/40,39.02%,B2M;TGFB2;YPEL3;HOMER1;ABI3;RSAD2;IFIH1;IL15;EEF1E1;PRKCD;NSMCE4A;NSMCE1;FMR1;FCGR2B;CD80;CGAS;MAVS;DHX9;ACOX2;ILK;ARG2;BCLAF1;ANKLE1;GATA3;HMGA1
prerank,wound healing (GO:0042060),0.4061323858826529,1.2992185683141042,0.13122923588039867,0.6525509497234677,1.0,12/62,11.64%,IGF1;TPM1;JAML;PDGFRA;MACF1;SYT11;FGF1;SMAD3;MIA3;DCBLD2;CFLAR;ERBB2
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.4716105764305879,-1.2982098409715896,0.16129032258064516,0.5163559832226736,1.0,9/18,31.49%,ATXN3;NCK1;BAG6;XBP1;FCGR2B;ERN1;BAX;PMAIP1;RNF185
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.4316398115594071,1.2975806811919852,0.12979890310786105,0.6560262754520262,1.0,6/43,8.77%,IGF1;LTF;SYT11;CACTIN;NLRC3;SIRPA
prerank,glycogen metabolic process (GO:0005977),0.47065768559368937,1.2965701590676078,0.16981132075471697,0.6575255602005944,1.0,4/27,9.65%,PRKAG2;PHKB;GYS1;NHLRC1
prerank,import into cell (GO:0098657),0.4259291941222301,1.2962619289503672,0.13989637305699482,0.656948036127239,1.0,5/41,2.01%,ATP1A2;SLC22A4;SLC6A13;SLC22A2;SLC1A3
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.4367394067262616,1.2962179621583758,0.13824057450628366,0.6555400751583464,1.0,5/40,7.38%,IGF1;PRKN;BNIP3;NOL3;MMP9
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.5573128285257012,1.2956435725063282,0.19958847736625515,0.6557122917062772,1.0,1/12,0.06%,UNC13C
prerank,positive regulation of phosphatase activity (GO:0010922),-0.4631515086813029,-1.2932834572610177,0.14770459081836326,0.5289379061734992,1.0,11/21,24.75%,MEF2C;CALM1;HSP90AB1;MTOR;BMP2;MTMR9;CALM2;CD300A;PPP1R15B;PPP1R15A;CALM3
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.5155037771055726,-1.2922194561309304,0.15065913370998116,0.530909634029902,1.0,9/13,24.39%,RACK1;NCK1;HSPA5;PTPN1;WFS1;DNAJB9;PPP1R15B;PPP1R15A;BFAR
prerank,iron ion transmembrane transport (GO:0034755),-0.556559985480112,-1.2917864522052485,0.17267552182163187,0.5310157311404375,1.0,6/10,28.67%,SCARA5;SLC40A1;SLC39A8;SLC39A14;SLC25A28;ABCB6
prerank,response to sterol (GO:0036314),0.570740113819307,1.2915231152963143,0.1902834008097166,0.6666766417576683,1.0,1/11,0.13%,RORA
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.4881003849267557,1.29139190820872,0.15111940298507462,0.6655800087964157,1.0,5/24,11.02%,LEPR;PID1;COQ10A;GFPT2;ADRB3
prerank,vasculogenesis (GO:0001570),-0.4242649315610121,-1.2913558826916813,0.12391304347826088,0.5310686916736667,1.0,13/32,10.93%,CAV1;KDR;RAMP2;RASIP1;ITGB8;ENG;NOTCH1;SOX17;TGFBR2;TGFB1;VEGFA;HEY2;SOX18
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.4958759247354566,-1.2913225297993969,0.1528046421663443,0.5301084298388883,1.0,4/14,19.01%,THBS1;IRAK3;CMKLR1;JAK3
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.5765651298921184,-1.2911177455835223,0.15977443609022557,0.5296153391231688,1.0,7/10,32.58%,NCK1;JUN;DNAJB1;VHL;CITED2;HIF1AN;HSPA1A
prerank,regulation of T cell chemotaxis (GO:0010819),0.5737157978046582,1.2910317409868435,0.1945031712473573,0.6651731599421165,1.0,2/11,3.26%,OXSR1;CXCL13
prerank,antigen receptor-mediated signaling pathway (GO:0050851),-0.3043377427265072,-1.291014111668614,0.028368794326241134,0.5288555260505384,1.0,39/163,15.96%,MEF2C;PTPRJ;PDE4D;PLCG2;FYN;INPP5D;BMX;DENND1B;BCAR1;IKBKB;NFATC2;CD38;RFTN1;NCK1;PTPRC;CSK;TNFRSF21;PAK1;PSMD13;PSMF1;PAK2;PLEKHA1;PIK3CD;PSMB10;CHUK;PSMB6;PSME3;PSMB5;PSMC3;STOML2;MOG;PSMD12;PSMB8;NFKBIZ;PSME1;CUL1;EIF2B5;PSMB3;EIF2B2
prerank,regulation of histone modification (GO:0031056),0.5514308853836434,1.290584661227086,0.19560878243512975,0.6649379255752321,1.0,6/13,18.52%,IGF2;MTHFR;AKAP8L;FLCN;NNMT;CDK9
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.5394058393828292,1.2905812508579662,0.17755102040816326,0.6634014175870349,1.0,3/16,6.54%,AUTS2;KMT2A;BCOR
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.47811338917787705,1.2905628769715023,0.1624087591240876,0.6619512771830144,1.0,5/26,11.59%,ATP1A2;GSTM2;THADA;GNB5;PKD2
prerank,regulation of ossification (GO:0030278),0.44374152374083764,1.290501157582864,0.13763066202090593,0.6605931484276276,1.0,9/36,7.11%,RBPJ;LRP4;SMAD6;BMP2K;DKK1;ECM1;CHSY1;PTN;DDR2
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.383393662691989,1.2904711923244938,0.09033280507131537,0.6591603134116463,1.0,13/77,11.35%,IGF1;TCF7L2;PRKN;BCL2;SH3RF1;NOL3;MMP9;SIAH2;BIRC6;BCL2L2;ACAA2;PHIP;CFLAR
prerank,cellular response to hexose stimulus (GO:0071331),-0.4454944132185458,-1.2895861726576934,0.14084507042253522,0.5317261129767038,1.0,8/23,11.70%,UNC13B;GAS6;RACK1;KCNB1;SOX4;XBP1;SLC26A6;GPER1
prerank,vitamin transport (GO:0051180),0.4701050368125129,1.2891271340070996,0.17540687160940324,0.6617440082379182,1.0,9/29,10.46%,SLC35F3;PDPN;TCN2;SLC2A10;FOLR1;FOLR2;SLC27A1;SLC19A2;SLC19A1
prerank,regulation of B cell proliferation (GO:0030888),-0.390007159302707,-1.289091965226789,0.116331096196868,0.5319313290642802,1.0,15/44,20.84%,MEF2C;TFRC;NFATC2;CD38;PTPRC;TNFRSF21;AHR;CD74;CD81;MIF;CD40;TYROBP;NCKAP1L;TIRAP;CD300A
prerank,chaperone-mediated protein complex assembly (GO:0051131),-0.47976740726517914,-1.2884547337547732,0.15217391304347827,0.5326359588753601,1.0,6/20,18.11%,HSP90AA1;HSP90AB1;HSPD1;CLU;TMEM35A;PFDN6
prerank,detection of visible light (GO:0009584),0.5282273320078427,1.2883440845821081,0.18089430894308944,0.6625097298105725,1.0,3/16,6.41%,ABCA4;TULP1;GNAQ
prerank,histone H2A monoubiquitination (GO:0035518),0.5198144519107469,1.2883326201318968,0.1830708661417323,0.6610349246723669,1.0,7/17,14.62%,RNF2;DDB2;KDM2B;BCOR;PCGF5;CUL4B;PCGF1
prerank,phospholipid catabolic process (GO:0009395),-0.4453314623464305,-1.2882971938094365,0.1228813559322034,0.5319846143501686,1.0,6/24,15.57%,GPCPD1;SMPD4;GDPD1;GDPD3;PNPLA6;PLA2G4A
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.5460404169397545,-1.287938226826511,0.1644100580270793,0.5318769576904414,1.0,4/11,23.27%,CBFB;RUNX1;CD274;VSIR
prerank,negative regulation by host of viral process (GO:0044793),0.5906974086380503,1.2878692841106298,0.20041753653444677,0.6609574293594928,1.0,2/10,2.80%,PRKN;LTF
prerank,histone H3-K4 trimethylation (GO:0080182),0.5829320446833282,1.287659335826925,0.20386266094420602,0.6600531785105558,1.0,6/11,22.51%,KMT2A;SETD1A;CTR9;WDR82;BEND3;TET3
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.5488678346096882,-1.2875625065154535,0.15310077519379844,0.5317449855023965,1.0,4/11,7.36%,KCNJ2;ATP1A1;ATP1B1;KCNQ1
prerank,protein deneddylation (GO:0000338),-0.5540707768148372,-1.2875368197687729,0.17391304347826086,0.530751321661388,1.0,3/10,18.15%,COPS7A;COPS8;COPS6
prerank,cardiac ventricle development (GO:0003231),-0.4581373773180019,-1.2874464613329097,0.17130620985010706,0.5299364282365189,1.0,7/20,12.27%,ENG;NOTCH1;HES1;STRA6;PDE2A;HEY2;HEYL
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.5282104056900053,-1.2870711784488074,0.17834394904458598,0.5300036946473694,1.0,7/13,30.08%,LGMN;PERP;TBC1D10A;CASP8;CYFIP2;NLRC4;FADD
prerank,brain development (GO:0007420),0.3538229929218991,1.2870507974187662,0.09038737446197992,0.6602158015303932,1.0,21/136,8.89%,EPHA7;AFF2;ARNT2;ZIC1;ATXN1;MEIS1;ZIC2;B3GNT5;SOX6;SHROOM2;PAFAH1B3;NFIB;ZFHX2;SYNJ2;SETD1A;PHF8;AMIGO3;PTEN;PBX4;PAFAH1B1;CDK5RAP1
prerank,serine family amino acid catabolic process (GO:0009071),0.599403957060994,1.2864935458323326,0.1774193548387097,0.6603470409689364,1.0,4/10,19.04%,CBS;THNSL2;SHMT1;DLD
prerank,B cell activation (GO:0042113),-0.3513023058743247,-1.286468575853244,0.08706467661691543,0.5306130499615153,1.0,23/68,19.80%,MEF2C;PTPRJ;TPD52;KLF6;ITGB1;PLCG2;HDAC5;ITGA4;PTPRC;ZBTB7A;PIK3CD;HHEX;MSH2;HSPD1;RABL3;FLT3;CR2;CASP8;TCF3;DNAJB9;JAK3;CD40;HDAC9
prerank,gland development (GO:0048732),0.3993254014233691,1.28636678122733,0.12521150592216582,0.6592423867951626,1.0,10/59,6.99%,TGFBR3;WNT4;FGFR2;DKK3;ARID5B;ANXA1;PRKCSH;PCSK9;SALL1;ARHGAP35
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.422717809982463,-1.2861505828025845,0.14380530973451328,0.5303601712405709,1.0,10/29,10.13%,SLIT2;SHANK3;KANK3;KANK1;TJP1;HIP1R;CYRIB;SSH2;KANK4;SSH1
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.5141072419695569,-1.2856633017364805,0.1596153846153846,0.5306129301564718,1.0,9/14,30.69%,RCC1L;UQCC2;RPUSD4;FASTKD3;TRMT10C;TRUB2;MRPS27;COA3;MPV17L2
prerank,mitochondrion morphogenesis (GO:0070584),0.5540539386733258,1.2848834342582043,0.20652173913043478,0.662137195280252,1.0,2/11,4.50%,PID1;WASF1
prerank,negative regulation of cellular process (GO:0048523),-0.2669974538362096,-1.2847216407612487,0.0,0.5320804998648401,1.0,103/521,12.25%,ZBTB7C;APBB2;SLIT2;PODXL;PTPRJ;FTH1;NOS3;IGFBP6;CD200;JAM2;CD34;ADAM10;PLPP1;BMP5;ACVRL1;TGFB2;PTPN14;CD9;CBFA2T3;TES;PLXND1;KLF4;PPP2R5C;ADAM15;PPP1R13B;ETS1;ADARB1;WNT9A;PDE8A;PTK2B;DAB2IP;NGF;NOTCH1;NDRG3;FHL1;SH3BP4;SEMA4D;RACK1;TBX1;TGFBI;ARHGDIB;P3H2;BMPR2;PLXNA4;SOX17;ROR2;CCDC85B;SFRP4;ACTN1;CCN3;RERG;WARS1;RHOB;OSGIN2;VPS13C;SOX4;PINX1;ARHGDIA;TGFB1;NCK1;FERMT2;CTNNB1;VAMP8;TOB1;ST18;ATP8A2;TNFRSF21;DDAH1;TNFRSF1B;APBB1;PDCD4;ADRA1A;APP;CRYAB;NOTCH4;MYH9;AQP11;NR4A1;PTHLH;WNT16;DYSF;SESN2;PODN;RTN4;ING4;APC;SOX7;BTG3;CDKN1B;LPCAT3;CDK6;NDUFA13;BMP2;NOS1;MEN1;NCK2;IFI35;HGS;CDH13;GPER1;PBRM1;LMNA;REST
prerank,translesion synthesis (GO:0019985),-0.3928975942376784,-1.2845303298372148,0.12378640776699029,0.5316313639936229,1.0,18/42,24.53%,UBB;REV3L;TRIM25;UBC;RPS27A;ISG15;RPA1;UBA52;USP43;POLK;FAAP20;SPRTN;POLN;POLD3;VCP;POLD1;POLI;DTL
prerank,B cell differentiation (GO:0030183),-0.37559906091993456,-1.284432875875167,0.102803738317757,0.5308414736669058,1.0,19/46,19.80%,PTPRJ;TPD52;KLF6;ITGB1;PLCG2;HDAC5;ITGA4;PTPRC;ZBTB7A;HHEX;MSH2;RABL3;FLT3;CR2;TCF3;DNAJB9;IRF2BP2;JAK3;HDAC9
prerank,homocysteine metabolic process (GO:0050667),0.5724299637744454,1.2842923553715364,0.19875776397515527,0.6624194740046766,1.0,2/11,5.31%,CBS;MTHFR
prerank,cellular response to increased oxygen levels (GO:0036295),-0.5436640114485576,-1.2841269747586237,0.18323586744639375,0.5306391595055001,1.0,6/11,18.99%,CAV1;ATG7;FOXO1;ATP6V1A;FAS;ATP6V0A2
prerank,regulation of platelet aggregation (GO:0090330),-0.4903425131809207,-1.2835845242611978,0.16506717850287908,0.5310275550776281,1.0,5/17,6.85%,PRKG1;CD9;F11R;SERPINE2;CEACAM1
prerank,insulin receptor signaling pathway (GO:0008286),-0.3487246081651147,-1.283378828120735,0.08958837772397095,0.5305203089322696,1.0,20/69,12.69%,GAB1;GRB14;BCAR3;NAMPT;CAV2;AP3S1;BCAR1;ATP6V0A1;GSK3B;FOXO1;C2CD5;APPL1;APC;ATP6V1A;ATP6V0C;PIK3C2A;PDK2;ATP6V1E1;IDE;TCIRG1
prerank,T cell receptor signaling pathway (GO:0050852),-0.3105060201599646,-1.2829322695874734,0.03767123287671233,0.5306289622638013,1.0,49/138,26.06%,PTPRJ;PDE4D;PLCG2;FYN;INPP5D;DENND1B;BCAR1;IKBKB;RFTN1;NCK1;PTPRC;CSK;TNFRSF21;PAK1;PSMD13;PSMF1;PAK2;PIK3CD;PSMB10;CHUK;PSMB6;PSME3;PSMB5;PSMC3;STOML2;MOG;PSMD12;PSMB8;NFKBIZ;PSME1;CUL1;EIF2B5;PSMB3;EIF2B2;BTN3A3;ZC3H12A;PSMD5;TXK;THY1;SKP1;FYB2;PSMD9;RBCK1;PSMB4;RELA;GRAP2;PSMD10;SKAP1;RNF31
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.3002447714586963,1.2818453930062355,0.013574660633484163,0.6681509929196114,1.0,143/834,13.64%,IGF1;GLIS3;RORA;BMP6;TCF7L2;TCF4;OSR1;AUTS2;RBPJ;ARNT2;ZNF462;FGFR2;PPARA;EPAS1;HLF;NR2F2;PID1;IL18;HOXC4;CDK8;ZEB2;WWOX;PRKN;BRD8;KMT2A;MEIS1;DAB2;HOXB4;FHOD1;CSRP3;MYBL1;DMRT1;SCX;NR1I2;ASCL2;TBL1XR1;CITED4;HOXB3;RNASEL;PPARGC1B;NFYB;CDK7;SSBP2;IGF2;STAT5B;MAML3;TFR2;NCOA2;NFAT5;HDAC8;ELF4;TEAD1;HOXA7;NFIB;FIZ1;SOX1;GLI3;WASL;DPF2;IRF8;ZMIZ1;FGF1;TET1;MAML1;SALL1;WWC1;IL6;SMAD3;NCOA3;RFXAP;SSBP3;GABPB1;GABPB2;NCOA7;TCF12;MTF2;ARNT;CCNT2;RSF1;CCNT1;ABRA;GTF2F1;MITF;RPRD1B;NFIA;FSTL3;KAT8;KAT6B;PCGF5;KDM6B;CEBPG;APLN;AKAP8L;IER5;IRF3;ASXL2;MED13;MED1;HDAC1;ABL1;AGO2;PIK3R1;DVL3;BCL9;PHIP;PRKDC;FLCN;ATOH8;ZBTB38;SMARCA5;TFAP2A;TFAP2B;NPAS2;PRKD2;PKD2;CDC73;RXRA;MYB;BMPR1A;BCLAF3;INO80;CRTC3;HIVEP1;CRTC1;MAML2;GLI2;SERPINE1;MLXIP;SMARCB1;FOXK2;AR;HSF1;METTL23;KLF5;TBK1;CLOCK;GDNF;NR1I3;CREBBP;ZMIZ2;HOXD4;MEIS2;BCL2L12
prerank,cellular response to organic cyclic compound (GO:0071407),0.3493993710524284,1.2814709559331021,0.09221902017291066,0.6677781292156458,1.0,16/141,7.38%,RORA;ATP1A2;ROCK2;ADCY5;ADCY1;TFPI;IL18;SLC5A5;CRHBP;LRRK2;AANAT;SSTR2;UBE2L3;NCOA3;BLM;FOLR1
prerank,regulation of cell differentiation (GO:0045595),-0.30877767898478814,-1.2814567073429002,0.0547945205479452,0.5336453693018,1.0,41/148,18.47%,SLC6A6;LTBP4;SPOCK2;ZFHX3;TRPS1;TIAM1;HSP90AB1;CBFB;KLF4;RUNX1;PTK2;PHLDB1;NGF;TBX1;TGFB1;SIX1;NOTCH4;DDX5;PTHLH;EMP2;HEY2;APC;UQCC2;YWHAG;CDK6;ATF4;RUNX2;RPS6KA1;MCRIP1;ZFP36L1;REST;BIN1;NR1D2;NF1;BCL6B;RAF1;APC2;YWHAH;ID2;CASZ1;GREM1
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.4916161080638064,1.2804578706586431,0.16962524654832348,0.6694205651848902,1.0,6/24,11.32%,EPHA7;PCSK9;SRPK2;NUPR1;TFAP2A;TFAP2B
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.4491356273919567,1.2801779203839228,0.14659685863874344,0.668758938046945,1.0,5/33,3.18%,TCF7L2;PPARA;ANGPT1;PDPK1;NDNF
prerank,nucleotide catabolic process (GO:0009166),-0.48021469563613467,-1.2800340567159496,0.1650294695481336,0.5366194178903413,1.0,6/16,14.53%,NT5C2;NUDT3;NT5C;GDA;XDH;NT5E
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),-0.4985387038032322,-1.2799185662539656,0.15667311411992263,0.5359025130822802,1.0,4/16,8.43%,STX7;PTPRC;CEACAM1;CYRIB
prerank,apoptotic process (GO:0006915),-0.29319516904961473,-1.2798895222198794,0.036585365853658534,0.5349403937329965,1.0,66/203,21.84%,HIP1;EFNA5;ELMO1;SEMA6A;FAP;ADAM15;MAL;PPARD;PTK2B;NFKBIA;PPIA;TBX1;NCKAP1;CDK11B;MAGI3;CIT;TGFBR2;RHOB;ARHGEF6;DCC;BCL2L1;EGLN3;BAG6;PLAGL1;TNFRSF21;PDCD4;AHR;ADRA1A;APP;GAPDH;MTOR;FOXO1;DDIT4;RTN4;ING4;BNIP2;PAEP;NDUFS1;OGT;HSPD1;BNIP1;YARS1;JADE1;PRUNE2;BBC3;FAS;RFK;AHCYL1;CASP8;RAF1;AKAP1;PRKCE;DAP;IAPP;CYFIP2;LIG4;TNFRSF10B;CDK5;MYD88;PRKCD;PAK5;PDE1B;AKT1;BIK;GADD45A;BMF
prerank,lipoxygenase pathway (GO:0019372),-0.5094101588079332,-1.2791936709548817,0.17025440313111545,0.5358688269648356,1.0,4/14,12.65%,GPX4;PTGS2;PON2;ALOX12
prerank,Rho protein signal transduction (GO:0007266),0.4111465789809722,1.2788623245741133,0.14886164623467601,0.6711804943903099,1.0,10/53,8.10%,ROCK2;ARHGAP6;ARHGAP29;RHOD;COL1A2;PDPN;ARHGEF11;EPS8L1;NTN1;MYO9B
prerank,toll-like receptor 4 signaling pathway (GO:0034142),-0.4706358367977038,-1.2781250972490283,0.15151515151515152,0.5377558283054792,1.0,9/19,27.67%,LBP;PIK3AP1;PRKCE;IRAK1;NR1H4;TIRAP;TRIL;ITGB2;TLR4
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.443596669091009,1.2778024720337156,0.16606498194945848,0.6728224398593416,1.0,5/35,3.11%,ADCY1;KSR1;IRAG1;PDE7B;PDE7A
prerank,glycosphingolipid metabolic process (GO:0006687),-0.3816475043233423,-1.2769214625635987,0.1313364055299539,0.540247616530832,1.0,11/42,10.76%,ST6GALNAC3;ESYT2;PSAP;ST6GALNAC5;SUMF1;ST8SIA1;SMPD4;HEXB;HEXA;CERK;GLTP
prerank,protein K48-linked deubiquitination (GO:0071108),-0.4489063597597212,-1.2768938493210125,0.15938864628820962,0.5392780624186061,1.0,14/23,25.89%,ATXN3;OTUD7A;MINDY2;MINDY1;USP50;USP37;OTUB1;OTUD3;USP8;OTUD7B;USP5;TNFAIP3;YOD1;USP33
prerank,regulation of fibrinolysis (GO:0051917),-0.5123564344835453,-1.2766668677986852,0.16633266533066132,0.5389241270424456,1.0,3/13,12.20%,THBS1;FAP;THBD
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.5026868934442467,1.2766617666174416,0.17803030303030304,0.6746968363606357,1.0,3/21,5.12%,ADCY5;ADCY1;NPR2
prerank,regulation of adaptive immune response (GO:0002819),-0.4785689574345421,-1.2763411631949175,0.17427385892116182,0.5387994924447777,1.0,10/18,36.46%,AHR;ADCY7;SAMSN1;TRIM27;FCGR2B;SKAP1;FADD;IL4I1;IL6ST;SASH3
prerank,cell morphogenesis involved in differentiation (GO:0000904),-0.3492461219287744,-1.2760791840541952,0.09114583333333333,0.5384242256095632,1.0,20/70,12.24%,MEF2C;TEK;FN1;TMEFF2;PARVB;RAC1;SIPA1L3;ACTN1;PXN;LAMA5;LAMB2;ITGA4;FERMT2;SRCIN1;RHOA;RELN;PEAK1;ATF4;ITGA8;NTN4
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.4217764648254258,1.2757238283170298,0.1605351170568562,0.6761483222625584,1.0,6/48,4.09%,JPH1;CEMIP;DMD;PDPK1;GSTM2;ANK2
prerank,chordate embryonic development (GO:0043009),0.39974101964500036,1.2754459634825985,0.14023372287145242,0.6754970468389591,1.0,7/55,4.47%,ALDH1A2;ARNT2;FGFR2;BMP7;RBP4;IGF2;SULF1
prerank,regulation of cardiac muscle contraction (GO:0055117),-0.4057277343982938,-1.2753077281413514,0.13646532438478748,0.5395477479357677,1.0,12/34,17.53%,PDE4D;CALM1;ATP1B1;KCNQ1;ADRA1A;ATP2A2;RYR2;NOS1;CHGA;CALM2;PLN;ZC3H12A
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),-0.4881015064429979,-1.2752519690709725,0.17755102040816326,0.5386828748230252,1.0,7/15,31.12%,TGFB2;TGFB1;IRAK3;JAK3;TGFB3;SMAD7;CUEDC2
prerank,regulation of cellular component size (GO:0032535),-0.4153185905267444,-1.2752122595140243,0.16017316017316016,0.5377722217307428,1.0,17/30,28.92%,MSN;RAC1;RIN3;MTOR;EPS8;AP2M1;PPP1CA;RAB3B;ATP13A2;PEX11B;RAP1GAP2;HP1BP3;LAMTOR4;PPP1R15A;EZR;NEB;RPTOR
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.3097152945898978,-1.2751140941426393,0.044444444444444446,0.5370460786807064,1.0,45/149,20.71%,PRKCH;CAV1;TFRC;RPS6KA5;UBB;NFKBIA;PPIA;RPS3;NOD1;TRIM14;IKBKB;ROR1;TRIM25;EDA;UBC;RPS27A;TNFRSF11A;CARD14;APP;IL1RAP;SLCO3A1;AIM2;ZBTB7A;CHUK;RTKN2;STAT3;ARHGEF2;CLU;TAB3;IRAK3;TRAF1;TERF2IP;UBA52;TRIM13;PRKD1;CX3CR1;RPS6KA4;CARD16;IRAK1;RNF25;MID2;CD40;MYD88;TRIM27;TIRAP
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),-0.39239131604326205,-1.2748262410204183,0.12751677852348994,0.5367988855904392,1.0,18/38,20.64%,CAV1;KLF2;CD34;RAC1;HSP90AA1;HSP90AB1;KLF4;DDAH1;PTGIS;EDN1;PTGS2;CLU;CD47;CX3CR1;ZC3H12A;ATP2B4;INSR;AKT1
prerank,endoderm development (GO:0007492),-0.5125189995164876,-1.2747792937958562,0.18762475049900199,0.5359097222719992,1.0,8/13,43.23%,SOX17;SOX7;DUSP1;DUSP4;TBX20;GATA4;DUSP5;DUSP2
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.5160927639522875,1.2744179496534096,0.19140625,0.6771666167912822,1.0,4/17,14.96%,LPGAT1;PLA2G10;PLA2G4C;PLA2G12A
prerank,Golgi localization (GO:0051645),-0.5403314670837394,-1.2741350744178472,0.1854043392504931,0.5366969819905428,1.0,6/11,27.97%,COPG1;PDCD10;STK25;RIPOR1;YWHAZ;TBCCD1
prerank,regulation of nervous system process (GO:0031644),0.5021337398590237,1.273749766176269,0.1905697445972495,0.6776130008283581,1.0,2/18,0.90%,ROCK2;SLC8A3
prerank,cell chemotaxis (GO:0060326),0.39879037597153694,1.2736112883893456,0.13008130081300814,0.6765775045158576,1.0,9/60,4.17%,KIT;ACKR2;CCR9;LPAR1;CXCR5;PDGFRB;RAB13;PDGFRA;CXCR6
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.5136293739323506,-1.2734292297869365,0.19172932330827067,0.5377158957416281,1.0,7/12,35.72%,PLCG2;RAB27A;GRIN1;TLR4;TLR6;CD36;ADGRB1
prerank,protein autoubiquitination (GO:0051865),0.3984881254911921,1.2728721069570297,0.13517915309446255,0.6773859876356839,1.0,18/61,18.30%,RNF220;PRKN;RNF213;DDB2;SH3RF1;RNF181;AMFR;WWP2;MDM2;ITCH;SH3RF2;UBE2A;RNF122;RAD18;TRIM17;DTX3L;OBI1;TRAF6
prerank,regulation of neuron migration (GO:2001222),-0.42673185412594644,-1.2727286062853038,0.15,0.5385959373692656,1.0,12/26,22.93%,SEMA6A;DAB2IP;SHTN1;NEXMIF;ARHGEF2;CAMK2B;ADGRG1;NTNG1;COL3A1;NSMF;PLAA;SEMA3A
prerank,regulation of protein kinase C signaling (GO:0090036),0.5449232686794055,1.2711678118809795,0.1950207468879668,0.6809568744850246,1.0,2/14,2.03%,ADGRV1;GPD1L
prerank,regulation of cholesterol efflux (GO:0010874),-0.42605109172004596,-1.2709691032852646,0.14161220043572983,0.5423723870305307,1.0,19/30,34.05%,CAV1;PLTP;SREBF2;NFKBIA;PTCH1;LAMTOR1;NR1H2;ABCA3;ABCA2;ZDHHC8;NR1H3;TTC39B;GPS2;TREM2;ABCA7;NAXE;PPARG;SHH;YJEFN3
prerank,cellular component assembly (GO:0022607),-0.28368772867531705,-1.2709554693963914,0.022727272727272728,0.5413739087413302,1.0,61/253,16.53%,SPTBN1;ACTB;SLC2A1;ACTG1;OCLN;PARVB;RHOJ;LIMS2;LIN7A;RAC1;GAS6;GSN;PPARGC1A;PTK2B;STX7;REPS2;RTN3;HES1;NCKAP1;PLS3;FLNA;LIMS1;WIPF1;CAPZA2;FAM107A;TGFB1;FERMT2;SKAP2;BAG6;BAIAP2L1;RP1;LRRTM3;VMP1;CARD10;ADD2;SHROOM1;PDCD10;IL1RAP;MICAL1;GPM6B;STK25;EPS8;RTN4;APC;RHOA;CD2AP;PCLO;ST13;YTHDF3;CD74;BSN;ELOB;NEDD9;TRAF1;TOGARAM1;FAS;RHOG;ARL6IP1;ABCA3;TLCD2;LRGUK
prerank,neuron projection morphogenesis (GO:0048812),0.3475856329359245,1.270870216356817,0.0945945945945946,0.6804312280912012,1.0,21/137,8.26%,DCDC2;ALCAM;FGFR2;NRK;BMP7;LRP4;GAS7;SDC2;PARD3;ALS2;DTNBP1;BAIAP2;NTNG2;LRRK2;WASL;LRP2;ARC;NBL1;PTEN;RYK;FARP1
prerank,regulation of protein modification process (GO:0031399),-0.37275359931348545,-1.2707250736914257,0.1188118811881188,0.5409791834724057,1.0,17/50,15.78%,FN1;FNIP2;PTK2;PPP1R16B;ATG7;HSPB1;CORO1C;WARS1;CCDC88A;SPRED2;SESN2;PPIB;CADM4;MT3;CCDC88C;RABL3;PPP1R16A
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.5571750938280694,1.2703278829721854,0.20489977728285078,0.6805738193665916,1.0,1/12,0.68%,B3GALT1
prerank,cellular response to drug (GO:0035690),-0.4115771409832897,-1.2702466868557996,0.15021459227467812,0.5413774669596312,1.0,7/25,12.25%,MEF2C;ACER2;TFRC;GAS6;KCNQ1;AIM2;REST
prerank,SNARE complex assembly (GO:0035493),-0.5546829540983623,-1.2701279858152954,0.1866913123844732,0.5407125000253492,1.0,2/10,6.23%,STXBP6;VAMP8
prerank,synapse organization (GO:0050808),0.346374841961884,1.2699189602270102,0.10823170731707317,0.6803581305444859,1.0,22/125,9.01%,UNC13C;PDZRN3;SDK1;SLC8A3;LRP4;NLGN2;GPC6;DKK1;NEDD4;OBSL1;SLC6A1;PPFIBP2;IGFN1;CACNB4;LRRK2;PTPRD;PTEN;RYK;PCDHB6;FARP1;MUSK;PCDHB10
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.3730954684558766,-1.2689575813790426,0.11435523114355231,0.5429873590019353,1.0,21/48,20.64%,TMSB4X;NOS3;RHOJ;KDR;THBS1;ETS1;HSPB1;ATP5F1A;GATA2;TGFB1;JCAD;VEGFA;PTGS2;PIK3C2A;MAP3K3;PRKD1;ATP5F1B;CD40;HDAC7;HDAC9;AKT1
prerank,positive regulation of actin filament polymerization (GO:0030838),-0.38072203607996286,-1.2689528405142707,0.11031175059952038,0.5419866208447397,1.0,17/44,20.26%,CARMIL1;GSN;PTK2B;CDC42EP3;NCKAP1;NCK1;BAIAP2L1;NCK2;BIN1;WHAMM;CDC42EP5;PRKCE;SPIRE1;ARPC4;CDC42EP2;EVL;NCKAP1L
prerank,regulation of cellular localization (GO:0060341),0.40841978674184154,1.26892073096067,0.15979381443298968,0.6819531646974641,1.0,10/46,11.09%,ADCY5;STXBP4;PARD6G;PRKN;FER;LRRK2;WWC1;CAMK2D;DVL3;MAD1L1
prerank,regulation of ion transmembrane transporter activity (GO:0032412),-0.3908541527071693,-1.2686722633595124,0.12442396313364056,0.5416962680784225,1.0,9/39,8.50%,UTRN;FXYD5;NEDD4L;FHL1;HOMER1;TRPC6;CHRM3;WNK3;FXYD6
prerank,regulation of mitochondrial fusion (GO:0010635),0.5674057670012567,1.2686051240014102,0.2180746561886051,0.6813929338655603,1.0,3/11,6.76%,PID1;PRKN;BNIP3
prerank,organonitrogen compound catabolic process (GO:1901565),0.40326667930428056,1.2684889046102674,0.13815789473684212,0.6802855890189905,1.0,9/57,7.68%,CPQ;CLPX;PLA2G10;GGACT;ACE;TPP1;ENPP2;NPEPPS;LIPC
prerank,regulation of metal ion transport (GO:0010959),0.5182884339613986,1.2681616837329055,0.18290258449304175,0.6797662311619589,1.0,5/16,7.01%,STIM1;BCL2;ANK2;DLG1;CACNA2D1
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.39983508880333907,-1.2677944852197345,0.14012738853503184,0.543112289971448,1.0,13/34,25.22%,MEF2C;GSK3B;GABRG3;GRIN1;INSYN2A;ARRB2;GABRA5;GRID2;AKT1;GABRE;MAPK8IP2;GABRG2;GLRA1
prerank,synapse assembly (GO:0007416),-0.3489687870276823,-1.2677712529077831,0.0812807881773399,0.5421645068864867,1.0,12/67,8.05%,DNM3;SHANK3;SPOCK2;ADGRL3;CDH1;PLXND1;CDH2;KIRREL3;GABRB3;NRCAM;LRRTM3;NRXN1
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.49161673322292215,-1.2676749318642802,0.17165668662674652,0.5414227839687953,1.0,11/16,32.37%,NOS3;GUCY1B1;GUCY1A1;DDAH1;NOS1;KCNC2;DDAH2;MAFA;CD36;AGT;NOS2
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.5005516201736747,-1.2675069028921013,0.17148362235067438,0.5398363323815832,1.0,4/14,15.54%,ABCG2;SLCO2B1;HMOX2;BLVRB
prerank,heme catabolic process (GO:0042167),-0.5005516201736747,-1.2675069028921013,0.17148362235067438,0.5398363323815832,1.0,4/14,15.54%,ABCG2;SLCO2B1;HMOX2;BLVRB
prerank,muscle tissue morphogenesis (GO:0060415),0.5176099048309903,1.2673459058506047,0.2046783625730994,0.680701133767348,1.0,2/16,2.29%,TGFBR3;MYLK
prerank,fatty acid transmembrane transport (GO:1902001),0.5066898192137435,1.267136403613118,0.18467583497053044,0.6798589839229112,1.0,3/19,5.67%,PRKAG2;PRKAA2;CPT2
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),-0.3290199079203943,-1.266758809432876,0.07932011331444759,0.5408542682702128,1.0,39/87,33.59%,NDUFC2;NDUFA7;NDUFA5;NDUFA6;NDUFB5;NDUFAF4;NDUFA12;NDUFV1;NDUFB7;UQCC2;NDUFA13;NDUFS1;NDUFB11;SDHAF2;SMIM20;NDUFB10;NDUFA1;UQCC3;NDUFB4;FASTKD3;NDUFAF8;NDUFS7;BCS1L;DMAC2;COA3;COX16;NDUFAF3;COA8;CHCHD4;COA5;NDUFC1;ACAD9;SDHAF1;NDUFS2;NDUFS5;TMEM126A;NDUFAB1;IMMP2L;NDUFA3
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.3921083179804105,1.266437590316755,0.13911620294599017,0.6804181291723728,1.0,16/66,11.72%,TGFBR3;ROBO1;FGFR2;MCC;NR2F2;DUSP10;SULF1;NFIB;NLRC3;MTSS1;NUPR1;BRCA2;MED1;ATOH8;APOH;CDC73
prerank,heart development (GO:0007507),-0.30053304927511537,-1.2662794280966283,0.05194805194805195,0.5411811385310119,1.0,34/150,11.65%,MEF2C;TEK;NTRK3;FN1;HEG1;SGCD;MEF2D;MICAL2;BMP5;ACVRL1;TGFB2;PTK2;RAMP2;NOTCH1;TBX1;CXADR;BMPR2;PKD1;SOX17;STRA6;TGFBR2;SOX4;TBX2;TGFB1;CRIP1;PDLIM7;VEGFA;LDB3;ECE1;CDKN1B;BMP2;SOX18;NDRG4;CACNA1C
prerank,telomere maintenance (GO:0000723),0.4032551252600998,1.265773414332101,0.15532286212914484,0.6809672056214465,1.0,19/50,21.72%,SP100;HUS1B;ACD;XRCC5;BLM;TEP1;PRKDC;DCLRE1B;RTEL1;MRE11;APEX1;WRN;RAD51;STN1;TPRKB;POLD2;RAD50;NBN;TERF2
prerank,postsynaptic membrane organization (GO:0001941),0.4981105498788929,1.2654660103651585,0.201171875,0.6804327525101069,1.0,6/17,10.96%,LRP4;CEL;NLGN2;DNAJA3;MUSK;DLG4
prerank,potassium ion import across plasma membrane (GO:1990573),-0.3881484072699835,-1.2652931735852724,0.13238770685579196,0.5428666660957552,1.0,12/41,13.84%,SLC12A2;SLC12A7;KCNJ2;ATP1A1;ABCC9;ATP1B1;SLC12A6;SLC12A8;SLC12A4;ATP1A3;KCNJ8;KCNJ15
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.3346850352724333,-1.264464533806808,0.11835748792270531,0.5441167425895261,1.0,34/79,28.33%,CTSD;LGMN;CAPZA2;AP2A2;ACTR10;DYNLL2;KIF26A;ARF1;DNM2;MFSD6;AP2M1;DCTN3;CD74;CANX;AP1S2;SEC23A;DCTN4;SH3GL2;KIF3B;AP2B1;KIF11;DCTN1;KIF15;CTSL;AP2A1;FCGR2B;CAPZA1;KIF4A;RAB7A;KLC2;CTSE;KIF23;KLC1;DYNC1I1
prerank,regulation of protein catabolic process (GO:0042176),-0.3272053108749898,-1.2642651004185226,0.07621951219512195,0.5436951686813759,1.0,28/99,16.10%,EEF1A1;WWP1;NSF;NEDD4L;DAB2IP;ATG7;FLNA;PLK2;FAF1;GFAP;GSK3B;CHEK2;FOXO1;ZDHHC2;APC;OAZ1;DDB1;FURIN;CDKN1B;NDUFA13;HGS;AZIN1;EGLN2;IDE;CYP51A1;IRAK3;ATP13A2;APC2
prerank,negative regulation of secretion (GO:0051048),-0.5470304425994326,-1.2637541154115066,0.17557251908396945,0.5441183586109226,1.0,9/10,41.16%,VAMP8;CD74;PTGER3;SPX;NR1H3;VAMP3;EGF;TIFAB;ERBB3
prerank,organic acid transport (GO:0015849),0.3657309030997278,1.2636477318274804,0.11392405063291139,0.6845260550929639,1.0,20/94,10.56%,SLC7A11;SLC6A13;SLC13A3;SLC38A3;SLC6A12;ACSL1;PDPN;NCOA2;SLCO1B1;SLC13A5;SLC43A1;FOLR1;FOLR2;ABCC2;SLC1A5;SLC25A11;SLC27A1;SLC19A1;SLC22A6;SLC36A2
prerank,regulation of postsynapse organization (GO:0099175),-0.416732190622803,-1.2633804889854554,0.1351931330472103,0.5441130629758302,1.0,10/28,10.32%,SHANK3;SIPA1L1;HOMER1;ZDHHC15;PPFIA2;ABHD17B;ABI3;SRCIN1;KIF1A;ABHD17A
prerank,microtubule anchoring at centrosome (GO:0034454),0.5806881370923775,1.2624201599782454,0.20977596741344195,0.6867866625294494,1.0,2/10,6.32%,NINL;CEP19
prerank,regulation of telomerase activity (GO:0051972),-0.374604565739943,-1.2623249900673044,0.1341991341991342,0.5460986178456725,1.0,9/45,10.79%,NEK7;HSP90AA1;HSP90AB1;KLF4;PINX1;CTNNB1;PARM1;MEN1;MAP2K7
prerank,negative regulation of angiogenesis (GO:0016525),-0.3381221648397501,-1.2623044059978645,0.10372340425531915,0.5451700801530671,1.0,20/84,12.21%,TEK;SLC12A2;CLDN5;PTPRM;SEMA6A;KLF2;THBS1;TGFB2;KLF4;DAB2IP;SEMA3E;CREB3L1;STAB1;CTNNB1;SARS1;SERPINF1;HHEX;HGS;SYNJ2BP;EPN2
prerank,dendrite morphogenesis (GO:0048813),0.43170534379745923,1.262233866236054,0.16987740805604204,0.685864230670751,1.0,8/35,8.26%,DCDC2;LRP4;SDC2;WASL;PTN;ARC;PTEN;FARP1
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.4236163837540514,-1.261822928714684,0.16804979253112035,0.5454783512183473,1.0,11/27,19.35%,CAV1;PDE4D;CTNNA3;ATP2A2;RYR2;CACNA1C;JUP;DSG2;PLN;DSP;TRPM4
prerank,sulfur amino acid metabolic process (GO:0000096),0.48265028559905265,1.261246795902464,0.18518518518518517,0.6873597471750363,1.0,5/24,10.44%,CBS;MTHFR;MSRA;AHCY;CDO1
prerank,nucleocytoplasmic transport (GO:0006913),0.42831249224501133,1.2604507327651855,0.18181818181818182,0.688355790983742,1.0,10/40,20.37%,ATXN1;PHAX;SMN1;NUTF2;NEMF;NXT2;LSG1;RSRC1;GEMIN5;SNRPF
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.4931418815924651,1.260230868164116,0.20948616600790515,0.687521054307932,1.0,3/18,9.43%,ROCK2;EPHA4;PICALM
prerank,lymphocyte differentiation (GO:0030098),-0.34439350398100516,-1.2600318039908311,0.10396039603960396,0.5493903721707619,1.0,26/68,19.95%,PTPRJ;TPD52;KLF6;ITGB1;PLCG2;SOX4;HDAC5;ITGA4;JAG2;PTPRC;LFNG;ZBTB7A;LMBR1L;PIK3CD;HHEX;IKZF1;MSH2;RABL3;FLT3;CR2;TCF3;TOX;DNAJB9;JAK3;HDAC9;DLL4
prerank,heterotypic cell-cell adhesion (GO:0034113),-0.426065969006893,-1.2596275994247421,0.162839248434238,0.5495589685949771,1.0,10/25,17.88%,CD200;ITGB1;CXADR;ITGA5;ITGA4;CTNNA3;ITGA7;JUP;DSG2;DSP
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.33941049386154815,1.2584287302966497,0.09631728045325778,0.6915158977313602,1.0,33/166,13.47%,RORA;RBPJ;PPARA;NOTCH2;POLR2D;ESRRG;CCN2;NR1I2;TBL1XR1;CDK7;MAML3;TEAD1;MAML1;TEAD3;NR6A1;NRBP1;RSF1;POLR2A;GTF2F1;MED1;HDAC1;TAF8;TAF1A;SMARCA5;POLR1F;RXRA;TAF3;POLR1A;MAML2;TAF1D;AR;NR1I3;CREBBP
prerank,positive regulation of cellular protein metabolic process (GO:0032270),-0.3223568266274896,-1.2582064706569887,0.08595988538681948,0.5523957410450628,1.0,29/101,15.98%,MSN;THBS1;NIBAN1;HSP90AA1;KLF4;EEF2;VIM;NFKBIA;RPL26;ATG7;PERP;SOX4;TGFB1;FAF1;RPL5;MTOR;PYM1;EIF4G1;EIF3D;OGT;RPS4X;BCL3;YTHDF3;TBC1D10A;RPS27L;NR1H2;EIF3C;VPS11;CASP8
prerank,regulation of anoikis (GO:2000209),-0.4584890121058849,-1.257950355544414,0.1762114537444934,0.5521146725261746,1.0,8/19,15.77%,CAV1;ITGB1;PTK2;NOTCH1;ITGA5;TLE5;MYBBP1A;BRMS1
prerank,lipid catabolic process (GO:0016042),0.4970421911597598,1.257676552871671,0.206,0.6923047329783552,1.0,4/18,7.68%,CEL;ACADL;LIPC;LIPH
prerank,regulation of lipid metabolic process (GO:0019216),0.36993465829606287,1.257623063884043,0.1320450885668277,0.6909967326550472,1.0,14/88,11.77%,PRKAG2;RORA;FGFR4;PPARA;TBL1XR1;NFYB;NCOA2;CHD9;PMVK;APOC1;MED1;NFYC;RXRA;FDPS
prerank,mesonephric tubule development (GO:0072164),0.5402223666495191,1.2573557743552453,0.2,0.6904487649929543,1.0,4/15,6.50%,OSR1;FGFR2;BMP7;SALL1
prerank,endoplasmic reticulum membrane organization (GO:0090158),-0.5234001575467839,-1.2572782376190639,0.21482889733840305,0.5529067147168647,1.0,5/11,16.25%,RTN4;LPCAT3;BNIP1;ARL6IP1;ATL2
prerank,negative regulation of ATP metabolic process (GO:1903579),0.5081874981939758,1.256998189174708,0.21370967741935484,0.6900323244338865,1.0,8/17,21.31%,PPARA;PID1;NUPR1;FLCN;PFKFB1;NCOR1;HDAC4;PDE12
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.4603498217450336,1.2568693400478455,0.20950704225352113,0.6889708400589324,1.0,3/25,4.09%,CEMIP;PDPK1;ANK2
prerank,lipid modification (GO:0030258),-0.39711533654721853,-1.2567772086294682,0.14965986394557823,0.5533438621335368,1.0,10/37,12.65%,DGKH;PLPP1;MBOAT1;DGKB;DGKI;LPCAT3;DGKZ;DGKG;PORCN;ALOX12
prerank,regulation of axon extension (GO:0030516),-0.3904669797970319,-1.2565074708804365,0.1386861313868613,0.5531065353043896,1.0,18/37,29.80%,SEMA7A;SHTN1;NRCAM;GSK3B;DNM2;RTN4;SEMA3G;CDKL3;DBNL;MT3;RTN4R;L1CAM;DBN1;SEMA3A;CTTN;ISLR2;SIN3A;OLFM1
prerank,serine family amino acid metabolic process (GO:0009069),0.5204194527028831,1.255951766684811,0.19361702127659575,0.6902585745332894,1.0,5/16,13.34%,CBS;SRR;THNSL2;CDO1;SHMT1
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.2981065748415966,-1.2555389780449089,0.07301587301587302,0.5548333715153092,1.0,36/151,14.62%,TEK;NTRK3;RAP1A;SEMA7A;BMPER;KDR;GAS6;PDE8A;PTK2B;NOTCH1;ACKR3;ROR2;TNFAIP8L3;TGFB1;ROR1;CD44;FERMT2;PTPRC;ARRB1;TNFRSF11A;PDGFC;FLT4;ADRA1A;APP;NPNT;HTR2A;BMP2;MAP2K7;NDRG4;GCNT2;GPER1;CD74;MAP3K12;MT3;DSTYK;CSF1R
prerank,response to peptide hormone (GO:0043434),0.4198561397515489,1.2554180888172122,0.16898954703832753,0.6904538377393417,1.0,4/43,3.69%,TGFBR3;ROCK2;ANXA1;STAT5B
prerank,positive regulation of B cell activation (GO:0050871),-0.3669381407561191,-1.2550962522103275,0.11538461538461539,0.5549663069094086,1.0,25/50,36.46%,MEF2C;SH3KBP1;TFRC;NFATC2;CD38;PTPRC;XBP1;CD74;CD81;MIF;PPP2R3C;CD40;NCKAP1L;TIRAP;CLCF1;KMT5C;SHLD3;SHLD2;RIF1;NOD2;BST1;SYK;IL7;VAV3;SASH3
prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.40261357249622115,-1.2548438602818812,0.1308016877637131,0.554687640224773,1.0,17/32,24.75%,CALM1;HSP90AB1;PPIA;PPP1R16B;TGFB1;MTOR;SYMPK;CALM2;PPP2R5A;PTBP1;PRKCD;CDCA2;CD300A;NSMF;PPP1R15B;PPP1R15A;CALM3
prerank,regulation of cellular respiration (GO:0043457),-0.4701591845757205,-1.2546838698133718,0.19008264462809918,0.5541185176126276,1.0,9/17,34.96%,CBFA2T3;PRDM16;IDE;NOP53;VCP;IFNAR1;NOS2;PRELID1;IFNLR1
prerank,cellular response to inorganic substance (GO:0071241),-0.44650650327496055,-1.2543697306847357,0.17718940936863545,0.5540085826004574,1.0,8/21,22.10%,GUCY1B1;FOXO1;SPIDR;MT3;CDK2;KCNC2;RTF2;FMR1
prerank,vacuolar acidification (GO:0007035),-0.44778898304378234,-1.2541343935487665,0.18651685393258427,0.5536777680364411,1.0,13/21,27.40%,DMXL1;ATP6V0A1;GRN;TCIRG1;DMXL2;ATP6V0A4;ATP6V0A2;SLC11A1;ATP6V0D2;CLN5;ATP6V0E2;TMEM9;ATP6V1H
prerank,embryonic appendage morphogenesis (GO:0035113),0.5562807131568175,1.2539749763524142,0.23758099352051837,0.6932862581970134,1.0,2/12,4.67%,CYP26B1;FBXW4
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.43197078043821,-1.2538425258651862,0.17475728155339806,0.5535551932774939,1.0,9/24,19.93%,B2M;CALR;MFSD6;IDE;CANX;BCAP31;SEC23A;TAPBP;TAPBPL
prerank,negative regulation of calcium ion transport (GO:0051926),0.5251428940715877,1.2532819066030487,0.23968565815324164,0.6938675143345895,1.0,1/15,0.21%,ATP1A2
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.5076402978092307,-1.2528494861957702,0.17928286852589642,0.5552638954672615,1.0,3/12,6.22%,PRKG1;MEF2C;IGFBP5
prerank,protein K63-linked ubiquitination (GO:0070534),0.42567021249049275,1.2524075772352041,0.16100178890876565,0.6951457177065877,1.0,9/41,9.63%,PRKN;UBE2E2;TRIM5;NEDD4;TRIM56;RNF152;RNF135;WWP2;ITCH
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.3034516839500567,1.2516638961493682,0.04460966542750929,0.6959884947257667,1.0,68/476,11.86%,IL31RA;IGF1;CREB5;RORA;TCF4;WNT4;ARNT2;ZIC1;PPARA;NR2F2;NPAS3;BMP7;KMT2A;ESRRG;MYBL1;ZIC2;SCX;NR1I2;SP100;TBL1XR1;PLCB1;TP53INP2;MYRFL;ZFP90;ELF4;TEAD1;NFIB;ARID1B;GLI3;NDP;ZMIZ1;MSANTD1;NIBAN2;PHF8;SALL1;ARHGEF11;IL6;SMAD3;NEK4;BLM;RGMB;TRIM56;PBX4;RSF1;MITF;KAT8;KAT6B;MAP3K2;BRCA2;PICALM;CREB3L2;NSD1;MED13;MED1;HDAC1;DVL3;PHIP;PARP9;ATOH8;SNAI1;KMT2B;TFAP2A;TFAP2B;NPAS2;RXRA;TRIM45;RNF14;MYB
prerank,regulation of actin nucleation (GO:0051125),-0.521568371737485,-1.2512327999551522,0.1970260223048327,0.5588138712776766,1.0,8/12,34.09%,GSN;ARF1;WHAMM;PICK1;ARFIP2;ARFIP1;CORO1A;SCIN
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.43378420028958714,1.2511653579317537,0.17953667953667954,0.694673899243646,1.0,9/29,11.10%,ITGB3BP;RBBP4;CENPI;NASP;RBBP7;MIS18BP1;RSF1;CENPQ;SMARCA5
prerank,CENP-A containing chromatin organization (GO:0061641),0.43378420028958714,1.2511653579317537,0.17953667953667954,0.694673899243646,1.0,9/29,11.10%,ITGB3BP;RBBP4;CENPI;NASP;RBBP7;MIS18BP1;RSF1;CENPQ;SMARCA5
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.5636258282459508,1.2510450331508913,0.24074074074074073,0.6936444387285976,1.0,1/11,0.42%,COLEC12
prerank,phosphate ion homeostasis (GO:0055062),0.5828529093977556,1.2509371931149234,0.23029045643153526,0.6925660556294613,1.0,3/10,11.32%,FGFR4;SLC34A3;TFAP2B
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.5505274944189649,1.2507930142192383,0.2260127931769723,0.6915304263738011,1.0,4/11,8.32%,NOS1AP;CACNG1;CACNA2D1;CAMK2D
prerank,positive regulation of cellular metabolic process (GO:0031325),-0.3145549516497637,-1.250499062407597,0.08547008547008547,0.5597030374909726,1.0,40/98,22.10%,SLCO1C1;NSF;THBS1;KLF4;PPARD;NFKBIA;SFRP4;CHCHD2;TGFBR2;TGFB1;ARRB1;GHITM;ACACA;VEGFA;CD63;ECE1;EIF4G1;ACE2;RAB1A;XDH;PICK1;ROMO1;MT3;NR1H2;FASN;INPP5F;ZC3H12A;AGTR1;GREM1;RAB1B;ACLY;ARRB2;INSR;AKT1;ATAD1;PAX8;GADD45A;CDKN1A;NR1H3;FMR1
prerank,activation of phospholipase C activity (GO:0007202),0.45287144797582984,1.2500741497606913,0.19814814814814816,0.6923046261404925,1.0,4/29,6.41%,ARHGAP6;LPAR1;LPAR2;GNAQ
prerank,response to X-ray (GO:0010165),0.5129067569373329,1.2498401429247654,0.21615720524017468,0.6915339966051673,1.0,4/14,7.80%,ANXA1;XRCC5;BLM;XRCC4
prerank,regulation of T cell mediated immunity (GO:0002709),-0.5447828516417459,-1.2496447338039067,0.1918819188191882,0.5610022922191259,1.0,4/10,23.67%,TNFRSF1B;TRPM4;AGER;CCR2
prerank,NIK/NF-kappaB signaling (GO:0038061),-0.3347089118022443,-1.2491752197519113,0.10610079575596817,0.5612804643553221,1.0,28/72,25.72%,CARD10;CARD14;PSMD13;BIRC3;PSMF1;PSMB10;CHUK;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;PSME1;CUL1;PSMB3;COPS8;IRAK1;TNFRSF10B;PSMD5;AKT1;TIRAP;SKP1;PSMD9;PSMB4;RELA;NFKB2;PSMD10
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.345591572515856,-1.2487381676376872,0.13903743315508021,0.5615225390548885,1.0,18/70,15.61%,B2M;IKBKB;CALR;VAMP8;MFSD6;PSMD13;PSMF1;PSMB10;CHUK;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;PSME1;PSMB3;CYBB
prerank,regulation of keratinocyte differentiation (GO:0045616),0.46304559679759866,1.2480343244557712,0.20433996383363473,0.695264179468264,1.0,5/24,7.03%,ERRFI1;ROCK2;HOXA7;SGPP1;NCOA3
prerank,histone lysine methylation (GO:0034968),0.4300796735143012,1.2471708863855684,0.1836734693877551,0.6964630940333524,1.0,10/33,19.23%,KMT2A;PRDM5;ASH2L;SETD6;KMT2B;SMYD3;KDM6A;N6AMT1;DYDC2;WDR82
prerank,positive regulation of endothelial cell proliferation (GO:0001938),-0.33756875899134936,-1.2468550117838555,0.128,0.5654709525961991,1.0,19/75,11.67%,TEK;NRP2;KDR;F3;BMPR2;PPP1R16B;NRAS;GATA2;PDCL3;ITGA4;EMC10;JCAD;FLT4;VEGFA;NR4A1;PIK3CD;BMP2;SCG2;CDH13
prerank,axonogenesis (GO:0007409),-0.28109537429291415,-1.2466465874223156,0.064,0.5650456493689817,1.0,55/237,12.24%,SPTBN1;GAB1;SLIT2;BSG;SHANK3;EFNA5;KLF7;ACTB;SEMA6A;SEMA7A;NRP2;SH3KBP1;SEMA6D;RPS6KA5;HSP90AA1;SEMA3C;MAP1B;HSP90AB1;UNC5C;S100A6;PTK2;TNR;UNC5D;LAMA1;FYN;NOTCH3;NOTCH1;SEMA4D;SHTN1;SEMA3E;LAMA5;NRCAM;B4GALT5;TUBB3;ROBO4;DCC;LAMA3;PDLIM7;APBB1;APP;NRXN1;SEMA4B;SEMA5B;GFRA2;SEMA6C;PIK3CD;RELN;LYPLA2;EPHB1;SEMA3G;SLITRK5;EFNB3;GPC1;LMTK2;NTN4
prerank,membrane repolarization (GO:0086009),0.5213731433598269,1.2459291086136837,0.22287968441814596,0.6987662488156736,1.0,3/15,4.29%,ATP1A2;ATP1B3;KCND3
prerank,positive regulation of lymphocyte migration (GO:2000403),-0.5187919934306924,-1.245198066703253,0.1852589641434263,0.5680987064796905,1.0,5/12,26.30%,JAM2;APP;RHOA;CXCL12;CXCL10
prerank,regulation of signal transduction (GO:0009966),0.32883316001698765,1.2450951565178514,0.11206896551724138,0.6998865327502111,1.0,38/190,13.47%,DCDC2;IGFBP2;RORA;ZIC1;SLC8A3;FGFR2;TULP3;NCAM1;SP100;INTU;PLCB1;TRIM5;DTNBP1;IGFBP4;IRAK2;LLGL2;SULF1;LRRK2;ITGA3;TCF7L1;GRK3;ZDHHC3;AMFR;IGFBP7;GRK5;GRK4;FBXL17;GNG7;DHRS3;WDR11;LLGL1;DTX1;GAS1;RGS16;TSPYL2;GDNF;VEPH1;CREBBP
prerank,negative regulation of protein secretion (GO:0050709),-0.39266519721604715,-1.2446233830128586,0.17882352941176471,0.5688214620407145,1.0,11/38,13.66%,CD200;KCNB1;CCN3;RAB11FIP1;RHBDF2;RSAD2;REST;CHGA;RAB11FIP5;CYP51A1;SIRT4
prerank,cell-cell junction assembly (GO:0007043),-0.3507943005760771,-1.2439259634070834,0.11951219512195121,0.5697835406183056,1.0,15/63,6.57%,ACTB;CLDN5;ACTG1;PKP4;CD9;CTNND2;CDH11;CLDN11;CDH2;RAMP2;GJC1;GJD3;WDR1;CTNNB1;TJP1
prerank,regulation of cell killing (GO:0031341),-0.48014622280485714,-1.2432923221090715,0.22176591375770022,0.5706302834570799,1.0,4/16,9.14%,TGFB2;RAC1;CD55;MAPK8
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.5476809195144186,-1.2423233871815986,0.2054263565891473,0.5723551660256089,1.0,5/10,23.77%,PTPRC;CEACAM1;CX3CR1;ARRB2;FCGR2B
prerank,gonad development (GO:0008406),0.41208058468346936,1.2422794782894744,0.1711229946524064,0.7067236488506948,1.0,7/41,10.11%,WNT4;NR2F2;KIT;LRP2;SALL1;FGF9;NUP107
prerank,negative regulation of protein binding (GO:0032091),-0.3402608711270805,-1.2416774748084103,0.11936339522546419,0.5732600043468494,1.0,25/71,20.64%,CAV1;ACTB;B2M;ADAM15;RACK1;ITGA4;GSK3B;ATP2A3;ATP2A2;MAPK8;CTNNBIP1;PPP1CA;RALB;TLE5;NES;ADRB2;SYMPK;CTSZ;DISC1;CARD16;TMBIM6;ARRB2;PRKCD;TTBK2;AKT1
prerank,phosphatidylinositol biosynthetic process (GO:0006661),-0.3081015622603912,-1.2411085220248446,0.05572755417956656,0.5738850667712269,1.0,37/119,17.31%,PIP5K1B;EFR3B;PITPNM2;PLCG2;INPP5D;BMX;PIK3R6;SOCS2;SYNJ1;INPP4A;SOCS5;PIK3C2B;CDS1;ARF1;CDIPT;PGAP4;TTC7A;PLEKHA1;PIK3CD;PIK3C2A;MTM1;MTMR6;PITPNM3;MTMR9;PIK3C3;INPPL1;PIK3R5;PIP5K1C;SBF1;ITPKB;SACM1L;PI4KB;CISH;PIGZ;PIK3R3;MTMR12;INPP5F
prerank,BMP signaling pathway (GO:0030509),0.38407075778283273,1.2406318617253853,0.1440536013400335,0.710073365524232,1.0,6/62,2.75%,TGFBR3;BMP6;BMP7;SMAD6;SLC39A5;SCX
prerank,2-oxoglutarate metabolic process (GO:0006103),0.5335075867258723,1.2401831655701976,0.2074688796680498,0.710098313730422,1.0,4/13,13.74%,ADHFE1;IDH2;PHYH;AADAT
prerank,heart trabecula morphogenesis (GO:0061384),0.4977128006983015,1.239694167653505,0.23193916349809887,0.7101589875588832,1.0,4/18,1.37%,TGFBR3;RBPJ;BMP7;RBP4
prerank,cellular response to ATP (GO:0071318),-0.4858441672834957,-1.239303957792154,0.20724346076458752,0.5779450400310412,1.0,9/14,43.73%,HSP90B1;SSH1;P2RY12;P2RY1;P2RX3;P2RX7;P2RY2;CIB2;PDXP
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.5263015707429582,-1.2390055487730307,0.22201492537313433,0.5777863945402876,1.0,5/11,24.89%,P3H2;EGLN3;EGLN2;P4HA2;P4HA1
prerank,calcium ion import across plasma membrane (GO:0098703),0.5233049287489122,1.2388257227444408,0.20816326530612245,0.7114153831849965,1.0,3/14,7.01%,SLC8A3;SLC8A1;CACNA2D1
prerank,mesenchyme development (GO:0060485),0.5321238709612733,1.2386231553620304,0.2399232245681382,0.7106328754390437,1.0,2/15,1.28%,FGFR2;BMP7
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.4767801749053205,1.2385646564898776,0.20528455284552846,0.7094065247406934,1.0,3/22,4.75%,ROCK2;PPP4R4;PTPA
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.4189091372030509,-1.2384312596950549,0.1868583162217659,0.5784521230380122,1.0,10/25,23.02%,HSPA8;BAG1;HSPA14;HSPA5;ST13;ERO1A;DNAJC7;DNAJB1;HSPA9;HSPA1B
prerank,limb morphogenesis (GO:0035108),0.48309781337541957,1.2378148691743338,0.20245398773006135,0.7101984761202377,1.0,3/20,5.23%,CYP26B1;FBXW4;GLI3
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.518213150440515,1.2366466863620111,0.2263779527559055,0.7123192911946932,1.0,3/13,9.48%,PDPK1;IGF2;APLN
prerank,cellular response to glucose stimulus (GO:0071333),-0.40031977246329,-1.2362223471832097,0.16632443531827515,0.5836952123978588,1.0,9/30,13.42%,UNC13B;GAS6;RACK1;PTPRN2;KCNB1;SOX4;XBP1;GPER1;RAB11FIP5
prerank,vasoconstriction (GO:0042310),-0.5225029981480919,-1.2345697851137085,0.2088495575221239,0.5873431559708598,1.0,4/11,10.44%,EDNRA;ACTA2;EDN1;PIK3C2A
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.4975484690535314,1.233998979206792,0.22151898734177214,0.7189314337327369,1.0,3/16,12.03%,LEPROT;VTA1;CHMP6
prerank,positive regulation of proteolysis (GO:0045862),0.3921516349094925,1.2337427594347365,0.16987179487179488,0.7182778927381153,1.0,8/55,8.12%,SH3D19;FGFR4;CTSH;CCBE1;SNX33;SNX9;NRDC;WDR48
prerank,cellular response to molecule of bacterial origin (GO:0071219),-0.31946709510803917,-1.233727936185609,0.10666666666666667,0.588784141317268,1.0,34/95,27.67%,MEF2C;DAB2IP;VIM;LBP;CHMP5;SBNO2;DEFA6;TNFRSF1B;PDCD4;CYRIB;MAPK8;RHOA;XBP1;CD180;GIT1;CX3CR1;CARD16;CD274;ZC3H12A;IRAK1;ADAM9;MYD88;TIRAP;NR1H3;PLAA;RELA;FCGR2B;CD80;CASP1;CD68;TNFAIP3;CXCL10;CCL2;TLR4
prerank,histone H2B ubiquitination (GO:0033523),0.549980809781411,1.2329929731550906,0.26024590163934425,0.7191608919666465,1.0,8/10,26.70%,CDC73;RNF20;UBE2E1;DTX3L;CTR9;PAF1;WAC;RNF40
prerank,regulation of vacuole organization (GO:0044088),0.48207348893584356,1.2329459482823815,0.1827309236947791,0.7178865026704903,1.0,3/20,5.42%,NPRL3;NPRL2;MTMR3
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.40955672797573117,-1.232811066177419,0.1963882618510158,0.5902771875139897,1.0,14/29,24.00%,ELOVL7;ELOVL5;ACSL4;ACACA;ELOVL6;ELOVL1;FASN;ACSL3;TECR;ACLY;SCD5;ACSL5;SCD;ACSF3
prerank,muscle tissue development (GO:0060537),-0.49685316449103967,-1.232410586301347,0.22957198443579765,0.5904271305632418,1.0,5/13,8.02%,PGM5;ENG;STRA6;PTCH1;CSRP2
prerank,regulation of extracellular matrix organization (GO:1903053),0.5105781454832095,1.232174260652937,0.22554890219560877,0.718772091322555,1.0,6/15,9.94%,AEBP1;FGFR4;DDR1;SLC2A10;DDR2;RIC1
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.5339349882051414,-1.23145054644006,0.1925343811394892,0.592260478895997,1.0,4/10,19.23%,ACTN4;TBX1;RARB;RXRB
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.4620580470521381,-1.2314421346115283,0.21912350597609562,0.5912751496237753,1.0,4/17,8.59%,TGFB2;MID1;PDCD10;STK25
prerank,regulation of mitotic spindle organization (GO:0060236),-0.38904598734298323,-1.2311474950836414,0.16166281755196305,0.5911002041115364,1.0,18/35,35.93%,CHMP5;CHMP2B;GNAI1;HNRNPU;CHMP1B;CHMP1A;DCTN1;NUMA1;HSPA1B;CHMP3;PDCD6IP;CHMP4C;DRG1;VPS4B;HSPA1A;PLK1;PSRC1;DYNC1H1
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.4332766115281837,-1.231056824919461,0.203125,0.590374280706659,1.0,11/23,25.19%,HSP90AA1;NDUFA13;TOMM22;TIMM9;ROMO1;TIMM10B;TIMM13;TIMM29;TIMM22;BMF;BAX
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.400797786526597,-1.2309850709015042,0.19624217118997914,0.5895775040107295,1.0,15/30,32.58%,HSPA8;SELENOF;BAG1;HSPA14;HSPA5;ST13;ERO1A;DNAJC7;DNAJB1;HSPA9;HSPA1B;HSPE1;CHCHD4;UGGT1;HSPA1A
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.5113382198027874,1.2306361822623477,0.23493975903614459,0.7219295074477979,1.0,3/15,4.01%,PPARA;ADM;SLC45A3
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.33052433046223834,-1.230026359441634,0.13114754098360656,0.5913274793859984,1.0,28/84,23.14%,UBB;BUB3;UBC;RPS27A;CUL3;ECRG4;PSMD13;PSMF1;PSMB10;FBXO31;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PTTG1;PSMB8;PSME1;ANAPC16;UBA52;PSMB3;CDK2;BUB1B;UBE2D1;PSMD5;ANAPC7;PSMD9;PSMB4
prerank,sphingolipid catabolic process (GO:0030149),-0.47602532363147065,-1.229945190619074,0.21703853955375255,0.5905486325027504,1.0,4/15,8.49%,ACER3;ACER2;SMPD4;SGPL1
prerank,ameboidal-type cell migration (GO:0001667),-0.3600912731249425,-1.2296338188656022,0.1451990632318501,0.5903539259872861,1.0,15/51,11.12%,SEMA6A;SEMA7A;SEMA6D;SEMA3C;SEMA4D;TBX1;SEMA3E;CCN3;CORO1C;ITGA4;SGPL1;SEMA4B;SEMA5B;SEMA6C;SEMA3G
prerank,regulation of endothelial cell migration (GO:0010594),-0.32384494154192595,-1.2296198462361148,0.11716621253405994,0.5894000952146845,1.0,28/85,9.89%,TEK;SLIT2;FOXP1;PTPRM;NRP2;BMPER;RHOJ;KDR;THBS1;ACVRL1;RAC1;SCARB1;PTK2;ETS1;PTK2B;DAB2IP;BMPR2;BCAR1;RHOB;CALR;EMC10;CEACAM1;FLT4;VEGFA;EMP2;GRN;EDN1;PIK3CD
prerank,ERBB signaling pathway (GO:0038127),-0.343335653549877,-1.229142587607568,0.13010204081632654,0.5897931399952869,1.0,15/64,11.14%,GAB1;RPS6KA5;HSP90AA1;IQGAP1;CBL;PTK2;PTK2B;REPS2;PTPN12;BCAR1;TGFB1;CDC37;CPNE3;PIK3C2A;NCK2
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.305399235392434,1.2290842944375586,0.07581699346405228,0.7252968486871828,1.0,42/348,8.75%,IGF1;ROBO1;BMP6;SLC24A3;ROCK2;OSR1;SLC22A2;RBPJ;FGFR4;AFDN;PID1;WNT6;BMP7;ANGPT1;PRKN;RBMS3;DKK1;SCX;NOS1AP;CTSH;DTNBP1;PCSK9;SRPK2;ITGAX;ANK2;MBIP;FOXD1;MAPK9;TNRC6B;GJA1;TNRC6A;EPHX2;FGF1;SLC2A10;IL6;SMAD3;PRKAA1;CSF1;TLE1;MITF;FUBP1;MUSK
prerank,amide transport (GO:0042886),-0.4098176128540273,-1.2289811757016673,0.19088937093275488,0.5892620413923914,1.0,7/26,10.76%,ABCG2;CERT1;PLTP;SLC5A6;SLC38A5;AQP11;GLTP
prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.4026716140667697,-1.2288220397948408,0.17362637362637362,0.58871413259021,1.0,14/31,22.15%,SHANK3;SIPA1L1;ZDHHC15;PPFIA2;LRP8;ABI3;SRCIN1;KIF1A;RELN;DBNL;CAMK2B;CDK5;CFL1;DBN1
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.4110703516228472,1.2278969522733043,0.19710669077757687,0.7273852064139443,1.0,5/41,8.77%,IGF1;SYT11;CACTIN;NLRC3;SIRPA
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.4404442339599232,-1.2277882687950439,0.1947261663286004,0.5905824493898484,1.0,6/20,10.74%,RPS6KA5;PPARGC1A;SOX4;ARRB1;GLYR1;NOS1
prerank,actin-myosin filament sliding (GO:0033275),0.41425865145520147,1.2277654759476297,0.20646319569120286,0.7249663884460241,1.0,4/38,2.69%,TPM1;DMD;TNNC1;TNNT2
prerank,muscle filament sliding (GO:0030049),0.41425865145520147,1.2277654759476297,0.20646319569120286,0.7249663884460241,1.0,4/38,2.69%,TPM1;DMD;TNNC1;TNNT2
prerank,collagen fibril organization (GO:0030199),0.3628775643331744,1.2267691304431905,0.15629984051036683,0.7266908994680673,1.0,12/88,4.88%,COL22A1;COL26A1;COL4A5;COL4A6;PXDN;LOXL1;COL9A2;SCX;LOXL3;COL1A2;COL13A1;COL18A1
prerank,phospholipid transport (GO:0015914),-0.3529120099687635,-1.2266147695875902,0.15365853658536585,0.592837058299633,1.0,12/52,9.33%,ATP10A;PITPNC1;ATP8B1;ATP8A1;PLTP;SCARB1;TNFAIP8L3;ATP8A2;MFSD2A;ATP11B;ATP11C;TMEM30A
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.3846022712281702,1.2265478675290984,0.18166939443535188,0.7259553011850939,1.0,7/59,8.36%,ALDH1A2;CYP27A1;HSD17B10;HOGA1;LIPC;LIPH;SRR
prerank,stabilization of membrane potential (GO:0030322),0.4930385916326458,1.2260527067528257,0.22362869198312235,0.7260647228293088,1.0,1/16,0.38%,KCNK2
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),-0.3254756453866008,-1.225890660303289,0.14425427872860636,0.592814274305289,1.0,33/78,28.33%,CTSD;LGMN;CAPZA2;AP2A2;ACTR10;DYNLL2;KIF26A;ARF1;DNM2;AP2M1;DCTN3;CD74;CANX;AP1S2;SEC23A;DCTN4;SH3GL2;KIF3B;AP2B1;KIF11;DCTN1;KIF15;CTSL;AP2A1;FCGR2B;CAPZA1;KIF4A;RAB7A;KLC2;CTSE;KIF23;KLC1;DYNC1I1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.3254756453866008,-1.225890660303289,0.14425427872860636,0.592814274305289,1.0,33/78,28.33%,CTSD;LGMN;CAPZA2;AP2A2;ACTR10;DYNLL2;KIF26A;ARF1;DNM2;AP2M1;DCTN3;CD74;CANX;AP1S2;SEC23A;DCTN4;SH3GL2;KIF3B;AP2B1;KIF11;DCTN1;KIF15;CTSL;AP2A1;FCGR2B;CAPZA1;KIF4A;RAB7A;KLC2;CTSE;KIF23;KLC1;DYNC1I1
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.44464448971682596,1.2255811486187358,0.22010398613518198,0.7261392043821382,1.0,10/26,19.40%,LTF;CACTIN;NLRC3;LYAR;ITCH;PCBP2;MAPKBP1;TRAFD1;ILRUN;TRAF3IP1
prerank,regulation of transmembrane transport (GO:0034762),-0.40246905099376606,-1.2255497560774464,0.18049792531120332,0.5928489927182177,1.0,5/31,2.55%,ACTB;SLC2A1;OCLN;KCNJ2;NEDD4L
prerank,chromatin remodeling at centromere (GO:0031055),0.4151671432689262,1.225517330870935,0.2,0.724943740038621,1.0,9/31,11.10%,ITGB3BP;RBBP4;CENPI;NASP;RBBP7;MIS18BP1;RSF1;CENPQ;SMARCA5
prerank,regulation of interleukin-12 production (GO:0032655),-0.3559521983137807,-1.2253717646210143,0.17511520737327188,0.5923336957390689,1.0,14/47,23.62%,FOXP1;THBS1;PLCG2;HSPD1;CD47;IRAK3;LAPTM5;CMKLR1;IRF5;JAK3;CD40;TIRAP;AGER;MAPK11
prerank,positive regulation of translation (GO:0045727),-0.3207270994722305,-1.2251714157484186,0.10512129380053908,0.5919082245274114,1.0,39/94,26.97%,THBS1;NIBAN1;RPS9;EEF2;VIM;PKM;RPL26;SOX4;YBX3;RPL5;MTOR;RCC1L;PYM1;EIF3D;UQCC2;RPUSD4;RPS4X;BCL3;YTHDF3;RPS27L;EIF2B5;EIF3C;POLR2G;EIF5A;EIF5AL1;FASTKD3;METTL3;UHMK1;EIF6;TRMT10C;FMR1;TRUB2;PCIF1;MRPS27;COA3;RPS6KB2;HNRNPD;EIF4A3;CPEB3
prerank,telomere capping (GO:0016233),0.49235524304505723,1.2251126020145717,0.23044397463002114,0.7247432443970733,1.0,9/16,21.72%,ACD;PRKDC;DCLRE1A;DCLRE1B;MRE11;STN1;RAD50;NBN;TERF2
prerank,cellular biogenic amine metabolic process (GO:0006576),-0.5084110703582851,-1.225057855813272,0.20634920634920634,0.5912660088731818,1.0,6/12,28.82%,MAOA;DDC;AMD1;SRM;SMS;ODC1
prerank,cellular sodium ion homeostasis (GO:0006883),0.5077406707897015,1.2250130649739144,0.24116424116424118,0.7236287888919632,1.0,3/15,3.10%,ATP1A2;ATP1B3;SLC8A1
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.28688097091279474,1.2249504300086913,0.03337041156840934,0.7224192216876278,1.0,140/807,12.94%,GLIS3;PRDM6;BMP6;TCF7L2;OSR1;AEBP1;WNT4;RBPJ;FHL2;FGFR2;PPARA;NR2F2;BMP7;ATXN1;ZEB2;WWOX;PRKN;KCNIP3;DAB2;SNX6;DKK3;ARID5B;RUNX1T1;MXI1;FNIP1;ZEB1;AASS;CUX1;PRDM5;SATB1;ZIC2;DKK1;DMRT1;NR1I2;ASCL2;SP100;TBL1XR1;PLCB1;LOXL3;TSHZ3;JARID2;MIDEAS;IGF2;VSX2;JAZF1;ZHX2;PRICKLE1;ZFP90;VGLL4;HDAC8;HOXA7;FOXD1;CBY1;BEND5;RNF2;ARID4A;L3MBTL2;KDM2B;IKZF4;SOX1;GLI3;DPF2;IRF8;SFMBT1;SUFU;CXXC5;ZBTB32;MXD1;ZFP37;NIBAN2;DLG1;SALL1;CBX8;BCOR;WWC1;THAP1;SMAD3;WWC2;XRCC5;KANK2;EN1;PHF21A;NR6A1;KDM2A;MTF2;RSF1;TLE1;LYAR;PER3;BIRC5;ZMYND15;MITF;WWP2;DNAJA3;CBX2;KAT8;KAT6B;MDM2;NSD1;SMURF2;MBTD1;FRK;SCMH1;MED1;HDAC1;IRX1;L3MBTL3;FLCN;PARP9;ZNF8;ATOH8;ZBTB38;SNAI1;TFAP2A;SMARCE1;CBX7;TFAP2B;ZNF568;ZNF177;CDC73;RXRA;MYB;TAF3;CNOT2;E2F6;CRY1;CGGBP1;HIVEP1;GLI2;CBFA2T2;ORC2;NONO;FOXK2;AR;IFI27;HSF1;PHF6;SOX13;PSPC1;EZH1
prerank,inner ear morphogenesis (GO:0042472),0.4702965198415185,1.224116100157259,0.2199248120300752,0.7235581975782452,1.0,2/22,0.99%,ZIC1;FGFR2
prerank,protein dephosphorylation (GO:0006470),0.33599283519275014,1.2238736802679526,0.14912280701754385,0.7228686871549423,1.0,15/135,5.44%,EYA4;EYA1;PTPN13;PPP2R2B;EYA2;LHPP;PPM1M;PTPN4;SSU72;DUSP10;CDC14B;PPM1E;PTPRA;MTMR3;PTPN9
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.5408557792778093,-1.2233615350838056,0.2389558232931727,0.5940312768963177,1.0,4/10,18.23%,CDC42EP3;APC;CDC42EP5;CDC42EP2
prerank,regulation of pseudopodium assembly (GO:0031272),-0.5408557792778093,-1.2233615350838056,0.2389558232931727,0.5940312768963177,1.0,4/10,18.23%,CDC42EP3;APC;CDC42EP5;CDC42EP2
prerank,respiratory system development (GO:0060541),0.432868697381016,1.223199987387747,0.22340425531914893,0.7234915464416469,1.0,6/32,5.81%,FGFR2;RBP4;LOXL3;PDPN;ITGA3;FGF1
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.5053637016166233,1.2231773924815992,0.23715415019762845,0.7221876676595808,1.0,4/15,8.96%,ADGRV1;KIT;TMC2;WHRN
prerank,lipid transport (GO:0006869),-0.3124472678966466,-1.2228208830574157,0.096,0.5945488896254104,1.0,27/97,17.49%,ABCC4;PITPNC1;CERT1;ATP8B1;SLCO1C1;ATP8A1;PLTP;SCARB1;SLCO2A1;SLCO2B1;PPARD;LBP;TNFAIP8L3;CEACAM1;SPNS2;MFSD2A;SLCO3A1;GLTP;ABCD3;ABCD2;STARD5;GM2A;ABCA3;PRELID3B;CLN8;PITPNA;MTTP
prerank,carbohydrate derivative catabolic process (GO:1901136),0.4933551791970724,1.2226424287572946,0.24949698189134809,0.7223733890671749,1.0,5/18,13.19%,ADAMTS9;FBXO44;FBXO6;DERA;NGLY1
prerank,modulation of chemical synaptic transmission (GO:0050804),-0.30707538234244686,-1.222369256801161,0.11911357340720222,0.5947971054458012,1.0,32/107,15.93%,MEF2C;SLC12A2;GRM3;GRM7;ITGB1;CDH2;NGF;MCTP1;HOMER1;GRIK4;DLGAP1;ABR;CLSTN2;DGKI;LRP8;BCR;APP;BTBD9;SLC4A8;KCNMB4;PXK;RELN;KCTD13;DGKZ;CLSTN3;GRM8;CPLX2;NRG3;CNTNAP4;CX3CR1;CACNA1B;TMEM108
prerank,calcium ion transmembrane transport (GO:0070588),0.3606739261457717,1.2222401575398276,0.17073170731707318,0.7221959822679024,1.0,14/86,11.59%,TRPM3;SLC24A3;SLC8A3;NALCN;SLC8A1;CACNA1D;MAIP1;TRPC4AP;CACNA2D1;MCU;YME1L1;MCOLN3;MICU1;PKD2
prerank,negative regulation of MAP kinase activity (GO:0043407),-0.3604080047786877,-1.2214168959884204,0.18287037037037038,0.5964736201773778,1.0,18/44,25.91%,PTPRJ;STK38;DAB2IP;DNAJA1;UCHL1;PDCD4;PTPN1;SPRY4;IRAK3;NF1;DUSP1;SH2B3;BMP4;PRKCD;CD300A;HYAL2;SORL1;SPRY2
prerank,positive regulation of cellular component movement (GO:0051272),-0.4147432477481131,-1.2205172365475094,0.18340611353711792,0.5980248852095656,1.0,6/24,7.98%,SPOCK2;ACTN4;CAVIN1;ETS1;RPS19;VEGFA
prerank,regulation of wound healing (GO:0061041),-0.3702209556816171,-1.2205169715526931,0.18632075471698112,0.5970556390422892,1.0,13/42,16.42%,CAV1;ACTG1;OCLN;ITGB1;PTK2;KANK1;CD109;AJAP1;CRK;CADM4;SRSF6;CASK;PRKCE
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.41688691300386704,1.2199495332205232,0.20441988950276244,0.7274962041530366,1.0,9/37,9.58%,IGF1;TPM1;MMP2;GJA1;TAFA5;MMP9;PTEN;APLN;FGF9
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.3332652467957779,1.2194457492456896,0.1497005988023952,0.7276895009084057,1.0,19/140,8.10%,ARHGAP28;ARHGAP24;ARHGAP6;GMIP;ARHGAP29;CGNL1;FGD4;RHOD;ARHGAP20;SYDE2;ARHGAP26;AKAP13;SOS2;ARHGAP12;ARHGAP40;ARHGEF11;ARHGAP35;ARHGAP9;MYO9B
prerank,heterochromatin organization (GO:0070828),-0.4788202487200908,-1.2191856394932243,0.19845857418111754,0.5998584576097372,1.0,4/14,11.72%,MECOM;PRDM16;SMCHD1;BAHD1
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.5191349231734254,-1.2183358467628198,0.23984526112185686,0.6013046071134506,1.0,3/10,19.25%,SEC14L1;RNF125;GPATCH3
prerank,metal ion transport (GO:0030001),-0.32266086128474486,-1.2182558513524853,0.11842105263157894,0.600596274019799,1.0,34/86,20.88%,CAV1;TRPC3;TPT1;RAMP2;MAGT1;FYN;SLC30A5;ATP2C1;SLC3A2;GRIN3A;CACNA1E;ATP2A3;RAMP1;SLC39A8;NIPAL3;TRPC4;RYR2;CACNG3;SLC30A1;NDFIP2;CACNA1C;SELENOK;NIPAL4;PANX1;MT3;TRPC1;CALCRL;CACNA1B;CACNB3;NIPA2;ATP2B2;NIPAL2;PSEN1;SLC11A1
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.522321702718164,-1.2181476198831884,0.25,0.5999802538924381,1.0,3/10,1.52%,LRCH1;APOD;CD200
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.4677723913686732,-1.2180619410150837,0.19715447154471544,0.599278125321497,1.0,10/17,28.07%,COX4I1;COX6C;NDUFA4;COX6A1;COX7C;COX8A;COX5A;CYCS;COX15;COX4I2
prerank,regulation of dendrite morphogenesis (GO:0048814),0.42811579103994785,1.2172622652795198,0.20344827586206896,0.7330371092827794,1.0,11/32,14.40%,SDC2;CUX1;IL1RAPL1;NEDD4;OBSL1;PTPRD;CUL7;RAP2A;ADGRB3;LZTS1;CDKL5
prerank,regulation of developmental growth (GO:0048638),0.44215087996606184,1.217167658234115,0.21032504780114722,0.7319687135029446,1.0,6/29,10.27%,IGF1;PLCB1;STAT5B;MUSK;ABL1;LATS1
prerank,sterol biosynthetic process (GO:0016126),0.429869616496817,1.2166803987929478,0.21706864564007422,0.7320133418785424,1.0,6/33,11.77%,PRKAG2;INSIG2;PMVK;ACAA2;ACAT2;FDPS
prerank,regulation of protein binding (GO:0043393),-0.3080118187679594,-1.216392763787082,0.1253731343283582,0.6029702572386254,1.0,27/114,12.62%,CAV1;ACTB;CLDN5;B2M;EPB41;TIAM1;RPL11;RACK1;PKD1;HDAC5;GSK3B;HIP1R;ADD2;APP;PRMT8;DERL1;MAPK8;CTNNBIP1;PPP1CA;RALB;CRK;BMP2;TLE5;MEN1;NES;MARK2;IDE
prerank,translational elongation (GO:0006414),-0.31548317001226284,-1.2158659030543626,0.13314447592067988,0.6033640693770977,1.0,39/101,30.43%,EEF1A1;EEF2;RACK1;EEF1D;GFM1;MRPL33;MRPL32;MRPS14;EEF1G;MRPL38;ERAL1;MRPS16;MRPL50;MRPL23;MRPS5;EEF1B2;MRPL24;EEFSEC;MRPS28;MRPS35;MRPL13;MRPL35;GTPBP2;MRPL34;MRPS23;MRPS11;MRPS2;MRPS27;TUFM;MRPS18C;MRPL11;MRPL18;MRPL57;MRPL14;EEF1A2;GTPBP1;AURKAIP1;CHCHD1;MRPS31
prerank,ATP transport (GO:0015867),-0.5367800504180189,-1.2157109057600894,0.25196850393700787,0.6028745901122976,1.0,5/10,26.89%,SLC25A42;CD47;SLC17A9;SLC25A4;ABCC6
prerank,positive regulation of cell projection organization (GO:0031346),0.3429503655489793,1.2151386895805527,0.16158536585365854,0.7352548265936144,1.0,17/115,7.11%,PLXNA2;ROBO1;PTK7;EPHA3;CAMK1D;CUX1;DPYSL3;AVIL;IL1RAPL1;NDNF;OBSL1;GRIP1;PLXNC1;PLK5;PTN;ARHGAP35;PTPRD
prerank,muscle organ development (GO:0007517),0.379491830073479,1.2144462794048507,0.19966442953020133,0.7359651772454545,1.0,7/54,2.82%,IGF1;LAMA2;VAMP5;DMD;LARGE1;SPEG;SOX6
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.42918674178056543,-1.2140777950141945,0.22332015810276679,0.6065057716642319,1.0,5/21,10.25%,CAV1;CTNNB1;GSK3B;APC;PPP1CA
prerank,zinc ion transport (GO:0006829),-0.42920517177540174,-1.2137656302080382,0.2052313883299799,0.6064105419293576,1.0,8/21,26.19%,SLC30A5;SLC39A8;SLC39A7;SLC30A1;MT3;SLC39A14;SLC39A6;TRPM2
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.2971602668944173,1.213166165171182,0.07926829268292683,0.7384982445198567,1.0,57/390,10.42%,IL31RA;IGF1;EPHA7;ROCK2;EPHA3;FGFR2;FGFR4;COL4A6;FGFBP1;EFNB2;BDKRB2;KIT;ANGPT1;POLR2D;SDC2;FLRT2;SORBS1;PDGFRB;PLCB1;MMP2;KL;FER;IGF2;EPHA8;PDGFRA;GRB10;EPHA4;BAIAP2;GFRAL;SULF1;DDR1;WASL;HNRNPH1;PDGFD;FRS2;FGF1;IGF1R;CLNK;DDR2;MMP9;RYK;CSF1;MTSS1;POLR2A;GTF2F1;ANGPT2;MUSK;VEGFB;FGF9;ATP6V0D1;ATP6V0E1;FRK;JAK2;PIK3R1;FGF20;PHIP;AXL
prerank,protein heterooligomerization (GO:0051291),-0.4636167188358289,-1.21263109708715,0.2124248496993988,0.6084789998160326,1.0,8/17,20.58%,PKD1;MAT2A;CPSF7;GRIN1;CPSF6;TMEM120A;KCNC2;FARSA
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.44490562930409033,1.2113067127319257,0.23674242424242425,0.7425974382235916,1.0,4/27,7.11%,IGF1;PDGFRA;SPHK1;DDR2
prerank,sprouting angiogenesis (GO:0002040),-0.3496812422342641,-1.211168828084925,0.16359447004608296,0.6116928513644252,1.0,15/51,9.50%,TEK;SLIT2;BMPER;RSPO3;KDR;THBS1;ACVRL1;RAMP2;ENG;PTK2B;SEMA3E;FLT4;VEGFA;NR4A1;ESM1
prerank,regulation of programmed cell death (GO:0043067),-0.28834959551205663,-1.2110918584704125,0.08333333333333333,0.6109260250567388,1.0,42/161,19.45%,MECOM;HIP1;ACTN4;ACER3;ACER2;TPT1;HSP90AA1;TARDBP;PPP1R13B;SLK;RPS3;TGM2;ACTN1;BCAR1;PERP;CALR;CTSB;LGALS1;LRP8;BIRC3;RTN4;MAGED1;ZBTB7A;RSL1D1;BCL3;CLU;MADD;FAS;FLT3;WFS1;BRMS1;RAF1;DCPS;SGK1;RTKN;PINK1;TIGAR;RABGGTB;JAK3;TNFRSF10B;NOP53;CDK5
prerank,regulation of coagulation (GO:0050818),-0.5090614136234957,-1.2109976635029172,0.232,0.6101952991187028,1.0,3/11,17.75%,CAV1;PROCR;HS3ST5
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.5232640097764086,1.2107922071151098,0.2570806100217865,0.7428547738396039,1.0,5/11,16.83%,DAB2;DKK1;WNT5B;NKD1;SFRP1
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.5012314131560782,-1.2107791076911707,0.2391304347826087,0.6098455144899056,1.0,3/12,9.07%,TMEFF2;TGFB1;EDN1
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.4008071468841105,-1.210725312482638,0.1873589164785553,0.6090322458508924,1.0,10/29,19.46%,UBB;IKBKB;UBC;RPS27A;BIRC3;CHUK;UBA52;CASP8;UBE2D1;CD40
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.49016726171171776,-1.2106775489651296,0.21485943775100402,0.6082144878781375,1.0,5/13,6.05%,NFKBIA;PKD1;FLNA;YWHAB;GOPC
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.3334644221093589,-1.2106273941364916,0.16795865633074936,0.6073869789761264,1.0,17/67,15.61%,B2M;IKBKB;CALR;VAMP8;PSMD13;PSMF1;PSMB10;CHUK;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;PSME1;PSMB3;CYBB
prerank,negative regulation of cell junction assembly (GO:1901889),0.43661854249828264,1.2103309055868527,0.2277992277992278,0.742812489509088,1.0,5/25,7.47%,ROCK2;ARHGAP6;ACE;PHLDB2;PTEN
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",-0.37156694682215885,-1.2100968807515236,0.17551963048498845,0.6079246511258932,1.0,20/39,33.35%,UBB;UBC;RPS27A;RBX1;DDB1;OGG1;RPA1;UBA52;POLK;POLD3;POLD1;NTHL1;GTF2H2;ERCC5;XPA;RFC5;ERCC3;GTF2H5;RPA3;RPA2
prerank,microvillus assembly (GO:0030033),-0.4872587066576636,-1.2100372297078597,0.2484472049689441,0.6071598791798541,1.0,3/14,3.98%,RAP1A;FXYD5;MINK1
prerank,negative regulation of transposition (GO:0010529),0.5083451245410072,1.209840871804218,0.2543689320388349,0.7428101103807021,1.0,7/16,22.04%,MYBL1;UBR2;MOV10;TUT4;DDX4;TUT7;PIWIL4
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.518726780961468,-1.209727534076345,0.24344569288389514,0.6070459868880435,1.0,3/11,7.55%,PTPRC;CEACAM1;AHR
prerank,meiosis I (GO:0007127),0.4623615081876019,1.209443386711372,0.2413793103448276,0.7425895175295992,1.0,3/23,6.49%,MYBL1;SLC25A31;HSF2BP
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.3056565481305449,-1.2094393005265072,0.11614730878186968,0.6059544170912147,1.0,31/104,23.64%,KRAS;RPS6KA5;PLCG2;FYN;NRAS;IKBKB;PAK1;PSMD13;PSMF1;PAK2;PSMB10;CHUK;PSMB6;PSME3;PSMB5;PSMC3;ICAM2;TAB3;PSMD12;PSMB8;PSME1;CUL1;PSMB3;RAF1;TYROBP;PSMD5;PRKCD;SKP1;PSMD9;PSMB4;RELA
prerank,cellular response to lectin (GO:1990858),-0.3056565481305449,-1.2094393005265072,0.11614730878186968,0.6059544170912147,1.0,31/104,23.64%,KRAS;RPS6KA5;PLCG2;FYN;NRAS;IKBKB;PAK1;PSMD13;PSMF1;PAK2;PSMB10;CHUK;PSMB6;PSME3;PSMB5;PSMC3;ICAM2;TAB3;PSMD12;PSMB8;PSME1;CUL1;PSMB3;RAF1;TYROBP;PSMD5;PRKCD;SKP1;PSMD9;PSMB4;RELA
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.35671725322178804,1.2091056633586186,0.17445482866043613,0.7422641216667293,1.0,14/87,10.36%,FGFR2;FGFR4;FGFBP1;POLR2D;FLRT2;KL;NDNF;HNRNPH1;FRS2;FGF1;POLR2A;GTF2F1;FGF9;FGF20
prerank,regulation of protein phosphorylation (GO:0001932),-0.27107850460103755,-1.2090635339203897,0.019157088122605363,0.6060295947943267,1.0,82/256,19.75%,TEK;NTRK3;FN1;LIMCH1;SLIT2;PECAM1;EFNA5;OCLN;FNIP2;PRR5L;BMPER;TFRC;KDR;KRAS;NIBAN1;RAC1;GAS6;HSP90AA1;PPP2R5C;TARDBP;PTK2;ENG;PDE8A;FYN;DAB2IP;PPIA;SEMA4D;RACK1;TBX1;HSPB1;LIMK2;CORO1C;WARS1;PDCL3;TGFB1;CAMKK2;CCDC88A;SOD1;ARRB1;CHP1;CARD14;FLT4;APP;VEGFA;SLCO3A1;PAK1;SESN2;WWTR1;FGF7;RALB;BMP2;MEN1;ATF4;GPER1;XDH;CD74;SPTBN4;CCN1;CADM4;IBTK;MT3;CSF1R;FAS;TERF2IP;CCDC88C;AKAP8;DNAJC10;ANKRD54;DVL2;PIK3R3;PPP2R5A;ZC3H12A;KNDC1;SH3GL2;PINK1;BMP4;PLAUR;NPTN;NOP53;CD40;ATF3;INSR
prerank,calcium ion import into cytosol (GO:1902656),0.5069527226027591,1.2089519498949213,0.24180327868852458,0.7413634110222642,1.0,3/15,7.01%,SLC8A3;SLC8A1;CACNA2D1
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.41829343696789956,1.2087183737676368,0.21178637200736647,0.7407586463496609,1.0,6/38,9.62%,LEPROT;PRKN;LRRK2;UBE2L3;NPEPPS;HSPA1L
prerank,sensory organ development (GO:0007423),0.3824960434941931,1.2086526943010663,0.2030716723549488,0.7396440443955914,1.0,9/51,8.79%,RBP4;MEIS1;SLC39A5;ASCL2;SHROOM2;SMOC1;SH3PXD2B;PBX4;CHRDL1
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.37382599741129613,-1.2081054495356411,0.19106699751861042,0.6077278350977207,1.0,10/39,11.70%,TEK;KDR;THBS1;GAS6;RAMP2;GATA2;ITGA4;PDCD4;SCG2;GPER1
prerank,negative regulation of cell communication (GO:0010648),-0.42288792516966733,-1.2080221701654617,0.2063157894736842,0.6070226763075631,1.0,5/21,11.22%,HHIP;UBASH3B;SOCS5;KIF26A;PTPN1
prerank,histone exchange (GO:0043486),0.4022190676764372,1.2079936006529781,0.1821561338289963,0.7402830624990784,1.0,12/37,15.54%,ITGB3BP;RBBP4;CENPI;NASP;RBBP7;MIS18BP1;RSF1;CENPQ;SMARCA5;SRCAP;CENPX;ACTR6
prerank,potassium ion transport (GO:0006813),0.3384092579543112,1.2079590798838296,0.14501510574018128,0.7390343775667801,1.0,8/120,2.41%,ATP1A2;SLC24A3;KCNK2;KCNQ4;NALCN;KCNA5;SLC1A3;ATP1B3
prerank,regulation of secretion (GO:0051046),-0.49216832749424894,-1.2078637400054317,0.21621621621621623,0.6065211212267534,1.0,5/13,17.17%,KCNQ1;OAS2;POFUT2;SGK1;ACSL3
prerank,regulation of cellular component organization (GO:0051128),-0.2941987934386164,-1.2069064306085708,0.09904153354632587,0.6082453733549674,1.0,32/135,14.78%,HIP1;LTBP4;RAP1A;HSPA8;TFRC;HSP90AA1;STON2;DAB2IP;SEMA4D;NET1;PACSIN2;CDK11B;STK38L;SOCS2;BCAR1;FAM107A;HJURP;TJP1;GFAP;CEACAM1;HNRNPU;HIP1R;MTOR;LAMTOR1;PTPN1;ERMN;CDH13;EGLN2;SPOCK1;NRG3;IRAK3;LAMTOR2
prerank,ERBB2 signaling pathway (GO:0038128),-0.39933032738551505,-1.2061701374588438,0.1978021978021978,0.6092736381804386,1.0,6/31,8.86%,GAB1;HSP90AA1;PTPN12;CDC37;MYOC;CPNE3
prerank,regulation of gastrulation (GO:0010470),0.49965191897767863,1.2060601823336325,0.24758220502901354,0.743312070929084,1.0,3/14,6.03%,OSR1;SCX;PHLDB2
prerank,regulation of smooth muscle contraction (GO:0006940),-0.44645624805249384,-1.2059680263519335,0.23260437375745527,0.6088780826573718,1.0,5/20,12.61%,CAV1;KCNB2;CHRM3;ADRB2;ATP2B1
prerank,cartilage development (GO:0051216),0.39461506923349415,1.2056843576365461,0.2062043795620438,0.7430448830610524,1.0,6/49,4.65%,SOX5;OSR1;SCX;SOX6;SULF1;NFIB
prerank,regulation of phosphatase activity (GO:0010921),-0.40975053026658986,-1.205292730672622,0.2063157894736842,0.6098038377901646,1.0,8/24,13.61%,TIPRL;HSP90B1;PPP1R2;CHP1;BMP2;PPP6R1;ZCCHC9;MTMR9
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.45403697942670374,-1.2051832429704155,0.22933884297520662,0.6091967615955626,1.0,6/18,18.81%,ESR1;TGFB1;DDX5;ZC3H12A;MAP2K2;BMP4
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.4434872931036695,1.2051264109350925,0.23946360153256704,0.7434113073367087,1.0,5/29,4.01%,PPARA;LPGAT1;SORBS1;ZBTB20;SLC45A3
prerank,regulation of gene expression (GO:0010468),0.27989559786478757,1.2045735380078535,0.032474804031354984,0.7437715409254937,1.0,120/903,10.88%,IGF1;RORA;PRDM6;ROBO1;BMP6;SLC24A3;ROCK2;OSR1;EFEMP1;SLC22A2;WNT4;AFF2;RBPJ;ARNT2;DENND4A;ZNF462;FGFR4;AFDN;PID1;WNT6;NOTCH2;BMP7;ANGPT1;ATXN1;IGF2BP1;PRKN;TULP3;NOVA1;ESRRG;RBMS3;MYBL1;PRDM5;DKK1;SCX;NR1I2;LTF;SOX6;NOS1AP;SLC8A1;PPARGC1B;ZC3H7B;NFYB;TRIM5;CTSH;CCN4;DTNBP1;SSBP2;IGF2;PTBP2;NCOA2;SRPK2;ITGAX;ANK2;MBIP;FOXD1;MAPK9;TNRC6B;SOX1;CACTIN;GJA1;PERM1;TNRC6A;PRKAA2;HNRNPH1;EPHX2;SON;FGF1;SUFU;METTL4;SLC2A10;ZUP1;ZFP37;TCF7L1;WWC1;THAP1;UBE2L3;IL6;GPBP1;SMAD3;WWC2;ABCC2;GPBP1L1;PRKAA1;ATG14;MTF2;ZKSCAN5;RBL2;CSF1;TLE1;POLR2A;MITF;WWP2;FUBP1;NFIA;ATRAID;YTHDF2;MUSK;SIRPA;ZNF628;KAT6B;KDM6B;BRCA2;PICALM;APLN;FGF9;NSD1;MED1;NUP107;PARP10;NFYC;HDAC1;ABL1;AGO2;FGF20;FLCN;ASCC2;ZBTB11;PARP9;ATOH8;ZBTB38
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.3921118882120731,1.2035537752929317,0.22203098106712565,0.7456991161302797,1.0,10/47,12.11%,ROCK2;WNT4;C1QTNF3;SIK1;ACADL;SIRPA;APOC1;SLC27A1;SNAI1;CRY1
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.5486104801834194,1.2033473240719441,0.27049180327868855,0.7450478116916499,1.0,5/10,11.59%,GRB10;PRKCB;VTN;ARNT;PRKD2
prerank,metanephros development (GO:0001656),0.45156701582226555,1.2033450851661105,0.23853211009174313,0.7437142152445695,1.0,4/26,4.38%,OSR1;BMP7;CTSH;FOXD1
prerank,"phototransduction, visible light (GO:0007603)",0.5033718224037068,1.2031988968809868,0.2540322580645161,0.7428173516133242,1.0,3/14,6.41%,ABCA4;PDE6G;GNAQ
prerank,polyol metabolic process (GO:0019751),-0.34947884664600776,-1.203127700448236,0.1662870159453303,0.6139313584036783,1.0,11/46,14.87%,CALM1;PLCG2;PLCB4;INPP5D;SYNJ1;INPP4A;NUDT3;PLCB3;NUDT4;INPPL1;ITPKB
prerank,myofibril assembly (GO:0030239),0.4064523040481583,1.2030831707916647,0.20282186948853614,0.7418673789276802,1.0,6/42,3.77%,TPM1;CSRP3;TNNT2;PDGFRB;OBSL1;PDGFRA
prerank,regulation of interleukin-10 production (GO:0032653),-0.36215398339314864,-1.2025508585396791,0.19294117647058823,0.6145479306573827,1.0,15/44,23.77%,CD34;PLCG2;TRIB2;TNFRSF21;ISG15;STAT3;HSPD1;CD47;CD274;JAK3;TYROBP;DLL1;VSIR;AGER;FCGR2B
prerank,positive regulation of vacuole organization (GO:0044090),-0.5171073801910757,-1.20226917809695,0.25,0.614421722496205,1.0,3/10,10.33%,SH3GLB1;GRN;RALB
prerank,amyloid fibril formation (GO:1990000),-0.3497903396863107,-1.202153919553593,0.16941176470588235,0.6138061560089837,1.0,12/51,9.96%,B2M;ADAM10;CST3;GSN;ITM2B;UBB;TGFBI;UBC;RPS27A;APP;H3-3A;FURIN
prerank,signal transduction by p53 class mediator (GO:0072331),-0.39438253115802446,-1.2021525501714978,0.2021505376344086,0.6128676144860342,1.0,8/30,12.07%,ACER2;PPP1R13B;DDX5;SESN2;BCL3;HINT1;MYBBP1A;PDK2
prerank,axon guidance (GO:0007411),-0.27853275276642314,-1.2020446445866795,0.06201550387596899,0.6122306927854098,1.0,50/201,12.24%,SPTBN1;GAB1;SLIT2;BSG;SHANK3;EFNA5;KLF7;PTPRM;SEMA6A;SEMA7A;NRP2;SH3KBP1;SEMA6D;RPS6KA5;RAC1;SEMA3C;PLXND1;UNC5C;PTK2;TNR;UNC5D;LAMA1;FYN;NOTCH3;CHN1;NOTCH1;SEMA4D;PLXNA4;SEMA3E;LAMA5;TUBB3;ROBO4;DCC;LAMA3;PDLIM7;TMEFF1;VEGFA;NRXN1;SEMA4B;SEMA5B;GFRA2;SEMA6C;PIK3CD;RELN;LYPLA2;EPHB1;SEMA3G;EFNB3;GPC1;NTN4
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.4455380963614722,-1.2017969681843266,0.22137404580152673,0.6119621940919218,1.0,3/17,6.67%,TEK;NTRK3;BAIAP2L1
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.3777440879592653,-1.2017447432172659,0.21518987341772153,0.61117371019266,1.0,13/33,25.08%,HIP1;BCAR3;CBL;CCDC88A;HIP1R;SHKBP1;GPER1;PDE6H;PLAUR;AKT1;AFAP1L2;ARAP1;HAP1
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.3275074784267305,-1.201744226441721,0.1524547803617571,0.6102482735319343,1.0,29/72,26.82%,LIFR;GAS6;HSP90AB1;CBFB;RUNX1;RACK1;IKBKB;PTPRC;CDC37;BIRC3;CHUK;PTPN1;CD74;IRAK3;TRAF1;MADD;IFNGR1;CASP8;SIGIRR;IRAK1;SHARPIN;RBCK1;OTULIN;SOCS1;JAK1;TRIM44;TNFAIP3;RNF31;STAT1
prerank,histone H2A ubiquitination (GO:0033522),0.49087126668144687,1.20113281438917,0.2380038387715931,0.7462962433225716,1.0,9/17,17.41%,RNF2;DDB2;KDM2B;BCOR;UBR2;CUL4B;PCGF1;UBE2A;DTX3L
prerank,mitochondrial fusion (GO:0008053),-0.43831392326063867,-1.2010249083361995,0.22113502935420742,0.6114008365524307,1.0,8/18,27.94%,CHCHD3;MIEF1;STOML2;MIEF2;MFN2;BAX;SPG7;FIS1
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.505611698620381,-1.2009785767942236,0.248046875,0.6106032333493759,1.0,5/12,17.53%,ESR1;TGFB1;STAT3;LIN28B;ZC3H12A
prerank,carbohydrate derivative transport (GO:1901264),-0.4376521626964026,-1.2007331383148965,0.23140495867768596,0.6103121610604602,1.0,5/18,7.94%,PLTP;SCARB1;LBP;SLC10A7;MFSD2A
prerank,cell-cell junction organization (GO:0045216),-0.3231572036215695,-1.2006676529931093,0.1756440281030445,0.60960813512165,1.0,17/79,6.92%,CLDN5;CADM1;OCLN;TJP2;LIMS2;PKP4;TGFB2;CDH1;CTNND2;CDH11;CDH2;GJC1;CXADR;LIMS1;TGFB1;TJP1;CSK
prerank,protein phosphorylation (GO:0006468),0.2926304348561062,1.1999597516510427,0.08482676224611709,0.7483959397649463,1.0,94/478,14.50%,PRKAG2;TGFBR3;ROCK2;OXSR1;EFEMP1;EPHA3;FGFR2;NRK;FGFR4;WNK4;KIT;CDK8;DAPK1;PRKAG3;PDPK1;PDK1;CAMK1D;BMP2K;PDGFRB;RNASEL;MAP4K5;DMPK;CDK7;FER;EPHA8;FAM20A;PDGFRA;SRPK2;EPHA4;ABI2;MAP2K6;MAPK9;BAZ1B;DDR1;RICTOR;SIK1;LRRK2;PRKAA2;PRKCZ;IGF1R;PRKCB;MAML1;STK17B;TTK;PRKCA;DDR2;NEK4;GRK3;PRKAA1;NRBP1;RYK;CCNT1;BIRC5;BIRC6;CAMK2D;GRK5;PIK3R4;MUSK;PKN2;CDK1;GRK4;CLSPN;NEK10;VRK2;FRK;ABL1;JAK2;LATS1;PRKDC;RPS6KB1;COQ8B;IKBKE;PRKD2;ERBB2;BMPR1A;MAPKAPK2;HIPK3;CRY1;PRKAG1;STK24;CCNE1;DCLK1;TBK1;MAPK1;MORC3;ROS1;PRKACB;MAP3K7;TEC;NLK;PRKCI;STK26;CDKL5;CDK15
prerank,protein homotetramerization (GO:0051289),0.38570894019873864,1.1987462180960136,0.205685618729097,0.7507090248566588,1.0,10/49,14.45%,ALDH1A2;APPL2;UPB1;CBY1;HSD17B10;SSBP1;GOLGA2;PKD2;SHMT1;CRYZ
prerank,cellular response to mechanical stimulus (GO:0071260),-0.3609301019985355,-1.198659362086436,0.1770573566084788,0.6141362762569005,1.0,16/46,24.37%,PIEZO2;F11R;PDE2A;PIEZO1;MAPK8;MAP3K1;CASP8AP2;FAS;CASP8;TNFRSF10B;CD40;MYD88;MAPK3;GADD45A;CASP1;CHEK1
prerank,bicellular tight junction assembly (GO:0070830),-0.3523648416963736,-1.19806131534416,0.18052256532066507,0.6148078295219783,1.0,10/46,9.51%,PECAM1;CLDN5;ESAM;OCLN;CLDN11;RAMP2;F11R;MPP7;PAK2;APC
prerank,negative regulation of cell population proliferation (GO:0008285),-0.261683256323788,-1.197773330670394,0.04433497536945813,0.6147223721318308,1.0,70/351,12.25%,ZBTB7C;PTPRJ;FTH1;APOD;B2M;NOS3;IGFBP6;CD200;PLPP1;BMP5;ACVRL1;TGFB2;PTPN14;CBFA2T3;TES;KLF4;FAP;PPP2R5C;ETS1;ADARB1;WNT9A;PTK2B;DAB2IP;NGF;NOTCH1;SH3BP4;P3H2;HES1;BMPR2;ROR2;SFRP4;CCN3;RERG;GATA2;WARS1;SOX4;PINX1;TGFB1;CTNNB1;IGFBP5;TOB1;ST18;ATP8A2;TBX3;DDAH1;ADRA1A;APP;AQP11;PTHLH;PAK1;PODN;MAGED1;ING4;APC;SOX7;CTNNBIP1;BTG3;CDKN1B;CDK6;BMP2;MEN1;NCK2;IFI35;HGS;NDRG4;CDH13;GPER1;PBRM1;LMNA;REST
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.47059533809312704,1.1976717009776743,0.25296442687747034,0.7525921655433035,1.0,3/19,3.58%,ROBO1;SMOC2;CCBE1
prerank,negative regulation of leukocyte migration (GO:0002686),-0.5205667705485431,-1.1975489262584154,0.2528301886792453,0.6143853259385944,1.0,3/10,1.96%,SLIT2;CD200;BMP5
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.303852003654629,-1.1972088170572035,0.12215909090909091,0.6143761985869101,1.0,31/105,23.64%,KRAS;RPS6KA5;PLCG2;FYN;NRAS;IKBKB;PAK1;PSMD13;PSMF1;PAK2;PSMB10;CHUK;PSMB6;PSME3;PSMB5;PSMC3;ICAM2;TAB3;PSMD12;PSMB8;PSME1;CUL1;PSMB3;RAF1;TYROBP;PSMD5;PRKCD;SKP1;PSMD9;PSMB4;RELA
prerank,positive regulation of cell population proliferation (GO:0008284),0.29341999124653895,1.1966684632102724,0.09457755359394704,0.7543267137219501,1.0,48/423,8.60%,IL31RA;IGF1;TGFBR3;BMP6;TCF7L2;OSR1;IL34;RBPJ;FGFR2;FGFR4;PID1;EFNB2;IL18;MEIS1;BCL2;SCX;LTF;PDGFRB;MEGF10;CTSH;CCN4;FER;IGF2;PDGFRA;SRPK2;ITGAX;IL13RA1;ASH2L;SPHK1;GJA1;UFL1;PTN;PDGFD;FGF1;IGF1R;TET1;TTK;CDC123;ADRA1D;IL6;DDR2;FOLR2;PTEN;CSF1;BIRC5;RPRD1B;GRK5;COX17
prerank,regulation of cellular response to heat (GO:1900034),-0.32211776416291693,-1.1960935679071023,0.14835164835164835,0.616519788863242,1.0,22/77,21.05%,HSPA8;CD34;HSP90AA1;HSP90AB1;GSK3B;CHORDC1;CRYAB;BAG1;MTOR;RPA1;HSPB8;NUP37;DNAJC7;CAMK2B;DNAJB1;NUP54;NUP85;NUP133;FKBP4;ATR;POM121;MAPK3
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.43205764530552543,1.1958167884749433,0.23217550274223034,0.7555887170189123,1.0,11/29,13.47%,TCF7L2;PYGO1;ASH2L;TLE3;TCF7L1;TLE1;AXIN2;HDAC1;BCL9;CDC73;CREBBP
prerank,pharyngeal system development (GO:0060037),-0.45763248706862986,-1.1956929317821696,0.23668639053254437,0.6166846709672266,1.0,6/15,7.73%,BMP5;TGFB2;TBX1;HES1;BMPR2;PTCH1
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.4003462605874658,-1.195604257355252,0.21145374449339208,0.616017925853951,1.0,16/27,32.36%,UBB;UBC;RPS27A;MAP3K1;HSPD1;TAB3;IRAK3;UBA52;IRAK1;MYD88;TIRAP;TLR4;TLR6;CD36;TLR1;TAB2
prerank,long-term synaptic potentiation (GO:0060291),0.4529761319127765,1.1949512080962859,0.2529182879377432,0.7568367344747485,1.0,4/21,7.02%,SLC8A3;TSHZ3;PRKCZ;ARC
prerank,skeletal muscle tissue development (GO:0007519),-0.3829818357914266,-1.1949239324147163,0.21238938053097345,0.6169629670617061,1.0,6/32,8.04%,MEF2C;CAV1;MYL6;CAV2;SIX1;LEMD2
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.504327190950346,1.1946593733338606,0.2755102040816326,0.7564496848639825,1.0,7/14,16.81%,FTSJ3;DDX18;NOL9;NIFK;ZNHIT3;BOP1;ZNHIT6
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.3909352239275293,-1.194214759320515,0.19911504424778761,0.6180832413726842,1.0,10/30,19.46%,UBB;IKBKB;UBC;RPS27A;BIRC3;CHUK;UBA52;CASP8;UBE2D1;CD40
prerank,organonitrogen compound biosynthetic process (GO:1901566),-0.2877519536451939,-1.1941726360791522,0.11074918566775244,0.6172844697624217,1.0,33/151,15.57%,ST3GAL4;CERT1;ELOVL7;SGMS1;SGMS2;ACER3;ELOVL5;ACER2;SPTLC2;PLPP1;CEPT1;DEGS2;GCH1;B4GALT5;KDSR;PRKD3;PPM1L;GPHN;SPNS2;MFSD2A;SGPL1;ELOVL6;FURIN;LPCAT3;GPAT4;ELOVL1;CERS4;CSNK2B;LPCAT1;TYW1;LPIN3;PRKD1;PLA2G4A
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.49122905848250376,1.19388979764199,0.28205128205128205,0.7574241961228743,1.0,2/16,2.87%,NPR3;NOS1AP
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.3151169792191952,1.1938251868152334,0.1506849315068493,0.7562676771297823,1.0,30/190,9.65%,RORA;NPRL3;ITPR1;C1QTNF3;CGNL1;PPARA;BMP7;GPD1L;BCL2;FNIP1;DEPTOR;MGRN1;VGLL4;ARHGAP12;NPRL2;UACA;CACTIN;PRKAA2;WWC1;PDCD6;WWC2;UBR2;MMP9;NLRC3;PTEN;PRKAA1;TLE1;BCL2L2;MDM2;EPM2A
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.34796994107355245,1.1935970462717052,0.20545746388443017,0.7555806963732993,1.0,10/86,6.47%,BMP6;RBPJ;BMP7;ZEB2;DAB2;RBPMS;FOXD1;SULF1;SLC2A10;TTK
prerank,protein deacylation (GO:0035601),-0.41079370603551507,-1.1930146947406741,0.23296703296703297,0.6196286332420774,1.0,11/23,29.75%,HDAC5;ABHD17B;ABHD17A;LYPLA2;HDAC7;SIRT7;HDAC6;LYPLA1;SIRT6;SIN3A;HDAC3
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.4736205647979611,-1.1930078332942897,0.2429718875502008,0.6187355136458131,1.0,5/13,12.71%,CD9;ITGB1;SREBF2;CDH13;CD81
prerank,autophagosome maturation (GO:0097352),-0.3862175823512928,-1.192775522668104,0.1829787234042553,0.6184603737864326,1.0,11/32,23.07%,CALM1;VAMP8;VTI1B;VMP1;MAP1LC3B;ATP2A2;SNX14;GABARAPL1;VCP;LIX1;CHMP3
prerank,cortical actin cytoskeleton organization (GO:0030866),0.4683176435751414,1.1921746239998088,0.2406311637080868,0.7584811925537256,1.0,5/20,6.45%,ROCK2;FHOD1;RAB13;LLGL2;DLG1
prerank,response to lipopolysaccharide (GO:0032496),-0.2896516673858389,-1.1919436814768445,0.11904761904761904,0.619907107093138,1.0,46/138,27.05%,MEF2C;FOXP1;NOS3;SCARB1;DAB2IP;VIM;LBP;CHMP5;GCH1;TNFRSF11A;SBNO2;DEFA6;TNFRSF1B;PDCD4;MAPK8;RHOA;XBP1;NOS1;CD180;GIT1;ERBIN;IRAK3;HNRNPA0;CX3CR1;CARD16;CD274;ZC3H12A;IRAK1;ADAM9;MYD88;TIRAP;LIAS;SLC11A1;GGT1;NR1H3;PLAA;PELI1;IFNAR1;RELA;CD80;CASP1;CD68;TNFAIP3;CXCL10;SELP;CCL2
prerank,sodium ion homeostasis (GO:0055078),0.45792516086412915,1.1916990080711374,0.2627450980392157,0.7586308441981889,1.0,3/21,3.10%,ATP1A2;ATP1B3;SLC8A1
prerank,glutamate receptor signaling pathway (GO:0007215),-0.3678154812941846,-1.1915369147973878,0.195852534562212,0.6201637596482865,1.0,13/37,19.44%,GRM3;GRM7;PTK2B;KCNB1;HOMER1;GRIK4;GRIN3A;APP;GRIN1;GRM8;GRIA2;GRIK2;GRID2
prerank,regulation of neuron projection development (GO:0010975),-0.2825580555687319,-1.191530434347885,0.11146496815286625,0.6192734665001243,1.0,64/163,23.15%,NTRK3;SHANK3;RAP1A;SIPA1L1;ITGA6;FBXO7;CDH2;PRAG1;PTK2B;DAB2IP;CHN1;MBOAT1;SERPINI1;ROR2;SCARF1;KANK1;RTN4RL1;ZDHHC15;ROR1;DCC;CCDC88A;PPFIA2;EFHC2;GSK3B;STMN2;RTN4IP1;MFSD2A;ABI3;SRCIN1;PAK1;MARK1;PAK2;KIF1A;RELN;NDRG4;MARK2;RET;SPOCK1;MT3;TENM3;CAMK2B;PRKD1;DISC1;TOX;NTNG1;ITM2C;KNDC1;SCN1B;RIT2;NPTN;CDK5;FKBP4;PLXNB3;CFL1;PSEN1;CRMP1;AKT1;FUT9;RTN4R;KIDINS220;DBN1;CSMD3;SEMA3A;BRSK2
prerank,positive regulation of interleukin-8 production (GO:0032757),-0.34433850986127873,-1.1913792981317022,0.1832579185520362,0.618828136140677,1.0,25/49,36.40%,F3;LBP;NOD1;STAT3;RAB1A;CD74;MYD88;TIRAP;AFAP1L2;HYAL2;HSPA1B;RELA;TLR4;TLR7;FADD;MAVS;NOD2;TLR1;NOS2;HSPA1A;SYK;F2R;PARK7;TLR8;RIPK1
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.4767246831731564,1.1913676766633328,0.2585858585858586,0.7583153502108974,1.0,5/20,10.75%,SLC8A3;MAIP1;MCU;YME1L1;MICU1
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.37643978751155294,1.191303674845303,0.21428571428571427,0.7572018108938638,1.0,7/61,7.28%,PRKAG2;FGFR4;PPARA;OAZ3;PSME4;PSMA2;PSMA3
prerank,potassium ion export across plasma membrane (GO:0097623),0.5177224989232659,1.191259314727806,0.27882599580712786,0.7560107982767535,1.0,3/13,4.29%,KCNA5;KCNT2;KCND3
prerank,apical junction assembly (GO:0043297),-0.34569601959035634,-1.1912386747919534,0.17444717444717445,0.6182888783584677,1.0,12/53,9.72%,PECAM1;CLDN5;ESAM;OCLN;CLDN11;RAMP2;F11R;WDR1;MPP7;PAK2;APC;RHOA
prerank,regulation of mononuclear cell migration (GO:0071675),-0.41021783479826773,-1.1909606911248134,0.2219873150105708,0.6181233866898298,1.0,5/23,2.67%,SLIT2;MSN;THBS1;BMP5;PTK2
prerank,cellular response to alkaloid (GO:0071312),0.47199030884236565,1.1907940214711399,0.25812619502868067,0.7560731260440875,1.0,4/17,7.32%,GSTM2;SLC8A1;CRHBP;BLM
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.40516576189160736,1.190610942539859,0.24319419237749546,0.7553371256166943,1.0,3/41,5.85%,PRKAG2;LACC1;NDC1
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.4864625178662677,-1.190597283929508,0.25865580448065173,0.6182268770900367,1.0,4/12,16.16%,STX3;STX1A;SNAP25;STX2
prerank,negative regulation of protein phosphorylation (GO:0001933),0.32511458018993605,1.1903726625270021,0.15201192250372578,0.7547328255712975,1.0,22/150,7.75%,PRKAG2;ERRFI1;PTPN13;PID1;PRKN;DMD;PLPP3;PDPK1;GPD1L;SMAD6;DEPTOR;PARD3;DKK1;DTNBP1;PPM1E;LRRK2;CACTIN;FBLN1;PRKCZ;GNAQ;PTEN;ATG14
prerank,positive regulation of biosynthetic process (GO:0009891),0.4086769825843868,1.189976088314352,0.2247191011235955,0.7545904270593992,1.0,5/40,2.75%,WNT4;PPARA;SORBS1;ZBTB20;SCX
prerank,tyrosine metabolic process (GO:0006570),0.5341625918856973,1.189900827464709,0.2824742268041237,0.7535258138068552,1.0,3/11,15.78%,FAH;DCT;GSTZ1
prerank,epiboly involved in wound healing (GO:0090505),-0.44593587082353403,-1.189716283436503,0.2624254473161034,0.6197327113921232,1.0,7/16,13.00%,TMEFF2;FLNA;CD44;CEACAM1;PDCD10;RHOA;CCN1
prerank,heme biosynthetic process (GO:0006783),-0.41643626414213875,-1.1896536771812587,0.23014256619144602,0.6189944968633659,1.0,12/22,31.87%,ABCG2;ABCB10;ATP5IF1;UROD;UROS;FECH;FLVCR1;COX15;HMBS;TSPO;ABCB6;ALAS2
prerank,cellular response to purine-containing compound (GO:0071415),0.5387431292364055,1.1892028982016705,0.28781512605042014,0.7542420778600022,1.0,2/10,3.10%,GSTM2;SLC8A1
prerank,monocarboxylic acid transport (GO:0015718),-0.3447686694849373,-1.189085610428227,0.16628175519630484,0.6196129811806275,1.0,13/51,9.48%,ABCC4;ABCG2;ATP8B1;SLCO1C1;SLC16A9;SLCO2A1;SLCO2B1;SLC16A1;SLC5A6;CEACAM1;SLCO3A1;SLC6A8;SLC16A4
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.44208296935940783,1.189047367413958,0.24829931972789115,0.753367167664393,1.0,3/26,5.19%,LGR4;APPL2;CACTIN
prerank,positive regulation of neuron death (GO:1901216),0.38444546364586224,1.1890360204254566,0.20107719928186715,0.7521064685591357,1.0,10/46,11.80%,EPHA7;EFNB2;DKK1;PCSK9;SRPK2;NUPR1;PICALM;TFAP2A;TFAP2B;EIF2S1
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.526906438641783,1.1888285045077809,0.2687224669603524,0.7514322604173812,1.0,4/11,12.97%,LEPROT;SNX33;PICALM;ACTN2
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.3448281826607586,1.1881762998457814,0.19614147909967847,0.7520303554200175,1.0,29/95,16.64%,TGFBR3;PPARA;ZEB2;DAB2;SNX6;DKK3;PDPK1;SMAD6;ITGA3;SLC2A10;SMAD3;FOLR1;NREP;SMURF2;LEMD3;LATS1;BCL9;FLCN;HTRA4;LDLRAD4;ADAMTSL2;VEPH1;CREBBP;CDKN1C;CDKN2B;SMAD4;PMEPA1;SKI;SDCBP
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),-0.4122588687983565,-1.188104963914661,0.2203742203742204,0.621437379282186,1.0,8/23,15.04%,MYO10;MAP6;CCDC88A;KIF1A;TUBA1B;TUBA1A;CCDC88C;HOOK1
prerank,leukotriene biosynthetic process (GO:0019370),-0.4663558040784702,-1.1876832773499144,0.24066390041493776,0.6217254586654798,1.0,8/14,36.66%,PLA2G4A;GGT1;LTA4H;GGTA1;MGST2;PLA2G5;ALOX5AP;GGT5
prerank,muscle contraction (GO:0006936),0.32473870387329584,1.187523353500278,0.1887905604719764,0.7526386919282085,1.0,13/126,4.73%,ROCK2;BDKRB2;TPM1;DMD;SNTA1;SORBS1;TNNC1;MYLK;TNNT2;SLC8A1;CALD1;TLN1;CHRNE
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.43524658852043446,-1.1866913791567386,0.21810699588477367,0.623609657728505,1.0,8/18,33.84%,HHEX;ENY2;NUP133;DDX25;THOC2;ZC3H11A;NUP93;IWS1
prerank,chromatin remodeling (GO:0006338),0.34260685193289864,1.1863498945433382,0.18856259659969088,0.7548155699385081,1.0,32/100,17.60%,SATB1;JARID2;RBBP4;BAZ1B;HNRNPC;ARID1B;CECR2;BAZ1A;CHD4;RSF1;KDM5B;KDM6B;HDAC1;TADA2A;SMARCA5;NPM2;SMARCE1;MYB;INO80;SMARCB1;EZH1;SRCAP;KDM5C;SMARCC1;SMARCA2;SMARCD3;INO80C;BAZ2B;KDM6A;MPND;KDM4D;SMARCA1
prerank,electron transport chain (GO:0022900),-0.4696402874297889,-1.1861012334405785,0.2596899224806202,0.6242324531259463,1.0,5/15,18.94%,PDIA5;PPARGC1A;NDUFA5;ENOX2;CYB561
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.4777824438712024,-1.1860316913617208,0.279383429672447,0.6235038459890041,1.0,6/13,23.49%,CBFB;RUNX1;TGFBR2;NCKAP1L;NKAP;SOCS1
prerank,positive regulation of phosphate metabolic process (GO:0045937),-0.4072776729123442,-1.1854409192314033,0.22857142857142856,0.6242364905012691,1.0,8/25,20.26%,ITGA6;THBS1;APP;KCTD20;MIF;ANG;PSEN1;NCKAP1L
prerank,response to retinoic acid (GO:0032526),0.36656225709944085,1.1853886013433323,0.21911037891268534,0.7563456409194544,1.0,5/59,3.29%,PTK7;EPHA3;WNT6;RBP4;CTSH
prerank,motor neuron axon guidance (GO:0008045),-0.46466257851750387,-1.1852083503832882,0.2575452716297787,0.6240069552862809,1.0,4/15,7.53%,SLIT2;RAC1;CHN1;TMEFF1
prerank,glycosaminoglycan metabolic process (GO:0030203),0.3717573050845946,1.1850113158733584,0.22445561139028475,0.756251789839479,1.0,13/54,12.47%,HS3ST3A1;PXYLP1;SDC2;HS3ST3B1;GPC6;GPC3;HAS1;XYLT2;NDST2;B3GALT6;UGDH;HS6ST1;GPC4
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.39553472093170505,1.1848650614035356,0.23089983022071306,0.7554188617799809,1.0,5/41,3.26%,AFDN;BMP7;PLPP3;MEGF10;CXCL13
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.5377554189536196,1.1843616352557749,0.302713987473904,0.7543114499717168,1.0,3/10,19.47%,TULP1;CACNA2D4;GNAT1
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.5377554189536196,1.1843616352557749,0.302713987473904,0.7543114499717168,1.0,3/10,19.47%,TULP1;CACNA2D4;GNAT1
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.4912075819070728,1.1837472638422306,0.268389662027833,0.7548192846126813,1.0,5/15,7.11%,FGFR4;PDPN;DDR1;IL6;DDR2
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.4821610372144952,-1.1836443251313118,0.26014760147601473,0.627379180920324,1.0,3/13,2.22%,CAV1;PDE4D;CALM1
prerank,regulation of cell-cell adhesion (GO:0022407),-0.35689901163930093,-1.1836039225516792,0.18944844124700239,0.6265971454496743,1.0,14/39,13.90%,PODXL;EFNA5;PTPRG;CDH1;JAG1;PTK2;MINK1;TGFB1;CEACAM1;ZDHHC2;DPP4;SPINT2;CD47;TENM3
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.4773143896166226,-1.1835989058623806,0.2623574144486692,0.6257097149960693,1.0,9/13,31.78%,TMEM30A;CD81;SEC16B;INSIG1;BRSK2;SORL1;SEC16A;TM9SF4;TMEM30B
prerank,inositol phosphate metabolic process (GO:0043647),-0.34524866857957764,-1.1833352401748274,0.18793503480278423,0.6255916840516635,1.0,11/46,14.87%,CALM1;PLCG2;PLCB4;INPP5D;SYNJ1;INPP4A;NUDT3;PLCB3;NUDT4;INPPL1;ITPKB
prerank,regulation of MAP kinase activity (GO:0043405),0.3507113732132119,1.183283057214567,0.19623233908948196,0.7548135869580304,1.0,9/92,5.81%,ROBO1;IL34;KSR1;KIT;BMP7;PDGFRB;LRRK2;PDGFD;FGF1
prerank,nitrogen compound transport (GO:0071705),0.3237115493883476,1.183072925405121,0.15835777126099707,0.7541775148155632,1.0,16/141,7.97%,SLC7A11;SLC22A4;SLC6A13;SLC22A2;SLC38A3;SLC6A12;SLC35F3;PDPN;TCN2;NDC1;LRP2;SLC43A1;ZG16;ABCC2;SLC1A5;MIA3
prerank,Ras protein signal transduction (GO:0007265),0.3254958097676301,1.1828422295800791,0.1816860465116279,0.7536295981418849,1.0,17/137,8.10%,IGF1;ROCK2;ARHGAP6;KSR1;ARHGAP29;RHOD;RRAS2;COL1A2;PDPN;PLD1;ABI2;WASF1;HACD3;ARHGEF11;EPS8L1;NTN1;MYO9B
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.4712790269863761,1.181880379035786,0.2559055118110236,0.7552260119284682,1.0,4/18,8.32%,ATP1A2;SLC43A1;MMP9;CAMK2D
prerank,epithelium development (GO:0060429),0.3374391758339129,1.181870177763084,0.19815668202764977,0.7540073171475871,1.0,10/107,7.16%,ALDH1A2;ERRFI1;OSR1;WNT4;FGFR2;LOXL3;TPP1;PTER;SALL1;KANK2
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),-0.35088188781675483,-1.1813331755095722,0.1938534278959811,0.6302671655211501,1.0,9/45,5.53%,GAB1;RPS6KA5;IQGAP1;CBL;PTK2;PTK2B;REPS2;BCAR1;TGFB1
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.5292252276255931,1.1812295796227372,0.3010989010989011,0.7546156963226015,1.0,2/11,1.79%,IGF2BP1;NOVA1
prerank,ceramide transport (GO:0035627),-0.4766707877194927,-1.180914732571764,0.2524271844660194,0.6305460779647195,1.0,4/12,10.76%,CERT1;PLTP;PSAP;GLTP
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.43499111449818306,1.1808447525414423,0.24060150375939848,0.7544185020189713,1.0,7/28,10.58%,APPL2;PID1;GRB10;PRKCZ;PRKCB;RPS6KB1;TNS2
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.481142458384227,-1.1806289877762173,0.2570281124497992,0.630479150882739,1.0,8/12,39.87%,HSPA5;SEC62;SEC61G;SEC63;SEC61B;SEC61A2;SGTB;SEC61A1
prerank,regulation of neuronal synaptic plasticity (GO:0048168),-0.39425783543989473,-1.1805559892797424,0.22489082969432314,0.6297919049676972,1.0,13/29,24.10%,SLC4A10;MCTP1;APP;ZDHHC2;CAMK2B;NCDN;GRIK2;SHISA6;PPFIA3;NSMF;DBN1;RAB3A;SYP
prerank,regulation of DNA biosynthetic process (GO:2000278),0.427176604869299,1.1805229233217607,0.2490974729241877,0.7540947460539533,1.0,5/27,6.39%,FGFR4;SMOC2;PDGFRB;PARP4;NIBAN2
prerank,regulation of TOR signaling (GO:0032006),0.36211007209781226,1.1805064240867256,0.23116438356164384,0.7528860115467007,1.0,25/67,20.75%,NPRL3;FNIP1;DEPTOR;ARAF;RICTOR;NPRL2;PRKAA2;SLC38A9;PDCD6;UBR2;PRKAA1;EPM2A;FLCN;MLST8;AKT1S1;ROS1;UBR1;TELO2;TSC1;TBC1D7;MIOS;LARS1;LAMTOR5;PIK3CA;TSC2
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.4860487646650381,1.1804862223928316,0.2700587084148728,0.7517006717313093,1.0,6/16,16.72%,PIGG;PIGV;PIGX;PIGC;PIGQ;PIGN
prerank,RNA metabolic process (GO:0016070),0.3261700838598521,1.1799453491793364,0.16920731707317074,0.7520770023862028,1.0,21/127,11.57%,CELF2;ATXN1;POLR2D;RBMS1;NOVA1;RNASEL;ADAD1;RBPMS;HNRNPC;HNRNPH1;RBMS2;RBM5;POLR2A;GTF2F1;SND1;NOL9;TENT2;AGO2;METTL14;RBM39;PCBP2
prerank,inositol lipid-mediated signaling (GO:0048017),0.3820061962557445,1.1798510525854506,0.2007168458781362,0.7510916789597682,1.0,12/50,13.84%,IGF1;ADAP2;PDGFRB;PLCB1;PDGFRA;IGF1R;GPR143;PIK3R1;RPS6KB1;PLCD1;GAB2;PLCL1
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.4841290458840986,-1.1794583505283815,0.24758220502901354,0.6319865233449916,1.0,7/13,36.12%,GLRX5;GLRX3;ISCA2;ISCA1;CIAO2B;BOLA2;YAE1
prerank,superoxide anion generation (GO:0042554),0.500209231316038,1.179359615121087,0.27044025157232704,0.7512540280062195,1.0,4/13,13.92%,DUOX2;TAFA4;NCF2;DUOX1
prerank,oligosaccharide metabolic process (GO:0009311),-0.3535038474096934,-1.179227824651648,0.1995249406175772,0.6316553834215665,1.0,9/46,9.64%,ST3GAL4;ST6GALNAC3;ST3GAL6;ST8SIA4;FUT8;ST6GALNAC5;ST8SIA1;ST8SIA6;MAN2B1
prerank,pancreas development (GO:0031016),0.5199257122653734,1.1790869047812125,0.2605042016806723,0.7507964094829975,1.0,1/12,0.48%,TCF7L2
prerank,protein kinase B signaling (GO:0043491),0.44502125233057177,1.1788215667335284,0.25903614457831325,0.7503343759518339,1.0,1/23,0.03%,IGF1
prerank,regulation of cell cycle (GO:0051726),-0.26391635508492595,-1.1784342540802943,0.0847457627118644,0.6329119392420506,1.0,87/271,25.07%,MECOM;APBB2;NEK7;THBS1;ADAM10;TGFB2;IQGAP1;HSP90AB1;RPL23;FAP;TARDBP;PPP1R13B;TTC28;ADARB1;DAB2IP;NOTCH1;RACK1;FBXL3;PKD1;CDK11B;RHOB;TGFB1;CALR;PTPRC;PLAGL1;TBX3;HNRNPU;APBB1;PDCD4;JUN;LIN54;NR4A1;BIRC3;ING4;APC;CDKN1B;CDK6;BMP2;MEN1;STAT3;GPER1;JUNB;MYBBP1A;BIN1;WHAMM;GADD45G;MASTL;TMEM8B;NLRP2B;MADD;DUSP1;MIF;GBF1;CTBP1;ZBTB17;ID2;SOX2;BMP4;GAS2L1;CAMK2N1;NOP53;CDK5;INHA;TFAP4;MYBL2;CHMP1A;METTL3;L3MBTL1;UHMK1;UHRF2;GADD45A;CDKN1A;GMNC;AFAP1L2;CDKN2D;MFN2;SIPA1;CCNB2;GADD45B;PPP1R15A;RGCC;CHEK1;DTL;ERN1;HRAS;NUPR2;CDKN3
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.4819337980672953,-1.1782114510364432,0.2528957528957529,0.632629594877767,1.0,7/12,30.94%,HNRNPU;LARP7;NELFCD;NELFE;RNF168;EAPP;RNF8
prerank,cellular response to cytokine stimulus (GO:0071345),0.2913566240648608,1.1778982228266606,0.11940298507462686,0.7517792385056113,1.0,36/416,5.52%,IL31RA;RORA;ADAMTS12;LEPR;OXSR1;PTPN13;IL34;PID1;IL18;KIT;DAPK1;BCL2;ZEB1;DPYSL3;DUOX2;PTPN4;MMP2;IL1RAPL1;FER;ANXA1;COL1A2;CNTFR;RIPOR2;STAT5B;IRAK2;GRB10;ITGAX;NFAT5;CRHBP;IL13RA1;ZFAND6;NPR2;CACTIN;ADAMTS7;PTPN9;IRF8
prerank,muscle cell differentiation (GO:0042692),0.4160134327283101,1.177417465704993,0.2641843971631206,0.7519615187428637,1.0,5/32,4.14%,RORA;DMD;SPEG;MEGF10;NEBL
prerank,substrate adhesion-dependent cell spreading (GO:0034446),-0.34590014538170155,-1.177390860272168,0.21311475409836064,0.6340617693394796,1.0,15/46,12.24%,TEK;FN1;TMEFF2;PARVB;RAC1;PXN;LAMA5;LAMB2;ITGA4;FERMT2;SRCIN1;RHOA;PEAK1;ITGA8;NTN4
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.4137674083558716,-1.1773743143918918,0.24793388429752067,0.633201312035611,1.0,12/20,37.86%,HSP90AB1;PKD1;CCNY;CCNYL1;AKT1;RGCC;PSMD10;PROX1;CCND1;PSRC1;ADAM17;CCND3
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),-0.31624978989309005,-1.1773664646311142,0.13559322033898305,0.6323322298144892,1.0,18/74,12.04%,LEF1;TIAM1;BMP5;TGFB2;PHLDB1;DAB2IP;IL17RD;TGFBR2;TGFB1;FERMT2;CTNNB1;SPRED2;MTOR;WWTR1;BMP2;MCRIP1;GCNT2;SDHAF2
prerank,ncRNA transcription (GO:0098781),-0.4915274523787073,-1.1772931851205044,0.2732793522267207,0.6316075419502428,1.0,7/13,25.17%,CAVIN1;BRF1;GTF3C1;SPIN1;ANG;SIRT7;SNAPC2
prerank,exit from mitosis (GO:0010458),-0.4952258085490032,-1.1769616183371991,0.2543352601156069,0.6316408574101771,1.0,8/12,41.25%,EPS8;PPP2R2D;SIRT7;CLASP2;CHMP7;CLASP1;UBE2C;UBE2S
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.32061103082774517,1.1768694649561142,0.1933139534883721,0.7523669796354715,1.0,21/140,11.24%,ADCY5;JPH1;BDKRB2;ACKR2;CCR9;LPAR1;CXCR5;SLC8A1;CXCL13;PDGFRA;CXCR6;LPAR2;ADRA1D;CACNA2D1;F2RL2;PTGIR;GLP1R;ABL1;PTGER1;DLG4;F2RL3
prerank,negative regulation of cell activation (GO:0050866),-0.4679617086551413,-1.1764810132253358,0.25,0.6320688282740401,1.0,4/14,12.20%,NOS3;CD200;GPER1;THBD
prerank,defense response to tumor cell (GO:0002357),0.548693043208007,1.1762525314514394,0.305327868852459,0.7529533742337666,1.0,3/10,4.77%,DAPK1;RBMS3;PLK5
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),-0.3000245690291307,-1.1761302479229574,0.15193370165745856,0.6321469466842079,1.0,20/100,8.44%,GAB1;TEK;NTRK3;FN1;PIP5K1B;KDR;TGFB2;CBL;PPP2R5C;PTK2;DAB2IP;SEMA4D;PIK3IP1;PPP1R16B;ROR2;ROR1;CEACAM1;PDGFC;MYOC;WNT16
prerank,RNA destabilization (GO:0050779),0.46638130989804233,1.176101813580986,0.2884990253411306,0.7521540842402825,1.0,3/18,10.76%,ROCK2;YTHDF2;METTL14
prerank,negative regulation of ATPase activity (GO:0032780),0.49620762958521747,1.176074156101631,0.2712871287128713,0.7510101811568347,1.0,4/16,11.58%,TNNT2;LTF;THADA;OXA1L
prerank,positive regulation of immune response (GO:0050778),-0.32253176980561254,-1.175681495749717,0.20246913580246914,0.6325228218538713,1.0,26/64,36.86%,TGFB2;PTPRC;GRN;XBP1;GBP5;IFI35;RSAD2;CD74;CD81;IL15;POLR3D;FCGR2B;POLR3F;SPHK2;SKAP1;ITGB2;SLC15A4;KARS1;FADD;DHX9;NOD2;NLRP3;TLR8;IL6ST;SASH3;CCL5
prerank,relaxation of muscle (GO:0090075),0.5086644981728693,1.1755831041125104,0.28857715430861725,0.7511995435812076,1.0,3/13,3.10%,ATP1A2;GSTM2;SLC8A1
prerank,cellular metal ion homeostasis (GO:0006875),0.3373312158846088,1.1750200286923287,0.19500780031201248,0.751540161555188,1.0,10/102,4.09%,ATP1A2;SLC24A3;SLC8A3;STIM1;SLC41A1;CSRP3;ATP1B3;SLC8A1;DMPK;ANK2
prerank,positive regulation of epithelial cell migration (GO:0010634),-0.3067938968762745,-1.1750040871357952,0.1685082872928177,0.6334708358894955,1.0,26/92,9.89%,TEK;FOXP1;NRP2;KDR;THBS1;TGFB2;RAC1;SCARB1;ETS1;PLCG2;DOCK1;PTK2B;BMPR2;IQSEC1;BCAR1;RHOB;CALR;EMC10;FLT4;MTOR;VEGFA;GRN;EDN1;RTN4;FGF7;PIK3CD
prerank,cellular respiration (GO:0045333),-0.35466234022787185,-1.174977957682137,0.20813397129186603,0.6326489828916374,1.0,17/41,29.29%,PPARGC1A;ATP5F1D;NDUFA5;UQCRH;NDUFS1;COQ10B;UQCRC2;MTFR1L;NDUFS7;UQCRC1;CYCS;UQCR10;MTLN;ETFB;COX15;COX4I2;NR4A3
prerank,cellular calcium ion homeostasis (GO:0006874),-0.28909710941768385,-1.1747765305068065,0.13069908814589665,0.6323588496930198,1.0,45/133,20.09%,CAV1;TRPC3;TPT1;SLC35G1;CAV2;ATP1B1;SLC10A7;TRPC6;CALR;ATP2C1;ATP2A3;SLC24A2;TRPC4;ATP2A2;RYR2;HTR2A;ATP13A4;CCDC47;EDN1;SMDT1;SLC30A1;KCTD17;RMDN3;STIM2;GPER1;SELENOK;STOML2;ATP2B1;ATP13A5;HERPUD1;MCUB;TRPC1;WFS1;ATP13A2;SLC24A5;PLN;CCL13;TMEM165;LETM1;CXCL12;ATP2B2;ATP2B4;NPTN;CD40;PSEN1
prerank,lung epithelium development (GO:0060428),0.5320832476019989,1.174441278749394,0.27848101265822783,0.7520254691507312,1.0,1/10,0.34%,ERRFI1
prerank,macroautophagy (GO:0016236),0.3296881971482442,1.1740789555562938,0.21225710014947682,0.7519735610945417,1.0,24/118,15.12%,PRKAG2;PRKN;PRKAG3;ATG10;WIPI1;MTMR3;PRKAA2;LAMP2;PRKAA1;ATG14;VTA1;PIK3R4;UVRAG;STAM2;FUNDC1;VPS37C;VPS37A;CHMP6;PRKAG1;STX17;VPS39;AMBRA1;ATG3;TMEM74
prerank,protein heterotetramerization (GO:0051290),-0.48215024460698663,-1.1737476902671193,0.28515625,0.6342996750474578,1.0,8/13,33.17%,PKD1;CPSF7;GRIN1;CPSF6;FARSA;HSD17B8;GRIN2B;KRT10
prerank,centromere complex assembly (GO:0034508),0.38308926140971616,1.1734844162005296,0.22382671480144403,0.7524914813458385,1.0,9/36,11.10%,ITGB3BP;RBBP4;CENPI;NASP;RBBP7;MIS18BP1;RSF1;CENPQ;SMARCA5
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.3840982391787082,-1.1732845108707097,0.23503325942350334,0.6347057540490053,1.0,14/32,25.88%,STMN2;APC;NAV3;ARHGEF2;STMN1;APC2;TUBB4A;FKBP4;TTBK2;MAPRE1;CLASP2;CAMSAP3;SPEF1;CAMSAP1
prerank,positive regulation of cholesterol transport (GO:0032376),-0.3992893732235983,-1.1726957923112689,0.25,0.6354590698165271,1.0,12/27,29.17%,CAV1;PLTP;NFKBIA;PTCH1;LPCAT3;NR1H2;ABCA3;ZDHHC8;NR1H3;GPS2;TREM2;ABCA7
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),-0.2935102603944527,-1.172494324818773,0.1488095238095238,0.6350765688543677,1.0,36/109,23.64%,RAC1;CALM1;PLCG2;IKBKB;NFATC2;NFATC1;JUN;PAK1;PSMD13;MAPK8;PSMF1;PAK2;MAP3K1;PSMB10;CHUK;MAP2K7;PSMB6;PSME3;PSMB5;PSMC3;PPP3CA;TAB3;PSMD12;PSMB8;PSME1;CUL1;PSMB3;PPP3R1;NFATC3;PSMD5;SKP1;MAPK3;PSMD9;MAPK10;PSMB4;RELA
prerank,autonomic nervous system development (GO:0048483),-0.44365258497141324,-1.172291839308628,0.2845691382765531,0.6347416557055948,1.0,7/17,22.99%,FN1;SOX4;KIF26A;NF1;SOX10;SEMA3A;SOX11
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.4437597776733374,1.1720292683645626,0.25946969696969696,0.7554626163813313,1.0,6/23,7.20%,TULP3;MGRN1;GLI3;GPC3;SUFU;HERC4
prerank,mRNA transport (GO:0051028),-0.3009350307711169,-1.1717270024271225,0.15804597701149425,0.635445329284077,1.0,43/101,33.42%,SRSF2;SRSF1;SRSF5;DDX39B;HHEX;CPSF3;SRSF9;RBM8A;ZFP36L1;RNPS1;SRSF6;NUP37;SYMPK;AGFG1;CPSF2;NXT1;NUP54;NUP85;SMG5;YTHDC1;NUP133;MAGOH;THOC3;POM121;FMR1;THOC6;EIF4E;DDX25;THOC2;EIF4A3;SRSF7;NUP153;ALYREF;KIF5C;SMG6;ZFP36;ZC3H11A;NUP42;CPSF1;NUP93;DHX38;U2AF1L4;CHTOP
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.5046581326492088,-1.171122945119045,0.2751798561151079,0.6362135602383532,1.0,5/10,24.10%,SHANK3;APP;CAMK2B;NPTN;SYP
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.5075078621245018,1.1710828973410905,0.2980392156862745,0.756927852220533,1.0,2/12,8.21%,RBP4;MUC13
prerank,sphingosine metabolic process (GO:0006670),-0.4434423771920202,-1.170987757343197,0.24904942965779467,0.6356838616471038,1.0,4/17,1.95%,ACER3;ACER2;SPTLC2;PLPP1
prerank,response to cytokine (GO:0034097),0.3204988158617169,1.1706450868197464,0.17846607669616518,0.7568843168538831,1.0,17/141,7.59%,ALDH1A2;PTPN13;PID1;TIMP3;BCL2;DPYSL3;PTPN4;SP100;IL1RAPL1;ANXA1;IRAK2;NFAT5;SPHK1;PTPN9;PRKCA;SMAD3;TRIM56
prerank,protein O-linked glycosylation (GO:0006493),0.3387265417155454,1.1705435786563272,0.192,0.7559355950999426,1.0,10/96,4.32%,TMTC4;ST3GAL3;GALNT18;GALNT14;GALNT15;LARGE1;GXYLT2;TMTC1;B3GNT5;CRPPA
prerank,visual system development (GO:0150063),0.3972143984721622,1.170129089187841,0.26,0.7559384759712074,1.0,7/37,8.79%,RBP4;MEIS1;SLC39A5;SMOC1;SH3PXD2B;PBX4;CHRDL1
prerank,cellular response to starvation (GO:0009267),0.3162491621516738,1.1699161007386605,0.1748148148148148,0.7553656324813894,1.0,35/147,15.56%,PRKAG2;NPRL3;PPARA;PRKAG3;FNIP1;SZT2;PCSK9;CPEB4;SIK1;NPRL2;SESN1;LRRK2;WIPI1;MTMR3;PRKAA2;SLC38A9;LAMP2;RNF152;PRKAA1;ATG14;PIK3R4;ATP6V0D1;ATP6V0E1;FLCN;MLST8;EIF2S1;PRKAG1;STK24;MAPK1;RRP8;STK26;ATP6V1D;NIM1K;BRSK1;WRN
prerank,positive regulation of gene expression (GO:0010628),0.2847765941169135,1.169678987354596,0.1167076167076167,0.7547859942892675,1.0,69/442,12.84%,IGF1;ROBO1;BMP6;SLC24A3;ROCK2;OSR1;SLC22A2;C1QTNF3;RBPJ;FGFR4;AFDN;PID1;WNT6;BMP7;ANGPT1;PRKN;RBMS3;PLA2R1;DKK1;SCX;NOS1AP;CTSH;DTNBP1;PLD1;TFR2;SRPK2;ITGAX;ANK2;MBIP;FOXD1;MAPK9;BAZ1B;TNRC6B;GJA1;TNRC6A;EPHX2;FGF1;SLC2A10;IL6;SMAD3;PRKAA1;CSF1;TLE1;POLR2A;MITF;FUBP1;MUSK;FGF9;SAMD4A;MED1;AGO2;PIK3R1;FGF20;PRKDC;RPS6KB1;TAF1A;METTL14;SMARCA5;TFAP2A;ERBB2;FXR1;POLR1F;LARP6;POLR1A;TAF1D;PRKAG1;SLC38A2;BATF;AR
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.35533473816005706,-1.1696229351356648,0.22121896162528218,0.6385780682372321,1.0,13/40,11.48%,LEF1;TIAM1;TGFB2;JAG1;NOTCH1;TGFBR2;TGFB1;FERMT2;CTNNB1;MTOR;WWTR1;BMP2;GCNT2
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.45065187238202054,1.1695447085464044,0.2783300198807157,0.7539886923401574,1.0,2/21,2.75%,OSBPL8;PLA2G10
prerank,protein localization to phagophore assembly site (GO:0034497),0.5194025032336245,1.1693999520691076,0.29831932773109243,0.7531896282626466,1.0,4/11,12.63%,WIPI1;TRAPPC8;ATG9A;STX17
prerank,regulation of oxidoreductase activity (GO:0051341),0.48932784025997345,1.1692968304309774,0.3020833333333333,0.7522801190815115,1.0,4/13,11.58%,SZT2;SLAMF8;ABL1;OXA1L
prerank,triglyceride catabolic process (GO:0019433),0.45435013428840904,1.1689246604086128,0.2808349146110057,0.7521131360884974,1.0,4/19,16.15%,LIPC;LIPH;FABP4;FABP7
prerank,nucleobase-containing compound catabolic process (GO:0034655),-0.35852243528975486,-1.1685953682033732,0.23394495412844038,0.6404754858743735,1.0,12/37,32.19%,ENTPD1;ENTPD7;ENTPD2;NUDT1;RNASE3;SUPV3L1;MTREX;NUDT16;RNASEH2C;HNRNPD;RNASEH2B;ISG20
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.5006174207474321,1.1677053912715618,0.29959514170040485,0.7544386718673751,1.0,3/12,6.85%,DOCK11;NOTCH2;IL6
prerank,establishment of protein localization to mitochondrion (GO:0072655),-0.34561060243324926,-1.1671713784594715,0.21136363636363636,0.6434828011868565,1.0,23/46,30.65%,FBXO7;TOMM20;HK1;TOMM22;HSPD1;TIMM9;ROMO1;BCAP31;TIMM10B;TIMM13;PINK1;TIMM22;AKT1;MFN2;TOMM7;TIMM50;TSPO;TIMM44;FIS1;CHCHD4;AIP;TOMM34;DNLZ
prerank,negative regulation of MAPK cascade (GO:0043409),-0.3004756890143614,-1.1660894521750813,0.20221606648199447,0.645521866905776,1.0,40/87,29.94%,CAV1;PTPRJ;SEMA6A;STK38;DAB2IP;PPIA;PTPRC;UCHL1;SPRED2;FOXO1;CNKSR3;DUSP3;PTPN1;SYNJ2BP;GPER1;SPRY4;IRAK3;NF1;DUSP1;WNK2;SH2B3;BMP4;CAMK2N1;PRKCD;CD300A;HYAL2;DUSP6;SORL1;EZR;DUSP4;PSMD10;SPRY2;PTPRR;EMILIN1;TLR4;SPRED3;ABCA7;PEBP1;DUSP7;DUSP26
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.3431883298391001,1.1660276020088398,0.22749590834697217,0.7582072756389447,1.0,9/86,7.35%,IGF1;EPHA7;BMP6;ANGPT1;IGF2;PRKCZ;ENPP2;IL6;VTN
prerank,nucleosome assembly (GO:0006334),0.4068711310323505,1.1659505219678612,0.2710951526032316,0.7572089016973732,1.0,8/31,16.27%,RBBP4;NASP;RSF1;KAT6B;SMARCA5;NAP1L3;NAA60;NAP1L1
prerank,regulation of apoptotic process (GO:0042981),-0.23768179081485563,-1.1658150026455445,0.01834862385321101,0.6453665011206782,1.0,132/676,13.25%,LEF1;MEF2C;UNC13B;TEK;SLIT2;HIP1;MAP3K5;MCF2L;ACTN4;PTMA;ITGA6;TIAM1;ACER2;TFRC;RASSF2;KDR;THBS1;ADAM10;TPT1;TRIO;ARHGEF3;GAS6;HSP90AA1;RNF144B;CBL;HNRNPK;ITGB1;TARDBP;PPP1R13B;PTK2;KCNMA1;SLK;PTK2B;RASGRF2;DAB2IP;NGF;UBB;NFKBIA;DNAJA1;PPIA;SEMA4D;RACK1;RPS3;NET1;TNFSF10;CTSD;ARHGEF12;PREX1;ATG7;TGM2;SFRP4;FLNA;HSPB1;SOCS2;RPS6;ACTN1;BCAR1;ARHGEF17;IKBKB;RHOB;ARHGEF6;PERP;SOX4;ARHGDIA;CD38;CD44;CALR;PLK2;CTNNB1;SOD1;BCL2L1;CTSB;HSP90B1;FAF1;ABR;UBC;RPS27A;TJP1;WNK3;LGALS1;EGLN3;LRP8;SIGMAR1;TBX3;GSK3B;HIP1R;SERPINB9;APBB1;DNM2;CARD14;FLT4;JUN;CRYAB;BAG1;VEGFA;PDCD10;RNF157;FOXO1;ARHGEF19;BIRC3;MAPK8;DDX20;RTN4;ARHGEF26;MAGED1;ING4;ZBTB7A;PAK2;APC;BNIP2;HYPK;ARHGEF5;HSPA5;XBP1;BMP2;ATF4;RPS6KA1;RSL1D1;GPER1;BCL3;EGLN2;REST;CD74;BIN1;RYBP;ARHGEF2;HSPD1;CLU;HIGD2A;GADD45G;BNIP1;RNPS1
prerank,fatty acid biosynthetic process (GO:0006633),-0.322459445025687,-1.1642453790108773,0.19239904988123516,0.6487392324084073,1.0,17/63,21.71%,ABHD2;ELOVL7;ELOVL5;GPX4;ACACA;PTGS2;ELOVL6;XBP1;ABCD3;ALOX12;ELOVL1;TECRL;TECR;ACLY;SCD5;LIAS;SCD
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.4511884737160128,1.1638808959665876,0.2824858757062147,0.7620367907948421,1.0,5/19,8.38%,CAMK1D;RIPOR2;CCL19;MCU;MOSPD2
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.36568304258842577,1.163855428715222,0.25811688311688313,0.7609151192494411,1.0,13/59,14.25%,ROCK2;OXSR1;PDPK1;LRRK2;PRKCA;CAMK2D;CDK1;PRKDC;PRKD2;HIPK3;TBK1;MAPK1;NLK
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.5062340078736165,-1.1634405784320296,0.3007518796992481,0.6500162568652762,1.0,2/10,2.60%,CBFB;RUNX1
prerank,cAMP-mediated signaling (GO:0019933),0.4366875165688703,1.163369377405486,0.2739463601532567,0.7611477535500297,1.0,4/24,3.11%,ADCY1;KSR1;PDE7B;PDE7A
prerank,regulation of vasculogenesis (GO:2001212),-0.4568429402822439,-1.1632948189953194,0.26968503937007876,0.6495483429519839,1.0,10/14,22.63%,RAP1A;CD34;KDR;CEACAM1;EMP2;HEY2;XDH;RRAS;TMEM100;HEY1
prerank,axonal fasciculation (GO:0007413),0.5235212170618264,1.1629364835796934,0.2868369351669941,0.7612370247081486,1.0,3/12,6.99%,EPHA3;EPHA4;ARHGAP35
prerank,regulation of mitochondrial translation (GO:0070129),-0.423806164052152,-1.1626439457430848,0.2674897119341564,0.650558392676409,1.0,9/21,25.51%,RCC1L;UQCC2;RPUSD4;FASTKD3;MTG1;TRMT10C;TRUB2;MRPS27;COA3
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.31727487615504457,1.162457459217178,0.20903954802259886,0.7614585570782129,1.0,12/142,4.33%,ATP1A2;ADCY5;BDKRB2;ACKR2;CCR9;LPAR1;CXCR5;SLC8A1;CXCL13;PDGFRA;CXCR6;LPAR2
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.42626630319682685,-1.161871899116984,0.2765072765072765,0.6517302200875508,1.0,11/17,37.86%,PKD1;CCNY;CCNYL1;AKT1;RGCC;PSMD10;PROX1;CCND1;PSRC1;ADAM17;CCND3
prerank,regulation of protein polymerization (GO:0032271),0.40855525906343654,1.1618475116730156,0.2615658362989324,0.7620468338652652,1.0,6/35,11.91%,ARHGAP28;ARHGAP40;COTL1;ABL1;LATS1;GBA2
prerank,response to histamine (GO:0034776),-0.5080718584261665,-1.1615058207971778,0.28489483747609945,0.6519251935747806,1.0,6/10,36.46%,GABRB3;GABRB1;HRH1;GABRG2;GABRB2;DRD3
prerank,negative regulation of heart contraction (GO:0045822),0.5190155322194575,1.161235143613492,0.3106212424849699,0.7626993386941282,1.0,1/11,0.21%,ATP1A2
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.4813452952459486,-1.1612221908387461,0.2981132075471698,0.6518431273832405,1.0,8/11,24.23%,SLIT2;RIN3;CCN3;DUSP1;MIF;GREM1;PADI2;DDT
prerank,regulation of viral entry into host cell (GO:0046596),-0.3724556931888445,-1.1610592737259713,0.23026315789473684,0.6514381152901239,1.0,11/30,22.00%,LY6E;GSN;TRIM14;TRIM25;LGALS1;CD74;HS3ST5;MID2;IFITM3;TRIM27;CIITA
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.47035065403056064,-1.1609593881160436,0.2823529411764706,0.6508645020151871,1.0,6/13,17.46%,ELOVL7;ELOVL5;ELOVL6;ELOVL1;TECRL;TECR
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),-0.47089690264551637,-1.1606909760406123,0.284,0.6506858516538113,1.0,7/13,23.77%,AQP11;LPCAT3;CLU;NR1H2;WFS1;NR1H3;FCGR2B
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.46370693532604607,1.1602659999112839,0.301556420233463,0.7643981638862829,1.0,5/17,8.38%,CAMK1D;RIPOR2;CCL19;MCU;MOSPD2
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.37389689329847836,-1.1602443034707044,0.2488986784140969,0.6510486481189457,1.0,14/28,27.49%,MAP1B;PRUNE1;STMN2;STMN1;STMN4;STMN3;GAS2L1;FKBP4;MAPRE1;MAP1A;CLASP2;CAMSAP3;CAMSAP1;SKA3
prerank,axonemal dynein complex assembly (GO:0070286),0.42803835241801813,1.1602182087832758,0.27140255009107467,0.7633522902418488,1.0,8/27,15.39%,ODAD3;DNAI4;SPAG1;TTC12;ODAD1;CCDC65;DNAAF3;ODAD2
prerank,epidermis development (GO:0008544),0.3642350399894132,1.1600973631140077,0.2552083333333333,0.7625153263765101,1.0,3/56,2.53%,SVEP1;FGFR2;CCN2
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.3621164127572455,1.1596411564385691,0.25127334465195245,0.76270627520226,1.0,7/56,6.47%,BMP6;BMP7;DAB2;SMAD6;DKK1;RBPMS;TTK
prerank,calcium ion transport (GO:0006816),0.32840432154421767,1.1595248135451073,0.19811320754716982,0.761871507851704,1.0,12/113,7.01%,TRPM3;SLC24A3;ITPR1;SLC8A3;STIM1;NALCN;SLC8A1;ANK2;CACNA1D;CACNG7;TRPC4AP;CACNA2D1
prerank,nucleoside salvage (GO:0043174),-0.5081869765554369,-1.1595161659506508,0.29545454545454547,0.6520850032869533,1.0,7/10,31.44%,HPRT1;UCKL1;CDA;DCK;UCK1;UCK2;UPP1
prerank,regulation of epidermal cell differentiation (GO:0045604),0.4532301634441577,1.1592369967608387,0.2788104089219331,0.761515580622003,1.0,2/21,0.38%,ERRFI1;ROCK2
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.339672429338457,-1.1591919389891632,0.21830985915492956,0.6520968193028623,1.0,14/46,13.47%,MEF2C;SHANK3;GRM3;GRM7;CDH2;PTK2B;HOMER1;DGKI;NRXN1;CACNG3;RELN;DGKZ;GRM8;CACNG2
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.44670923494528747,-1.1591350880759907,0.26129666011787817,0.6513651476626238,1.0,9/16,19.95%,THBS1;PPP1R16B;GATA2;JCAD;VEGFA;PDCD10;APLNR;AGTR1;DLL4
prerank,"phagocytosis, engulfment (GO:0006911)",-0.3580423934773692,-1.158980499580889,0.26057906458797325,0.6509270148993899,1.0,7/36,9.45%,ELMO1;THBS1;RAC1;GSN;DOCK1;MYH9;ARHGAP25
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.36074650438240247,-1.1583606916330351,0.22119815668202766,0.6517703526148468,1.0,19/37,33.35%,UBB;UBC;RPS27A;RBX1;DDB1;RPA1;UBA52;POLK;POLD3;POLD1;NTHL1;GTF2H2;ERCC5;XPA;RFC5;ERCC3;GTF2H5;RPA3;RPA2
prerank,regulation of dopamine secretion (GO:0014059),0.4323551240996816,1.1582190040171276,0.2841121495327103,0.7632769760133242,1.0,9/25,18.48%,PRKN;DTNBP1;SYT11;SYT12;FGF20;GDNF;CHRNB2;DRD2;SNCA
prerank,chromatin assembly or disassembly (GO:0006333),0.5236372211030704,1.1581561578149169,0.3247863247863248,0.7622813708864867,1.0,2/11,4.36%,HDAC8;RBBP4
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),-0.43163592952898533,-1.1576151694769048,0.2710843373493976,0.6529052175330053,1.0,9/16,34.18%,TARDBP;ZFP36L1;PLEKHN1;ZC3H12A;RBM24;CPEB3;ZFP36;RC3H1;ZC3H12D
prerank,retinol metabolic process (GO:0042572),0.4822822088086437,1.157549651112582,0.29273504273504275,0.7628565591041234,1.0,3/14,16.03%,RBP4;DHRS3;RDH11
prerank,negative regulation of cell aging (GO:0090344),-0.44824353895764646,-1.1575050816745631,0.2710843373493976,0.652299128453908,1.0,4/16,16.37%,YBX1;CDK6;MAP3K3;MIF
prerank,relaxation of cardiac muscle (GO:0055119),0.49735333017260797,1.1574687652385913,0.3188118811881188,0.7618992588661974,1.0,3/13,3.10%,ATP1A2;GSTM2;SLC8A1
prerank,negative regulation of cytokine production (GO:0001818),-0.27365386793727725,-1.1574528356159195,0.14814814814814814,0.65159300595952,1.0,50/163,21.06%,LEF1;FN1;TMSB4X;APOD;CD200;CD34;RPS6KA5;THBS1;RAC1;GAS6;KLF4;TRIB2;TRIM25;SARS1;PTPRC;ARRB1;CEACAM1;TNFRSF21;RNF125;PDCD4;SRGN;NAV3;ADCY7;NLRC5;ISG15;BCL3;ATP2B1;ABCD2;ASB1;IRAK3;IFIH1;LAPTM5;CMKLR1;SIGIRR;RPS6KA4;CD274;N4BP1;ZC3H12A;NR1H4;JAK3;GPATCH3;NPTN;INHA;TYROBP;HDAC7;HDAC9;NCKAP1L;TRIM27;SLC11A1;OTUD7B
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.44868159011296543,-1.1573098518332925,0.29273084479371314,0.6511007629749926,1.0,8/15,29.86%,HSP90B1;DERL1;HERPUD1;AUP1;TMEM129;VCP;SYVN1;SEC61B
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.47210507699203086,1.1569842830641304,0.31673306772908366,0.7622438745300649,1.0,4/15,7.99%,IL18;PLA2G10;MAPK9;CSF1
prerank,mitotic nuclear membrane organization (GO:0101024),-0.33497881037535693,-1.1569537130716225,0.22355769230769232,0.6503941746117199,1.0,19/51,26.18%,REEP3;CHMP2B;LEMD2;LBR;RANGAP1;LMNA;NUP37;VRK1;PPP2R2A;NUP85;CC2D1B;NUP133;POM121;BANF1;CHMP3;CCNB2;CHMP7;CHMP4C;UBE2I
prerank,mitotic nuclear membrane reassembly (GO:0007084),-0.33497881037535693,-1.1569537130716225,0.22355769230769232,0.6503941746117199,1.0,19/51,26.18%,REEP3;CHMP2B;LEMD2;LBR;RANGAP1;LMNA;NUP37;VRK1;PPP2R2A;NUP85;CC2D1B;NUP133;POM121;BANF1;CHMP3;CCNB2;CHMP7;CHMP4C;UBE2I
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.4976900450636087,1.1569373707859665,0.31092436974789917,0.7612035186246712,1.0,2/12,7.97%,PPARA;MIA3
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.473938588381739,-1.1568377768757503,0.3061630218687873,0.6498519590028153,1.0,3/12,19.35%,ANO1;CFTR;TRPM4
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.4327286422418841,1.156764906939626,0.2803921568627451,0.7594445897505854,1.0,9/23,16.64%,ZEB2;DAB2;SLC2A10;FLCN;CREBBP;CDKN1C;CDKN2B;SMAD4;SDCBP
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.4327286422418841,1.156764906939626,0.2803921568627451,0.7594445897505854,1.0,9/23,16.64%,ZEB2;DAB2;SLC2A10;FLCN;CREBBP;CDKN1C;CDKN2B;SMAD4;SDCBP
prerank,positive regulation of locomotion (GO:0040017),-0.3824278719247668,-1.1567473653725155,0.2533632286995516,0.6492859387963262,1.0,5/27,5.53%,SPOCK2;THBS1;STX3;CAVIN1;TGFB1
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.40950263529235065,-1.1562429941193193,0.2618556701030928,0.6497298705372767,1.0,6/20,11.70%,THBS1;GSN;SFRP4;ITGA4;PDCD4;GPER1
prerank,protein modification by small protein conjugation (GO:0032446),0.28707295522052667,1.1557736012138742,0.1515527950310559,0.7610832782317918,1.0,57/361,12.65%,ASB2;PDZRN3;RNF220;EYA1;TRIM63;EPAS1;RNF43;PRKN;SPSB1;HIF3A;TRIM5;MGRN1;NEDD4;RNF213;RNF138;ATG10;ZNRF3;UFL1;NDC1;TRPC4AP;CAND1;UBE2L3;RNF181;UBR2;RNF152;CUL9;RNF135;KLHL7;PIAS1;BIRC6;AMFR;WWP2;USP7;CUL7;CRBN;TRAF7;MDM2;FBXL17;ITCH;SMURF2;TRIM35;NUP107;PRKDC;UBA7;MYCBP2;NEUROD2;UBA3;DTX1;FBXO4;CDC73;RNF14;CUL4B;TRIM26;TRIM43;FBXO11;RNF20;ASB5
prerank,intracellular protein transmembrane transport (GO:0065002),-0.3521730388372142,-1.1552635282211623,0.22380952380952382,0.6514596598637868,1.0,22/42,35.66%,TOMM20;C2CD5;HSPA5;HSPD1;SEC62;ROMO1;SEC61G;ZFAND2B;PEX1;PEX5;TIMM50;PEX10;PEX16;SEC63;TIMM44;CHCHD4;RTN2;SEC61B;DNLZ;AKT2;SEC61A2;TIMM21
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.39226443780273973,1.1552058125261582,0.2615658362989324,0.7615993066416684,1.0,6/39,8.15%,TCF7L2;RBP4;NLGN2;TFR2;MCU;SLC30A8
prerank,negative regulation of translation (GO:0017148),0.33873003123884765,1.1551986509580143,0.21428571428571427,0.7604651388530832,1.0,26/87,20.20%,ROCK2;IGF2BP1;DAPK1;CPEB2;EIF4EBP1;CPEB4;TYMS;YTHDF2;SAMD4A;AGO2;METTL14;UNK;FXR1;SHMT1;CNOT7;LARP1;CNOT8;TSC1;CNOT10;ENC1;GIGYF2;DDX3X;LSM14A;RBM4;DHFR;DDX6
prerank,negative regulation of translational initiation (GO:0045947),0.48728004902916033,1.154614392029598,0.30043859649122806,0.7610024145923844,1.0,7/13,26.18%,EIF4EBP1;AGO2;LARP1;RBM4;TPR;PAIP2B;PAIP2
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.45117303710349616,1.1545864509870016,0.30642201834862387,0.759928558910885,1.0,7/21,17.53%,PPARA;PRKN;TFAP2A;SLC30A10;PLIN5;ABCB7;TRAP1
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.3978427048223612,-1.1544239371931528,0.2577962577962578,0.6529570928263279,1.0,12/24,18.59%,RACK1;UBXN1;CREB3L1;BCL2L1;AQP11;LPCAT3;XBP1;HERPUD1;CLU;NR1H2;WFS1;TMBIM6
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.2973986531686425,-1.1533090963467383,0.1978319783197832,0.6551049418403404,1.0,39/96,33.42%,SRSF2;SRSF1;SRSF5;DDX39B;HHEX;CPSF3;SRSF9;RBM8A;RNPS1;SRSF6;NUP37;SYMPK;AGFG1;CPSF2;NXT1;NUP54;NUP85;SMG5;YTHDC1;NUP133;MAGOH;THOC3;POM121;THOC6;EIF4E;DDX25;THOC2;EIF4A3;SRSF7;NUP153;ALYREF;SMG6;ZC3H11A;NUP42;CPSF1;NUP93;DHX38;U2AF1L4;CHTOP
prerank,regulation of neuron death (GO:1901214),-0.3036476450783362,-1.1526743561996469,0.18673218673218672,0.6559740350808675,1.0,33/82,23.77%,MEF2C;MAP3K5;CD200;CD34;PPARGC1A;FYN;UBB;DCC;EGLN3;SIGMAR1;GSK3B;TNFRSF1B;CHP1;DDIT4;EIF4G1;EPHB1;EGLN2;REST;CHGA;CLU;C1QA;NENF;CTSZ;ATP13A2;TRIM2;GRID2;CDK5;TYROBP;AKT1;NSMF;SARM1;SNCG;FCGR2B
prerank,cellular response to tumor necrosis factor (GO:0071356),-0.26887383028647444,-1.1522939072300022,0.1678832116788321,0.656171984534486,1.0,38/175,14.57%,TMSB4X;ACTN4;TNFRSF11B;PTK2B;DAB2IP;NFKBIA;RPS3;LIMS1;IKBKB;YBX3;EDA;ST18;TNFRSF11A;TNFRSF21;TNFRSF1B;CARD14;SMPD4;NPNT;AIM2;PSMD13;BIRC3;PSMF1;COMMD7;PSMB10;CHUK;PSMB6;PSME3;GPER1;ZFP36L1;PSMB5;PSMC3;ARHGEF2;PSMD12;ERBIN;GBP3;PSMB8;TRAF1;PSME1
prerank,neural tube closure (GO:0001843),0.40475394974213,1.152274027281232,0.26666666666666666,0.7654429797675806,1.0,9/34,11.81%,LMO4;PRICKLE1;KDM2B;MTHFR;LRP2;FOLR1;DVL3;COBL;IFT122
prerank,positive regulation of cell development (GO:0010720),-0.3734547589861459,-1.1521056572869321,0.25684210526315787,0.655808844902175,1.0,11/31,22.99%,PDE3A;TGM2;SERPINF1;GPER1;CX3CR1;SPEN;LIG4;BMP4;TYROBP;FAIM;SOX11
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.3846582121779032,1.1520427926509007,0.28399311531841653,0.7649372883140232,1.0,9/43,10.58%,PID1;SORBS1;IGF2;GRB10;PRKCZ;PRKCB;GKAP1;RPS6KB1;TNS2
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.47536519197940674,1.151592268328337,0.2891566265060241,0.7650052468602212,1.0,2/14,3.26%,OXSR1;CXCL13
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.4816207544000564,-1.1513063372607943,0.28846153846153844,0.6572201942270088,1.0,4/11,11.70%,MEF2C;TGFB2;TGFB1;GPER1
prerank,endothelial cell development (GO:0001885),-0.39166256802752714,-1.1511372545559821,0.25,0.6568331529806437,1.0,9/25,7.13%,PECAM1;RAP1A;PDE4D;MSN;PPP1R16B;COL15A1;ROBO4;MET;PDE2A
prerank,glucose transmembrane transport (GO:1904659),-0.42176212274109093,-1.1510732069336638,0.2859960552268245,0.6561525562234773,1.0,2/18,3.11%,SLC2A1;PPARD
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.373771429209072,-1.1509036288412644,0.23883928571428573,0.6557708528147189,1.0,8/33,11.37%,TGFB2;KLF4;ETS1;GATA2;TGFB1;GNL3;JUN;STAT3
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.4188165027789921,-1.1506035195856346,0.2450199203187251,0.6557380298132838,1.0,8/19,17.75%,CSGALNACT1;NDST3;HS6ST2;EXT1;EXTL3;XYLT1;HS6ST3;HS3ST5
prerank,regulation of actin cytoskeleton organization (GO:0032956),-0.3052731546967288,-1.1505768709615982,0.17857142857142858,0.654953504307211,1.0,23/87,10.48%,EFNA5;ESAM;RAC1;IQGAP1;CORO2B;F11R;PTK2B;ARHGDIB;SEMA3E;RHOB;ARHGDIA;FAM107A;CCDC88A;HIP1R;MTOR;ABI3;GPM6B;PAK1;EPS8;ARHGEF19;RHOA;ARHGEF5;CRK
prerank,regulation of cellular metabolic process (GO:0031323),0.3788793619399472,1.150255278993966,0.24420677361853832,0.7676362207164811,1.0,4/45,2.70%,PPARA;PID1;PRKN;DKK1
prerank,cell-matrix adhesion (GO:0007160),0.33713151183210716,1.150221528285946,0.24726134585289514,0.76657265739629,1.0,11/95,5.41%,ADAMTS12;NID2;ADAMTS9;FBLN5;RHOD;SORBS1;COL13A1;FERMT1;DDR1;SGCE;ITGA3
prerank,pulmonary valve development (GO:0003177),-0.4244239131340882,-1.1501999513983092,0.2654320987654321,0.6551725878428483,1.0,10/18,9.08%,SLIT2;NOS3;TGFB2;JAG1;NOTCH1;BMPR2;STRA6;NFATC1;TNFRSF1B;HEY2
prerank,regulation of protein autophosphorylation (GO:0031952),0.3989636123549045,1.1498516127056408,0.2931654676258993,0.766422752089908,1.0,2/36,0.34%,EPHA7;ERRFI1
prerank,positive regulation of neutrophil migration (GO:1902624),0.4540200784256245,1.1498322599317776,0.301556420233463,0.7653371808399602,1.0,5/18,8.38%,CAMK1D;RIPOR2;CCL19;MCU;MOSPD2
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.44437522287744413,-1.1498299694666874,0.289272030651341,0.6553357735551268,1.0,7/15,15.12%,KCNJ2;ATP1A1;ATP1B1;KCNQ1;KCNN2;KCNJ8;KCNIP2
prerank,neurotrophin signaling pathway (GO:0038179),-0.4008505901742697,-1.149634504350454,0.2907949790794979,0.6550332266782625,1.0,4/21,9.02%,RAP1A;NGF;BCAR1;DDIT4
prerank,keratan sulfate biosynthetic process (GO:0018146),0.4168696082172775,1.1495949247916035,0.2629558541266795,0.7648564218129896,1.0,6/26,5.12%,ST3GAL3;FMOD;OGN;OMD;B4GALT1;PRELP
prerank,regulation of neurotransmitter transport (GO:0051588),-0.44233236983131596,-1.1493124166043933,0.2920168067226891,0.6550640193534502,1.0,4/16,12.63%,MEF2C;MCTP1;KCNMB4;CPLX2
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.38599765297422983,-1.14908412407353,0.27586206896551724,0.6548858866321627,1.0,17/28,25.19%,MAP3K5;DAB2IP;TMEM117;BAG6;ATP2A3;ATF4;SELENOK;ERO1A;BBC3;DNAJC10;TNFRSF10B;CEBPB;BRSK2;TRIB3;PPP1R15A;ERN1;BAX
prerank,regulation of insulin secretion (GO:0050796),0.3294453254993433,1.1487233528411158,0.2398753894080997,0.7662019836935732,1.0,14/101,8.15%,ADCY5;TCF7L2;ITPR1;STXBP4;RBP4;PRKN;KCNA5;NLGN2;CACNA1D;PRKCA;IL6;RAPGEF4;MCU;SLC30A8
prerank,excitatory postsynaptic potential (GO:0060079),-0.41479802262689913,-1.148686940650697,0.28286852589641437,0.6551326075698058,1.0,7/19,22.96%,MEF2C;GSK3B;GRIN1;ARRB2;GRID2;AKT1;MAPK8IP2
prerank,dendritic spine organization (GO:0097061),-0.38770181892202676,-1.1485402356269308,0.2599118942731278,0.6546785533442078,1.0,8/26,13.34%,SHANK3;CTNND2;FYN;DOCK10;LGMN;ARF1;EPHB1;PICK1
prerank,sarcomere organization (GO:0045214),0.424346749476516,1.1485048712755432,0.30206378986866794,0.7656837155278261,1.0,3/27,2.69%,TPM1;CSRP3;TNNT2
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.38037137685289946,-1.1483894160960308,0.2445414847161572,0.6542401193325982,1.0,13/27,23.77%,FBXO7;MBOAT1;HOMER1;CCDC88A;EFHC2;GSK3B;MARK1;DISC1;NTNG1;PSEN1;AKT1;BRSK2;FCGR2B
prerank,positive regulation of hormone secretion (GO:0046887),0.4568988839063347,1.1483308071917857,0.29183673469387755,0.7650555427659692,1.0,2/17,3.76%,C1QTNF3;TFR2
prerank,cellular response to retinoic acid (GO:0071300),0.38037139421728755,1.1483172666153412,0.26527050610820246,0.7639559494469742,1.0,3/42,1.15%,PTK7;EPHA3;WNT6
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.5064366510776196,1.1482880029477958,0.28336755646817247,0.7628971095080962,1.0,1/11,0.25%,TGFBR3
prerank,icosanoid secretion (GO:0032309),0.4980150363341538,1.1481926945553564,0.3312368972746331,0.7620499502492075,1.0,3/12,5.50%,BDKRB2;ANXA1;ACE
prerank,regulation of feeding behavior (GO:0060259),0.5077894862445068,1.1472659165871355,0.30851063829787234,0.7635545600970095,1.0,1/11,0.35%,LEPR
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),-0.3122997558974808,-1.1469549514388702,0.22163588390501318,0.6573954649658978,1.0,16/75,11.66%,TEK;CLDN5;PTPRM;SEMA6A;THBS1;TGFB2;KLF4;DAB2IP;SEMA3E;STAB1;CTNNB1;SARS1;SERPINF1;HHEX;HGS;SYNJ2BP
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.4997713260047543,-1.146441419999192,0.3053435114503817,0.657977749376821,1.0,6/10,19.26%,EMC10;EMC7;EMC1;EMC3;EMC6;EMC9
prerank,regulation of neuron projection arborization (GO:0150011),0.4688538626978945,1.1462820384566645,0.30357142857142855,0.7652213223973212,1.0,7/15,14.95%,GRIP1;MACF1;NTNG2;DVL3;DLG4;MYO9A;MOV10
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.2960024575696132,-1.1456415860222986,0.17866666666666667,0.659226285159863,1.0,24/87,12.08%,CLDN5;ID1;ACVRL1;TGFB2;CBL;ITGB1;PTK2;F11R;ENG;UBB;PXN;TGFBR2;TGFB1;FERMT2;UBC;RPS27A;SMAD9;JUN;SMAD5;APPL1;RHOA;FURIN;GCNT2;NRROS
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.4536420980777013,-1.14531782448379,0.29865125240847784,0.6593002387431675,1.0,6/14,20.71%,CARD10;CARD14;COPS8;IRAK1;TNFRSF10B;TIRAP
prerank,clathrin-dependent endocytosis (GO:0072583),-0.3866137204330563,-1.144927490249155,0.2525879917184265,0.659481659106513,1.0,12/26,22.41%,SGIP1;FNBP1L;AP2A2;ITSN2;AP2M1;CANX;PIP5K1C;INPP5F;SNAP91;AP2B1;DLL1;AP2A1
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.40273725315480446,-1.1448256413134767,0.2612244897959184,0.6589343547913217,1.0,5/22,17.42%,APOD;CEACAM1;GPER1;BSCL2;PPP2R5A
prerank,TOR signaling (GO:0031929),0.4228872903281589,1.1441311150863036,0.2899628252788104,0.7701837008613389,1.0,8/26,10.90%,NPRL3;FNIP1;EIF4EBP1;RICTOR;SYAP1;RPS6KB1;FLCN;MLST8
prerank,acylglycerol catabolic process (GO:0046464),-0.3699809155540474,-1.1438689009599985,0.2713347921225383,0.6607622870860954,1.0,4/30,10.46%,ABHD2;MGLL;LIPE;LYPLA2
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.31632890457737706,-1.1431015388494272,0.22613065326633167,0.6620564757234585,1.0,24/65,26.67%,FHL1;PINX1;PSMD13;RBX1;PSMF1;PSMB10;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;PSME1;CUL1;PSMB3;PSMD5;SKP1;PSMD9;INTS3;PSMB4;CHEK1;PSMD10;CHMP4C;AVEN
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.4454407730062401,1.1430488351322468,0.30357142857142855,0.7721626783724713,1.0,4/20,3.44%,ATP1A2;ATP1B3;SLC8A1;LACC1
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.3329248503973536,-1.1424936992709576,0.23587223587223588,0.6629603465131335,1.0,24/47,33.05%,THBS1;PLCG2;RAB27A;TGFBR2;TGFB1;SOD1;GRIN1;ACE2;XDH;ROMO1;ZC3H12A;AGTR1;TYROBP;PRKCD;GADD45A;CDKN1A;ITGB2;TLR4;DCXR;CBR1;TLR6;CD36;AGT;SYK
prerank,glycerophospholipid biosynthetic process (GO:0046474),-0.26905120250102915,-1.1424592295961244,0.1903114186851211,0.6622231301560203,1.0,47/172,17.31%,PIP5K1B;DGKH;PITPNM2;CEPT1;PLCG2;INPP5D;BMX;PIK3R6;CRLS1;SYNJ1;INPP4A;DGKB;PIK3C2B;CDS1;ARF1;MFSD2A;FAR1;CDIPT;CPNE3;PLEKHA1;PIK3CD;PIK3C2A;LPCAT3;GPAT4;DGKZ;MTM1;DGKG;GPAT3;MTMR6;PITPNM3;MTMR9;PIK3C3;INPPL1;PIK3R5;PIP5K1C;CSNK2B;LPCAT1;LPIN3;SBF1;SACM1L;PI4KB;PLA2G4A;ETNK1;LPIN1;PIK3R3;MTMR12;INPP5F
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.32038097773322743,-1.1423210416730132,0.22033898305084745,0.6618097178917578,1.0,18/59,14.77%,HMCN1;PECAM1;BSG;PTPRM;CADM1;CDH1;ITGB1;CDH2;PKD1;KIRREL3;ROBO4;CEACAM1;PVR;CADM3;CDH13;CNTN6;TENM3;MPZL2
prerank,cellular response to amino acid stimulus (GO:0071230),-0.3687557966855783,-1.1422481306339203,0.26095617529880477,0.6611697354362935,1.0,17/33,26.97%,SESN3;FYN;SH3BP4;CAPN2;MTOR;SESN2;LAMTOR1;XBP1;CPEB1;SPAAR;LAMTOR2;RRAGB;NSMF;LAMTOR4;CASTOR1;GLRA1;CPEB3
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.4106691902074995,-1.142206644824044,0.3016194331983806,0.6604290795592851,1.0,10/20,13.88%,NOTCH1;SMAD9;VEGFA;SMAD5;SESN2;XBP1;BMP2;ATF4;RUNX2;MT3
prerank,regulation of transposition (GO:0010528),0.49901684402583646,1.1414039739386737,0.3399602385685885,0.7756100603375322,1.0,2/13,7.18%,MYBL1;UBR2
prerank,regulation of macrophage differentiation (GO:0045649),0.485819496712095,1.1410512686690721,0.31736526946107785,0.7754393510864183,1.0,4/15,12.85%,IL34;PRKCA;CSF1;HSF1
prerank,regulation of cell population proliferation (GO:0042127),-0.23464447615635928,-1.1404560531000407,0.03424657534246575,0.6642993050356566,1.0,134/691,13.14%,LEF1;KITLG;ZBTB7C;NTRK3;FN1;PTPRJ;FTH1;CLDN5;NOS3;ACER3;TIAM1;IGFBP6;ACER2;CD200;LIFR;TFRC;KDR;KRAS;THBS1;ADAM10;NAMPT;PLPP1;BMP5;ACVRL1;STX3;TGFB2;PTPN14;CBFA2T3;TES;RPL23;JAG1;KLF4;RPS9;PPP2R5C;RUNX1;PTK2;ETS1;TBC1D8;ADARB1;WNT9A;ENG;PTK2B;DAB2IP;NGF;NOTCH1;SH3BP4;TBX1;P3H2;HES1;BMPR2;ROR2;LGMN;SFRP4;RPS6;LIMS1;RERG;TGFBR2;WARS1;RBFOX2;SOX4;PINX1;TBX2;TGFB1;CALR;TSPAN31;KDM4C;JAG2;CCDC88A;CTNNB1;TOB1;ST18;LRP5;TNFRSF11A;TJP1;EGLN3;SIX1;ATP8A2;GNL3;TBX3;DDAH1;PDGFC;CUL3;FLT4;ADRA1A;APP;JUN;ELN;ECRG4;VEGFA;PDCD10;AQP11;CNOT6L;PTHLH;EMP2;PAK1;EDN1;PODN;DPP4;ING4;ESM1;APC;WWTR1;FGF7;RHOA;SOX7;BTG3;CDKN1B;RTKN2;XBP1;CDK6;BMP2;MEN1;HHEX;NCK2;IFI35;HGS;STAT3;GCNT2;ACE2;RPS4X;CDH13;GPER1;PBRM1;ZFP36L1;JUNB;LMNA;REST;GLI1;TCIRG1;CD81;ARHGEF2;CLU;COPS9;CADM4
prerank,megakaryocyte differentiation (GO:0030219),0.5066465139291293,1.1404227317090254,0.3196078431372549,0.7760576785079356,1.0,4/11,17.86%,KIT;MED1;CDKN2B;IL11
prerank,peripheral nervous system development (GO:0007422),-0.3935296382599863,-1.140079797578605,0.2536082474226804,0.6645500376734523,1.0,7/23,18.83%,ADGRG6;NGF;SERPINI1;SCN8A;GPC1;NF1;SOX10
prerank,error-prone translesion synthesis (GO:0042276),-0.4091681204173877,-1.1399361910573185,0.2907949790794979,0.6640980797426446,1.0,7/21,15.72%,UBB;REV3L;UBC;RPS27A;RPA1;UBA52;POLK
prerank,Golgi to plasma membrane transport (GO:0006893),-0.33537176915898964,-1.1397751786517019,0.23842592592592593,0.663696742160733,1.0,9/47,9.80%,SPTBN1;STXBP6;EXOC6;NSF;RAB31;EXOC4;GOPC;GOLGA7;EXOC5
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.39467805935100075,-1.1397567457395734,0.2661122661122661,0.6629180393753514,1.0,11/25,19.35%,CAV1;CALM1;CXADR;CTNNA3;ATP2A2;RYR2;CACNA1C;JUP;DSG2;DSP;TRPM4
prerank,positive regulation of macrophage differentiation (GO:0045651),0.5231530962378066,1.1391569685554481,0.3237113402061856,0.7785277042239573,1.0,4/11,12.85%,IL34;PRKCA;CSF1;HSF1
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.32696523535390476,-1.1389097760837719,0.24205378973105135,0.6643734577255366,1.0,19/55,23.14%,FHL1;PINX1;PSMD13;RBX1;PSMF1;PSMB10;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;PSME1;CUL1;PSMB3;PSMD5;SKP1;PSMD9;PSMB4
prerank,potassium ion transmembrane transport (GO:0071805),0.3132687463705619,1.138732480686909,0.21907600596125187,0.7784814326350371,1.0,9/135,2.41%,ATP1A2;SLC24A3;KCNK2;KCNQ4;NALCN;KCNA5;SLC1A3;KCNT2;ATP1B3
prerank,ion transport (GO:0006811),0.32260579585453825,1.138694309289793,0.262015503875969,0.777459219270695,1.0,8/111,3.10%,TRPM3;SLC24A3;SLC8A3;WNK4;SLC5A5;SLC1A3;SLC20A2;SLC8A1
prerank,amino acid transport (GO:0006865),0.36073476114599845,1.1384724946251412,0.2833333333333333,0.7769621725229389,1.0,7/49,7.55%,SLC7A11;SLC38A3;SLC6A12;PDPN;SLC38A9;SLC43A1;SLC1A5
prerank,PERK-mediated unfolded protein response (GO:0036499),-0.4958007222704369,-1.1382989198183864,0.30739299610894943,0.6652816045244782,1.0,5/10,31.13%,HSPA5;ATF4;HERPUD1;CCL2;NFE2L2
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.5050432071527381,1.138229654930663,0.33544303797468356,0.7764994099574188,1.0,4/11,5.79%,EFNB2;DKK1;SOX6;FRS2
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),-0.3691822394545548,-1.1380538013381094,0.26247288503253796,0.6651536649384874,1.0,8/33,11.70%,PRKG1;MEF2C;APOD;IGFBP5;PDCD4;CDKN1B;NDRG4;GPER1
prerank,actin nucleation (GO:0045010),-0.404683186931841,-1.1380083038144027,0.2776659959758551,0.6644205926727149,1.0,10/21,21.25%,ARPC1B;ARPC3;WHAMM;ACTR2;SPIRE1;ARPC4;ARPC5L;ARPC1A;TRIM27;ACTR3
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.29703493166022443,1.1378833433402584,0.19158200290275762,0.7763409489786842,1.0,28/182,10.96%,IGF1;ROBO1;SLC24A3;ROCK2;WNT4;NOTCH2;PRKN;RBMS3;PCSK9;TNRC6B;TNRC6A;PRKAA2;SLC2A10;TET1;OPTN;ABCC2;PRKAA1;RBL2;WWP2;PICALM;APLN;PARP10;HDAC1;AGO2;FLCN;PARP9;ATOH8;DLG4
prerank,regulation of interleukin-6 production (GO:0032675),-0.2909903235211059,-1.1377512719338898,0.19946091644204852,0.6643136965033738,1.0,47/96,35.55%,IL33;CD200;GAS6;PLCG2;MBP;LBP;ARRB1;APP;XBP1;STAT3;CD74;ARHGEF2;HSPD1;CD47;IRAK3;IFIH1;ZC3H12A;TYROBP;MYD88;NCKAP1L;TIRAP;AFAP1L2;HYAL2;AGER;RAB7B;TNFAIP3;SPHK2;FOXJ1;TLR4;TLR7;TREM2;C1QTNF4;MAVS;TLR6;DHX9;NOD2;TLR1;C5AR2;NOS2;PTPN22;LPL;SYK;IL1A;F2R;IL16;TSLP;TLR8
prerank,regulation of AMPA receptor activity (GO:2000311),-0.386524621716278,-1.1377414502567471,0.30103092783505153,0.6635050443689071,1.0,11/25,23.10%,MEF2C;SHANK3;MINK1;CACNG3;RELN;ADRB2;CACNG2;CNIH3;SHISA6;MAPK8IP2;SHANK1
prerank,microtubule nucleation (GO:0007020),0.44371285563972956,1.1375635150390642,0.30784708249496984,0.7761004448110701,1.0,8/19,18.67%,CCDC57;TUBGCP6;TUBGCP2;GOLGA2;RANBP9;TUBG1;AKAP9;TPX2
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.4334484657260818,-1.137300632843307,0.31210191082802546,0.6638739892645261,1.0,10/17,22.49%,CAV1;KLF7;CEACAM1;APOLD1;AJAP1;MAFF;DSPP;PRKX;DLL1;CEBPB
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.4831957218803702,1.13717525913018,0.32112068965517243,0.7760136377873769,1.0,3/13,11.25%,LARGE1;CHST3;RENBP
prerank,glycerolipid metabolic process (GO:0046486),-0.47933344085485424,-1.1367607469927423,0.30210325047801145,0.6645774699131811,1.0,6/11,29.21%,DGKB;DGKZ;DGKG;PGP;DGKQ;PLA2G15
prerank,phagolysosome assembly (GO:0001845),-0.4738926280275756,-1.13661165842499,0.30975143403441685,0.6641247044123498,1.0,8/12,31.95%,SYT7;RAB39A;RAB14;RAB7B;RAB7A;RAB20;CORO1A;PLA2G5
prerank,protein localization to cell surface (GO:0034394),0.42604901081027247,1.1362975399574127,0.3132295719844358,0.7773033836951401,1.0,5/26,7.89%,ANGPT1;FBLN5;PIGU;ANK2;GGA2
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.3904820503257774,-1.135788064780063,0.2839506172839506,0.6656013247499459,1.0,14/25,25.08%,HIP1;BCAR3;CBL;CCDC88A;HIP1R;RTN4;SHKBP1;GPER1;PDE6H;PLAUR;AKT1;AFAP1L2;ARAP1;HAP1
prerank,regulation of tube diameter (GO:0035296),0.49452762767022124,1.135545376819568,0.3353658536585366,0.7772338108189599,1.0,3/13,6.13%,ROCK2;ACE;SCPEP1
prerank,vascular process in circulatory system (GO:0003018),0.49452762767022124,1.135545376819568,0.3353658536585366,0.7772338108189599,1.0,3/13,6.13%,ROCK2;ACE;SCPEP1
prerank,female gonad development (GO:0008585),0.44758218794173665,1.1355210368054303,0.2914285714285714,0.7761928697379596,1.0,2/19,1.24%,NR2F2;KIT
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.446346677735149,1.1353877219273092,0.3045977011494253,0.7754457393019265,1.0,2/17,1.17%,ROBO1;EFNB2
prerank,regulation of Notch signaling pathway (GO:0008593),-0.3013587789254646,-1.1350410791012848,0.22015915119363394,0.6667985483294393,1.0,19/76,12.21%,NOS3;TGFB2;JAG1;PRAG1;SREBF2;NOTCH3;NOTCH1;CCN3;GATA2;JAG2;ARRB1;NOTCH4;PDCD10;LFNG;ZBTB7A;MFNG;STAT3;SYNJ2BP;EPN2
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.26451885249689144,-1.134568468267902,0.14705882352941177,0.6673808469302069,1.0,68/173,31.93%,SPTBN1;NSF;GAS6;CD55;MIA2;CAPZA2;ACTR10;DYNLL2;GOPC;TMED5;VTI1B;COPG1;CUL3;TMED2;BET1L;LMAN2;MCFD2;DCTN3;RAB1A;TRAPPC6B;ARFGAP2;WHAMM;SPTBN4;TMED3;CNIH1;TMED10;LMAN2L;BCAP31;SEC23A;CTSZ;DCTN4;ATL2;GBF1;PREB;TRIP11;TEX261;RAB1B;TRAPPC2;CNIH3;ANK3;DCTN1;CTSC;SEC16B;VAPA;TMEM115;TRAPPC4;TMED7;CAPZA1;USE1;RAB2A;ATL3;SEC16A;TRAPPC1;DYNC1I1;TRAPPC5;GRIA1;STX5;COL7A1;MPPE1;RANGRF;KDELR3;GORASP1;BCAP29;TMED1;SPTBN5;COPA;PGAP1;PEF1
prerank,triglyceride biosynthetic process (GO:0019432),0.45744946917490537,1.1343144203635167,0.31947069943289225,0.7773285506591414,1.0,2/18,1.81%,AGMO;LPGAT1
prerank,cellular response to nitrogen compound (GO:1901699),0.4501230308668209,1.1337004181046517,0.296,0.7780033314793164,1.0,2/20,7.32%,ROCK2;BLM
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.4672735256093774,1.1331794094711272,0.32,0.7785158844013398,1.0,4/16,8.77%,APPL2;PPARA;NLRC3;SIRPA
prerank,anterograde trans-synaptic signaling (GO:0098916),-0.26154835328191156,-1.133041336161121,0.1736111111111111,0.6708815040367606,1.0,76/224,26.21%,UNC13B;SLC12A7;GRM3;DLG2;KCNQ3;CALM1;ATXN3;GRM7;PLP1;MBP;EXOC4;MINK1;SLC12A6;SLC1A1;GABRB3;HOMER1;SYPL1;GRIK4;CAMKK2;GABRB1;CHRM3;DLGAP1;CACNA1E;NRXN1;HTR2A;AMPH;KCNMB4;KCNA1;GABRG3;GRIN1;RPS6KA1;SLC12A4;SYT10;SYNJ2BP;CACNB2;GAD1;SNAP25;PCDHB14;BSN;PRKAR1A;APBA3;SYN2;HRH1;KCNQ2;CAMK4;KCNIP2;PTCHD1;CACNA1B;GLRA3;GRIA2;SLC6A5;KCND2;CACNB3;RIT2;GABRA5;GRIK2;CDK5;CAMKK1;HRH2;GABRE;CHRNB1;NPTX1;SST;SNCG;NPY;HTR2C;GABRG2;PNOC;CPLX1;HAP1;GLRA1;CNP;APBA2;KCNC4;SLC1A2;CHRM1
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.4701963074645668,1.1328633585722396,0.3183673469387755,0.7782279494602102,1.0,7/16,20.56%,NAA80;AANAT;NAA35;CREBBP;NAA60;NAA50;KAT2B
prerank,mammary gland epithelium development (GO:0061180),0.4857857197405159,1.1326139684846082,0.3182751540041068,0.7778054958877569,1.0,4/14,10.91%,WNT4;JAK2;LATS1;EPHA2
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.4471242698122745,-1.1325202911035008,0.3141683778234086,0.6714808767569947,1.0,5/14,28.12%,GAS6;NLRP2B;CARD16;TRAIP;GPS2
prerank,aortic valve development (GO:0003176),-0.3492254056325802,-1.1323811515038682,0.27488151658767773,0.67097719774127,1.0,13/34,12.27%,SLIT2;NOS3;TIE1;JAG1;NOTCH1;BMPR2;NFATC1;TGFB1;TNFRSF1B;ELN;HEY2;BMP2;HEYL
prerank,protein O-linked glycosylation via serine (GO:0018242),-0.4941523158671779,-1.1323142645754078,0.33206831119544594,0.6703515980784742,1.0,6/10,29.09%,GALNT13;GALNT2;GALNT1;POGLUT3;MGAT5B;POGLUT1
prerank,hydrogen peroxide metabolic process (GO:0042743),0.45288195541085713,1.132295366153277,0.316,0.7775850423232752,1.0,5/19,15.03%,PXDN;DUOX2;ACOX1;DUOX1;MAOB
prerank,cardiac atrium morphogenesis (GO:0003209),-0.43512368209819985,-1.1318652683283466,0.310126582278481,0.6707945976113516,1.0,6/16,10.71%,TGFB2;ENG;NOTCH1;BMPR2;HEY2;BMP2
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.5014208054208052,-1.1314633313640663,0.33269961977186313,0.6710598011011224,1.0,7/10,36.73%,DNAJB1;HSPA1B;SORL1;DNAJB6;HSPA1A;DNAJB2;DNAJA4
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.4992026901882274,1.1311995914647555,0.33877551020408164,0.7795810722733165,1.0,3/12,8.78%,IL18;IL6;NUPR1
prerank,negative regulation of catalytic activity (GO:0043086),-0.38381713619488234,-1.1311736542075432,0.2857142857142857,0.6710223969076253,1.0,8/24,16.46%,NOTCH1;NOS1;TMBIM1;NES;APBA3;MT3;ATP5IF1;PLN
prerank,neuronal action potential (GO:0019228),0.4338665873437378,1.1311166717987589,0.30443548387096775,0.7787157002275724,1.0,1/22,0.08%,SCN7A
prerank,positive regulation of RNA metabolic process (GO:0051254),-0.33433100997496196,-1.1310228781111065,0.25295508274231676,0.6706353050344741,1.0,17/45,24.81%,TGFB1;DDX5;BUD23;GRSF1;LIN28B;UTP15;MAP2K2;BMP4;SUPV3L1;HNRNPLL;RBM22;SIRT7;RBM20;RELA;ZPR1;ERN1;HRAS
prerank,microglial cell activation (GO:0001774),-0.4165607062868202,-1.130994729060734,0.2842535787321063,0.6698888127058983,1.0,10/21,28.80%,APP;GRN;CLU;C1QA;IFNGR1;CX3CR1;TYROBP;AGER;ITGB2;TREM2
prerank,regulation of sodium ion transport (GO:0002028),0.39938993685321955,1.1307111062582975,0.2984014209591474,0.7787845437473586,1.0,7/34,6.45%,WNK4;SNTA1;GPD1L;NKAIN4;NEDD4;SIK1;DLG1
prerank,cardiocyte differentiation (GO:0035051),0.5082523400947668,1.1306124666246613,0.3606194690265487,0.7779406790761993,1.0,4/10,9.06%,CBY1;AKAP13;SIK1;KDM6B
prerank,regulation of autophagosome assembly (GO:2000785),0.40155071927447966,1.1304878288551377,0.2966601178781925,0.7771464945688835,1.0,8/33,13.38%,NPRL3;NPRL2;LRRK2;MTMR3;NUPR1;TMEM39A;RAB3GAP1;FEZ1
prerank,protein palmitoylation (GO:0018345),-0.37128810674387824,-1.130286160438083,0.2735229759299781,0.6709739260486707,1.0,13/30,26.41%,ZDHHC14;ZDHHC15;GOLGA7;ZDHHC2;ZDHHC7;PORCN;SELENOK;HHAT;ZDHHC4;ZDHHC8;ZDHHC20;ZDHHC17;ZDHHC5
prerank,positive regulation by host of viral transcription (GO:0043923),-0.4467613729634605,-1.1302393478744508,0.3143418467583497,0.6702631505379874,1.0,2/15,7.67%,LEF1;JUN
prerank,response to UV-B (GO:0010224),-0.47702190482315576,-1.1302322481990725,0.3145009416195857,0.6694664156560982,1.0,6/12,23.64%,CRIP1;MFAP4;MSH2;CDKN1A;HYAL2;RELA
prerank,actin filament organization (GO:0007015),0.30361056527686453,1.130199513469548,0.22436849925705796,0.7768510000344877,1.0,23/151,8.07%,SHROOM3;CGNL1;TPM1;MYO5C;RHOD;FHOD1;DPYSL3;SHROOM2;AVIL;MYO1H;BAIAP2;NEBL;ABI2;ARHGAP12;WASL;FAT1;SPIRE2;DLG1;BAIAP2L2;PPP1R9A;RHOBTB2;CORO7;MCU
prerank,cellular response to UV-A (GO:0071492),0.5052353575167926,1.130183243971473,0.31910569105691056,0.7757942557760009,1.0,3/11,9.46%,MMP2;MMP9;CERS1
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.4409442592344299,-1.1301647528594763,0.310838445807771,0.6688536627010173,1.0,8/15,33.68%,SIX1;VEGFA;SIX4;BMP4;PAX8;AGT;NOG;PAX2
prerank,cellular response to fatty acid (GO:0071398),0.510696481747805,1.1298356271641337,0.3112128146453089,0.7756516716171825,1.0,1/12,1.13%,PID1
prerank,negative regulation of endothelial cell migration (GO:0010596),-0.35965785020556446,-1.1296868727052771,0.28634361233480177,0.6693264270123831,1.0,8/36,5.53%,MEF2C;SLIT2;PTPRM;THBS1;ACVRL1;DAB2IP;NOTCH1;TGFB1
prerank,second-messenger-mediated signaling (GO:0019932),0.3386382663387314,1.129599981135749,0.27732463295269166,0.7751816243545098,1.0,11/82,8.07%,RCAN2;ACKR2;CCR9;CXCR5;PDPK1;NDNF;CXCR6;SPHK1;LRRK2;PPP1R9A;MCU
prerank,regulation of aerobic respiration (GO:1903715),-0.4346127096910942,-1.1295175948666436,0.31189083820662766,0.6689952310861892,1.0,6/15,22.36%,CBFA2T3;UQCC2;IDE;PINK1;NOP53;VCP
prerank,apoptotic cell clearance (GO:0043277),-0.3676368817457002,-1.1294264196736021,0.2817551963048499,0.6684112038921682,1.0,5/30,4.36%,THBS1;RAC1;GAS6;SCARB1;TGM2
prerank,regulation of protein localization to plasma membrane (GO:1903076),-0.3026833721045168,-1.1293345768480016,0.24736842105263157,0.6678572012078396,1.0,17/78,9.08%,SPTBN1;PRKCH;ACTB;STX3;ITGB1;STX7;TGFB1;BCL2L1;VAMP8;VTI1B;NKD2;WNK3;ABI3;ZDHHC2;ZDHHC7;AP2M1;APPL1
prerank,tetrahydrofolate metabolic process (GO:0046653),0.4919998341861619,1.1293010849027991,0.3388773388773389,0.7749375152208454,1.0,6/10,20.76%,MTHFR;TYMS;SHMT1;MTHFS;DHFR;MTHFD2
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.4500810804638698,1.1292094271050344,0.29098360655737704,0.7741149726967312,1.0,4/16,9.67%,LHPP;AMPD3;ADSL;GMPS
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.3995107485922538,1.1291938538363158,0.3032015065913371,0.7730707575714619,1.0,4/33,3.35%,STXBP4;PLCB1;UBE2E2;ANXA1
prerank,peptidyl-lysine monomethylation (GO:0018026),0.5104753823322341,1.1285297506985137,0.329938900203666,0.7738403056279147,1.0,4/10,19.84%,SETD7;SETD6;SETD2;SETD4
prerank,synaptic vesicle localization (GO:0097479),-0.45755842978121564,-1.1282649236672337,0.3010752688172043,0.6698565311507059,1.0,4/13,8.61%,RAB27A;SYNJ1;DNM2;SYNDIG1
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.3383504592140355,-1.127807430537999,0.2740740740740741,0.6702667814646687,1.0,13/48,13.39%,LIMS2;RAC1;CARMIL1;DOCK1;FLNA;LIMS1;FERMT2;CALR;MYOC;CRK;CDKL3;S100A10;NEDD9
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.34521399774658296,1.127689045292264,0.2981878088962109,0.7751137186513183,1.0,13/69,12.15%,POLR2D;PHAX;CDK7;INTS8;CCNT2;CCNT1;POLR2A;GTF2F1;RPRD1B;SNAPC5;TAF8;RPRD2;ICE2
prerank,glycerophospholipid metabolic process (GO:0006650),-0.2993361324151758,-1.1276268548868358,0.23342175066312998,0.6699269547971588,1.0,18/75,17.14%,GPCPD1;DGKH;SERINC1;SERINC5;CRLS1;SYNJ1;SMPD4;FAR1;GDPD1;CPNE3;PLCB3;GDPD3;PNPLA6;CSF1R;PLA2G4A;ABCA3;PGP;PIGZ
prerank,endocrine system development (GO:0035270),0.4309801157637636,1.1271689486716738,0.30833333333333335,0.7755027375679492,1.0,3/21,6.50%,WNT4;DKK3;SALL1
prerank,cellular response to metal ion (GO:0071248),-0.27915640639729,-1.1269586916904832,0.21450151057401812,0.670920296708702,1.0,28/123,10.77%,MEF2C;SLC12A2;B2M;DLG2;CLIC4;CDH1;IQGAP1;PLCG2;MT1E;MT1F;MT1G;MT1B;MT1M;MT1A;MT1H;MT1X;LGMN;CPNE8;MT2A;JUN;CPNE3;CPNE2;MAPK8;ADCY7;CHUK;CACNA1H;CDKN1B;KCNA1
prerank,secondary alcohol metabolic process (GO:1902652),0.3759584021295998,1.1267321750218433,0.2935153583617747,0.7756679380280105,1.0,8/42,12.51%,CYP27A1;ABCA1;IDH2;ABCA5;SOAT2;RXRA;GBA2;IDH3G
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.4518494762013976,-1.1267095833002527,0.3111545988258317,0.6707889784801736,1.0,7/13,30.94%,HNRNPU;LARP7;NELFCD;NELFE;RNF168;EAPP;RNF8
prerank,chemical synaptic transmission (GO:0007268),-0.2530784687206041,-1.1262041403221958,0.16929133858267717,0.6713691868924017,1.0,90/284,26.21%,UNC13B;SLC12A7;GRM3;DLG2;HSPA8;KCNQ3;LIN7A;CALM1;ATXN3;GRM7;PLP1;MBP;PTPRN2;EXOC4;MINK1;SLC12A6;SLC1A1;GABRB3;HOMER1;STX1A;SYPL1;GRIK4;CAMKK2;GABRB1;CHRM3;DLGAP1;CACNA1E;SLC17A6;NRXN1;HTR2A;NAPB;AMPH;KCNMB4;KCNA1;GABRG3;GRIN1;RPS6KA1;SLC12A4;SYT10;SYNJ2BP;CACNB2;SLC1A4;GAD1;SNAP25;PCDHB14;BSN;PRKAR1A;APBA3;SYN2;HRH1;KCNQ2;CAMK4;KCNIP2;PTCHD1;CACNA1B;GLRA3;GRIA2;SLC6A5;STAC3;KCND2;CACNB3;RIT2;GABRA5;GRIK2;GRID2;CDK5;CAMKK1;SHISA6;PPFIA3;TSPOAP1;HRH2;GABRE;CHRNB1;NPTX1;SST;SNCG;RAB3A;NPY;HTR2C;KIF1B;GABRG2;PNOC;CPLX1;HAP1;GLRA1;CNP;APBA2;KCNC4;SLC1A2;CHRM1
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",-0.38237837153233634,-1.1261972022918723,0.2871900826446281,0.6705759107226386,1.0,9/25,25.22%,MEF2C;GSK3B;GRIN1;INSYN2A;ARRB2;GRID2;AKT1;MAPK8IP2;GLRA1
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),-0.3693616139493732,-1.1257302069223474,0.28051391862955033,0.6710497663495368,1.0,9/29,18.02%,HSP90AA1;HSP90AB1;PPIA;PINX1;RPA1;TERF2IP;ANKRD28;TNKS1BP1;CDK2
prerank,erythrocyte differentiation (GO:0030218),0.3682546081460137,1.12537099049803,0.30412371134020616,0.7784640331844521,1.0,8/44,10.25%,TGFBR3;KIT;ACIN1;UFL1;LYAR;CEBPG;MED1;JAK2
prerank,negative regulation of inflammatory response (GO:0050728),0.29948682954585615,1.125154133703987,0.24585635359116023,0.7779532954765032,1.0,8/182,3.30%,IGF1;RORA;ADCY5;ADCY1;C1QTNF3;PPARA;ADM;SLAMF8
prerank,regulation of cellular protein metabolic process (GO:0032268),-0.33570557323493067,-1.1247218051837582,0.2585812356979405,0.672908770921181,1.0,24/47,34.66%,KLF4;NFKBIA;TGFB1;APP;EDN1;EIF4G1;SSH1;NR1H2;EIF2A;AGTR1;NOLC1;AKT1;NR1H3;EIF4E;PUM3;PCIF1;DDX25;RBM4B;RPL10;METTL18;AGT;WNT7A;ATXN2;PM20D2
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.4957386766751392,-1.1246455792127312,0.32827324478178366,0.6722847058936301,1.0,4/10,22.17%,APC;RCC2;KNSTRN;SPAG5
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.4233838152262574,-1.1240962456605723,0.3091684434968017,0.6730464433410378,1.0,8/18,20.01%,ELOVL7;ELOVL5;ACSL4;ELOVL6;ELOVL1;ACSL3;TECR;ACSL5
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.3698368210645948,1.1235787758924694,0.28990825688073396,0.7813236420283872,1.0,9/38,11.10%,ITGB3BP;RBBP4;CENPI;NASP;RBBP7;MIS18BP1;RSF1;CENPQ;SMARCA5
prerank,negative regulation of biomineral tissue development (GO:0070168),-0.3936663385708846,-1.1234945427305971,0.3050847457627119,0.673845280599868,1.0,8/21,9.08%,NOS3;GAS6;PTK2B;NOTCH1;ASPN;TGFB1;SRGN;HEY2
prerank,positive regulation of mononuclear cell migration (GO:0071677),-0.36141858910032476,-1.1227460820646498,0.2653061224489796,0.6751785061231054,1.0,4/29,5.78%,JAM2;GAS6;LGMN;CALR
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.4882114251483244,-1.1223322196007541,0.34392523364485983,0.6755068509855064,1.0,6/10,35.03%,GABRG3;GABRA5;GABRE;GABRG2;GABRG1;GABRB2
prerank,regulation of protein transport (GO:0051223),-0.37665328234274126,-1.1222263787310531,0.29559748427672955,0.6749409254016511,1.0,14/27,29.05%,HSPA8;DNAJA1;RHBDF2;CHP1;NDFIP2;DNAJC1;PTPN1;ATP13A2;NDFIP1;DISP1;ARFIP1;SNX3;PPM1F;STXBP5L
prerank,negative regulation of neuron death (GO:1901215),-0.2912383259084732,-1.1221113001854903,0.23300970873786409,0.6744471576651072,1.0,30/93,19.45%,MEF2C;CD200;CD34;PPARGC1A;FBXO7;PTK2B;NGF;LGMN;SOD1;FOXQ1;SIX1;GSK3B;TNFRSF1B;GRN;SET;EIF4G1;ATF4;MSH2;REST;CHGA;MT3;NENF;SIX4;WFS1;ATP13A2;PRKCG;PINK1;LIG4;TYRO3;CDK5
prerank,positive regulation of endocytosis (GO:0045807),-0.3275438982016885,-1.1220031667504393,0.2853881278538813,0.6739465622115794,1.0,7/45,3.42%,HIP1;SGIP1;B2M;CBL;HNRNPK;NEDD4L;RAB31
prerank,regulation of endocytosis (GO:0030100),0.3447872367603364,1.121877929690738,0.2894308943089431,0.785026253481879,1.0,14/61,12.80%,EPHA3;DAB2;TFR2;SYT11;SPHK1;SNX33;RUFY2;GPC3;CCL19;PICALM;ABL1;RUBCN;SNX12;PACSIN3
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.45603027487197156,-1.1216640508957287,0.3144016227180527,0.6740815584153539,1.0,8/13,31.57%,SLC4A10;GRIK2;SHISA6;PPFIA3;RAB3A;SYP;SLC8A2;SHISA8
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),-0.380168002352702,-1.121368534853311,0.27155172413793105,0.6741057450108344,1.0,4/25,3.76%,B2M;SLC7A5;PLCG2;CD55
prerank,regulation of tissue remodeling (GO:0034103),0.44175450688471696,1.1213511837290597,0.31898238747553814,0.7853995364011319,1.0,2/18,1.22%,LEPR;IL18
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.4702796969032517,1.1213124320731294,0.3146551724137931,0.7844103106491057,1.0,3/15,9.22%,PRKN;BCL2;MDM2
prerank,positive regulation of secretion by cell (GO:1903532),0.33840030055504944,1.120755493551737,0.28125,0.7850164501330504,1.0,5/70,3.46%,IGF1;BMP6;FRMD4A;PLA2G10;DTNBP1
prerank,sterol transport (GO:0015918),-0.4084242190574128,-1.1202130611594676,0.30962343096234307,0.6765191655389018,1.0,7/19,38.64%,CAV1;LCAT;OSBPL5;NPC2;CD36;LDLR;LDLRAP1
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.43256741338887933,1.1201569394498783,0.3217726396917148,0.7855624252422124,1.0,6/24,11.59%,JPH1;DMD;GSTM2;CAMK2D;SELENON;PKD2
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.44759790982188297,-1.1201514110816937,0.30980392156862746,0.6758803732056968,1.0,6/13,33.05%,TGFB1;SOD1;TYROBP;PRKCD;ITGB2;SYK
prerank,membrane assembly (GO:0071709),0.386047528781142,1.1201414742933924,0.31645569620253167,0.7845323291404875,1.0,8/34,9.43%,LRP4;CEL;NLGN2;IL1RAPL1;PTPRD;UBXN2B;PTEN;PICALM
prerank,nuclear membrane reassembly (GO:0031468),-0.3209820052505552,-1.120044954327903,0.26520681265206814,0.6753770674088407,1.0,20/54,26.18%,REEP3;CHMP2B;LEMD2;LBR;NSFL1C;RANGAP1;LMNA;NUP37;VRK1;PPP2R2A;NUP85;CC2D1B;NUP133;POM121;BANF1;CHMP3;CCNB2;CHMP7;CHMP4C;UBE2I
prerank,protein exit from endoplasmic reticulum (GO:0032527),-0.39667233052959483,-1.1196508659953464,0.3259109311740891,0.6756394066198509,1.0,11/23,30.04%,HSP90B1;DERL1;HERPUD1;PREB;AUP1;TMEM129;VCP;SEC16A;SYVN1;SEC61B;RANGRF
prerank,regulation of calcium-mediated signaling (GO:0050848),0.42182382878215674,1.11914908447267,0.3032015065913371,0.7862279100532283,1.0,6/25,12.16%,ITPR1;LRRK2;GPR143;CCL4;NEUROD2;TMBIM4
prerank,positive regulation of viral life cycle (GO:1903902),-0.3947005612147315,-1.119106523496155,0.31411530815109345,0.6763682519893047,1.0,7/22,23.07%,CHMP2B;LGALS1;DDB1;CD74;TYRO3;FMR1;CHMP3
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.42601707166656694,-1.1190119713869209,0.3008130081300813,0.6758238585324539,1.0,11/17,29.90%,CALM1;SPRED2;DDIT4;EIF4G1;CADM4;CALM2;DGKQ;CALM3;SPRY2;SPRED3;SMAD7
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.37969144873257366,1.1187134950942565,0.296028880866426,0.7863770976063774,1.0,6/39,6.22%,ROBO1;RBPJ;BMP2K;MAML3;ZMIZ1;MAML1
prerank,regulation of epithelial cell migration (GO:0010632),-0.32547684656861847,-1.1183098755588312,0.29219143576826195,0.676994346105516,1.0,13/51,9.36%,PTPRG;BMPER;RHOJ;TGFB2;PTK2;PLCG2;DOCK1;DAB2IP;BMPR2;CORO1C;CEACAM1;EMP2;RTN4
prerank,sodium ion import across plasma membrane (GO:0098719),-0.42221540568467986,-1.1176658098747347,0.314453125,0.6778930736626193,1.0,2/17,0.51%,SLC12A2;SLC9A2
prerank,oligodendrocyte differentiation (GO:0048709),0.437923429012418,1.117530175284818,0.328125,0.7886422216188056,1.0,2/19,2.82%,SLC8A3;SOX6
prerank,positive regulation of protein export from nucleus (GO:0046827),0.46972456745126295,1.1174486443870129,0.342911877394636,0.7878174816685923,1.0,1/15,0.48%,TCF7L2
prerank,neural tube development (GO:0021915),0.4545727219847034,1.117314286821561,0.3405511811023622,0.7870801637473264,1.0,1/15,0.21%,ALDH1A2
prerank,positive regulation of epithelial cell differentiation (GO:0030858),-0.41745127808264565,-1.1171953731345583,0.3094262295081967,0.6783616358329987,1.0,10/17,30.22%,SFRP4;BMP4;TMEM100;BTG1;RFX3;FOXJ1;SFN;FGF2;AHI1;SULT2B1
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.449941797350106,1.1169112333831295,0.32437619961612285,0.7871139744575005,1.0,3/17,5.22%,ATP1A2;SLC8A1;GJA1
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.4369696129882117,1.1168678634549045,0.30528375733855184,0.7861654613841105,1.0,2/21,2.80%,EPHA7;LTF
prerank,artery morphogenesis (GO:0048844),-0.36382536001426174,-1.1168093438287208,0.2887323943661972,0.6786107188487199,1.0,11/30,9.08%,TGFB2;JAG1;ENG;NOTCH1;TBX1;HES1;BMPR2;STRA6;TBX2;VEGFA;HEY2
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.306948848487493,-1.116298565301247,0.26034063260340634,0.6776581652385083,1.0,29/61,32.40%,NSF;CUL3;TMED2;MCFD2;RAB1A;TRAPPC6B;PPP6R1;CNIH1;TMED10;SEC23A;ANKRD28;CTSZ;PREB;RAB1B;TRAPPC2;CNIH3;CTSC;SEC16B;TRAPPC4;TRAPPC9;SEC16A;TRAPPC1;TRAPPC5;GRIA1;STX5;COL7A1;GORASP1;PEF1;SEC31A
prerank,vesicle coating (GO:0006901),-0.306948848487493,-1.116298565301247,0.26034063260340634,0.6776581652385083,1.0,29/61,32.40%,NSF;CUL3;TMED2;MCFD2;RAB1A;TRAPPC6B;PPP6R1;CNIH1;TMED10;SEC23A;ANKRD28;CTSZ;PREB;RAB1B;TRAPPC2;CNIH3;CTSC;SEC16B;TRAPPC4;TRAPPC9;SEC16A;TRAPPC1;TRAPPC5;GRIA1;STX5;COL7A1;GORASP1;PEF1;SEC31A
prerank,COPII vesicle coating (GO:0048208),-0.306948848487493,-1.116298565301247,0.26034063260340634,0.6776581652385083,1.0,29/61,32.40%,NSF;CUL3;TMED2;MCFD2;RAB1A;TRAPPC6B;PPP6R1;CNIH1;TMED10;SEC23A;ANKRD28;CTSZ;PREB;RAB1B;TRAPPC2;CNIH3;CTSC;SEC16B;TRAPPC4;TRAPPC9;SEC16A;TRAPPC1;TRAPPC5;GRIA1;STX5;COL7A1;GORASP1;PEF1;SEC31A
prerank,proteolysis (GO:0006508),0.2835202350401522,1.1162196143038476,0.24115334207077327,0.7869858783534857,1.0,23/252,9.73%,ADAMTS12;ADAMTS9;CPQ;ADGRV1;AEBP1;TRABD2B;CLPX;CAPN9;MMP2;CTSH;ADAMTS7;ACE;TPP1;SUFU;MMP19;NPEPPS;CPXM1;MMP9;USP25;CUL7;MDM2;YME1L1;FBXO6
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.47939153661366,-1.115651578742336,0.3333333333333333,0.6785838446131545,1.0,6/10,28.13%,RPUSD4;TSR3;RPUSD1;NHP2;RPUSD2;NOP10
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.39740486326969116,-1.1154118051226862,0.32696390658174096,0.6784323232923591,1.0,7/21,13.02%,SLIT2;TGFB2;DAB2IP;CYRIB;ARHGAP25;CD2AP;SPRY4
prerank,positive regulation of cell cycle process (GO:0090068),0.32906390447433476,1.1152800557183467,0.2731707317073171,0.7885258372409195,1.0,12/91,12.53%,IGF1;CXCR5;DMRT1;PDGFRB;IGF2;CDC14B;UBXN2B;PKN2;PHIP;NPM2;INO80;TGFA
prerank,DNA biosynthetic process (GO:0071897),-0.42592369318605716,-1.1149795412150574,0.3360323886639676,0.6788167394328379,1.0,8/16,25.99%,PPIA;WRNIP1;POLA1;POLE;POLD3;CDKN2D;POLD1;POLL
prerank,neuron maturation (GO:0042551),-0.41657464677317935,-1.11492047280852,0.32179226069246436,0.6782151519688173,1.0,11/18,28.28%,SCARF1;ANKS1A;B4GALT5;APP;PICK1;C1QA;B4GALT6;CLN5;RND1;C3;ACTL6B
prerank,regulation of interleukin-8 production (GO:0032677),-0.30411759823395923,-1.1147670832354937,0.2625,0.6778625854619863,1.0,36/69,36.43%,TMSB4X;F3;KLF4;LBP;NOD1;PTPRC;ARRB1;STAT3;RAB1A;BCL3;CD74;MYD88;TIRAP;OTUD7B;AFAP1L2;HYAL2;HSPA1B;RELA;TLR4;TLR7;FADD;MAVS;TLR6;NOD2;TLR1;C5AR2;NOS2;PTPN22;HSPA1A;SYK;F2R;PARK7;CD33;TLR8;RIPK1;ANXA4
prerank,negative regulation of cellular senescence (GO:2000773),-0.44884986835991897,-1.1146638621114615,0.3235867446393762,0.6773572346412308,1.0,3/13,12.68%,YBX1;CDK6;MAP3K3
prerank,cilium assembly (GO:0060271),0.27754715815836695,1.1146218559699463,0.22236842105263158,0.7892930025308329,1.0,77/296,18.94%,DCDC2;ASAP1;NINL;ALMS1;INTU;AVIL;RAB3IP;ARL3;DYNC2H1;CDC14B;CCDC57;IFT80;HAUS4;CEP152;CC2D2A;ARMC9;CEP19;TTC8;SDCCAG8;WDR19;UBXN10;WDR35;KIF27;WDPCP;TBC1D32;ARL6;IQCB1;ARL13A;PAFAH1B1;CDK1;TCTN1;RPGRIP1L;TEKT2;PARVA;ATP6V0D1;BBS7;SCLT1;CEP89;WDR11;FBF1;OFD1;HAUS1;IFT27;SFI1;IFT122;TTC39C;TNPO1;CFAP74;KIF3C;EXOC3;CEP57;IFT140;WDR90;CFAP298;CCDC65;ATP6V1D;CFAP410;CEP63;CEP164;DNAAF3;CFAP70;EXOC7;EXOC1;TUBG1;PDE6D;DYNC2I1;CFAP20;IFT22;ARF4;RAB11FIP3;CEP97;AKAP9;CNTRL;IFT81;TMEM237;RP2;BBS1
prerank,regulation of monocyte differentiation (GO:0045655),0.48175615106345065,1.114405327867486,0.3433734939759036,0.7888388029098298,1.0,4/14,7.99%,IL34;HOXA7;ACIN1;CSF1
prerank,aggrephagy (GO:0035973),-0.36920212305553585,-1.114240406699775,0.3333333333333333,0.6776565982612983,1.0,8/27,15.15%,VIM;UBB;DYNLL2;UBC;RPS27A;WDFY3;CFTR;UBA52
prerank,positive regulation of response to wounding (GO:1903036),-0.38281138820555366,-1.1142401006235467,0.294238683127572,0.6768695406558846,1.0,7/24,8.57%,ACTG1;OCLN;ITGB1;PTK2;SCARF1;KANK1;GRN
prerank,negative regulation of fat cell differentiation (GO:0045599),0.39031688075310694,1.1135377651490637,0.32228360957642727,0.7901193634031388,1.0,5/34,6.95%,RORA;RUNX1T1;ANKRD26;IL6;SMAD3
prerank,regulation of interleukin-1 production (GO:0032652),-0.4204723540842885,-1.1126174583644146,0.33663366336633666,0.6803313697634373,1.0,3/15,6.85%,FOXP1;GAS6;CEACAM1
prerank,small GTPase mediated signal transduction (GO:0007264),-0.2820090977345241,-1.1124676528534267,0.23976608187134502,0.6799589581916883,1.0,33/103,18.05%,ARHGAP31;RAPGEF5;TIAM1;RASGRP3;KRAS;RAC1;SHTN1;NRAS;RERG;G3BP1;PLK2;CCDC88A;ABR;BCR;MRAS;CHP1;JUN;NUCB1;RAB38;RALB;KSR2;USP50;RHEB;GRAP;RUNDC3A;CCDC88C;PRKD1;NF1;RRAS;USP28;USP8;CDK2;RGS19
prerank,positive regulation of isotype switching (GO:0045830),-0.436220662373798,-1.112357395483703,0.348,0.6794579881145982,1.0,8/15,30.44%,TFRC;TGFB1;CD40;CLCF1;KMT5C;SHLD3;SHLD2;RIF1
prerank,glycosaminoglycan catabolic process (GO:0006027),0.35348810580875284,1.1122763510455276,0.2897822445561139,0.7926087669048572,1.0,8/55,5.64%,CEMIP;FMOD;SDC2;OGN;GPC6;OMD;PRELP;GPC3
prerank,cellular response to insulin stimulus (GO:0032869),-0.2702434169039384,-1.1122075382235324,0.21008403361344538,0.6790590076908325,1.0,47/124,24.78%,GAB1;GRB14;BCAR3;NAMPT;CAV2;AP3S1;RAB31;PKM;BCAR1;ATP6V0A1;HDAC5;CEACAM1;GSK3B;FOXO1;ZDHHC7;C2CD5;APPL1;APC;ATP6V1A;ATP6V0C;PIK3C2A;XBP1;CPEB1;ZFP36L1;PDK2;ATP6V1E1;IDE;TCIRG1;MYO5A;LPIN3;LPIN1;ATP6V0A4;PIK3R3;SLC39A14;ATP6V0A2;INSR;HDAC9;AKT1;ATP6V0D2;RAB8A;CAPN10;INSIG1;TRIB3;DENND4C;ATP6V0E2;ATP6V1B2;RAB8B
prerank,mitotic cytokinesis (GO:0000281),0.35328833952947597,1.111991013577411,0.2903225806451613,0.7923750392417485,1.0,7/47,5.80%,ROCK2;KLHDC8B;ARL3;SNX18;SNX33;SNX9;SON
prerank,axon development (GO:0061564),-0.29395357984148773,-1.1118647470525185,0.1970074812967581,0.679239413810167,1.0,28/78,24.55%,KLF7;ACTB;MAP1B;GRM7;S100A6;PLP1;SHTN1;NRCAM;RTN4RL1;DCC;APBB1;APP;RTN4;SLITRK5;LMTK2;MARK2;SPTBN4;NTNG1;DSCAML1;CDK5;ANK3;L1CAM;MAP1A;RAB8A;BRSK2;RAB3A;ZPR1;ZDHHC17
prerank,cilium organization (GO:0044782),0.2873839936691431,1.1118077656516647,0.24039829302987198,0.7917949387440668,1.0,59/209,19.40%,DCDC2;ASAP1;INTU;AVIL;RAB3IP;ARL3;DYNC2H1;CDC14B;CCDC57;IFT80;CC2D2A;ARMC9;CEP19;TTC8;WDR19;UBXN10;WDR35;KIF27;WDPCP;ARL6;IQCB1;TCTN1;TEKT2;PARVA;ATP6V0D1;BBS7;SCLT1;CEP89;WDR11;FBF1;OFD1;PKD2;IFT122;CFAP126;TTC39C;EXOC3;ARMC2;IFT140;WDR90;CFAP298;CCDC65;ATP6V1D;CFAP410;CEP164;CFAP70;EXOC7;EXOC1;PDE6D;DYNC2I1;CFAP20;ARF4;RAB11FIP3;TTC17;IFT81;TMEM237;RP2;BBS1;RTTN;TRAF3IP1
prerank,regulation of microtubule nucleation (GO:0010968),-0.4861663348226166,-1.1116993047124708,0.3376383763837638,0.6788751387748778,1.0,7/10,32.58%,PAK1;GIT1;CKAP5;DCTN1;HSPA1B;RANGRF;HSPA1A
prerank,negative regulation of histone acetylation (GO:0035067),-0.4690655938538857,-1.1116894035020841,0.3707865168539326,0.6781162129086814,1.0,6/11,31.38%,SET;CTBP1;SPI1;NOC2L;SIN3A;THAP7
prerank,neuron cell-cell adhesion (GO:0007158),0.4703352801956812,1.1112365803096835,0.3176229508196721,0.7923107289341844,1.0,2/14,2.26%,CEL;NLGN2
prerank,negative regulation of epithelial cell migration (GO:0010633),0.3971808297001096,1.1112229955345079,0.33212341197822143,0.7912793530550577,1.0,5/33,4.43%,ADAMTS9;MCC;NR2F2;SP100;DUSP10
prerank,positive regulation of transferase activity (GO:0051347),0.3018419149360833,1.1109462127133172,0.2657856093979442,0.7909686384551167,1.0,19/142,8.75%,EPHA7;EPHA3;FGFR2;FGFR4;KIT;LMO4;PDGFRB;IGF2;EPHA8;PDGFRA;EPHA4;DDR1;ACD;IGF1R;UBE2L3;DDR2;XRCC5;RYK;MUSK
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.3878390422479217,1.1105163120510073,0.3098106712564544,0.7910487055329678,1.0,3/32,2.58%,CEMIP;PDPK1;GSTM2
prerank,positive regulation of protein modification process (GO:0031401),-0.25457397502270696,-1.1103891693268697,0.17770034843205576,0.6808384304994202,1.0,62/203,20.64%,TEK;NTRK3;LIMCH1;PECAM1;EFNA5;TFRC;KDR;KRAS;NIBAN1;RAC1;GAS6;HSP90AA1;CALM1;PTK2;ENG;PDE8A;PPIA;SEMA4D;RACK1;TBX1;PPP1R16B;ATG7;LIMK2;TGFB1;CAMKK2;ARRB1;CHP1;RAMP1;CARD14;FLT4;APP;VEGFA;SLCO3A1;PAK1;FGF7;RALB;BMP2;GPER1;CD74;SVIP;CCN1;MT3;CSF1R;FAS;TERF2IP;SYMPK;BRMS1;CALM2;DVL2;PIK3R3;PPP2R5A;KNDC1;PINK1;BMP4;PLAUR;NPTN;CD40;INSR;PTBP1;PRKCD;CDCA2;AKT1
prerank,protein modification process (GO:0036211),-0.2990463249282157,-1.109691278679349,0.2668463611859838,0.681956786910691,1.0,26/76,23.79%,ST3GAL6;ST8SIA4;STK38;CHRM3;FBXW2;ADPRH;NEDD8;MAN2B1;RPN1;CDKL3;MMP15;PLOD2;ERO1A;UBA52;FBXL2;ST8SIA2;QPCT;DUSP12;YES1;RABGGTB;ST3GAL1;PPP4R2;RABGGTA;MANBA;ICMT;SEPHS1
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.49093950781834433,1.1096442574348493,0.34573304157549234,0.792302873623142,1.0,3/12,8.58%,PPARA;ABCA1;ABCA5
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.47030448917202716,-1.1095309320724651,0.34823091247672255,0.6815756592949536,1.0,6/10,26.35%,SVIP;ERLEC1;INSIG1;YOD1;UBAC2;UBE2J1
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.42203805708545383,1.109403117578753,0.32796780684104626,0.791918362744068,1.0,2/22,3.90%,ROCK2;EPHA4
prerank,positive regulation of histone modification (GO:0031058),-0.3516515455937312,-1.1091501435665954,0.31343283582089554,0.6818314426186115,1.0,11/33,22.10%,RPS6KA5;PPARGC1A;ARRB1;GLYR1;NOS1;AKAP8;APLNR;RPS6KA4;CTBP1;MAPK3;FMR1
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.5071264353271369,1.108664224763097,0.34930139720558884,0.7929496955633653,1.0,1/10,0.31%,BMP6
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),-0.4523957765008044,-1.1084390479652273,0.34637964774951074,0.6829627504968847,1.0,9/12,41.01%,UCKL1;CDA;DCK;UCK1;UCK2;UPP1;UMPS;TK2;CAD
prerank,positive regulation of lipid transport (GO:0032370),-0.4624024812830732,-1.1084038238027192,0.3694029850746269,0.6822606512520258,1.0,9/12,50.08%,SPP1;ABCA3;DBI;PRELID1;ABCB4;TRIAP1;LRP1;ABCA12;CYP19A1
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.4543066116290655,-1.108260000495362,0.34502923976608185,0.6818681393036551,1.0,8/13,32.81%,SOD1;ZC3H8;CAMK4;TOX;BMP4;FOXJ1;VNN1;SHH
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.3912052409064391,1.1082271527462897,0.32,0.7931037764175635,1.0,6/33,11.64%,IGF1;IGF1R;PTEN;MYO16;PIK3R1;ERBB2
prerank,snRNA transcription (GO:0009301),0.34001436791760525,1.1081714042217954,0.3190789473684211,0.7921868385559206,1.0,13/70,12.15%,POLR2D;PHAX;CDK7;INTS8;CCNT2;CCNT1;POLR2A;GTF2F1;RPRD1B;SNAPC5;TAF8;RPRD2;ICE2
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.4822419806068666,-1.1079763718373925,0.35517241379310344,0.6818747842774106,1.0,4/10,13.34%,DGKH;PLPP1;PRKD3;PICK1
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.29063779045654,-1.1075157333947623,0.24390243902439024,0.6822945210123398,1.0,34/86,26.15%,KLF2;UBB;UBC;RPS27A;EGLN3;VEGFA;PSMD13;RBX1;PSMF1;LIMD1;PSMB10;ATF4;PSMB6;PSME3;PSMB5;EGLN2;PSMC3;ELOB;PSMD12;PSMB8;PSME1;UBA52;PSMB3;DNAJB1;ATF3;PSMD5;HIGD1A;PSMD9;PSMB4;CUL2;VHL;CHEK1;PSMD10;EPO
prerank,regulation of translation (GO:0006417),-0.26052170641678785,-1.1073571996912623,0.18006430868167203,0.6819249623205563,1.0,56/173,27.52%,THBS1;NIBAN1;EEF2;VIM;RACK1;RPS3;RPL26;HSPB1;SOX4;CALR;EIF1B;IGFBP5;TOB1;RPL5;APP;GAPDH;MTOR;YBX1;EIF4G3;PYM1;EIF4G1;EIF3D;RPS6KA1;RPS4X;BCL3;YTHDF3;EIF4H;EIF3B;RPS27L;SHFL;RIDA;RPL13A;EIF3C;EIF2B2;EIF1;EIF2A;MRPL13;NOLC1;EIF5B;MTG1;METTL3;EIF4B;EIF6;FMR1;EIF4E;PUM3;PCIF1;DDX25;PUS7;EIF5;RBM4B;HNRNPD;EIF4A3;CPEB3;ETF1;RPL10
prerank,positive regulation of heart rate (GO:0010460),-0.40948812608408997,-1.107085520178737,0.31287128712871287,0.6818297503485271,1.0,7/17,9.07%,PDE4D;ADRA1B;KCNQ1;ADRA1A;ATP2A2;RYR2;EDN1
prerank,positive regulation of cellular component organization (GO:0051130),0.31150192185341435,1.1068176512471042,0.2870229007633588,0.7948426856272854,1.0,15/107,7.72%,FRMPD4;TRABD2B;ASAP1;BMP7;LRP4;ADGRL1;DAB2;FNIP1;TFR2;CRB3;GPC3;IGF1R;BNIP3;SLF1;CCL19
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.4787182417894076,1.1067767236247046,0.3333333333333333,0.7939102777811473,1.0,1/12,1.22%,IL18
prerank,cellular response to heat (GO:0034605),-0.35253966151169147,-1.106360002630825,0.3225058004640371,0.6830638804816521,1.0,5/35,2.30%,ANO1;THBS1;HSP90AA1;HSP90AB1;ATXN3
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.40895561286346505,1.1061196055039797,0.34714003944773175,0.7947080540865995,1.0,6/26,14.18%,ERRFI1;SNX6;CHMP6;TGFA;AREG;CBLB
prerank,vasculature development (GO:0001944),0.4561755542951881,1.106112234193418,0.35647279549718575,0.7936753991544712,1.0,3/16,3.77%,ERRFI1;PDGFRB;PDGFRA
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.4064121139523933,-1.1056568331666374,0.3277661795407098,0.6841517856995069,1.0,11/18,27.66%,MSN;HSP90AA1;FAF1;CD81;VPS11;ATP5IF1;ABCA2;CTSC;PTTG1IP;EZR;RNF128
prerank,glutathione biosynthetic process (GO:0006750),-0.46351495560390366,-1.1049347164987953,0.344106463878327,0.6852980780919742,1.0,5/11,32.39%,GCLM;GGT1;CHAC2;MGST2;OPLAH
prerank,anion transport (GO:0006820),-0.3534316936321017,-1.1045843229674797,0.3099787685774947,0.685489473247287,1.0,6/33,2.74%,ABCG2;SLC26A7;LRRC8C;LRRC8D;LRRC8B;SLCO2B1
prerank,cellular senescence (GO:0090398),-0.37325727589166846,-1.1045338036700614,0.3355119825708061,0.6848569691939382,1.0,9/27,24.81%,TBX2;CALR;TBX3;ECRG4;ID2;SPI1;PRKCD;CDKN1A;HRAS
prerank,organophosphate ester transport (GO:0015748),-0.38719329447195017,-1.1043610548459288,0.3231083844580777,0.6845733558529531,1.0,12/24,25.87%,PITPNC1;PLTP;SCARB1;TNFAIP8L3;ABCA3;PRELID3B;PITPNA;MTTP;PITPNB;OSBPL5;NPC2;PITPNM1
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.3794033282224628,1.1041704054908252,0.32111692844677137,0.7978435269412731,1.0,6/39,3.86%,OSR1;WNK4;DMD;GPD1L;NEDD4;PCSK9
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.4960880071728718,1.1039317685010903,0.3488372093023256,0.7974884820073029,1.0,5/10,14.26%,ACD;DCLRE1A;DCLRE1B;RTEL1;APEX1
prerank,reticulophagy (GO:0061709),0.48286392020432634,1.1035685916022517,0.3514018691588785,0.7974442420829355,1.0,3/12,11.17%,UFL1;RETREG1;TEX264
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.4541919398700749,1.1035529052591357,0.3590733590733591,0.7964431846240578,1.0,3/17,4.09%,SNTA1;GPD1L;ANK2
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.4566575642840503,1.1033884892261727,0.34663865546218486,0.7958382105451034,1.0,4/14,9.28%,ACD;TPP1;XRCC5;BRCA2
prerank,Golgi to endosome transport (GO:0006895),-0.42219669151723105,-1.1027722136123965,0.33137254901960783,0.6880223227033615,1.0,8/16,23.85%,MON2;VPS13A;VPS13C;AP1AR;GBF1;SYS1;AP2A1;RAB14
prerank,positive regulation of T cell migration (GO:2000406),0.42636766406332927,1.1022813810010192,0.3560606060606061,0.7978250406002829,1.0,2/20,3.26%,OXSR1;CXCL13
prerank,hemopoiesis (GO:0030097),-0.28455041709219553,-1.1021609948235052,0.25569620253164554,0.6889081817755948,1.0,33/87,22.47%,MECOM;KITLG;TEK;MFAP5;CD34;KDR;TGFB2;JAG1;RUNX1;KIRREL3;TGFBR2;TGFB1;PTPRC;FLT4;NOTCH4;RTKN2;ATF4;RUNX2;TAL1;GLRX5;CSF1R;ARIH2;FLT3;TOX;RRAS;SH2B3;BMP4;MKNK2;L3MBTL1;TIRAP;PRKX;DLL1;CEBPA
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.485949481692315,-1.102159255997468,0.372,0.6881411988637112,1.0,5/10,35.78%,ESR1;PSMC3;THRA;PSMC4;PSMC5
prerank,transition metal ion transport (GO:0000041),-0.3531304276879519,-1.101523768050007,0.3233256351039261,0.6890752437114208,1.0,12/35,9.85%,FTH1;TFRC;TRPC3;ATOX1;IREB2;SLC30A5;TRPC6;ATP2C1;SLC31A1;SLC39A8;TRPC4;SLC30A1
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),-0.3276266385182704,-1.101189357504792,0.297423887587822,0.6892533511206528,1.0,17/40,22.10%,HIP1;SGIP1;B2M;CBL;HNRNPK;SFRP4;ARRB1;VEGFA;CD63;CLU;PICK1;BICD1;GREM1;ARRB2;INSR;ATAD1;FMR1
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.26900023313835786,-1.1010740277651154,0.2229965156794425,0.6887797203096334,1.0,41/136,19.60%,TMSB4X;ID1;ESR1;CD200;GAS6;KLF4;BHLHE40;DAB2IP;NFKBIA;HES1;PKD1;SFRP4;FLNA;FZD6;ARRB1;CHP1;LRRC14;PTCH1;AIM2;PTGIS;NLRC5;COMMD7;CTNNBIP1;CHUK;MEN1;HEYL;ERBIN;NLRP2B;IRAK3;WFS1;BRMS1;CMKLR1;SIGIRR;DAP;ID2;ZC3H12A;IRAK1;HES6;ARRB2;GLIS2;SPI1
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.45994993306580206,1.1010527013558815,0.3333333333333333,0.8001255466887099,1.0,3/15,4.01%,PPARA;LPGAT1;SLC45A3
prerank,negative regulation of protein modification process (GO:0031400),0.3269017420640381,1.1008148147743144,0.29372937293729373,0.799811740976267,1.0,15/79,8.77%,PTPN13;PID1;PRKN;DMD;SNTA1;PLPP3;PTPA;LRRK2;CACTIN;FBLN1;PRKAA2;PTEN;PRKAA1;ATG14;SIRPA
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.3019953480437241,1.1007792413978126,0.2743988684582744,0.7988484349882585,1.0,18/150,5.93%,TCF7L2;OSBPL8;FGFR2;FGFR4;IL18;KIT;ANGPT1;PDPK1;PDGFRB;KL;IGF2;PDGFRA;GFRAL;RICTOR;FRS2;FGF1;IGF1R;LRP2
prerank,peptidyl-arginine modification (GO:0018195),-0.42941708069233414,-1.1007023811087482,0.35564053537284895,0.6889627740007639,1.0,3/15,8.07%,ART3;KRTCAP2;PRMT8
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.45161929684515023,1.1006184556886565,0.3616600790513834,0.7982584432824096,1.0,2/14,4.09%,ATP1B3;ANK2
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.40564805082458194,1.0997840504252792,0.33271375464684017,0.7994896741760501,1.0,10/26,13.60%,SMOC2;SPHK1;EIF4EBP1;CCDC57;PRKCA;PKN2;MDM2;RPS6KB1;HSF1;MEIS2
prerank,regulation of isotype switching (GO:0045191),-0.4336807640238074,-1.0994407194948919,0.3379721669980119,0.6916660492440917,1.0,9/14,43.23%,TFRC;KMT5C;SHLD3;SLC15A4;SHLD2;RIF1;KMT5B;IL4;MAD2L2
prerank,neural crest cell differentiation (GO:0014033),-0.4178476871120304,-1.0992010583228538,0.35070140280561124,0.6915090061272285,1.0,2/18,2.72%,MEF2C;CDH2
prerank,regulation of DNA binding (GO:0051101),0.36131196026948836,1.0990936303234329,0.32685512367491165,0.8003313775321884,1.0,7/44,10.25%,IGF1;PRKN;SP100;MMP9;RSF1;CEBPG;JAK2
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.43479857079611334,1.0987432720066117,0.33988212180746563,0.8002604791473824,1.0,5/19,8.66%,CUX1;IL1RAPL1;OBSL1;PTPRD;CUL7
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.4099783704187956,1.0986947212858909,0.33084112149532713,0.7993322352810004,1.0,4/26,8.84%,FBN1;LRRC17;HOXA7;FSTL3
prerank,RNA export from nucleus (GO:0006405),-0.2824575366472345,-1.0985561609897272,0.26571428571428574,0.6923818017919541,1.0,40/100,34.02%,SRSF2;SRSF1;SRSF5;DDX39B;HHEX;CPSF3;SRSF9;RBM8A;RNPS1;SRSF6;NUP37;SYMPK;AGFG1;CPSF2;NXT1;NUP54;NUP85;SMG5;YTHDC1;NUP133;MAGOH;THOC3;POM121;THOC6;EIF4E;DDX25;THOC2;EIF4A3;SRSF7;NUP153;ALYREF;SMG6;ZC3H11A;NUP42;CPSF1;NUP93;DHX38;U2AF1L4;CHTOP;HNRNPA1
prerank,negative regulation of gene silencing by miRNA (GO:0060965),-0.4607702071358098,-1.0984717331428053,0.3380281690140845,0.6918361873441954,1.0,2/12,5.53%,ESR1;TGFB1
prerank,regulation of cell-substrate junction assembly (GO:0090109),-0.3927295294822626,-1.0980323054204086,0.3270042194092827,0.6922267340080115,1.0,10/21,11.18%,LIMCH1;EFNA5;ACTG1;PTK2;SLK;CORO1C;GPM6B;RHOA;PEAK1;DUSP3
prerank,positive regulation of cation channel activity (GO:2001259),-0.3382573840779265,-1.0976455874495088,0.28888888888888886,0.6925342273548029,1.0,15/40,27.05%,SHANK3;TMSB4X;CALM1;RELN;ADRB2;KCNIP2;CALM2;STAC3;JPH2;ANK3;CCR2;CALM3;HAP1;CASQ1;CCL2
prerank,positive regulation of phospholipid transport (GO:2001140),-0.48447547977873606,-1.0972572881339149,0.34709193245778613,0.6928111849553035,1.0,7/10,42.55%,TMEM30A;ABCA3;DBI;ABCA7;PRELID1;ABCB4;TRIAP1
prerank,protein transport (GO:0015031),-0.24107425266341867,-1.0972300471744183,0.14814814814814814,0.6921296078097403,1.0,113/332,25.44%,SPTBN1;TFRC;NSF;TBC1D30;STX3;TBC1D8;RAMP2;RAB3C;RAB31;STX7;MIA2;RABGAP1L;CHMP2B;STX1A;TANGO6;SLC10A7;ATP6V0A1;HSP90B1;EHD1;TMED5;ARF5;ADPRH;GRTP1;SCG5;COPG1;SGSM1;VMP1;ARF1;DNM2;RAMP1;STX6;TBC1D8B;MYH9;TBC1D1;GOLGA7;RAB28;OLFM2;TMED2;SYNDIG1;SIL1;NAPB;TBC1D13;RAB38;ATP6V1A;STX12;SCAMP1;ATP6V0C;RAB3B;SCG2;EVI5;RAB1A;LMTK2;TBC1D10A;ATP6V1E1;CD74;SCAMP2;TCIRG1;ARHGEF2;CLU;PICK1;KIF13A;CANX;TMED3;TMED10;LMAN2L;CALCRL;RABL3;TMEM167A;LAPTM5;STX2;ATP6V0A4;HERC2;YWHAH;MTTP;PREB;CHMP1B;SNX1;KIF3B;RABGAP1;RAB1B;SCAMP3;ATP6V0A2;TBC1D10B;SYS1;ANK3;CHMP1A;EIF2D;ARFIP2;ATP6V0D2;TVP23A;ABCG1;HDAC6;TBC1D22A;RAB8A;NECAB3;AP2A1;CHMP3;RAB3A;SCFD2;RAB14;TMED7;ARL4A;SNX27;ATP6V0E2;ZDHHC17;ATP6V1B2;RAB8B;MCOLN1;RAB6B;TBC1D5;RAB5B;ARFIP1;RAB7A
prerank,actin cytoskeleton reorganization (GO:0031532),0.34400024243737687,1.0972079325981015,0.30528052805280526,0.8024069169099939,1.0,9/63,5.02%,AUTS2;PTK7;NRK;KIT;ANTXR1;FER;ANXA1;DTNBP1;RICTOR
prerank,iron ion homeostasis (GO:0055072),-0.31525435269892066,-1.096807096032053,0.3089622641509434,0.6925118896836466,1.0,16/58,9.95%,ABCG2;FTH1;B2M;TFRC;SCARA5;FTL;IREB2;SLC40A1;SOD1;NEDD8;SLC22A17;ISCU;HMOX2;FBXL5;ATP6V1A;FRRS1
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.28675875318732236,-1.0965153781393897,0.2659279778393352,0.692530096920081,1.0,33/87,27.05%,KLF4;FHL1;PINX1;FAM107A;PSMD13;RBX1;PSMF1;APC;PSMB10;CDK6;PSMB6;PSME3;ZFP36L1;PSMB5;PSMC3;PSMD12;PSMB8;JADE1;PSME1;CUL1;CDK2AP2;PSMB3;PSMD5;SKP1;CDKN1A;CDKN2D;PSMD9;E2F7;PSMB4;RGCC;PSMD10;AVEN;CCL2
prerank,L-glutamate transmembrane transport (GO:0015813),0.49793247079360703,1.0963599321107949,0.3592436974789916,0.8037173076415309,1.0,3/10,9.18%,SLC1A3;SLC25A18;SLC25A22
prerank,cellular response to hormone stimulus (GO:0032870),0.3351220512528438,1.0961902083849442,0.30806451612903224,0.803135717264323,1.0,10/69,7.03%,ATP1A2;TFPI;SLC5A5;BRD8;CTSH;STAT5B;NCOA2;CRHBP;UBE2L3;NCOA3
prerank,androgen receptor signaling pathway (GO:0030521),-0.4684359860405724,-1.0961300914778458,0.36792452830188677,0.6927587764904204,1.0,4/11,9.06%,PLPP1;KDM3A;DDX5;TMF1
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.43228646050751024,1.0960113701409255,0.33076923076923076,0.8026105599728854,1.0,5/20,9.89%,EPAS1;PRKN;ZMIZ1;ITCH;WASHC1
prerank,carboxylic acid metabolic process (GO:0019752),-0.3568157501453973,-1.0959631212419338,0.3200883002207506,0.6924426965531526,1.0,12/33,23.10%,CSGALNACT1;ST6GAL1;SLC2A1;PTGIS;SIRT4;PLA2G4A;CYB5R3;MIF;GSTO2;ST3GAL1;LIAS;SLC2A3
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.4357675613994553,-1.0959577552303417,0.36801541425818884,0.69168868666023,1.0,3/13,1.95%,ABHD2;ESR1;PLPP1
prerank,negative regulation of viral life cycle (GO:1903901),-0.4250293586217259,-1.0959114538337191,0.34347826086956523,0.6910585279790366,1.0,7/15,22.00%,LY6E;GSN;PPIA;BST2;MID2;IFITM3;CIITA
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.26112652268269126,-1.0955910584050914,0.22321428571428573,0.6911867279086019,1.0,23/159,6.85%,HMCN1;PECAM1;BSG;ADGRL3;CLDN5;PTPRM;CADM1;TGFB2;CDH1;CDH11;CLDN11;ITGB1;CDH2;UNC5D;LRFN5;TENM2;CXADR;PKD1;KIRREL3;TGFBR2;ROBO4;ATP2C1;CEACAM1
prerank,regulation of establishment of planar polarity (GO:0090175),-0.29081630989002866,-1.095549400565784,0.25513196480938416,0.6905622045327683,1.0,30/88,23.91%,TIAM1;RAC1;FZD4;ROR2;AP2A2;FZD6;ARHGEF19;PSMD13;AP2M1;PSMF1;RHOA;PSMB10;VANGL2;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;PSME1;PSMB3;DVL2;AP2B1;ARRB2;PSMD5;PRICKLE2;AP2A1;PSMD9;PSMB4;SPEF1
prerank,T cell differentiation (GO:0030217),0.3690713348869383,1.0952090252148767,0.3237410071942446,0.803818726176471,1.0,4/40,5.23%,LEPR;KIT;ANXA1;GLI3
prerank,glucose catabolic process to pyruvate (GO:0061718),-0.3825399006724,-1.0951920342747619,0.3143459915611814,0.690028741630261,1.0,9/24,16.87%,PKM;HK1;GAPDH;PFKM;FOXK1;TPI1;ALDOA;PFKP;ALDOC
prerank,canonical glycolysis (GO:0061621),-0.3825399006724,-1.0951920342747619,0.3143459915611814,0.690028741630261,1.0,9/24,16.87%,PKM;HK1;GAPDH;PFKM;FOXK1;TPI1;ALDOA;PFKP;ALDOC
prerank,negative regulation of type I interferon production (GO:0032480),0.3727099476680431,1.0950093503021783,0.3339317773788151,0.8033185212580041,1.0,13/40,14.72%,CACTIN;NLRC3;RNF135;RNF216;SIRPA;ITCH;IRF3;UBA7;IKBKE;PCBP2;CYLD;TBK1;NLRX1
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.4883692656481425,1.09480498110688,0.3657505285412262,0.80284638258878,1.0,2/11,1.84%,PRKN;DAB2
prerank,regulation of potassium ion transmembrane transport (GO:1901379),-0.3161679087991998,-1.0946196070279544,0.308411214953271,0.6907331762910853,1.0,14/54,15.12%,CAV1;KCNJ2;NEDD4L;KCNMA1;FHL1;FLNA;KCNAB1;KCNQ1;CD63;KCNMB4;KCNN2;BIN1;KCNJ15;KCNIP2
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.4820481862836993,1.094504704608992,0.3814229249011858,0.8026196027114183,1.0,2/12,6.32%,NINL;CEP19
prerank,organelle fission (GO:0048285),-0.3742702377249273,-1.0941855573979136,0.33954451345755693,0.6911577437992639,1.0,7/24,18.63%,DNM3;CORO1C;DNM2;MIEF1;DNM1;PEX11B;MTFR1L
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),-0.3693984277879543,-1.0940796568247892,0.33986928104575165,0.6906897656760987,1.0,5/24,5.15%,TEK;KDR;GAS6;RAMP2;GATA2
prerank,N-glycan processing (GO:0006491),-0.40532315944746045,-1.0936393095790566,0.3534136546184739,0.691063291973312,1.0,7/18,15.37%,ST8SIA4;FUT8;ST8SIA1;ST8SIA6;MAN1A2;ST8SIA2;MAN2A2
prerank,cell part morphogenesis (GO:0032990),0.46199127000874535,1.0934420870339276,0.36774193548387096,0.8045924834188916,1.0,2/13,4.50%,PID1;WASF1
prerank,positive regulation of multicellular organismal process (GO:0051240),0.2755633359388268,1.0933123724024976,0.2613784135240572,0.8039118035580509,1.0,33/308,7.03%,SOX5;LEPR;C1QTNF3;APPL2;EPAS1;IL18;DAB2;ACSL1;ESRRG;GNAS;PLA2R1;ALMS1;SCX;SOX6;PLCB1;PPARGC1B;ABCA1;PDPN;GRB10;ITGAX;FOXD1;GLIPR2;GJA1;ACADL;PTN;CPT2;IGF1R;NIBAN2;ADRA1D;IL6;SMAD3;PTH2R;NCOA3
prerank,maturation of LSU-rRNA (GO:0000470),0.4013466094081623,1.0929503313246134,0.33653846153846156,0.8038767717003618,1.0,7/26,16.81%,NSA2;FTSJ3;DDX18;NIFK;ZNHIT3;BOP1;ZNHIT6
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.27959936301057214,-1.0928830790083999,0.2747875354107649,0.6924063251111442,1.0,38/100,23.66%,RPL11;RNF144B;CBFA2T3;HSP90AB1;RNF144A;RACK1;TRIB2;UCHL5;UBXN1;NKD2;BAG6;SOCS5;GNA12;GSK3B;ZYG11B;RBX1;CAMLG;FOXF2;OGT;UBQLN4;RYBP;HERPUD1;CLU;ELOB;ARIH2;COP1;N4BP1;RNF19B;NOP53;TLK2;RNF19A;USP5;MAP1A;VCP;CEBPA;ARIH1;HSPA1B;TRIB3
prerank,glycolipid biosynthetic process (GO:0009247),0.37353148189419033,1.0923978447659515,0.3470483005366726,0.8042859655737108,1.0,10/38,13.27%,LARGE1;B3GNT5;PIGU;A4GALT;ST3GAL5;PIGG;PIGV;GBGT1;PIGC;PIGQ
prerank,response to estrogen (GO:0043627),-0.34799308191113065,-1.0920568946314915,0.31662870159453305,0.6938636164701689,1.0,7/31,11.35%,CAV1;ESR1;TRIM25;SERPINB9;ARID5A;WBP2;SFR1
prerank,regulation of melanin biosynthetic process (GO:0048021),0.49452299407516415,1.091981615541644,0.3624733475479744,0.8043983993082706,1.0,1/10,1.32%,ZEB2
prerank,blood circulation (GO:0008015),-0.3194966163160117,-1.0917545395390649,0.3009950248756219,0.6939007816759228,1.0,17/49,19.95%,SGCD;NOS3;ACVRL1;MEOX2;TBC1D8;GUCY1B1;GCLM;GUCY1A1;SOD1;ELN;ACE2;SGCZ;CYB5R3;PLN;AGTR1;CXCL12;DLL4
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.34159394119804615,-1.0910940124877508,0.3495575221238938,0.6950000281358387,1.0,8/34,11.22%,PTPRB;PTPRJ;DUSP16;PTPN12;UBASH3B;DUSP8;DUSP3;PTPN1
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.4403252807623336,-1.0910831194551072,0.37169811320754714,0.6942681063145284,1.0,5/13,10.23%,SHANK3;LGMN;APP;ZDHHC2;RELN
prerank,telomere organization (GO:0032200),0.3593479116127331,1.0909985209050899,0.33513513513513515,0.8060771906411565,1.0,16/43,21.72%,SP100;HUS1B;ACD;XRCC5;BLM;PRKDC;DCLRE1B;RTEL1;MRE11;APEX1;WRN;STN1;POLD2;RAD50;NBN;TERF2
prerank,positive regulation of monooxygenase activity (GO:0032770),0.40287805754996175,1.090588720955701,0.37250996015936255,0.8062089374161989,1.0,2/26,2.87%,NPR3;NOS1AP
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),-0.3768997044560027,-1.0904161647213313,0.3333333333333333,0.6952211433437561,1.0,9/25,16.87%,PKM;HK1;GAPDH;PFKM;FOXK1;TPI1;ALDOA;PFKP;ALDOC
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.3577038444531677,1.0904083410000516,0.3262411347517731,0.8056982598378292,1.0,5/45,6.47%,BMP6;BMP7;DAB2;RBPMS;TTK
prerank,regulation of actin filament depolymerization (GO:0030834),0.4904643479407426,1.0900875860484944,0.36210526315789476,0.8056221437089173,1.0,2/12,6.80%,PLEKHH2;LIMA1
prerank,negative regulation of cell death (GO:0060548),-0.2877450078576134,-1.0900604215295586,0.28378378378378377,0.6953853686432854,1.0,28/88,19.45%,MECOM;CD200;CD34;PPARGC1A;PDE8A;FYN;CCN3;SOX4;NCK1;FERMT2;GSK3B;TNFRSF1B;WNT16;EIF4G1;CHGA;CLU;CCN1;SRSF6;MT3;NENF;PRKD1;WFS1;ATP13A2;DCPS;PINK1;TIGAR;BMP4;CDK5
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.5001362500368821,1.0900300072354019,0.3752577319587629,0.8047703334896094,1.0,3/10,16.30%,KIT;BTLA;LYN
prerank,O-glycan processing (GO:0016266),0.3470290682491032,1.0898218597764004,0.3283582089552239,0.8042875077118722,1.0,5/54,2.79%,ST3GAL3;GALNT14;GALNT15;GXYLT2;B3GNT5
prerank,protein ubiquitination (GO:0016567),0.26678751149519536,1.089585268922304,0.24428399518652227,0.803888337887691,1.0,73/471,12.65%,ASB2;PDZRN3;RNF220;SASH1;TRIM63;EPAS1;RNF43;PRKN;PELI2;BCL2;SPSB1;UBE2E2;HIF3A;TRIM5;MGRN1;NEDD4;RNF213;RNF138;FBXW4;DDB2;RNF217;ZNRF3;PSME4;SH3RF1;PSMA2;TRPC4AP;CAND1;UBE2L3;FBXO44;RNF181;NPEPPS;UBR2;SPOP;PSMA3;RNF152;SIAH2;CUL9;RNF135;KLHL7;BIRC6;AMFR;WWP2;USP7;CUL7;CRBN;RC3H2;TRAF7;MDM2;FBXL17;UBE4A;ITCH;NHLRC1;SMURF2;FBXO6;PSMD8;TRIM35;PRKDC;MYCBP2;NEUROD2;KLHL22;DTX1;RBBP6;PSMD3;FBXO4;CDC73;RNF14;CUL4B;SH3RF2;TRIM26;TRIM43;FBXO11;RNF20;ASB5
prerank,positive regulation of catabolic process (GO:0009896),-0.30062399698267755,-1.0895267214013427,0.3125,0.695985842627989,1.0,15/65,12.62%,WWP1;NSF;NEDD4L;DAB2IP;ATG7;PLK2;GSK3B;FOXO1;APC;OAZ1;DDB1;CDKN1B;NDUFA13;EGLN2;IDE
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.42039607329217044,1.0893429558270011,0.3432282003710575,0.803548494262629,1.0,2/20,0.85%,TGFBR3;RBPJ
prerank,phospholipid translocation (GO:0045332),-0.3655012826007138,-1.0892129530679062,0.34459459459459457,0.6960471194744736,1.0,8/28,9.33%,ATP10A;ATP8B1;ATP8A1;ATP8A2;MFSD2A;ATP11B;ATP11C;TMEM30A
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.41218782034045703,-1.0886186220524416,0.3679060665362035,0.6969069734853648,1.0,5/17,11.70%,PRKG1;MEF2C;PDCD4;CDKN1B;GPER1
prerank,sensory perception of smell (GO:0007608),-0.469315398680339,-1.0880040048163195,0.3616600790513834,0.6977613417782296,1.0,2/11,11.59%,ADCY3;SYT10
prerank,glial cell differentiation (GO:0010001),-0.36645554216976306,-1.087388701149469,0.3422680412371134,0.6986223176514803,1.0,12/28,19.45%,ADGRG6;CDH2;SOX4;RELN;STAT3;GPC1;PICK1;EIF2B5;TPPP;SOX2;SOX10;CDK5
prerank,regulation of mRNA processing (GO:0050684),-0.34939378941094323,-1.087314692905459,0.3370288248337029,0.6980484110131506,1.0,10/32,18.49%,HNRNPK;QKI;CDK11B;LARP7;ZFP36L1;KHDRBS3;SRPK1;AHCYL1;SAFB2;YTHDC1
prerank,regulation of cellular amide metabolic process (GO:0034248),-0.3544794769123948,-1.087191871485691,0.31027253668763105,0.6975902115046129,1.0,18/32,38.03%,APP;TMED10;EIF2A;TIGAR;NR1H4;NOLC1;PRKCD;EIF4E;PUM3;PCIF1;DDX25;RBM4B;RPL10;METTL18;PGAM1;ATXN2;MAPKAPK5;MTPN
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.46457089630210036,-1.0871773460452274,0.37404580152671757,0.6968766203245702,1.0,5/11,19.15%,GSN;ST18;PIH1D1;FAS;PLAUR
prerank,positive regulation of wound healing (GO:0090303),-0.34085959137317995,-1.0869408481403229,0.3436123348017621,0.6967921950616657,1.0,9/36,7.91%,ST3GAL4;ACTG1;OCLN;THBS1;ITGB1;PTK2;KANK1;FERMT2;MTOR
prerank,gliogenesis (GO:0042063),-0.4295322542437008,-1.0867294133186187,0.3474088291746641,0.696657506334086,1.0,5/15,10.65%,TGFB2;CD9;CDH2;RELN;CDK6
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.31364317229850747,1.0862878670901017,0.3232,0.811112910065927,1.0,19/94,12.74%,NINL;ALMS1;RAB3IP;HAUS4;CEP152;CC2D2A;SDCCAG8;IQCB1;PAFAH1B1;CDK1;TCTN1;RPGRIP1L;SCLT1;CEP89;FBF1;OFD1;HAUS1;SFI1;CEP57
prerank,mitotic cytokinetic process (GO:1902410),-0.39255319570009695,-1.0860467214386191,0.32815533980582523,0.697754079550385,1.0,12/20,31.27%,CHMP5;CHMP2B;RHOA;CHMP1B;CHMP1A;CHMP3;CHMP7;PDCD6IP;CHMP4C;CEP55;CNTROB;VPS4B
prerank,Rap protein signal transduction (GO:0032486),-0.4808167250043407,-1.0858482739108115,0.37425742574257426,0.6975191736892652,1.0,2/10,5.90%,RAP1A;PLK2
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.38346684000653397,-1.085846998485123,0.3533190578158458,0.6967759567807678,1.0,8/21,11.14%,CAV1;PDE4D;RASSF2;RACK1;NCK1;DDIT4;CNKSR3;NCK2
prerank,regulation of cilium assembly (GO:1902017),0.3366702947717186,1.0853844413834508,0.3614864864864865,0.8124835137898824,1.0,17/62,18.45%,DCDC2;ODAD3;TBC1D9B;SDCCAG8;ARHGAP35;TBC1D19;CROCC;CYLD;IFT140;CDKL5;ATG3;TBC1D17;CEP120;USP6NL;TBC1D7;CEP97;TBC1D15
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),-0.3115250831484803,-1.0853000662094767,0.28832951945080093,0.6974897753675809,1.0,11/48,13.54%,FNIP2;CRIP1;BCL2L1;BAG6;TNFRSF1B;CHEK2;DDIT4;MSH2;BCL3;AEN;RPS27L
prerank,nuclear body organization (GO:0030575),0.4855977968012023,1.0849909642117874,0.36419753086419754,0.8125225113585558,1.0,2/12,3.90%,AFF2;SRPK2
prerank,central nervous system neuron axonogenesis (GO:0021955),-0.45100483312257833,-1.0848286436364654,0.3757115749525617,0.6980336228525216,1.0,6/12,17.19%,HSP90AA1;HSP90AB1;B4GALT5;EPHB1;SPTBN4;B4GALT6
prerank,regulation of cell adhesion (GO:0030155),0.3008032124834974,1.084735528470277,0.2927927927927928,0.812214436664019,1.0,12/129,5.45%,EPHA7;PLXNA2;ROCK2;IL18;ANGPT1;TPM1;RHOD;EPHA8;RIPOR2;EPHA4;PLXNC1;FBLN1
prerank,negative regulation by host of viral transcription (GO:0043922),-0.4401376047476292,-1.0847161773405494,0.37103174603174605,0.6976132547290744,1.0,5/12,19.53%,TARDBP;JUN;REST;PSMC3;TFAP4
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.2938744985785161,1.0842555278377417,0.3024251069900143,0.8124695502275584,1.0,27/166,11.70%,IGF1;FGFR4;ZEB2;SMOC2;SLC6A9;LPGAT1;SORBS1;PDGFRB;NOS1AP;IGF2;PLD1;SLC45A3;IL6;SMAD3;CCL19;ARNT;SAMD4A;SLC27A1;PRKDC;RPS6KB1;METTL14;NPM2;PRKD2;PKD2;ERBB2;FXR1;LARP6
prerank,transition metal ion homeostasis (GO:0055076),0.4027022080017416,1.084153491392808,0.3543307086614173,0.8117435942270619,1.0,6/28,9.43%,CP;HEPH;PRKN;TFR2;NEO1;PICALM
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.38771865373250514,-1.0841356170962198,0.3475336322869955,0.6984371475690451,1.0,5/21,8.41%,CSGALNACT1;CSPG4;CHST9;BGN;CHST11
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.43408360649817246,1.0838862823440791,0.35812133072407043,0.8114444618049019,1.0,4/18,5.46%,IL34;SLC45A3;SOX1;PTN
prerank,regulation of cytoskeleton organization (GO:0051493),-0.2749426354458773,-1.0838634427107858,0.3056379821958457,0.6984614263765764,1.0,25/108,11.10%,EFNA5;CLIC4;RAC1;IQGAP1;PTK2;CORO2B;PHLDB1;F11R;MAP6;RHOB;FAM107A;CCDC88A;CAPN2;TJP1;GSK3B;HIP1R;MTOR;GPM6B;PAK1;ARHGEF19;PAK2;RHOA;ARHGEF5;CRK;SORBS3
prerank,pyruvate metabolic process (GO:0006090),-0.314002894990142,-1.083548920993829,0.3192488262910798,0.6985522693230114,1.0,12/52,16.87%,BSG;PKM;SLC16A1;ME1;HK1;GAPDH;PDHA1;PFKM;TPI1;ALDOA;LDHA;ALDOC
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.473890381613703,-1.083352679764281,0.3621013133208255,0.6983161356932212,1.0,6/10,28.40%,ST6GAL1;ST3GAL1;GNPDA1;AMDHD2;GNPDA2;NANP
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.4027072870020381,-1.08316085261192,0.36699029126213595,0.6980674459449235,1.0,9/17,32.10%,HSP90B1;DERL1;HERPUD1;AUP1;TMEM129;VCP;SYVN1;SEC61B;HM13
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.45157606996275396,-1.0831100265125788,0.35567970204841715,0.697452876579196,1.0,6/12,28.21%,DAB2IP;XBP1;PTPN1;ERN1;BAX;TMEM33
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.2717277115687481,-1.0827763796487828,0.2837465564738292,0.6976462723198299,1.0,29/108,16.70%,HIP1;MAP3K5;ACER2;GSN;F3;NGF;RACK1;RPS3;TNFSF10;CTSD;NOD1;ST18;EGLN3;ATP2A3;HIP1R;SOX7;NDUFA13;GPER1;XDH;REST;HSPD1;RPS27L;BBC3;CASP8AP2;FAS;BCAP31;CASP8;LAPTM5;DAP
prerank,protein autophosphorylation (GO:0046777),0.2961610250590598,1.0823274763511805,0.3252840909090909,0.8147557173661301,1.0,26/157,11.87%,OXSR1;FGFR2;FGFR4;KIT;DAPK1;PDPK1;PDGFRB;FER;EPHA8;PDGFRA;EPHA4;DDR1;SIK1;LRRK2;IGF1R;STK17B;DDR2;CAMK2D;GRK5;MUSK;VRK2;ABL1;JAK2;PRKD2;ERBB2;MAPKAPK2
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.3147546029077253,1.0822392099713392,0.3180428134556575,0.8139640575212924,1.0,9/101,5.81%,ROBO1;IL34;CEMIP;KIT;LTF;PDGFRB;LRRK2;PDGFD;FGF1
prerank,regulation of necroptotic process (GO:0060544),-0.38115248908753097,-1.082218905238423,0.3456221198156682,0.6983847479676856,1.0,10/23,24.23%,HSP90AA1;YBX3;CDC37;BIRC3;OGT;ARHGEF2;CASP8;SLC25A4;PELI1;PDCD6IP
prerank,peptidyl-threonine modification (GO:0018210),0.33537940883076117,1.0819928227931948,0.33116883116883117,0.8136564927290171,1.0,15/66,14.82%,ROCK2;OXSR1;PDPK1;LRRK2;PRKCA;CAMK2D;CDK1;GALNT16;PRKDC;PRKD2;HIPK3;TBK1;MAPK1;NLK;GALNTL6
prerank,artery development (GO:0060840),-0.3726797281579022,-1.0817854939972782,0.3786848072562358,0.6987788756986336,1.0,8/23,7.98%,ACVRL1;ENG;TBX1;HES1;BMPR2;STRA6;PDE2A;VEGFA
prerank,negative regulation of programmed cell death (GO:0043069),0.2685746614295268,1.0816139053993437,0.2700636942675159,0.8136812275994216,1.0,57/355,12.16%,IL31RA;IGF1;OSR1;FHL2;NOTCH2;ANGPT1;DAB2;BCL2;SMAD6;DKK1;SCX;LTF;IFIT3;CTSH;ANXA1;PDPN;ARAF;SPHK1;ZFAND6;PRKAA2;SON;IGF1R;LRP2;NIBAN2;SH3RF1;KRT18;MYO18A;BNIP3;IL6;NOL3;KANK2;MMP9;PRKAA1;SIAH2;BIRC5;BIRC6;GRK5;NUPR1;BCL2L2;CDK1;YME1L1;ITCH;MED1;HDAC1;PIK3R1;NAA35;PHIP;PRKDC;AXL;RPS6KB1;TFAP2A;TFAP2B;CFLAR;FSTL1;HIPK3;SH3RF2;TMBIM4
prerank,negative regulation of cell cycle process (GO:0010948),0.34034773299260845,1.0815353181495393,0.3434343434343434,0.8128905008628827,1.0,8/61,6.63%,BMP7;DMRT1;RBBP4;RNF2;MGA;L3MBTL2;TOM1L2;RBBP7
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.288529280745419,-1.0814954043204703,0.30791788856304986,0.6987707076329182,1.0,29/85,23.14%,TIAM1;RAC1;FZD4;ROR2;AP2A2;FZD6;ARHGEF19;PSMD13;AP2M1;PSMF1;RHOA;PSMB10;VANGL2;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;PSME1;PSMB3;DVL2;AP2B1;ARRB2;PSMD5;PRICKLE2;AP2A1;PSMD9;PSMB4
prerank,cellular biogenic amine catabolic process (GO:0042402),0.4778061168785239,1.080821989041793,0.37945492662473795,0.8138396212231139,1.0,4/10,22.55%,ALDH7A1;LRTOMT;SMOX;COMT
prerank,negative regulation of insulin secretion (GO:0046676),-0.4129066168899962,-1.0807719964284412,0.34297520661157027,0.6999939853238357,1.0,6/17,13.66%,KLF7;KCNB1;CCN3;REST;CHGA;SIRT4
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.4775441199769674,1.0800599722473212,0.36983471074380164,0.8149099524606028,1.0,1/12,0.18%,ADAMTS12
prerank,positive regulation of heart contraction (GO:0045823),0.4243915401502935,1.0797323397609841,0.3497942386831276,0.8147613317706264,1.0,4/19,11.17%,ATP1A2;ADM;APLN;SCN3B
prerank,negative regulation of defense response (GO:0031348),0.3274555630775359,1.0794250858052012,0.3300813008130081,0.8145828235152519,1.0,13/77,14.03%,RORA;C1QTNF3;PPARA;CACTIN;NLRC3;LYAR;SIRPA;ITCH;PCBP2;ENPP3;PTGER4;MAPKBP1;NLRP12
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.38037045268697206,-1.0793842062110552,0.3623481781376518,0.7029503007287867,1.0,4/23,9.24%,CADM1;PIK3R6;LAMP1;PVR
prerank,supramolecular fiber organization (GO:0097435),0.270390514097501,1.079297262421368,0.2838541666666667,0.813933555569915,1.0,39/333,8.14%,COL22A1;COL26A1;COL4A5;SHROOM3;CGNL1;FIGN;COL4A6;TPM1;PRKN;MYO5C;FBLN5;RHOD;KIF2A;HOOK2;PXDN;LOXL1;COL9A2;SNCAIP;SCX;LTF;LOXL3;SHROOM2;AVIL;MYO1H;FIGNL2;COL1A2;COL13A1;ARHGAP12;COL18A1;FAT1;KATNAL2;DLG1;DDR2;PPP1R9A;RHOBTB2;SIAH2;GGA2;CORO7;SERF1A
prerank,folic acid-containing compound metabolic process (GO:0006760),0.4181533493293128,1.0789663488899983,0.3695652173913043,0.8138146459400862,1.0,8/19,22.76%,MTHFR;FOLR2;SLC19A1;SHMT1;MTHFS;DHFR;MTHFD2;FPGS
prerank,regulation of hormone secretion (GO:0046883),0.44230836742961954,1.0789000242446547,0.35876288659793815,0.8130038173541266,1.0,2/15,3.35%,SNX6;ANXA1
prerank,response to interferon-alpha (GO:0035455),-0.4170027931122997,-1.0787861704582355,0.375,0.7037346276377773,1.0,6/16,23.18%,GAS6;ADAR;BST2;IFITM3;RO60;IFNAR1
prerank,nervous system development (GO:0007399),0.26292047198387575,1.07859390418938,0.27744270205066346,0.8127938000970135,1.0,49/429,8.26%,ALDH1A2;ROBO1;ADGRV1;SDK1;ARNT2;ZIC1;NOTCH2;ATXN1;ZEB2;IGF2BP1;PRKN;LPAR1;NLGN2;IGSF8;ZIC2;SZT2;PCDHA3;B3GNT5;SOX6;FAT4;INTU;AVIL;JARID2;ZIC5;CNTFR;OBSL1;PCSK9;ARTN;GFRAL;TEAD1;PAFAH1B3;ARHGAP26;IGFN1;PMP22;NDP;NRSN2;DPF2;PTN;TPP1;WDPCP;NBL1;NDUFV2;PTEN;DAGLB;RYK;PCDHB6;SERF1A;RAPGEFL1;FARP1
prerank,embryonic organ development (GO:0048568),0.34078241110131585,1.078550125857919,0.3393829401088929,0.8119138465155865,1.0,11/61,7.65%,RBPJ;FGFR2;KIT;RBP4;KMT2A;COL13A1;TEAD1;GLI3;SALL1;TEAD3;PBX4
prerank,negative regulation of programmed necrotic cell death (GO:0062099),-0.45641629210984674,-1.078139599467051,0.36257309941520466,0.7046337100927434,1.0,6/11,22.30%,YBX3;BIRC3;ARHGEF2;CASP8;SLC25A4;PELI1
prerank,positive regulation of protein depolymerization (GO:1901881),-0.4607179983394034,-1.0779785969544546,0.3654223968565815,0.7043340135948452,1.0,5/11,26.52%,WDR1;STMN2;NES;CFL2;TRPV4
prerank,Notch signaling involved in heart development (GO:0061314),0.4882796508999343,1.0777989585119996,0.3957894736842105,0.8129548496476601,1.0,2/11,1.18%,RBPJ;NOTCH2
prerank,cellular potassium ion homeostasis (GO:0030007),-0.4360897749634894,-1.0775045227681526,0.3684210526315789,0.7048375111114511,1.0,5/13,3.34%,SLC12A2;KCNJ2;ATP1A1;KCNMA1;ATP1B1
prerank,cellular response to osmotic stress (GO:0071470),0.4207563703003161,1.0774457978049086,0.3517110266159696,0.8129289792042332,1.0,5/21,11.59%,OXSR1;MYLK;LRRC8E;RCSD1;PKD2
prerank,spliceosomal complex assembly (GO:0000245),0.3579774052121324,1.077399166278993,0.34125636672325976,0.8120665349904254,1.0,10/46,13.84%,CELF2;SRPK2;NOL3;RBM5;SF3A3;DDX23;SMN1;SNRNP200;SCAF11;CRNKL1
prerank,regulation of actin filament polymerization (GO:0030833),-0.29838377440859015,-1.0770996986890329,0.309462915601023,0.7052051603339738,1.0,18/69,12.40%,SLIT2;ESAM;KANK3;CARMIL1;PTK2B;CDC42EP3;NCKAP1;KANK1;NCK1;BAIAP2L1;HIP1R;CYRIB;SSH2;KANK4;SSH1;NCK2;DBNL;BIN1
prerank,organelle fusion (GO:0048284),-0.37336439470086835,-1.0768039515648777,0.34285714285714286,0.7052617554898952,1.0,9/22,27.94%,CHCHD3;MIEF1;VPS18;MIEF2;VPS11;MFN2;BAX;SPG7;FIS1
prerank,regulation of astrocyte differentiation (GO:0048710),-0.4406048178304646,-1.0766957311616527,0.37213740458015265,0.7048351632026432,1.0,6/12,17.44%,NOTCH1;SERPINE2;HES1;BMP2;BIN1;ID2
prerank,ephrin receptor signaling pathway (GO:0048013),0.31909666320024255,1.0766822074072777,0.32896890343698854,0.8130492055091075,1.0,9/82,5.37%,EPHA7;ROCK2;EPHA3;EFNB2;SDC2;MMP2;EPHA8;EPHA4;WASL
prerank,protein deubiquitination (GO:0016579),-0.24445956436398905,-1.0762176330152264,0.23107569721115537,0.7053967912664174,1.0,63/242,21.06%,ACTB;ESR1;IL33;ATXN3;USP38;OTUD7A;MINDY2;UBB;NFKBIA;UCHL5;TOMM20;MINDY1;EIF3F;USP29;NEDD8;RHOT1;UBC;RPS27A;USP31;UCHL1;ZRANB1;PSMD13;BIRC3;PSMF1;APC;RHOA;PSMB10;USP50;HGS;PSMB6;OGT;ENY2;PSME3;USP37;PSMB5;PSMC3;ADRB2;OTUB1;UCHL3;OTUD3;FOXK1;PSMD12;PSMB8;OTUD1;PSME1;IFIH1;CFTR;UBA52;PSMB3;RUVBL1;USP28;USP8;MYSM1;WDR20;ZC3H12A;UBE2D1;ARRB2;USP9X;RCE1;PSMD5;POLB;OTUD6B;OTUD7B
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.46627495592409207,1.0761147564479174,0.3983402489626556,0.8136819036366976,1.0,2/12,10.07%,IL18;IL17D
prerank,cardiac muscle cell development (GO:0055013),0.4219368981077945,1.076098776870203,0.3518886679920477,0.8127244249649561,1.0,5/20,3.77%,CSRP3;PDGFRB;SLC8A1;OBSL1;PDGFRA
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.3876050682172453,1.0760677182627942,0.3657243816254417,0.8117980012038548,1.0,5/27,8.32%,JPH1;DMD;ANK2;CACNB4;CAMK2D
prerank,inner dynein arm assembly (GO:0036159),-0.4684933402611061,-1.0755039175192338,0.3722334004024145,0.7064719894484867,1.0,8/10,46.88%,CFAP100;CCDC40;CCDC39;DNAAF4;DNAH1;DNAAF1;DNAI3;CFAP73
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.41771519198775403,-1.075472754281367,0.3889943074003795,0.7058076057373726,1.0,5/14,9.23%,LIMS2;FLNA;LIMS1;EMP2;CD63
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.45484274018740667,-1.0754675011099055,0.3919694072657744,0.7050910260433557,1.0,5/11,22.02%,SCARB1;MFSD2A;NR1H2;CTDNEP1;NR1H3
prerank,regulation of autophagy (GO:0010506),0.2795451353157265,1.0753433071239629,0.30385164051355207,0.8127486190862989,1.0,31/216,10.90%,PRKAG2;LEPR;ITPR1;DAPK1;PRKN;PRKAG3;SNX6;BCL2;TRIM5;NEDD4;NPRL2;LRRK2;MTMR3;UFL1;PRKAA2;SLC38A9;BNIP3;OPTN;RNF152;PRKAA1;NUPR1;KAT8;PLEKHF1;ATP6V0D1;ATP6V0E1;WASHC1;GOLGA2;ABL1;FLCN;KLHL22;MLST8
prerank,T cell activation (GO:0042110),0.325288509937598,1.075315934084487,0.3207236842105263,0.8118233293828753,1.0,5/69,2.54%,LEPR;KIT;JAML;KIF13B;CTPS1
prerank,embryonic digestive tract development (GO:0048566),0.41741155141848596,1.0753139942426542,0.3938144329896907,0.810836492566636,1.0,4/18,6.50%,FGFR2;PDGFRA;GLI3;SALL1
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),-0.436612235288125,-1.0752297341739006,0.38537549407114624,0.7049623784961131,1.0,5/13,15.14%,BMP5;SOD1;BMP2;REST;ERLIN2
prerank,protein targeting to lysosome (GO:0006622),-0.39175498067594394,-1.075171514170926,0.38524590163934425,0.704364403540545,1.0,11/20,25.44%,HSPA8;SNX16;HGS;CLU;M6PR;NCOA4;LAPTM5;GNPTAB;SCARB2;SORL1;RAB7A
prerank,regulation of axonogenesis (GO:0050770),0.3494340665290616,1.0749058525210404,0.3445378151260504,0.810962922617224,1.0,8/51,7.47%,PLXNA2;ROBO1;LRP4;KIF13B;EPHA4;PLXNC1;ARHGAP35;PTEN
prerank,Wnt signaling pathway (GO:0016055),0.31154598396683036,1.0745512312718355,0.33860759493670883,0.8109375986330215,1.0,26/92,17.56%,WLS;TCF7L2;WNT4;WNT6;PLPP3;LRRK2;FRAT1;TCF7L1;ARL6;WNT5B;PTEN;RYK;USP34;DVL3;BCL9;GPC4;FZD2;FZD10;AXIN1;FZD7;CSNK1A1;VPS26A;SFRP1;VPS35;FZD8;WNT2
prerank,negative regulation of hippo signaling (GO:0035331),0.4759627913289791,1.0745466985233738,0.39400428265524623,0.809969690242656,1.0,3/12,6.96%,VGLL4;WWC1;WWC2
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.3871420537945415,1.074423529302686,0.358695652173913,0.8093336592243715,1.0,7/30,7.01%,SNTA1;KCNA5;GPD1L;ANK2;CACNA1D;GJA1;CACNA2D1
prerank,cellular response to growth factor stimulus (GO:0071363),0.2923872087468188,1.0738762309245242,0.3274336283185841,0.8098057328340279,1.0,18/151,6.95%,SOX5;ADAMTS12;BMP6;WNT4;APPL2;BMP7;WWOX;PDPK1;SOX6;NDNF;ANXA1;STAT5B;SPHK1;PLK5;ADAMTS7;LRP2;HAS1;SMAD3
prerank,regulation of ATP biosynthetic process (GO:2001169),0.44978546831709165,1.073523810411004,0.3879310344827586,0.8097568156603019,1.0,2/16,1.13%,PPARA;PID1
prerank,regulation of protein localization to centrosome (GO:1904779),-0.4571433114680745,-1.0734857958332535,0.39165009940357853,0.7080697553487939,1.0,4/10,14.69%,GSK3B;APC;NSFL1C;BICD1
prerank,negative regulation of kinase activity (GO:0033673),0.3363796186590028,1.0734802962760739,0.33620689655172414,0.8088822873597585,1.0,7/62,6.41%,PRKAG2;PDPK1;DEPTOR;DTNBP1;PPM1E;NPRL2;GNAQ
prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.36486118275880147,-1.0733787503613876,0.3490759753593429,0.7076101517758876,1.0,4/27,2.55%,UTRN;FXYD5;SLMAP;NEDD4L
prerank,positive regulation of protein transport (GO:0051222),0.3277962415487673,1.0731675536882124,0.3310225303292894,0.8087430893701676,1.0,3/67,1.87%,IGF1;BMP6;FRMD4A
prerank,striated muscle cell development (GO:0055002),-0.4182872815834525,-1.0731327672098336,0.36926147704590817,0.7075466344877912,1.0,1/14,0.31%,PGM5
prerank,COPII-coated vesicle budding (GO:0090114),-0.2904514674334757,-1.0730131862211383,0.3,0.7071695525383195,1.0,32/68,32.67%,NSF;CUL3;TMED2;MCFD2;RAB1A;TRAPPC6B;PPP6R1;CNIH1;TMED10;SEC23A;ANKRD28;CTSZ;PREB;RAB1B;TRAPPC2;CNIH3;CTSC;SEC16B;VAPA;TRAPPC4;TRAPPC9;SEC23B;SEC16A;TRAPPC1;TRAPPC5;GRIA1;STX5;COL7A1;GORASP1;PEF1;SEC31A;SEC31B
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.42496824268375505,1.0729756287857863,0.3717171717171717,0.8072766928004556,1.0,3/19,8.27%,POLR2D;ACD;POLR2A
prerank,regulation of DNA recombination at telomere (GO:0072695),0.42496824268375505,1.0729756287857863,0.3717171717171717,0.8072766928004556,1.0,3/19,8.27%,POLR2D;ACD;POLR2A
prerank,nuclear membrane organization (GO:0071763),-0.3864929868459303,-1.072713173876574,0.37763713080168776,0.7071702216910511,1.0,5/19,11.70%,TARDBP;TOR1B;NSFL1C;TMEM43;GPER1
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.29004177920466245,-1.0726601181630333,0.3242506811989101,0.7065725172032732,1.0,17/76,18.14%,ANO1;ESR1;GPR4;TGM2;HOMER1;ADRA1B;GNA14;ADRA1A;HTR2A;GNA11;LPAR6;PTGER3;HRH1;CX3CR1;CMKLR1;AGTR1;CCKBR
prerank,phagosome maturation (GO:0090382),-0.3398587593102023,-1.0724810341597426,0.33555555555555555,0.7063568553736769,1.0,19/35,28.50%,RAB31;ATP6V0A1;RAB38;ATP6V1A;ATP6V0C;ATP6V1E1;TCIRG1;ATP6V0A4;ATP6V0A2;MREG;RAB39A;ATP6V0D2;RAB14;ATP6V0E2;ATP6V1B2;MCOLN1;RAB7A;ATP6V1H;RAB20
prerank,fatty acid oxidation (GO:0019395),0.341290670413488,1.0724472895306425,0.3577371048252912,0.8077337201449267,1.0,15/57,14.50%,EHHADH;ACADL;ECI2;CPT2;HSD17B10;ACAD11;ECHDC1;ACADS;PHYH;ACAA2;ACAT2;AUH;ACOX1;BDH2;HACL1
prerank,positive regulation of binding (GO:0051099),-0.27913830178910237,-1.0724146104843364,0.31842105263157894,0.7057958050991159,1.0,18/84,10.76%,CAV1;CLDN5;B2M;EPB41;TIAM1;RPL11;NGF;HES1;PKD1;MET;GSK3B;HIP1R;ADD2;APP;DERL1;RALB;BMP2;MEN1
prerank,regulation of organelle organization (GO:0033043),-0.2855442635620532,-1.0722895351333255,0.2991913746630728,0.7053741012165828,1.0,23/80,18.35%,MSN;CLIC4;PTK2;F11R;PDE4DIP;RHOT1;CAPN2;TJP1;PDE2A;PDCD10;PAK2;ARHGEF5;MTM1;MARK2;EHD3;MYO5A;MIEF2;VPS11;ATP13A2;ARL6IP1;PREB;STMN3;PINK1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.36483774451993106,-1.071904362227541,0.342,0.7056170487566941,1.0,8/24,18.61%,TPT1;ACKR3;CD44;BCL2L1;CD74;CLU;MIF;CXCL12
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.3854348072784244,1.0718937098023404,0.3666026871401152,0.8082265113267219,1.0,4/31,6.04%,RANBP3L;SMAD6;TMEM64;SUFU
prerank,keratan sulfate metabolic process (GO:0042339),0.37313091069651594,1.0715809227060584,0.3612662942271881,0.8081214258282404,1.0,6/31,5.12%,ST3GAL3;FMOD;OGN;OMD;B4GALT1;PRELP
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.47569961131307165,1.0715526338850812,0.38446969696969696,0.8072118631037902,1.0,2/11,7.68%,PLA2G10;LIPC
prerank,sympathetic nervous system development (GO:0048485),-0.42348865469593083,-1.0710983913513266,0.37524950099800397,0.7069960781997953,1.0,6/15,22.99%,NRP2;SOX4;CTNNB1;NF1;SEMA3A;SOX11
prerank,Fc receptor signaling pathway (GO:0038093),-0.26787757128542616,-1.0703727160169936,0.2767857142857143,0.7082356588633499,1.0,36/110,23.64%,RAC1;CALM1;PLCG2;IKBKB;NFATC2;NFATC1;JUN;PAK1;PSMD13;MAPK8;PSMF1;PAK2;MAP3K1;PSMB10;CHUK;MAP2K7;PSMB6;PSME3;PSMB5;PSMC3;PPP3CA;TAB3;PSMD12;PSMB8;PSME1;CUL1;PSMB3;PPP3R1;NFATC3;PSMD5;SKP1;MAPK3;PSMD9;MAPK10;PSMB4;RELA
prerank,pre-replicative complex assembly (GO:0036388),-0.2969355886959812,-1.0703292907257764,0.35443037974683544,0.707610187466718,1.0,17/64,17.03%,UBB;UBC;RPS27A;PSMD13;PSMF1;PSMB10;PSMB6;PSME3;PSMB5;PSMC3;MCM4;PSMD12;PSMB8;PSME1;UBA52;PSMB3;MCM8
prerank,regulation of adenylate cyclase activity (GO:0045761),0.4182164326418713,1.0702485284854317,0.3576923076923077,0.8097496501339942,1.0,3/22,4.86%,ADGRV1;STIM1;CACNA1D
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.36272380789187353,-1.0700813970824705,0.3686534216335541,0.7075645713673943,1.0,5/29,9.24%,CADM1;STX7;LAMP1;CYRIB;PVR
prerank,homotypic cell-cell adhesion (GO:0034109),0.368172446494189,1.0698117370038736,0.36585365853658536,0.809962512428359,1.0,6/39,4.22%,MEGF11;PLPP3;GNAS;MEGF10;PDGFRA;TLN1
prerank,RNA 3'-end processing (GO:0031123),-0.29560556367356394,-1.0697647103569985,0.3107769423558897,0.7076048874697257,1.0,33/69,33.42%,SRSF2;SRSF1;CPSF7;SRSF5;DDX39B;CPSF3;SRSF9;RBM8A;RNPS1;SRSF6;SYMPK;CLP1;LIN28B;CPSF2;CSTF2;CSTF2T;PCF11;SUPV3L1;MAGOH;THOC3;THOC6;THOC2;EIF4A3;SRSF7;ALYREF;ZC3H11A;TENT4B;CSTF1;CPSF1;DHX38;U2AF1L4;MTPAP;CHTOP
prerank,cellular protein modification process (GO:0006464),0.24924217510769106,1.069553455028263,0.2676056338028169,0.8096985025096198,1.0,147/982,11.96%,PRKAG2;ASB2;ROCK2;OXSR1;PTPN13;B3GALT1;CP;FBN1;APLP2;NRK;EPAS1;WNK4;CDK8;ST3GAL3;DAPK1;PRKAG3;GALNTL5;LARGE1;UST;PDPK1;PDK1;SDC2;ITIH2;LHPP;CEL;TNC;BMP2K;SPSB1;LOXL1;PPM1M;SERPIND1;B3GNT5;PTPN4;UBE2E2;RNASEL;HIF3A;MAP4K5;DMPK;CDK7;FER;ANXA1;PIGU;RAB13;PRKCSH;IGFBP4;FAM20A;OBSL1;NAA80;PCSK9;SRPK2;ST3GAL5;NEURL2;ARAF;DUSP10;MAPK9;CDC14B;FBXW4;PPM1E;PTPRA;ATG10;DCAF4;DDB2;SIK1;LRRK2;WIPI1;MTMR3;PTPN9;UFL1;PRKAA2;MSRA;GPC3;PRKCZ;PSME4;PRKCB;MAML1;PARP4;STK17B;PSMA2;RBBP7;CAND1;UBE2L3;PRKCA;FBXO44;IL6;F5;CCDC8;PTPRD;PSMA3;NEK4;GRK3;PTEN;PRKAA1;NRBP1;CUL9;DCAF10;RYK;MIA3;CSF1;CCNT1;BIRC5;BIRC6;IGFBP7;CAMK2D;USP25;WWP2;GRK5;PIK3R4;CUL7;PKN2;CHRDL1;FSTL3;CDK1;TGM5;KLHL11;GRK4;ASB3;NEK10;VRK2;FBXO6;FEM1B;FRK;PSMD8;GOLGA2;PARP10;ABL1;JAK2;KBTBD7;LATS1;PMM2;PRKDC;UBA7;COQ8B;PARP9;IKBKE;KLHL22;UBA3;PTPN3;PSMD3;PRKD2;FSTL1;ERBB2;SLC35A1;FBXO4;CUL4B;BMPR1A;MAPKAPK2;HIPK3
prerank,polarized epithelial cell differentiation (GO:0030859),-0.4202161736841188,-1.0695461018462467,0.38140417457305503,0.7074804791062734,1.0,3/13,9.72%,MSN;ZDHHC7;RHOA
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.23597908390144787,-1.0692768614995218,0.23376623376623376,0.7074636897685411,1.0,92/314,23.14%,WWP1;ATXN3;NEDD4L;PPP2R5C;UBB;FBXL3;STT3B;UBXN1;ZNRF1;BUB3;TRIM25;CTNNB1;HSP90B1;FAF1;ARRB1;UBC;RPS27A;BAG6;RMND5B;UCHL1;CUL3;ECRG4;DERL1;PSMD13;RBX1;UBE2B;FBXL5;PSMF1;DDB1;PSMB10;KCTD17;KCTD13;FBXO31;HSPA5;FBXL20;FEM1A;PSMB6;NSFL1C;PSME3;PSMB5;ERCC8;PSMC3;HERPUD1;AGAP3;RNF34;KLHL42;PSMD12;PTTG1;PSMB8;PSME1;CUL1;ANAPC16;ERLIN2;UBA52;FBXL2;ZFAND2B;TRIM13;UBE2G1;PSMB3;WFS1;DNAJC10;SPSB3;SPOPL;COP1;CCNF;AUP1;FBXL14;CDK2;BUB1B;RNF5;UBE2D1;DNAJB9;TRIM2;DCAF12;SHARPIN;ARRB2;FBXO17;PSMD5;SKP1;ZSWIM8;TMEM129;KCTD5;PLAA;PELI1;FBXO9;VCP;ANAPC7;PSMD9;HUWE1;RBCK1;RNF103-CHMP3;PSMB4
prerank,cellular response to interleukin-1 (GO:0071347),-0.25832647072406273,-1.0691645370331933,0.2733333333333333,0.7070464387816289,1.0,49/143,23.64%,RPS6KA5;DAB2IP;UBB;NFKBIA;NOD1;IKBKB;ST18;UBC;RPS27A;IL1R1;IL1RAP;PSMD13;PTGIS;RBX1;PSMF1;PSMB10;CHUK;PSMB6;TOLLIP;PSME3;PSMB5;PSMC3;MAP3K3;TAB3;MAP3K8;CD47;PSMD12;GBP3;PSMB8;IRAK3;PSME1;CUL1;UBA52;PSMB3;RPS6KA4;CCL13;ZC3H12A;IRAK1;CD40;PSMD5;MYD88;SKP1;MAPK3;PELI1;HYAL2;PSMD9;PSMB4;MAPK11;RELA
prerank,negative regulation of establishment of protein localization (GO:1904950),-0.4626858871200206,-1.0690808185056349,0.3980952380952381,0.7065468293447579,1.0,6/10,27.32%,CORO2B;DNAJA1;NDFIP2;NDFIP1;SNX3;PPM1F
prerank,cortical cytoskeleton organization (GO:0030865),0.3580447140972495,1.0689716930815925,0.375,0.8103005945900572,1.0,7/41,7.74%,ROCK2;RHOD;FHOD1;RAB13;LLGL2;DLG1;RHOBTB2
prerank,negative regulation of Ras protein signal transduction (GO:0046580),-0.3374955179569368,-1.0685339536674483,0.34101382488479265,0.7072632198218732,1.0,12/35,13.48%,HEG1;TGFB2;RASIP1;DAB2IP;CCDC125;KANK1;MET;CUL3;MYOC;KCTD13;SPRY4;STMN1
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.3492915707269988,1.0683519876155023,0.3333333333333333,0.8110023158740606,1.0,5/48,5.70%,ADCY5;ADCY1;AMPD3;NPR2;ADSL
prerank,regulation of cellular protein catabolic process (GO:1903362),-0.390034802174613,-1.0681796323434403,0.38445807770961143,0.7074935642108454,1.0,4/18,6.14%,MSN;HSP90AA1;DAB2IP;FAF1
prerank,response to UV (GO:0009411),-0.27643162547252764,-1.0679831807286428,0.31413612565445026,0.707317754284823,1.0,32/95,26.08%,RPL26;UVSSA;MAPK8;UBE2B;MEN1;MAP2K7;ATF4;MFAP4;MSH2;BCL3;ERCC8;SDF4;COPS9;POLK;USP28;N4BP1;SPRTN;ATR;PRKCD;METTL3;AKT1;NOC2L;BMF;FMR1;CDKN2D;POLD1;GTF2H2;RELA;DTL;ERCC5;CAT;XPA
prerank,negative regulation of histone modification (GO:0031057),0.45223249514676356,1.067951230029995,0.39549180327868855,0.8110752122862179,1.0,2/14,3.13%,AASS;JARID2
prerank,regulation of neurogenesis (GO:0050767),-0.30765222857214974,-1.067711629182295,0.3226600985221675,0.7072751223129213,1.0,20/55,22.99%,B2M;BHLHE40;NOTCH1;HES1;TGM2;CTNNB1;PRUNE1;SERPINF1;HEY2;GPER1;REST;HEYL;CX3CR1;SPEN;LIG4;HES6;DLL1;FAIM;HEY1;SOX11
prerank,phagosome acidification (GO:0090383),-0.3645746542273326,-1.0673464852158336,0.38204592901878914,0.7075399099773372,1.0,15/26,28.50%,ATP6V0A1;RAB38;ATP6V1A;ATP6V0C;ATP6V1E1;TCIRG1;ATP6V0A4;ATP6V0A2;RAB39A;ATP6V0D2;ATP6V0E2;ATP6V1B2;RAB7A;ATP6V1H;RAB20
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.3117727157933944,1.0671515165976786,0.3453355155482815,0.8122473626072227,1.0,10/102,4.53%,ADCY5;ADCY1;PDPK1;SORBS1;INSIG2;FER;RAB13;PCSK9;CRHBP;CPEB2
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.314400629411648,-1.0668166192003798,0.3374384236453202,0.7082358042588452,1.0,14/50,16.38%,THBS1;GAS6;KLF4;NGF;CD44;VEGFA;PAK2;RPS6KA1;PIH1D1;RNF34;MT3;ARL6IP1;RAF1;CARD16
prerank,chondroitin sulfate metabolic process (GO:0030204),-0.3497240142914917,-1.0667263121968091,0.37557603686635943,0.7077702204542344,1.0,8/30,10.34%,CSGALNACT1;CSPG4;CHST9;BGN;CHST11;HEXB;HEXA;IDS
prerank,regulation of response to external stimulus (GO:0032101),0.30147685551589387,1.0665976300572038,0.3394216133942161,0.8127235705245899,1.0,17/121,9.17%,ADAMTS12;APPL2;EFNB2;NMT2;TRIM5;ANXA1;LACC1;PDGFRA;CASP12;UFL1;PDE6G;SETD6;CAMKMT;DAGLB;RNF135;ZBP1;GRK4
prerank,protein stabilization (GO:0050821),-0.2513998101104625,-1.06621171319878,0.2913907284768212,0.7084045511704526,1.0,39/168,13.88%,HIP1;RASSF2;RPL11;HSP90AA1;HSP90AB1;RPL23;PPARGC1A;ATP1B1;RPS7;SOX17;FLNA;SOX4;PDCL3;CALR;BAG6;RPL5;HIP1R;CHP1;CDC37;CRYAB;GAPDH;BAG1;LAMP1;GOLGA7;PDCD10;CHEK2;GRN;UBE2B;RTN4;PPIB;HYPK;STX12;CAMLG;CDC37L1;HSPD1;CLU;OTUD3;MTMR9;MT3
prerank,protein secretion (GO:0009306),0.3336170463681128,1.0661496629629867,0.3685121107266436,0.8129557426890566,1.0,9/56,9.49%,WLS;TANGO2;ANXA1;ABCA1;ARFGAP3;RAB13;MIA3;SLC30A8;STEAP3
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.33477452941441127,-1.0660629341826662,0.36607142857142855,0.7080764056087965,1.0,16/35,24.75%,CALM1;HSP90AB1;TIPRL;HSP90B1;PPP1R2;GSK3B;MTOR;PPP6R1;MASTL;CSNK2B;CALM2;BOD1;CD300A;PPP1R15B;PPP1R15A;CALM3
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.39942425808634785,-1.0656009772463326,0.39878542510121456,0.7085647185223531,1.0,9/17,24.75%,CALM1;HSP90AB1;PTPRC;MTOR;CALM2;CD300A;PPP1R15B;PPP1R15A;CALM3
prerank,positive regulation of vasculature development (GO:1904018),0.30980093227629296,1.0655488037080612,0.37245696400625977,0.8135870933757379,1.0,15/94,6.79%,SASH1;ADAM12;STIM1;SMOC2;HK2;PDPK1;ECM1;CTSH;ANXA3;ITGAX;SPHK1;FGF1;PRKCB;PDCD6;PRKCA
prerank,plasma membrane invagination (GO:0099024),0.38855072675451574,1.06550415809593,0.3847583643122677,0.8127416233107215,1.0,6/29,6.37%,GULP1;ARHGAP12;SNX18;SNX33;SNX9;SPIRE2
prerank,protein neddylation (GO:0045116),-0.42336535577878126,-1.0654282679080922,0.3772455089820359,0.7083272499981748,1.0,4/13,14.50%,NEDD8;RBX1;DCUN1D1;DCUN1D2
prerank,icosanoid biosynthetic process (GO:0046456),-0.45235170885655857,-1.064869003643161,0.3980392156862745,0.7091172413002643,1.0,7/10,44.39%,PLA2G4A;LTA4H;MGST2;PLA2G5;ALOX5AP;FADS1;LTC4S
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.47602550474456784,1.0648091374860063,0.39565217391304347,0.8137555885979596,1.0,1/10,0.34%,ERRFI1
prerank,regulation of cell motility (GO:2000145),-0.2638413691973086,-1.064508287950067,0.29411764705882354,0.7094286670904232,1.0,29/121,12.18%,FRMD5;TMSB4X;SPOCK2;RAC1;CAVIN1;PLXND1;PRAG1;SLK;SERPINE2;DOCK10;TMSB10;CCDC125;MINK1;PLXNA4;FLNA;SPATA13;RHOB;TGFB1;ROBO4;CEACAM1;ABI3;SRCIN1;CYRIB;FGF7;RHOA;CRK;CDK6;SPINT2;LMNA
prerank,response to steroid hormone (GO:0048545),-0.34241241964261593,-1.0644846212542762,0.36504424778761063,0.7087887212859533,1.0,7/31,5.53%,ABHD2;CAV1;THBS1;ATP1A1;TGFB2;UBE3A;TGFB1
prerank,negative regulation of response to wounding (GO:1903035),-0.3860509341531805,-1.064461014574037,0.3724279835390947,0.7081298521930219,1.0,8/19,21.01%,RTN4RL1;CD109;AJAP1;CRK;GIT1;CASK;INPP5F;RTN4R
prerank,modulation by symbiont of entry into host (GO:0052372),-0.4069553290400988,-1.064160863810103,0.37425742574257426,0.7082495447695699,1.0,6/16,20.55%,CAV1;TRIM14;TRIM25;FUCA2;HS3ST5;TRIM27
prerank,establishment of epithelial cell polarity (GO:0090162),-0.3820019002525118,-1.0640874303607086,0.3641732283464567,0.7077337110705441,1.0,4/19,3.92%,CYTH3;MSN;CYTH1;SIPA1L3
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.27265416727741826,-1.0638842155346917,0.3070652173913043,0.7075423915374639,1.0,20/104,8.13%,CAV1;BMPER;HTRA3;NOTCH1;UBB;ASPN;BMPR2;PRDM16;CCN3;IL17RD;TGFBR2;TGFB1;CD109;CRIM1;UBC;RPS27A;SPRED2;SMAD9;LEMD2;SMAD5
prerank,positive regulation of cellular protein localization (GO:1903829),-0.2907763775187019,-1.0638820380305896,0.3482849604221636,0.7068404401145142,1.0,15/69,9.53%,TFRC;STX3;HSP90AB1;FYN;LIMK2;TGFB1;FERMT2;CCDC88A;GNL3;GSK3B;CARD10;SESN2;RTN4;APC;WWTR1
prerank,cardiac muscle cell contraction (GO:0086003),-0.38858161827704524,-1.0638160886986239,0.37601626016260165,0.7063130380712563,1.0,7/19,18.02%,KCNJ2;ATP1A1;GSN;CACNA1G;CACNA1C;SCN1A;SCN1B
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.390743755968584,-1.0634355512593952,0.378099173553719,0.7065901812183637,1.0,8/18,12.68%,RHOJ;KDR;GATA2;JCAD;VEGFA;PTGS2;PIK3C2A;MAP3K3
prerank,central nervous system neuron development (GO:0021954),-0.41622183829781295,-1.0632012840006841,0.42011834319526625,0.7064520478457951,1.0,4/15,9.71%,HSP90AA1;HSP90AB1;B4GALT5;LHX6
prerank,negative regulation of centrosome duplication (GO:0010826),-0.45294616515617403,-1.0630892433141674,0.40655105973025046,0.7060223900835239,1.0,8/11,45.78%,MDM1;RBM14;CCNF;NPM1;TMEM67;KAT2A;CENATAC;BRCA1
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.4419593385834645,1.06255680420723,0.37267080745341613,0.8188397358822742,1.0,4/14,13.99%,MRNIP;WDR48;ARID2;FANCB
prerank,cellular protein catabolic process (GO:0044257),0.343800883222087,1.062421347482792,0.3691275167785235,0.8182123184330806,1.0,10/59,9.50%,ADAMTS12;PRKN;CLPX;CTSH;PCSK9;ADAMTS7;BNIP3;SIAH2;MDM2;YME1L1
prerank,regulation of glucose transmembrane transport (GO:0010827),0.4315747558743086,1.0617595916502462,0.3929273084479371,0.8190536838302753,1.0,2/18,6.08%,PRKAG2;PRKCB
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.4385876650340831,-1.061452678123903,0.414,0.709553439541553,1.0,7/12,33.68%,SIX1;VEGFA;SIX4;PAX8;AGT;NOG;PAX2
prerank,fatty acid elongation (GO:0030497),-0.4305906128390087,-1.0614021007618102,0.3883495145631068,0.7089748318320729,1.0,5/13,17.46%,ELOVL7;ELOVL5;ELOVL6;ELOVL1;TECR
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.4504120051529177,1.0612067426922274,0.38323353293413176,0.8195853071134437,1.0,3/14,7.38%,OSR1;ZEB1;MMP9
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.41202716773255815,-1.06081613382708,0.40082644628099173,0.7098131597783395,1.0,8/15,30.22%,PRKCH;SFRP4;BMP4;NUMA1;ETV4;NME2;SFN;SULT2B1
prerank,inorganic cation import across plasma membrane (GO:0098659),-0.28901405159328997,-1.0607189852918262,0.3182957393483709,0.7093596861874618,1.0,17/75,13.84%,SLC12A2;SLC12A7;SLC9A2;SLC39A10;KCNJ2;ATP1A1;ABCC9;ATP1B1;SLC12A6;SLC39A8;SLC12A8;SLC24A2;SLC12A4;ATP1A3;KCNJ8;TRPV2;KCNJ15
prerank,regulation of phagocytosis (GO:0050764),-0.30573757615322406,-1.0606645654024531,0.3688118811881188,0.7087807744036976,1.0,11/53,10.24%,GAS6;SCARB1;RACK1;RAB27A;TGM2;GATA2;CALR;DOCK2;PTPRC;DYSF;LMAN2
prerank,regulation of nervous system development (GO:0051960),-0.3301092139732764,-1.060527078251448,0.36830357142857145,0.7084687183781386,1.0,15/37,25.74%,BHLHE40;HES1;CTNNB1;PRUNE1;TNFRSF1B;TENM4;HEY2;HEYL;CX3CR1;HES6;DLL1;HEY1;GBX1;ZPR1;KIF14
prerank,positive regulation of stress fiber assembly (GO:0051496),0.35074142479716663,1.0603386503907122,0.35456110154905335,0.8209838139498093,1.0,6/44,4.71%,ROCK2;TPM1;LPAR1;FHOD1;CCN2;PPM1E
prerank,negative regulation of ERBB signaling pathway (GO:1901185),-0.32592563181557954,-1.0602046202979534,0.3419811320754717,0.7086306594081452,1.0,6/39,4.56%,PTPRJ;SH3KBP1;CBL;DAB2IP;PTPN12;LGMN
prerank,peptidyl-proline modification (GO:0018208),-0.35380156340289387,-1.0601575208800402,0.35157894736842105,0.7080652334932607,1.0,6/25,12.28%,PPIA;P3H2;PPWD1;PPIE;PPIB;NKTR
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.420899602250341,-1.059899163719087,0.3970037453183521,0.7080318727609894,1.0,8/13,33.82%,RPS21;BMS1;TBL3;KRI1;TSR1;ABT1;UTP20;RPP40
prerank,negative regulation of protein metabolic process (GO:0051248),-0.30399207704765974,-1.0597313581078895,0.35207823960880197,0.7077537661866681,1.0,12/48,18.49%,HSP90AB1;FLNA;CRYAB;EDN1;AZIN1;CLU;CYP51A1;IRAK3;IAPP;PRKCG;PFDN6;PFDN5
prerank,positive regulation of cell adhesion (GO:0045785),-0.2890016802595368,-1.0596884468569032,0.3411458333333333,0.7071633336984108,1.0,13/74,8.27%,FRMD5;PTPRJ;ZFHX3;VIT;STX3;TGFB2;RAC1;TGM2;LIMS1;ECM2;FBLN2;VEGFA;NPNT
prerank,extracellular matrix assembly (GO:0085029),-0.3741979668597777,-1.059556519444134,0.3693877551020408,0.7068238961302991,1.0,9/23,12.24%,GAS6;RAMP2;MYH11;TNXB;TGFB1;LAMB2;GPM6B;MFAP4;NTN4
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.3928568318020818,1.0592549105393227,0.3857965451055662,0.8228798216707066,1.0,2/23,1.88%,ERRFI1;SNX6
prerank,response to nitric oxide (GO:0071731),-0.4207434065223082,-1.059113590345118,0.38235294117647056,0.707232787572111,1.0,5/13,20.42%,GUCY1B1;FOXO1;MT3;CDK2;KCNC2
prerank,negative regulation of gene expression (GO:0010629),0.262099749595716,1.0588933644562684,0.3143989431968296,0.8228372021085392,1.0,36/302,10.85%,IGF1;ROBO1;SLC24A3;ROCK2;WNT4;LGR4;NOTCH2;IGF2BP1;DAPK1;PRKN;RBMS3;JARID2;PTBP2;SYT11;RBBP4;TNRC6B;TNRC6A;PRKAA2;SLC2A10;TYMS;RBBP7;ABCC2;PRKAA1;MTF2;RBL2;WWP2;YTHDF2;PICALM;APLN;SAMD4A;PARP10;HDAC1;AGO2;FLCN;PARP9;ATOH8
prerank,folic acid metabolic process (GO:0046655),0.41394536481156663,1.0587998729690602,0.40118577075098816,0.8221228978039744,1.0,8/18,22.76%,MTHFR;FOLR2;SLC19A1;SHMT1;MTHFS;DHFR;MTHFD2;FPGS
prerank,negative regulation of wound healing (GO:0061045),-0.3540511336775119,-1.0586573409028932,0.3956043956043956,0.7077463242143203,1.0,9/28,14.36%,SLC12A2;CD34;SERPINE2;CD109;EDN1;AJAP1;CRK;THBD;CASK
prerank,synaptic vesicle membrane organization (GO:0048499),-0.39777557023173277,-1.0586207367975948,0.40329218106995884,0.7071472432812639,1.0,6/17,25.49%,STX3;STX1A;SNAP25;STX2;SYP;SYNGR2
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.4235525488887568,-1.0585744653714635,0.3843137254901961,0.7065668773103126,1.0,3/13,6.64%,PDE8A;RACK1;MET
prerank,mesenchymal cell development (GO:0014031),-0.39385631536769433,-1.0584455852255057,0.3847695390781563,0.7062493997139395,1.0,10/18,32.80%,CDH2;NOTCH1;HEY2;HEYL;NOLC1;SOX11;SNAI2;TBX20;PEF1;KBTBD8
prerank,neutrophil migration (GO:1990266),-0.30151677917961545,-1.0582413668830581,0.34352941176470586,0.7060857206260345,1.0,8/58,9.89%,PECAM1;BSG;TGFB2;PPIA;CXADR;EDN1;PPIB;PIK3CD
prerank,calcium ion import (GO:0070509),-0.3518311666515155,-1.0579541209132346,0.3885480572597137,0.7061726707849546,1.0,11/28,15.66%,CACNA1G;CACNA1E;TRPC4;ATP2A2;SMDT1;CACNA1H;CACNA1C;CACNB2;MCUB;CACNA1I;CACNA1B
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.3599519289731487,1.0577850164528722,0.38278388278388276,0.8238790327091702,1.0,1/41,0.09%,PRKAG2
prerank,regulation of proteasomal protein catabolic process (GO:0061136),-0.3092876388317894,-1.0577277434053105,0.3490566037735849,0.7060585256857176,1.0,15/53,18.35%,HSP90AB1;DAB2IP;UBB;PKD1;UCHL5;GNA12;TMF1;PSMF1;FOXF2;PSME3;UBQLN4;PSMC3;PSME1;PRKCG;PINK1
prerank,hippo signaling (GO:0035329),0.39259861423604026,1.057654816318212,0.38,0.8232579146846446,1.0,6/26,10.27%,AMOTL2;FAT4;TEAD1;WWC1;TEAD3;LATS1
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.25262974877438105,1.0574889442827053,0.31889290012033694,0.8227908695550441,1.0,47/509,6.85%,IGF1;ROCK2;SASH1;WLS;ADGRV1;TCF7L2;OSBPL8;KSR1;FGFR2;FGFR4;IL18;KIT;ANGPT1;PRKN;PELI2;LPAR1;PDPK1;BCL2;FNIP1;LTF;PDGFRB;NOS1AP;KL;ECM1;TRIM5;NEDD4;IGF2;EPHA8;PDGFRA;NFAT5;GFRAL;AKAP13;SPHK1;RICTOR;GJA1;PDGFD;DDX60;SLC38A9;FRS2;FGF1;IGF1R;LRP2;PRKCB;CXXC5;WWC1;ADRA1D;IL6
prerank,positive regulation of autophagy (GO:0010508),0.30645950747113293,1.0574214435201694,0.36217948717948717,0.8220021544890292,1.0,22/81,16.67%,DAPK1;PRKN;TRIM5;NPRL2;SESN1;LRRK2;UFL1;PRKAA2;BNIP3;OPTN;RNF152;PRKAA1;PLEKHF1;EPM2A;FLCN;GPSM1;TBK1;MAP3K7;MTDH;RUFY4;IRGM;LARP1
prerank,regulation of lymphocyte migration (GO:2000401),-0.4517321397626954,-1.0574105740919384,0.4207547169811321,0.7061442417967402,1.0,2/10,1.59%,MSN;JAM2
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.3376916826718074,1.0569465980044834,0.37458745874587457,0.8223924510215912,1.0,6/51,4.71%,ROCK2;TPM1;LPAR1;FHOD1;CCN2;PPM1E
prerank,regulation of membrane depolarization (GO:0003254),0.4226751084857372,1.0566630468625584,0.406,0.8222154396702609,1.0,6/18,11.92%,GPD1L;LRRK2;CAMK2D;PTPN3;SCN3B;SCN2B
prerank,aortic valve morphogenesis (GO:0003180),0.3805009540430279,1.0566575289212095,0.3506944444444444,0.8212813762271972,1.0,3/30,2.30%,ROBO1;ROCK2;SMAD6
prerank,zinc ion transmembrane transport (GO:0071577),-0.372160367458207,-1.056335228798773,0.3831967213114754,0.7082155110473475,1.0,5/22,9.85%,SLC39A10;SLC30A5;SLC39A8;SLC39A7;SLC30A1
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.2829145929779101,-1.0557413543928518,0.34831460674157305,0.7090828932334198,1.0,24/76,19.60%,TMSB4X;CD200;KLF4;DAB2IP;NFKBIA;FAF1;ARRB1;CHP1;LRRC14;AIM2;PTGIS;NLRC5;COMMD7;CHUK;ERBIN;NLRP2B;IRAK3;BRMS1;CMKLR1;DAP;ZC3H12A;IRAK1;ARRB2;SPI1
prerank,cellular response to leucine starvation (GO:1990253),-0.4581871553521061,-1.0554303538769008,0.4158607350096712,0.709188259687038,1.0,4/10,17.59%,SESN3;MTOR;SESN2;RRAGB
prerank,positive regulation of type 2 immune response (GO:0002830),0.43745358056620987,1.0552329553200255,0.38832997987927564,0.8242056540504573,1.0,3/14,6.85%,IL18;PRKCZ;IL6
prerank,canonical Wnt signaling pathway (GO:0060070),0.3222309338071648,1.0550221112948948,0.3768595041322314,0.8238034745643092,1.0,12/68,10.36%,TCF7L2;WNT4;WNT6;PLPP3;LRRK2;FRAT1;TCF7L1;WNT5B;PTEN;RYK;DVL3;BCL9
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.3317888259249934,-1.0545673594636114,0.3625866050808314,0.7107126254237041,1.0,7/33,8.94%,ESR1;CBFB;RUNX1;CALR;KDM4C;DDX5;H3-3A
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.4313534104780638,1.0536426261936553,0.3843137254901961,0.826511335806237,1.0,5/17,15.72%,LPGAT1;PLA2G10;PLA2G4B;PLA2G12A;SERAC1
prerank,stress granule assembly (GO:0034063),-0.38501904516235774,-1.0533794827028984,0.40301724137931033,0.7131047024516595,1.0,5/20,14.69%,RPS23;G3BP1;ATXN2L;YTHDF3;BICD1
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),-0.3767852443785016,-1.0527202061384933,0.3895582329317269,0.7141375087644676,1.0,5/21,11.74%,RPL11;RPL23;RPS7;RPL5;RAB1A
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.4361232654580268,-1.0526864996004308,0.3952569169960474,0.7135354473010905,1.0,3/12,6.18%,CBFB;RUNX1;PTPRC
prerank,regulation of Ras protein signal transduction (GO:0046578),0.3063755470448733,1.0526800380007322,0.3652037617554859,0.8281200562312468,1.0,13/85,10.77%,IGF1;DENND4A;NOTCH2;AKAP13;KANK2;EPS8L1;RALGPS1;MYO9B;ARHGEF18;JAK2;KBTBD7;FLCN;DENND4B
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.3950342458280131,1.0521290277675313,0.39880952380952384,0.8286678210783391,1.0,4/23,7.46%,C1QTNF3;BMP7;UACA;NLRC3
prerank,vesicle transport along actin filament (GO:0030050),-0.38394547950490937,-1.051738521677259,0.402020202020202,0.7152954232249109,1.0,3/19,1.89%,MYO1D;ACTN4;FNBP1L
prerank,iron-sulfur cluster assembly (GO:0016226),-0.3582599430912252,-1.0510710783336878,0.38461538461538464,0.7163209514650432,1.0,11/24,33.25%,ISCU;CIAPIN1;GLRX5;GLRX3;HSCB;ISCA2;HSPA9;ISCA1;CIAO2B;BOLA2;NFS1
prerank,retinal metabolic process (GO:0042574),0.4512495278907836,1.0508514067161154,0.4012345679012346,0.8311182694060962,1.0,4/12,19.88%,ABCA4;RDH11;RDH13;BCO2
prerank,regulation of macroautophagy (GO:0016241),0.2968441518214255,1.0507458451252434,0.3616,0.8304579084740843,1.0,28/105,17.70%,PRKAG2;PRKAG3;SNX6;NEDD4;SESN1;LRRK2;PRKAA2;SLC38A9;BNIP3;PRKAA1;ATP6V0D1;EPM2A;ATP6V0E1;MLST8;GPSM1;PRKAG1;TBK1;LZTS1;MAP3K7;ATP6V1D;EXOC7;EXOC1;RUFY4;LARP1;ATP6V1G2;VPS26A;VPS35;TSC1
prerank,ventricular septum morphogenesis (GO:0060412),0.39135426203626267,1.0507413017648637,0.40530973451327434,0.829508425814028,1.0,2/27,0.29%,TGFBR3;ROBO1
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.3224904823333353,-1.0505605688706052,0.36596736596736595,0.7170117408438268,1.0,10/39,15.47%,MYO1D;ACTN4;FNBP1L;PPFIA2;KIF1A;RAB1A;SYT4;MYO5A;NDE1;BICDL1
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.46025828057796714,1.0505230390719125,0.4166666666666667,0.8281628189358806,1.0,1/12,0.98%,FHL2
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.46025828057796714,1.0505230390719125,0.4166666666666667,0.8281628189358806,1.0,1/12,0.98%,FHL2
prerank,regulation of vasoconstriction (GO:0019229),-0.35510038934178845,-1.0504521086436398,0.37154989384288745,0.716581923597233,1.0,9/27,12.61%,CAV1;BMPR2;ADRA1B;CHRM3;ADRA1A;ECE1;KCNMB4;ACE2;ATP2B1
prerank,organelle transport along microtubule (GO:0072384),-0.34321863081864856,-1.0503490629047312,0.37117903930131,0.7161691097645803,1.0,7/31,15.47%,UBB;RHOT1;COPG1;RAB1A;NDE1;BICD1;BICDL1
prerank,response to reactive oxygen species (GO:0000302),-0.3002377601582997,-1.050345383401483,0.38902147971360385,0.7154899313709494,1.0,14/54,13.40%,APOD;FYN;RPS3;PXN;CAMKK2;SOD1;JUN;PDCD10;STK25;MAPK8;CHUK;PDK2;AGAP3;ROMO1
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.38638644661836186,1.0497841915261938,0.39579349904397704,0.8291608789736924,1.0,12/25,24.65%,SLU7;SF3A3;DDX23;PRPF3;SCAF11;DBR1;SNRNP40;PRPF6;LSM1;KHSRP;SF3B3;SRRM1
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.3960623511357768,-1.049380811516024,0.4116504854368932,0.7173799238790897,1.0,8/17,12.40%,NOTCH1;SERPINE2;HES1;TGFB1;TNFRSF1B;TENM4;BMP2;BIN1
prerank,estrogen metabolic process (GO:0008210),0.43002884363813565,1.049359200158999,0.40606060606060607,0.8293062849246431,1.0,2/15,5.83%,HSD17B1;HSD17B10
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.36584853362969116,1.0491513915143684,0.3898916967509025,0.828877528677848,1.0,14/37,20.32%,DYNC2H1;IFT80;WDR19;WDR35;IFT27;IFT122;TNPO1;KIF3C;IFT140;DYNC2I1;IFT22;IFT81;TRAF3IP1;IFT46
prerank,positive regulation of protein localization to cell periphery (GO:1904377),-0.3044844884807249,-1.0490245377493341,0.3855140186915888,0.7175879160236114,1.0,8/52,6.59%,SPTBN1;PRKCH;EPB41;STX3;ITGB1;GNAI1;NKD2;WNK3
prerank,lysosome localization (GO:0032418),-0.33030589082944106,-1.048999408096648,0.3783783783783784,0.716967336275198,1.0,19/37,29.29%,MAP6;BLOC1S2;MYH9;PIK3CD;LAMTOR1;CHGA;PLEKHM1;SPAG9;HDAC6;S100A13;RAB3A;SYTL4;BORCS6;KLC2;SNAPIN;MILR1;HPS6;VPS33B;NR4A3
prerank,plasma membrane repair (GO:0001778),-0.41884106850495084,-1.0489755397803693,0.4376237623762376,0.7163447282910305,1.0,6/13,24.34%,AHNAK2;MYH9;DYSF;SYT7;RAB3A;SYTL4
prerank,cellular iron ion homeostasis (GO:0006879),-0.30432686904432277,-1.048837625956549,0.38028169014084506,0.7160288608873799,1.0,15/55,9.95%,ABCG2;FTH1;TFRC;SCARA5;FTL;IREB2;SLC40A1;SOD1;NEDD8;SLC22A17;ISCU;HMOX2;FBXL5;ATP6V1A;FRRS1
prerank,positive regulation of mitochondrion organization (GO:0010822),-0.2950932777929158,-1.0481937563227681,0.37817258883248733,0.7169560360576794,1.0,22/57,28.80%,KDR;PPARGC1A;FBXO7;TNFSF10;CAMKK2;GSK3B;HIP1R;MIEF1;GPER1;MIEF2;BBC3;SPIRE1;PINK1;PLAUR;BIK;BMF;CHCHD10;BAX;DCN;BID;FIS1;TREM2
prerank,negative regulation of RNA splicing (GO:0033119),-0.38531023794559505,-1.047997554242115,0.42213114754098363,0.7168188851878825,1.0,7/19,20.21%,SRSF9;RNPS1;SRSF6;RPS26;TMBIM6;PTBP1;PCBP4
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.43069452197999464,-1.0479971074774246,0.4050880626223092,0.7161357279242567,1.0,3/13,9.24%,STX7;CYRIB;PVR
prerank,axon extension (GO:0048675),0.40051508889558707,1.0479168786631181,0.38394415357766143,0.8312712880999918,1.0,2/23,0.59%,ALCAM;AUTS2
prerank,DNA replication initiation (GO:0006270),-0.32764777344956886,-1.0476100306350857,0.38004750593824227,0.716443909620255,1.0,20/37,37.02%,RPA1;MCM4;TOPBP1;PRIM1;MCM8;POLA1;CDK2;POLE4;POLE;MCM5;MCM10;ORC1;RPA3;MCM6;GMNN;POLE3;RPA2;CDC6;CDC7;CDC34
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.2789918996999345,-1.047343981384525,0.3673469387755102,0.7164314095618001,1.0,22/79,14.36%,SLIT2;BMPER;THBS1;HTRA3;DAB2IP;NOTCH1;BMPR2;CREB3L1;CRIM1;SMAD9;LEMD2;SMAD5;BMP2;HHEX;PTPN1;HGS;GPC1;EPN2;SPRY4;CADM4;SKIL;CASK
prerank,negative regulation of RNA metabolic process (GO:0051253),-0.38768403703360266,-1.047310702356527,0.3995943204868154,0.7158475779184955,1.0,7/18,20.04%,ESR1;TGFB1;RPS26;ZC3H12A;TMBIM6;NRDE2;PTBP1
prerank,hydrogen peroxide catabolic process (GO:0042744),0.4773970862691548,1.047128430246076,0.38626609442060084,0.8324805607774628,1.0,1/11,2.30%,PXDN
prerank,plasma membrane bounded cell projection organization (GO:0120036),-0.254330092576057,-1.04680958762613,0.33647798742138363,0.7164426890513178,1.0,38/124,26.98%,FRY;PTPRM;STX3;RAC1;CARMIL1;PLP1;MAP4;BLOC1S2;EHD1;GSK3B;STMN2;MYOC;APP;GPM6B;PLEKHA1;STMN1;CSF1R;ODF2;BICDL1;TMEM108;STMN4;SH3GL2;NCDN;STMN3;CDK5;GPM6A;ARFIP2;UHMK1;L1CAM;VAPA;AGER;NPY;ATCAY;ADCYAP1;CAMSAP1;MICALL2;CTTN;SNAPIN
prerank,mitochondrion transport along microtubule (GO:0047497),-0.42194757678417233,-1.0465801458587216,0.39846743295019155,0.7163546865825833,1.0,2/13,6.34%,UBB;RHOT1
prerank,sulfur compound transport (GO:0072348),0.3797968823298845,1.0463306984608658,0.3913857677902622,0.833669587510747,1.0,7/27,10.67%,SLC6A13;SLC13A4;SLC35F3;SLC25A11;SLC27A1;SLC19A2;SLC13A1
prerank,protein import into peroxisome matrix (GO:0016558),-0.4261805706885605,-1.045983577898014,0.4163265306122449,0.7171905304498913,1.0,6/12,29.53%,PEX5L;PEX1;PEX5;PEX10;PEX16;PEX13
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.37077109781983636,-1.0453732141606715,0.406570841889117,0.7180375297178418,1.0,4/22,13.95%,ESR1;MED17;PSMC3;MED14
prerank,cGMP metabolic process (GO:0046068),-0.43224773926045723,-1.0448738398628696,0.43520309477756286,0.7186325482306828,1.0,3/12,7.13%,GUCY1B1;GUCY1A1;PDE2A
prerank,RNA processing (GO:0006396),0.2790777299028017,1.0448449133936313,0.3727144866385373,0.8366733014994685,1.0,54/176,20.74%,CELF2;ATXN1;RBMS1;NOVA1;RNASEL;ADAD1;SRPK2;RBPMS;HNRNPC;HNRNPH1;RBMS2;SON;TSEN34;NOL3;RBM5;SLU7;SF3A3;DDX23;RP9;AKAP8L;PRPF3;NOL9;TENT2;RBM39;PDCD7;TUT1;SCAF11;NONO;TSEN2;DICER1;SNRNP40;DHX8;LSM5;SRRM4;CSTF3;DHX15;HNRNPH3;SNRPA1;U2AF1;HNRNPA2B1;HNRNPR;NUDT21;RSRC1;RNGTT;PRPF6;TUT4;LSM3;SRSF11;RBM4;LSM1;LSM4;SNRPF;SETX;DDX47
prerank,sulfur compound biosynthetic process (GO:0044272),0.29789734468388307,1.0448216221950202,0.37593984962406013,0.8357829681805227,1.0,13/104,6.08%,ST3GAL3;ANGPT1;FMOD;UST;CBS;OGN;GSTM2;OMD;B4GALT1;GSTT1;PRELP;CHSY1;CHST3
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.4479267202903767,-1.0448155691670886,0.4142581888246628,0.7181114247265352,1.0,9/11,49.71%,CAMK4;SPI1;TYROBP;ITGB2;MAVS;TICAM1;STAP1;F2RL1;CD177
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.3793743960734493,1.0447521839996396,0.4033457249070632,0.8350053630100154,1.0,6/26,8.46%,ATP1B3;NEDD4;ANK2;CACNA1D;DLG1;WWP2
prerank,protein localization to chromatin (GO:0071168),-0.3874521620331951,-1.0438318605154808,0.3917525773195876,0.7200140412534842,1.0,6/18,17.03%,ESR1;LEMD2;PIH1D1;MSH2;TASOR;MCM8
prerank,protein acetylation (GO:0006473),0.3766834528301055,1.043765528942229,0.41834862385321103,0.836640708521529,1.0,12/30,21.31%,NAA80;SPHK1;AANAT;NAA35;CLOCK;CREBBP;NAA60;ESCO1;DSCC1;NAA50;KAT2B;KAT5
prerank,cellular response to hypoxia (GO:0071456),0.2926854086462536,1.043647697339385,0.37026239067055394,0.8359855957259003,1.0,16/126,9.85%,RORA;SLC8A3;EPAS1;BMP7;HIF3A;NDNF;CPEB2;PSME4;PSMA2;BNIP3;NPEPPS;PSMA3;ARNT;ACAA2;MDM2;PSMD8
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.4569117828874623,1.0433638007607788,0.42857142857142855,0.8358723606721777,1.0,2/13,4.34%,PLXNA2;PLXNC1
prerank,spinal cord development (GO:0021510),-0.41867257572108113,-1.043332119673416,0.3890977443609023,0.7205864589583869,1.0,8/12,24.09%,VIT;PKD1;SOX4;RELN;NF1;DLL1;SOX11;ZPR1
prerank,receptor recycling (GO:0001881),0.45982279555591365,1.0433313812099074,0.41755888650963596,0.835015526165669,1.0,5/10,15.10%,PLEKHJ1;REP15;ARFGEF2;PHETA1;RAB11B
prerank,anterograde axonal transport (GO:0008089),-0.3246461893922939,-1.0429710859973518,0.3795454545454545,0.7208438971079665,1.0,18/37,33.47%,DLG2;AP3S1;HSPB1;BLOC1S2;SOD1;AP3M2;KIF1A;KIF3B;NEFL;MAP1A;KIF1B;KIF4A;HAP1;SNAPIN;KIF5C;MAPK8IP3;AP3B2;KIF5B
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.23673834759438755,-1.042718447168751,0.3103448275862069,0.7207555711197287,1.0,54/234,16.38%,PRKCH;CAV1;ESR1;CD200;TFRC;RPS6KA5;PPARGC1A;PLCG2;UBB;NFKBIA;PPIA;RPS3;NOD1;FZD4;TRIM14;IKBKB;ROR1;HDAC5;TRIM25;EDA;CTNNB1;UBC;RPS27A;TNFRSF11A;LRP8;CARD14;APP;VEGFA;IL1RAP;SLCO3A1;AIM2;EDN1;ZBTB7A;ARHGEF5;RELN;CHUK;RTKN2;STAT3;ARHGEF2;CLU;TAB3;JUP;STK36;IRAK3;TRAF1;PPRC1;TERF2IP;UBA52;TRIM13;PRKD1;CX3CR1;RPS6KA4;TCF3;CARD16
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),-0.4427180048692124,-1.0424915432313169,0.42996108949416345,0.7207117175731086,1.0,6/11,31.11%,PUM2;LIMD1;STAT3;FMR1;ZFP36;DHX9
prerank,neuron projection development (GO:0031175),-0.2454370785413878,-1.0424805232420244,0.3356401384083045,0.7200661666601864,1.0,26/168,9.12%,FRY;SHANK3;PTPRM;TRIO;STX3;CTNND2;GRM7;PLP1;DAB2IP;NGF;MAP4;UBB;DOCK10;MINK1;NCKAP1;SHTN1;BLOC1S2;EHD1;GSK3B;STMN2;DNM2;MYOC;APP;GPM6B;PAK1;NYAP2
prerank,cholesterol metabolic process (GO:0008203),0.3197510848019875,1.0422627219023002,0.39403973509933776,0.836886035794076,1.0,12/68,11.91%,CYP27A1;CEL;INSIG2;ABCA1;ABCA5;PMVK;ACAA2;SOAT2;ACAT2;RXRA;FDPS;GBA2
prerank,skeletal muscle organ development (GO:0060538),-0.3509640168314159,-1.0421815555220908,0.41041666666666665,0.7201167541233757,1.0,5/26,6.82%,MEF2C;CAV1;MYL6;STRA6;SIX1
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.3884978316675872,1.0420477153545191,0.40529531568228105,0.8365115405647425,1.0,3/22,5.17%,APPL2;KDM2B;LRRK2
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),-0.3696107570740381,-1.0418261885575846,0.40122199592668023,0.7202955809643815,1.0,9/21,17.75%,NDST3;HS3ST4;HS6ST2;EXT1;EXTL3;XYLT1;GPC1;HS6ST3;HS3ST5
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.44646420913195584,-1.041639108358433,0.42226487523992323,0.7201335690664974,1.0,5/10,27.76%,ACER2;NEXMIF;CYP1B1;JAM3;SNAI2
prerank,regulation of histone acetylation (GO:0035065),-0.3406770286384935,-1.041008020369058,0.421875,0.7210995046582654,1.0,12/33,21.09%,RPS6KA5;PPARGC1A;HDAC5;ARRB1;SET;GLYR1;NOS1;RPS6KA4;CTBP1;SPI1;MAPK3;NOC2L
prerank,positive regulation of filopodium assembly (GO:0051491),0.3902269713694581,1.040598445398707,0.402321083172147,0.8394357736066405,1.0,4/24,5.37%,DOCK11;DPYSL3;RIPOR2;WASL
prerank,response to muscle stretch (GO:0035994),0.43483359888330114,1.0400248879142449,0.4215885947046843,0.8399978261930992,1.0,3/15,3.10%,DMD;CSRP3;SLC8A1
prerank,regulation of inflammatory response (GO:0050727),0.2733941704097427,1.0396963403407833,0.3672316384180791,0.8399335988863739,1.0,19/190,7.82%,RORA;ADAMTS12;C1QTNF3;PPARA;IL18;SNX6;CCN4;ANXA1;LACC1;SPHK1;CASP12;UFL1;GPSM3;SETD6;NAPEPLD;IL6;MMP9;NLRC3;DAGLB
prerank,regulation of nuclear division (GO:0051783),0.4063172703303787,1.0395040412460628,0.4049904030710173,0.839524928856997,1.0,4/20,8.66%,OBSL1;CCDC8;CUL9;CUL7
prerank,regulation of intracellular signal transduction (GO:1902531),0.25631207833542236,1.0392265704841819,0.38681592039800994,0.8393449566250635,1.0,50/420,9.58%,ARHGAP28;PRKAG2;ARHGAP24;ARHGAP6;PTPN13;GMIP;ARHGAP29;NRK;FGD4;PRKAG3;RHOD;PDPK1;ARHGAP20;AKAP7;SYDE2;ATRIP;ARAF;MAP2K6;RBBP4;ARHGAP26;AKAP13;SOS2;ARHGAP12;RICTOR;ZFAND6;LRRK2;UFL1;ARHGAP40;PRKAA2;FGF1;DLG1;ARHGEF11;RBBP7;WWC1;BANP;WWC2;ARHGAP35;OPTN;BLM;PTEN;CHD4;ARHGAP9;PRKAA1;MYO9B;GPR143;USP7;CDK1;MDM2;ARHGEF18;VRK2
prerank,dendritic spine morphogenesis (GO:0060997),-0.404074938696208,-1.0392258096601856,0.40606060606060607,0.7251024715151877,1.0,3/15,3.87%,SHANK3;CTNND2;DOCK10
prerank,ion homeostasis (GO:0050801),-0.33584131692490216,-1.039210293295482,0.41501103752759383,0.7244574836249956,1.0,6/30,10.86%,SLC4A10;NEDD4L;FHL1;WNK3;SLC4A8;SLC4A2
prerank,positive regulation of response to external stimulus (GO:0032103),0.2913393933798014,1.0391478099286875,0.3691376701966717,0.8386162976171516,1.0,22/128,14.15%,BMP6;SASH1;IL18;PDGFRB;CCN4;PTN;GPSM3;DDX60;NAPEPLD;PRKCA;OPTN;CCL19;POLR3G;ZBP1;APOH;SERPINE1;GPRC5B;NINJ1;S100A9;PTGER4;NLRP12;POLR3C
prerank,nucleosome organization (GO:0034728),0.32812927061084335,1.0389857003099345,0.391304347826087,0.8381114906793947,1.0,16/55,17.16%,NASP;RSF1;ARID2;KAT6B;SMARCA5;SMARCE1;NAP1L3;INO80;SMARCB1;SRCAP;NAA60;SMARCC1;ACTR6;SMARCD3;NAP1L1;SETD2
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.3275134250755202,1.0389378880110847,0.4035656401944895,0.8373071466040071,1.0,3/57,1.83%,ADCY5;ADCY1;LPAR1
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.32657461715815395,-1.0388360057242882,0.41002277904328016,0.7247528606603205,1.0,13/36,22.96%,SGMS1;DAB2IP;PPIA;RPS3;TPD52L1;TRAF1;MADD;FAS;CX3CR1;NR4A2;TMBIM6;MAZ;MAPK8IP2
prerank,regulation of superoxide anion generation (GO:0032928),-0.4086593668145314,-1.0387525903545607,0.40236686390532544,0.7242945517922496,1.0,6/14,33.05%,TGFB1;SOD1;TYROBP;PRKCD;ITGB2;SYK
prerank,base conversion or substitution editing (GO:0016553),-0.44738336369961706,-1.0387457604797101,0.4268292682926829,0.7236322715681878,1.0,5/11,24.72%,ADARB1;ADARB2;ADAR;METTL3;NUDT16
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.4206660317027178,1.0386106514051894,0.423728813559322,0.8372181410033765,1.0,3/18,6.76%,BCL2;SLC25A31;BNIP3
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.38644286028947883,-1.038590778989421,0.4073319755600815,0.7233512677901096,1.0,6/18,19.40%,SEC14L1;RNF125;PUM2;BIRC3;GPATCH3;NOP53
prerank,negative chemotaxis (GO:0050919),0.36324025112721015,1.0385316402007192,0.4177215189873418,0.8364840412303532,1.0,3/33,2.48%,EPHA7;ROBO1;SEMA3B
prerank,purine-containing compound catabolic process (GO:0072523),0.44423125205711345,1.0384968420681662,0.3967611336032389,0.8356510226821875,1.0,1/13,0.43%,DPYD
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),-0.39835488721383716,-1.038412355316454,0.4246575342465753,0.723102081007445,1.0,3/16,9.24%,CADM1;LAMP1;PVR
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.31162938521369565,-1.0382323767960735,0.3726851851851852,0.7228752431918211,1.0,17/46,26.07%,MSN;PPIA;SOD1;ARF1;PDCD4;RPLP0;PAK2;TALDO1;HNRNPDL;MIF;PITPNA;HSPA9;CFL1;JAK1;HNRNPF;CAPZA1;IL12RB2
prerank,regulation of protein secretion (GO:0050708),0.286727373776063,1.0381903472212508,0.3755656108597285,0.8355330230123048,1.0,11/119,7.16%,IGF1;BMP6;ITPR1;FRMD4A;KCNA5;LLGL2;CACNA1D;MYO18A;PRKCA;IL6;RAPGEF4
prerank,regulation of ion transmembrane transport (GO:0034765),-0.32761842972462313,-1.0381891267176024,0.376940133037694,0.7223354420304234,1.0,16/33,34.27%,KCNJ2;NEDD4L;CHRM3;WNK3;KCNQ1;KCNJ8;KCNJ15;AHCYL1;KCNH2;KCNJ6;KCNJ16;KCNJ10;CASQ2;AKAP6;WNK1;P2RX7
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.29185910127980075,1.0378098938183289,0.36419753086419754,0.8356069230033363,1.0,11/112,5.73%,SOX5;TGFBR3;WNT4;APPL2;WWOX;SMAD6;PARD3;SOX6;COL1A2;ZMIZ1;PRKCZ
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.43024538346590335,-1.0375268852228807,0.4352720450281426,0.7232841028396919,1.0,5/13,12.14%,NOS3;GLS;DDAH1;NOS1;GAD1
prerank,negative regulation of transport (GO:0051051),0.33414776472077357,1.0372116799053874,0.38160136286201024,0.8362298741990197,1.0,11/51,13.69%,EPHA3;PRKN;SYT11;SNX33;PTEN;WWP2;SIRPA;RUBCN;SNX12;PACSIN3;PRTN3
prerank,intermediate filament organization (GO:0045109),-0.39003103475846657,-1.037140391074513,0.4187866927592955,0.7235981193221702,1.0,5/17,21.26%,VIM;GFAP;MTM1;DSP;NEFL
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.4184762276864137,1.0369298621773961,0.4369287020109689,0.8360215252709443,1.0,1/18,0.06%,UNC13C
prerank,response to nutrient levels (GO:0031667),-0.3862669746833957,-1.0368741343934433,0.4115308151093439,0.7236416080427758,1.0,5/17,10.89%,KCNB1;FAM107A;MTOR;EIF4G1;ATF4
prerank,mitochondrial fission (GO:0000266),-0.39393430635967364,-1.0368615738877414,0.41975308641975306,0.723004556822588,1.0,4/16,12.68%,DNM3;DNM2;MIEF1;DNM1
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.4257566091236029,1.0367730185832265,0.41304347826086957,0.8354976408535272,1.0,3/16,9.19%,APPL2;ACADL;APOC1
prerank,negative regulation of myoblast differentiation (GO:0045662),-0.42273074258143445,-1.0366507759534829,0.4448979591836735,0.7228702672907694,1.0,6/13,23.82%,NOTCH1;TGFB1;TBX3;BMP4;DLL1;EID2B
prerank,myeloid leukocyte differentiation (GO:0002573),0.3229332775463317,1.03655626767801,0.3895253682487725,0.8351207552443832,1.0,12/65,13.69%,IL31RA;KIT;MMP9;CCL19;OSTM1;CSF1;BATF2;EPHA2;RXRA;BATF;GAB2;PRTN3
prerank,telomere maintenance via recombination (GO:0000722),0.468525160539305,1.036460478703973,0.4385245901639344,0.8344563463145583,1.0,6/11,26.78%,TEP1;RAD51;TPRKB;RAD50;ERCC4;SMC5
prerank,positive regulation of protein kinase activity (GO:0045860),-0.24989489648041605,-1.0364354154252327,0.35789473684210527,0.7227476154533554,1.0,34/148,13.39%,RAP1A;RASSF2;TGFB2;GAS6;HSP90AA1;IQGAP1;CALM1;HSP90AB1;PTK2;PTK2B;DAB2IP;MINK1;TGFBR2;MTCP1;CCDC88A;PTPRC;LRP8;VEGFA;PDCD10;EMP2;SRCIN1;MMD2;PAK1;PAK2;RHOA;RELN;RALB;PTPN1;PIH1D1;MARK2;ADRB2;CLU;CCN1;NEDD9
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),-0.26923018100626106,-1.0362345035044447,0.3654390934844193,0.7225931239290126,1.0,17/93,8.59%,MAP3K5;RASSF2;TGFB2;ANKRD6;PTK2B;DAB2IP;MID1;MINK1;TPD52L1;SH3RF3;EMC10;FLT4;APP;VEGFA;PDCD10;WNT16;STK25
prerank,mitochondrion organization (GO:0007005),-0.2444218436199813,-1.0360683423579427,0.34626865671641793,0.7223531415585416,1.0,55/165,25.28%,DNM3;NOS3;PPARGC1A;FBXO7;CAV2;CXADR;CHCHD2;TOMM20;VPS13C;BCL2L1;ATP5F1D;TFB2M;RHOT1;DNM2;CHCHD3;RAB38;MIEF1;MTM1;NDUFS1;TOMM22;STOML2;DNM1;HSPD1;HIGD2A;TIMM9;SIRT4;MIEF2;MTX3;PPRC1;BCAP31;TIMM10B;TIMM13;MSTO1;ATP5F1B;PINK1;MTFR1L;VPS13D;SUPV3L1;SLC25A4;TIMM22;HIGD1A;MYH14;BIK;CYCS;HIGD1B;MFN2;BCS1L;TOMM7;TIMM50;CHCHD10;ATCAY;HAP1;RAB5IF;BAX;SPG7
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),-0.33330477914925094,-1.0359207343310397,0.4022727272727273,0.7220826274735861,1.0,10/31,18.13%,KCNB1;STX1A;CACNA1G;CACNA1H;SYT10;REST;SYT4;CACNA1I;SYT7;SYT2
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.35503160657044863,-1.035853423289719,0.4016393442622951,0.7215959882479274,1.0,10/24,17.83%,UBB;NOD1;UBC;RPS27A;TAB3;RNF34;AAMP;UBA52;CASP8;IRAK1
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.4294974378133918,1.0354075212735236,0.4321503131524008,0.8363289485743534,1.0,3/16,5.50%,KLK2;ADM;ACE
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.3977544492621259,1.0353509310888132,0.4225352112676056,0.8355710890011919,1.0,4/22,9.43%,DMD;NOS1AP;CACNB4;GNB5
prerank,negative regulation of apoptotic process (GO:0043066),0.2515444467448952,1.035283721410492,0.39316239316239315,0.8348417532283685,1.0,68/444,12.16%,IL31RA;IGF1;OSR1;FHL2;NOTCH2;ANGPT1;PRKN;DAB2;SNX6;BCL2;FNIP1;SMAD6;DKK1;SCX;LTF;IFIT3;NDNF;CTSH;ANXA1;PDPN;RNF213;ARAF;SPHK1;KDM2B;CPEB4;ZFAND6;PRKAA2;SON;IGF1R;LRP2;NIBAN2;SH3RF1;KRT18;MYO18A;BNIP3;PRKCA;IL6;NOL3;MMP9;PRKAA1;SIAH2;TLE1;BIRC5;BIRC6;GRK5;NUPR1;BCL2L2;CDK1;RETREG1;YME1L1;ITCH;MED1;HDAC1;PIK3R1;NAA35;FGF20;PHIP;PRKDC;AXL;RPS6KB1;APOH;TFAP2A;TFAP2B;CFLAR;FSTL1;HIPK3;SH3RF2;TMBIM4
prerank,signal peptide processing (GO:0006465),-0.4364793663415209,-1.0349749386170586,0.3965183752417795,0.7232549106856244,1.0,6/11,32.10%,FURIN;PCSK5;CLN5;SEC11A;SPCS3;HM13
prerank,dicarboxylic acid metabolic process (GO:0043648),0.3280868251575798,1.034934840872979,0.40142095914742454,0.8348511124757578,1.0,12/52,16.13%,ADHFE1;ACOT4;MTHFR;HOGA1;FOLR2;IDH2;PHYH;SLC19A1;SHMT1;AADAT;ME3;MTHFS
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.3850505548931248,1.0347652238142355,0.4225865209471767,0.834383162319326,1.0,3/24,4.21%,AUTS2;AVIL;ABI2
prerank,inorganic anion transport (GO:0015698),-0.29514101621693367,-1.034025446940713,0.3829787234042553,0.7249488748569085,1.0,7/53,6.07%,SLC4A10;SLC26A7;ANO1;ANO4;CLIC4;CLIC5;TTYH3
prerank,positive regulation of viral transcription (GO:0050434),0.38654588442082266,1.033923717360191,0.4225621414913958,0.8357360716673907,1.0,5/25,8.29%,POLR2D;RSF1;CCNT1;POLR2A;GTF2F1
prerank,myelin maintenance (GO:0043217),-0.4524558584222003,-1.0334708783847486,0.44029850746268656,0.7257149235907963,1.0,6/10,27.73%,SOD1;CLU;ABCD2;PRX;EPB41L3;MYRF
prerank,phosphorylation (GO:0016310),0.25552490283343604,1.0334504181016044,0.3915737298636927,0.8360820425994947,1.0,74/384,14.87%,PRKAG2;EPHA7;ROCK2;OXSR1;NRK;WNK4;CDK8;DAPK1;PRKAG3;PDPK1;PDK1;BMP2K;RNASEL;MAP4K5;DMPK;CDK7;FER;FAM20A;SRPK2;MAPK9;SPHK1;SIK1;LRRK2;PRKAA2;PRKCZ;PRKCB;MAML1;STK17B;PRKCA;NEK4;GRK3;PRKAA1;NRBP1;RYK;CCNT1;BIRC5;BIRC6;CAMK2D;GRK5;PIK3R4;PKN2;CDK1;GRK4;NEK10;VRK2;FRK;ABL1;JAK2;LATS1;PRKDC;COQ8B;IKBKE;PRKD2;ERBB2;BMPR1A;MAPKAPK2;HIPK3;PRKAG1;STK24;CCNE1;DCLK1;TBK1;MAPK1;MORC3;ROS1;PRKACB;TEC;NLK;PRKCI;STK26;CDKL5;CDK15;SIK3;NIM1K
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.37640111627729367,-1.0334231296429446,0.4148296593186373,0.7251743196419652,1.0,8/20,32.39%,GATM;GCLM;PLOD2;GGT1;GAMT;CHAC2;MGST2;OPLAH
prerank,synaptic vesicle endocytosis (GO:0048488),-0.3317054644400507,-1.0331922380573282,0.4083885209713024,0.72509369163405,1.0,13/33,19.45%,DNM3;STON2;SYNJ1;STX1A;ITSN2;DNM2;AMPH;DNM1;CANX;PIP5K1C;SYT2;SNAP91;CDK5
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.44784058467753945,1.0329288861816976,0.41025641025641024,0.83650736434391,1.0,4/12,16.30%,IL34;CSF1;MAPK1;LYN
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.30610877847369816,1.0328648827015374,0.41042345276872966,0.8357185725504364,1.0,3/84,1.34%,IGF1;IGF2BP1;DAPK1
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),-0.31284689780003483,-1.0325764081864368,0.3971631205673759,0.7259959909999514,1.0,18/37,23.91%,EFNA5;PHLDB1;MAP6;FAM107A;GSK3B;STMN2;MARK2;STMN1;BICD1;CDK2AP2;TPPP;STMN4;STMN3;GAS2L1;MAPRE1;TRIM36;CLASP2;CAMSAP3
prerank,negative regulation of blood pressure (GO:0045776),-0.42070373302834063,-1.032554846006289,0.4359925788497217,0.7253848711796325,1.0,4/13,17.39%,NOS3;BMPR2;NOS1;PRCP
prerank,negative regulation of Notch signaling pathway (GO:0045746),-0.34039873846255186,-1.031799751005426,0.4276018099547511,0.7265985913324413,1.0,10/28,22.63%,NOTCH3;GATA2;ARRB1;LFNG;ZBTB7A;DLL4;METTL3;AKT1;DLL1;HEY1
prerank,regulation of secretion by cell (GO:1903530),-0.29850107830275197,-1.0317587561468906,0.40294840294840295,0.7260422600815093,1.0,26/54,31.96%,MEF2C;NSF;RAB3C;MCTP1;VAMP8;SCG5;RHBDF2;KCNMB4;RAB3B;DNAJC1;CPLX2;FMR1;RAB8A;RAB3A;LGI3;DISP1;RAB8B;CPLX1;HAP1;ARFIP1;RIMS2;VAMP3;STXBP5L;SYT1;RAB15;SYN1
prerank,regulation of protein tyrosine kinase activity (GO:0061097),-0.31311674752478136,-1.0307548984094856,0.39955357142857145,0.7279410438017094,1.0,11/38,14.62%,CAV1;GAS6;PTPRC;LRP8;APP;SRCIN1;RELN;NCK2;PTPN1;NEDD9;CSF1R
prerank,glutamate metabolic process (GO:0006536),-0.3778139300608692,-1.0302326312244492,0.40556660039761433,0.7285506919439392,1.0,4/19,12.85%,GLS;GCLM;GAD1;ALDH18A1
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.39302265074072024,-1.0301863409693217,0.43687374749499,0.7280043048812529,1.0,8/17,25.93%,PODXL;TGFB2;PIEZO1;RET;ADAM9;NCKAP1L;P2RY12;SKAP1
prerank,phosphatidylcholine metabolic process (GO:0046470),-0.27722676736703894,-1.0297634146338404,0.39473684210526316,0.7284293063265557,1.0,31/70,35.69%,CEPT1;MBOAT1;MFSD2A;LPCAT3;GPAT4;TMEM86B;CSNK2B;LPCAT1;NR1H2;LPIN3;PLA2G4A;ABCA3;LPIN1;LCAT;NR1H3;SLC44A5;PLA2G4F;DBI;CHPT1;SLC44A2;PLAAT1;PLA2G15;PEMT;STARD10;LPCAT4;MBOAT2;PLA2G5;ACHE;PLAAT3;PLBD1;PLB1
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),-0.40365710477953504,-1.029740337480575,0.40384615384615385,0.7278107008777825,1.0,4/15,7.61%,KDR;PTK2B;BMX;AATK
prerank,positive regulation of cell killing (GO:0031343),-0.41945635528926073,-1.0289700662263204,0.42641509433962266,0.7291559106174671,1.0,3/13,17.09%,RAC1;MAPK8;DVL2
prerank,positive regulation of response to cytokine stimulus (GO:0060760),-0.4083363699540208,-1.0286633583895528,0.44621513944223107,0.7292361321601358,1.0,8/13,35.32%,GAS6;CD74;IFIH1;TRIM44;MAVS;DHX9;IL7;TSLP
prerank,positive regulation of exocytosis (GO:0045921),-0.3285135401554574,-1.0281736744376804,0.4288888888888889,0.729837219219639,1.0,14/35,31.64%,RAB27A;HGS;CFTR;ATP13A2;SDC4;RAB3A;CLASP2;PDCD6IP;SYTL4;RAB7A;UNC13D;ATP6AP1;VPS4B;RAB15
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.36035896890342506,-1.0280592403779787,0.41164241164241167,0.7288311631862429,1.0,8/22,21.98%,ZDHHC14;ZDHHC15;GOLGA7;ZDHHC2;ZDHHC7;ZDHHC4;ZDHHC8;ZDHHC20
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.36035896890342506,-1.0280592403779787,0.41164241164241167,0.7288311631862429,1.0,8/22,21.98%,ZDHHC14;ZDHHC15;GOLGA7;ZDHHC2;ZDHHC7;ZDHHC4;ZDHHC8;ZDHHC20
prerank,myelin assembly (GO:0032288),-0.44987356335525686,-1.0269439213330305,0.4352720450281426,0.7308945615045347,1.0,7/10,25.45%,CD9;TENM4;GPC1;TPPP;ABCA2;NCMAP;EPB41L3
prerank,central nervous system development (GO:0007417),0.26492948330836674,1.0267052411385884,0.4067796610169492,0.8510882199305715,1.0,26/250,7.65%,EPHA7;AFF2;ARNT2;ZIC1;SLC8A3;ATXN1;PRKN;MEIS1;ZIC2;SZT2;B3GNT5;SOX6;LOXL3;SHROOM2;JARID2;ZIC5;PAFAH1B3;NFIB;ZFHX2;TPP1;SYNJ2;SETD1A;PHF8;AMIGO3;PTEN;PBX4
prerank,negative regulation of interleukin-17 production (GO:0032700),-0.4559712419184032,-1.0266423150100503,0.4332129963898917,0.7309718346740649,1.0,6/10,49.41%,NCKAP1L;VSIR;TLR4;IL12A;FOXP3;IL12B
prerank,positive regulation of interleukin-1 production (GO:0032732),-0.29580869896151857,-1.026300468906779,0.41025641025641024,0.7311440044648555,1.0,24/51,35.55%,HSPB1;APP;AIM2;GBP5;USP50;STAT3;PANX1;TMED10;CASP8;TYROBP;MYD88;S100A13;AGER;CASP1;TLR4;NLRC4;TLR6;NOD2;CD36;LPL;NLRP3;P2RX7;IL16;TLR8
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.33271969759280434,1.0261964045339191,0.4230769230769231,0.8515450160387422,1.0,9/46,15.15%,AGPAT4;GPD1L;PLA2G10;PLD1;LIPH;SLC27A1;PLA2G4B;PLA2G12A;GPD1
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.39585466966305327,-1.0258386431573927,0.4466230936819172,0.7316340484033036,1.0,3/15,5.09%,CSGALNACT1;CSPG4;BGN
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.42967747133264916,-1.0257167194421986,0.4288389513108614,0.7312785072970821,1.0,2/11,9.89%,MEF2C;PIK3CD
prerank,positive regulation of developmental process (GO:0051094),0.2743939660717767,1.0255374208374786,0.40789473684210525,0.8524419562110379,1.0,31/164,14.36%,SOX5;BMP7;PRKN;ADGRL1;CCN2;SCX;SOX6;PLCB1;GRIP1;FOXD1;GJA1;PTN;PHLDB2;NIBAN2;BNIP3;ENPP2;NCOA3;MCU;SMURF2;AGO2;DVL3;NEUROD2;DLG4;COBL;BMPR1A;RBM19;AR;GDNF;RAPGEF3;SYDE1;SRF
prerank,regulation of brown fat cell differentiation (GO:0090335),0.4071237211093113,1.0254378375763549,0.4329268292682927,0.8517828213297197,1.0,4/16,12.89%,BMP7;NAPEPLD;FLCN;SOX13
prerank,inositol phosphate-mediated signaling (GO:0048016),-0.3787154326792658,-1.0253081143667264,0.4490644490644491,0.7316687337648069,1.0,7/19,19.26%,NFATC2;NFATC1;EDN1;PPP3CA;HRH1;PPP3R1;NFATC3
prerank,negative regulation of cell-substrate junction organization (GO:0150118),-0.3873291129167379,-1.024957175670825,0.4198473282442748,0.7313057366241579,1.0,5/16,5.52%,APOD;THBS1;ACVRL1;CORO1C;FAM107A
prerank,negative regulation of focal adhesion assembly (GO:0051895),-0.3873291129167379,-1.024957175670825,0.4198473282442748,0.7313057366241579,1.0,5/16,5.52%,APOD;THBS1;ACVRL1;CORO1C;FAM107A
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.3573745998882278,-1.0248913163910947,0.4012875536480687,0.730833112440175,1.0,8/24,13.88%,KLF2;NOTCH1;CREB3L1;VEGFA;SESN2;HSPA5;ATF4;MT3
prerank,cellular response to interleukin-12 (GO:0071349),-0.30480811791515716,-1.0248759431117833,0.41784037558685444,0.7302066189083577,1.0,18/48,26.07%,MSN;PPIA;SOD1;ARF1;PDCD4;RPLP0;PAK2;TALDO1;CD47;HNRNPDL;MIF;PITPNA;HSPA9;CFL1;JAK1;HNRNPF;CAPZA1;IL12RB2
prerank,MAPK cascade (GO:0000165),0.2576128080832303,1.0248544556679031,0.39763779527559057,0.8524623684595103,1.0,23/295,6.48%,IL31RA;IGF1;KSR1;FGFR2;NRK;FGFR4;IL18;KIT;ANGPT1;NCAM1;PDGFRB;KL;CTSH;PDGFRA;ARTN;ARAF;PTPRA;LRRK2;FRS2;FGF1;PSME4;DLG1;PSMA2
prerank,epithelial structure maintenance (GO:0010669),0.4544561623783676,1.0248390675627457,0.43564356435643564,0.8515769451231846,1.0,2/11,8.21%,RBP4;MUC13
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),-0.419990532727069,-1.024822832305124,0.4455252918287938,0.7296786153026348,1.0,4/12,20.47%,SMCHD1;HNRNPU;YTHDC1;METTL3
prerank,receptor catabolic process (GO:0032801),0.3883794270721381,1.0247126524477341,0.424,0.8509934533191965,1.0,6/24,9.08%,RNF43;NEDD4;PCSK9;ZNRF3;PIK3R4;UVRAG
prerank,positive regulation of vascular permeability (GO:0043117),0.44087238008755125,1.0245611778271133,0.4462474645030426,0.8504650937605874,1.0,2/12,1.29%,BMP6;ANGPT1
prerank,positive regulation of vasculogenesis (GO:2001214),-0.44156710912909225,-1.0243661186875017,0.4417293233082707,0.7301474030590386,1.0,4/10,6.85%,RAP1A;CD34;KDR;CEACAM1
prerank,negative regulation of phosphorylation (GO:0042326),0.3002821688734807,1.0243554817111582,0.4029126213592233,0.8500885364051388,1.0,14/85,8.78%,PTPN13;PPARA;PID1;BMP7;PRKN;PLPP3;NPRL2;LRRK2;CACTIN;FBLN1;PTEN;ATG14;SIRPA;NUPR1
prerank,acute inflammatory response (GO:0002526),-0.35826222087878246,-1.0241782041942777,0.425531914893617,0.7299811064079668,1.0,11/23,39.70%,F3;LBP;CTNNBIP1;SIGIRR;CEBPB;AHSG;VNN1;MYLK3;HPR;HP;CRP
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),-0.3883568514836924,-1.0240535032628084,0.4433198380566802,0.7296479290428982,1.0,3/15,9.02%,NGF;BCAR1;DDIT4
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.4401269908798826,-1.0240391361256316,0.4372549019607843,0.7290282979728063,1.0,2/10,4.97%,CARMIL1;WDR1
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),-0.3460381865557157,-1.0237547453372193,0.3955056179775281,0.7290952800862732,1.0,7/26,11.88%,EEF1A1;IQGAP1;PDE8A;DAB2IP;PTPN12;DUSP3;ZFP36L1
prerank,T cell proliferation (GO:0042098),-0.414161419120512,-1.0234506065096816,0.432,0.7292240425981892,1.0,3/13,9.77%,CADM1;MSN;LMBR1L
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.30900933150772747,1.023173743118051,0.42122719734660036,0.8521538843404859,1.0,8/72,5.86%,IGF1;IL18;KIT;PDGFRB;NEDD4;PDGFRA;PDGFD;IGF1R
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.3056858157154445,1.0230841100309898,0.41402337228714525,0.8514375862803082,1.0,7/75,4.99%,DCDC2;FGFR2;LRP4;SDC2;PARD3;BAIAP2;NTNG2
prerank,regulation of RNA metabolic process (GO:0051252),0.32183887989932897,1.0228970549316148,0.40878378378378377,0.8510036680163348,1.0,12/59,11.57%,AFF2;IGF2BP1;NOVA1;PTBP2;HNRNPH1;SON;METTL4;MITF;YTHDF2;RC3H2;MED1;PCBP2
prerank,positive regulation of catalytic activity (GO:0043085),0.34646554365129983,1.0228805355858348,0.4034090909090909,0.8501226259631598,1.0,11/37,15.56%,FGFR4;IGF2;AZIN2;XRCC5;XRCC4;SSBP1;ABL1;NHEJ1;PSENEN;CIB1;WRN
prerank,cellular response to reactive oxygen species (GO:0034614),0.3239139453985878,1.0227637192037693,0.4242928452579035,0.8495246826290989,1.0,11/59,11.59%,OSER1;TPM1;FER;ANXA1;PDGFRA;MAPK9;IL6;MMP9;SIRPA;ABL1;PKD2
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.3311369985434609,1.022516708032062,0.4090121317157712,0.8492701544540108,1.0,9/51,9.05%,NRK;BMP7;GAS7;ALS2;DTNBP1;WASF1;LRRK2;NBL1;MYO16
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.3871843699650644,-1.02244317116592,0.44466403162055335,0.7310752520550132,1.0,3/17,9.24%,CADM1;LAMP1;PVR
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.43083868268584563,-1.0223409501647973,0.44793713163064836,0.7306678386938302,1.0,5/11,22.36%,ITM2B;ITM2A;ITM2C;ABCA2;NECAB3
prerank,regulation of cellular component movement (GO:0051270),0.3355588420737036,1.0223405566419224,0.4095744680851064,0.8488229659410166,1.0,4/49,3.58%,TGFBR3;ROCK2;SP100;PDPN
prerank,protein modification by small protein removal (GO:0070646),-0.22962877669859125,-1.0216607196678629,0.4297520661157025,0.7318065085707693,1.0,63/252,21.06%,ACTB;ESR1;IL33;ATXN3;USP38;OTUD7A;UBB;NFKBIA;UCHL5;TOMM20;EIF3F;COPS7A;USP29;NEDD8;RHOT1;UBC;RPS27A;USP31;UCHL1;ZRANB1;PSMD13;BIRC3;PSMF1;APC;RHOA;PSMB10;USP50;HGS;PSMB6;OGT;PSME3;USP37;PSMB5;PSMC3;ADRB2;OTUB1;UCHL3;OTUD3;FOXK1;PSMD12;PSMB8;OTUD1;PSME1;IFIH1;CFTR;UBA52;PSMB3;COPS8;RUVBL1;USP28;USP8;MYSM1;WDR20;ZC3H12A;COPS6;UBE2D1;ARRB2;USP9X;RCE1;PSMD5;POLB;OTUD6B;OTUD7B
prerank,positive regulation of cellular component biogenesis (GO:0044089),-0.2697724468938305,-1.0214628583962446,0.39664804469273746,0.7316797128239682,1.0,35/88,27.63%,FNIP2;TFRC;DAB2IP;RACK1;RPS3;SH3GLB1;WARS1;TGFB1;MPP7;FAF1;GSK3B;VEGFA;SPIDR;TAL1;PIH1D1;HGS;CHGA;CLU;ATP13A2;TPPP;CDC42EP2;MMP1;TIRAP;BIK;SDC4;BMF;VCP;MTLN;RGCC;PDCD6IP;BAX;RAB7A;HAS3;EMILIN1;BID
prerank,organelle organization (GO:0006996),-0.22108083319352195,-1.0213410732327222,0.35353535353535354,0.7313285097983401,1.0,127/388,27.56%,FMNL2;FGD5;CAV1;ATP8B1;SYNE1;FGD6;SEMA6A;NOS3;MICAL2;SH3KBP1;FNBP1L;PPARGC1A;ARAP3;CAV2;RAB31;PPIA;STX7;CXADR;SIPA1L3;PACSIN2;REEP5;CHMP5;LYSMD3;CHMP2B;CHCHD2;VPS13C;TFB2M;TMED5;RHOT1;VMP1;ZRANB1;SMPD4;TMED2;MICAL1;MARK1;RAB38;TOR1B;LIMD1;LMAN2;PCLO;SPRYD3;ABCD3;NSFL1C;RAB1A;YTHDF3;BIN1;CHGA;STOML2;VPS18;MAST3;BNIP1;NEDD9;SIRT4;TMED3;ABCD2;MIEF2;TMED10;MTX3;PPRC1;LMAN2L;BRWD3;ODF2;PRKD1;DIAPH3;MSTO1;FMNL3;VPS11;ABCA3;ATL2;PEX11B;BSCL2;PEX1;GBF1;CCL13;AUP1;TRIP11;CHMP1B;ATP5F1B;VPS51;PINK1;ABCD4;LIG4;VPS13D;PITPNB;MREG;SPTSSB;CFL1;IRAG2;CHMP1A;PAK5;THY1;ARHGAP10;NUMA1;MAST1;CYCS;SEC16B;VAPA;BCS1L;SIPA1;HUWE1;CHMP3;PEX10;GEM;CLASP2;RAB14;TMED7;CHCHD10;CHMP7;TMEM135;PDCD6IP;KIF4A;PEX16;MCOLN1;CDC42BPB;RAB7A;TNFAIP3;CAMSAP1;CHMP4C;CDCA8;CEP55;RNF112;RAB2A;CCL2;ATL3;FGD2;FBXW8;SEC16A
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.4264565192468125,1.021288464536487,0.429769392033543,0.8506995401144519,1.0,2/14,10.07%,IL18;IL17D
prerank,negative regulation of neuron projection development (GO:0010977),0.316263920842631,1.0209950702774873,0.4225589225589226,0.8505337003214581,1.0,7/56,7.47%,EFNB2;LRP4;LPAR1;DPYSL3;EPHA4;PTPN9;PTEN
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.42263983667616434,1.0207578710519267,0.4004237288135593,0.8502501488041422,1.0,4/15,12.27%,WNT6;ANKRD11;HDAC1;GLI2
prerank,outflow tract septum morphogenesis (GO:0003148),0.38318868407290724,1.0202942941709479,0.4092664092664093,0.8505946148322054,1.0,4/24,5.93%,ROBO1;FGFR2;SMAD6;LRP2
prerank,positive regulation of protein phosphorylation (GO:0001934),0.2512348461418668,1.0201988164475337,0.40892193308550184,0.8499398129542676,1.0,46/348,10.78%,IGF1;PRKAG2;BMP6;LEPR;ROCK2;IL34;CEMIP;BMP7;ANGPT1;PELI2;DAB2;FNIP1;ALS2;IGF2;FAM20A;RBPMS;ARAF;SPHK1;LRRK2;MRNIP;SNX9;PDGFD;FGF1;TTK;ENPP2;IL6;DDR2;XRCC5;VTN;MMP9;CCL19;ATG14;CSF1;MUSK;VEGFB;GDF1;AXIN2;NEK10;FGF9;ABL1;JAK2;LATS1;DVL3;FGF20;FLCN;RAP2A
prerank,cytokine-mediated signaling pathway (GO:0019221),-0.21414861210327324,-1.0193922872173662,0.36054421768707484,0.7355261785600842,1.0,138/532,20.64%,FN1;PTPRJ;TMSB4X;ADIPOR2;B2M;ACTN4;MSN;IL33;HSPA8;LIFR;RPS6KA5;MAOA;TNFRSF11B;STX3;HSP90AA1;F3;CBL;ITGB1;FYN;PTK2B;INPP5D;VIM;S1PR1;ACKR3;UBB;NFKBIA;LBP;PPIA;MID1;NOD1;SOCS2;LIMS1;LAMA5;STX1A;IKBKB;TGFB1;TRIM25;CD44;EDA;SOD1;BCL2L1;HSP90B1;ST18;UBC;RPS27A;TNFRSF11A;MT2A;SOCS5;LRP8;CEACAM1;CSK;TNFRSF1B;IL1R1;ARF1;PDCD4;CARD14;VEGFA;IL1RAP;FOXO1;AIM2;PSMD13;BIRC3;APPL1;RBX1;RPLP0;ADAR;PSMF1;PTGS2;PAK2;PIK3CD;COMMD7;TALDO1;PSMB10;CHUK;CDKN1B;CRK;ISG15;IFI35;PSMB6;TOLLIP;STAT3;PSME3;PSMB5;JUNB;RSAD2;OAS2;PSMC3;MAP3K3;TAB3;IL17RE;MAP3K8;IL1RL2;CANX;PSMD12;INPPL1;MT3;PSMB8;CSNK2B;HNRNPDL;IRAK3;TRAF1;PSME1;CSF1R;CUL1;IFNGR1;UBA52;FLT3;CAMK2B;PSMB3;CISH;IL20RB;RPS6KA4;IL18BP;MIF;IL15;CCL13;PITPNA;SOX2;IRAK1;EIF5A;IRF5;SH2B3;BST2;CXCL12;IL4R;JAK3;HSPA9;CD40;SPI1;CFL1;PSMD5;MYD88;SLA;IFITM3;PRKCD;MMP1;CSF3R;AKT1
prerank,negative regulation of peptidase activity (GO:0010466),-0.2985106654062447,-1.019344204103548,0.4254278728606357,0.7349995453955526,1.0,8/47,7.80%,SPOCK2;CST3;SERPINE2;SERPINI1;UBXN1;SERPINB9;SERPINF1;GAPDH
prerank,renal filtration (GO:0097205),-0.44228127828737274,-1.019195413241397,0.4695817490494297,0.7347414987293157,1.0,3/10,7.66%,CD34;MCAM;TBC1D8B
prerank,neuron projection regeneration (GO:0031102),0.4622731153506806,1.0191114498148999,0.4539614561027837,0.8518369793026536,1.0,3/10,7.94%,PTN;FOLR1;NREP
prerank,response to calcium ion (GO:0051592),-0.2565516359086916,-1.0191102870707958,0.3675675675675676,0.7343036512098747,1.0,29/102,18.13%,MEF2C;CAV1;CLIC4;THBS1;TRPC3;IQGAP1;CALM1;PLCG2;KCNMA1;LGMN;HOMER1;CPNE8;RYR2;CPNE3;CPNE2;KCNMB4;SYT10;SYT4;PPP3CA;ITPR3;ITPKB;TRPC1;KCNIP2;AHCYL1;CALM2;CPNE9;SYT7;ADAM9;SYT2
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.28416035000342216,-1.0190105023383762,0.43424317617866004,0.7339200144477683,1.0,27/62,27.92%,TPT1;ACKR3;DNAJA1;PPIA;HSPB1;CREB3L1;YBX3;BCL2L1;RTKN2;XBP1;NDUFA13;ARHGEF2;HERPUD1;CLU;PINK1;TMBIM6;CXCL12;PLAUR;AKT1;NOC2L;CDKN2D;URI1;PTTG1IP;EPO;CREB3;SNAI2;SYVN1
prerank,oxoacid metabolic process (GO:0043436),0.3696937878870149,1.0183434479496014,0.42700729927007297,0.8529061837350742,1.0,2/27,2.97%,DDO;TPST1
prerank,aerobic respiration (GO:0009060),-0.3635011980829843,-1.0181404886104395,0.4093816631130064,0.7354679423222347,1.0,7/20,22.34%,ATP5F1D;UQCRH;UQCRC2;MTFR1L;NDUFS7;UQCRC1;UQCR10
prerank,negative regulation of signaling (GO:0023057),-0.3466865105818616,-1.0179191186038763,0.4661016949152542,0.7353980763945835,1.0,6/25,11.22%,HHIP;AP1AR;UBASH3B;SOCS5;KIF26A;PTPN1
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.28803270810942105,1.0178929541707116,0.4344512195121951,0.8531597059822512,1.0,22/122,12.84%,IGF1;FGFR4;SMOC2;SLC6A9;SORBS1;PDGFRB;IGF2;PLD1;IL6;CCL19;SAMD4A;JAK2;PRKDC;RPS6KB1;METTL14;NPM2;PRKD2;ERBB2;FXR1;LARP6;GLI2;AR
prerank,regulation of transport (GO:0051049),-0.31673401340125906,-1.0171846495798615,0.4116331096196868,0.7365126519435032,1.0,6/36,4.17%,ACTB;EPB41;ACTG1;ICA1;DNAJA1;REEP5
prerank,phosphatidic acid metabolic process (GO:0046473),0.32628069624549677,1.016964771981385,0.4212328767123288,0.8547108111040296,1.0,9/48,15.15%,AGPAT4;GPD1L;PLA2G10;PLD1;LIPH;SLC27A1;PLA2G4B;PLA2G12A;GPD1
prerank,ESCRT III complex disassembly (GO:1904903),-0.4517907721134228,-1.016598281874705,0.4766536964980545,0.7366975473100893,1.0,7/10,35.24%,CHMP5;CHMP2B;CHMP1B;CHMP1A;CHMP7;VPS4B;IST1
prerank,ESCRT complex disassembly (GO:1904896),-0.4517907721134228,-1.016598281874705,0.4766536964980545,0.7366975473100893,1.0,7/10,35.24%,CHMP5;CHMP2B;CHMP1B;CHMP1A;CHMP7;VPS4B;IST1
prerank,barbed-end actin filament capping (GO:0051016),-0.3775733574308594,-1.0164746900759543,0.43711340206185567,0.7357301608607072,1.0,5/18,8.70%,GSN;CAPZA2;VILL;ADD2;EPS8
prerank,actin filament capping (GO:0051693),-0.3775733574308594,-1.0164746900759543,0.43711340206185567,0.7357301608607072,1.0,5/18,8.70%,GSN;CAPZA2;VILL;ADD2;EPS8
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.3820295254262407,1.016407132260806,0.45294117647058824,0.8552433095077234,1.0,3/26,3.35%,PLCB1;UBE2E2;ANXA1
prerank,organic substance transport (GO:0071702),0.2837541313086152,1.016384170022293,0.4229607250755287,0.854388159726355,1.0,19/121,11.42%,SLC22A4;SLC22A2;ABCA4;SLC35F3;ABCA9;ABCA1;TCN2;ABCA13;SLCO1B1;NDC1;LRP2;ZG16;MIA3;ABCA5;SLC19A2;SLC19A1;SLC22A6;PLEKHA8;MFSD2B
prerank,response to laminar fluid shear stress (GO:0034616),-0.44270252207681193,-1.0162650867623895,0.4417744916820702,0.7356240768394505,1.0,3/10,2.99%,KLF2;KLF4;SREBF2
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.39585986083305574,-1.016031382040499,0.443359375,0.7355986811877148,1.0,4/17,7.75%,PPIA;HSPB1;SOD1;SFPQ
prerank,cellular response to lipopolysaccharide (GO:0071222),-0.2596717073688456,-1.0157845539755546,0.43967828418230565,0.7355870622933032,1.0,33/101,27.67%,MEF2C;DAB2IP;VIM;LBP;CHMP5;TGFB1;SBNO2;DEFA6;TNFRSF1B;PDCD4;MAPK8;RHOA;XBP1;CD180;GIT1;CX3CR1;CARD16;PRKCE;CD274;ZC3H12A;IRAK1;ADAM9;MYD88;NR1H3;PLAA;RELA;CD80;CASP1;CD68;TNFAIP3;CXCL10;CCL2;TLR4
prerank,mRNA splice site selection (GO:0006376),0.36472492601448286,1.0157823138080577,0.45714285714285713,0.8550281794082546,1.0,4/30,8.53%,CELF2;NOL3;SLU7;SF3A3
prerank,actin filament-based transport (GO:0099515),0.3899526804017008,1.0156294683388285,0.43133462282398455,0.8545054084109635,1.0,4/21,5.37%,MYO5C;SYNE2;MYO1H;WASL
prerank,peptidyl-lysine trimethylation (GO:0018023),0.3789808776937617,1.015528525189366,0.44423791821561337,0.8538431463218954,1.0,8/26,22.51%,KMT2A;SETD1A;SETD2;CTR9;WDR82;SETD4;BEND3;TET3
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.3008656090669664,1.0150368818159734,0.4365079365079365,0.8542514431481865,1.0,14/75,12.44%,ROCK2;TULP3;NMT2;PLCB1;MGRN1;PDE6G;CAMKMT;ZDHHC3;GRK5;RPGRIP1L;GRK4;GNG7;CRY1;RGS16
prerank,protein auto-ADP-ribosylation (GO:0070213),0.45203736309190007,1.014576258240694,0.45213849287169044,0.854521435142445,1.0,6/12,28.19%,PARP10;PARP12;TIPARP;TNKS2;PARP2;TNKS
prerank,regulation of protein ubiquitination (GO:0031396),-0.25696236922944793,-1.0145703196691434,0.3908355795148248,0.7381029147708769,1.0,33/108,18.35%,CAV1;HSP90AA1;HSP90AB1;UBE3A;UBB;DNAJA1;RPS3;IVNS1ABP;UBXN1;SOX4;PINX1;FAM107A;ARRB1;CHP1;CUL3;DERL1;BIRC3;NDFIP2;ISG15;CAMLG;FOXF2;OGT;DCUN1D1;WFS1;NXN;LAPTM5;SPOPL;PRMT3;N4BP1;SPRTN;PRKCG;UBE2D1;PINK1
prerank,stress fiber assembly (GO:0043149),-0.3936752949438791,-1.0139327253046726,0.4588235294117647,0.7384725447821752,1.0,6/15,10.38%,ITGB1;ARRB1;CUL3;PDCD10;RHOA;KCTD13
prerank,contractile actin filament bundle assembly (GO:0030038),-0.3936752949438791,-1.0139327253046726,0.4588235294117647,0.7384725447821752,1.0,6/15,10.38%,ITGB1;ARRB1;CUL3;PDCD10;RHOA;KCTD13
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.417950537195779,-1.013873243300407,0.4426559356136821,0.7379814626690596,1.0,7/13,27.76%,CD44;CD74;MIF;PTTG1IP;PSMD10;YJU2;SNAI2
prerank,protein homooligomerization (GO:0051260),0.288097217071133,1.0136443518253606,0.42684766214177977,0.8560798971922049,1.0,18/114,11.59%,ALDH1A2;APPL2;UPB1;ALS2;RNF213;CBY1;IKZF4;HSD17B10;ARC;BLM;SLC1A5;RNF135;SSBP1;GSDMD;GOLGA2;CLYBL;MICU1;PKD2
prerank,regulation of G0 to G1 transition (GO:0070316),0.3485812633238173,1.012667886945339,0.4452423698384201,0.8577588796696565,1.0,11/38,16.39%,RBBP4;RNF2;MGA;L3MBTL2;RBBP7;E2F6;TFDP2;CDKN2B;APAF1;RAD51;UXT
prerank,regulation of calcium ion import (GO:0090279),-0.3598554256384915,-1.0123047314641658,0.417910447761194,0.7413018862766731,1.0,9/21,27.05%,FYN;CTNNB1;WNK3;SLC30A1;PLN;CXCL12;TRIM27;SPHK2;CCL2
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.313099530754721,1.0121211509783552,0.4387755102040816,0.8582745359379906,1.0,10/59,10.09%,TCF7L2;CDK8;TNRC6B;TNRC6A;IL6;PTEN;MITF;CDK1;MED13;MED1
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.437520781243946,-1.0120267790366153,0.44016227180527384,0.7413712163835049,1.0,6/10,30.84%,OGT;PDK2;ZNF692;SIRT7;DGKQ;GNMT
prerank,positive regulation of lipid catabolic process (GO:0050996),0.41019386594606877,1.0118650333401504,0.4528301886792453,0.8580202179055724,1.0,5/19,20.25%,PPARA;DAGLB;PLIN5;IRS1;IRS2
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.3840075482253557,1.011744464046929,0.4378585086042065,0.8574236972623831,1.0,9/22,18.13%,FTSJ3;ERI3;ERI2;EXOSC8;NOL9;ERI1;NOP9;EXOSC3;NOP14
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.39457696995882685,1.011614458758672,0.458252427184466,0.8568303292820654,1.0,2/20,1.84%,PID1;DAB2
prerank,negative regulation of sequestering of calcium ion (GO:0051283),-0.3445638005040788,-1.0115812251890073,0.4416135881104034,0.7418479277577612,1.0,8/24,13.63%,ITPR2;PLCG2;PTPRC;RYR2;HTR2A;ERO1A;IBTK;ITPR3
prerank,T cell activation involved in immune response (GO:0002286),-0.4229127432517263,-1.01119889314873,0.4624277456647399,0.7421825733551899,1.0,12/12,57.75%,CD74;SLC11A1;LCP1;MDK;ITGAL;F2RL1;ICAM1;IFNK;TNFSF18;EIF2AK4;LILRB1;FCER1G
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.3112024080446148,1.0109159381926072,0.43066884176182707,0.8578147122158044,1.0,22/62,24.43%,POLR2D;CDK7;ELOA;CCNT2;CCNT1;POLR2A;GTF2F1;CDC73;MNAT1;NELFB;TCEA1;SETD2;ELL;CTR9;CDK9;ELP2;PAF1;SUPT4H1;GTF2H1;POLR2K;CDK13;ERCC2
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.4017084953830585,-1.0108386153466618,0.45972495088408644,0.7424572719482954,1.0,7/14,28.21%,DAB2IP;HSPA5;PTPN1;DNAJB9;BFAR;BAX;TMEM33
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.30506133521567114,-1.0108087813204567,0.4386792452830189,0.741887499633533,1.0,11/43,12.25%,TGFB2;KLF4;ETS1;PPARD;GATA2;TGFB1;GNL3;JUN;DDX5;STAT3;REST
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.34289920956195413,-1.0106378539646033,0.44946236559139785,0.741686914950042,1.0,10/26,17.83%,UBB;NOD1;UBC;RPS27A;TAB3;AAMP;IFIH1;UBA52;CASP8;IRAK1
prerank,negative regulation of organelle assembly (GO:1902116),-0.3206127151407246,-1.0106203445840491,0.45879732739420936,0.7411110353018482,1.0,9/35,18.35%,TBC1D30;LIMK2;MDM1;RBM14;MTM1;ODF2L;FEZ2;SMCR8;PINK1
prerank,C-terminal protein amino acid modification (GO:0018410),-0.4271748418631247,-1.0103399915288327,0.46122448979591835,0.7411461665883083,1.0,4/11,30.36%,ATG7;TTL;ICMT;AGTPBP1
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.3569653760007133,-1.0102508851986725,0.4451345755693582,0.7407306649967365,1.0,10/22,27.96%,UBB;UBC;RPS27A;RBX1;DDB1;UBA52;CETN2;GTF2H2;XPA;ERCC3
prerank,regulation of neuron differentiation (GO:0045664),-0.26887229192115714,-1.009951156334721,0.455026455026455,0.7408406110225785,1.0,23/76,17.95%,MEF2C;ZFHX3;TIAM1;NGF;HES1;NRCAM;CALR;SIX1;MMD2;RHOA;YWHAG;BMP2;REST;HEYL;BIN1;ARHGEF2;BRINP2;TCF3;DISP3;YWHAH;ID2;SOX2;CASZ1
prerank,positive regulation of lipid localization (GO:1905954),0.44645304818705006,1.0097869956780265,0.45841784989858014,0.8598191634190071,1.0,5/11,21.08%,PLA2G10;IKBKE;PLIN5;HILPDA;NFKB1
prerank,response to fatty acid (GO:0070542),0.4035377455893923,1.00976724754416,0.4639175257731959,0.8589661020717452,1.0,1/17,1.13%,PID1
prerank,regulation of myoblast differentiation (GO:0045661),0.35836620809947667,1.009583732263243,0.4357142857142857,0.858494493344432,1.0,3/32,3.68%,RANBP3L;PLCB1;RIPOR2
prerank,oligosaccharide biosynthetic process (GO:0009312),0.39456458805439454,1.009528972616286,0.4427966101694915,0.85772857260284,1.0,3/20,4.58%,B3GALT1;ST3GAL3;B4GALT1
prerank,negative regulation of proteolysis (GO:0045861),0.35104025414161777,1.0094685895106608,0.4185639229422067,0.8569831034573755,1.0,8/34,12.77%,TIMP3;ECM1;EPHA4;LRRK2;CST7;PTPN3;GAS1;SNX12
prerank,inorganic ion transmembrane transport (GO:0098660),-0.42151137351191215,-1.0090723376932507,0.43953934740882916,0.7423713240718441,1.0,4/12,19.35%,ABCC9;CACNA1H;KCNJ8;TRPM4
prerank,positive regulation of cellular amide metabolic process (GO:0034250),-0.27070585479769926,-1.0090048929602946,0.45118733509234826,0.741889155220789,1.0,31/80,26.97%,THBS1;NIBAN1;EEF2;VIM;RACK1;RPL26;SOX4;RPL5;LRRTM3;MTOR;PYM1;EIF3D;RPS4X;BCL3;YTHDF3;CLU;RPS27L;IFNGR1;EIF3C;ABCA2;PRKCD;METTL3;EIF6;ABCG1;FMR1;PCIF1;RELA;SPHK2;HNRNPD;EIF4A3;CPEB3
prerank,regulation of cell death (GO:0010941),-0.2605011080867204,-1.008730045343405,0.4233983286908078,0.7419533972403183,1.0,25/94,15.63%,ACER3;ACER2;PDE8A;UBB;CCN3;SOX4;NCK1;FERMT2;DCC;FAF1;TNFRSF1B;CHP1;CRYAB;WNT16;APC;EIF4G1;CDKN1B;EPHB1;CLU;CCN1;SRSF6;MT3;TRIM13;PRKD1;CTSZ
prerank,cellular response to amino acid starvation (GO:0034198),-0.2759544738866892,-1.0084282483976414,0.42105263157894735,0.742080239870377,1.0,31/71,25.82%,MAP3K5;SESN3;SH3GLB1;DAPL1;MTOR;MAPK8;SESN2;ATP6V1A;WDR59;ATP6V0C;LAMTOR1;ATF4;RHEB;ATP6V1E1;TCIRG1;FAS;LAMTOR2;PRKD1;ITFG2;DAP;RRAGB;MAPK3;ATP6V0D2;DEPDC5;CDKN1A;LAMTOR4;CEBPB;ATP6V0E2;ATP6V1B2;CASTOR1;WDR24
prerank,purine nucleotide metabolic process (GO:0006163),-0.34715319960540847,-1.007607909000132,0.45208333333333334,0.743518813504203,1.0,8/24,14.53%,PRPS2;NT5C2;HPRT1;NT5C;GDA;XDH;GUK1;NT5E
prerank,proteasomal protein catabolic process (GO:0010498),-0.23190736194209394,-1.0074958768354214,0.41568627450980394,0.7431548193469611,1.0,65/201,25.74%,WWP1;ATXN3;NEDD4L;PPP2R5C;UBXN1;ZNRF1;CTNNB1;FAF1;ARRB1;BAG6;RMND5B;UCHL1;CUL3;DERL1;PSMD13;CCDC47;RBX1;UBE2B;PSMF1;UBXN6;DDB1;PSMB10;KCTD17;KCTD13;PSMB6;NSFL1C;PSME3;PSMB5;ERCC8;PSMC3;AGAP3;RNF34;KLHL42;PSMD12;PSMB8;PSME1;ERLEC1;ZFAND2B;TRIM13;UBE2G1;PSMB3;SPSB3;SPOPL;COP1;RNF5;TRIM2;SHARPIN;ARRB2;PSMD5;ZSWIM8;KCTD5;PLAA;PELI1;VCP;PSMD9;HUWE1;RBCK1;PSMB4;BRSK2;SPSB4;BFAR;ATE1;PCNP;PSMD10;KIF14
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.4257849584925527,1.007207500536485,0.4506769825918762,0.8610081348411812,1.0,2/13,3.69%,PLCB1;STAT5B
prerank,cellular response to interleukin-15 (GO:0071350),0.4257849584925527,1.007207500536485,0.4506769825918762,0.8610081348411812,1.0,2/13,3.69%,PLCB1;STAT5B
prerank,telomere maintenance via telomerase (GO:0007004),-0.331991913322661,-1.0071508218535252,0.4456066945606695,0.7434015504954523,1.0,9/28,21.37%,HSP90AA1;HSP90AB1;PINX1;RPA1;TERF2IP;ANKRD28;TNKS1BP1;CDK2;NHP2
prerank,glutathione derivative biosynthetic process (GO:1901687),0.3935309350535987,1.0071126901586152,0.45714285714285713,0.8594527559478323,1.0,2/20,4.82%,GSTM2;GSTT1
prerank,glutathione derivative metabolic process (GO:1901685),0.3935309350535987,1.0071126901586152,0.45714285714285713,0.8594527559478323,1.0,2/20,4.82%,GSTM2;GSTT1
prerank,positive regulation of protein catabolic process (GO:0045732),-0.2633628539471218,-1.0061527094103018,0.43386243386243384,0.7452362116174175,1.0,20/84,12.62%,WWP1;MSN;NSF;HSP90AA1;NEDD4L;DAB2IP;ATG7;PLK2;FAF1;GSK3B;TNFRSF1B;FOXO1;APC;OAZ1;DDB1;FURIN;CDKN1B;NDUFA13;EGLN2;IDE
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.26548202681819866,-1.0059887875920357,0.42777777777777776,0.7449811939792158,1.0,27/84,22.10%,MBNL1;NOVA2;HNRNPK;RBFOX1;QKI;RBFOX3;RBFOX2;HNRNPU;LARP7;DDX5;ZBTB7A;SRSF9;RBM8A;REST;KHDRBS3;RNPS1;SRSF6;SRPK1;RBMXL1;YTHDC1;PTBP1;MAGOH;PCBP4;DDX17;TRA2B;RBM24;FMR1
prerank,regulation of chromatin organization (GO:1902275),0.41405214476470326,1.0056029134896602,0.45979381443298967,0.8625121106542871,1.0,3/14,6.37%,IGF2;METTL4;SETD1A
prerank,tRNA metabolic process (GO:0006399),-0.3756629641607756,-1.0055198109208512,0.4647887323943662,0.7455107894762429,1.0,8/17,28.37%,SARS1;SSB;POP5;RPP21;RPP30;ADAT1;POP7;KARS1
prerank,positive regulation of lymphocyte proliferation (GO:0050671),-0.27853404422755657,-1.005342310432548,0.4244604316546763,0.7453029647622087,1.0,17/63,20.71%,MEF2C;TFRC;SLC7A1;NFATC2;CD38;NCK1;PTPRC;NCK2;CD74;CD81;MIF;IL15;CD274;JAK3;CD40;NCKAP1L;TIRAP
prerank,synaptic vesicle transport (GO:0048489),-0.421872097320864,-1.0052071331806383,0.4605809128630705,0.7450389637157757,1.0,3/11,7.40%,RAB27A;SYNJ1;DNM2
prerank,DNA repair (GO:0006281),0.2536475304637628,1.0048770986155675,0.4355263157894737,0.8634577899906041,1.0,71/284,17.88%,EYA1;FANCA;APEX2;RAD51B;ATRIP;BAZ1B;RAD51AP2;DDB2;HUS1B;RAD51C;TDP2;INIP;PDS5B;PSME4;PARP4;XRCC5;BLM;XRCC4;WDR48;FANCI;CDK1;UVRAG;BRCA2;MGME1;FBXO6;MDC1;PDS5A;MBD4;ABL1;PRKDC;ASCC2;DCLRE1A;PARP9;SMARCA5;TEX264;LIG1;DCLRE1B;MPG;CUL4B;INO80;PRIMPOL;MRE11;FANCE;USP45;FANCB;FANCF;RAD23B;CIB1;BABAM2;APEX1;MNAT1;MLH1;WDR33;UBE2V1;FAAP100;UBE2A;CENPX;BRIP1;BACH1;FANCC;WRN;RAD18;RAD51;SETD2;RNASEH2A;REXO4;RPAIN;DTX3L;TRRAP;VCPIP1;XPC
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),-0.4171177554884542,-1.0042091902197812,0.4817813765182186,0.7456077479997609,1.0,6/12,35.89%,CUL3;ANAPC7;NSMCE2;DLGAP5;ESPL1;ANAPC4
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.4171177554884542,-1.0042091902197812,0.4817813765182186,0.7456077479997609,1.0,6/12,35.89%,CUL3;ANAPC7;NSMCE2;DLGAP5;ESPL1;ANAPC4
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.4171177554884542,-1.0042091902197812,0.4817813765182186,0.7456077479997609,1.0,6/12,35.89%,CUL3;ANAPC7;NSMCE2;DLGAP5;ESPL1;ANAPC4
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.4470853557643115,1.0040527687208651,0.44763860369609854,0.8647345831212198,1.0,2/11,6.31%,RBBP4;NASP
prerank,positive regulation of neurogenesis (GO:0050769),0.30908531359796976,1.0039898006957386,0.44642857142857145,0.8639880327959268,1.0,8/68,7.11%,PLXNA2;ROBO1;CUX1;IL1RAPL1;OBSL1;PLXNC1;LRP2;PTPRD
prerank,regulation of cell development (GO:0060284),-0.3206795582390498,-1.0039150679170186,0.453125,0.7457148916018081,1.0,17/36,22.63%,BHLHE40;RPS19;HES1;CTNNB1;PRUNE1;FOXO1;GRN;HEY2;RHEB;HEYL;CX3CR1;HES6;HDAC9;ADGRA2;AKT1;DLL1;HEY1
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.4495582031530117,1.0038967642219756,0.4603854389721627,0.8633391980202572,1.0,1/11,0.35%,LEPROT
prerank,negative regulation of response to external stimulus (GO:0032102),0.2837235988948321,1.0032847272692877,0.46616541353383456,0.8640338708565886,1.0,17/105,14.03%,RORA;C1QTNF3;PPARA;LTF;EPHA4;CACTIN;NLRC3;PTEN;LYAR;SIRPA;ITCH;PCBP2;ENPP3;SERPINE1;PTGER4;MAPKBP1;NLRP12
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.3958370679228215,-1.0032553157275788,0.45124282982791586,0.7467358707791457,1.0,7/13,26.35%,SVIP;BCAP31;ERLEC1;BRSK2;YOD1;UBAC2;UBE2J1
prerank,negative regulation of cellular component movement (GO:0051271),0.4246334021125565,1.002989437808918,0.46153846153846156,0.863909037724481,1.0,3/15,5.45%,TGFBR3;SP100;FBLN1
prerank,regulation of dendrite development (GO:0050773),-0.30866975701680094,-1.002752024783469,0.461038961038961,0.7473661722112758,1.0,11/37,9.33%,BMP5;NEDD4L;DAB2IP;SEMA4D;ZDHHC15;DCC;LRP8;GSK3B;RTN4IP1;MFSD2A;MARK1
prerank,cellular amide metabolic process (GO:0043603),0.2913797382008562,1.0024796291886222,0.4419713831478537,0.8643029065006537,1.0,10/102,7.39%,AEBP1;PCCA;PLPP3;MCCC2;PM20D1;ACOT4;MTHFR;NAPEPLD;CPXM1;FOLR2
prerank,myelination in peripheral nervous system (GO:0022011),-0.4050847935249459,-1.0024369096295564,0.48653846153846153,0.7475353593602228,1.0,7/13,24.66%,ADGRG6;SOD1;MYOC;ARHGEF10;NF1;NCMAP;PRX
prerank,negative regulation of defense response to virus (GO:0050687),0.46001078966146164,1.0018800796499192,0.5,0.8648884347878071,1.0,4/10,19.40%,ITCH;PCBP2;ILRUN;TRAF3IP1
prerank,Golgi ribbon formation (GO:0090161),0.43138712229246773,1.001843988684038,0.453781512605042,0.8640952563884363,1.0,5/13,11.22%,MYO18A;OPTN;STX16;GOLGA2;VTI1A
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.36045209801754313,1.001452718866574,0.44507575757575757,0.8642362546611976,1.0,13/27,23.03%,BRD8;KAT8;KAT6B;CREBBP;NAT8;TRRAP;NAA50;PHF20;RUVBL2;KAT2B;KAT5;MSL3;TAF6L
prerank,bile acid metabolic process (GO:0008206),0.3660357307689161,1.0013959844080336,0.4567669172932331,0.8634741146957449,1.0,5/27,15.81%,CYP27A1;HSD17B10;GBA2;AMACR;CYP7B1
prerank,regulation of protein localization (GO:0032880),-0.28503958310378014,-1.0013203865200244,0.455012853470437,0.7496227934541478,1.0,12/58,11.21%,HSP90AA1;HSP90AB1;RACK1;CTSD;RABGAP1L;TRIM14;TRIM25;STX6;MMD2;ZDHHC7;MAPK8;RSL1D1
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.43438197098720455,-1.0011664625091494,0.490272373540856,0.749393271610091,1.0,3/10,9.35%,PODXL;PIEZO1;DPP4
prerank,regulation of potassium ion transport (GO:0043266),0.353460237735077,1.0010728066494254,0.4576271186440678,0.8633830364995873,1.0,5/31,6.45%,KCNIP3;KCNA5;ANK2;CACNA1D;DLG1
prerank,carbohydrate catabolic process (GO:0016052),-0.31212501347124644,-1.000971712687833,0.45594713656387664,0.7492420428234084,1.0,11/38,17.47%,PKM;HK1;GAPDH;MAN2B1;PFKM;MAN2C1;TPI1;ALDOA;LDHA;ALDOC;MAN2B2
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),-0.2907057227021774,-1.0009229339928576,0.4295612009237875,0.7487189723731275,1.0,17/52,20.64%,SPTBN1;PRKCH;STX3;ITGB1;RACK1;ATP2C1;NKD2;WNK3;ZDHHC2;GPER1;RHOG;PRKCE;ACSL3;STAC3;ATP2B4;ZDHHC8;AKT1
prerank,vesicle organization (GO:0016050),-0.2911658445877816,-1.0006517102738381,0.43838862559241704,0.7487544634553649,1.0,14/46,16.94%,CAV1;CD34;FNBP1L;CAV2;CHMP2B;ALS2CL;SRGN;LAMTOR1;USP50;DNM1;VPS18;HOOK1;VPS11;USP8
prerank,protein trimerization (GO:0070206),-0.39993934622063576,-1.000616334371966,0.47346938775510206,0.7475735700557942,1.0,9/14,34.04%,SCARA5;SIGMAR1;MIF;DISP1;SLC1A2;ASIC1;ALOX5AP;STEAP4;P2RX3
prerank,protein homotrimerization (GO:0070207),-0.39993934622063576,-1.000616334371966,0.47346938775510206,0.7475735700557942,1.0,9/14,34.04%,SCARA5;SIGMAR1;MIF;DISP1;SLC1A2;ASIC1;ALOX5AP;STEAP4;P2RX3
prerank,digestive tract development (GO:0048565),0.3534778717166074,1.0005868722692817,0.4481409001956947,0.8637426424326817,1.0,7/32,12.27%,FGFR2;KIT;GLI3;SALL1;BBS7;COBL;GLI2
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.329856892882985,-1.000250077178011,0.45336225596529284,0.7478823933882299,1.0,5/26,12.23%,CAV1;LBP;RTN4;IFI35;RSAD2
prerank,tube closure (GO:0060606),0.35703934206335997,1.000052345412157,0.46285714285714286,0.8642392011114416,1.0,7/31,11.81%,LMO4;PRICKLE1;MTHFR;LRP2;FOLR1;COBL;IFT122
prerank,response to molecule of bacterial origin (GO:0002237),-0.27028755966402224,-1.0000196657204317,0.40852130325814534,0.7477851957980048,1.0,22/69,27.67%,FOXP1;NOS3;LBP;GCH1;TNFRSF11A;CYRIB;NOS1;ERBIN;IRAK3;HNRNPA0;IRAK1;IRF5;TIRAP;LIAS;SLC11A1;GGT1;PELI1;IFNAR1;FCGR2B;TNFAIP3;SELP;TLR4
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.42724597936463815,-0.9989328078260553,0.4697855750487329,0.7498386075744323,1.0,4/11,18.81%,TGFB1;DDX5;MAP2K2;BMP4
prerank,regulation of protein kinase B signaling (GO:0051896),0.2646953565225177,0.9985055316667357,0.47319034852546915,0.8673389478837913,1.0,22/193,7.72%,TCF7L2;OSBPL8;FGFR2;FGFR4;PPARA;IL18;KIT;ANGPT1;PDPK1;PDGFRB;KL;IGF2;PDGFRA;GFRAL;RICTOR;FRS2;FGF1;IGF1R;LRP2;PDCD6;PTEN;CCL19
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.25986733273604196,0.9982364988791766,0.4637482900136799,0.8671170224789693,1.0,36/208,15.02%,RORA;WLS;PRKN;PELI2;LPAR1;PDPK1;LTF;ECM1;TRIM5;AKAP13;ZFAND6;CACTIN;GJA1;UFL1;PRKCB;CXXC5;OPTN;NLRC3;CCL19;TLE1;SLC20A1;GOLT1B;IKBKE;CFLAR;UNC5CL;GPRC5B;TBK1;MAP3K7;MAPKBP1;NLRP12;MTDH;UBE2V1;TRIM62;NLRX1;CX3CL1;BIRC2
prerank,tRNA 5'-leader removal (GO:0001682),-0.4056163817956977,-0.9981654298157279,0.4714003944773176,0.7511430911985869,1.0,7/13,28.10%,SSB;POP5;RPP21;POP4;RPP30;PRORP;POP7
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.4315428103707777,-0.998013110174098,0.4612546125461255,0.7508746239789461,1.0,8/10,34.16%,MYD88;AKT1;CD68;TLR4;TREM2;TLR6;CD36;TICAM1
prerank,central nervous system neuron differentiation (GO:0021953),-0.32616438578778756,-0.9978828917559336,0.46325167037861914,0.7505858843689535,1.0,14/33,32.56%,SOX4;CTNNB1;MDGA2;SPOCK1;NR4A2;TOX;KNDC1;GRID2;NPY;LMX1A;SIN3A;AGTPBP1;FAIM2;PROX1
prerank,negative regulation of hemostasis (GO:1900047),0.4331984282606569,0.9976102592334773,0.47334754797441364,0.8679089390921648,1.0,4/12,12.57%,TFPI;VTN;APOH;SERPINE1
prerank,sensory perception (GO:0007600),0.3298283999516146,0.9971847189688398,0.4375,0.8681442843587501,1.0,5/45,9.47%,ADGRV1;GNAS;TTC8;WHRN;RETREG1
prerank,establishment of protein localization to membrane (GO:0090150),0.30806683358322245,0.9968536728034523,0.46116504854368934,0.8680941409529256,1.0,18/66,17.46%,AFDN;PARD3;RAB3IP;SYNE3;ZDHHC1;ARL6;ZDHHC3;MICALL1;VPS37C;OXA1L;VPS37A;RAB3GAP1;PRKCI;ATG3;RAB11B;SDCBP;GRIN3B;VPS37D
prerank,"wound healing, spreading of cells (GO:0044319)",0.3695164056601104,0.9966255496357812,0.45794392523364486,0.8678282652789443,1.0,4/24,6.99%,ARHGAP24;PDPN;DDR1;ARHGAP35
prerank,multivesicular body organization (GO:0036257),-0.3284437293348287,-0.9963970519846376,0.4829059829059829,0.7536804492204195,1.0,14/31,31.27%,RAB27A;CHMP5;CHMP2B;HGS;MVB12A;CHMP1B;CHMP1A;CHMP3;CHMP7;PDCD6IP;CHMP4C;VPS36;VPS28;VPS4B
prerank,positive regulation of immune system process (GO:0002684),-0.38908371080762677,-0.9963921082019176,0.4898785425101215,0.7530578570214209,1.0,6/16,20.26%,TGFB2;VEGFA;PIK3CD;RSAD2;IL15;NCKAP1L
prerank,regulation of cell cycle phase transition (GO:1901987),-0.2607660125619699,-0.9963202784907984,0.48169014084507045,0.7526214239373481,1.0,27/91,23.44%,BUB3;PSMD13;PSMF1;DDB1;PSMB10;CDKN1B;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;PSME1;CUL1;ANAPC16;PSMB3;BUB1B;UBE2D1;ATP2B4;TFAP4;PSMD5;SKP1;CDKN1A;ANAPC7;PSMD9;PSMB4;NEK11
prerank,glycine transport (GO:0015816),0.4300724601573873,0.9961857228047849,0.4357894736842105,0.8681125192277427,1.0,3/10,12.97%,SLC6A9;SLC36A2;SLC25A38
prerank,regulation of microglial cell activation (GO:1903978),0.4233810566532329,0.9961756451772709,0.4538310412573674,0.8672587240047884,1.0,5/15,14.90%,SYT11;SPHK1;IL6;CST7;CX3CL1
prerank,DNA geometric change (GO:0032392),0.3707643811459012,0.9959531429624524,0.4444444444444444,0.8669560508579404,1.0,9/24,21.35%,ANXA1;BLM;RTEL1;MRE11;WRN;HNRNPA2B1;RECQL5;RAD50;NBN
prerank,response to amino acid starvation (GO:1990928),-0.27092860940024793,-0.9957444703906212,0.4475,0.7533733938078602,1.0,31/72,25.82%,MAP3K5;SESN3;SH3GLB1;DAPL1;MTOR;MAPK8;SESN2;ATP6V1A;WDR59;ATP6V0C;LAMTOR1;ATF4;RHEB;ATP6V1E1;TCIRG1;FAS;LAMTOR2;PRKD1;ITFG2;DAP;RRAGB;MAPK3;ATP6V0D2;DEPDC5;CDKN1A;LAMTOR4;CEBPB;ATP6V0E2;ATP6V1B2;CASTOR1;WDR24
prerank,positive regulation of cell cycle (GO:0045787),0.30956081071078057,0.9954281880335061,0.4520547945205479,0.8673711287926679,1.0,14/62,13.60%,FGFR2;SMOC2;SRPK2;SPHK1;EIF4EBP1;CCDC57;PRKCA;PKN2;NUPR1;MDM2;RPS6KB1;PKD2;HSF1;MEIS2
prerank,phosphatidylinositol metabolic process (GO:0046488),-0.24797999914373275,-0.9953590176229383,0.463855421686747,0.7536710083886627,1.0,32/109,17.31%,PIP5K1B;PITPNM2;PLCG2;INPP5D;BMX;PIK3R6;SYNJ1;INPP4A;PIK3C2B;CDS1;ARF1;CDIPT;PLCB3;PLEKHA1;PIK3CD;PIK3C2A;MTM1;MTMR6;PITPNM3;MTMR9;PIK3C3;INPPL1;PIK3R5;PIP5K1C;CSF1R;SBF1;SACM1L;PI4KB;PLA2G4A;PIK3R3;MTMR12;INPP5F
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.3542567979278788,0.9953514682876611,0.4665523156089194,0.866703440689644,1.0,14/32,21.35%,CDC14B;MRNIP;BLM;CDK1;CLSPN;RINT1;MRE11;BABAM2;BRSK1;TAOK3;TRIM39;TAOK2;UIMC1;NBN
prerank,skeletal muscle contraction (GO:0003009),0.3907589765895582,0.9953325721914431,0.4871287128712871,0.8658664004659798,1.0,3/19,12.29%,TNNC1;RCSD1;CCDC78
prerank,I-kappaB phosphorylation (GO:0007252),-0.4375648558547176,-0.9951434489690678,0.50293542074364,0.7535735225635443,1.0,4/10,28.25%,DAB2IP;CHUK;TLR4;TLR7
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.35335241525694155,0.9951410550728983,0.4523364485981308,0.8654970547030894,1.0,4/30,9.62%,LEPROT;UBE2L3;NPEPPS;HSPA1L
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.3225594177721126,-0.9950171533315654,0.4517543859649123,0.7532645486240844,1.0,7/29,15.82%,ESR1;CBFB;RUNX1;PAK1;WBP2;VPS18;VPS11
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.3702131566633301,0.9949726938209879,0.467687074829932,0.8650236890778541,1.0,7/27,8.65%,KIT;PDGFRB;EPHA8;PDGFRA;CCL19;ATG14;PIK3R4
prerank,positive regulation of protein maturation (GO:1903319),0.43539187218400344,0.9949671928118017,0.49469214437367304,0.8641644892985146,1.0,2/11,3.76%,CCBE1;TFR2
prerank,response to interleukin-1 (GO:0070555),0.3036063201385644,0.9946423504079678,0.45171849427168576,0.8640970981744523,1.0,9/73,10.28%,ADAMTS12;ANXA1;IRAK2;CACTIN;ADAMTS7;PRKCA;CCL19;SIRPA;CCL4
prerank,membrane protein intracellular domain proteolysis (GO:0031293),-0.3619937911201272,-0.9943321204246782,0.47105788423153694,0.7543128958882849,1.0,10/20,35.11%,ADAM10;TGFB1;ADAM9;PSEN1;MBTPS1;RELA;HM13;NGFR;SPPL2B;ADAM17
prerank,positive regulation of JNK cascade (GO:0046330),-0.2725562573693596,-0.9942683373499572,0.48324022346368717,0.7538439448993666,1.0,11/70,8.44%,MAP3K5;RASSF2;ANKRD6;PTK2B;DAB2IP;MINK1;TPD52L1;SH3RF3;FLT4;APP;WNT16
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.3571757627842991,-0.9942007307500517,0.4555084745762712,0.753387921579877,1.0,6/20,12.71%,B2M;CD55;DENND1B;IL1R1;RSAD2;CD81
prerank,negative regulation of B cell activation (GO:0050869),-0.3522159060509007,-0.9939711079662777,0.4621676891615542,0.7532948124582682,1.0,10/21,27.59%,TNFRSF21;SAMSN1;LAPTM5;ID2;INHA;TYROBP;CD300A;FCGR2B;TNFAIP3;FOXJ1
prerank,regulation of immune response (GO:0050776),-0.2425512711134774,-0.9939650937695251,0.4503105590062112,0.7526814649078287,1.0,32/135,20.84%,FOXP1;B2M;CLEC2D;CD200;CD34;TGFB2;ITGB1;CXADR;DENND1B;ITGA4;LRP8;CSK;AHR;BIRC3;APPL1;PVR;ADCY7;NPDC1;RSAD2;ICAM2;CD81;CASP8;IL15;ULBP1;N4BP1;PIANP;CD40;TYROBP;COL1A1;TIRAP;COL3A1;CD300A
prerank,positive regulation of axonogenesis (GO:0050772),0.33331325089990055,0.9937475083119124,0.46503496503496505,0.8654485455131327,1.0,4/43,4.34%,PLXNA2;ROBO1;MACF1;PLXNC1
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.3479205663815144,0.993724533417878,0.4500941619585687,0.8646332515515743,1.0,6/33,12.08%,APPL2;STXBP4;PLK5;PTEN;CDC73;INO80
prerank,error-free translesion synthesis (GO:0070987),-0.34603191391436217,-0.9935143111926025,0.45569620253164556,0.7531714922432237,1.0,8/22,22.42%,UBB;UBC;RPS27A;RPA1;UBA52;SPRTN;VCP;POLD1
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.3500411852695786,-0.9928821381478884,0.4538152610441767,0.7540936428292476,1.0,10/23,26.82%,HSP90AB1;CDC37;NLRC5;NR1H2;IFNGR1;TXK;NR1H3;SOCS1;JAK1;STAT1
prerank,lymphocyte proliferation (GO:0046651),-0.35094327119298097,-0.9925873108518446,0.4678111587982833,0.7542207322320184,1.0,7/22,15.70%,MEF2C;MSN;PTPRC;LMBR1L;HSPD1;FLT3;CR2
prerank,protein localization to Golgi apparatus (GO:0034067),-0.3289968072304264,-0.9925862855539518,0.4767676767676768,0.7535975003472623,1.0,10/27,20.32%,VPS13A;VPS13C;ZDHHC15;GBP5;RIPOR1;TMED10;GBF1;VPS13D;SYS1;IFT20
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.37893345920944566,-0.9924539875591061,0.4645030425963489,0.7532697118779905,1.0,5/16,8.96%,ST6GALNAC3;ST8SIA4;ST6GALNAC5;ST8SIA1;ST8SIA6
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.2730685400066179,-0.9923440403138948,0.484149855907781,0.7529239082241436,1.0,18/73,16.32%,KITLG;LMO2;CBFB;RUNX1;GATA2;PSMD13;PSMF1;PSMB10;TAL1;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;PSME1;PSMB3;TCF3
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.36006456679212473,-0.9922157970797926,0.4698544698544699,0.7526296736099108,1.0,4/19,8.10%,PTPRJ;KDR;PTPRC;RYR2
prerank,B cell activation involved in immune response (GO:0002312),-0.4117436885053345,-0.9921099641184775,0.5174418604651163,0.7522933110405992,1.0,6/13,30.94%,CD180;MSH2;LIG4;RNF168;FCGR2B;RNF8
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.30709369827450805,0.9918969245658141,0.4469565217391304,0.8683834872573576,1.0,8/56,6.37%,ROCK2;ARL3;SNX18;SNX33;SNX9;CECR2;SON;SPIRE2
prerank,phosphate ion transport (GO:0006817),0.4018907822406856,0.991835893919762,0.4772277227722772,0.8676791670943425,1.0,4/16,9.34%,SLC20A2;SLC34A3;SLC20A1;SLC25A11
prerank,positive regulation of synapse assembly (GO:0051965),-0.32469264448870466,-0.9916988715152321,0.4925373134328358,0.7527248750582204,1.0,8/27,11.75%,AGRN;SEMA4D;CLSTN2;NRXN1;IL1RAP;SYNDIG1;EPHB1;CLSTN3
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.384555249418907,0.9916788418143153,0.45627376425855515,0.8671942728826564,1.0,5/20,10.08%,WNT4;SIK1;ACADL;APOC1;SLC27A1
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.369737130463728,0.9913707664725011,0.4634615384615385,0.8670998483776515,1.0,7/24,7.98%,NEDD4;GRB10;PRKCB;NIBAN2;PDCD6;VTN;ARNT
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.3057565654859517,0.9912478326060612,0.46760070052539404,0.866521712396389,1.0,13/65,12.17%,FBN1;PPARA;FBN2;SNX6;PDPK1;SMAD6;SLC2A10;SMAD3;SMURF2;LEMD3;HTRA4;LDLRAD4;ADAMTSL2
prerank,calcium ion transport into cytosol (GO:0060402),0.3819374325127168,0.9911548568182382,0.4816247582205029,0.8658635631940014,1.0,3/21,7.01%,JPH1;SLC8A1;CACNA2D1
prerank,positive regulation of protein localization to membrane (GO:1905477),-0.25550643147952606,-0.9908117299652875,0.43768115942028984,0.7543275625763727,1.0,32/98,20.64%,SPTBN1;PRKCH;STX3;ITGB1;PPP1R13B;FYN;KCNB1;YWHAB;NMT1;NKD2;WNK3;CHP1;C2CD5;MAPK8;YWHAG;MIEF1;GPER1;CD81;MTCL1;MIEF2;BBC3;RHOG;CASP8;PRKCE;YWHAQ;YWHAH;STAC3;PPP3R1;ATP2B4;ANK3;ZDHHC8;AKT1
prerank,positive regulation of protein localization to nucleus (GO:1900182),-0.27814309377374097,-0.9907325498484274,0.4869109947643979,0.7539074593162832,1.0,12/66,10.30%,TFRC;CDH1;FLNA;LIMK2;PINX1;TGFB1;FERMT2;CARD10;LARP7;SESN2;WWTR1;MEPCE
prerank,regulation of cell morphogenesis (GO:0022604),0.353900043762162,0.990190894583157,0.46397188049209137,0.8674411959574481,1.0,8/30,10.39%,SH3D19;PDPN;MACF1;NTNG2;CAPZB;ARC;ZMYM4;PHIP
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.4015278627146347,-0.9900789456889739,0.47058823529411764,0.7548721723973805,1.0,6/13,13.14%,DAB2IP;HHEX;PTPN1;HGS;EPN2;CADM4
prerank,cilium movement (GO:0003341),0.3269674426703909,0.9900133012688838,0.5041736227045075,0.8670156674581514,1.0,9/47,15.39%,ODAD3;DNAI4;DNAH11;TEKT2;SPA17;DNHD1;ODAD1;CFAP70;ODAD2
prerank,positive chemotaxis (GO:0050918),-0.3688067024349138,-0.9899647506345369,0.47257383966244726,0.7545501088491418,1.0,5/17,10.75%,PTPRJ;MET;VEGFA;FGF7;SCG2
prerank,tRNA aminoacylation for protein translation (GO:0006418),-0.3035919211776152,-0.989394645262366,0.4604966139954853,0.7553062090131462,1.0,14/42,30.27%,WARS2;LARS2;WARS1;SARS1;YARS1;IARS1;NARS1;EEF1E1;FARSA;AARS2;CARS1;KARS1;MARS2;GARS1
prerank,triglyceride metabolic process (GO:0006641),0.3307341492548497,0.9892481126602174,0.4863481228668942,0.8681421011222991,1.0,10/48,16.45%,AGMO;LPGAT1;LIPC;LIPH;APOC1;APOH;FABP4;FABP7;LMF1;GK
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.4032847588510772,0.989121694769824,0.47808764940239046,0.867591858719863,1.0,6/17,13.47%,RBPJ;MAML3;MAML1;WWC1;MAML2;CREBBP
prerank,negative regulation of cyclase activity (GO:0031280),0.42658169383707484,0.9888603666489733,0.47657841140529533,0.8673792391437033,1.0,1/14,0.46%,ADGRV1
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.2641941214158654,-0.9888264518292482,0.4712328767123288,0.7560223780927463,1.0,26/75,22.47%,PTPRJ;HEG1;STK38;RASIP1;DAB2IP;LRP5;UCHL1;APC;CDKN1B;MEN1;HHEX;PTPN1;SPRY4;PRKAR1A;IRAK3;NF1;DUSP1;SH2B3;BMP4;TFAP4;PRKCD;AKT1;CD300A;GADD45A;HYAL2;CEBPA
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.35855465130627295,0.9887207114977097,0.4811320754716981,0.866833540352656,1.0,5/26,7.47%,SLC8A3;NLGN2;LRRK2;PRKCZ;PTEN
prerank,neuron migration (GO:0001764),0.32376767826266833,0.988392477091528,0.4744645799011532,0.866826298748512,1.0,8/48,9.91%,DCDC2;AUTS2;NDNF;SOX1;SH3RF1;SDCCAG8;PAFAH1B1;TUBGCP2
prerank,cellular response to peptide (GO:1901653),0.31230160704269544,0.9882291457332659,0.48007246376811596,0.8664191267238501,1.0,6/56,7.01%,IGF1;SNX6;EPHA4;GJA1;IGF1R;CACNA2D1
prerank,B cell mediated immunity (GO:0019724),-0.42983896622365686,-0.9882142886968941,0.52,0.756881859168644,1.0,7/10,49.66%,MSH2;CD74;FCGR2B;TLR8;CARD9;SLA2;CD27
prerank,cellular response to unfolded protein (GO:0034620),-0.3406671602411047,-0.9879004475206041,0.47109207708779444,0.7570539294916893,1.0,13/26,25.19%,HSPA8;DAB2IP;ABCB10;HSPA14;HSPA5;PTPN1;HSPB8;HSPD1;TMBIM6;HSPA9;HSPA1B;ERN1;BAX
prerank,regulation of exocytosis (GO:0017157),-0.29315926557484256,-0.9877671845303143,0.47845804988662133,0.7567745805411278,1.0,21/46,29.85%,STXBP6;NSF;RAB3C;RAB27A;RAB3B;CPLX2;CFTR;RAB8A;CHMP3;RAB3A;LGI3;CLASP2;SYTL4;RAB8B;CPLX1;HAP1;RIMS2;STXBP5L;UNC13D;ATP6AP1;SYT1
prerank,innate immune response (GO:0045087),-0.22611033792509688,-0.9876806706411331,0.4763636363636364,0.7563662442208801,1.0,50/217,20.88%,B2M;SERINC5;ADAM15;PTK2;PLCG2;FYN;PTK2B;LBP;GCH1;TRIM14;CAPZA2;IKBKB;PGLYRP1;TRIM25;DEFA6;APP;ADAR;NLRC5;PIK3CD;ANKHD1;CHUK;ISG15;MFAP4;NRROS;CD74;CHGA;SRPK1;SHFL;IFIH1;TRIM13;CX3CR1;CYBB;CR2;RNASE3;AKAP1;STYK1;IRAK1;IRF5;YES1;BST2;MID2;SERINC3;CD40;TYROBP;ANG;MYD88;SLA;IFITM3;TRIM27;SLC11A1
prerank,regulation of actin filament-based process (GO:0032970),0.30074426055564707,0.9868272251371132,0.47096774193548385,0.8691430024224749,1.0,9/70,7.74%,ROCK2;EPHA3;RHOD;PDGFRB;BAIAP2;CNN2;RICTOR;ARHGAP35;RHOBTB2
prerank,phagosome-lysosome fusion (GO:0090385),-0.4306418245085204,-0.9866501034654023,0.5056179775280899,0.758268349618035,1.0,7/10,38.98%,SYT7;RAB39A;RAB7B;RAB7A;RAB20;PLA2G5;CLN3
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.29627241110444086,-0.9866009924862338,0.4716981132075472,0.7577623037645903,1.0,19/41,33.78%,KCNJ2;KCNMA1;FLNA;KCNQ1;KCNMB4;NOS1;ACE2;KCNN2;KCNJ15;ANK3;KCNH2;KCNJ6;GABBR1;GNB1;KCNJ16;KCNJ10;KCNN4;KCNMB2;AKAP6
prerank,protein localization to mitochondrion (GO:0070585),0.4408506640239585,0.9863005532645982,0.48760330578512395,0.8696389074899662,1.0,3/11,6.45%,HK2;LRRK2;MAIP1
prerank,cellular protein-containing complex assembly (GO:0034622),-0.23522848356078224,-0.9860811484171708,0.5287009063444109,0.7583771121358063,1.0,27/159,13.03%,STXBP6;HIP1;SGIP1;TIAM1;HSP90AA1;HSP90AB1;RPL38;PDE4DIP;PXN;TGFB1;GPX4;NCK1;VAMP8;HIP1R;PSMD13;AP2M1;RTN4;POMP;PIK3C2A;NCK2;NSG2;BIN1;ADRB2;HSPD1;CLU;HIGD2A;EIF4H
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),-0.21440360756654556,-0.9859915025485,0.5071090047393365,0.7579907622827501,1.0,98/341,23.14%,WWP1;RNF144B;ATXN3;CBL;NEDD4L;PPP2R5C;FBXO7;OTUD7A;RNF144A;MVB12B;UBXN1;ZNRF1;BUB3;TRIM25;UBAP1;CTNNB1;UBE3C;FAF1;NEDD8;ARRB1;BAG6;RMND5B;RNF125;UCHL1;CUL3;ZRANB1;PSMD13;RBX1;UBE2B;PSMF1;DDB1;PSMB10;KCTD17;KCTD13;RNF215;NDFIP2;XBP1;FEM1A;PSMB6;TOLLIP;NSFL1C;PSME3;UBQLN4;PSMB5;PTPN23;ERCC8;PSMC3;HERPUD1;AGAP3;RNF34;KLHL42;RNF150;MVB12A;PSMD12;PTTG1;PSMB8;PSME1;ANAPC16;ARIH2;ZFAND2B;TRIM13;UBE2G1;PSMB3;SPSB3;SPOPL;COP1;KCTD21;UBAP1L;FBXL14;BUB1B;RNF5;UBE2D1;RNF19B;PINK1;TRIM2;TGFB1I1;SHARPIN;ARRB2;USP9X;PSMD5;RNF168;OTUD7B;ZSWIM8;RNF11;UBL7;RNF19A;UBA1;NDFIP1;KCTD5;PLAA;PELI1;VCP;ARIH1;ANAPC7;PSMD9;HUWE1;RBCK1;PSMB4
prerank,response to hexose (GO:0009746),0.3676157785163093,0.9858177832131763,0.4500907441016334,0.8700455152921229,1.0,1/25,0.48%,TCF7L2
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.3912352793910081,-0.9856971177190001,0.47704590818363274,0.7581069970990801,1.0,2/15,2.38%,PLTP;SCARB1
prerank,mRNA export from nucleus (GO:0006406),-0.25025925659320314,-0.9856385913154455,0.48138297872340424,0.757625575738178,1.0,41/102,33.84%,SRSF2;SRSF1;SRSF5;DDX39B;HHEX;CPSF3;SRSF9;ENY2;RBM8A;RNPS1;SRSF6;NUP37;SYMPK;AGFG1;CPSF2;NXT1;NUP54;NUP85;SMG5;YTHDC1;NUP133;MAGOH;THOC3;POM121;THOC6;EIF4E;DDX25;THOC2;EIF4A3;SRSF7;NUP153;ALYREF;SMG6;ZC3H11A;NUP42;CPSF1;NUP93;DHX38;U2AF1L4;CHTOP;IWS1
prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.3303720323810048,-0.9853214212200374,0.4830508474576271,0.7577930363219336,1.0,8/26,13.63%,ITPR2;PLCG2;PTPRC;RYR2;HTR2A;ERO1A;IBTK;ITPR3
prerank,negative regulation of lyase activity (GO:0051350),0.409596082542463,0.9847293334400039,0.4675834970530452,0.8719369343211496,1.0,1/16,0.46%,ADGRV1
prerank,neuron projection extension (GO:1990138),0.35192055240735154,0.9845597928559111,0.4731369150779896,0.8714911115610344,1.0,2/32,0.59%,ALCAM;AUTS2
prerank,actin filament depolymerization (GO:0030042),0.4306997850862355,0.9842627299149349,0.46750524109014674,0.8713681432465532,1.0,1/11,0.33%,MICAL3
prerank,regulation of ion transport (GO:0043269),0.2935855056206341,0.9834289612601897,0.46855345911949686,0.872655553398482,1.0,9/76,5.04%,PRKN;SNX6;KCNA5;DTNBP1;NKAIN4;NEDD4;SYT11;SYT12;SIK1
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.30216594548388465,0.9831005117493564,0.49581239530988275,0.8726612812919015,1.0,14/69,13.84%,IGF1;PDGFRB;PLCB1;PDGFRA;IGF1R;PTEN;GPR143;MYO16;PIK3R1;RPS6KB1;ERBB2;PLCD1;GAB2;PLCL1
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.28089702005370243,0.9830920451351851,0.4788519637462236,0.8718236460360017,1.0,11/110,6.66%,ADCY5;ADCY1;LGR4;ADGRL1;LPAR1;GNAS;ADM;ABCA1;LPAR2;GNAQ;ADRA1D
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.4249465815819451,0.9830518673765972,0.48414376321353064,0.8710682779822642,1.0,7/12,23.55%,IGF1R;BNIP3;UVRAG;IRGM;SETX;FYCO1;JMJD4
prerank,sulfation (GO:0051923),0.4347977625773646,0.9829928570100351,0.4782608695652174,0.8703657276111496,1.0,2/11,10.99%,UST;SULT4A1
prerank,glycerophospholipid catabolic process (GO:0046475),-0.3287108199548023,-0.9828748114545557,0.5011185682326622,0.763302198115082,1.0,7/27,17.31%,GPCPD1;SMPD4;GDPD1;GDPD3;PNPLA6;PLA2G4A;INPP5F
prerank,negative regulation of endocytosis (GO:0045806),0.37202052988912543,0.9825579843419007,0.47924528301886793,0.8705982655598007,1.0,7/24,12.80%,EPHA3;SYT11;SNX33;APOC1;PICALM;RUBCN;PACSIN3
prerank,L-amino acid transport (GO:0015807),-0.3176524427378439,-0.9824287985180084,0.48478260869565215,0.7638010376216117,1.0,8/28,12.02%,SLC7A5;SLC7A1;SFXN1;SLC1A1;SLC38A5;SLC3A2;SLC36A1;SLC1A4
prerank,positive regulation of synaptic transmission (GO:0050806),0.29579122433575494,0.982423966682933,0.4806070826306914,0.8700592024980582,1.0,9/72,7.84%,ADCY1;SLC8A3;NLGN2;TSHZ3;DTNBP1;CACNG7;PRKCZ;ARC;ZDHHC3
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.3775499201677081,0.9821375162982465,0.5095785440613027,0.8699677214165478,1.0,4/23,9.17%,NMT2;PDE6G;CAMKMT;GRK4
prerank,C4-dicarboxylate transport (GO:0015740),0.4036450890761473,0.9818999777590572,0.4682203389830508,0.8697265475215713,1.0,5/14,9.34%,SLC25A18;SLC13A5;LRRC8E;SLC25A22;SLC25A11
prerank,mRNA destabilization (GO:0061157),0.33649949407592783,0.9815114012221284,0.48788927335640137,0.8698672043649812,1.0,5/38,10.76%,ROCK2;POLR2D;YTHDF2;RC3H2;METTL14
prerank,double-strand break repair (GO:0006302),0.2624250810880147,0.9812345520442268,0.5187861271676301,0.8697163471451577,1.0,36/158,17.42%,EYA1;RAD51B;RNF138;BAZ1B;RAD51AP2;HUS1B;RAD51C;TDP2;XRCC5;HELQ;BLM;XRCC4;KDM2A;AUNIP;BRCA2;POLM;ZSWIM7;MDC1;PRKDC;DCLRE1A;PARP9;NHEJ1;ZFYVE26;SMARCA5;DCLRE1B;INO80;MRE11;CIB1;BABAM2;BRIP1;WRN;SWI5;RAD51;IFFO1;DTX3L;KDM4D
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.39097795960585524,-0.9811180787788722,0.4672131147540984,0.76637427924814,1.0,3/13,9.45%,NAMPT;PTGIS;PTGS2
prerank,UV protection (GO:0009650),-0.43341004973846076,-0.9808447923779093,0.4962962962962963,0.7664094281271325,1.0,6/10,33.26%,MFAP4;SDF4;ERCC5;CAT;XPA;FEN1
prerank,positive regulation of cell division (GO:0051781),0.3379120623875009,0.9807431849558059,0.4924812030075188,0.870104622775824,1.0,5/38,8.76%,FGFR2;CXCR5;CDC14B;FGF1;PKN2
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.3688456181318004,0.9807277130790024,0.4849624060150376,0.8692978412023336,1.0,2/26,1.30%,ADCY5;STXBP4
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.30721289400790086,0.9805180626278045,0.48353552859618715,0.8689611126736542,1.0,16/60,17.50%,TCF7L2;CDK8;TNRC6B;TNRC6A;IL6;PTEN;CDK1;MED13;MED1;SRF;MOV10;ATF7IP;CDK4;MED15;MED10;MED26
prerank,regulation of peptidase activity (GO:0052547),0.3904951577445962,0.9805149421338517,0.4864864864864865,0.8681202020301036,1.0,7/19,10.54%,ECM1;CTSH;A2ML1;NRDC;PSMA3;HDAC1;CST7
prerank,cellular response to misfolded protein (GO:0071218),-0.34828904201752875,-0.9804997296497164,0.4613733905579399,0.7666108852602386,1.0,10/20,31.67%,ATXN3;BAG6;CUL3;DERL1;AUP1;RNF5;VCP;STUB1;RNF185;UGGT1
prerank,regulation of vasculature development (GO:1901342),-0.3249662654120846,-0.9804412660274509,0.485838779956427,0.7661507274943468,1.0,6/26,8.32%,BMPER;PLXND1;ETS1;WARS1;CTNNB1;EMP2
prerank,pyroptosis (GO:0070269),0.42106240344993173,0.9796728828794259,0.5088408644400786,0.8693622312154945,1.0,4/15,10.89%,GSDMA;ZBP1;GSDMD;GSDME
prerank,response to UV-A (GO:0070141),0.4175761409165323,0.9793728424800716,0.5061224489795918,0.8692696018993763,1.0,3/14,9.46%,MMP2;MMP9;CERS1
prerank,DNA metabolic process (GO:0006259),0.24886434703656612,0.9789144082757075,0.5073825503355704,0.8695686609145119,1.0,59/270,18.17%,TCF7L2;CBS;FANCA;SP100;RAD51B;SRPK2;TOP2B;ATRIP;DDB2;HUS1B;RAD51C;INIP;PDS5B;ACD;DMC1;PSME4;PARP4;TYMS;XRCC5;BLM;USP7;DDX23;CDK1;UVRAG;AXIN2;FBXO6;PDS5A;MBD4;PRKDC;RFC1;LIG1;DCLRE1B;MPG;RTEL1;INO80;ORC2;SMARCB1;PRIMPOL;MRE11;USP45;APEX1;MNAT1;TOP1MT;UBE2A;MCM2;BACH1;FANCC;WRN;ORC3;RAD18;RAD51;STN1;ORC6;RNASEH2A;REXO4;RPAIN;TRRAP;XPC;PURA
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.3930202704020439,-0.9788502525230232,0.5127701375245579,0.769419839296119,1.0,5/14,11.37%,PTK2;SOCS2;PXN;PTPN1;STAT3
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.3691067708216873,0.978833786227976,0.4686907020872865,0.8689338430498035,1.0,7/24,17.24%,LPGAT1;PLA2G10;SLC27A1;PLA2G4B;PLA2G12A;SERAC1;CDS2
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.29949895140367355,0.9788206127081593,0.4741100323624595,0.8681258120114087,1.0,22/64,24.43%,POLR2D;CDK7;ELOA;CCNT2;CCNT1;POLR2A;GTF2F1;CDC73;MNAT1;NELFB;TCEA1;SETD2;ELL;CTR9;CDK9;ELP2;PAF1;SUPT4H1;GTF2H1;POLR2K;CDK13;ERCC2
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.26285570791677293,-0.9787544735228747,0.4906166219839142,0.76904883865371,1.0,22/74,15.39%,NOTCH1;UBB;UBC;RPS27A;EGLN3;VEGFA;PSMD13;RBX1;PSMF1;LIMD1;PSMB10;PSMB6;PSME3;PSMB5;EGLN2;PSMC3;ELOB;PSMD12;PSMB8;PSME1;UBA52;PSMB3
prerank,gas transport (GO:0015669),-0.4252535880602405,-0.9786212281189087,0.4961089494163424,0.7687355269946821,1.0,2/10,11.87%,CA2;CYGB
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.3302716090361982,-0.9784976643042897,0.48314606741573035,0.7684172902028709,1.0,14/27,29.29%,ETS1;CD44;CYRIB;RHOA;HSPD1;CD47;IRAK1;THY1;RELA;CCR2;SKAP1;CCL2;ITGB2;NR4A3
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.257434789326875,-0.9784420708894348,0.5013477088948787,0.767939438674467,1.0,30/88,25.74%,FBXL3;PSMD13;RBX1;FBXL5;PSMF1;PSMB10;FBXO31;FBXL20;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;PSME1;CUL1;FBXL2;PSMB3;CCNF;FBXL14;FBXO17;PSMD5;SKP1;FBXO9;PSMD9;PSMB4;CUL2;DMAC2;PSMD10;KIF14
prerank,autophagy of mitochondrion (GO:0000422),0.33239503072612453,0.9778802358088139,0.4859154929577465,0.869643281600465,1.0,9/38,14.73%,PRKN;WIPI1;BNIP3;ATG14;FUNDC2;FUNDC1;ATG9A;AMBRA1;ATG3
prerank,linoleic acid metabolic process (GO:0043651),0.3910387268991449,0.9776906363494459,0.474609375,0.8692783536419358,1.0,2/17,2.58%,ACSL1;GSTM2
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.4506798218908097,0.9776862212053409,0.4876543209876543,0.86845232715513,1.0,1/10,0.97%,APPL2
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),-0.4167637318902118,-0.9776224775766028,0.4952741020793951,0.7694004416598501,1.0,4/10,25.01%,MSN;RHOA;CAMSAP3;EZR
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.37403870407919715,-0.977232833000208,0.509765625,0.7697535358275497,1.0,9/15,35.84%,GBP5;USP50;NLRP2B;MYD88;TLR4;TREM2;TLR6;CD36;DHX33
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.38868401210165254,0.9770044694266683,0.4895238095238095,0.8693664563951031,1.0,3/18,8.93%,RAD51B;RAD51C;CDK1
prerank,negative regulation of axonogenesis (GO:0050771),-0.3248320938167213,-0.9764448533208187,0.5,0.7710338268906002,1.0,11/27,21.01%,ARHGDIA;DCC;RTN4;RHOA;SEMA3G;EFNB3;CDKL3;MT3;GDI1;THY1;RTN4R
prerank,pulmonary valve morphogenesis (GO:0003184),0.4034082816271469,0.9761921842586243,0.490272373540856,0.8705774196942803,1.0,3/17,2.30%,ROBO1;NOTCH2;SMAD6
prerank,regulation of osteoclast differentiation (GO:0045670),0.33784956523372195,0.976025667686501,0.4694589877835951,0.8701505610233808,1.0,4/33,8.84%,FBN1;LRRC17;CSF1;FSTL3
prerank,prostaglandin metabolic process (GO:0006693),-0.3248492966937857,-0.9755834898252053,0.5084745762711864,0.7725411023263442,1.0,12/26,33.85%,PTGIS;PTGDS;EDN1;PTGS2;CD74;PLA2G4A;MIF;PLAA;HPGDS;PRXL2B;CYP2S1;HPGD
prerank,membrane raft organization (GO:0031579),-0.37596583743410217,-0.9754631457658642,0.5129224652087475,0.7722177334398906,1.0,3/15,12.15%,RFTN1;EMP2;S100A10
prerank,secondary palate development (GO:0062009),0.4133875254173143,0.97520845242687,0.487551867219917,0.871369704027984,1.0,1/14,0.25%,TGFBR3
prerank,regulation of trans-synaptic signaling (GO:0099177),-0.31963787297994306,-0.9748531731927333,0.5112107623318386,0.7730661976970348,1.0,14/33,19.44%,NGF;GRIK4;ABR;LRP8;BCR;BTBD9;SLC4A8;PXK;RELN;NRG3;CX3CR1;CACNA1B;GRIK2;GRID2
prerank,regulation of lamellipodium assembly (GO:0010591),0.34009852561105747,0.9747938848151868,0.4956217162872154,0.8715729944691931,1.0,7/34,10.91%,AUTS2;AVIL;FER;ABI2;CAPZB;PIK3R1;EPHA2
prerank,regulation of fat cell differentiation (GO:0045598),0.2919212319344627,0.9744721555732899,0.4923599320882852,0.871584800933756,1.0,11/74,10.51%,RORA;MEDAG;RUNX1T1;ANKRD26;TMEM64;IL6;SMAD3;LMO3;SYAP1;ASXL2;TAF8
prerank,regulation of lamellipodium morphogenesis (GO:2000392),-0.4133618901867285,-0.9741784321736406,0.5099099099099099,0.7741067091953423,1.0,3/11,5.71%,KANK1;CORO1C;CD44
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.3767899326160307,-0.9739169539172307,0.487378640776699,0.7741307241260067,1.0,6/14,39.17%,ADRB2;PRKAR1A;ATP2B4;PKIG;PRKAR2B;PRKAR2A
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.38333637202865667,-0.9738538629815754,0.5,0.7736705989412991,1.0,4/14,13.02%,THBS1;CREB3L1;GPC1;SPRY4
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.4179410309469863,0.9736924595796403,0.4690831556503198,0.8726444332629649,1.0,3/12,9.67%,LHPP;ADSL;GMPS
prerank,ventricular septum development (GO:0003281),0.33935362794604496,0.9734728249067823,0.4724137931034483,0.8723220646116965,1.0,2/37,0.29%,TGFBR3;ROBO1
prerank,cytoskeleton organization (GO:0007010),0.2813805438848624,0.9733988134520575,0.5061919504643962,0.8716657811084247,1.0,15/114,7.74%,MICAL3;SH3D19;FGD4;TPM1;RHOD;OBSL1;ABI2;SYNE3;CNN2;CECR2;CAPZB;WDPCP;ARC;WASF3;RHOBTB2
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.3991271386089828,0.9733164281951125,0.4909819639278557,0.8710426231818009,1.0,1/16,0.35%,LEPROT
prerank,regulation of cellular catabolic process (GO:0031329),0.3039287537412927,0.9730663934577326,0.48713550600343053,0.8708543720394228,1.0,8/62,10.22%,ITPR1;DAPK1;PRKN;LRRK2;MTMR3;NUPR1;KAT8;ABL1
prerank,carbohydrate biosynthetic process (GO:0016051),0.37561857368169704,0.9730304449508531,0.49272349272349275,0.8701076574035381,1.0,3/21,4.58%,B3GALT1;ST3GAL3;B4GALT1
prerank,negative regulation of blood coagulation (GO:0030195),-0.29750804995084157,-0.9728990569605425,0.5023584905660378,0.7754745225576456,1.0,7/38,12.20%,NOS3;CD34;F3;SERPINE2;EDN1;A2M;THBD
prerank,peptide cross-linking (GO:0018149),-0.3295696496316805,-0.9728804846899595,0.49193548387096775,0.7748930022647293,1.0,3/25,4.36%,FN1;THBS1;TGM2
prerank,cellular response to exogenous dsRNA (GO:0071360),0.43423922758924705,0.9728644585746511,0.4877126654064272,0.8696681375930628,1.0,1/12,0.42%,COLEC12
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.3601742068352355,-0.9726751236482496,0.4969939879759519,0.7747711600359064,1.0,10/18,47.33%,BCAR1;BAG6;CMKLR1;LAX1;C5AR2;FPR3;C5AR1;SLA2;BLK;GPLD1
prerank,immunoglobulin mediated immune response (GO:0016064),-0.42279688676876725,-0.9725504725778084,0.5076335877862596,0.7744597154182363,1.0,9/10,57.75%,CD74;CD81;FCGR2B;TLR8;CARD9;CD27;CD19;GAPT;FCER1G
prerank,cellular macromolecule catabolic process (GO:0044265),0.3114695087380931,0.9725329799462181,0.5074135090609555,0.8696584998301969,1.0,8/49,13.40%,ADAMTS9;PRKN;FBXO44;SIAH2;SND1;FBXO6;NGLY1;RAB12
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.38387505613404627,0.9723907309522081,0.4768339768339768,0.8691790946482648,1.0,2/19,2.21%,IL34;CAMK1D
prerank,melanosome organization (GO:0032438),0.34819702480044284,0.9723632304907218,0.5077519379844961,0.8684248212831448,1.0,7/26,15.63%,SHROOM2;DTNBP1;GPR143;RAB32;BLOC1S4;AP3B1;AP1M1
prerank,polyamine metabolic process (GO:0006595),-0.393117915965734,-0.971944452863531,0.5048543689320388,0.7753081123583445,1.0,8/13,36.25%,AMD1;HDAC6;DHPS;SRM;SMS;ODC1;HDAC10;OAZ2
prerank,epithelial cell differentiation (GO:0030855),0.2893491318805815,0.9719383153316382,0.5223140495867769,0.8686953319965931,1.0,13/88,13.03%,MAF;FGFR2;DAB2;ANXA1;TPP1;PTER;CDK1;KDM6B;HDAC1;LATS1;FSTL1;CNN3;UPK1A
prerank,positive regulation of insulin secretion (GO:0032024),0.33312126315915386,0.9718887936877747,0.5017921146953405,0.8680104806929724,1.0,5/36,8.15%,TCF7L2;RBP4;NLGN2;MCU;SLC30A8
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.35722821090310597,-0.971705598729132,0.4778225806451613,0.775290809763055,1.0,5/18,10.80%,SHANK3;PTK2B;NRXN1;RELN;GRIN1
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.4316467728760535,0.9715946028092731,0.4957983193277311,0.8678700862869783,1.0,1/13,0.46%,ADGRV1
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.3742169028997182,-0.9714518119783134,0.5173160173160173,0.7752896110751989,1.0,7/17,22.31%,SREBF2;SOD1;LPCAT3;ERLIN2;ABCA2;ABCG1;MBTPS1
prerank,cochlea morphogenesis (GO:0090103),-0.41478790669454974,-0.9711043138900118,0.5050100200400801,0.7755623851476572,1.0,8/10,49.52%,TBX1;MYO3B;MYO3A;PAX2;TIFAB;HOXA1;HPN;POU3F4
prerank,protein depolymerization (GO:0051261),0.35169808534710073,0.9701948581248274,0.4816849816849817,0.8704960782942833,1.0,2/27,1.89%,MICAL3;KIF2A
prerank,protein export from nucleus (GO:0006611),0.3534344831018161,0.969841950371614,0.49256505576208176,0.8705505039982243,1.0,1/27,0.14%,RANBP3L
prerank,calcium ion homeostasis (GO:0055074),0.28302661193455964,0.969697608059124,0.5,0.8700742791814399,1.0,8/95,4.09%,SLC24A3;SLC8A3;STIM1;CSRP3;SLC8A1;DMPK;FAM20A;ANK2
prerank,post-translational protein modification (GO:0043687),0.24472067114184437,0.9688448958213915,0.5543766578249337,0.8713694626960896,1.0,50/332,11.82%,ASB2;CP;FBN1;APLP2;EPAS1;SDC2;ITIH2;TNC;SPSB1;SERPIND1;HIF3A;RAB13;PRKCSH;IGFBP4;OBSL1;PCSK9;NEURL2;FBXW4;DCAF4;DDB2;GPC3;PSME4;PSMA2;RBBP7;CAND1;FBXO44;IL6;F5;CCDC8;PSMA3;CUL9;DCAF10;MIA3;CSF1;IGFBP7;CUL7;CHRDL1;FSTL3;KLHL11;ASB3;FBXO6;FEM1B;PSMD8;KBTBD7;KLHL22;UBA3;PSMD3;FSTL1;FBXO4;CUL4B
prerank,negative regulation of DNA binding (GO:0043392),-0.31541949583875917,-0.96871145257389,0.4778761061946903,0.780723923658203,1.0,8/28,22.99%,LEF1;NFKBIA;JUN;HEY2;SUMO3;TFAP4;HEY1;SOX11
prerank,cellular response to organic substance (GO:0071310),0.2749822285687429,0.9687079027449641,0.5068702290076336,0.8708789139068365,1.0,16/116,7.03%,PTPN13;PID1;IL18;DPYSL3;PTPN4;IL1RAPL1;STAT5B;NCOA2;NFAT5;SPHK1;PLK5;LRRK2;PTPN9;LRP2;SMAD3;NCOA3
prerank,negative regulation of chemokine production (GO:0032682),0.40765523824785865,0.9681843295029561,0.4830188679245283,0.8713259501534476,1.0,3/14,8.77%,C1QTNF3;IL6;SIRPA
prerank,positive regulation of intracellular transport (GO:0032388),-0.29431159429934095,-0.9679746013503064,0.4933920704845815,0.7819230185068732,1.0,19/38,36.25%,PRR5L;EHD1;PDCD10;OAZ1;RIPOR1;NUMA1;MLC1;SPAG5;CAPN10;SORL1;PCM1;CEP131;PGAP1;ATP2A1;STK11;PLK3;PCNT;DYNC1H1;OAZ2
prerank,positive regulation of nervous system development (GO:0051962),-0.2941468493191392,-0.9679435145627833,0.4976635514018692,0.7813814839605303,1.0,18/42,26.78%,TGM2;CLSTN2;SERPINF1;NRXN1;IL1RAP;SYNDIG1;EPHB1;GPER1;CLSTN3;CX3CR1;SPEN;LIG4;GRID2;LRRC4B;FAIM;SOX11;CLSTN1;EPHB3
prerank,regulation of JUN kinase activity (GO:0043506),-0.31333374880647996,-0.9679312691483238,0.47649572649572647,0.7807936636560812,1.0,9/33,9.97%,MAP3K5;DAB2IP;DNAJA1;RPS3;TNFRSF11A;PDCD4;PAK1;EDN1;ARHGEF5
prerank,acylglycerol biosynthetic process (GO:0046463),0.3751436800674688,0.9679085431231658,0.4943820224719101,0.8712028722808421,1.0,2/23,1.81%,AGMO;LPGAT1
prerank,regulation of phospholipase C activity (GO:1900274),0.40894562073913926,0.9677216970493597,0.5040160642570282,0.8708452419685385,1.0,3/15,3.77%,KIT;PDGFRB;PDGFRA
prerank,negative regulation of DNA biosynthetic process (GO:2000279),-0.3193740398836638,-0.9674801043196596,0.5253863134657837,0.7812920835501838,1.0,6/30,10.76%,ACVRL1;DACH1;BMPR2;PINX1;HNRNPU;MEN1
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.27287781959141866,-0.9673458721977601,0.5351473922902494,0.7810054661985243,1.0,20/57,23.10%,MEF2C;DLG2;PTK2B;MINK1;DLGAP1;APP;CACNG3;RELN;GRIN1;CACNG2;LYNX1;CAMK2B;GRIA2;CNIH3;NPTXR;SHISA6;NEFL;NPTX1;MAPK8IP2;SHANK1
prerank,positive regulation of protein metabolic process (GO:0051247),-0.24187756263500843,-0.9673378547744508,0.5333333333333333,0.7804051446077215,1.0,26/110,12.92%,WWP1;KLF2;NSF;KLF4;NEDD4L;DAB2IP;NFKBIA;ATG7;TGFB1;PLK2;GSK3B;APP;ABCB10;FOXO1;MAPK8;APC;OAZ1;PAEP;DDB1;EIF4G1;CDKN1B;NDUFA13;RAB1A;EGLN2;IDE;CLU
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.39601807080687124,-0.9671593649254857,0.5258964143426295,0.7802473774297161,1.0,8/12,36.35%,PTK2B;UBASH3B;RYR2;MTLN;CASQ1;TRDN;CASQ2;FKBP1B
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.37549732778904166,-0.967047343902712,0.48484848484848486,0.7799117644491134,1.0,10/16,48.07%,RBMXL1;TRA2B;PRDX6;DAZAP1;CELF4;CELF3;SF3B4;NCBP1;RBM3;TRA2A
prerank,negative regulation of viral release from host cell (GO:1902187),0.4274077406502337,0.9666912016084155,0.524896265560166,0.872470640539103,1.0,4/13,16.48%,TRIM5;TRIM35;TRIM26;PML
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.3311262454278099,0.9666087021828647,0.4890909090909091,0.8718417701720861,1.0,4/35,6.85%,LEPROT;KIT;PIGU;IL6
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.2537820598386617,0.9664291520051084,0.5189340813464236,0.8714820113516992,1.0,21/214,7.72%,EPHA7;TGFBR3;FGFR2;FGFR4;NOTCH2;TIMP3;ANGPT1;MTURN;CCN2;PDGFRB;PDGFRA;DUSP10;GLIPR2;FBLN1;PDGFD;PRKCZ;DLG1;PRKCA;LMO3;PTEN;CCL19
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.3744735851398557,0.9664128527133097,0.5,0.870699028931341,1.0,7/21,16.45%,HK2;H6PD;RPE;RBKS;DERA;GPI;GCK
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.4115273114732029,0.9663862908514306,0.4879518072289157,0.8699588505200248,1.0,2/14,1.56%,WNK4;DMD
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.39266057033442325,-0.966188083271161,0.5200764818355641,0.7813624285503203,1.0,8/13,31.78%,TMEM30A;CD81;BCAP31;SEC16B;SORL1;SEC16A;TM9SF4;TMEM30B
prerank,regulation of cholesterol esterification (GO:0010872),-0.42332843208313325,-0.9661694012807375,0.5168539325842697,0.7807911483592457,1.0,6/10,32.26%,LAMTOR1;AGTR1;ABCA2;ABCG1;STARD4;AGT
prerank,establishment of apical/basal cell polarity (GO:0035089),-0.3748618599180201,-0.9661497843089476,0.5352941176470588,0.7802340305920016,1.0,5/14,27.59%,MSN;RHOA;CAMSAP3;EZR;FOXJ1
prerank,female gamete generation (GO:0007292),0.34591146601123124,0.9661462852400873,0.4901185770750988,0.8697072174935627,1.0,4/29,5.62%,DIAPH2;HORMAD1;PTN;DMC1
prerank,positive regulation of protein acetylation (GO:1901985),0.43033927653933185,0.9660832432623769,0.4970178926441352,0.8690602909926204,1.0,5/12,21.31%,PRKAA2;PRKAA1;RAPGEF3;DDX3X;KAT5
prerank,oogenesis (GO:0048477),0.40114031580065806,0.965950490973405,0.48484848484848486,0.8685878730467425,1.0,2/15,5.46%,HORMAD1;PTN
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.2782075536212423,-0.9657239852911562,0.5232273838630807,0.7806617327591352,1.0,20/52,22.10%,MBNL1;NOVA2;RBFOX1;RBFOX3;RBFOX2;HNRNPU;DDX5;ZBTB7A;RBM8A;REST;KHDRBS3;RNPS1;SRSF6;YTHDC1;PTBP1;MAGOH;DDX17;TRA2B;RBM24;FMR1
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.4024346603232825,0.9657170070974721,0.512396694214876,0.8683188920813586,1.0,3/15,11.25%,LARGE1;CHST3;RENBP
prerank,regulation of Golgi organization (GO:1903358),-0.36236834190391987,-0.9656237927422754,0.49798387096774194,0.7802671036276073,1.0,7/17,23.91%,PDE4DIP;PDCD10;EHD3;MYO5A;MAP2K2;MAPK3;CAMSAP3
prerank,positive regulation of exosomal secretion (GO:1903543),-0.3820946026665357,-0.9654754661440011,0.5337301587301587,0.7799930293887091,1.0,6/15,31.27%,HGS;ATP13A2;SDC4;PDCD6IP;RAB7A;VPS4B
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.3581175196413794,0.9652877093155546,0.5060728744939271,0.8685651463622401,1.0,5/26,6.72%,LARGE1;B3GNT5;GAL3ST2;ALG6;ALG2
prerank,regulation of neuron apoptotic process (GO:0043523),0.2732346980156871,0.9651709697823552,0.5048076923076923,0.8680190067390824,1.0,9/96,4.93%,EPHA7;PRKN;SNX6;BCL2;NDNF;PCSK9;SRPK2;KDM2B;CPEB4
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.321573086972004,0.9645393463716126,0.5225225225225225,0.8687780199407752,1.0,1/48,0.09%,PRKAG2
prerank,regulation of protein export from nucleus (GO:0046825),0.37066184780588535,0.963625416093776,0.4874551971326165,0.8701586146237185,1.0,2/23,2.83%,TCF7L2;SP100
prerank,peroxisome organization (GO:0007031),-0.32456238263258885,-0.9635683987620469,0.5166666666666667,0.7839278135766458,1.0,13/25,36.14%,ABCD3;ABCD2;PEX11B;PEX1;ABCD4;SEC16B;PEX10;TMEM135;PEX16;FIS1;PLAAT3;DNM1L;PEX3
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),-0.30804602152862554,-0.9635033924747592,0.5138248847926268,0.7834813582755703,1.0,12/33,24.79%,ACER2;TGFB2;PTK2;NEXMIF;DPP4;RET;ADAM9;NCKAP1L;CYP1B1;JAM3;ADA;P2RY12
prerank,negative regulation of binding (GO:0051100),0.2912464349381566,0.9633365283374141,0.5074875207986689,0.8700082180061475,1.0,11/81,10.25%,ARHGAP28;DAB2;DKK1;SP100;IFIT2;LRRK2;PSME3IP1;RSF1;GTF2F1;GOLGA2;JAK2
prerank,myeloid dendritic cell activation (GO:0001773),-0.3906483230546165,-0.963259148989187,0.5010060362173038,0.7834640558077486,1.0,3/12,15.07%,TGFBR2;DOCK2;CAMK4
prerank,regulation of tau-protein kinase activity (GO:1902947),-0.41396230246296933,-0.9631693900113738,0.5231316725978647,0.7830889937187626,1.0,2/10,2.29%,HSP90AA1;HSP90AB1
prerank,regulation of neurotransmitter secretion (GO:0046928),-0.3082517310069379,-0.9629834075029561,0.4863013698630137,0.7829332406320205,1.0,8/32,12.95%,MEF2C;MCTP1;GSK3B;SLC30A1;KCNMB4;GPER1;CPLX2;VPS18
prerank,regulation of B cell activation (GO:0050864),-0.3284092288844691,-0.9627493975055125,0.5043859649122807,0.7829102652199472,1.0,12/25,34.56%,SH3KBP1;AHR;ZFP36L1;SAMSN1;LAPTM5;FCGR2B;TNFAIP3;FOXJ1;IL4I1;NOD2;IKZF3;THEMIS2
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.3402470090061917,-0.9622350441575972,0.5441176470588235,0.783575782371895,1.0,8/21,16.37%,MTUS1;THBS1;PTK2;PTK2B;AKIRIN1;CSF1R;CMKLR1;MIF
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.43795342031967965,0.9620515335323072,0.5157894736842106,0.872311178374755,1.0,3/11,13.49%,ARID1B;ZMIZ1;ZMIZ2
prerank,protein insertion into membrane (GO:0051205),-0.30505788221223656,-0.9616272056985432,0.5084745762711864,0.7843962426644587,1.0,13/32,31.34%,REEP1;STX1A;APP;CCDC47;SEC61G;GET4;VAPA;OTOF;RTP4;STX5;WDR83OS;SEC61B;UBE2J2
prerank,positive regulation of histone deacetylation (GO:0031065),-0.38894332970720474,-0.9615904728373942,0.48434237995824636,0.7838774383359952,1.0,5/12,17.12%,VEGFA;AKAP8;PRKD1;APLNR;CTBP1
prerank,natural killer cell activation (GO:0030101),-0.3329714704019283,-0.9613357077783335,0.5072164948453608,0.783817047875257,1.0,7/23,17.02%,PTPRC;BAG6;PIK3CD;RABL3;CASP8;TOX;ULBP1
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.3693907029501245,-0.9609900381035582,0.518664047151277,0.784113454770027,1.0,3/16,9.72%,ST3GAL4;ETS1;RHOA
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.3354340299921691,0.9608744071895184,0.5009107468123861,0.8744128036582547,1.0,10/36,16.39%,RBBP4;RNF2;MGA;L3MBTL2;RBBP7;E2F6;TFDP2;APAF1;RAD51;UXT
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.3069793452823537,-0.960648334860998,0.5165562913907285,0.7843447529547262,1.0,9/31,14.09%,DLG2;MSN;LIN7A;WDR1;RHOA;SYNJ2BP;MARK2;ERBIN;MTCL1
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.3226043163502281,-0.9605374960437572,0.5102459016393442,0.7840240128678552,1.0,9/25,19.58%,TMTC2;CAV1;KCNA1;GRIN1;MT3;WFS1;ATP13A2;JPH2;ANK3
prerank,macrophage chemotaxis (GO:0048246),0.44007471955111976,0.960289772212036,0.5158562367864693,0.8749730070904705,1.0,3/10,18.00%,TAFA4;CKLF;EDNRB
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.37041483217805443,-0.9596496417102002,0.5373134328358209,0.7855328310539519,1.0,3/15,4.60%,TIAM1;RSPO3;SFRP4
prerank,cellular response to ionizing radiation (GO:0071479),-0.2833135413005931,-0.9595801699057414,0.54,0.785094877751117,1.0,16/47,24.83%,NET1;RPL26;RHOB;EEF1D;CRYAB;SPIDR;TNKS1BP1;RAD9A;LIG4;TLK2;ATR;GADD45A;CDKN1A;TMEM109;HRAS;TSPYL5
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.29704908105049993,0.9591591908985012,0.5264054514480409,0.8769199218739018,1.0,16/66,15.55%,APPL2;PLCB1;UBE2E2;ANXA1;PLK5;DLG1;KANK2;PTEN;RBL2;MYO16;PKD2;CDC73;INO80;CDKN2B;CDK4;HYAL1
prerank,regulation of fibroblast proliferation (GO:0048145),0.3174113817263981,0.95891325260013,0.5211267605633803,0.8766981871162194,1.0,5/45,7.46%,IGF1;PDGFRA;SPHK1;DDR2;NLRC3
prerank,phospholipid biosynthetic process (GO:0008654),-0.30381544103589125,-0.9587417624338287,0.5255813953488372,0.7864350469437587,1.0,6/36,8.86%,SGMS1;SGMS2;MBOAT1;CRLS1;FAR1;CPNE3
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.34403947763410664,-0.9582897953963055,0.508,0.786904680985791,1.0,6/18,13.47%,SHANK3;PTK2B;NRXN1;CACNG3;RELN;CACNG2
prerank,protein tetramerization (GO:0051262),0.29265349119389955,0.9577868468471873,0.5293159609120521,0.8785758539175736,1.0,9/67,11.59%,ALDH1A2;APPL2;UPB1;CBY1;HSD17B10;SSBP1;GOLGA2;OXA1L;PKD2
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.38542396297924614,0.9577788065982706,0.5105973025048169,0.8777828142724794,1.0,3/18,4.07%,ROCK2;RIPOR2;LLGL2
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.3112194991467562,-0.9575036305888452,0.5342465753424658,0.7882022305369779,1.0,5/29,12.04%,BMP5;DAB2IP;IL17RD;SPRED2;SDHAF2
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.2639209684639946,0.9573662877727637,0.5223214285714286,0.8780001838969582,1.0,29/128,16.47%,TGFBR3;BMP6;APPL2;BMP7;SMAD6;PARD3;SLC39A5;SCX;COL1A2;ZMIZ1;PRKCZ;SMAD3;RGMB;GDF1;ARHGEF18;SMURF2;ZFYVE9;BMPR1A;ITGB5;HIVEP1;ZMIZ2;MAP3K7;NLK;FAM83G;SMAD4;CGN;SKI;CDH5;SLC33A1
prerank,regulation of store-operated calcium entry (GO:2001256),0.4430183891451373,0.9572959663830166,0.5,0.8773858491490352,1.0,1/10,1.35%,STIM1
prerank,tRNA aminoacylation (GO:0043039),-0.303669282520631,-0.9571261281679001,0.5197215777262181,0.7884899123247625,1.0,13/37,30.27%,WARS2;LARS2;WARS1;SARS1;YARS1;IARS1;NARS1;EEF1E1;FARSA;CARS1;KARS1;MARS2;GARS1
prerank,cellular protein localization (GO:0034613),-0.2112814851988017,-0.9567273675428036,0.6083650190114068,0.7888466004276335,1.0,59/285,15.03%,ESAM;OCLN;ID1;NSF;TBC1D30;STX3;TBC1D8;REEP1;RAB31;STX7;RABGAP1L;FLNA;STX1A;ZDHHC15;FERMT2;CTNNB1;EHD1;TMED5;ARF5;ADPRH;GRTP1;SCG5;SGSM1;ARF1;STX6;TBC1D8B;TBC1D1;RAB28;TMED2;EMP2;SYNDIG1;SIL1;NAPB;SEPTIN9;HEY2;TBC1D13;CD63;RAB38;FGF7;STX12;LAMTOR1;ABHD17A;HHEX;CEP68;HGS;EVI5;RAB1A;MESD;TBC1D10A;TM9SF3;CD74;ARHGEF2;PICK1;KIF13A;TMED3;TMED10;BICD1;LAMTOR2;RABL3
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.4375352794645223,0.9564923128441174,0.5071868583162218,0.8784900872574731,1.0,2/10,11.86%,JARID2;MYB
prerank,regulation of cilium movement (GO:0003352),0.4276326173737529,0.9564640887951343,0.48367346938775513,0.877748901090563,1.0,4/10,15.39%,DNAH11;CFAP298;CCDC65;ODAD2
prerank,chromatin organization (GO:0006325),0.2656244894765786,0.956057563605326,0.5136363636363637,0.8779092430085895,1.0,36/132,18.07%,SATB1;JARID2;HDAC8;RBBP4;BAZ1B;SOX1;BAZ1A;SETD7;TCF7L1;MTF2;RSF1;KDM5B;KDM6B;HDAC1;TADA2A;SNAI1;SMARCA5;NPM2;SMARCE1;MYB;INO80;SMARCB1;EZH1;KDM5C;SMARCC1;PHF1;SMARCA2;SMARCD3;INO80C;BAZ2B;KDM6A;SETD2;MPND;KDM4D;SMARCA1;HMGN3
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.4058232571497711,-0.955688929872502,0.5117647058823529,0.7907954454655521,1.0,6/11,12.21%,SEMA6A;KLF2;THBS1;CREB3L1;SYNJ2BP;EPN2
prerank,regulation of defense response (GO:0031347),0.28985857587508457,0.9556299003994931,0.5080645161290323,0.8781569103427284,1.0,11/76,10.25%,ADAMTS12;APPL2;ANXA1;LACC1;CASP12;UFL1;SETD6;DAGLB;RNF135;ZBP1;JAK2
prerank,establishment of vesicle localization (GO:0051650),-0.35533713577684967,-0.9549667359874893,0.535031847133758,0.7919975401935777,1.0,4/18,7.40%,RAB27A;SYNJ1;LIMK2;DNM2
prerank,regulation of cell size (GO:0008361),-0.3290251230509006,-0.9548768308373387,0.5346534653465347,0.7915962697990109,1.0,5/23,9.72%,MSN;RAC1;MTOR;EDN1;RHOA
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.3089863512005452,-0.9548379965285491,0.5414012738853503,0.7910675302640313,1.0,13/31,25.19%,HSPA8;ATXN3;DAB2IP;HSPA14;HSPA5;PTPN1;HSPB8;TMBIM6;HSPA9;HDAC6;HSPA1B;ERN1;BAX
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.42919453830825055,0.9547538667693722,0.4894957983193277,0.8793769661804058,1.0,2/10,8.02%,HK2;GFPT2
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.4120667330286442,0.9545546041199076,0.5314401622718052,0.879012271993312,1.0,4/12,14.91%,BRD8;CTSH;MED1;KLF9
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),-0.32759746413254887,-0.954452991885429,0.5063291139240507,0.7913525258981146,1.0,7/26,12.25%,FBXO7;PDE8A;FYN;PPIA;HSPB1;ATF4;REST
prerank,nucleotide-sugar metabolic process (GO:0009225),-0.3952913779447583,-0.9543703925143019,0.5180265654648957,0.7909595973700236,1.0,2/12,1.94%,CSGALNACT1;FUT8
prerank,regulation of catecholamine secretion (GO:0050433),0.3423080570379837,0.9539011601603382,0.5181818181818182,0.879818795721883,1.0,4/29,4.23%,PRKN;DTNBP1;SYT11;SYT12
prerank,positive regulation of macroautophagy (GO:0016239),-0.2844260459210811,-0.9537301319459996,0.5358851674641149,0.7919401930643365,1.0,16/48,23.18%,KDR;SPTLC2;SESN3;SH3GLB1;SESN2;RALB;HSPB8;ADRB2;TRIM13;SMCR8;PINK1;VPS13D;SLC25A4;PIP4K2A;SPTLC1;SCOC
prerank,phosphate-containing compound metabolic process (GO:0006796),-0.22090807223330683,-0.9536141816793215,0.6121794871794872,0.7916060881185647,1.0,55/198,21.05%,PTPRB;PLPP1;CALM1;DUSP16;PLCG2;PLCB4;INPP5D;TNFAIP8L3;SYNJ1;INPP4A;LIMK2;TGFB1;GPX4;NUDT3;PTPRC;PGM2L1;NADK;HK1;ALPL;MTOR;PAK1;PLCB3;PAK2;CERK;NT5C;PIK3CD;LIMD1;GPD2;PPP1CA;DUSP8;NUDT4;DUSP3;TOLLIP;STAT3;PFKM;PPP3CA;ALDOA;INPPL1;PFKP;ITPKB;PLA2G4A;DUSP12;PGP;ALDOC;CLN8;PPM1A;PRKCG;TIGAR;ACP2;CDK5;PFKFB3;LCAT;PANK2;AKT1;MAPK3
prerank,negative regulation of glycolytic process (GO:0045820),0.43380386235102447,0.9532254161927397,0.5219298245614035,0.8798122168797746,1.0,5/10,19.24%,PPARA;NUPR1;PFKFB1;NCOR1;HDAC4
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.43380386235102447,0.9532254161927397,0.5219298245614035,0.8798122168797746,1.0,5/10,19.24%,PPARA;NUPR1;PFKFB1;NCOR1;HDAC4
prerank,histone H3-K9 demethylation (GO:0033169),0.42242120731860205,0.9531891846652154,0.5075268817204301,0.8791072954339608,1.0,3/11,8.91%,KDM7A;PHF8;KDM3B
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.36253019378673795,-0.9527278440683374,0.5069306930693069,0.7930804029381459,1.0,6/17,17.18%,JAG1;CD55;STAT3;MSH2;IL18BP;BTN3A3
prerank,regulation of biomineral tissue development (GO:0070167),0.3530147243953754,0.9524990414907402,0.5218181818181818,0.8799395381045289,1.0,4/26,7.11%,ROCK2;BMP2K;ECM1;DDR2
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.25524543840738,-0.9521228974822548,0.5703324808184144,0.7939115091633351,1.0,27/78,23.66%,CAV1;RNF144B;CBFA2T3;RNF144A;RACK1;TRIB2;NKD2;SOCS5;GSK3B;ZYG11B;RBX1;HERPUD1;CLU;ELOB;BCAP31;ARIH2;COP1;RNF19B;NOP53;RNF19A;USP5;VCP;CEBPA;ARIH1;HSPA1B;SIRT6;TRIB3
prerank,regulation of synapse assembly (GO:0051963),-0.28192351124558723,-0.9520734446947107,0.5566037735849056,0.7934225730576643,1.0,10/46,11.75%,MEF2C;LRFN5;CLSTN2;APP;NRXN1;IL1RAP;SYNDIG1;EIF4G1;EPHB1;CLSTN3
prerank,mitochondrial translation (GO:0032543),-0.2451681286926488,-0.95172553586966,0.5586592178770949,0.7936225083722067,1.0,30/104,26.30%,LARS2;MRRF;GFM1;NDUFA7;MRPL33;MRPL32;MRPS14;MRPL38;ERAL1;MRPS16;MRPL50;MRPL23;MRPS5;MRPL24;MRPS28;MRPS35;MRPL13;MRPL35;MRPL34;MRPS23;MTRF1L;MRPS11;MRPS2;MRPS27;TUFM;MRPS18C;MRPL11;MRPL18;MRPL57;MRPL14
prerank,negative regulation of protein kinase activity (GO:0006469),0.27798366439771377,0.9516652396214326,0.5336463223787168,0.8810870078095814,1.0,8/88,4.71%,PRKAG2;SLC8A3;PDPK1;DEPTOR;SLC8A1;DTNBP1;DUSP10;PPM1E
prerank,defense response to Gram-positive bacterium (GO:0050830),-0.2893602186473613,-0.9514038094503472,0.5361990950226244,0.7937241547133186,1.0,10/40,20.71%,LBP;PGLYRP1;GBP4;DEFA6;CHGA;ROMO1;RNASE3;ANG;MYD88;TIRAP
prerank,regulation of cell communication (GO:0010646),0.3310813766358439,0.9508941825067345,0.532967032967033,0.8821635235073981,1.0,10/35,13.46%,SLC8A1;ANXA1;ANK2;GRK3;IGFBP7;CAMK2D;GRK5;GRK4;TSPYL2;VEPH1
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.41798280314617475,-0.9508683463592236,0.5456389452332657,0.7943976241905502,1.0,1/10,0.19%,PRKCH
prerank,negative regulation of protein localization to membrane (GO:1905476),0.35891368760058373,0.9508236379534186,0.5029239766081871,0.8815417555119934,1.0,2/24,1.84%,PID1;DAB2
prerank,positive regulation of calcium ion transport (GO:0051928),-0.2968867672552687,-0.9507243544954586,0.5321100917431193,0.7941406633261879,1.0,11/36,18.61%,CAV1;TRPC3;TRPC6;WNK3;STIM2;GRIN1;CACNB2;ATP2B1;WFS1;ORAI1;CXCL12
prerank,positive regulation of interleukin-10 production (GO:0032733),-0.3126256503396674,-0.9501877336738105,0.5422993492407809,0.7948333607187988,1.0,6/30,16.66%,CD34;PLCG2;ISG15;STAT3;HSPD1;CD274
prerank,response to hydrogen peroxide (GO:0042542),-0.2797587817381719,-0.9500385969643533,0.5324074074074074,0.7946218729979097,1.0,9/45,9.81%,MAP3K5;FYN;RPS3;NET1;RHOB;SOD1;PDCD10;STK25;PLEKHA1
prerank,hexose metabolic process (GO:0019318),-0.28915327891249265,-0.9499084664503733,0.5242290748898678,0.794340500966607,1.0,15/39,30.12%,APOD;PPARD;HECTD4;HK1;FUCA2;ALDOA;ALDOC;GALT;AKR1A1;FUOM;SLC37A4;GALM;DCXR;GDPGP1;PMM1
prerank,apoptotic mitochondrial changes (GO:0008637),0.3349257066102947,0.9498352252968156,0.5401869158878505,0.8831666466243954,1.0,4/32,6.76%,HK2;BCL2;IFIT2;BNIP3
prerank,negative regulation of phagocytosis (GO:0050765),-0.34827932438852105,-0.9497958771113905,0.5421455938697318,0.7940142157578222,1.0,8/17,26.95%,RACK1;DYSF;APPL1;CD47;PIP4P2;CD300A;FCGR2B;SNX3
prerank,secretory granule organization (GO:0033363),0.4194642334791113,0.9495831347673671,0.5228758169934641,0.8829399971602886,1.0,3/10,11.24%,ABCA1;DTNBP1;F2RL3
prerank,negative regulation of neuron differentiation (GO:0045665),-0.33377058653563507,-0.9493682903381901,0.5323590814196242,0.7944509896977388,1.0,9/22,22.63%,B2M;HES1;CALR;GSK3B;REST;DISP3;SOX2;DLL1;HEY1
prerank,stem cell development (GO:0048864),-0.36432799053451137,-0.9491913172769049,0.5275142314990512,0.794261796220428,1.0,9/16,32.81%,CDH2;PTPRC;NOLC1;SOX11;SNAI2;PEF1;WNT7A;KBTBD8;SHH
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.282460404766309,0.9490219575227936,0.5389507154213037,0.8834987590697603,1.0,12/80,10.32%,AUTS2;DOCK11;DPYSL3;AVIL;RIPOR2;ABI2;WASL;ARHGAP35;EPS8L1;CCL19;WASHC1;PIK3R1
prerank,protein monoubiquitination (GO:0006513),0.3247404900695211,0.9489706822635421,0.5111111111111111,0.8828053999065779,1.0,12/36,21.08%,PRKN;MGRN1;KLHL22;CDC73;RNF20;RAD18;UBE2E1;DTX3L;OBI1;CTR9;KLHL12;PAF1
prerank,regulation of centriole replication (GO:0046599),0.38077026680132864,0.9487868377312425,0.5051124744376279,0.8824663549659351,1.0,2/17,2.61%,SPICE1;ALMS1
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.41727418967530394,0.948389412924395,0.538160469667319,0.8826101912807695,1.0,4/11,13.64%,CTPS2;SLC19A2;ENPP3;THTPA
prerank,regulation of establishment of cell polarity (GO:2000114),0.3903561701746315,0.9482310862023229,0.5206286836935167,0.8822157756962928,1.0,2/16,3.68%,ROCK2;RIPOR2
prerank,response to insulin (GO:0032868),0.2833325909380642,0.9481487138612356,0.5557324840764332,0.8816057683865931,1.0,13/80,10.49%,PDPK1;SORBS1;INSIG2;FER;RAB13;PCSK9;CPEB2;SYAP1;TBC1D4;SLC27A1;PIK3R1;PRKDC;RPS6KB1
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.4004244062074258,0.9479276826323603,0.5295315682281059,0.881311274853309,1.0,2/15,3.77%,FGFR2;PDGFRA
prerank,response to estradiol (GO:0032355),0.3327004625806715,0.947735317792878,0.546448087431694,0.8809962075698693,1.0,6/31,7.88%,ANXA1;STAT5B;CRHBP;SSTR2;NCOA3;STRN3
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.39405188229199295,-0.94748067337046,0.518664047151277,0.7977211052896088,1.0,7/11,39.98%,TIRAP;TNFAIP3;TREM2;TLR6;MFHAS1;TLR1;PJA2
prerank,positive regulation of neuron projection development (GO:0010976),0.2785967387610507,0.9474174217666952,0.5478806907378336,0.8808933721731796,1.0,10/85,6.99%,PTK7;EPHA3;BMP7;CAMK1D;DPYSL3;AVIL;NDNF;PLK5;PTN;ARHGAP35
prerank,high-density lipoprotein particle assembly (GO:0034380),0.42628941475557197,0.9473343313714776,0.5032537960954447,0.8803102454976197,1.0,2/10,13.70%,ABCA1;PRKACB
prerank,cellular response to chemical stress (GO:0062197),-0.24269038715825358,-0.947231397608969,0.5837696335078534,0.7977523212948702,1.0,34/96,27.96%,CAV1;PRR5L;LRRC8D;PPARGC1A;PPIA;ATG7;CHCHD2;SOD1;FOXO1;SESN2;ATF4;VKORC1L1;GSR;ERO1A;MT3;FAS;PRKD1;CYBB;ATP13A2;STX2;ZC3H12A;PINK1;GPX7;PYROXD1;CYCS;HSPA1B;PYCR2;PRDX6;CAT;TRPV4;GPX3;PRDX1;KEAP1;GPX8
prerank,negative regulation of cell projection organization (GO:0031345),0.3033739315522749,0.9469800225451664,0.5440140845070423,0.880373353006497,1.0,6/48,7.47%,EFNB2;LPAR1;DPYSL3;EPHA4;PTPN9;PTEN
prerank,lipoprotein localization (GO:0044872),0.4293167685999564,0.9469619565298104,0.5257731958762887,0.8796235113171168,1.0,3/11,7.97%,PRKCB;ZDHHC3;MIA3
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.4064844851845268,0.9465907706419903,0.5270541082164328,0.8797154038635625,1.0,4/13,14.36%,PPARA;NFIB;NFATC4;SRF
prerank,positive regulation of immune effector process (GO:0002699),-0.3183522982114016,-0.9464411440034564,0.5413043478260869,0.7990533895921953,1.0,6/27,12.71%,PTPRJ;LBP;RPS19;PTPRC;XBP1;CD81
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.2689151557537853,-0.946190782937445,0.5420560747663551,0.7990639558093245,1.0,12/55,14.75%,CAV1;DAB2IP;RACK1;RPS3;TNFSF10;TPD52L1;BCL2L1;PAK2;GPER1;BBC3;FAS;BCAP31
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.37026781376009604,0.945610540966867,0.51953125,0.8812999079951797,1.0,4/21,10.75%,SLC8A3;MAIP1;MCU;MICU1
prerank,response to thyroid hormone (GO:0097066),0.4015970150477778,0.9450635671257659,0.5249500998003992,0.8817942516811228,1.0,3/13,10.09%,BRD8;CTSH;MED1
prerank,positive regulation of innate immune response (GO:0045089),-0.30803627805764316,-0.9449235026130339,0.5688487584650113,0.8015398082269128,1.0,13/30,31.95%,LBP;RPS19;NLRC5;GBP5;IFI35;SPI1;POLR3D;POLR3F;SLC15A4;FADD;MAVS;DHX9;PLA2G5
prerank,positive regulation of neuroblast proliferation (GO:0002052),-0.4129761075187139,-0.9448984455143785,0.5626204238921002,0.8010042516072953,1.0,4/10,15.67%,CTNNB1;VEGFA;CX3CR1;DISC1
prerank,cellular response to calcium ion (GO:0071277),0.28768802772894203,0.9448422765949098,0.5560975609756098,0.8815350020848289,1.0,11/67,11.59%,ADGRV1;ADCY1;CRHBP;SYT11;SYT12;PRKAA2;PRKAA1;CAMK2D;CPNE4;NEUROD2;PKD2
prerank,rRNA modification (GO:0000154),-0.33796250962242524,-0.9441389381552836,0.520746887966805,0.80215444670136,1.0,8/21,21.37%,TFB2M;BUD23;FBL;TSR3;NSUN4;MRM2;THUMPD1;NHP2
prerank,lipid biosynthetic process (GO:0008610),0.28506258532480183,0.9433923093414804,0.5349593495934959,0.8841941810454128,1.0,8/77,7.73%,AGPAT4;ACSL1;HSD17B1;FDXR;PRKAA2;LIPC;LIPH;PRKAA1
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.23548086322737152,0.9433066870404521,0.5834411384217335,0.8836002055227288,1.0,61/327,15.86%,RORA;EFEMP1;ARNT2;DENND4A;ATXN1;TULP3;ESRRG;MYBL1;NR1I2;SOX6;PPARGC1B;NFYB;SSBP2;IGF2;NCOA2;SOX1;PERM1;ZMIZ1;SUFU;ZFP37;TCF7L1;WWC1;THAP1;UBE2L3;GPBP1;WWC2;GPBP1L1;MTF2;ZKSCAN5;POLR2A;MITF;NFIA;ZNF628;KAT6B;BRCA2;NSD1;NUP107;NFYC;ABL1;ASCC2;ZBTB11;ZBTB38;RNF14;MYB;NONO;RNF20;FOXK2;SOX13;PSPC1;CLOCK;CREBBP;NLK;UBE2V1;PCGF1;BACH1;PATZ1;SOX12;PHF1;SMARCA2;ZNHIT3;FZD7
prerank,negative regulation of cellular catabolic process (GO:0031330),0.2927939866885736,0.9431607709690338,0.5435897435897435,0.8831833091127896,1.0,13/63,12.66%,LEPR;TIMP3;BCL2;ATRAID;NUPR1;APOC1;WASHC1;RIC1;GOLGA2;KLHL22;PTPN3;RUBCN;FOXK2
prerank,interleukin-27-mediated signaling pathway (GO:0070106),-0.38940939300458316,-0.9431310532867205,0.5340909090909091,0.8040135466940039,1.0,6/13,28.01%,STAT3;OAS2;CANX;JAK1;STAT1;OASL
prerank,cellular response to dsRNA (GO:0071359),0.402855521069639,0.9428557153643516,0.5093632958801498,0.8831188808503575,1.0,1/15,0.42%,COLEC12
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.25999595555091387,0.9424158363173936,0.5540123456790124,0.8834236299682142,1.0,27/148,16.48%,PRKAG2;PRKAG3;PDPK1;ATRIP;MAP2K6;RBBP4;RICTOR;PRKAA2;RBBP7;BANP;BLM;CHD4;PRKAA1;USP7;CDK1;MDM2;HDAC1;MLST8;TAF3;PRKAG1;TTC5;MRE11;JMY;BRIP1;WRN;BOP1;PML
prerank,integrated stress response signaling (GO:0140467),-0.3691810725872908,-0.9422210168459904,0.5333333333333333,0.8055423424567753,1.0,3/14,12.81%,HSPA5;ATF4;HERPUD1
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.4286320200103908,0.941777621799842,0.5313807531380753,0.8841414605092599,1.0,4/10,15.71%,KMT2A;SMARCB1;RAPGEF3;SMAD4
prerank,7-methylguanosine mRNA capping (GO:0006370),0.34223580864892844,0.9416728259673185,0.5442307692307692,0.8828311054477336,1.0,4/31,8.29%,POLR2D;CDK7;POLR2A;GTF2F1
prerank,7-methylguanosine RNA capping (GO:0009452),0.34223580864892844,0.9416728259673185,0.5442307692307692,0.8828311054477336,1.0,4/31,8.29%,POLR2D;CDK7;POLR2A;GTF2F1
prerank,regulation of cation channel activity (GO:2001257),-0.24681868960811293,-0.9416374712270116,0.6005089058524173,0.8063253357314145,1.0,27/89,19.58%,MEF2C;PDE4D;DLG2;CALM1;SLMAP;ITGB1;AHNAK;PTK2B;MINK1;HOMER1;KCNAB1;APP;CACNG3;RELN;NOS1;GRIN1;CACNB2;JPH4;CACNG2;FGF14;CAMK2B;CALM2;GRIA2;CACNB3;CNIH3;JPH2;ANK3
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.34870833211456115,0.9416359192233389,0.5597014925373134,0.8821237082387916,1.0,6/27,10.58%,PID1;GRB10;PRKCZ;PRKCB;RPS6KB1;TNS2
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),-0.25596589106779005,-0.941608812140102,0.5742574257425742,0.8058025833154278,1.0,27/72,28.60%,UBB;UVSSA;COPS7A;UBC;RPS27A;PPIE;RBX1;DDB1;RPA1;ERCC8;POLR2C;XAB2;UBA52;COPS8;POLR2G;POLK;COPS6;POLD3;POLD1;GTF2H2;POLR2L;ERCC5;XPA;HMGN1;RFC5;ERCC3;LIG3
prerank,negative regulation of lymphocyte activation (GO:0051250),-0.3389614153316981,-0.941511982094181,0.5726681127982647,0.8054439920594146,1.0,12/21,32.96%,DUSP3;SAMSN1;LAPTM5;JAK3;SOX11;FCGR2B;TNFAIP3;FOXJ1;LAX1;IL4I1;PTPN22;GPNMB
prerank,cellular response to oxidative stress (GO:0034599),0.26725208514243165,0.9412116353946604,0.5541984732824428,0.882370478494174,1.0,24/118,13.30%,TPM1;DAPK1;PLA2R1;SOD3;FER;PDGFRA;MAPK9;CPEB2;LRRK2;PRKAA2;MSRA;MMP9;PRKAA1;ARNT;TXNRD1;TXNRD2;VRK2;ABL1;CCS;PKD2;EIF2S1;ADNP2;NCF2;MAPK1
prerank,B cell proliferation (GO:0042100),-0.35337759022229603,-0.9412019978285664,0.5375494071146245,0.8055731441951108,1.0,6/17,19.46%,MEF2C;PTPRC;CD180;HSPD1;CR2;CD40
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),-0.2464082188688694,-0.94098087503206,0.5788043478260869,0.8055330619787376,1.0,28/85,23.66%,RNF144B;CBFA2T3;ATXN3;DAB2IP;RNF144A;RACK1;TRIB2;NKD2;BAG6;SOCS5;GSK3B;ZYG11B;RBX1;PSMC3;CLU;ELOB;ARIH2;COP1;RNF19B;NOP53;RNF19A;USP5;FMR1;VCP;CEBPA;ARIH1;HSPA1B;TRIB3
prerank,positive regulation of interleukin-17 production (GO:0032740),0.3631697897017948,0.9408964078897908,0.503030303030303,0.8823263227647387,1.0,4/22,8.76%,IL18;SPHK1;IL6;SLAMF6
prerank,regulation of stem cell proliferation (GO:0072091),0.3792975088055709,0.9406622040072196,0.5432595573440644,0.8821100197430728,1.0,3/17,5.50%,GJA1;FBLN1;ACE
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.4038244061213443,0.9405247223112837,0.5335968379446641,0.881638379374976,1.0,5/12,7.97%,PLCB1;SLAMF8;WASL;NBL1;MIA3
prerank,positive regulation of intracellular protein transport (GO:0090316),-0.22884118395206446,-0.940319538072973,0.6149253731343284,0.8065276228654397,1.0,57/144,27.94%,PRR5L;GAS6;CDH1;PPP1R13B;SREBF2;FYN;SH3GLB1;KCNB1;FLNA;TGFB1;YWHAB;NMT1;GSK3B;CHP1;PDCD10;ZDHHC2;C2CD5;MAPK8;TMEM30A;OAZ1;YWHAG;MIEF1;RIPOR1;CD81;JUP;MTCL1;MIEF2;BBC3;ARIH2;VPS11;CASP8;YWHAQ;YWHAH;ZC3H12A;PINK1;PPP3R1;ANK3;PSEN1;PRKCD;RBM22;SEC16B;HYAL2;HUWE1;TOMM7;ZPR1;HRAS;SORL1;RNF31;PPP3CC;ABLIM3;YWHAZ;MICALL2;ITGB2;SEC16A;BID;PCM1;FIS1
prerank,histone H4-K5 acetylation (GO:0043981),-0.3591278176411184,-0.9402320221268736,0.5469061876247505,0.8055270213163976,1.0,5/15,16.54%,ING4;OGT;JADE1;KANSL3;WDR5
prerank,histone H4-K8 acetylation (GO:0043982),-0.3591278176411184,-0.9402320221268736,0.5469061876247505,0.8055270213163976,1.0,5/15,16.54%,ING4;OGT;JADE1;KANSL3;WDR5
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.3085235321213341,0.9401897718394574,0.5199306759098787,0.8816904991515441,1.0,5/41,7.72%,ITPR1;SLC8A3;SLC8A1;CACNA2D1;CCL19
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.39439054724569045,0.9399591466156346,0.525,0.8814975964572029,1.0,3/13,12.89%,BMP7;NAPEPLD;SOX13
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.3768780916009006,0.9394250684738981,0.5295238095238095,0.8820248759228062,1.0,5/18,12.23%,ADCY1;CAMK1D;PRKD2;CRTC3;CRTC1
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.40115682462498525,-0.9393941570963613,0.5611650485436893,0.806875778360251,1.0,4/11,11.74%,TJP2;F11R;TJP1;RAB1A
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.4188951720676326,0.9389328107491568,0.535031847133758,0.8824321521355093,1.0,1/11,2.87%,NOS1AP
prerank,monoacylglycerol metabolic process (GO:0046462),-0.3799360144750352,-0.9387880029214041,0.5593561368209256,0.8076962458050254,1.0,4/13,19.73%,MGLL;DGAT1;PLA2G4A;ABHD6
prerank,positive regulation of viral process (GO:0048524),0.2944908455374932,0.9386500303320507,0.5374592833876222,0.8822787624395271,1.0,11/60,11.40%,PPARA;POLR2D;SRPK2;HACD3;RSF1;CCNT1;POLR2A;GTF2F1;PKN2;AXL;TMEM39A
prerank,regulation of translational initiation (GO:0006446),-0.2609878203028595,-0.9382565464189923,0.556390977443609,0.808332899125191,1.0,22/63,24.58%,HSPB1;NCK1;EIF1B;EIF4G3;EIF4G1;ATF4;NCK2;YTHDF3;EIF4H;EIF3B;EIF2B5;POLR2G;EIF2B2;EIF1;ATF3;EIF5B;UHMK1;EIF4B;FMR1;CEBPB;PPP1R15B;EIF5
prerank,embryonic hemopoiesis (GO:0035162),-0.3802081093961408,-0.9379067231777423,0.555992141453831,0.8085339287922508,1.0,5/12,11.15%,KITLG;KDR;TGFBR2;ATF4;TAL1
prerank,blood vessel diameter maintenance (GO:0097746),0.3287499890548045,0.9376285864275553,0.5359116022099447,0.8839474417786092,1.0,4/34,6.13%,ROCK2;BDKRB2;ACE;SCPEP1
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.37533363238843176,0.9371687921570607,0.566793893129771,0.8842419037635647,1.0,2/17,1.18%,RBPJ;NOTCH2
prerank,ovarian follicle development (GO:0001541),-0.376665931192149,-0.937039364423855,0.5564681724845996,0.809983908120251,1.0,8/13,22.49%,SOD1;VEGFA;EIF2B5;EIF2B2;FOXL2;INHA;ANG;CEBPB
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.3295831880493725,0.9369096283488961,0.5492227979274611,0.8840825829456648,1.0,10/34,11.54%,KIT;PDGFRB;EPHA8;PDGFRA;CCL19;ATG14;PIK3R4;WASHC1;PIK3R1;RUBCN
prerank,in utero embryonic development (GO:0001701),0.34907500495110794,0.936324584758788,0.5416666666666666,0.8847130970998287,1.0,3/25,3.59%,ARNT2;FGFR2;IGF2
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.38723491914808716,-0.935771989658577,0.5610687022900763,0.8123862044889686,1.0,4/12,14.18%,PROM1;VEGFA;STAT3;RORB
prerank,long-chain fatty acid metabolic process (GO:0001676),0.29235427071178055,0.9356832695912014,0.5449915110356537,0.8854735884777735,1.0,13/64,14.50%,ACSL1;GSTM2;PLA2G10;ACOT4;ACADL;CPT2;EPHX2;DAGLB;ACOX1;ACOT1;PLA2G4B;PLA2G4C;HACL1
prerank,bile acid biosynthetic process (GO:0006699),0.35052988736101437,0.9355566152582553,0.5276190476190477,0.8850216918420682,1.0,2/24,5.83%,CYP27A1;HSD17B10
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.3054960837883429,0.9350873819906375,0.5581787521079258,0.8853951178206791,1.0,22/52,23.38%,POLR2D;EXOSC8;RC3H2;SAMD4A;CNOT2;DCP2;LSM5;PARN;CNOT7;CNOT8;EXOSC3;CNOT10;TUT4;LSM3;LSM1;DDX6;LSM4;PDE12;TUT7;EXOSC4;LSM6;DCP1B
prerank,histone mRNA catabolic process (GO:0071044),0.3894055935351231,0.9350177027760783,0.5358490566037736,0.8847881384998536,1.0,9/15,22.48%,TENT2;DCP2;TUT1;ERI1;TUT4;LSM1;XRN1;TUT7;EXOSC4
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.30975878906130516,0.9349445898830554,0.5526770293609672,0.8841885145610436,1.0,4/46,6.95%,TCF7L2;ZIC1;NEDD4;SMAD3
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.32346812398554387,-0.9348390690319792,0.5625,0.8139603020451422,1.0,8/22,18.12%,UBB;EDEM3;UBC;RPS27A;MAN1A2;UBA52;TRIM13;RNF5
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.40825296741285966,0.934443083571607,0.5491452991452992,0.8845679796784948,1.0,2/13,1.13%,PPARA;PID1
prerank,male gonad development (GO:0008584),0.32119856460878454,0.9338439824690012,0.5412186379928315,0.8851596597075281,1.0,3/34,5.93%,WNT4;KIT;LRP2
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.3875215847351129,0.933521942945235,0.5634920634920635,0.885168743850129,1.0,2/16,2.75%,WNT4;SCX
prerank,cellular response to nutrient levels (GO:0031669),-0.26215549776105074,-0.9333592943189825,0.5845410628019324,0.8167499822673843,1.0,15/62,12.39%,HSPA8;SREBF2;BMPR2;KCNB1;ATG7;FAM107A;MAP1LC3B;MTOR;MFSD2A;FOXO1;EIF4G1;RALB;XBP1;PDK2;RIPOR1
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.2960703953852717,0.9331205472734507,0.5641447368421053,0.8853691460271725,1.0,5/56,4.94%,RAD51B;PLCB1;UBE2E2;ANXA1;RAD51C
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.36711595939256086,0.9329114325859987,0.5553398058252427,0.8850951983712593,1.0,3/19,6.45%,PARD3B;PARD3;DLG1
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.33992794881723054,0.9326607715595366,0.5627306273062731,0.8849187930078599,1.0,4/27,5.05%,SLC22A2;SLC6A9;SLC1A3;SLC25A18
prerank,action potential (GO:0001508),0.3114648499738608,0.9325232237675042,0.5436363636363636,0.8844494015142089,1.0,2/44,1.56%,SCN7A;DMD
prerank,regulation of humoral immune response (GO:0002920),0.30869531700586383,0.9321677164692039,0.5501730103806228,0.8844770352704759,1.0,7/44,11.62%,PROS1;CXCL13;C2;CFH;VTN;C8B;C8G
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.2863150942217442,0.9320897265830814,0.5336617405582923,0.8839174914517801,1.0,14/67,14.73%,DCDC2;ODAD3;FER;PLD1;TBC1D9B;SDCCAG8;CAPZB;EPHA2;FXR1;TBC1D19;CYLD;IFT140;CDKL5;ATG3
prerank,hexose biosynthetic process (GO:0019319),0.3101758629209032,0.9311749162036175,0.5509838998211091,0.8852810375443702,1.0,9/42,14.25%,RBP4;SORD;SLC25A11;CHST15;CRY1;AKR1B1;ENO2;PFKFB1;GPI
prerank,positive regulation of translational initiation (GO:0045948),0.370201474063295,0.9311482683312602,0.5254237288135594,0.8845713407851564,1.0,7/18,18.91%,POLR2D;CDC123;YTHDF2;RPS6KB1;BOLL;LARP1;DDX3X
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.3111615071409848,0.9311441281669751,0.5482233502538071,0.8838122531609214,1.0,16/43,21.35%,CDC14B;HUS1B;MRNIP;BLM;CDK1;CLSPN;RINT1;MRE11;BABAM2;CHFR;BRSK1;TAOK3;TRIM39;TAOK2;UIMC1;NBN
prerank,positive regulation of stem cell proliferation (GO:2000648),-0.3532050342529842,-0.9309184823786709,0.5531496062992126,0.8219862957909021,1.0,3/17,7.23%,FERMT2;PTPRC;HNRNPU
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.393437350533304,0.9305043309622202,0.5490981963927856,0.8845569116640549,1.0,4/14,13.19%,EHHADH;ECI2;AMACR;ACOX1
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.23434422822123588,0.9304379498495248,0.6272108843537415,0.8839406312465012,1.0,39/259,10.78%,DCDC2;ASAP1;KIT;FGD4;RHOD;MYLK;INTU;AVIL;RAB3IP;ARL3;DYNC2H1;CDC14B;CCDC57;IFT80;PMP22;CC2D2A;ARMC9;CEP19;TTC8;WDR19;UBXN10;WDR35;KIF27;WDPCP;ARL6;IQCB1;NTN1;MTSS1;TCTN1;TEKT2;PARVA;ATP6V0D1;BBS7;SCLT1;CEP89;WDR11;FBF1;OFD1;RAP2A
prerank,morphogenesis of an epithelium (GO:0002009),-0.31503873239222907,-0.9302794596605105,0.5582959641255605,0.8228834438087774,1.0,4/25,5.96%,ACTB;ACTG1;LAMA5;LAMA3
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.3589917601495414,-0.930028000997659,0.5719844357976653,0.8228868693190261,1.0,7/15,13.64%,MVB12B;PTPN12;LGMN;CEACAM1;RHBDF2;CDH13;MVB12A
prerank,regulation of filopodium assembly (GO:0051489),-0.288488221359667,-0.9299281833964415,0.5797752808988764,0.8225075298265293,1.0,6/38,4.03%,MYO10;FNBP1L;AGRN;TENM2;PPP1R16B;PALM
prerank,negative regulation of interferon-gamma production (GO:0032689),-0.32368201591084567,-0.9299064797921619,0.533066132264529,0.8219425304983075,1.0,8/23,27.67%,GAS6;LAPTM5;CD274;ZC3H12A;NR1H4;INHA;VSIR;TLR4
prerank,spermatid development (GO:0007286),0.3279679528171976,0.9299030950728747,0.5674157303370787,0.8844827249235462,1.0,6/32,14.66%,GALNTL5;ZMYND15;NME5;CEP57;CIB1;NECTIN2
prerank,regulation of presynapse organization (GO:0099174),0.36460407255805827,0.9297216090381816,0.5122448979591837,0.8834007965823516,1.0,7/18,18.92%,GPC6;IL1RAPL1;PTPRD;GPC4;VPS35;SNCA;MDGA1
prerank,regulation of presynapse assembly (GO:1905606),0.36460407255805827,0.9297216090381816,0.5122448979591837,0.8834007965823516,1.0,7/18,18.92%,GPC6;IL1RAPL1;PTPRD;GPC4;VPS35;SNCA;MDGA1
prerank,sulfur amino acid catabolic process (GO:0000098),0.4225947297257858,0.9297178118246696,0.5384615384615384,0.882654378788001,1.0,1/10,2.13%,CBS
prerank,cellular response to estrogen stimulus (GO:0071391),-0.3635339002583964,-0.9294144318642729,0.5745526838966203,0.8225674983687513,1.0,5/14,14.95%,SERPINB9;ARID5A;WBP2;SFR1;NCOA4
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.27836019614207175,0.9293651487613598,0.5724020442930153,0.8827328327174078,1.0,9/76,7.72%,SASH1;C1QTNF3;BMP7;NFAT5;SPHK1;UACA;DLG1;NLRC3;CCL19
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.21040649545624487,-0.929343670392704,0.6802973977695167,0.8221233714681551,1.0,58/241,20.83%,HSPA8;NOVA2;HNRNPK;SRSF2;PABPC1;SRSF1;HNRNPU;HNRNPA3;PPWD1;SFPQ;PPIE;YBX1;SF3B1;SF3B2;DDX5;CPSF7;RBM14;PHF5A;SRSF5;DDX39B;CPSF3;RALY;SRSF9;CWC15;HNRNPH2;USP39;RBM8A;POLR2C;XAB2;SNRPC;PRPF40B;RNPS1;SRSF6;SF3B5;FUS;HNRNPA0;SYMPK;CLP1;PRPF4;POLR2G;CPSF2;CSTF2;SPEN;PCBP1;CSTF2T;PCF11;ESS2;YTHDC1;GTF2F2;MTREX;HNRNPUL1;PTBP1;RBM17;MAGOH;CTNNBL1;METTL3;SNIP1;RBM22
prerank,regulation of protein kinase activity (GO:0045859),0.265970361193774,0.9290763629982135,0.5897435897435898,0.8826680756264752,1.0,14/106,9.08%,PRKAG2;PDPK1;DEPTOR;ALS2;DTNBP1;PPM1E;MRNIP;SNX9;GNAQ;DDR2;XRCC5;CCL19;CSF1;UVRAG
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.3541409643353645,0.929075683919655,0.5616438356164384,0.8819133885827667,1.0,4/20,10.27%,NR2F2;PTEN;CDK5RAP1;LATS1
prerank,regulation of primary metabolic process (GO:0080090),0.25652614727011264,0.9289036020951835,0.602919708029197,0.8815529735462928,1.0,18/126,11.77%,ROCK2;FGFR4;PPARA;TBL1XR1;NFYB;OAZ3;NCOA2;PSME4;PSMA2;CHD9;PSMA3;PMVK;PSMD8;MED1;NFYC;PSMD3;RXRA;FDPS
prerank,negative regulation of protein transport (GO:0051224),-0.31787749963875245,-0.9288354957153915,0.5539112050739958,0.8226372869187542,1.0,9/25,28.98%,CSK;RHBDF2;NDFIP2;RSAD2;CYP51A1;NDFIP1;SNX3;PPM1F;HMGCR
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.33542201544130423,-0.9287872890336227,0.5557768924302788,0.8221196672589519,1.0,12/20,27.94%,TGM2;ATP2A2;CCDC47;KCTD17;SELENOK;HERPUD1;BCAP31;WFS1;PSEN1;RAP1GDS1;BAX;FIS1
prerank,positive regulation of cellular process (GO:0048522),0.22278084638954504,0.9287359728651374,0.6741176470588235,0.8811908614613692,1.0,83/565,13.69%,IL31RA;IGF1;BMP6;COLEC12;IL34;FGFR2;FGFR4;EFNB2;TPM1;MEIS1;RHOD;BCL2;CAMK1D;CCN2;PARD3;DKK1;SCX;PDGFRB;CTSH;FER;PDPN;IGF2;PDGFRA;SRPK2;EPHA4;ITGAX;IL13RA1;TULP1;ASH2L;SPHK1;UFL1;PTN;PRKAA2;PDGFD;FGF1;IGF1R;TET1;TTK;CDC123;ECHDC3;ADRA1D;PRKCA;IL6;FOLR2;PTEN;PRKAA1;CSF1;LYAR;BIRC5;RPRD1B;GRK5;COX17;SIRPA;NUPR1;MDM2;AXIN2;FGF9;IER5;HDAC1;FGF20;PHIP;CST7;FLCN;KLHL22;TNFSF13;TFAP2B;PRKD2;ERBB2;FXR1;INO80;PRODH;ADNP2;TGFA;AREG;AR;HSF1;GAB2;S100A9;DICER1;GDNF;P4HB;MEIS2;PRTN3
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.3365832591531508,0.928606539452282,0.5480225988700564,0.8807152994872246,1.0,4/29,8.85%,TERB2;HORMAD1;TEX11;MAJIN
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.3317320380773867,0.9284178821068092,0.5526802218114603,0.8803937964651097,1.0,5/30,8.44%,ROBO1;LPAR1;AKAP13;ABRA;F2RL2
prerank,intrinsic apoptotic signaling pathway (GO:0097193),-0.23762404773161655,-0.9284140743361579,0.6202185792349727,0.8223749040048318,1.0,36/94,27.32%,MAP3K5;FNIP2;PPP1R13B;DAB2IP;TMEM117;CRIP1;BCL2L1;BAG6;TNFRSF1B;ATP2A3;CUL3;DDX5;CHEK2;ATF4;HINT1;SELENOK;MYBBP1A;PDK2;ERO1A;BBC3;CUL1;DNAJC10;TNFRSF10B;PRKCD;CYP1B1;CDKN1A;CEBPB;BRSK2;TRIB3;CUL2;PPP1R15A;ERN1;BAX;SCN2A;ARL6IP5;PPM1F
prerank,metallo-sulfur cluster assembly (GO:0031163),-0.32450061240448264,-0.9282224206620789,0.5711159737417943,0.822217401302821,1.0,11/22,39.48%,ISCU;CIAPIN1;GLRX5;HSCB;ISCA2;HSPA9;ISCA1;CIAO2B;NFS1;NUBP1;NUBP2
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.3604618676762772,-0.9278132529931891,0.5536062378167641,0.8225835071056253,1.0,8/14,43.23%,TFRC;KMT5C;SHLD3;SHLD2;RIF1;CD226;KMT5B;MAD2L2
prerank,transferrin transport (GO:0033572),-0.29798576867912935,-0.9274984101752606,0.5635964912280702,0.8227000284044351,1.0,14/33,25.00%,TFRC;ATP6V0A1;DNM2;ATP6V1A;ATP6V0C;LMTK2;ATP6V1E1;TCIRG1;ATP6V0A4;ATP6V0A2;ATP6V0D2;ATP6V0E2;ATP6V1B2;MCOLN1
prerank,extrinsic apoptotic signaling pathway (GO:0097191),-0.2501105082959111,-0.9273576869158343,0.6274509803921569,0.8224074231859113,1.0,10/70,9.08%,TGFB2;DAB2IP;NGF;BLOC1S2;TGFB1;DCC;BCL2L1;GSK3B;TNFRSF1B;APPL1
prerank,non-canonical Wnt signaling pathway (GO:0035567),-0.22942547459208296,-0.927171966635378,0.646875,0.8221890243805098,1.0,30/124,15.39%,LEF1;TIAM1;RAC1;CALM1;FZD4;ROR2;SFRP4;AP2A2;FZD6;NFATC1;CTNNB1;ARHGEF19;PSMD13;AP2M1;PLCB3;PSMF1;RHOA;PSMB10;VANGL2;PSMB6;PSME3;PSMB5;PSMC3;PPP3CA;PSMD12;PSMB8;PSME1;CCDC88C;TNRC6C;PSMB3
prerank,protein-containing complex assembly (GO:0065003),0.23685864892905692,0.9270372603524346,0.6352785145888594,0.8829081659532111,1.0,59/259,16.81%,TCF7L2;PLEKHA7;AFDN;KMT2A;DMD;FANCA;PARD3;SH3PXD2B;PYGO1;TEAD1;ASH2L;WASF1;LRRK2;TLE3;WASL;SNX9;TCF7L1;CDC123;CAND1;WDR19;PDCD6;NOL3;F5;BLM;FOLR1;WASF3;MCU;TLE1;MITF;MDM2;PICALM;AXIN2;GSDMD;TUBGCP2;GOLGA2;HDAC1;BCL9;LLGL1;DLG4;CDC73;DNAJB12;TGFA;SAR1B;AREG;HSF1;CREBBP;TRAPPC10;MNAT1;NIFK;CX3CL1;RANBP9;AXIN1;F8;FANCC;SEC24A;PML;CAND2;CSNK1A1;ZNHIT6
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.38349192492952583,0.926894339570765,0.5229007633587787,0.8825107701837984,1.0,5/16,10.22%,PDGFRB;FER;PDGFRA;PDGFD;ABL1
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.36626506040119644,0.9268537368941203,0.5515873015873016,0.8818498217968282,1.0,2/20,1.84%,PID1;DAB2
prerank,negative regulation of interleukin-6 production (GO:0032715),0.33429652047427366,0.9267681415329242,0.5463320463320464,0.8812874663935102,1.0,7/27,15.66%,C1QTNF3;SYT11;NLRC3;SIRPA;NLRP12;CX3CL1;CD200R1
prerank,blood vessel endothelial cell migration (GO:0043534),0.3547113421519842,0.9267006576480789,0.5452830188679245,0.8806746923502068,1.0,2/22,1.17%,ROBO1;EFNB2
prerank,regulation of ruffle assembly (GO:1900027),0.35076489568996483,0.9265960906891165,0.5294117647058824,0.8801702216563847,1.0,1/23,0.18%,ARHGAP24
prerank,lipid droplet formation (GO:0140042),-0.3888842914910052,-0.9262712890030219,0.5717017208413002,0.8236672904130493,1.0,3/10,17.63%,CDS1;BSCL2;AUP1
prerank,fluid transport (GO:0042044),-0.38115599279587775,-0.9261002554658204,0.5374015748031497,0.8234689743414175,1.0,3/12,11.51%,AQP11;AQP4;SLC26A6
prerank,positive regulation of lipid kinase activity (GO:0090218),0.3394775770367013,0.9260201546905343,0.565587734241908,0.8807941905789893,1.0,7/29,8.65%,KIT;PDGFRB;EPHA8;PDGFRA;CCL19;ATG14;PIK3R4
prerank,global genome nucleotide-excision repair (GO:0070911),-0.3154964776977318,-0.9259874586730051,0.5680345572354212,0.8231195984930296,1.0,10/26,27.96%,UBB;UBC;RPS27A;RBX1;DDB1;UBA52;CETN2;GTF2H2;XPA;ERCC3
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.33726428949305676,0.9254753729811213,0.5737704918032787,0.8813482635612615,1.0,5/30,8.84%,KIT;HOXB4;UFL1;ACE;FSTL3
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.43795078699908985,0.925218681251984,0.5466101694915254,0.8812143789944177,1.0,2/10,4.01%,LPGAT1;SLC45A3
prerank,acyl-CoA biosynthetic process (GO:0071616),-0.34971479690956603,-0.9251757025699251,0.5671641791044776,0.8244335667033806,1.0,11/16,44.50%,ACACA;FASN;ACLY;SCD5;SCD;HSD17B8;SLC25A1;MLYCD;PPT2;DIP2A;ACSS1
prerank,cell differentiation in hindbrain (GO:0021533),-0.3869330139880174,-0.9243926518674828,0.5678776290630975,0.8256514477496065,1.0,6/11,32.71%,KNDC1;GRID2;AGTPBP1;FAIM2;PROX1;NOG
prerank,actomyosin structure organization (GO:0031032),0.2794442971552378,0.9243631029700129,0.5805921052631579,0.882561253379391,1.0,9/75,6.59%,ROCK2;TPM1;CSRP3;SORBS1;FRMD6;TNNT2;EPB41L5;FAM171A1;MYO18A
prerank,regulation of protein import into nucleus (GO:0042306),-0.29140158228668944,-0.9243018517600534,0.5869074492099323,0.8252715262778269,1.0,14/36,24.09%,APOD;CDH1;FLNA;TGFB1;CHP1;JUP;ZC3H12A;BMP4;MDFIC;PSEN1;PRKCD;RBM22;HYAL2;ZPR1
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.27229161787970735,-0.9238868170692716,0.596244131455399,0.8256343291340471,1.0,17/49,27.94%,CAV1;SGMS1;RACK1;BCL2L1;RTKN2;NDUFA13;HERPUD1;BBC3;BCAP31;PINK1;PLAUR;NOC2L;BMF;URI1;BAX;BID;FIS1
prerank,"base-excision repair, gap-filling (GO:0006287)",-0.2893417409198765,-0.9235148163895173,0.6,0.8258878267755044,1.0,20/35,39.34%,SMUG1;OGG1;RPA1;NEIL1;POLE;POLD3;POLB;POLD1;NTHL1;POLL;RFC5;LIG3;RPA3;FEN1;RPA2;XRCC1;RFC2;POLG;UNG;PCNA
prerank,positive regulation of gene silencing by miRNA (GO:2000637),-0.3052145663168805,-0.9234381861989197,0.5618448637316562,0.8254657531034856,1.0,9/27,22.10%,TGFB1;PUM2;DDX5;EIF4G1;LIMD1;STAT3;MAP2K2;BMP4;FMR1
prerank,brain morphogenesis (GO:0048854),-0.38304902320710155,-0.9234164069748428,0.5602294455066922,0.8249052463255596,1.0,1/12,0.49%,SHANK3
prerank,mitochondrial translational elongation (GO:0070125),-0.24454491214028864,-0.9232825896905501,0.6212534059945504,0.8246160680378108,1.0,26/88,26.30%,GFM1;MRPL33;MRPL32;MRPS14;MRPL38;ERAL1;MRPS16;MRPL50;MRPL23;MRPS5;MRPL24;MRPS28;MRPS35;MRPL13;MRPL35;MRPL34;MRPS23;MRPS11;MRPS2;MRPS27;TUFM;MRPS18C;MRPL11;MRPL18;MRPL57;MRPL14
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.288680930879205,-0.9231361697983161,0.5891647855530474,0.8243306010883762,1.0,14/38,21.17%,CAV1;KCNJ2;CACNA1G;CTNNA3;KCNQ1;CACNA1C;CACNB2;BIN1;JUP;DSG2;DSP;SCN1B;TRPM4;KCNH2
prerank,regulation of muscle cell differentiation (GO:0051147),-0.2990166730184362,-0.922486709540608,0.5668789808917197,0.8252795071869782,1.0,12/31,21.38%,MEF2C;CDH2;CDON;CTNNB1;BNIP2;BOC;TCF3;ID2;HDAC9;PTBP1;CTNNA1;SPAG9
prerank,translational termination (GO:0006415),-0.23972021729865325,-0.9224000710766438,0.6126373626373627,0.8248659912828897,1.0,29/95,27.00%,MRRF;MRPL33;MRPL32;APEH;MRPS14;GSPT2;MRPL38;ERAL1;MRPS16;MRPL50;MRPL23;MRPS5;MRPL24;MRPS28;MRPS35;MRPL13;MRPL35;MRPL34;MRPS23;MTRF1L;MRPS11;MRPS2;MRPS27;MRPS18C;MRPL11;MRPL18;MRPL57;MRPL14;ETF1
prerank,regulation of RNA splicing (GO:0043484),-0.2502123285587675,-0.9223812658628355,0.6047120418848168,0.824293222634578,1.0,26/69,25.11%,MBNL1;AHNAK2;HNRNPK;AHNAK;QKI;LARP7;HNRNPH2;KHDRBS3;SRPK1;RPS26;GRSF1;FUS;YTHDC1;TMBIM6;HNRNPLL;PTBP1;RBM22;TRA2B;RBM20;FASTK;FAM50A;HNRNPF;ZPR1;ERN1;PRX;MBNL2
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.40366681270983323,0.9223174629878029,0.5480572597137015,0.8866523152714648,1.0,1/12,1.28%,BMP7
prerank,cellular response to cAMP (GO:0071320),-0.2930039509615263,-0.9222391395453491,0.5747663551401869,0.8240014560292773,1.0,10/30,17.90%,RAP1A;IGFBP5;PDE2A;KCNQ1;AHR;SLC26A6;ZFP36L1;HCN1;CFTR;HCN2
prerank,cellular response to oxygen-containing compound (GO:1901701),0.23453423982979735,0.9222120374059848,0.6542056074766355,0.886117144421191,1.0,25/291,7.40%,RORA;ROCK2;PTK7;EPHA3;PID1;WNT6;SLC5A5;TPM1;DAPK1;CXCL13;FER;PDGFRA;CRHBP;MAPK9;CPEB4;CACTIN;AANAT;SSTR2;SLC38A9;IL6;NCOA3;PDCD1LG2;MMP9;FOLR1;WNT5B
prerank,positive regulation of phagocytosis (GO:0050766),-0.27467184138045864,-0.9221008907300211,0.5888324873096447,0.8237297627639711,1.0,8/47,6.18%,PTPRJ;GAS6;RAB31;RAB27A;GATA2;CALR;DOCK2;PTPRC
prerank,cardiac muscle cell differentiation (GO:0055007),-0.32866611882268765,-0.9219003547938126,0.5810276679841897,0.8236057053843236,1.0,5/21,10.71%,MEF2C;CXADR;MYH11;VEGFA;BMP2
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.31096536374310396,0.9218243132358029,0.5561694290976059,0.8862652881638858,1.0,9/41,14.20%,ACSL1;GSTM2;PLA2G10;PTGR1;DAGLB;ACOX1;FADS3;PLA2G4B;PLA2G4C
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.3163535008589949,0.9208093473081269,0.5514184397163121,0.8878909948197453,1.0,6/36,8.63%,AFDN;VAMP5;MACF1;OPTN;GGA2;BLZF1
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.29326833055316687,0.9206961774967529,0.5549738219895288,0.8873842658421889,1.0,11/51,11.87%,FBN1;SMAD6;SPART;LRP2;NBL1;CHRDL1;FSTL3;SMURF2;LEMD3;FSTL1;BMPR1A
prerank,regulation of receptor recycling (GO:0001919),-0.35033063415875365,-0.919565937312202,0.5788461538461539,0.8284581183755857,1.0,4/16,10.20%,NSF;AP1AR;ECE1;LAMTOR1
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.3278675212590099,-0.9194577958607438,0.5676229508196722,0.82813639091147,1.0,5/20,12.28%,PPIA;PPWD1;PPIE;PPIB;NKTR
prerank,glycolytic process (GO:0006096),-0.31376505554623735,-0.9194223065688848,0.5797413793103449,0.8276184289721651,1.0,8/28,16.87%,PKM;HK1;GAPDH;PFKM;TPI1;ALDOA;LDHA;ALDOC
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.2678900945146443,-0.9188305467551431,0.6090047393364929,0.8283482818527456,1.0,13/50,15.39%,PSMD13;PSMF1;OAZ1;PSMB10;PSMB6;AZIN1;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;PSME1;PSMB3
prerank,focal adhesion assembly (GO:0048041),-0.3246224125985351,-0.9181194493423774,0.5723270440251572,0.8293590642672345,1.0,7/21,14.48%,THSD1;ACTN1;FERMT2;BCR;PEAK1;WHAMM;RCC2
prerank,regulation of supramolecular fiber organization (GO:1902903),0.3508247279690937,0.9181111787084385,0.5462794918330308,0.8924841555937884,1.0,4/22,11.91%,AEBP1;AKAP13;ABL1;GBA2
prerank,mRNA 3'-end processing (GO:0031124),-0.24373630286440517,-0.9180425639692027,0.6458333333333334,0.8289048680398261,1.0,38/78,33.42%,SRSF2;PABPC1;SRSF1;APP;CPSF7;SRSF5;DDX39B;CPSF3;SRSF9;CPSF6;RBM8A;RNPS1;SRSF6;GRSF1;SYMPK;CLP1;AHCYL1;CPSF2;CSTF2;CSTF2T;PCF11;MAGOH;THOC3;THOC6;THOC2;EIF4A3;SRSF7;LSM11;ALYREF;CPSF4L;ZC3H11A;TENT4B;CSTF1;CPSF1;DHX38;U2AF1L4;MTPAP;CHTOP
prerank,neutral amino acid transport (GO:0015804),0.3265531385680216,0.9177441130326783,0.5613382899628253,0.8926180865963217,1.0,7/28,12.73%,SLC38A3;SLC6A9;LLGL2;SLC43A1;SLC1A5;SLC36A2;SLC38A2
prerank,positive regulation of lamellipodium organization (GO:1902745),0.3167893781645707,0.9172947489974862,0.5849731663685152,0.8928829975131503,1.0,4/32,6.84%,AUTS2;AVIL;ABI2;ENPP2
prerank,purine-containing compound biosynthetic process (GO:0072522),0.33604745409482895,0.917204504031919,0.5817490494296578,0.8923374015806915,1.0,8/25,18.11%,PRPSAP2;AMPD3;ADSL;GMPS;SHMT1;ADK;APRT;GMPR2
prerank,positive regulation of inflammatory response (GO:0050729),-0.2397219240260323,-0.9169122121142722,0.6166219839142091,0.8309253568880409,1.0,16/86,14.43%,IL33;ETS1;NFKBIA;LBP;RPS19;GPR4;VAMP8;PDE2A;PDCD4;APP;GRN;FEM1A;IFI35;CD81;CD47;NFKBIZ
prerank,inflammatory response (GO:0006954),0.24460034649207776,0.916653605959679,0.6407624633431085,0.8928777013710751,1.0,31/195,15.64%,ADCY1;BDKRB2;IL18;KIT;LOXL3;TPST1;CXCL13;ADM;ANXA1;CRHBP;PARP4;IL6;FOLR2;CCL19;ITCH;PTGIR;IL17D;CCL4;CDO1;PTGER1;MAPKAPK2;S100A9;NFATC4;TBK1;PLA2G4B;PTGER4;PLA2G4C;ADORA1;CX3CL1;HYAL1;LTB4R2
prerank,cell cycle checkpoint signaling (GO:0000075),-0.37864110790451844,-0.9162429408852285,0.5892193308550185,0.8317807986088944,1.0,8/12,45.53%,PLK2;BUB1B;ZWINT;BUB1;WEE2;NABP1;ZW10;PRCC
prerank,regulation of T cell proliferation (GO:0042129),-0.2554526576594941,-0.9162426616742165,0.6068601583113457,0.8311779320310064,1.0,14/61,23.92%,TFRC;SLC7A1;NCK1;PTPRC;TNFRSF21;TNFRSF1B;NCK2;IL15;CD274;JAK3;NCKAP1L;SDC4;CEBPB;CD80
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.26078512120717096,-0.9159768421243095,0.6474654377880185,0.8312125887702868,1.0,19/54,26.06%,GAS6;RACK1;IKBKB;BIRC3;CHUK;NLRP2B;TRAF1;MADD;CASP8;LAPTM5;CARD16;SHARPIN;TRAIP;RBCK1;HSPA1B;OTULIN;CASP1;TNFAIP3;RNF31
prerank,primary neural tube formation (GO:0014020),0.32643550188729276,0.9159603176020371,0.5763358778625954,0.8937597893918646,1.0,6/30,11.81%,LMO4;PRICKLE1;MTHFR;LRP2;COBL;IFT122
prerank,adipose tissue development (GO:0060612),-0.39053993942056753,-0.915073265804622,0.5952380952380952,0.8327410955245104,1.0,4/11,10.63%,SPTLC2;NAMPT;LRP5;XBP1
prerank,regulation of JNK cascade (GO:0046328),0.2643939900296425,0.9150255345519975,0.6185410334346505,0.8951029883917226,1.0,16/101,12.61%,TGFBR3;PRKN;MTURN;CCN2;PLCB1;MBIP;DUSP10;IGF1R;SH3RF1;CCL19;SIRPA;ITCH;RAP2A;SH3RF2;UNC5CL;CYLD
prerank,reverse cholesterol transport (GO:0043691),0.37777901806461966,0.9149334780511105,0.5515873015873016,0.894566423744679,1.0,3/13,8.58%,ABCA1;LIPC;ABCA5
prerank,regulation of ATP metabolic process (GO:1903578),0.2924105813829482,0.9146887971398767,0.5834767641996558,0.8943839113795444,1.0,1/54,0.09%,PRKAG2
prerank,mRNA metabolic process (GO:0016071),-0.24143941323074145,-0.9141403874475087,0.6778115501519757,0.8341903525204459,1.0,31/90,29.87%,PPARGC1A;SRSF2;SRSF1;SFPQ;SF3B2;DDX5;SRSF5;SSB;CPSF3;KIN;SRSF9;CPSF6;USP39;PRPF18;RIDA;HNRNPA0;RNASE4;PCF11;PTBP1;AGO3;METTL3;SNRPG;HSPA1B;ERN1;NUDT16;RNH1;DIS3L2;SRSF7;LSM11;AURKAIP1;ZFP36
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.2450684308835988,-0.9138672892652898,0.6538461538461539,0.8342276127174063,1.0,31/72,36.17%,ACER2;RPL26;SOX4;PLK2;PLAGL1;CNOT6L;CHEK2;SESN2;ING4;CDKN1B;BCL3;RPS27L;TNKS1BP1;TFAP4;PCBP4;GADD45A;CDKN1A;E2F7;RGCC;BAX;SFN;USP10;NDRG1;PIDD1;AURKA;RPS6KA6;CNOT1;E2F8;CRADD;PLK3;CNOT9
prerank,atrial septum development (GO:0003283),0.39858592233955703,0.9137588151607049,0.5619834710743802,0.8957450811856069,1.0,2/13,4.09%,NOTCH2;ANK2
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.37038320486190557,0.9136242750232383,0.5787476280834914,0.8952741127794753,1.0,1/17,0.38%,ROCK2
prerank,"mRNA splicing, via spliceosome (GO:0000398)",-0.20594422985540917,-0.9133972483682911,0.7578125,0.8346810040153396,1.0,86/264,29.10%,HSPA8;NOVA2;HNRNPK;SRSF2;PABPC1;SRSF1;HNRNPU;HNRNPA3;PPWD1;SFPQ;PPIE;YBX1;SF3B1;SF3B2;DDX5;CPSF7;RBM14;PHF5A;DDX20;SRSF5;DDX39B;CPSF3;RALY;CLNS1A;SRSF9;CWC15;HNRNPH2;USP39;RBM8A;POLR2C;STRAP;XAB2;SNRPC;PRPF40B;RNPS1;SRSF6;SRPK1;SF3B5;FUS;HNRNPA0;SYMPK;CLP1;PRPF4;POLR2G;CPSF2;DCPS;CSTF2;SPEN;PCBP1;CSTF2T;PCF11;ESS2;YTHDC1;GTF2F2;MTREX;HNRNPUL1;PTBP1;RBM17;MAGOH;CTNNBL1;METTL3;SNIP1;RBM22;DDX17;TRA2B;SNRPG;USP49;HNRNPF;SNRNP35;HNRNPM;POLR2L;RBM4B;SRPK3;WDR77;LSM8;PUF60;HNRNPD;EIF4A3;TFIP11;SRSF7;ZCRB1;RBM6;SCNM1;ALYREF;CELF4;BUD31
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.24563606580850147,-0.9132371621257912,0.6384615384615384,0.8344362840490525,1.0,19/73,16.70%,HIP1;ACER2;F3;NGF;RACK1;TNFSF10;NOD1;EGLN3;ATP2A3;HIP1R;XDH;HSPD1;RPS27L;BBC3;CASP8AP2;FAS;CASP8;LAPTM5;DAP
prerank,negative regulation of mRNA catabolic process (GO:1902373),-0.30224891613921223,-0.9129231014625728,0.5893271461716937,0.8345856709377154,1.0,8/29,22.10%,PABPC1;HNRNPU;YBX1;FUS;TENT5A;SLC11A1;RBM24;FMR1
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.33707491036559795,-0.9128852871156256,0.6093418259023354,0.8340820236518229,1.0,5/20,14.53%,ENTPD1;HSP90AB1;APP;PSTPIP1;NT5E
prerank,mitotic metaphase plate congression (GO:0007080),-0.2671555097686737,-0.9126390790552138,0.6068965517241379,0.834028803221718,1.0,18/51,26.38%,CHMP5;CHMP2B;PINX1;CUL3;RMDN1;BOD1;CHMP1B;CHMP1A;CHMP3;NDC80;CHMP7;PDCD6IP;KIFC1;KIF14;SPDL1;CHMP4C;CDCA8;CEP55
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.22417691230550682,0.9122568985676078,0.7029339853300733,0.8976898225513894,1.0,62/417,12.90%,TCF7L2;WNT4;RBPJ;NR2F2;BMP7;ATXN1;SNX6;DKK3;ARID5B;RUNX1T1;ZEB1;PRDM5;ZIC2;NR1I2;PLCB1;LOXL3;TSHZ3;JARID2;MIDEAS;ZHX2;PRICKLE1;VGLL4;HOXA7;FOXD1;CBY1;BEND5;ARID4A;L3MBTL2;IKZF4;GLI3;DPF2;SFMBT1;NIBAN2;SALL1;BCOR;XRCC5;RSF1;TLE1;BIRC5;ZMYND15;WWP2;KAT8;KAT6B;MDM2;SMURF2;MBTD1;SCMH1;HDAC1;L3MBTL3;ATOH8;ZBTB38;TFAP2A;SMARCE1;TFAP2B;ZNF568;MYB;CRY1;CBFA2T2;NONO;FOXK2;SOX13;PSPC1
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.24865215875982677,-0.9119291271962882,0.625,0.8349913925544535,1.0,31/72,36.01%,UBB;UBC;RPS27A;RBX1;DDB1;OGG1;RPA1;UBA52;RNASE4;POLK;ZC3H12A;EDC3;POLD3;POLD1;GTF2H2;ERCC5;XPA;RFC5;EDC4;ERCC3;PNRC2;GTF2H5;RPA3;ISG20;FEN1;RPA2;MEI4;DNA2;RFC2;DCP1A;DNASE1L1
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.4088999235210006,-0.9117569141919186,0.5965250965250966,0.8347828036154671,1.0,8/10,47.23%,INPP5F;SH2B3;SOCS1;PPP2CA;PPP2R1A;PIBF1;NF2;PTPN2
prerank,regulation of mRNA catabolic process (GO:0061013),-0.23018667086127778,-0.9116775378177193,0.6748466257668712,0.8343723058542653,1.0,36/121,23.14%,PRR5L;HSPA8;VIM;UBB;HSPB1;PABPC1;YWHAB;UBC;RPS27A;PUM2;PSMD13;SET;PSMF1;EIF4G1;PSMB10;PSMB6;PSME3;ZFP36L1;YTHDF3;PSMB5;PSMC3;PSMD12;PSMB8;PSME1;UBA52;PSMB3;SERBP1;ZC3H12A;PSMD5;PCBP4;PRKCD;AKT1;RBM24;FMR1;PSMD9;PSMB4
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.416785445527145,0.9115811937876619,0.5415730337078651,0.898503325195915,1.0,1/10,1.41%,PRKN
prerank,negative regulation of cell cycle (GO:0045786),-0.2427844378588042,-0.9115228552655417,0.6658097686375322,0.8341378968086539,1.0,26/73,22.74%,PPP1R13B;RHOB;TGFB1;PDCD4;NR4A1;APC;BTG3;CDKN1B;CDK6;BMP2;MEN1;HHEX;GPER1;NLRP2B;BRINP2;DUSP1;ZBTB17;BMP4;CAMK2N1;INHA;TFAP4;CHMP1A;GMNC;BTG1;CEBPA;SIPA1
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.37698031280680316,0.91141502178365,0.552,0.898136438401219,1.0,5/14,17.23%,LHPP;ADSL;GMPS;ADK;PFAS
prerank,positive regulation of collagen metabolic process (GO:0010714),0.37354245331124014,0.9113894823159226,0.5798816568047337,0.8974405493654277,1.0,2/17,2.75%,WNT4;SCX
prerank,mitochondrion localization (GO:0051646),-0.33123829525567955,-0.9112258055410457,0.5949367088607594,0.834227216318841,1.0,10/19,28.58%,MARK1;MTM1;MARK2;MSTO1;MFN2;TLE6;ATCAY;HAP1;MEF2A;ZBED3
prerank,glycoprotein metabolic process (GO:0009100),0.29151268397514946,0.9111581355873882,0.5916955017301038,0.897188439154205,1.0,7/53,7.42%,ADAMTS9;LARGE1;PRKCSH;GAL3ST2;MAN1C1;FBXO44;GANC
prerank,protein localization to lysosome (GO:0061462),-0.3019848335733883,-0.9107099793018347,0.5886214442013129,0.8348019494641103,1.0,14/28,27.66%,SH3BP4;SNX16;RTN4;HGS;CD81;M6PR;NCOA4;ATP13A2;LAPTM5;LAMTOR4;SCARB2;SORL1;RAB7A;RNF128
prerank,mitochondrial transport (GO:0006839),-0.25891532355393376,-0.9102312124413325,0.6439024390243903,0.8353397083395653,1.0,24/53,30.32%,HSP90AA1;FBXO7;TOMM20;BCL2L1;ABCB10;TOMM22;TMEM14C;TIMM9;BCAP31;TIMM10B;TIMM13;SLC25A4;TIMM22;MFN2;BCS1L;TOMM7;FLVCR1;SPG7;TSPO;TIMM44;FIS1;AIP;TOMM34;PMAIP1
prerank,regulation of myotube differentiation (GO:0010830),-0.30781288476200297,-0.9092433510673988,0.5911949685534591,0.836987664334463,1.0,7/24,13.45%,NOTCH1;CCN3;HDAC5;PIEZO1;XBP1;ATP11A;SMYD1
prerank,regulation of cellular protein localization (GO:1903827),-0.26941583400959684,-0.9092327476832976,0.6117381489841986,0.8364169222277315,1.0,15/45,22.36%,HSP90AA1;HSP90AB1;CTNNB1;SPIDR;RALB;PTPN1;GPC1;RAB11FIP5;CCDC66;ATP13A2;SUMO3;GBF1;ABCA2;MAP1A;VCP
prerank,regulation of erythrocyte differentiation (GO:0045646),-0.2880342512884492,-0.9090723365952288,0.6165919282511211,0.8361692305573307,1.0,15/35,29.87%,ETS1;ABCB10;CDK6;TAL1;STAT3;ZFP36L1;ANKRD54;HSPA9;SPI1;NCKAP1L;HSPA1B;MAPK11;STAT1;ZFPM1;ZFP36
prerank,glucose import (GO:0046323),-0.36678768802013617,-0.9089420188052173,0.581532416502947,0.8358754358408851,1.0,2/13,8.92%,SLC2A1;ZDHHC7
prerank,digestive tract morphogenesis (GO:0048546),0.38115869568397626,0.9088453753080981,0.5654885654885655,0.9016868319356922,1.0,3/14,9.92%,FGFR2;PDGFRA;BBS7
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.34840955308029387,0.9080650256378627,0.55765595463138,0.9026876105407865,1.0,3/21,8.93%,RAD51B;RAD51C;CDK1
prerank,embryo development ending in birth or egg hatching (GO:0009792),-0.3602831949929659,-0.9079814043973689,0.5788461538461539,0.8374486528200986,1.0,2/15,2.03%,STOX2;TGFB2
prerank,positive regulation of ruffle assembly (GO:1900029),-0.3712870925979953,-0.9078314855745169,0.5873015873015873,0.8371687605743873,1.0,8/13,39.91%,EPS8L2;EPS8;PLEKHM1;P2RY12;HRAS;CARMIL2;FAM98A;PFN1
prerank,protein localization to cell junction (GO:1902414),-0.32284017367257245,-0.9071422155518933,0.6078028747433265,0.8381585262329025,1.0,11/22,23.54%,HEG1;TJP2;FERMT2;TJP1;PAK2;PCLO;BSN;DSP;JAM3;SHANK1;JAK1
prerank,positive regulation of dendrite development (GO:1900006),-0.3968046487241986,-0.9066497086566657,0.6062378167641326,0.8386436907675647,1.0,4/10,6.80%,BMP5;DAB2IP;ZDHHC15;LRP8
prerank,calcineurin-mediated signaling (GO:0097720),-0.39637444145348016,-0.9062290322896833,0.6114519427402862,0.8384235636126334,1.0,5/10,19.26%,NFATC2;NFATC1;PPP3CA;PPP3R1;NFATC3
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.39637444145348016,-0.9062290322896833,0.6114519427402862,0.8384235636126334,1.0,5/10,19.26%,NFATC2;NFATC1;PPP3CA;PPP3R1;NFATC3
prerank,protein polyubiquitination (GO:0000209),0.22987638374325947,0.9060537816596846,0.6765083440308087,0.9065648195576309,1.0,65/297,17.65%,SASH1;PRKN;PELI2;BCL2;SPSB1;UBE2E2;TRIM5;NEDD4;RNF213;FBXW4;DDB2;ANAPC13;RNF217;PSME4;PSMA2;UBE2L3;FBXO44;NPEPPS;UBR2;SPOP;PSMA3;TTC3;TRIM56;RNF152;SIAH2;RNF135;AMFR;WWP2;RNF216;RC3H2;MDM2;FBXL17;UBE4A;ITCH;NHLRC1;SMURF2;FBXO6;PSMD8;KBTBD7;FBXO38;RBBP6;PSMD3;FBXO4;RNF14;FBXO11;RNF20;IFI27;CDC26;CHFR;UBE2V1;TRIM62;UBE2A;BIRC2;PPIL2;UBE2H;SKP2;ANAPC2;HECTD1;PELI3;UBE2E1;HERC6;TRIM69;FBXW10;DTX3L;NHLRC3
prerank,positive regulation of cilium assembly (GO:0045724),-0.3390601948794454,-0.905349893610003,0.6147704590818364,0.839773842929925,1.0,6/18,25.08%,CCDC88A;SEPTIN9;KCTD17;WRAP73;ENTR1;HAP1
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.36948327290049293,-0.9052749870260174,0.5957446808510638,0.8393565039918632,1.0,5/12,32.39%,GCLM;GGT1;CHAC2;MGST2;OPLAH
prerank,positive regulation of myelination (GO:0031643),0.40204677323034005,0.905128072389738,0.5543478260869565,0.9078896304502878,1.0,4/11,13.35%,PARD3;ITGAX;CST7;DICER1
prerank,atrial septum morphogenesis (GO:0060413),-0.39514619284612595,-0.9048306412154167,0.6159695817490495,0.8397793992530371,1.0,4/10,9.08%,TGFB2;BMPR2;SOX4;HEY2
prerank,positive regulation of cytokine production (GO:0001819),-0.1990551447845199,-0.9047685696485249,0.7927927927927928,0.8393204990450758,1.0,82/292,26.07%,SPTBN1;FOXP1;CADM1;PDE4D;LRRFIP1;IL33;CD200;SLC7A5;CD34;F3;RUNX1;PLCG2;MBP;LBP;RPS3;NOD1;G3BP1;TGFB1;RFTN1;CTNNB1;SOD1;PTPRC;IL1R1;FLT4;APP;GAPDH;CYRIB;APPL1;PTGS2;PAEP;PIK3CD;XBP1;GBP5;ISG15;ATF4;STAT3;CRCP;RAB1A;CD74;STOML2;ARHGEF2;HSPD1;TMED10;CSF1R;IFIH1;LAPTM5;MIF;IL15;CD274;IRAK1;IRF5;NR1H4;CD40;TYROBP;MYD88;TXK;TRIM27;TIRAP;SLC11A1;CYP1B1;AFAP1L2;HYAL2;S100A13;CEBPB;HPSE;HSPA1B;POLR3D;AGER;MAPK11;RELA;CCR2;CD80;RGCC;POLR3F;CRLF2;POLR2L;NFKB2;SORL1;RAB7B;SPHK2;C3;IL12RB2
prerank,cellular response to alcohol (GO:0097306),0.3003756742773602,0.9046806272527785,0.5921052631578947,0.9081386715942006,1.0,3/42,3.73%,ADCY5;ADCY1;GRAMD1C
prerank,ubiquinone biosynthetic process (GO:0006744),0.37871010545819567,0.9044682804324179,0.5889328063241107,0.9078774582765962,1.0,5/15,11.00%,FDXR;COQ10A;COQ6;COQ8B;NDUFA9
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.3126325082510178,-0.9042107620257607,0.6232179226069247,0.8400265395596977,1.0,4/24,3.97%,ACVRL1;DACH1;RPS3;BMPR2
prerank,rRNA transcription (GO:0009303),-0.34200342013707724,-0.9033279811189181,0.615678776290631,0.8414240948759557,1.0,8/17,23.48%,CAVIN1;BRF1;GTF3C1;SPIN1;ANG;GTF3C2;SIRT7;GTF3C4
prerank,mitochondrion disassembly (GO:0061726),0.3142200766049135,0.9027649210692328,0.6138790035587188,0.9109767593555632,1.0,8/34,14.73%,PRKN;WIPI1;BNIP3;FUNDC2;FUNDC1;ATG9A;AMBRA1;ATG3
prerank,response to purine-containing compound (GO:0014074),-0.3420927436269204,-0.9026286186992093,0.6147540983606558,0.8423792139793738,1.0,10/17,34.74%,ABCC9;TRPC3;RYR2;VGF;DGKQ;TRPM2;STAT1;P2RY1;P2RX7;RYR1
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.2445466229767363,0.9024079633200273,0.6484593837535014,0.9110430264221108,1.0,19/152,11.40%,ADCY5;ADCY1;LGR4;ADGRL1;LPAR1;GNAS;ADM;ABCA1;LPAR2;CACNA1D;GNAQ;ADRA1D;PTH2R;GRK5;PTGIR;GLP1R;PTGER1;ADRB3;AKAP12
prerank,regulation of exit from mitosis (GO:0007096),-0.2806258899487697,-0.9023309066615661,0.6187363834422658,0.8424804547249136,1.0,13/38,27.99%,UBB;BUB3;UBC;RPS27A;ANAPC16;UBA52;BUB1B;UBE2D1;ANAPC7;RGCC;KNTC1;CDC14A;MAD2L1BP
prerank,axonal transport (GO:0098930),-0.2819414053917507,-0.9022862132141829,0.6009070294784581,0.8420077941713597,1.0,13/36,26.98%,AP3S1;BLOC1S2;SOD1;AP3M2;KIF1A;TMEM108;KIF3B;DCTN1;NEFL;KIF1B;KIF4A;HAP1;SNAPIN
prerank,steroid hormone biosynthetic process (GO:0120178),0.3312193723012027,0.9021662304451527,0.58203125,0.9108589905198144,1.0,5/29,15.42%,HSD17B1;FDXR;MED1;AKR1B1;HSD17B14
prerank,phosphatidylserine metabolic process (GO:0006658),0.31503279419167185,0.901886235402717,0.587360594795539,0.9107310591908955,1.0,8/32,18.10%,OSBPL8;PLA2G10;SLC27A1;PLA2G4B;PLA2G12A;OSBPL10;ABHD16A;ABHD12
prerank,Notch signaling pathway (GO:0007219),0.28078591623073645,0.9014464196008573,0.6081771720613288,0.9109906475415658,1.0,14/59,13.47%,RBPJ;NOTCH2;GMDS;SUSD5;MAML3;MAML1;WWC1;TRAF7;ITCH;SNAI1;DTX1;MAML2;PSENEN;CREBBP
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.3140323412985556,0.9014333032894432,0.5934664246823956,0.9102700787991987,1.0,4/38,8.15%,RORA;CACTIN;NLRC3;TLE1
prerank,GPI anchor biosynthetic process (GO:0006506),0.3204972652135081,0.9013763640532947,0.6101083032490975,0.9096456948984618,1.0,7/30,16.72%,PIGU;PIGG;PIGV;PIGX;PIGC;PIGQ;PIGN
prerank,sphingoid metabolic process (GO:0046519),0.3953529099841329,0.9012515255011695,0.5857461024498887,0.9092017960752723,1.0,5/12,15.69%,PLPP3;SPHK1;SGPP1;PLPP2;NAAA
prerank,establishment of melanosome localization (GO:0032401),0.35768553428508726,0.9012023084144767,0.5705521472392638,0.9085593120154609,1.0,4/19,9.92%,SHROOM2;ARL6;GPR143;BBS7
prerank,methylguanosine-cap decapping (GO:0110156),-0.4002671754877011,-0.9011930268940295,0.6172607879924953,0.8439107768756942,1.0,7/10,35.67%,PATL1;DCPS;EDC3;EDC4;PNRC2;PATL2;DCP1A
prerank,chromosome organization (GO:0051276),0.26100440540513803,0.9005333516896377,0.6265822784810127,0.9092608612214984,1.0,14/99,10.27%,TCF7L2;SATB1;TOP2B;HDAC8;DDB2;SOX1;MTHFR;SETD7;TCF7L1;MTF2;AXIN2;HDAC1;ABL1;LATS1
prerank,phospholipid dephosphorylation (GO:0046839),0.3074248426750167,0.9002571518160062,0.5802919708029197,0.909134977223122,1.0,6/37,7.47%,PLPP3;MTMR3;EPHX2;SYNJ2;SGPP1;PTEN
prerank,regulation of interferon-gamma production (GO:0032649),-0.24419170834258652,-0.8999489444186655,0.6463104325699746,0.8461315674287283,1.0,24/71,30.08%,PDE4D;SLC7A5;GAS6;IL1R1;CYRIB;ISG15;HSPD1;CD47;LAPTM5;CD274;ZC3H12A;NR1H4;INHA;TXK;TRIM27;SLC11A1;VSIR;CCR2;IL12RB2;TLR4;TLR7;RASGRP1;ZFPM1;FADD
prerank,engulfment of apoptotic cell (GO:0043652),-0.34860634826941805,-0.8996432522376411,0.5859213250517599,0.8462006083977601,1.0,2/15,2.05%,THBS1;RAC1
prerank,negative regulation of cation channel activity (GO:2001258),0.3381766829095063,0.899608479742748,0.6138059701492538,0.9098385987896876,1.0,5/26,11.59%,SLC6A9;GSTM2;MMP9;GNB5;PKD2
prerank,regulation of telomere maintenance (GO:0032204),0.3364076584986975,0.8990398521121282,0.5875706214689266,0.9103941014275156,1.0,11/26,22.13%,HDAC8;YLPM1;XRCC5;USP7;RTEL1;MRE11;PML;RAD50;NBN;TERF2;SMG1
prerank,dendrite self-avoidance (GO:0070593),-0.33790329221779103,-0.8989707471372536,0.5969289827255279,0.8470732288218054,1.0,11/16,36.49%,BSG;ROBO4;CNTN6;DSCAML1;NPTN;VSTM2L;EMB;CNTN2;MYPN;CNTN4;IGSF9
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.322567389405109,-0.8987715030305652,0.6190476190476191,0.8469527725861528,1.0,8/21,19.95%,CTNNB1;VEGFA;NES;CX3CR1;DISC1;DISP3;TOX;DLL4
prerank,lysosome organization (GO:0007040),0.3138524058818847,0.8984086762622683,0.6025179856115108,0.9110372439516767,1.0,6/36,6.92%,HOOK2;ABCA1;LRRK2;TPP1;ACP3;ATP10B
prerank,neutrophil chemotaxis (GO:0030593),-0.2601459525236825,-0.898284316503613,0.6488372093023256,0.8474361689308967,1.0,10/53,17.21%,BSG;TGFB2;PPIA;CXADR;EDN1;PPIB;PIK3CD;PIP5K1C;GBF1;CCL13
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.26893205498182843,-0.8982702840203807,0.6451612903225806,0.8468669297241986,1.0,21/45,35.55%,HSPB1;APP;AIM2;GBP5;USP50;STAT3;PANX1;CASP8;TYROBP;MYD88;AGER;CASP1;TLR4;NLRC4;TLR6;NOD2;CD36;LPL;NLRP3;P2RX7;TLR8
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.30606308159599266,0.8982198801384643,0.6226415094339622,0.9107090324009288,1.0,4/40,5.17%,PID1;BCL2;SPART;LRRK2
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.30713447354029155,0.8975052627319713,0.5887681159420289,0.9116499692322019,1.0,6/37,10.07%,APPL2;PPARA;IL6;NLRC3;SIRPA;IL17D
prerank,protein localization to vacuole (GO:0072665),-0.3608155355553234,-0.8973709813639777,0.6167664670658682,0.8482244022329241,1.0,5/13,15.83%,SH3BP4;SH3GLB1;RTN4;CD81;ATP13A2
prerank,transcription preinitiation complex assembly (GO:0070897),-0.36754569970050066,-0.8972746993391283,0.6068548387096774,0.8478318007993598,1.0,8/12,50.88%,TAF11;TAF1B;POLR1E;TBP;TAF7;TAF7L;BDP1;DR1
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.39020737508829395,0.8971210595716267,0.5809935205183585,0.9117995264290679,1.0,3/13,5.22%,KCNA5;ANK2;GJA1
prerank,monocyte chemotaxis (GO:0002548),0.31528796351471206,0.8970802285231283,0.5868372943327239,0.9111456674598614,1.0,5/32,10.28%,ANXA1;IL6;FOLR2;CCL19;CCL4
prerank,isotype switching (GO:0045190),-0.3912403960884314,-0.8963949193714974,0.603448275862069,0.8491111407162621,1.0,4/10,21.01%,MSH2;HSPD1;LIG4;RNF168
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.38803542934666824,-0.8963501945911564,0.6182495344506518,0.8486013013083404,1.0,7/11,38.92%,STAT3;CANX;JAK1;IL12RB2;STAT1;IL6ST;IL12A
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.387039768486816,-0.8961345778415587,0.6228239845261122,0.848487435982471,1.0,4/10,21.05%,FAS;MAP2K2;GREM1;MAPK3
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.2736629703171471,-0.8954703660421078,0.6346153846153846,0.8493545058278882,1.0,11/44,16.38%,THBS1;GAS6;KLF4;NGF;CD44;VEGFA;RPS6KA1;MT3;ARL6IP1;RAF1;CARD16
prerank,smooth muscle tissue development (GO:0048745),-0.38469549814958054,-0.8952940891947282,0.5926605504587156,0.849150031553675,1.0,5/10,18.81%,ENG;STRA6;PTCH1;NF1;BMP4
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.3128224050820132,-0.8952220504971631,0.6107660455486542,0.8487113840866083,1.0,7/23,9.97%,MAP3K5;DAB2IP;RPS3;TNFRSF11A;PAK1;EDN1;ARHGEF5
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.40587176399012026,0.8945184925569303,0.5856573705179283,0.9162104404280752,1.0,2/10,4.72%,BMP7;ARHGAP12
prerank,regulation of cation transmembrane transport (GO:1904062),0.3188008026741383,0.8943684557332404,0.5988909426987061,0.9157736100456166,1.0,4/29,6.45%,KCNIP3;SNTA1;CACNA1D;DLG1
prerank,steroid catabolic process (GO:0006706),-0.38547999663413735,-0.8936386724112522,0.6177024482109228,0.8516169621891703,1.0,3/10,18.45%,SPP1;YWHAH;HSD11B1
prerank,respiratory electron transport chain (GO:0022904),-0.3546428097677015,-0.8935088225180724,0.6200787401574803,0.8513181503197673,1.0,3/14,10.19%,PPARGC1A;NDUFA5;GPD2
prerank,regulation of glycogen metabolic process (GO:0070873),0.39677194046318875,0.8927085439914384,0.5923566878980892,0.9187308936140348,1.0,2/12,10.41%,PPP1R3G;PPP1R3F
prerank,negative regulation of coagulation (GO:0050819),0.3779206782420148,0.8926888293779965,0.5690376569037657,0.9180185395285843,1.0,4/14,12.57%,TFPI;VTN;APOH;SERPINE1
prerank,regulation of collagen biosynthetic process (GO:0032965),0.3590254211105963,0.8925287691853252,0.5980582524271845,0.9176421033838233,1.0,3/19,6.85%,WNT4;SCX;IL6
prerank,cGMP biosynthetic process (GO:0006182),-0.38559635657613045,-0.8923514163759315,0.6293577981651376,0.8532819666248014,1.0,2/10,4.49%,GUCY1B1;GUCY1A1
prerank,synaptic vesicle exocytosis (GO:0016079),0.29749767297963453,0.8921647362413989,0.6286201022146508,0.917680545875315,1.0,1/40,0.06%,UNC13C
prerank,multivesicular body assembly (GO:0036258),-0.2944693572785976,-0.8920908474389498,0.66875,0.8532420169466854,1.0,13/30,31.27%,CHMP5;CHMP2B;HGS;MVB12A;CHMP1B;CHMP1A;CHMP3;CHMP7;PDCD6IP;CHMP4C;VPS36;VPS28;VPS4B
prerank,dephosphorylation (GO:0016311),0.24331232027131458,0.8919454831136812,0.6798825256975036,0.9173971423099013,1.0,19/147,9.18%,PTPN13;PXYLP1;PLPP3;LHPP;PPM1M;PTPN4;DUSP10;CDC14B;PPM1E;PTPRA;MTMR3;PTPN9;EPHX2;SGPP1;ACP3;PTPRD;PTEN;HDHD2;THNSL2
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.3792659253787739,-0.8917200659399958,0.6393762183235867,0.853478741255558,1.0,7/11,31.67%,BAG6;DERL1;AUP1;RNF5;VCP;RNF185;UGGT1
prerank,cytosolic calcium ion transport (GO:0060401),0.3241419904312212,0.8915272614757666,0.6223908918406073,0.9176300961872869,1.0,6/28,10.75%,JPH1;SLC8A1;MAIP1;CACNA2D1;MCU;MICU1
prerank,response to organic cyclic compound (GO:0014070),0.2842471086258295,0.8912607847884563,0.6033898305084746,0.9174727771135958,1.0,6/52,7.88%,FGFR4;IL18;ANXA1;STAT5B;LRRK2;STRN3
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),-0.24430977558351202,-0.8905209259984662,0.6459459459459459,0.8555493786887215,1.0,17/70,16.32%,LMO2;CBFB;RUNX1;GATA2;PSMD13;PSMF1;PSMB10;TAL1;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;PSME1;PSMB3;TCF3
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.3857520063742974,-0.8904120406697348,0.618421052631579,0.8551833186480486,1.0,5/10,38.93%,SET;CTBP1;NOC2L;THAP7;TAF7
prerank,ether lipid biosynthetic process (GO:0008611),-0.3911065779161016,-0.8901526994027349,0.5922330097087378,0.8551437140425439,1.0,5/10,27.95%,FAR1;AGPS;PLA2G4A;DHRS7B;CHPT1
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.3567283124385663,-0.8899071104501345,0.6129666011787819,0.8550636447233783,1.0,8/14,31.37%,CPSF7;CPSF6;CPSF2;CSTF2;CSTF2T;ERN1;CPSF4L;CPSF1
prerank,positive regulation of ATPase activity (GO:0032781),0.30004934076020795,0.8895134293635869,0.6097972972972973,0.9206563221491397,1.0,3/41,2.69%,TPM1;ATP1B3;TNNT2
prerank,type I interferon signaling pathway (GO:0060337),0.3018676834949769,0.8893771064019887,0.6013289036544851,0.9195086686738018,1.0,5/41,5.52%,SP100;IFIT3;RNASEL;IFIT2;IRF8
prerank,cellular response to type I interferon (GO:0071357),0.3018676834949769,0.8893771064019887,0.6013289036544851,0.9195086686738018,1.0,5/41,5.52%,SP100;IFIT3;RNASEL;IFIT2;IRF8
prerank,P-body assembly (GO:0033962),-0.3659084721797507,-0.8892973210127154,0.592156862745098,0.8558199961502587,1.0,7/12,35.93%,PATL1;LIMD1;EDC3;PATL2;RC3H1;ATXN2;DYNC1H1
prerank,negative regulation of immune system process (GO:0002683),0.3681522795567981,0.8892972319886371,0.5809128630705395,0.918948604764861,1.0,4/16,10.07%,HOXA7;FCRLB;PDCD1;IL17D
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.34055851503729234,-0.8887309985549428,0.6262833675564682,0.8564764705381784,1.0,9/16,34.27%,SMCHD1;UBQLN4;POLQ;RMI2;CGAS;SHLD3;SHLD2;RIF1;HELB
prerank,positive regulation of interferon-alpha production (GO:0032727),-0.32067527162170795,-0.888172178439789,0.6134969325153374,0.8571125918025131,1.0,9/19,31.11%,CHUK;HSPD1;IFIH1;IRF5;STAT1;TLR4;TLR7;MAVS;DHX9
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.3407194659019421,0.8876643919819683,0.6147704590818364,0.9218610723632809,1.0,4/20,9.67%,LHPP;AMPD3;ADSL;GMPS
prerank,DNA-dependent DNA replication (GO:0006261),-0.21550362319439512,-0.8873901376805006,0.742603550295858,0.8582389327937299,1.0,56/128,35.78%,UBB;REV3L;UBC;RPS27A;WRNIP1;PSMD13;PSMF1;PSMB10;PSMB6;RPA1;PSME3;PSMB5;PSMC3;MCM4;PSMD12;PSMB8;TOPBP1;PSME1;UBA52;PSMB3;PRIM1;WDHD1;MCM8;POLA1;CDK2;POLE4;RECQL;POLE;PSMD5;POLD3;POLB;SIRT7;POLD1;GINS4;PSMD9;PSMB4;PSMD10;MCM5;MCM10;RFC5;ORC1;TWNK;RPA3;MCM6;GMNN;GINS2;POLE3;RPA2;CDC6;PSMC1;HELB;PSMC4;CDC7;DNA2;RFC2;PSMC5
prerank,response to organonitrogen compound (GO:0010243),-0.2734194296761586,-0.8873216979080853,0.652073732718894,0.8577943556007681,1.0,16/38,27.92%,MTOR;DERL1;CCDC47;UBXN6;IRAK3;ERLEC1;GLRA3;RNF5;IRF5;NR1H4;VCP;BRSK2;GLRA1;MEAK7;TRPM2;SYVN1
prerank,plasma membrane organization (GO:0007009),-0.2453223501597981,-0.8867530894116098,0.7100737100737101,0.8584220300930026,1.0,14/61,17.43%,SPTBN1;AHNAK2;NSF;FNBP1L;PACSIN2;CAVIN2;MYH9;DYSF;BIN1;WHAMM;ABCD2;STX2;TLCD2;SYT7
prerank,actin crosslink formation (GO:0051764),0.38803399884153605,0.8864255198863775,0.5881104033970276,0.9240022707374465,1.0,3/12,6.57%,DPYSL3;BAIAP2;BAIAP2L2
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.29041486824626855,-0.885127785532645,0.631578947368421,0.8613798259209301,1.0,6/29,13.52%,CAV1;THBS1;TNFSF10;PAK2;GPER1;RET
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.32274005469175415,0.8847589518184578,0.6352087114337568,0.926967684272686,1.0,7/27,15.69%,PLA2G10;ETNK2;NAPEPLD;SLC27A1;PISD;CHKA;NAAA
prerank,RNA transport (GO:0050658),-0.23964113285883834,-0.8847250434564863,0.6890080428954424,0.861692632295512,1.0,34/71,34.58%,RBFOX1;SRSF2;TGFBR2;RFTN1;SRSF1;YBX1;SRSF5;DDX39B;SRSF9;RBM8A;ZFP36L1;RNPS1;SRSF6;RTRAF;CKAP5;MAGOH;THOC3;POM121;FMR1;THOC6;EIF4E;THOC2;EIF4A3;SRSF7;NUP153;ALYREF;KIF5C;ZFP36;ZC3H11A;DHX38;U2AF1L4;CHTOP;HNRNPA1;ATXN2
prerank,cellular response to DNA damage stimulus (GO:0006974),0.22032145749431536,0.8845883664710023,0.7701005025125628,0.9266007376488319,1.0,100/336,22.11%,STXBP4;BCL2;FANCA;RAD51B;UBE2E2;ATRIP;MAP2K6;ASH2L;BAZ1B;PLK5;DDB2;RAD51C;CTLA4;MRNIP;UFL1;INIP;PDS5B;PSME4;SETD7;PARP4;XRCC5;NEK4;BLM;SLF1;WDR48;CHCHD6;BCL2L2;CDK1;UVRAG;FBXO6;IRF3;PDS5A;MBD4;ABL1;PRKDC;UBA7;IKBKE;ZBTB38;EPHA2;LIG1;RBBP6;RTEL1;CUL4B;MAPKAPK2;INO80;CRY1;BATF;BOD1L1;MRE11;USP45;FANCF;CIB1;BABAM2;APEX1;MNAT1;UBE2A;BACH1;CEP63;HTRA2;FANCC;PHF1;NIPBL;BRSK1;WRN;RAD18;RAD51;TAOK3;LYN;MACROD1;PML;ZDHHC16;REXO4;RPAIN;DTX3L;TRRAP;VCPIP1;XPC;MCM7;TAOK2;DCUN1D5;USP47;BCL2L11;XIAP;TRIP12;HIC1;SHPRH;RECQL5;SETX;RAD9B;RAD50;RNF169;STK33;NBN;CBX3;AATF;SUSD6;SLF2;ETAA1;SAMHD1;RAD52
prerank,L-serine metabolic process (GO:0006563),0.388547262387833,0.8844715189081851,0.5811088295687885,0.9260988336428134,1.0,3/10,13.34%,CBS;SRR;SHMT1
prerank,presynapse organization (GO:0099172),0.4050917951374406,0.8844323940568167,0.593952483801296,0.9254499850925679,1.0,1/10,2.26%,NLGN2
prerank,positive regulation of leukocyte migration (GO:0002687),0.3271433143071793,0.8838714654075354,0.5925925925925926,0.9259123195396816,1.0,4/27,7.99%,PTN;IL6;MIA3;CSF1
prerank,positive regulation of potassium ion transport (GO:0043268),-0.2732844373477087,-0.8838173160168532,0.6954643628509719,0.8630364694312233,1.0,8/38,13.84%,KCNJ2;KCNMA1;FHL1;FLNA;KCNQ1;KCNMB4;KCNN2;KCNJ15
prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.3189996590626252,-0.8827789589247562,0.628968253968254,0.864667087592808,1.0,6/18,18.12%,UBB;UBC;RPS27A;UBA52;TRIM13;RNF5
prerank,positive regulation of integrin activation (GO:0033625),0.3967437936303426,0.8824427957831367,0.6025641025641025,0.9283913868976813,1.0,3/11,6.38%,CXCL13;FERMT1;CDH17
prerank,mitochondrial membrane organization (GO:0007006),0.3133201432537759,0.881970990609094,0.6114081996434938,0.9287039475697275,1.0,7/32,10.93%,BCL2;SLC25A31;MAIP1;BNIP3;CHCHD6;MTX1;MTX2
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.36555791322400477,0.8818363634094047,0.6064908722109533,0.9282579593210055,1.0,3/16,6.89%,PDE6G;PRKCA;ACP3
prerank,positive regulation of T cell activation (GO:0050870),-0.24278980627088556,-0.88141273510226,0.6879795396419437,0.8669349706009473,1.0,17/62,23.92%,TFRC;SLC7A1;NCK1;PTPRC;CYRIB;XBP1;NCK2;CD81;HSPD1;CD47;IL15;CD274;JAK3;NCKAP1L;THY1;CCR2;CD80
prerank,negative regulation of T cell differentiation (GO:0045581),0.40301574285050085,0.8813649407663275,0.5723140495867769,0.9286422635705588,1.0,3/10,13.73%,CTLA4;GLI3;LAG3
prerank,regulation of phosphate metabolic process (GO:0019220),-0.3309501059360763,-0.8807364585634266,0.6262833675564682,0.8677291435810446,1.0,8/16,33.95%,IKBKB;RAD17;SMG5;TIGAR;PSEN1;BARD1;SMG6;PGAM1
prerank,positive regulation of neuron differentiation (GO:0045666),-0.2721426457472778,-0.8806974747015198,0.6844547563805105,0.8671970674138131,1.0,11/40,16.32%,MEF2C;NGF;NRCAM;MMD2;RHOA;BMP2;REST;HEYL;ARHGEF2;BRINP2;TCF3
prerank,epithelial cell migration (GO:0010631),-0.27557282604004946,-0.8806331539692717,0.665943600867679,0.866759873086388,1.0,15/37,22.38%,NOS3;PLXND1;FAP;PXN;KANK1;DPP4;RHOA;SCG2;CDH13;PKN3;PLEKHG5;ADGRA2;CYP1B1;PRKX;PTP4A3
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.3288946772350254,0.8805738313203714,0.584870848708487,0.9296717855907376,1.0,4/24,7.92%,JARID2;RBBP4;RBBP7;MTF2
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.24841787577264002,-0.8802888057790785,0.6909547738693468,0.8668870056528994,1.0,28/63,36.17%,RPL26;SOX4;PLK2;PLAGL1;CNOT6L;CHEK2;CDKN1B;FBXO31;RPS27L;TNKS1BP1;CDK2;PCBP4;GADD45A;CDKN1A;E2F7;RGCC;BAX;RFWD3;SFN;PIDD1;AURKA;RPA2;CCND1;CNOT1;E2F8;CRADD;PLK3;CNOT9
prerank,negative regulation of ion transport (GO:0043271),0.3324396613968529,0.8799403948733449,0.6086142322097379,0.9302747323636935,1.0,3/24,4.23%,WNK4;NEDD4;SYT11
prerank,chemokine-mediated signaling pathway (GO:0070098),0.29837030637728634,0.879831901129086,0.6183745583038869,0.929777100012981,1.0,6/42,14.90%,OXSR1;CXCL13;CCL19;CCL4;CIB1;CX3CL1
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.24254922856144626,-0.8797755379162928,0.6683673469387755,0.8673730796441251,1.0,28/69,31.49%,STT3B;TRIM25;HSP90B1;BAG6;DERL1;HSPA5;HERPUD1;ERLIN2;TRIM13;WFS1;DNAJC10;AUP1;RNF5;DNAJB9;FBXO17;TMEM129;VCP;RNF103-CHMP3;YOD1;UBE2J1;SYVN1;FOXRED2;SEC61B;FBXO2;RHBDD2;STUB1;UBE2J2;RNF185
prerank,mitotic recombination (GO:0006312),0.3704461465088067,0.8797279351303753,0.6012526096033403,0.9292586898794108,1.0,6/15,22.11%,DMC1;TEP1;RAD51;TPRKB;RAD50;RAD52
prerank,protein glycosylation (GO:0006486),0.243218296950699,0.8797102042719909,0.6906584992343032,0.9285514235624214,1.0,14/125,8.14%,B3GALT1;ST3GAL3;GALNT18;GALNTL5;LARGE1;B3GNT5;ST3GAL5;B4GALT1;ALG6;MAN1C1;TET1;ALG2;GFPT2;ALG9
prerank,proton transmembrane transport (GO:1902600),0.30248477712264754,0.8795212089764178,0.6466302367941712,0.9282444499301842,1.0,5/36,12.71%,ATP1A2;ATP6V0D1;ATP6V0E1;SLC36A2;DMAC2L
prerank,nucleotide-excision repair (GO:0006289),-0.2262784680351503,-0.8794118637832519,0.7506702412868632,0.8675542922948359,1.0,35/101,28.60%,ATXN3;UBB;UVSSA;COPS7A;UBC;RPS27A;PPIE;RBX1;DDB1;OGG1;RPA1;ERCC8;POLR2C;XAB2;UBA52;COPS8;POLR2G;POLK;POLA1;CETN2;COPS6;LIG4;POLE;POLD3;POLB;POLD1;GTF2H2;POLR2L;ERCC5;POLL;XPA;HMGN1;RFC5;ERCC3;LIG3
prerank,transcription by RNA polymerase III (GO:0006383),-0.2933107818471007,-0.8792622878414507,0.6352201257861635,0.8672842840619923,1.0,12/27,25.17%,IVNS1ABP;SNAPC1;BRF1;ZC3H8;SNAPC4;CRCP;GTF3C1;RO60;GTF3C2;GTF3C4;POLR2L;SNAPC2
prerank,negative regulation of protein processing (GO:0010955),-0.36111632368638136,-0.8791535466371467,0.6202290076335878,0.8669323592464003,1.0,2/12,3.73%,THBS1;SERPINE2
prerank,regulation of mast cell degranulation (GO:0043304),0.3703918908216444,0.8788746980654053,0.6079664570230608,0.9289458447911008,1.0,5/14,19.15%,FER;GAB2;LYN;CD84;LGALS9
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.3095889523627433,0.8786593240879657,0.614853195164076,0.9286863533741417,1.0,2/32,1.95%,CEMIP;PDPK1
prerank,hyaluronan catabolic process (GO:0030214),-0.32726578959992186,-0.8786039039587152,0.6347826086956522,0.8674885379566479,1.0,6/18,8.83%,TGFB1;CD44;CEMIP2;CHP1;HEXB;HEXA
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.3150769031105244,-0.8785529033094146,0.6221294363256785,0.8669971820552981,1.0,7/22,25.69%,SLC7A5;TNFRSF1B;LAPTM5;TRPM4;TRIL;CCR2;SPHK2
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.2938056039081509,-0.8781835727527658,0.6586433260393874,0.8671972174083251,1.0,15/27,33.94%,CD44;SPRED2;DDX5;CD74;MIF;EEF1E1;ATR;PTTG1IP;PSMD10;YJU2;SNAI2;SPRED3;PMAIP1;KMT5A;SMYD2
prerank,protein catabolic process (GO:0030163),0.2765157106420266,0.8781504253742047,0.6565008025682183,0.9291040944861421,1.0,12/59,14.11%,ADAMTS9;PRKN;CLPX;TPP1;FBXO44;LAMP2;SIAH2;FBXO6;CUL4B;NGLY1;RAB12;TRIM24
prerank,regulation of cellular amino acid metabolic process (GO:0006521),-0.25451893615022814,-0.8781289116279958,0.6802884615384616,0.8667197732528945,1.0,13/53,15.39%,PSMD13;PSMF1;OAZ1;PSMB10;PSMB6;AZIN1;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;PSME1;PSMB3
prerank,nuclear export (GO:0051168),0.2639988035370721,0.8781223770702116,0.6725806451612903,0.9284391201541556,1.0,3/80,1.76%,RANBP3L;ATXN1;PHAX
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.3171825603058236,0.8781101062609133,0.599624060150376,0.9277237159529399,1.0,5/28,10.22%,ADCY1;EPHA4;PTN;ARC;ABL1
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.34241195685524717,-0.8779665917343443,0.6424116424116424,0.8664851694696823,1.0,10/15,44.20%,RYR2;SRPRB;SEC61G;ZFAND2B;SRP14;SPCS3;RAB10;SEC61A1;SPCS1;SRPRA
prerank,positive regulation of telomere maintenance (GO:0032206),-0.2835764072661066,-0.8777788606455156,0.6485260770975056,0.866305264975179,1.0,4/31,10.79%,NEK7;GNL3;PPP1R10;MAP2K7
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.3230114193124657,-0.8776795864591264,0.6361788617886179,0.865921255132554,1.0,4/17,11.76%,TMSB4X;KLF4;ARRB1;BCL3
prerank,positive regulation of calcium ion import (GO:0090280),0.3861882522883558,0.8770293868527124,0.5935727788279773,0.9293101612356081,1.0,1/12,2.84%,PDGFRB
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.3991640423670938,0.876802260443169,0.5805785123966942,0.9290456977004828,1.0,1/10,0.99%,FGFR2
prerank,negative regulation of cellular protein metabolic process (GO:0032269),-0.2273387539288789,-0.8766127065944154,0.7353689567430025,0.8676143068240758,1.0,24/88,24.08%,CST3;DAB2IP;RACK1;RPS3;SERPINE2;CALR;IGFBP5;TOB1;BAG6;GAPDH;YBX1;EDN1;DNAJC1;RIDA;RPL13A;CLN8;CAMK2N1;MRPL13;CDK5;AKT1;HDAC6;FMR1;PCIF1;PUS7
prerank,cellular response to virus (GO:0098586),-0.2889506286197029,-0.8765656341380599,0.6428571428571429,0.8671106939451512,1.0,12/30,26.30%,HSP90AA1;ARF1;CHUK;IFIH1;GBF1;ZC3H12A;EIF5A;FMR1;MAPK11;VWCE;BAX;CXCL10
prerank,regulation of actin filament-based movement (GO:1903115),0.3998604139408464,0.8762883724309279,0.6079664570230608,0.9294400992428011,1.0,2/10,4.09%,PDPN;ANK2
prerank,mitochondrial translational termination (GO:0070126),-0.2307758326747454,-0.8760845691121082,0.7297297297297297,0.8675831333907559,1.0,26/88,26.30%,MRRF;MRPL33;MRPL32;MRPS14;MRPL38;ERAL1;MRPS16;MRPL50;MRPL23;MRPS5;MRPL24;MRPS28;MRPS35;MRPL13;MRPL35;MRPL34;MRPS23;MTRF1L;MRPS11;MRPS2;MRPS27;MRPS18C;MRPL11;MRPL18;MRPL57;MRPL14
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.30095584534163383,0.8759559694935762,0.6481149012567325,0.9294539479981433,1.0,11/36,15.73%,TCF7L2;PLCB1;TNRC6B;TNRC6A;PDE6G;AGO2;FZD2;MAP3K7;NLK;MOV10;GNG2
prerank,regulation of mitochondrial depolarization (GO:0051900),-0.3801559571855274,-0.875362061186796,0.6194852941176471,0.8684983889940567,1.0,3/10,7.57%,KDR;RACK1;MYOC
prerank,negative regulation of fibroblast proliferation (GO:0048147),-0.3253855990783381,-0.8744294160920489,0.638,0.8698631820979609,1.0,2/18,3.28%,FTH1;DAB2IP
prerank,regulation of phosphorylation (GO:0042325),-0.21715672126734986,-0.8737289718511271,0.7701492537313432,0.8707329507155093,1.0,36/120,22.34%,FN1;FNIP2;ITGA6;THBS1;PTK2;HSPB1;CORO1C;IKBKB;CCDC88A;APP;EMP2;SESN2;ZBTB7A;NLRC5;CDKN1B;KCTD20;OGT;RAD17;CADM4;NUP37;CCDC88C;MIF;NUP54;NUP85;BMP4;NOP53;NUP133;INHA;ANG;PSEN1;NCKAP1L;PRKRIP1;POM121;EIF6;CDKN1A;CDKN2D
prerank,positive regulation of cellular respiration (GO:1901857),-0.36978004773529416,-0.8734676958548638,0.6413255360623782,0.8706989052373011,1.0,8/11,39.96%,ISCU;PINK1;VCP;IFNAR1;PRELID1;PARK7;IFNLR1;IL4
prerank,negative regulation of cholesterol transport (GO:0032375),0.39107842926112335,0.8725347482926853,0.6029723991507431,0.9363423963748689,1.0,2/10,9.19%,PLA2G10;APOC1
prerank,interleukin-7-mediated signaling pathway (GO:0038111),-0.32732054554298057,-0.872449504071179,0.6505791505791506,0.8716137466318957,1.0,11/17,35.32%,SOCS2;STAT3;CISH;JAK3;SOCS1;JAK1;CRLF2;IL2RG;IL7R;IL7;TSLP
prerank,cellular response to interleukin-7 (GO:0098761),-0.32732054554298057,-0.872449504071179,0.6505791505791506,0.8716137466318957,1.0,11/17,35.32%,SOCS2;STAT3;CISH;JAK3;SOCS1;JAK1;CRLF2;IL2RG;IL7R;IL7;TSLP
prerank,skin development (GO:0043588),-0.24175677229627118,-0.8722854118233645,0.6994818652849741,0.8713921727281217,1.0,13/65,13.48%,ITGA6;CLIC4;JAG1;LSR;ITGB4;COL5A2;PKD1;MET;BCR;WNT16;HRNR;ALOX12;STMN1
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.38076068496779847,0.8722485687112601,0.5891783567134269,0.9362240911286833,1.0,1/12,2.31%,INSIG2
prerank,histone H2A acetylation (GO:0043968),0.35374047741897113,0.8717980797410845,0.615866388308977,0.9364451788215541,1.0,1/16,1.41%,BRD8
prerank,water-soluble vitamin metabolic process (GO:0006767),0.26313712533893174,0.8715751020797657,0.6870109546165885,0.936214710122032,1.0,12/68,14.18%,PCCA;MCCC2;TCN2;MTHFR;FOLR2;SLC19A2;SLC19A1;FLAD1;SHMT1;TCN1;THTPA;MMAB
prerank,negative regulation of cellular component organization (GO:0051129),0.2639806565462788,0.8711734190644881,0.6568144499178982,0.9363438663343241,1.0,13/74,13.82%,BMP6;EPHA3;SYT11;SNX33;WASL;PRKCZ;XRCC5;RUBCN;RTEL1;PACSIN3;AR;HSF1;RAPGEF3
prerank,negative regulation of endopeptidase activity (GO:0010951),-0.2539534802155359,-0.8708126167924978,0.6943127962085308,0.8739200459790625,1.0,17/47,26.27%,SPOCK2;SERPINE2;SERPINI1;SERPINB9;SERPINF1;GAPDH;BIN1;SPOCK1;MT3;TIMP2;SERPINA2;AKT1;SPOCK3;SORL1;TIMP1;ANXA8;ANXA8L1
prerank,piRNA metabolic process (GO:0034587),0.34581366788368123,0.870390597821757,0.587360594795539,0.937342597823939,1.0,1/19,2.38%,MYBL1
prerank,defense response to bacterium (GO:0042742),0.24786233311256609,0.8702093239257539,0.7252252252252253,0.9369985452627159,1.0,13/105,13.13%,COLEC12;GSDMA;LTF;CXCL13;SLAMF8;ANXA3;IL6;OPTN;GSDMD;PGLYRP3;MR1;SERPINE1;S100A9
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.31803600920787906,0.8701770338194225,0.6177606177606177,0.9363391190243494,1.0,5/27,8.20%,CTPS1;CTPS2;NUDT13;TYMS;TXNRD1
prerank,development of primary male sexual characteristics (GO:0046546),0.3021817084508045,0.8699034426310998,0.6459854014598541,0.9362044803553643,1.0,3/34,5.93%,WNT4;KIT;LRP2
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.244276647086166,0.8697913013824766,0.7229832572298326,0.9357065436077909,1.0,27/128,17.25%,NINL;ALMS1;PLCB1;PHLDA1;CDK7;CCDC57;HAUS4;CEP152;SDCCAG8;OPTN;PAFAH1B1;CDK1;FBXL17;LATS1;OFD1;HAUS1;SFI1;CEP57;MNAT1;CDKN2B;BACH1;CEP63;CEP164;BRSK1;SKP2;TUBG1;PPP1R12B
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.31672589811455115,-0.8697583636983461,0.6377118644067796,0.8755122792899532,1.0,9/18,31.42%,APOD;GSK3B;CHP1;MDFIC;CTNNA1;OTUD7B;CABP1;SIN3A;MFHAS1
prerank,negative regulation of biosynthetic process (GO:0009890),0.3587258591137026,0.8691211762174242,0.61328125,0.9364071802544496,1.0,5/16,17.53%,PPARA;IL6;SLC30A10;ABCB7;TRAP1
prerank,negative regulation of autophagosome assembly (GO:1902902),0.3709612487514252,0.8687989414758369,0.6280487804878049,0.9363476522768244,1.0,4/13,13.38%,LRRK2;NUPR1;TMEM39A;FEZ1
prerank,V(D)J recombination (GO:0033151),0.38735571965986837,0.8687618549772946,0.625531914893617,0.9356913176783778,1.0,3/11,11.23%,XRCC4;PRKDC;LIG1
prerank,cell cycle G2/M phase transition (GO:0044839),0.24228609279419366,0.8686532992342899,0.7061469265367316,0.9351967509606235,1.0,27/129,17.25%,NINL;ALMS1;PLCB1;PHLDA1;CDK7;CCDC57;HAUS4;CEP152;SDCCAG8;OPTN;PAFAH1B1;CDK1;FBXL17;AKAP8L;LATS1;OFD1;HAUS1;SFI1;CEP57;MNAT1;CDKN2B;CEP63;CEP164;BRSK1;SKP2;TUBG1;PPP1R12B
prerank,carboxylic acid catabolic process (GO:0046395),0.3829893760983399,0.8682479280356994,0.6194503171247357,0.9353876850372342,1.0,3/12,14.19%,ACOT4;RENBP;NPL
prerank,water transport (GO:0006833),-0.35455731855180994,-0.8678905245416267,0.6173076923076923,0.8788175733395367,1.0,3/12,15.12%,AQP11;AQP4;CFTR
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),-0.3397098036298593,-0.8677880808915389,0.6313645621181263,0.8784423711690128,1.0,5/14,18.60%,CEPT1;LPIN3;ETNK1;LPIN1;ETNPPL
prerank,rRNA 3'-end processing (GO:0031125),0.39985284653441344,0.8677519578315123,0.6144329896907217,0.9357641508373774,1.0,5/10,18.02%,ERI3;ERI2;EXOSC8;ERI1;EXOSC3
prerank,membrane depolarization (GO:0051899),0.3064558693313459,0.8675914203160211,0.6454545454545455,0.935380408448608,1.0,2/32,4.95%,SCN7A;CACNB4
prerank,transport along microtubule (GO:0010970),-0.34898493377849404,-0.8675552813953291,0.6653771760154739,0.8783388924098949,1.0,5/13,28.33%,COPG1;APP;CAMSAP3;APBA1;DYNC1I1
prerank,apical protein localization (GO:0045176),0.39058125443939773,0.8675040549111744,0.6135371179039302,0.9348517843758174,1.0,2/10,2.96%,SHROOM3;SHROOM2
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.3722574562327546,0.8670884392642231,0.6533864541832669,0.9350030657274998,1.0,1/14,1.05%,PPARA
prerank,regulation of T cell activation (GO:0050863),-0.2637097739312559,-0.8670169725971537,0.6771084337349398,0.8788881488857636,1.0,21/42,39.23%,TNFRSF1B;CYRIB;DUSP3;HSPD1;CD47;LAPTM5;JAK3;METTL3;THY1;CCR2;CCL2;LAX1;IL4I1;PTPN22;GPNMB;PRELID1;KAT2A;CCL5;VTCN1;CRTAM;LCK
prerank,replication fork processing (GO:0031297),0.2906913059371333,0.8667760686589683,0.653448275862069,0.9349478090234187,1.0,16/38,25.38%,BLM;BRCA2;ZGRF1;RTEL1;BOD1L1;PRIMPOL;MRE11;CENPX;WRN;RAD51;CDK9;ETAA1;SAMHD1;THOC1;SMARCAL1;ATRX
prerank,GPI anchor metabolic process (GO:0006505),0.32096231000963854,0.8667087394586547,0.6355140186915887,0.9343541452780004,1.0,6/26,16.72%,PIGU;PIGG;PIGV;PIGC;PIGQ;PIGN
prerank,regulation of dephosphorylation (GO:0035303),-0.33135919926690055,-0.8666187820742214,0.642023346303502,0.8791105853310299,1.0,8/15,35.48%,PPP1R16B;MTMR9;PPP1R16A;SMG5;MTMR1;SMG6;INPP5K;CDK5RAP3
prerank,protein-containing complex subunit organization (GO:0043933),-0.21713596912075298,-0.8665247165753215,0.7988668555240793,0.8787097381412871,1.0,20/109,14.63%,SLC2A1;OCLN;LIN7A;PPARGC1A;PTK2B;REPS2;HES1;WIPF1;CAPZA2;SKAP2;CARD10;ADD2;IL1RAP;APC;CD2AP;ST13;CD74;ELOB;TRAF1;FAS
prerank,positive regulation of signaling (GO:0023056),-0.2709059159259508,-0.86611821689224,0.6894273127753304,0.878927461326789,1.0,18/37,32.95%,NSF;HOMER1;CLSTN2;EDN1;ECE1;KCTD13;CLSTN3;PTPN23;INPP5F;GRIK2;SOX11;CD80;CLSTN1;RIMS2;VAMP3;SYT1;ILK;NMB
prerank,mammary gland development (GO:0030879),0.32925082516176446,0.865819674254468,0.6416184971098265,0.9355367697774034,1.0,5/21,12.27%,WNT4;ARHGAP35;APLN;JAK2;GLI2
prerank,regulation of response to interferon-gamma (GO:0060330),-0.3484644163450927,-0.8658108682952895,0.6698292220113852,0.8789523588240027,1.0,6/14,26.82%,HSP90AB1;CDC37;IFNGR1;SOCS1;JAK1;STAT1
prerank,protein autoprocessing (GO:0016540),0.3506658942677356,0.8658083208308968,0.6173076923076923,0.9348301591034515,1.0,4/17,15.25%,PCSK9;MYRFL;OMA1;HTRA2
prerank,response to gamma radiation (GO:0010332),-0.297371797116539,-0.8655975240583103,0.6832971800433839,0.8787984022685433,1.0,10/24,24.83%,RPL26;CRYAB;MEN1;TRIM13;LIG4;TLK2;ATR;TMEM109;HRAS;TSPYL5
prerank,phosphatidylinositol dephosphorylation (GO:0046856),-0.304512408454736,-0.86452815309636,0.6561797752808989,0.8803652993723119,1.0,10/23,25.03%,SYNJ1;MTM1;MTMR6;MTMR9;SACM1L;MTMR12;INPP5F;PIP4P2;MTMR1;TPTE
prerank,response to growth factor (GO:0070848),-0.2633441547978075,-0.8643064375493096,0.6772009029345373,0.8802429986810161,1.0,13/41,21.60%,ACVRL1;KLF4;RACK1;BMPR2;TGFBR2;CTNNB1;CPNE3;NOS1;SOX2;ACVR1;AKT1;ACVR1C;HDAC6
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.20975761719321437,0.8641268834052365,0.8421686746987952,0.9377146319405042,1.0,71/497,13.37%,TCF7L2;WNT4;RBPJ;NR2F2;BMP7;ATXN1;IGF2BP1;DAPK1;SNX6;DKK3;ARID5B;RUNX1T1;ZEB1;PRDM5;ZIC2;NR1I2;PLCB1;LOXL3;TSHZ3;JARID2;MIDEAS;ZHX2;PRICKLE1;VGLL4;HOXA7;FOXD1;CBY1;BEND5;ARID4A;L3MBTL2;IKZF4;GLI3;DPF2;SFMBT1;NIBAN2;SALL1;BCOR;TYMS;XRCC5;RSF1;TLE1;BIRC5;ZMYND15;WWP2;KAT8;KAT6B;MDM2;SAMD4A;SMURF2;MBTD1;SCMH1;PDS5A;HDAC1;L3MBTL3;ATOH8;ZBTB38;TFAP2A;SMARCE1;TFAP2B;ZNF568;FXR1;MYB;CRY1;CBFA2T2;NONO;FOXK2;SOX13;PSPC1;TSPYL2;SHMT1;CLOCK
prerank,regulation of interleukin-1 beta production (GO:0032651),0.2650156966316365,0.8640172286029153,0.6895368782161235,0.9372206190916181,1.0,6/66,10.25%,IGF1;IL6;CCL19;SIRPA;GSDMD;JAK2
prerank,generation of neurons (GO:0048699),0.23048463843576683,0.8638482157367912,0.7387640449438202,0.9368824269735085,1.0,21/190,10.85%,DCDC2;AUTS2;WNT4;WNT6;ASCL2;IL1RAPL1;NDNF;PCSK9;ARTN;SH3RF1;SDCCAG8;PTPRD;WNT5B;EN1;RYK;YTHDF2;PAFAH1B1;TUBGCP2;IRX1;NEUROD2;ATOH8
prerank,negative regulation of bone remodeling (GO:0046851),-0.36296265199050315,-0.8637152653763747,0.6470588235294118,0.8808904209397218,1.0,6/11,27.98%,UBASH3B;GPR137B;GPR137;GREM1;TNFAIP3;CALCA
prerank,neuron remodeling (GO:0016322),-0.37423913125265107,-0.8636117545766285,0.6509433962264151,0.8805188587136313,1.0,4/10,13.96%,SCARF1;ANKS1A;APP;C1QA
prerank,granulocyte chemotaxis (GO:0071621),-0.250347617873987,-0.8631517609957016,0.7177033492822966,0.8807839710063893,1.0,11/55,17.21%,BSG;TGFB2;PPIA;CXADR;EDN1;PPIB;PIK3CD;SCG2;PIP5K1C;GBF1;CCL13
prerank,protein maturation (GO:0051604),-0.2197067162546505,-0.8628268117392001,0.7612732095490716,0.8808518407060071,1.0,25/95,24.96%,ADAM10;F3;CPD;PCSK2;GALNT2;PTCH1;SRGN;TSPAN17;ECE1;FURIN;CPXM2;OGT;NAA40;DNAJB11;HSPD1;GLRX3;PCSK1;ADAMTS3;PSEN1;PCSK5;TYSND1;NNAT;ISCA1;NAA16;SORL1
prerank,melanosome localization (GO:0032400),0.3350038152572484,0.8627698319062077,0.6209677419354839,0.9384814427150298,1.0,4/21,9.92%,SHROOM2;ARL6;GPR143;BBS7
prerank,chemical homeostasis (GO:0048878),-0.24376903145398843,-0.8625076362119014,0.7100271002710027,0.8809113585786991,1.0,14/61,17.27%,SLC4A10;NEDD4L;WNK3;ACOX3;AQP11;SLC4A8;AQP4;SLC4A2;VGF;NR1D2;ATP13A2;WNK2;TLCD2;CLN8
prerank,negative regulation of protein kinase B signaling (GO:0051898),-0.2656165161743388,-0.8619980666577438,0.708433734939759,0.8813377742313593,1.0,13/38,23.66%,PTPRJ;PPP2R5C;RACK1;PLEKHA1;GPER1;XDH;OTUD3;SH2B3;ARRB2;NOP53;AKT1;HYAL2;TRIB3
prerank,endochondral bone morphogenesis (GO:0060350),-0.3674015914707065,-0.8619890988302962,0.664783427495292,0.8807661681028721,1.0,2/11,3.97%,MEF2C;BMPR2
prerank,protein complex oligomerization (GO:0051259),-0.22956601126108814,-0.8616417778821558,0.7320954907161804,0.8808803342733983,1.0,21/85,17.85%,LRRC8C;LRRC8D;EHD4;MAT2A;HOMER1;EHD1;PRMT8;AQP11;TRMT61B;CPSF7;LRRC8A;CPSF6;STOML2;EHD3;FUS;TMEM120A;POLQ;GLRA3;ATL2;ZC3H12A;LETM1
prerank,establishment of mitotic spindle localization (GO:0040001),-0.2833194736798523,-0.8614666317366665,0.7006237006237006,0.8806400905572817,1.0,14/28,35.17%,ITGB1;NSFL1C;NDE1;INSC;DCTN1;NUMA1;CLASP2;NDC80;SPDL1;PLK1;ESPL1;PKHD1;CLASP1;NUSAP1
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.2129982945622625,0.8612358952569453,0.8121827411167513,0.9410787004652782,1.0,63/366,15.88%,RORA;EFEMP1;ARNT2;DENND4A;ATXN1;TULP3;ESRRG;MYBL1;NR1I2;SOX6;PPARGC1B;NFYB;SSBP2;IGF2;NCOA2;SOX1;PERM1;SUFU;ZFP37;TCF7L1;WWC1;THAP1;UBE2L3;GPBP1;WWC2;GPBP1L1;MTF2;ZKSCAN5;POLR2A;MITF;NFIA;ZNF628;KAT6B;BRCA2;NSD1;NUP107;NFYC;ABL1;ASCC2;ZBTB11;ZBTB38;RBBP6;RNF14;MYB;NONO;RNF20;FOXK2;SOX13;PSPC1;CLOCK;CREBBP;ESCO1;NLK;UBE2V1;PCGF1;BACH1;PATZ1;SOX12;PHF1;SMARCA2;ZNHIT3;FZD7;ORC3
prerank,positive regulation of nervous system process (GO:0031646),0.33687612823283475,0.8611108492174228,0.597979797979798,0.9406066093427302,1.0,3/18,3.93%,NLGN2;PARD3;ITGAX
prerank,positive regulation of transport (GO:0051050),-0.227009833381773,-0.8611031496188776,0.7653333333333333,0.8807579305656876,1.0,36/85,29.43%,ACTB;GAS6;NEDD4L;RAB27A;GATA2;CALR;DOCK2;GSK3B;HIP1R;CHP1;C2CD5;LMAN2;CD47;IL15;SGK1;ACSL3;SLC11A1;NUMA1;MLC1;NR1H3;DLL1;FMR1;PLAA;SPAG5;CAPN10;FCGR2B;CHCHD10;BAX;SYNGR3;CHRM1;BID;DOC2B;IL2RG;TREM2;ABCA7;AHSG
prerank,response to cholesterol (GO:0070723),-0.32747430051606125,-0.8610257587181658,0.6614481409001957,0.8803288573382609,1.0,4/17,9.79%,TGFBR2;TGFB1;PTCH1;GRAMD1A
prerank,maintenance of protein localization in organelle (GO:0072595),-0.3137182099828081,-0.8604989424863476,0.6707070707070707,0.8807950622033486,1.0,9/19,24.01%,HK1;HNRNPU;ARL2BP;HSPA5;BCL3;PINK1;AKT1;SKP1;CHCHD10
prerank,negative regulation of neurogenesis (GO:0050768),0.3032357591889763,0.8601682692184467,0.6541889483065954,0.9418432376990963,1.0,5/34,7.47%,APPL2;LRP4;PTN;IL6;PTEN
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.32651711898616753,0.8601362992238214,0.6376518218623481,0.9411785629826233,1.0,1/25,0.35%,LEPROT
prerank,pentose-phosphate shunt (GO:0006098),0.3912332220737325,0.8601068880273417,0.6242299794661191,0.9405093523060165,1.0,4/11,11.79%,H6PD;RPE;RBKS;DERA
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.3670411083790922,0.859961640579032,0.6452905811623246,0.9401343266583263,1.0,1/13,0.85%,RBPJ
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.35593592589607237,0.8598840423119407,0.6406570841889117,0.9395752375195568,1.0,3/16,6.76%,IGF1R;MTRF1;BNIP3
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.3837118599000157,0.8597016240052411,0.6278586278586279,0.9392452055608491,1.0,1/12,1.05%,PPARA
prerank,modulation by host of symbiont process (GO:0051851),-0.27590498278481607,-0.8596763442103756,0.6646090534979424,0.8819411214886019,1.0,5/31,15.51%,LEF1;TARDBP;JUN;REST;CX3CR1
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.3470509193109048,0.8595585143520796,0.6509803921568628,0.9388325126463175,1.0,6/18,17.53%,PRKN;NOL3;NONO;NME5;HTRA2;TRAP1
prerank,B cell homeostasis (GO:0001782),-0.3794614056414913,-0.8593014211476804,0.6398467432950191,0.8820756933115986,1.0,5/10,20.26%,MEF2C;DOCK10;CAMLG;PPP2R3C;NCKAP1L
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.3494623710905208,0.859204773691154,0.5991735537190083,0.9388761453144719,1.0,8/16,20.67%,BLM;SSBP1;MCM2;WRN;RAD51;PURA;MCM7;RECQL5
prerank,regulation of chemotaxis (GO:0050920),0.3147060955648639,0.8570014462507785,0.6716981132075471,0.9428406274368227,1.0,5/30,10.59%,EFNB2;PDGFRB;PDGFRA;CCL19;MYCBP2
prerank,protein acylation (GO:0043543),-0.26202469619077023,-0.8566902401268135,0.7152777777777778,0.8867216503649459,1.0,9/38,12.39%,ZDHHC14;ZDHHC15;FOXO1;ZDHHC2;ZDHHC7;ING4;PORCN;SELENOK;HHAT
prerank,microtubule anchoring (GO:0034453),-0.34818614920009106,-0.8566683603325269,0.6566265060240963,0.8861722484968257,1.0,8/12,40.35%,BICD1;CLASP2;CAMSAP3;SAXO2;PCM1;BCCIP;CLASP1;GCC2
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.3748424591574906,0.8564878456311482,0.6171548117154811,0.9432123344346829,1.0,3/12,9.94%,CDC14B;PTEN;GOLGA2
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.3281952952324467,0.8564547028176278,0.6519337016574586,0.9425491244368067,1.0,2/22,2.80%,APPL2;LTF
prerank,early endosome to late endosome transport (GO:0045022),-0.30658216513209513,-0.8564492553687921,0.6645962732919255,0.8860601286555141,1.0,6/20,15.04%,EMP2;SNX16;LMTK2;PTPN23;PIK3C3;HOOK1
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.30251198119748657,0.8564033035386115,0.6685185185185185,0.9419366408786921,1.0,6/30,12.84%,DAB2;KLK2;NCOA2;HDAC1;RNF14;AR
prerank,protein K48-linked ubiquitination (GO:0070936),0.27608152735862335,0.8561980039092492,0.6894824707846411,0.9416376147088704,1.0,15/54,17.41%,PRKN;UBE2E2;TTC3;RNF152;AMFR;RNF216;ITCH;KBTBD7;FBXO38;IFI27;UBE2A;UBE2H;SKP2;UBE2E1;DTX3L
prerank,regulation of BMP signaling pathway (GO:0030510),0.2564932802588254,0.8561679459471778,0.7018121911037891,0.9409723063102094,1.0,14/73,11.87%,RBPJ;SMAD6;FOXD1;SPART;SULF1;ITGA3;LRP2;NBL1;FSTL3;SMURF2;LEMD3;TFAP2B;FSTL1;BMPR1A
prerank,ERAD pathway (GO:0036503),-0.22862997874943378,-0.8560189251280512,0.7455012853470437,0.8863285822025964,1.0,35/83,31.67%,ATXN3;STT3B;TRIM25;HSP90B1;BAG6;DERL1;CCDC47;UBXN6;HSPA5;HERPUD1;ERLEC1;ERLIN2;TRIM13;WFS1;DNAJC10;AUP1;RNF5;DNAJB9;GET4;FBXO17;TMEM129;VCP;RNF103-CHMP3;BRSK2;YOD1;UBE2J1;SYVN1;FOXRED2;SEC61B;FBXO2;RHBDD2;STUB1;UBE2J2;RNF185;UGGT1
prerank,cGMP-mediated signaling (GO:0019934),0.3641154986273475,0.8557259952945963,0.6242299794661191,0.941152525076244,1.0,1/13,0.92%,IRAG1
prerank,nucleotide biosynthetic process (GO:0009165),0.33201708342749203,0.8557106058206401,0.6145833333333334,0.9404624480954913,1.0,3/18,5.70%,PRPSAP2;NMNAT2;ADSL
prerank,epidermal cell differentiation (GO:0009913),-0.2584840676274608,-0.8556399274566294,0.677570093457944,0.8865155853023661,1.0,9/41,20.51%,CLIC4;JAG1;CTNNB1;BCR;WNT16;GLI1;DSP;ADAM9;USH2A
prerank,regulation of tumor necrosis factor production (GO:0032680),-0.21258421044601242,-0.8553659914231977,0.7932011331444759,0.8864644261708686,1.0,28/112,20.71%,PTPRJ;FOXP1;IL33;CD34;THBS1;GAS6;PLCG2;LBP;HSPB1;PTPRC;APP;STAT3;OAS2;ARHGEF2;CLU;CD47;IRAK3;IFNGR1;IFIH1;CX3CR1;MIF;ZC3H12A;NR1H4;TYROBP;PSEN1;FRMD8;TRIM27;TIRAP
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.39553103086546243,0.8551451837406938,0.6373165618448637,0.9409295859536865,1.0,1/11,1.05%,PPARA
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.33793704127026675,-0.8544467794510584,0.6692759295499021,0.8877611113728981,1.0,5/14,16.01%,SEMA7A;PLCG2;CD74;CAMK4;LAPTM5
prerank,response to tumor necrosis factor (GO:0034612),0.2543425083363834,0.8542617357154466,0.7147385103011094,0.9420557781034085,1.0,11/91,10.89%,ADAMTS12;PID1;CRHBP;SPHK1;ZFAND6;CACTIN;ADAMTS7;CCL19;JAK2;CCL4;GSDME
prerank,telomere maintenance via telomere lengthening (GO:0010833),-0.27060793438736963,-0.8539929822327041,0.7292110874200426,0.888092319273582,1.0,8/33,18.02%,HSP90AA1;HSP90AB1;PINX1;RPA1;TERF2IP;ANKRD28;TNKS1BP1;CDK2
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.30150273676516737,-0.8539483828473994,0.6687370600414079,0.8876165338187159,1.0,10/22,26.28%,CALM1;ATP1B1;VMP1;RYR2;CALM2;STAC3;JPH2;CALM3;HAP1;CASQ1
prerank,positive regulation of double-strand break repair (GO:2000781),0.28745194356393855,0.8538043253249783,0.6678899082568808,0.9423122224792648,1.0,10/39,17.42%,MRNIP;SPIRE2;SLF1;WDR48;ARID2;PRKDC;PARP9;FANCB;DTX3L;KDM4D
prerank,RNA polyadenylation (GO:0043631),-0.2851501077309816,-0.8536915721290179,0.7044025157232704,0.8869558510882984,1.0,9/26,18.19%,PABPC1;APP;CPSF3;GRSF1;SYMPK;CLP1;AHCYL1;CPSF2;PCF11
prerank,mRNA polyadenylation (GO:0006378),-0.2851501077309816,-0.8536915721290179,0.7044025157232704,0.8869558510882984,1.0,9/26,18.19%,PABPC1;APP;CPSF3;GRSF1;SYMPK;CLP1;AHCYL1;CPSF2;PCF11
prerank,lytic vacuole organization (GO:0080171),0.3033599775960612,0.8532059320715145,0.66728280961183,0.9428660915337566,1.0,5/32,6.89%,HOOK2;ABCA1;LRRK2;TPP1;ACP3
prerank,signal transduction in response to DNA damage (GO:0042770),-0.25529466700698566,-0.8529046349000685,0.735897435897436,0.8879546690300032,1.0,14/49,24.37%,ACER2;TIPRL;CHEK2;SESN2;BCL3;DONSON;RAD17;USP28;RAD9A;ATR;GADD45A;DOT1L;E2F7;CHEK1
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.28906584076742325,0.8528964148061212,0.6549912434325744,0.9427855417160486,1.0,9/41,13.31%,IL34;EPHA4;ACE;DLG4;TGFA;DLG3;GPRC5B;AREG;DOK7
prerank,cytosolic transport (GO:0016482),-0.21521855023392844,-0.852575342941656,0.8112676056338028,0.887998999119868,1.0,34/108,25.44%,MYO1D;MON2;HEATR5A;VPS13A;VPS13C;VTI1B;STX6;LAMP1;EMP2;BET1L;SNX16;EVI5;LMTK2;TBC1D10A;PTPN23;EHD3;PIK3C3;HOOK1;LAPTM5;GBF1;SNX1;VPS51;TBC1D10B;SYS1;TRIM27;DCTN1;SNX2;SPAG9;CLN5;AP2A1;RAB14;RAB6B;TBC1D5;RAB7A
prerank,histone H4 acetylation (GO:0043967),-0.2472169095772291,-0.8525567557919106,0.7321814254859611,0.8874575500533141,1.0,11/47,16.80%,LEF1;MORF4L1;APBB1;ING4;OGT;NAA40;JADE1;KANSL3;PER1;WDR5;RUVBL1
prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.2973979448036234,-0.8524012515658692,0.6610169491525424,0.8872146568138048,1.0,7/22,18.47%,RASSF2;CALM1;PDGFC;VEGFA;CALM2;TNKS1BP1;GREM1
prerank,negative regulation of developmental growth (GO:0048640),-0.27663589103271596,-0.8522255985106922,0.7183406113537117,0.8869565744847381,1.0,11/30,24.24%,DCC;PTCH1;RTN4;CDKN1B;SEMA3G;CDKL3;MT3;RTN4R;CDKN1A;FGFR3;ULK2
prerank,organelle assembly (GO:0070925),0.2082265267101884,0.8519267580766392,0.8492975734355045,0.9441309463264702,1.0,81/384,17.24%,DCDC2;ASAP1;INTU;AVIL;RAB3IP;TP53INP2;SH3PXD2B;ARL3;DYNC2H1;RAB19;CDC14B;MAPRE2;CCDC57;IFT80;WIPI1;HAUS4;CC2D2A;ARMC9;CEP19;TTC8;WDR19;UBXN10;WDR35;KIF27;WDPCP;ARL6;UBXN2B;IQCB1;ATG14;VTA1;RAB32;YTHDF2;TUBGCP6;TCTN1;TEKT2;STAM2;PARVA;ATP6V0D1;TUBGCP2;BBS7;GOLGA2;SCLT1;CEP89;WDR11;FBF1;OFD1;HAUS1;ATG9A;VPS37C;VPS37A;EIF2S1;IFT122;CHMP6;INO80;TTC39C;EXOC3;IFT140;WDR90;PLA2G4C;CFAP298;CCDC65;ATP6V1D;AMBRA1;CFAP410;ATG3;LMOD1;CEP63;CEP164;RAB43;CFAP70;EXOC7;EXOC1;MIS12;RUFY4;IRGM;ATG16L2;NEK6;PDE6D;DYNC2I1;CFAP20;CDS2
prerank,regulation of receptor internalization (GO:0002090),-0.2654898359867888,-0.8519000345272166,0.7172897196261683,0.886999232094757,1.0,15/35,22.10%,RIN3;SFRP4;ARRB1;ARF1;VEGFA;CD63;ANKRD13A;PICK1;MKLN1;GREM1;ARRB2;ANKRD13B;INSR;ATAD1;FMR1
prerank,osteoclast differentiation (GO:0030316),-0.3043837236475763,-0.8512261711783269,0.6895833333333333,0.8877735274703574,1.0,3/22,7.05%,FOXP1;TNFRSF11A;SBNO2
prerank,mitochondrial gene expression (GO:0140053),-0.2570183337774421,-0.8511471294912477,0.705607476635514,0.8873578458800963,1.0,10/42,26.23%,LARS2;TFB2M;NDUFA7;MRPS14;MRPS16;MRPL23;MRPS28;MRPS11;MRPS2;MRPL57
prerank,double-strand break repair via break-induced replication (GO:0000727),-0.35493795202510325,-0.8510128391328909,0.6615087040618955,0.8870473124262496,1.0,7/12,41.75%,MCM4;GINS4;MCM5;MCM6;GINS2;CDC7;CDC45
prerank,glutamine family amino acid metabolic process (GO:0009064),-0.27459604998254883,-0.8508499847133231,0.6969026548672567,0.8867887175024478,1.0,7/33,13.66%,GLS;GCLM;KYAT1;DDAH1;SLC39A8;ALDH18A1;SIRT4
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.35046886413968464,-0.8507440586459146,0.6601178781925344,0.8864171721558436,1.0,5/13,18.01%,CPSF7;CPSF6;CPSF2;CSTF2;CSTF2T
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.37258992582873063,0.8506634799494819,0.6391129032258065,0.9460391392521561,1.0,3/13,13.49%,ARID1B;ZMIZ1;ZMIZ2
prerank,regulation of interleukin-17 production (GO:0032660),0.30491241254291634,0.8506373362725423,0.65625,0.9453837499803686,1.0,4/31,8.76%,IL18;SPHK1;IL6;SLAMF6
prerank,muscle cell migration (GO:0014812),0.38241770038792905,0.8506368771709886,0.6365591397849463,0.9446664633718858,1.0,2/10,4.69%,MEGF10;DDR1
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.3207367175148875,0.8504743951784893,0.6513761467889908,0.9442842948431281,1.0,1/25,0.18%,ARHGAP24
prerank,glucose metabolic process (GO:0006006),-0.24156330609771062,-0.8504082557340507,0.7575757575757576,0.8864769250401378,1.0,9/58,13.71%,APOD;PPARGC1A;PPARD;HECTD4;LRP5;GAPDH;ATF4;TPI1;ALDOA
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.35192837686322087,-0.8500980279074676,0.6625258799171843,0.8864770897530179,1.0,2/12,2.26%,LY6E;GSN
prerank,keratinocyte differentiation (GO:0030216),-0.27396837337252483,-0.849936351321915,0.6885593220338984,0.8861938512456659,1.0,4/29,8.44%,CLIC4;JAG1;BCR;WNT16
prerank,mRNA processing (GO:0006397),-0.18888785212931375,-0.8496182748808105,0.9306122448979591,0.8862514318734671,1.0,104/287,33.58%,HSPA8;NOVA2;HNRNPK;PPARGC1A;SRSF2;PABPC1;SRSF1;HNRNPU;HNRNPA3;PPWD1;SFPQ;PPIE;YBX1;SF3B1;SF3B2;DDX5;CPSF7;RBM14;PHF5A;SRSF5;DDX39B;CPSF3;RALY;KIN;SRSF9;CWC15;HNRNPH2;CPSF6;USP39;RBM8A;POLR2C;XAB2;SNRPC;PRPF40B;RNPS1;PRPF18;SRSF6;SF3B5;FUS;HNRNPA0;SYMPK;CLP1;PRPF4;POLR2G;CPSF2;CSTF2;SPEN;PCBP1;CSTF2T;PCF11;ESS2;YTHDC1;GTF2F2;MTREX;HNRNPUL1;PTBP1;RBM17;MAGOH;THOC3;CTNNBL1;METTL3;SNIP1;RBM22;CMTR2;TRA2B;THOC6;SNRPG;GTF2H2;USP49;HNRNPF;SNRNP35;HNRNPM;POLR2L;ERN1;THOC2;RBM4B;LSM8;PUF60;HNRNPD;EIF4A3;TFIP11;SRSF7;ERCC3;ZCRB1;RBM6;ALYREF;BUD31;AURKAIP1;RBM15;ZC3H11A;HNRNPL;DHX9;CSTF1;GTF2H5;CPSF1;SNRNP48;POLR2B;IK;SYF2;DHX38;U2AF1L4;CHTOP;SNRNP25;PQBP1
prerank,regulation of acute inflammatory response (GO:0002673),0.33484049233860824,0.8495895391837446,0.6431372549019608,0.9453640906807774,1.0,18/18,66.55%,IL6;OSMR;ADAM8;PTGES;KLKB1;F12;DNASE1L3;C2CD4A;C2CD4B;PLA2G2D;DNASE1;FFAR2;OSM;CREB3L3;GSTP1;IL4;IL6ST;NLRP3
prerank,maintenance of protein location in nucleus (GO:0051457),-0.30402776297908296,-0.8489586314674432,0.6913319238900634,0.8869571227209979,1.0,8/20,24.01%,SYNE1;HNRNPU;ARL2BP;BCL3;RANGAP1;SUN1;SKP1;CHCHD10
prerank,protein destabilization (GO:0031648),-0.2693926029729018,-0.8486658971491142,0.7191011235955056,0.8869467136667882,1.0,6/32,9.37%,GSN;FBXL3;SOX17;CUL3;DERL1;SERF2
prerank,regulation of lamellipodium organization (GO:1902743),0.3545240092243218,0.8486524535173091,0.656441717791411,0.9466352731745914,1.0,4/14,10.91%,FER;PDPN;CAPZB;EPHA2
prerank,positive regulation of cyclase activity (GO:0031281),-0.33994148915075506,-0.848245763591108,0.6830188679245283,0.887191152177626,1.0,7/14,21.05%,NOS3;MAPK8;NOS1;CACNA1C;NF1;ORAI1;MAPK3
prerank,response to lipid (GO:0033993),0.24414920418476466,0.8476738103514855,0.7445482866043613,0.9479154371680605,1.0,8/105,3.69%,FGFR4;PPARA;RBP4;SMAD6;CTSH;FER;ANXA1;STAT5B
prerank,vesicle transport along microtubule (GO:0047496),-0.2901437343160102,-0.8465986970607338,0.7063829787234043,0.8897119072973502,1.0,12/23,41.07%,KIF1A;RAB1A;KIF13A;NDE1;BICDL1;KIF3B;HAP1;DYNC1I1;KIF5B;DYNC1H1;CLN3;KIF3A
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.28421164200924237,0.8465912521222428,0.6672597864768683,0.9494803768523412,1.0,8/43,14.18%,ERRFI1;SNX6;STAM2;PTPN3;CHMP6;TGFA;AREG;CBLB
prerank,response to chemokine (GO:1990868),0.3630958990981322,0.846438979746715,0.6209523809523809,0.949074239376529,1.0,2/13,3.68%,OXSR1;RIPOR2
prerank,regulation of synapse maturation (GO:0090128),-0.3636038252421011,-0.8462318480577359,0.6505576208178439,0.8898664587468652,1.0,5/10,15.36%,DAB2IP;ARHGEF15;NRXN1;RELN;CAMK2B
prerank,tRNA 5'-end processing (GO:0099116),-0.32975479023664217,-0.8461880408337015,0.6789883268482491,0.8893776640693399,1.0,8/15,28.10%,SSB;POP5;RPP21;POP4;RPP30;TRMT10C;PRORP;POP7
prerank,DNA double-strand break processing (GO:0000729),0.33984018414098005,0.8460688429005868,0.6342857142857142,0.9491501518503275,1.0,7/18,22.11%,RNF138;BLM;MRE11;RAD50;KAT5;NBN;RAD52
prerank,mitochondrial outer membrane permeabilization (GO:0097345),-0.339449663121106,-0.8459907581283879,0.6723404255319149,0.8891860374118626,1.0,8/13,40.50%,BLOC1S2;RHOT1;BMF;BAX;PMAIP1;BNIP3L;BAD;RHOT2
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.2993052752978706,0.845982710585043,0.6738351254480287,0.9486042230443954,1.0,8/35,14.53%,ACSS3;HMGCL;BDH1;GCDH;PAM;BDH2;HMGCLL1;AWAT2
prerank,protein N-linked glycosylation (GO:0006487),-0.2326410571613838,-0.84563725629794,0.7414634146341463,0.8892428240163261,1.0,27/66,31.67%,ST6GAL1;FUT8;MAGT1;STT3B;KRTCAP2;SLC39A8;MCFD2;RPN1;MGAT1;ALG11;TMEM165;ST3GAL1;DDOST;MGAT2;ALG14;ALG5;ALG1;DPM1;ALG8;MGAT5;UBE2J1;DOLPP1;MGAT5B;ALG3;PMM1;DPAGT1;UGGT1
prerank,regulation of protein localization to cell surface (GO:2000008),0.2974861606515943,0.8453346015520617,0.6666666666666666,0.9492147253019958,1.0,3/33,5.33%,LEPROT;GPD1L;SNX33
prerank,positive regulation of lyase activity (GO:0051349),-0.3427650761913714,-0.8450581789247015,0.6777996070726916,0.8897700094300732,1.0,6/14,17.48%,NOS3;ISCU;NOS1;CACNA1C;NF1;ORAI1
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.31768559826548254,0.8445434731987379,0.6768642447418738,0.9501011196059408,1.0,4/22,10.27%,NR2F2;PTEN;CDK5RAP1;LATS1
prerank,peptidyl-threonine dephosphorylation (GO:0035970),-0.30019926936801455,-0.8438649666537928,0.697228144989339,0.8915269579627595,1.0,11/22,29.63%,DUSP16;PPP1CA;DUSP8;DUSP1;PPM1A;DUSP6;DUSP4;PPM1F;DUSP18;PPP2CA;DUSP7
prerank,mesoderm formation (GO:0001707),-0.3201384223787064,-0.8434712373774647,0.6756756756756757,0.8916891929034577,1.0,3/17,3.97%,ITGB4;ITGB1;BMPR2
prerank,endothelial tube morphogenesis (GO:0061154),-0.3657654237179956,-0.8433164410515219,0.6924528301886792,0.8914093262449019,1.0,6/10,18.81%,ACVRL1;RHOB;CTNNB1;RHOA;CSNK2B;BMP4
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.32324094212006793,-0.8430101024360143,0.6861924686192469,0.8913997325873484,1.0,5/16,22.02%,SCARB1;MFSD2A;NR1H2;CTDNEP1;NR1H3
prerank,regulation of monocyte chemotaxis (GO:0090025),-0.28756352917826344,-0.8429380692567404,0.7068181818181818,0.890943019327065,1.0,9/24,26.81%,SLIT2;LGMN;CCN3;DUSP1;GREM1;CXCL12;CCR2;CXCL10;CREB3
prerank,regulation of viral life cycle (GO:1903900),-0.295602234094691,-0.842774044331094,0.7151767151767152,0.8906845270659388,1.0,6/21,20.55%,PPIA;TRIM14;TRIM25;HS3ST5;TYRO3;TRIM27
prerank,defense response to virus (GO:0051607),0.24351460175395645,0.8425044673580058,0.7444608567208272,0.9535237430894296,1.0,13/100,9.87%,BCL2;PLA2G10;IFIT3;RNASEL;IFIT2;TRIM5;ZDHHC1;BNIP3;IL6;TRIM56;RNF135;ZBP1;IRF3
prerank,pinocytosis (GO:0006907),-0.36798993579974926,-0.8422110382218734,0.6614173228346457,0.8911539225252936,1.0,2/10,5.82%,CARMIL1;DOCK2
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.3339512422871032,0.8418945060533006,0.6647173489278753,0.9540824260778202,1.0,4/19,16.60%,CHRNE;SLC5A7;NQO1;CHRNB2
prerank,microtubule polymerization (GO:0046785),0.3058640283353772,0.8417598002488225,0.6472868217054264,0.9536214894807962,1.0,9/28,20.08%,CCDC57;TUBGCP6;TUBGCP2;GOLGA2;RANBP9;TUBG1;AKAP9;TPX2;MAP7D3
prerank,interstrand cross-link repair (GO:0036297),0.2700132504102654,0.8416279415244539,0.7081174438687392,0.9531781555329557,1.0,16/53,18.45%,FANCA;ATRIP;RAD51AP2;WDR48;FANCI;DCLRE1A;DCLRE1B;FANCE;FANCB;FANCF;FAAP100;CENPX;FANCC;RAD51;FAAP24;ERCC6L2
prerank,positive regulation of peptidase activity (GO:0010952),-0.30753431347806126,-0.8412079200683276,0.7320261437908496,0.8924310590686642,1.0,7/20,23.27%,GRN;NDUFA13;PSME3;PSME1;PINK1;VCP;VSIR
prerank,pseudouridine synthesis (GO:0001522),-0.336165868736679,-0.8408893169439411,0.6679316888045541,0.8924585421353507,1.0,7/13,29.07%,NHP2;TRUB2;PUS7;PUSL1;RPUSD2;NOP10;PUS1
prerank,regulation of mitotic cell cycle (GO:0007346),-0.1977463232959033,-0.8407602144903166,0.9133333333333333,0.8921729243257382,1.0,46/171,23.44%,NEK7;IQGAP1;TTC28;CAV2;CDK11B;LGMN;BUB3;TGFB1;HNRNPU;APP;PSMD13;PSMF1;DDB1;PSMB10;BTG3;CDKN1B;TAL1;DUSP3;PSMB6;PSME3;PSMB5;PSMC3;PSMD12;PSMB8;TMEM8B;BRINP2;PSME1;CUL1;ANAPC16;PSMB3;GBF1;BUB1B;UBE2D1;TFAP4;PSMD5;L3MBTL1;SKP1;TTL;AFAP1L2;BTG1;ANAPC7;MKI67;PSMD9;EIF4E;PSMB4;NEK11
prerank,nuclear membrane disassembly (GO:0051081),0.35828941257207936,0.8406533182204644,0.6466942148760331,0.9544455508021911,1.0,4/14,9.82%,PRKCB;PRKCA;CDK1;AKAP8L
prerank,camera-type eye morphogenesis (GO:0048593),0.3942193645461737,0.8402205647498773,0.6218487394957983,0.9546324194139628,1.0,4/10,16.10%,SHROOM2;KDM2B;IFT122;SKI
prerank,positive regulation of rRNA processing (GO:2000234),-0.3665845757689685,-0.8401971224490513,0.7024952015355086,0.8926618663086876,1.0,3/10,21.56%,BUD23;UTP15;SIRT7
prerank,lipid homeostasis (GO:0055088),0.26594878977880876,0.8401081195103349,0.7258566978193146,0.9541528797612463,1.0,6/57,7.73%,ZBTB20;ABCA1;RBP1;PRKAA2;THADA;PRKAA1
prerank,extracellular matrix disassembly (GO:0022617),0.27035218336150957,0.8399370717660167,0.6998341625207297,0.9537907286410844,1.0,7/53,7.38%,ADAMTS5;KLK2;ADAMTS15;MMP2;SH3PXD2B;MMP19;MMP9
prerank,substrate-dependent cell migration (GO:0006929),-0.33469133775564386,-0.8397986362771087,0.702,0.8928382391160745,1.0,4/14,10.01%,SHTN1;ANKS1A;PTPRC;CD2AP
prerank,regulation of cytoplasmic transport (GO:1903649),0.3760859338676063,0.8393317755922239,0.6533613445378151,0.9543038316725742,1.0,3/11,13.30%,LRRK2;USP7;MAPK1
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.2774580611831753,-0.8391710220054066,0.7080610021786492,0.8934852402316966,1.0,15/29,33.35%,UBB;UBC;RPS27A;RBX1;DDB1;RPA1;UBA52;CETN2;GTF2H2;ERCC5;XPA;ERCC3;GTF2H5;RPA3;RPA2
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),-0.3589065474917879,-0.8383233641763654,0.6878727634194831,0.8944834154508944,1.0,7/11,51.50%,NFKBIZ;IL12RB1;CARD9;IL23A;IL12B;IL23R;CLEC6A
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.2799023776313674,0.8380293980799369,0.7061855670103093,0.9561858405627464,1.0,6/44,10.76%,ROCK2;TNRC6B;TNRC6A;YTHDF2;AGO2;METTL14
prerank,cellular component disassembly (GO:0022411),0.27090002950611064,0.8378926029322248,0.6976351351351351,0.9557624228351855,1.0,7/53,7.38%,ADAMTS5;KLK2;ADAMTS15;MMP2;SH3PXD2B;MMP19;MMP9
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.31287816129299045,0.8378678852998288,0.6660117878192534,0.9551016132280082,1.0,3/25,4.47%,RBPJ;FOXD1;SULF1
prerank,regulation of calcium ion transport (GO:0051924),0.26934667740408147,0.8377676957660233,0.7138047138047138,0.9545976658717076,1.0,9/54,12.80%,STIM1;BCL2;MYLK;ANK2;CACNA1D;CACNA2D1;CCL4;PKD2;PACSIN3
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.32541507664595,0.8373672866936429,0.6900369003690037,0.9546812571470291,1.0,2/22,4.56%,SASH1;SPHK1
prerank,peptidyl-serine modification (GO:0018209),0.2260064533596318,0.8372632683732701,0.7944444444444444,0.9541756897415181,1.0,29/166,13.44%,ROCK2;PDPK1;CAMK1D;NDNF;DMPK;SRPK2;MAPK9;RICTOR;LRRK2;PRKCZ;PRKCB;TTK;PRKCA;CAMK2D;PKN2;CDK1;CLSPN;VRK2;GALNT16;LATS1;PRKDC;RPS6KB1;IKBKE;PRKD2;MAPKAPK2;HIPK3;TBK1;MAPK1;MORC3
prerank,iron ion transport (GO:0006826),0.2756876655722092,0.8368942338603398,0.7040280210157618,0.9541830469784585,1.0,8/47,9.66%,CP;HEPH;LTF;TFR2;REP15;STEAP3;ATP6V0D1;ATP6V0E1
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.3669527659914719,0.836797861274817,0.6314741035856574,0.9536645341947646,1.0,1/11,0.99%,FGFR2
prerank,negative regulation of autophagy (GO:0010507),0.2657390534851329,0.8367272122558475,0.7188612099644128,0.9531012735793897,1.0,10/54,13.39%,LEPR;BCL2;LRRK2;NUPR1;WASHC1;GOLGA2;KLHL22;RUBCN;FOXK2;LZTS1
prerank,plasma membrane tubulation (GO:0097320),-0.3378714254832805,-0.8365088560275253,0.685546875,0.8974161919702756,1.0,4/13,12.67%,FNBP1L;PACSIN2;CAVIN2;WHAMM
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.3254865212678781,0.8363339492098846,0.6842105263157895,0.9532398455286502,1.0,6/20,16.85%,TNRC6B;TNRC6A;AGO2;MOV10;CNOT7;CNOT8
prerank,outer dynein arm assembly (GO:0036158),0.3573480479536083,0.8362678593988937,0.6621359223300971,0.9526690465490522,1.0,3/14,15.39%,ODAD3;ODAD1;ODAD2
prerank,establishment of protein localization to extracellular region (GO:0035592),-0.2549577793799156,-0.8362171959805639,0.7655913978494624,0.8974092916643187,1.0,16/39,24.78%,RAB3C;MIA2;TANGO6;COPG1;OLFM2;RAB3B;SCG2;CANX;TMEM167A;MTTP;PREB;TVP23A;RAB8A;NECAB3;RAB3A;RAB8B
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.35600956188872923,0.8361764509931391,0.6492693110647182,0.9521411713899625,1.0,3/13,8.14%,ALG6;ALG2;ALG9
prerank,neurogenesis (GO:0022008),0.28069075669759747,0.8361329162089771,0.6886446886446886,0.9515359921023481,1.0,11/43,17.56%,LPAR1;FAT4;ANXA1;PCSK9;DAGLB;RYK;METTL14;TRAK1;TRAK2;ASCL1;WNT2
prerank,regulation of trophoblast cell migration (GO:1901163),-0.33306757369993123,-0.8360888778131935,0.6943866943866944,0.8970604494089927,1.0,4/14,11.89%,ARHGDIB;CALR;VEGFA;YTHDF3
prerank,negative regulation of neuron apoptotic process (GO:0043524),-0.23091526117718647,-0.8359709378496056,0.7898550724637681,0.8966918703776628,1.0,19/69,19.07%,MEF2C;PPARGC1A;PTK2B;NGF;LGMN;SOD1;FOXQ1;SIX1;GRN;SET;MSH2;MT3;SIX4;WFS1;CX3CR1;PRKCG;PINK1;LIG4;TYRO3
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.3218429639467607,0.8359185526181974,0.6533333333333333,0.9512471567266393,1.0,9/22,24.39%,CCNT2;CCNT1;CDC73;ELL;TCERG1;BRD4;SUPT4H1;THOC1;CDK13
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.32782291715278766,0.8358771339771363,0.6842105263157895,0.9506182101260445,1.0,2/18,3.99%,PRKN;CRHBP
prerank,C21-steroid hormone metabolic process (GO:0008207),0.3245962642158293,0.8356560303174491,0.6632443531827515,0.9503491258892183,1.0,3/20,12.83%,FDXR;HSD17B10;AKR1B1
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),-0.2848582369299132,-0.8355889411369006,0.7019867549668874,0.8968209014128249,1.0,9/25,22.36%,ATXN3;BAG6;CUL3;ZYG11B;DERL1;AUP1;RNF5;HDAC6;VCP
prerank,cholesterol efflux (GO:0033344),0.31646251020066835,0.8354377696272278,0.6735849056603773,0.9500837662754184,1.0,4/20,10.61%,ABCA1;ABCA5;APOC1;SOAT2
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.35681039828577105,0.8353480415859451,0.6720321931589537,0.9495727703941308,1.0,5/13,17.36%,ATG10;UBA7;UBA3;DESI1;DESI2
prerank,synaptonemal complex assembly (GO:0007130),0.3499588091968967,0.8353385580754746,0.6646216768916156,0.9481958273305471,1.0,2/15,6.27%,HORMAD1;TEX11
prerank,synaptonemal complex organization (GO:0070193),0.3499588091968967,0.8353385580754746,0.6646216768916156,0.9481958273305471,1.0,2/15,6.27%,HORMAD1;TEX11
prerank,regulation of peptide hormone secretion (GO:0090276),0.2562078131033505,0.8353354729031284,0.760797342192691,0.9475015785367282,1.0,8/67,7.16%,ITPR1;KCNA5;TFR2;CRHBP;CACNA1D;PRKCA;IL6;RAPGEF4
prerank,alanine transport (GO:0032328),-0.360824021942338,-0.8351013670715758,0.6666666666666666,0.8971204114235157,1.0,4/10,16.42%,SLC6A6;SLC36A1;SLC1A4;SLC36A4
prerank,positive regulation of cell death (GO:0010942),0.2615289904748293,0.8347524744598301,0.7470489038785835,0.9479712240481054,1.0,9/59,12.45%,SLC6A13;EFNB2;DKK1;LRRK2;BNIP3;PICALM;AXIN2;EIF2S1;PRODH
prerank,neuron differentiation (GO:0030182),-0.19647555050185928,-0.8346555864695762,0.8868501529051988,0.8974101817055389,1.0,21/165,10.92%,MEF2C;PBX3;TGFB2;RUNX1;ACSL4;WNT9A;TENM2;FZD4;VSX1;SOX4;CTNNB1;MET;ATP8A2;TENM4;VEGFA;WNT16;DDIT4;LHX6;XBP1;IER2;RUNX2
prerank,response to alcohol (GO:0097305),0.30492624205340063,0.8344534127727318,0.6623853211009174,0.9479101823038848,1.0,3/27,8.64%,TGFBR3;CCL19;PMVK
prerank,purine nucleotide biosynthetic process (GO:0006164),0.35952797022911487,0.8344056875521155,0.6434782608695652,0.9473096929429025,1.0,2/12,5.70%,PRPSAP2;ADSL
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),-0.3293488543969382,-0.8340243391100388,0.678,0.8980490597728874,1.0,9/14,39.23%,RPS3;CD81;RELA;CARD11;KCNN4;TRAT1;CD226;TESPA1;LCK
prerank,regulation of cell projection organization (GO:0031344),0.3576262920921038,0.8339141905947132,0.6483739837398373,0.947591233890837,1.0,5/13,14.95%,MACF1;NTNG2;CCL19;MYO9A;MOV10
prerank,positive regulation of natural killer cell activation (GO:0032816),0.35291788217111864,0.8336485787693422,0.6469298245614035,0.9474268223907355,1.0,1/13,1.22%,IL18
prerank,regulation of interferon-beta production (GO:0032648),0.27275760925179865,0.8336079760126048,0.709731543624161,0.9468167787234801,1.0,10/46,14.15%,CACTIN;NLRC3;TRIM56;POLR3G;RNF135;RNF216;SIRPA;IRF3;TBK1;POLR3C
prerank,DNA recombination (GO:0006310),0.27989697437415184,0.8331451751142299,0.7282809611829945,0.9470670387651882,1.0,12/37,22.11%,RAD51B;RAD51C;DMC1;BLM;RTEL1;MRE11;WRN;RAD51;RPAIN;RECQL5;RAD50;RAD52
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.35203820992381063,0.8330641042472005,0.660455486542443,0.946521471903314,1.0,2/14,5.17%,PRKN;LRRK2
prerank,peroxisomal membrane transport (GO:0015919),-0.2792117545616313,-0.8329729024692785,0.7074235807860262,0.8993920961183942,1.0,13/27,32.24%,ABCD3;ABCD2;PEX11B;PEX1;ABCD4;ATAD1;PEX5;PEX10;RAB8B;PEX16;FIS1;PEX13;ACBD5
prerank,RNA catabolic process (GO:0006401),-0.24460525906055902,-0.8324114858288406,0.7638190954773869,0.8998392832339193,1.0,21/46,35.32%,RIDA;RNASE3;SUPV3L1;MTREX;AGO3;METTL3;HSPA1B;ZPR1;ERN1;NUDT16;RNASEH2C;HNRNPD;RNH1;DIS3L2;ZFP36;RNASEH2B;ISG20;HSPA1A;FEN1;ZC3H12D;DNA2
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.2230453509915878,-0.8323695806414417,0.7929155313351499,0.8993385177939625,1.0,25/76,23.66%,RNF144B;CBFA2T3;PTK2;RNF144A;RACK1;TRIB2;NKD2;SOCS5;GSK3B;ZYG11B;RBX1;CLU;ELOB;ARIH2;LAPTM5;COP1;RNF19B;NOP53;RNF19A;USP5;VCP;CEBPA;ARIH1;HSPA1B;TRIB3
prerank,regulation of programmed necrotic cell death (GO:0062098),-0.30109540957894215,-0.8322553600979321,0.6973094170403588,0.8989918864056047,1.0,7/20,24.23%,HSP90AA1;CDC37;BIRC3;OGT;CASP8;PELI1;PDCD6IP
prerank,positive regulation of defense response (GO:0031349),-0.2181874711492307,-0.832018786177574,0.8333333333333334,0.8988585862973102,1.0,12/89,11.17%,MEF2C;IL33;ETS1;NFKBIA;GPR4;PDE2A;PDCD4;APP;GRN;GBP5;FEM1A;IFI35
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.24817320102145105,0.8319608196642315,0.7384868421052632,0.948051560447882,1.0,21/80,17.78%,DENND2A;SNX6;STX16;PLEKHJ1;TMEM87B;WASHC1;RIC1;TMEM87A;VTI1A;SNX12;CLTC;TRAPPC10;PHETA1;RAB9A;TBC1D17;VPS26A;VPS54;VPS35;RHOBTB3;GOSR1;PREPL
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.2562839567417085,0.8317360753018794,0.7220447284345048,0.9478037684396735,1.0,9/71,9.50%,ADAMTS12;PRKN;CLPX;CTSH;ADAMTS7;FBXO44;MDM2;FBXL17;YME1L1
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.2416001925927709,-0.8316867715589775,0.7617924528301887,0.8988687233086398,1.0,24/52,28.60%,PPP1R13B;SREBF2;SH3GLB1;YWHAB;NMT1;MAPK8;YWHAG;BBC3;ARIH2;VPS11;CASP8;YWHAQ;YWHAH;PINK1;PPP3R1;HUWE1;TOMM7;RNF31;PPP3CC;ABLIM3;YWHAZ;MICALL2;BID;SFN
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.2437355792098277,-0.831366405065874,0.7577092511013216,0.89889531242079,1.0,17/50,23.64%,ACTN4;RPS3;NOD1;LIMS1;PDCD4;APP;RHOA;RTKN2;IFI35;TERF2IP;NR3C2;LAPTM5;IRAK1;PTP4A3;AGER;LRRC19;RELA
prerank,Golgi to lysosome transport (GO:0090160),-0.3492438400040576,-0.8312020164334204,0.6940298507462687,0.8986242548504457,1.0,3/11,16.01%,LAMP1;EHD3;LAPTM5
prerank,regulation of p38MAPK cascade (GO:1900744),0.2893168749780683,0.8307737173092282,0.7050359712230215,0.9489739728781308,1.0,4/35,6.45%,SASH1;DUSP10;SPHK1;DLG1
prerank,neuromuscular process (GO:0050905),-0.3198859699256944,-0.8306938576380299,0.7025862068965517,0.8989991506318393,1.0,4/16,10.77%,GCH1;STRA6;NRXN1;KCNA1
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.2382628159131456,0.8300981059063316,0.7857142857142857,0.9496656654779664,1.0,12/104,10.22%,KSR1;SLC8A3;LTF;SLC8A1;CDK7;BLM;CCNT2;CCNT1;SYAP1;UVRAG;SLC27A1;ABL1
prerank,protein localization to organelle (GO:0033365),-0.20157747889172004,-0.8296861282721112,0.8979591836734694,0.900263120781813,1.0,36/133,20.32%,RPL11;DNAJA1;PACSIN2;STX1A;CALR;EHD1;SIX1;APP;LAMP1;YBX1;CCDC47;TSPAN17;TMEM30A;ZBTB7A;TOR1B;SSB;GBP5;ISG15;HHEX;CEP68;TOLLIP;RPA1;BBS9;LMNA;RIPOR1;SEC61G;BICD1;SIX4;GBF1;AUP1;BMP4;SYS1;GET4;COL1A1;CTDNEP1;IFT20
prerank,cellular response to interleukin-6 (GO:0071354),-0.2831420098598068,-0.8295122675649079,0.7551020408163265,0.9000052758838725,1.0,12/26,24.35%,ST3GAL6;CBL;ST18;SBNO2;PTGIS;STAT3;SPI1;CEBPA;PTPRT;JAK1;RELA;SELPLG
prerank,aminoglycan catabolic process (GO:0006026),0.3000440558075815,0.8292848762170308,0.6810506566604128,0.9506257929759077,1.0,4/28,8.20%,SDC2;GPC6;GPC3;CTBS
prerank,response to glucocorticoid (GO:0051384),-0.28060225401581523,-0.8291471433737636,0.720682302771855,0.900092423490966,1.0,5/26,12.25%,SLIT2;FAM107A;HNRNPU;ZFP36L1;REST
prerank,inhibitory synapse assembly (GO:1904862),-0.34480868299554596,-0.8287880366754303,0.7094972067039106,0.9001644841316796,1.0,4/11,35.03%,GABRB3;GABRG2;FGF13;GABRB2
prerank,actin filament network formation (GO:0051639),-0.3433609117502121,-0.8287610440729377,0.6957328385899815,0.8996356643229327,1.0,5/11,17.39%,CARMIL1;PLS3;ACTN1;FHOD3;SPIRE1
prerank,negative regulation of GTPase activity (GO:0034260),0.3198651840880143,0.8282929541433032,0.685823754789272,0.951909588027981,1.0,3/22,5.17%,GMIP;CPEB2;LRRK2
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.33911831553105803,0.8282155043016382,0.6618556701030928,0.9513816499038716,1.0,1/14,1.22%,IL18
prerank,long-chain fatty acid import into cell (GO:0044539),0.3728446479482635,0.8280162254393362,0.6372549019607843,0.9510603843136487,1.0,3/10,10.49%,ACSL1;SLC27A1;RPS6KB1
prerank,regulation of T cell differentiation (GO:0045580),-0.25903463618902034,-0.8278969386641192,0.734341252699784,0.900617435801379,1.0,7/33,15.07%,CBFB;RUNX1;NFATC2;SOD1;XBP1;TCF7;CAMK4
prerank,receptor clustering (GO:0043113),0.2968146666011963,0.8278501653572913,0.688715953307393,0.9506825776572267,1.0,8/27,13.77%,LRP4;PTN;DLG1;DNAJA3;MUSK;DLG4;DLG3;MAGI2
prerank,anterograde synaptic vesicle transport (GO:0048490),-0.3204164307923407,-0.8278162500227854,0.7156673114119922,0.8996231230725255,1.0,3/15,6.74%,AP3S1;BLOC1S2;AP3M2
prerank,synaptic vesicle transport along microtubule (GO:0099517),-0.3204164307923407,-0.8278162500227854,0.7156673114119922,0.8996231230725255,1.0,3/15,6.74%,AP3S1;BLOC1S2;AP3M2
prerank,regulation of cytokine production (GO:0001817),0.23097836703960306,0.8275677696509838,0.7849462365591398,0.9505410453705565,1.0,14/126,9.87%,C1QTNF3;LGR4;IGF2BP1;PLA2R1;LTF;CCN4;ANXA1;SYT11;IRF8;IL6;TRIM56;SIRPA;ZBP1;IRF3
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.29350039838524816,-0.8273918444437709,0.7235421166306696,0.899826763392176,1.0,4/20,12.59%,PDE4D;ADRA1B;ADRA1A;ADRB2
prerank,magnesium ion transport (GO:0015693),0.36275364826655776,0.8273462532712859,0.6473029045643154,0.950267546658312,1.0,2/12,4.37%,SLC41A1;MMGT1
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.22221505427281263,0.8272133545727381,0.826530612244898,0.9498447150874866,1.0,25/158,15.02%,WLS;PRKN;PELI2;LPAR1;LTF;ECM1;TRIM5;AKAP13;GJA1;PRKCB;CXXC5;CCL19;SLC20A1;GOLT1B;IKBKE;CFLAR;UNC5CL;GPRC5B;TBK1;MAP3K7;MTDH;UBE2V1;TRIM62;CX3CL1;BIRC2
prerank,N-terminal protein amino acid modification (GO:0031365),0.3591480703473946,0.8272022498054428,0.6618556701030928,0.9491800973000172,1.0,3/14,13.55%,AANAT;NAA35;NAA60
prerank,peptidyl-serine phosphorylation (GO:0018105),0.22660160034119214,0.8269891044730567,0.7931034482758621,0.9488957743515506,1.0,29/153,14.31%,ROCK2;PDPK1;CAMK1D;DMPK;SRPK2;MAPK9;RICTOR;LRRK2;PRKCZ;PRKCB;TTK;PRKCA;CAMK2D;PKN2;CDK1;CLSPN;VRK2;LATS1;PRKDC;RPS6KB1;IKBKE;PRKD2;MAPKAPK2;HIPK3;TBK1;MAPK1;MORC3;NLK;PRKCI
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.34335383914061535,0.8268715697621094,0.6755102040816326,0.9484285326991516,1.0,1/14,1.00%,PPP2R2B
prerank,regulation of autophagy of mitochondrion (GO:1903146),-0.3045263447401478,-0.8266415158544326,0.7276422764227642,0.9006254729968934,1.0,6/19,21.60%,FBXO7;SREBF2;CAMKK2;ATP13A2;PINK1;HDAC6
prerank,neurotransmitter transport (GO:0006836),0.25188988512663824,0.8263961237651218,0.7466216216216216,0.9486641168492413,1.0,3/73,2.01%,ATP1A2;SLC22A2;SLC1A3
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.3312291504987704,0.826064779638092,0.6740442655935613,0.9486068466440082,1.0,4/18,10.21%,DKK1;SOX6;FRS2;HDAC1
prerank,aminoglycan metabolic process (GO:0006022),0.3783923412360341,0.8260550604600545,0.6772908366533864,0.9479429203164362,1.0,3/10,10.11%,GAL3ST3;XYLT2;B3GALT6
prerank,positive regulation of transporter activity (GO:0032411),0.35021432177684203,0.8259233703248223,0.6908713692946058,0.9475356139032362,1.0,1/13,1.51%,KMT2A
prerank,regulation of stem cell differentiation (GO:2000736),0.24382317157280875,0.825860548728464,0.7654135338345864,0.9469624778308136,1.0,17/89,11.87%,KMT2A;HOXB4;PDGFRA;PTN;PSME4;SETD1A;PSMA2;PSMA3;TCF12;YTHDF2;ITCH;PSMD8;ABL1;PRKDC;PSMD3;MYB;BMPR1A
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.279474482381919,-0.8256049893999705,0.6894273127753304,0.9019208533170497,1.0,11/26,39.36%,CUL3;DUSP1;ANAPC7;NSMCE2;DLGAP5;PLK1;CDC6;ESPL1;ANAPC4;UBE2C;CCNB1
prerank,negative regulation of immune effector process (GO:0002698),-0.3433293446614174,-0.8255229991110657,0.7237903225806451,0.9014982759192661,1.0,5/13,13.62%,RPS19;CD55;GRN;APPL1;CD47
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.2938081045558851,-0.8246887264984875,0.7221095334685599,0.902456072731509,1.0,6/20,14.69%,YWHAB;MET;RNF157;STMN1;APLP1;BICD1
prerank,regulation of response to oxidative stress (GO:1902882),0.37343149463307596,0.8246257406107669,0.676,0.9486858521031867,1.0,1/11,1.41%,PRKN
prerank,regulation of protein neddylation (GO:2000434),-0.35993761818858977,-0.8246017261678179,0.7077534791252486,0.9020549501796749,1.0,5/10,14.50%,RPL11;RPL5;COPS9;DCUN1D1;DCUN1D2
prerank,positive regulation of TORC1 signaling (GO:1904263),0.33699435797607186,0.8245640054174134,0.6666666666666666,0.9481159588297905,1.0,8/16,19.87%,GPR137C;FLCN;KLHL22;SIK3;TELO2;LARS1;CLEC16A;LAMTOR5
prerank,chromatin assembly (GO:0031497),0.2828225436299038,0.8243509521206333,0.7176258992805755,0.9478524068555403,1.0,8/38,16.27%,RBBP4;RSF1;KAT6B;SMARCA5;NAP1L3;EZH1;NAA60;NAP1L1
prerank,regulation of vesicle-mediated transport (GO:0060627),-0.21530779564336425,-0.8243476830845058,0.8486486486486486,0.9019715939549978,1.0,27/91,25.39%,HIP1;NSF;SCARB1;STON2;RAB3C;PACSIN2;PTPRC;HIP1R;BET1L;RAB3B;PTPN1;CDH13;CPLX2;INPP5F;SYT7;MAP2K2;RIT2;MAPK3;RAB8A;MBTPS1;CHMP3;RAB3A;LGI3;RAB8B;CPLX1;HAP1;RAB5B
prerank,positive regulation of endopeptidase activity (GO:0010950),0.30684138780158415,0.82417155377399,0.6899810964083176,0.9475101540244691,1.0,2/26,3.90%,ROCK2;EPHA4
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.3269701562717919,0.8239815872230887,0.6782273603082851,0.9471936548096962,1.0,2/18,7.97%,PPARA;MIA3
prerank,cellular response to estradiol stimulus (GO:0071392),0.3240013212333579,0.8235197345765077,0.6739130434782609,0.9473760051268182,1.0,3/18,7.03%,CRHBP;SSTR2;NCOA3
prerank,regulation of chromosome organization (GO:0033044),0.30916672576423676,0.8234777341868428,0.6888454011741683,0.9467884000790354,1.0,3/22,7.14%,HDAC8;YLPM1;XRCC5
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.3729953987745813,0.8229635815819175,0.6795698924731183,0.9470916445664403,1.0,4/10,16.30%,STAT5B;JAK2;GHR;LYN
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.3370509136415785,0.8224061394504657,0.6817325800376648,0.9474977941336611,1.0,5/16,13.39%,FOXD1;FGF1;SALL1;PKD2;GDNF
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.3458569126484913,-0.8220308378914526,0.7039106145251397,0.9055408734827858,1.0,4/12,16.37%,RPL26;CD44;CD74;MIF
prerank,negative regulation of T cell activation (GO:0050868),-0.2598573108153602,-0.8212864511164244,0.7747747747747747,0.9062885817669378,1.0,15/35,32.96%,CEACAM1;TNFRSF21;DUSP3;LAPTM5;CD274;JAK3;NCKAP1L;SDC4;CEBPB;FCGR2B;CD80;LAX1;IL4I1;PTPN22;GPNMB
prerank,regulation of centrosome duplication (GO:0010824),-0.2767707069333682,-0.8210501195136737,0.7432150313152401,0.9061489889522168,1.0,18/29,34.45%,CHMP5;CHMP2B;PLK2;CCNF;CEP295NL;CHMP1B;CHMP1A;GEN1;CHMP3;CEP295;PDCD6IP;CHMP4C;CEP131;VPS4B;STIL;NPM1;TMEM67;PKHD1
prerank,nucleic acid metabolic process (GO:0090304),-0.2239520012503426,-0.8209537492389863,0.8242894056847545,0.9057672854239763,1.0,36/69,38.78%,HNRNPK;RBFOX2;HNRNPU;HNRNPA3;DDX54;HNRNPH2;POLR2C;TOPBP1;NT5E;HNRNPA0;POLR2G;PCBP1;GTF2F2;PTBP1;METTL3;DDX24;DUSP11;WDR74;HNRNPF;HNRNPM;POLR2L;LSM8;HNRNPD;HNRNPL;POLR2B;FEN1;HNRNPA1;KPNA2;ATXN2;DNA2;DNASE1L1;NCBP2;ANKLE1;POLR2F;POLG;RAN
prerank,regulation of immunoglobulin production (GO:0002637),0.3027875793589725,0.8208972741379474,0.7019230769230769,0.9497692459881442,1.0,2/23,6.85%,RBP4;IL6
prerank,regulation of mRNA stability (GO:0043488),-0.2005097586587588,-0.8205842852405835,0.8947368421052632,0.9058244466089146,1.0,42/145,23.14%,HSPA8;VIM;UBB;HSPB1;PABPC1;YWHAB;UBC;RPS27A;HNRNPU;PUM2;YBX1;PSMD13;SET;PSMF1;EIF4G1;PSMB10;PSMB6;PSME3;ZFP36L1;YTHDF3;PSMB5;PSMC3;PSMD12;PSMB8;PSME1;FUS;RIDA;UBA52;PSMB3;TENT5A;SERBP1;FASTKD3;PSMD5;PCBP4;PRKCD;METTL3;AKT1;SLC11A1;RBM24;FMR1;PSMD9;PSMB4
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.29870072791133506,-0.8201873609544874,0.7430997876857749,0.9059492622257257,1.0,5/20,14.63%,DCC;BCL2L1;GSK3B;APPL1;FAS
prerank,histone ubiquitination (GO:0016574),0.30895810579228916,0.8197916418250433,0.6660682226211849,0.9512170703891646,1.0,9/21,23.57%,UBR2;CDC73;RNF20;UBE2A;UBE2E1;DTX3L;CTR9;PAF1;WAC
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.2904587710000573,0.8194141990467776,0.7164179104477612,0.9512868416356236,1.0,13/30,19.79%,VAMP5;MACF1;KRT18;OPTN;GGA2;BLZF1;GOLPH3L;RAB26;PREPL;BBS1;GOLGA4;RAB34;BBS2
prerank,positive regulation of lymphocyte activation (GO:0051251),-0.2714828738137216,-0.8189514130608723,0.7448132780082988,0.9075968072238388,1.0,9/28,27.05%,SH3KBP1;CYRIB;HSPD1;CD47;TYROBP;NCKAP1L;THY1;CCR2;CCL2
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.28670854417292635,-0.8186325230544693,0.7206477732793523,0.9075815433483925,1.0,10/22,31.27%,MVB12B;UBAP1;PTPN23;MVB12A;UBAP1L;PLAA;VPS36;TOM1L1;VPS28;VPS4B
prerank,negative regulation of innate immune response (GO:0045824),-0.25720263238931373,-0.8184930580001145,0.742152466367713,0.9072635132444764,1.0,10/34,20.47%,RPS19;SUSD4;GRN;A2M;NLRC5;ISG15;YTHDF3;IRAK3;TYRO3;METTL3
prerank,response to exogenous dsRNA (GO:0043330),0.33110171140534833,0.8183589275476277,0.6945996275605214,0.9525962657287066,1.0,1/18,0.42%,COLEC12
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.24916868020138752,0.8182557046978168,0.7665056360708534,0.952124999197286,1.0,13/73,12.31%,JARID2;IGF2;RBBP4;BAZ1B;RBBP7;MTF2;PRMT7;TAF1A;SMARCA5;POLR1F;POLR1A;CGGBP1;TAF1D
prerank,regulation of mRNA metabolic process (GO:1903311),-0.3489813265799601,-0.8179761813041493,0.7083333333333334,0.9075876661050938,1.0,7/11,33.84%,CDK11B;SRPK1;SAFB2;SLTM;SRPK3;DHX9;IWS1
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.24285269424095146,0.8178786543304906,0.7983606557377049,0.9521566727225812,1.0,18/82,18.67%,NINL;ALMS1;HAUS4;CEP152;SDCCAG8;PAFAH1B1;CDK1;NEK10;OFD1;HAUS1;SFI1;CEP57;CEP63;CEP164;TUBG1;AKAP9;CNTRL;TPX2
prerank,lipoprotein biosynthetic process (GO:0042158),0.3631903598423153,0.8178580393227027,0.6686868686868687,0.9515167326189736,1.0,2/11,5.21%,ATG10;WIPI1
prerank,histone H3 acetylation (GO:0043966),-0.25072244760428575,-0.8176939174858584,0.7671232876712328,0.9075042199291065,1.0,8/40,16.54%,LEF1;ING4;YEATS2;BRPF1;JADE1;KAT14;PER1;WDR5
prerank,phospholipid homeostasis (GO:0055091),0.36263774784526287,0.8172740877994287,0.6848484848484848,0.9519257607608768,1.0,1/11,3.43%,ABCA1
prerank,cellular lipid catabolic process (GO:0044242),0.2984446896799571,0.8169938601297672,0.7056603773584905,0.9517752561231885,1.0,3/27,6.84%,CEL;ACADL;ENPP2
prerank,regulation of protein processing (GO:0070613),-0.2906319996899184,-0.8169809443261926,0.7282157676348547,0.9081321370055045,1.0,3/21,6.56%,RUNX1;SERPINE2;NKD2
prerank,AMP metabolic process (GO:0046033),0.3475877915357487,0.8169497908261915,0.6751054852320675,0.951179278194299,1.0,2/13,5.70%,AMPD3;ADSL
prerank,negative regulation of cellular metabolic process (GO:0031324),0.27917811688664473,0.8157255273075503,0.7223230490018149,0.95287508283653,1.0,10/37,18.00%,PRKN;PCSK9;OPTN;DLG4;TFAP2A;PLIN5;SDCBP;TRAP1;NCOR1;EDNRB
prerank,negative regulation of macroautophagy (GO:0016242),0.29701394731526715,0.8155624797586859,0.7103321033210332,0.9525231496320512,1.0,11/26,22.13%,LRRK2;NUPR1;TMEM39A;RUBCN;FEZ1;LZTS1;TSC1;CLEC16A;PIK3CA;TSC2;SMG1
prerank,positive regulation of DNA replication (GO:0045740),-0.3146419200999116,-0.8153417084511126,0.7125748502994012,0.9104632463712895,1.0,3/16,12.42%,BCAR3;FAF1;GLI1
prerank,negative regulation of transferase activity (GO:0051348),-0.26813267009974373,-0.8151351563446679,0.7317596566523605,0.910291813334661,1.0,5/28,10.76%,PINX1;GSK3B;HNRNPU;CDKN1B;MEN1
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.24066401061498535,-0.8146455214645427,0.8157248157248157,0.910571660992185,1.0,16/48,22.68%,SLIT2;GAS6;PTPRC;NLRC5;ISG15;YTHDF3;NR1H2;NLRP2B;IRAK3;SIGIRR;CARD16;SH2B3;PADI2;METTL3;NR1H3;TRAIP
prerank,regulation of hemopoiesis (GO:1903706),-0.35416156133250704,-0.8144931617469865,0.7115384615384616,0.9102776891159801,1.0,2/10,2.60%,CBFB;RUNX1
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.2310249156866884,-0.8142404837339432,0.8079625292740047,0.9101634450188814,1.0,23/59,29.56%,DAB2IP;UBB;NFKBIA;IKBKB;UBC;RPS27A;NKIRAS1;BIRC3;CHUK;BCL3;TAB3;TBKBP1;UBA52;SHARPIN;AKT1;FAIM;RBCK1;RELA;RNF31;TLR4;TLR7;RELB;CARD11
prerank,negative regulation of phosphatase activity (GO:0010923),-0.28117954329272477,-0.814173990156959,0.7657841140529531,0.9097195573696304,1.0,8/25,16.71%,TGFB2;SEMA4D;TIPRL;GSK3B;CHP1;MASTL;ZCCHC9;BOD1
prerank,very-low-density lipoprotein particle assembly (GO:0034379),-0.33170078364784644,-0.8140445110079209,0.7225433526011561,0.9093755891716905,1.0,5/12,17.49%,MFSD2A;LPCAT3;DGAT1;ACSL3;MTTP
prerank,histone H3 deacetylation (GO:0070932),-0.3163776209538728,-0.8137742573997241,0.6933867735470942,0.9092670187382932,1.0,8/15,29.75%,SFPQ;PER1;HDAC9;SMARCAD1;SIRT7;SIRT6;PER2;HDAC3
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.32636362253907786,0.8133992534676743,0.7114228456913828,0.9560655727483096,1.0,4/18,7.11%,PDPN;IL6;SMAD3;DDR2
prerank,macromolecule catabolic process (GO:0009057),0.2962179145324701,0.8128388108529926,0.7084870848708487,0.956438297323288,1.0,5/26,9.08%,CLPX;NEDD4;TPP1;PIK3R4;UVRAG
prerank,regulation of stem cell population maintenance (GO:2000036),0.3307989320328697,0.8121134727393028,0.6790606653620352,0.9571434137705035,1.0,3/18,11.93%,PTN;NCOA3;CNOT2
prerank,regulation of NMDA receptor activity (GO:2000310),0.2803088672265706,0.8120667718061839,0.702247191011236,0.9565608522675553,1.0,8/32,12.97%,DAPK1;SLC6A9;CRHBP;DLG1;DLG4;GRIA4;DLG3;ACTN2
prerank,cholesterol transport (GO:0030301),0.2669988761474393,0.8116217509029165,0.7649186256781193,0.9567282428454512,1.0,10/45,16.33%,CEL;ABCA1;LIMA1;LIPC;ABCA5;APOC1;SOAT2;SERAC1;ABCG4;RELCH
prerank,response to ionizing radiation (GO:0010212),0.2499905539190209,0.8113478832498828,0.7615894039735099,0.9565689215888296,1.0,14/70,16.05%,EYA1;ANXA1;MRNIP;INIP;BLM;PRKAA1;XRCC4;NHEJ1;INO80;CLOCK;BABAM2;BRSK1;SWI5;RAD51
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.26419065508431505,-0.8112545259517278,0.7947019867549668,0.9130303297650685,1.0,9/32,19.85%,RPS19;PGLYRP1;DEFA6;GAPDH;RPL30;ROMO1;RNASE3;CCL13;ANG
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),-0.2889982144996967,-0.8112476562485958,0.7219917012448133,0.9124712171914997,1.0,4/22,11.48%,KLF4;MBP;CD44;GCNT2
prerank,sulfur compound catabolic process (GO:0044273),0.27610742161880203,0.8109034851228603,0.7513043478260869,0.9567010239541247,1.0,4/38,5.12%,FMOD;OGN;OMD;PRELP
prerank,peptidyl-lysine methylation (GO:0018022),0.3008552505199868,0.8099144967679636,0.7014925373134329,0.9578485479288517,1.0,7/26,19.84%,SETD7;SETD6;EEF1AKMT1;SMYD3;N6AMT1;SETD2;SETD4
prerank,positive regulation of heterochromatin assembly (GO:0031453),-0.3459858556229585,-0.8098207353898801,0.7475728155339806,0.9144095435398666,1.0,5/11,32.27%,TASOR;SIRT6;SETDB2;DNMT1;PPHLN1
prerank,regulation of gluconeogenesis (GO:0006111),0.2997952174529962,0.8097022992308106,0.7349177330895795,0.9575914198522538,1.0,7/27,18.42%,C1QTNF3;SIK1;USP7;CRY1;GCK;NNMT;C1QTNF12
prerank,membrane lipid metabolic process (GO:0006643),-0.28672424227962007,-0.8095617635119559,0.743801652892562,0.9142974061280836,1.0,4/22,9.62%,ST3GAL6;SERINC1;B4GALT4;CERK
prerank,protein targeting (GO:0006605),-0.19989033796893751,-0.8092094033655192,0.9021739130434783,0.9143241370608286,1.0,44/118,31.32%,RASSF9;RPL11;FBXO7;TOMM20;ZDHHC14;ZDHHC15;CDC37;GOLGA7;AQP11;ZDHHC2;CACNG3;ZDHHC7;TOMM22;SRPRB;TIMM9;NACA;SEC61G;BCAP31;TIMM10B;ZFAND2B;TIMM13;ZDHHC4;PEX1;TIMM22;ZDHHC20;MFN2;ICMT;TOMM7;PEX16;SORL1;HAP1;SRP14;RTP4;SEC63;TSPO;TIMM44;FIS1;AIP;TOMM34;RABGEF1;SPCS3;ZDHHC18;NACAD;AP4B1
prerank,establishment of protein localization to organelle (GO:0072594),0.2444203467268848,0.8089957715120928,0.7847896440129449,0.9582331055301059,1.0,10/72,13.32%,APPL2;IPO13;HK2;PRICKLE1;LAMP2;NUTF2;NUP107;TNPO1;LAMP5;NXT2
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.26291008542332295,0.8088800651167771,0.7689530685920578,0.957781637162257,1.0,6/49,6.37%,KMT2A;MTURN;ASH2L;TNRC6B;TNRC6A;SETD1A
prerank,glycerol metabolic process (GO:0006071),-0.3487963758821818,-0.8087951667867482,0.7262135922330097,0.9144706660356663,1.0,3/10,17.41%,TPI1;PGP;COQ2
prerank,negative regulation of viral process (GO:0048525),-0.23091872740812386,-0.8086087527978787,0.8228155339805825,0.9142069153357802,1.0,27/57,32.56%,PPIA;TRIM14;LARP7;ISG15;RSAD2;OAS2;SRPK1;SHFL;IFIH1;TRIM13;FAM111A;N4BP1;BST2;MID2;IFITM3;TRIM27;UBP1;BANF1;CHMP3;STAT1;OASL;ZC3HAV1;ZFP36;MAVS;IFITM2;ISG20;PROX1
prerank,response to peptide (GO:1901652),0.2827216767403512,0.8085089321787636,0.7367491166077739,0.957774000297446,1.0,4/33,7.38%,MMP2;ANXA1;STAT5B;MMP9
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.3481510010980833,-0.8078338048549493,0.7216890595009597,0.9149510501396031,1.0,4/10,30.45%,DLGAP1;NPTXR;NPTX1;CACNG5
prerank,quinone biosynthetic process (GO:1901663),0.3411293757941454,0.8075444386679475,0.6967871485943775,0.9589148245687368,1.0,4/14,10.63%,FDXR;COQ10A;COQ6;COQ8B
prerank,NAD biosynthetic process (GO:0009435),0.3141130212058854,0.8075402568044961,0.7038461538461539,0.9582476163393774,1.0,8/20,17.88%,NMNAT2;NADSYN1;PARP10;PARP9;NMNAT1;NUDT12;QPRT;NNMT
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.3508828034203394,-0.807468130809213,0.7387033398821218,0.9144003064462287,1.0,4/10,34.04%,RACK1;PRKCD;SPHK2;NSMAF
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),-0.3508828034203394,-0.807468130809213,0.7387033398821218,0.9144003064462287,1.0,4/10,34.04%,RACK1;PRKCD;SPHK2;NSMAF
prerank,regulation of transferase activity (GO:0051338),0.3212709555060469,0.807359143231717,0.7296222664015904,0.9578899148624497,1.0,4/17,10.41%,SLAMF8;PARP4;FEM1B;PPP1R3F
prerank,determination of bilateral symmetry (GO:0009855),0.3039671257727205,0.8073576806050373,0.7142857142857143,0.9572218319663873,1.0,5/24,11.59%,ODAD3;DNAH11;ARL6;BBS7;PKD2
prerank,positive regulation of viral genome replication (GO:0045070),0.2985540985542519,0.8072643469761324,0.7297794117647058,0.9567172965987812,1.0,6/29,11.40%,PPARA;SRPK2;TOP2B;HACD3;PKN2;TMEM39A
prerank,positive regulation of sodium ion transport (GO:0010765),-0.33205081043680845,-0.8071733283968154,0.7348927875243665,0.9142914404467729,1.0,6/12,19.58%,WNK3;CNKSR3;NOS1;AHCYL1;SCN1B;ANK3
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.28115856052224053,-0.8070076539012097,0.7610062893081762,0.9140064084185974,1.0,8/23,25.81%,ITGB1;NSFL1C;NDE1;INSC;DCTN1;NUMA1;NDC80;SPDL1
prerank,negative regulation of immune response (GO:0050777),0.2214436935957571,0.8068848725351361,0.8522727272727273,0.9567749310127546,1.0,20/154,13.99%,ADCY5;ADCY1;ADM;FER;FCRLB;CACTIN;PDCD1;IL6;PTH2R;NLRC3;LYAR;ITCH;PTGIR;GLP1R;ADRB3;PCBP2;ENPP3;PRKACB;PTGER4;MAPKBP1
prerank,response to organophosphorus (GO:0046683),-0.31481928241580454,-0.8067904280769015,0.7450592885375494,0.9138139879465604,1.0,2/16,1.88%,ABCC9;TRPC3
prerank,regulation of interleukin-13 production (GO:0032656),0.3364364306273463,0.8061275750974178,0.6993736951983298,0.9574674770136938,1.0,2/13,5.73%,IL18;PRKCZ
prerank,autophagosome assembly (GO:0000045),0.25859961509804125,0.8054801597764109,0.7614840989399293,0.9580119383997528,1.0,14/52,16.69%,TP53INP2;RAB19;WIPI1;UBXN2B;ATG14;TRAPPC8;ATG9A;STX17;AMBRA1;ATG3;RAB43;RUFY4;IRGM;ATG16L2
prerank,intracellular sterol transport (GO:0032366),0.3521034493767033,0.8053758555927949,0.6973415132924335,0.9575271914506758,1.0,3/13,16.33%,ABCA1;SERAC1;RELCH
prerank,regulation of complement activation (GO:0030449),0.2720194398438408,0.8052872661048576,0.7522603978300181,0.9570191636853006,1.0,6/40,11.62%,PROS1;C2;CFH;VTN;C8B;C8G
prerank,positive regulation of organelle organization (GO:0010638),-0.26282620140227947,-0.805242611709243,0.7928730512249443,0.9158117465165496,1.0,8/32,18.55%,PPARGC1A;SYNJ1;GSK3B;C2CD5;SORBS3;ADRB2;SMCR8;LIG4
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.32208878018131354,0.8049057035862309,0.7083333333333334,0.9570266102792775,1.0,3/17,10.97%,PRKN;MDM2;SNAI1
prerank,response to glucose (GO:0009749),0.26540150906867477,0.80459566651048,0.7584973166368515,0.9569226027361066,1.0,6/46,8.15%,TCF7L2;ZBTB20;PRKAA2;IGF1R;PRKAA1;SLC30A8
prerank,calcium import into the mitochondrion (GO:0036444),0.37185805127924,0.8043947416791936,0.6774193548387096,0.9566262095669167,1.0,3/10,10.75%,MAIP1;MCU;MICU1
prerank,positive regulation of keratinocyte migration (GO:0051549),-0.34542832167459636,-0.8042147063446251,0.7167630057803468,0.9170123776322588,1.0,4/10,18.03%,IQSEC1;MTOR;FGF7;ADAM9
prerank,motile cilium assembly (GO:0044458),0.35568110483364723,0.8040128646541826,0.7067961165048544,0.9566351722828601,1.0,12/12,64.46%,DNAAF3;RSPH9;E2F4;BBOF1;MCIDAS;BBS5;SPATA6;ZMYND10;DNAAF1;RSPH6A;CCDC39;CCDC40
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.3329465818825236,0.8035749025820216,0.6983805668016194,0.9567785804923921,1.0,1/14,0.61%,IL34
prerank,renal absorption (GO:0070293),0.3642689579120035,0.8035162524413108,0.680327868852459,0.9562298754979712,1.0,1/10,1.22%,WNK4
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.30514458431938746,0.8033159111332305,0.71939736346516,0.9559517310362149,1.0,5/23,8.38%,CAMK1D;RIPOR2;CCL19;MCU;MOSPD2
prerank,sensory perception of chemical stimulus (GO:0007606),-0.3157161953658345,-0.8032313552095915,0.7281746031746031,0.9180176554952411,1.0,3/15,11.59%,GNAL;ADCY3;SYT10
prerank,aspartate family amino acid metabolic process (GO:0009066),0.3201974808899095,0.8030031272080672,0.6884920634920635,0.9558714776450612,1.0,2/18,5.59%,MTHFR;MSRA
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.33515030338995266,0.8027502668818677,0.6938369781312127,0.9556516128460896,1.0,3/15,6.71%,ANXA1;SSTR2;UBE2L3
prerank,positive regulation of cell communication (GO:0010647),0.2838506347502281,0.8021454651003815,0.7347740667976425,0.9561245481428329,1.0,1/28,0.45%,WLS
prerank,regulation of chemokine production (GO:0032642),-0.24755173412041132,-0.8018064701860022,0.7670329670329671,0.9198174334940489,1.0,16/36,35.32%,FOXP1;IL33;APP;CD74;CSF1R;SIGIRR;ACKR1;AGER;TLR4;SNAI2;TLR7;TREM2;LPL;IL7;ADAM17;TSLP
prerank,ether lipid metabolic process (GO:0046485),0.3404598610215796,0.801714848241863,0.6953125,0.9562420601105819,1.0,2/14,8.78%,AGMO;PAFAH1B1
prerank,base-excision repair (GO:0006284),-0.23712178144777926,-0.8015344308258708,0.8383371824480369,0.9197001564774054,1.0,27/48,39.34%,SMUG1;OGG1;RPA1;POLQ;NEIL1;NEIL3;POLE;POLD3;POLB;POLD1;NTHL1;HUWE1;ERCC5;POLL;XPA;RFC5;LIG3;NEIL2;RPA3;FEN1;RPA2;DNA2;XRCC1;RFC2;POLG;UNG;PCNA
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.3292905396429161,-0.8014746558552145,0.7253787878787878,0.9192174345147989,1.0,9/12,54.05%,SLC11A1;CCR2;IL12RB1;CARD9;IL23A;IL12B;IL23R;CLEC6A;IL1B
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.2802032405349372,0.8014712739716225,0.7436399217221135,0.9559805037079614,1.0,3/34,6.85%,RBP4;LACC1;IL6
prerank,early endosome to Golgi transport (GO:0034498),-0.34554966603584336,-0.8009611940291697,0.7140151515151515,0.9194922825079652,1.0,5/11,34.51%,EHD3;SNX1;SNX2;STX5;RBSN
prerank,mitotic sister chromatid cohesion (GO:0007064),0.32343930506010016,0.8009276277707562,0.6990291262135923,0.9563078929840787,1.0,6/16,20.19%,PDS5B;MAU2;PDS5A;NIPBL;DSCC1;NAA50
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.3253467515324277,-0.8007865396024259,0.7365384615384616,0.9192042431086525,1.0,3/12,12.27%,FOXP1;ZBTB7A;HEYL
prerank,phosphate ion transmembrane transport (GO:0035435),0.3491359072399039,0.8002722856160861,0.7274633123689728,0.9568508673065046,1.0,3/12,9.34%,SLC20A2;SLC20A1;SLC25A11
prerank,synaptic membrane adhesion (GO:0099560),0.3309620763892651,0.8000153280955129,0.6939203354297694,0.9566293659538418,1.0,3/14,12.47%,GPC6;PTPRD;GPC4
prerank,response to axon injury (GO:0048678),-0.3005218790402805,-0.7996320007345696,0.7489795918367347,0.9205403888357976,1.0,3/18,6.04%,APOD;RTN4RL1;SOD1
prerank,regulation of leukocyte activation (GO:0002694),-0.31878546514895323,-0.799449196393059,0.7552182163187856,0.9202782553142523,1.0,5/14,16.37%,CD200;GPR137B;GPER1;CD74;MIF
prerank,detection of calcium ion (GO:0005513),-0.3183489674303357,-0.7994063501786621,0.7412844036697248,0.9197780621751834,1.0,5/13,16.18%,CALM1;RYR2;KCNMB4;KCNIP2;CALM2
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.3347337729221235,0.7991817538434963,0.7139830508474576,0.9574450939380597,1.0,5/15,16.75%,FSTL3;LEMD3;MAGI2;SKI;IGSF1
prerank,response to interleukin-6 (GO:0070741),-0.3504194125200122,-0.7987570063247237,0.7378815080789947,0.920307856717189,1.0,3/10,8.86%,ST3GAL6;SBNO2;PTGIS
prerank,modulation by host of viral genome replication (GO:0044827),0.34184016492526365,0.7987141441252842,0.6957403651115619,0.9576334839915651,1.0,1/13,1.41%,PRKN
prerank,positive regulation of fat cell differentiation (GO:0045600),0.25813400842754375,0.7987078183430982,0.7828571428571428,0.9569816404694781,1.0,7/47,9.98%,BMP7;MEDAG;TMEM64;NAPEPLD;LMO3;SYAP1;ASXL2
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.3637632459771202,0.7986909470662776,0.6842105263157895,0.9563574533275955,1.0,3/10,9.94%,EPHA4;ATRAID;RIC1
prerank,cell differentiation in spinal cord (GO:0021515),0.36966702116030203,0.7985149920774232,0.6878980891719745,0.9560301065054886,1.0,4/10,20.62%,SOX6;SOX13;MDGA1;DRAXIN
prerank,regulation of hippo signaling (GO:0035330),0.32096584444967247,0.7984343859374134,0.710204081632653,0.9555167985988459,1.0,4/17,11.03%,VGLL4;WWC1;WWC2;SCHIP1
prerank,regulation of innate immune response (GO:0045088),0.2508490674518716,0.7983516340203224,0.7733118971061094,0.9550041982151618,1.0,7/57,8.17%,APPL2;RNASEL;CACTIN;NLRC3;POLR3G;RNF135;LYAR
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.28873734567227805,0.798127921138654,0.7604562737642585,0.9547851890662956,1.0,15/29,25.49%,EXOSC8;DCP2;LSM5;CNOT7;CNOT8;EXOSC3;LSM3;LSM1;DDX6;LSM4;EXOSC4;LSM6;DCP1B;DIS3;NT5C3B
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.26902374703934906,-0.7981252934439227,0.7588652482269503,0.9207826377867185,1.0,6/27,10.64%,CSGALNACT1;CSPG4;CHST9;BGN;CHST11;XYLT1
prerank,negative regulation of JNK cascade (GO:0046329),-0.25633748557628083,-0.7978952311736606,0.7766179540709812,0.9205945836089103,1.0,5/31,11.18%,MECOM;DNAJA1;PDCD4;MEN1;DUSP3
prerank,sulfate transport (GO:0008272),-0.3160816166109181,-0.7974115597046812,0.7429718875502008,0.9207916336660144,1.0,2/14,1.01%,SLC26A7;SLC26A2
prerank,negative regulation of TORC1 signaling (GO:1904262),0.3400512727932908,0.7974109208225362,0.7333333333333333,0.9554005056195563,1.0,3/13,7.64%,SZT2;SESN1;RNF152
prerank,cellular response to oxygen levels (GO:0071453),0.36064779327433893,0.7973905803709478,0.6943866943866944,0.9547824603171401,1.0,3/10,9.60%,CPEB4;TMEM199;ATP6V0D1
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.32148963210090475,0.7972393502636184,0.7125748502994012,0.9544024334869902,1.0,3/18,6.71%,ANXA1;SSTR2;UBE2L3
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),-0.3088344526443479,-0.7970529248393846,0.7183673469387755,0.9208009312753208,1.0,5/14,20.71%,TARDBP;YBX3;HNRNPA0;MYD88;TIRAP
prerank,cellular response to hydrogen peroxide (GO:0070301),0.2865959640885541,0.7970526144197637,0.7439703153988868,0.9540879042164816,1.0,5/33,10.22%,OSER1;ANXA1;IL6;SIRPA;ABL1
prerank,regulation of mitochondrial fission (GO:0090140),0.3013751952379581,0.796982160637573,0.7288135593220338,0.9535518046874255,1.0,4/24,8.07%,PRKN;LRRK2;BNIP3;MCU
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.2878710144646053,-0.79664181407546,0.7489361702127659,0.9203132180588219,1.0,10/21,33.35%,RBX1;DDB1;RPA1;GTF2H2;ERCC5;XPA;ERCC3;GTF2H5;RPA3;RPA2
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.2878710144646053,-0.79664181407546,0.7489361702127659,0.9203132180588219,1.0,10/21,33.35%,RBX1;DDB1;RPA1;GTF2H2;ERCC5;XPA;ERCC3;GTF2H5;RPA3;RPA2
prerank,amide biosynthetic process (GO:0043604),0.26531294926889853,0.7965957645360903,0.734982332155477,0.9535614864352887,1.0,9/47,12.35%,DMD;PM20D1;CERS6;CERS5;AANAT;ASL;CERS1;PAM;SLC25A2
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.33046260363771834,-0.7961006382710123,0.7429111531190926,0.9206114243608823,1.0,4/12,20.56%,STMN2;STMN1;TUBB4A;MAPRE1
prerank,glucan catabolic process (GO:0009251),0.3315507576981266,0.795825712264539,0.7397260273972602,0.9542665075450816,1.0,2/15,4.64%,PHKB;MGAM
prerank,DNA strand elongation involved in DNA replication (GO:0006271),-0.3040787645127862,-0.7957614758853819,0.7366255144032922,0.9205776440379951,1.0,8/18,32.96%,MCM4;POLA1;POLE;POLD3;GINS4;LIG3;GINS2;POLE3
prerank,termination of RNA polymerase II transcription (GO:0006369),-0.25423410380284717,-0.7956088674588692,0.7754629629629629,0.9202556261189926,1.0,10/33,22.51%,CPSF7;CPSF3;SYMPK;CLP1;CPSF2;CSTF2;CSTF2T;PCF11;MAZ;SNRPG
prerank,positive regulation of telomere capping (GO:1904355),-0.3003964489535304,-0.7955997216251982,0.7398373983739838,0.9197095424083563,1.0,2/17,10.79%,NEK7;MAP2K7
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),-0.26199398126042467,-0.7955621235526277,0.7722342733188721,0.9192024256797423,1.0,3/29,6.59%,NSF;VTI1B;COPG1
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.34484603607231323,0.7948283249773677,0.7297830374753451,0.9553494741407055,1.0,2/12,7.32%,METTL4;BLM
prerank,polyol biosynthetic process (GO:0046173),0.32779251830188655,0.7945919493099372,0.7034220532319392,0.9551106100999224,1.0,1/16,1.12%,CYP27A1
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.33710596788461505,-0.7945183434880388,0.7409420289855072,0.9202980353004383,1.0,4/11,21.56%,MTOR;PIH1D1;NOP53;SIRT7
prerank,cellular response to superoxide (GO:0071451),-0.34844383241999594,-0.7942711859023477,0.7504835589941973,0.9201327161279369,1.0,3/10,13.88%,NOS3;SOD1;MT3
prerank,modification-dependent protein catabolic process (GO:0019941),0.2131414132558197,0.793592735793574,0.8685376661742984,0.9562137037517708,1.0,29/193,13.29%,ASB2;RNF43;PRKN;SPSB1;NEDD4;RNF213;FBXW4;RNF217;ZNRF3;TRPC4AP;UBE2L3;TTC3;SIAH2;BIRC6;AMFR;RC3H2;MDM2;UBE4A;ITCH;SMURF2;RNF149;RBBP6;PSMD3;KLHL15;RNF14;FBXO11;RNF20;CDC26;RCHY1
prerank,cytoplasmic microtubule organization (GO:0031122),0.2516082792592663,0.7921591914743892,0.7810945273631841,0.9580641677283723,1.0,7/54,9.91%,FIGN;HOOK2;FIGNL2;KATNAL2;DLG1;TUBGCP6;TUBGCP2
prerank,organelle disassembly (GO:1903008),0.2815411300456651,0.7919220886022188,0.7442680776014109,0.9577943980700613,1.0,6/33,11.17%,PLK5;UFL1;CDK1;RETREG1;GOLGA2;TEX264
prerank,import into nucleus (GO:0051170),0.23884224295710357,0.7918295050789698,0.8286163522012578,0.9572986718698288,1.0,19/73,23.47%,APPL2;IPO13;PRICKLE1;SMN1;NUTF2;NUP107;TNPO1;NXT2;NUP214;RPAIN;IPO9;KPNB1;GEMIN5;SNRPF;TSC2;RANBP17;TPR;NUP62;NUP155
prerank,histone deacetylation (GO:0016575),0.26294020685840686,0.7914166153159047,0.7703180212014135,0.9574200593502242,1.0,4/43,4.25%,PRDM5;TBL1XR1;MIDEAS;HDAC8
prerank,positive regulation of bone resorption (GO:0045780),-0.3325414662940309,-0.7906393734237233,0.7456647398843931,0.9253414821710384,1.0,3/11,15.94%,SPP1;TNFRSF11A;PLEKHM1
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.3318745627681614,0.7904464355541252,0.6919917864476386,0.9584256928448676,1.0,2/14,5.50%,CORIN;ACE
prerank,Golgi organization (GO:0007030),0.22424946516893293,0.7904419408702125,0.8566929133858268,0.9577795656266,1.0,18/112,9.94%,TANGO2;OBSL1;DYNC2H1;PLK5;LRRK2;RAB30;FAM174B;MYO18A;OPTN;STX16;UBXN2B;DYM;BLZF1;CUL7;CDK1;TRAPPC8;TJAP1;GOLGA2
prerank,cellular response to radiation (GO:0071478),-0.23726060739303656,-0.7904029004345017,0.8303964757709251,0.9251644184427993,1.0,9/40,21.90%,NET1;RHOB;EEF1D;SPIDR;TNKS1BP1;RAD9A;LIG4;GADD45A;CDKN1A
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.24644224799744008,0.7903853564499942,0.8055105348460292,0.9572226388319014,1.0,12/60,16.58%,FGFR4;SMOC2;PDGFRB;ACD;XRCC5;CCT6A;PRKD2;FBXO4;MAPK1;TCP1;PARN;HGF
prerank,positive regulation of actin nucleation (GO:0051127),0.3574894544450442,0.7897158321857262,0.7137176938369781,0.9577102746300638,1.0,3/11,7.70%,ABI2;WASF1;WASF3
prerank,positive regulation of mitochondrial fission (GO:0090141),0.3246592995011418,0.7893391598363844,0.725050916496945,0.9577201063700678,1.0,3/18,8.07%,PRKN;BNIP3;MCU
prerank,histone acetylation (GO:0016573),-0.2154094084183543,-0.7892755216426977,0.8796068796068796,0.9263403123140362,1.0,13/69,16.80%,LEF1;MORF4L1;APBB1;ING4;MRGBP;YEATS2;NAA40;BRPF1;JADE1;KAT14;PER1;WDR5;RUVBL1
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.21280607492881412,-0.7890999816326328,0.8946015424164524,0.926055192942857,1.0,30/80,29.04%,NSF;ARF5;COPG1;KIF26A;TMED2;LMAN2;RAB1A;ARFGAP2;BNIP1;PICK1;TMED3;TMED10;GBF1;SCYL1;TAPBP;KIF3B;RAB1B;PITPNB;KIF11;KIF15;TMEM115;TMED7;KIF4A;RAB6B;USE1;KLC2;KIF23;KLC1;ARF3;DNAJC28
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.2758057218966098,0.7888095610755648,0.7658349328214972,0.9579649667223568,1.0,5/33,10.40%,MTURN;STAT5B;ARNT;MED1;PRKDC
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.331964358042543,-0.7882423458575707,0.7667342799188641,0.926823920051485,1.0,5/11,18.35%,FBXO7;RACK1;ATF4;REST;PINK1
prerank,superoxide metabolic process (GO:0006801),0.2835468113947029,0.7882173760118492,0.7320754716981132,0.9583306058492562,1.0,4/29,4.39%,SOD3;DUOX2;SH3PXD2B;TAFA4
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.2758104182353105,0.7880271273710561,0.7777777777777778,0.9580129737259402,1.0,4/33,7.99%,IL34;ACIN1;PRKCA;CSF1
prerank,hyaluronan metabolic process (GO:0030212),-0.27414593258435227,-0.7879885773518149,0.7671232876712328,0.9266593161514055,1.0,6/23,8.83%,TGFB1;CD44;CEMIP2;CHP1;HEXB;HEXA
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.232557878164252,0.7879163326689151,0.8172920065252854,0.9575412288747597,1.0,7/80,7.78%,EPHA7;DAPK1;FNIP1;UACA;SH3RF1;PDCD6;SIAH2
prerank,positive regulation of protein deacetylation (GO:0090312),-0.3039443330534728,-0.7877634448476375,0.7758620689655172,0.9264622645076256,1.0,4/14,17.12%,AKAP8;APLNR;BRMS1;CTBP1
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.34361169336241215,0.7875053152548828,0.7230443974630021,0.9575895989094532,1.0,3/12,8.93%,PRKCB;PRKCA;CDK1
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.33344294068269154,-0.7874811972871621,0.7618069815195072,0.9263694546523428,1.0,5/12,21.56%,PTPN14;TGFB1;BMP4;UHMK1;SIRT7
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.33734308589597267,-0.787184432532899,0.7576335877862596,0.9262808336075192,1.0,3/11,8.59%,MAP3K5;PDCD10;STK25
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.35760929750855686,0.7871686120578053,0.7105263157894737,0.9575287105111194,1.0,3/11,14.38%,PRKN;P4HB;STK26
prerank,organophosphate catabolic process (GO:0046434),0.3519553072625702,0.7868326344533082,0.7079107505070994,0.9574490067920508,1.0,11/11,64.83%,ENPP2;ABHD12;PLBD2;PNLIPRP2;APOA2;LIPG;ANGPTL3;PON1;PDXP;NUDT15;PLBD1
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.30014607350283096,-0.7863484535545907,0.7668711656441718,0.927031474661677,1.0,6/16,20.83%,SRSF1;PRPF39;CWC15;SNRPC;DCPS;RBM22
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.24743933238215776,0.7859305892927146,0.8260162601626017,0.9582941635425681,1.0,3/55,2.84%,PID1;PRKN;PDGFRB
prerank,positive regulation of interferon-gamma production (GO:0032729),-0.23158447784179986,-0.7857411194627679,0.8387850467289719,0.9273781664741159,1.0,16/48,30.08%,PDE4D;SLC7A5;IL1R1;CYRIB;ISG15;HSPD1;TXK;TRIM27;SLC11A1;CCR2;IL12RB2;TLR4;TLR7;RASGRP1;ZFPM1;FADD
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.2599557797786895,0.7852114479044264,0.7663716814159292,0.9589202349927308,1.0,4/44,4.09%,WNK4;ATP1B3;NOS1AP;ANK2
prerank,protein localization to chromosome (GO:0034502),0.27429467486527126,0.7851690833670877,0.7771535580524345,0.9583402823414878,1.0,6/34,7.80%,MRNIP;ACD;TPP1;XRCC5;SLF1;XRCC4
prerank,snRNA metabolic process (GO:0016073),-0.2897650102759325,-0.7848313899798776,0.762278978388998,0.9282180976090385,1.0,6/17,22.80%,MEPCE;INTS11;INTS6;INTS1;MTREX;INTS3
prerank,protein K63-linked deubiquitination (GO:0070536),-0.25591003747815516,-0.7844893499510166,0.8123620309050773,0.9281895633980363,1.0,10/31,25.89%,ATXN3;OTUD7A;ZRANB1;USP50;OTUD1;USP8;OTUD7B;TNFAIP3;YOD1;USP33
prerank,negative regulation of transmembrane transport (GO:0034763),0.37026252918461167,0.7842802618825989,0.7072649572649573,0.9592226441382583,1.0,2/10,6.08%,OAZ3;PRKCB
prerank,cellular response to gamma radiation (GO:0071480),-0.2941176770329568,-0.7837080451184567,0.7755102040816326,0.9288559557907057,1.0,7/17,24.83%,RPL26;CRYAB;TLK2;ATR;TMEM109;HRAS;TSPYL5
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.32466190357026525,0.7835453391010944,0.7107942973523421,0.9597702719156231,1.0,1/15,1.30%,STXBP4
prerank,recombinational repair (GO:0000725),0.23075921484512804,0.783099457470858,0.8518518518518519,0.9598800215969734,1.0,16/77,16.05%,RAD51B;RNF138;RAD51AP2;HUS1B;RAD51C;HELQ;BLM;AUNIP;BRCA2;ZSWIM7;ZFYVE26;INO80;MRE11;WRN;SWI5;RAD51
prerank,DNA dealkylation (GO:0035510),0.3545642885028232,0.7830104438108605,0.7136929460580913,0.9587312158048469,1.0,3/10,19.33%,ASCC2;MPG;ASCC1
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.3545642885028232,0.7830104438108605,0.7136929460580913,0.9587312158048469,1.0,3/10,19.33%,ASCC2;MPG;ASCC1
prerank,RNA interference (GO:0016246),-0.29875335605840597,-0.7827068895266286,0.7745901639344263,0.9298058279512925,1.0,7/17,31.11%,CLP1;NRDE2;AGO3;TSN;TSNAX;DROSHA;DHX9
prerank,regulation of leukocyte migration (GO:0002685),0.3200063764697336,0.7821065743154242,0.7065637065637066,0.9596151950940981,1.0,3/16,7.97%,ANXA1;HOXA7;MIA3
prerank,cellular response to leucine (GO:0071233),-0.3408946584628101,-0.782029923590234,0.7630597014925373,0.929695597552545,1.0,3/10,9.18%,SESN3;MTOR;SESN2
prerank,response to leucine (GO:0043201),-0.3408946584628101,-0.782029923590234,0.7630597014925373,0.929695597552545,1.0,3/10,9.18%,SESN3;MTOR;SESN2
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.29098777529470493,-0.7819039946477201,0.7640692640692641,0.9293297852145068,1.0,5/19,19.33%,SLC26A2;PAPSS2;BPNT2;SLC35B2;SULT1A1
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.26219030197340104,-0.7815125615885389,0.7905982905982906,0.9293965668401937,1.0,13/25,36.18%,TNFSF10;GPER1;BBC3;PINK1;PLAUR;BIK;BMF;BAX;BID;PMAIP1;HRK;DNM1L;BAD
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.29813374126511355,-0.7813985882199519,0.7799227799227799,0.9289929111789726,1.0,10/16,30.39%,RYR2;HSPA5;BCAP31;GBF1;SEC16B;VAPA;PPP1R15A;UBAC2;SEC16A;BCAP29
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.30419838120146786,-0.7812000643312607,0.7747035573122529,0.9281857116989247,1.0,4/15,15.21%,PABPC1;TOB1;ZFP36L1;TNRC6C
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.30419838120146786,-0.7812000643312607,0.7747035573122529,0.9281857116989247,1.0,4/15,15.21%,PABPC1;TOB1;ZFP36L1;TNRC6C
prerank,protein localization to synapse (GO:0035418),-0.3275288988393241,-0.7806236149447823,0.7447619047619047,0.9284766603494612,1.0,4/12,13.10%,ZDHHC15;NRXN1;PCLO;BSN
prerank,positive regulation of axon extension (GO:0045773),-0.2707399214976128,-0.7805108240452994,0.7827050997782705,0.9280772234143123,1.0,4/22,12.10%,SEMA7A;SHTN1;VEGFA;DBNL
prerank,positive regulation of type I interferon production (GO:0032481),-0.20887837319235858,-0.7792288208049055,0.8598382749326146,0.9294349481340848,1.0,26/73,31.11%,LRRFIP1;HSP90AA1;G3BP1;CTNNB1;GAPDH;CHUK;ISG15;CRCP;OAS2;HSPD1;IFIH1;IRAK1;IRF5;MYD88;POLR3D;RELA;POLR3F;POLR2L;NFKB2;STAT1;CGAS;TLR4;TLR7;POLR1C;MAVS;DHX9
prerank,release of cytochrome c from mitochondria (GO:0001836),-0.29510992694216576,-0.7790488626823926,0.7792706333973128,0.9291524121568102,1.0,10/17,36.18%,BCL2L1;CLU;BBC3;TIMM50;BAX;BID;FIS1;SFN;DNM1L;BAD
prerank,regulation of cell division (GO:0051302),0.23376136585855153,0.7787772752770227,0.8341708542713567,0.96463299264601,1.0,19/72,18.53%,FGFR2;PLK5;FGF1;NCOA3;BLM;BIRC6;PIK3R4;UVRAG;FLCN;ZFYVE26;TXNIP;CIB1;MYO19;CSPP1;KLHL13;ORC6;SETD2;RAB11FIP3;PRPF40A
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.2637038461740465,-0.7787443603631833,0.7697095435684648,0.9290402295945015,1.0,7/25,20.09%,RAC1;RIN3;APP;ANKRD13A;ANKRD13B;ABCA2;PSEN1
prerank,protein deacetylation (GO:0006476),-0.2376915294812712,-0.7785204388820067,0.8482142857142857,0.9288099823299885,1.0,14/41,23.25%,FLNA;HDAC5;MORF4L1;RBM14;SIN3B;SIRT4;BRMS1;HDAC11;HDAC7;HDAC9;SIRT7;HDAC6;RCOR3;SIRT6
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.30209382111779665,0.7784418265447923,0.7408829174664108,0.9645031189457451,1.0,6/22,15.40%,PHF8;LYAR;RASL11A;ERBB2;SMARCB1;NOL11
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.3485952397270409,0.7783699513085572,0.720173535791757,0.9639900435082002,1.0,1/11,2.14%,BCL2
prerank,positive regulation of reproductive process (GO:2000243),0.2747256321296404,0.7778326290588949,0.7670250896057348,0.9642366427132586,1.0,6/31,15.07%,PLA2G10;PLCB1;SMURF2;AGO2;SYDE1;TACR3
prerank,lymphocyte chemotaxis (GO:0048247),-0.24795365026845165,-0.7777553040340545,0.8355555555555556,0.9294196635379997,1.0,2/34,2.07%,SLC12A2;GAS6
prerank,ubiquinone metabolic process (GO:0006743),0.32447481170031106,0.7776518118527763,0.7394789579158316,0.9638766122963126,1.0,4/15,10.63%,FDXR;COQ10A;COQ6;COQ8B
prerank,nucleic acid-templated transcription (GO:0097659),0.25673734330168924,0.7773447226662108,0.7768014059753954,0.9637469896884319,1.0,5/42,11.46%,POLR2D;SCX;THAP1;POLR2A;DTX1
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.2583778509612296,0.7769529220804172,0.8049180327868852,0.9637948446883913,1.0,8/45,12.13%,NCAM1;SP100;TRIM5;IRF8;CAMK2D;IRF3;JAK2;TRIM26
prerank,response to cAMP (GO:0051591),0.2663009623820778,0.7768920749091703,0.7811447811447811,0.9632520173831178,1.0,4/37,5.19%,SLC5A5;DUOX2;CRHBP;AANAT
prerank,protein localization to nucleus (GO:0034504),-0.19938073815757315,-0.7764615102423977,0.936231884057971,0.9308865435476741,1.0,29/102,20.97%,RPL11;PINX1;CALR;SIX1;HNRNPU;PPP1R10;APPL1;ZBTB7A;TOR1B;ARL2BP;HHEX;STAT3;BCL3;LMNA;SIX4;E2F3;NXT1;CSE1L;NUP85;FAM53C;HEATR3;BMP4;NOP53;NUP133;COL1A1;CTDNEP1;AKT1;POM121;SKP1
prerank,neuron apoptotic process (GO:0051402),-0.28535000258833987,-0.7764126761229087,0.7907444668008048,0.9303981776022789,1.0,7/19,19.45%,CIT;TNFRSF21;APP;GAPDH;FAS;LIG4;CDK5
prerank,negative regulation of nervous system development (GO:0051961),0.307530972814528,0.7758662762412492,0.7237354085603113,0.9642715989474858,1.0,2/17,6.85%,APPL2;IL6
prerank,tRNA transport (GO:0051031),-0.2429192258002184,-0.7758083593924542,0.8390022675736961,0.9307612692681607,1.0,8/35,20.80%,TOMM20;YBX1;SSB;NUP37;NUP54;NUP85;NUP133;POM121
prerank,microtubule polymerization or depolymerization (GO:0031109),-0.2656467327079937,-0.775654732548501,0.7829787234042553,0.9304416270528755,1.0,11/24,31.18%,STMN2;STMN1;TPPP;STMN4;TPPP3;STMN3;CKAP5;KIF14;TRPV4;FGF13;NCKAP5L
prerank,regulation of myelination (GO:0031641),0.2869785313515784,0.7756520467535274,0.766798418972332,0.9639741380738703,1.0,6/25,13.35%,PARD3;ITGAX;PTN;CST7;TMEM98;DICER1
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.2698457378584601,0.7754748996515141,0.7537037037037037,0.9636181307971271,1.0,10/33,15.36%,PLK5;DLG1;KANK2;PTEN;RBL2;MYO16;PKD2;CDC73;CDKN2B;CDK4
prerank,alpha-linolenic acid metabolic process (GO:0036109),-0.3184884238574528,-0.7753588243206357,0.7574626865671642,0.9303144210323101,1.0,3/12,13.30%,ELOVL5;FADS2;ELOVL1
prerank,cellular polysaccharide catabolic process (GO:0044247),0.3208715790978762,0.7752823631476555,0.7690802348336595,0.9632662048945521,1.0,2/16,4.64%,PHKB;MGAM
prerank,regulation of sister chromatid cohesion (GO:0007063),0.33753634810533584,0.7748465291545099,0.726,0.9633616413599996,1.0,2/12,9.51%,HDAC8;AXIN2
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.3078612971000695,-0.774791705754247,0.7901960784313725,0.9306026771592688,1.0,6/13,34.17%,PRR5L;ZC3H12A;GTPBP1;ZC3HAV1;RC3H1;CNOT1
prerank,regulation of cholesterol storage (GO:0010885),0.32912319837472,0.7745714288495796,0.7596741344195519,0.9631772282719531,1.0,2/15,3.43%,PPARA;ABCA1
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.2555063908459384,-0.7732201571882378,0.8241525423728814,0.9323075466568321,1.0,7/28,19.60%,DAB2IP;NGF;BLOC1S2;CASP8AP2;CASP8;TNFRSF10B;SPI1
prerank,regulation of inclusion body assembly (GO:0090083),0.35498903125002124,0.7730061375822727,0.7064989517819706,0.9650805839684228,1.0,1/11,2.63%,SNCAIP
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),-0.18027176696866537,-0.7729540203117192,0.9657534246575342,0.9321106523122208,1.0,55/184,26.51%,HSP90AA1;UBB;PKD1;BUB3;UBC;RPS27A;CUL3;PSMD13;APPL1;PSMF1;DDB1;PSMB10;YWHAG;TUBB4B;PSMB6;DCTN3;PSME3;ZFP36L1;PSMB5;PSMC3;PSMD12;PSMB8;TUBA1A;PSME1;CUL1;NDE1;ANAPC16;ODF2;UBA52;PSMB3;TUBB4A;ID2;CETN2;CDK2;BUB1B;UBE2D1;TFAP4;CKAP5;PSMD5;HAUS6;MAPRE1;DCTN1;SKP1;ANAPC7;PSMD9;PSMB4;CEP41;NEK11;RGCC;HMMR;KNTC1;PSMD10;KIF14;PLK4;CDC14A
prerank,lipid droplet organization (GO:0034389),-0.26511247810845007,-0.7726501460794043,0.80625,0.9320021134060631,1.0,4/22,17.63%,PPIA;CDS1;BSCL2;AUP1
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.2555326115008172,-0.7726468054195136,0.8195991091314031,0.9314506964863833,1.0,6/29,11.89%,HSP90AB1;CDC37;NLRC5;ISG15;PTPN1;YTHDF3
prerank,regulation of immune effector process (GO:0002697),0.2605489774142488,0.7723129698402081,0.7888086642599278,0.9655666721516962,1.0,6/41,11.62%,PROS1;C2;CFH;VTN;C8B;C8G
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.24825216682553966,0.7716326646085081,0.8372093023255814,0.9660137737615032,1.0,19/57,21.35%,CDC14B;HUS1B;MRNIP;BLM;CDK1;CLSPN;MDC1;PRKDC;RINT1;MRE11;BABAM2;BRSK1;TAOK3;TRIM39;TAOK2;UIMC1;RAD9B;STK33;NBN
prerank,regulation of multicellular organismal development (GO:2000026),-0.26502846170313593,-0.7715067899192837,0.820675105485232,0.9325202178896412,1.0,10/25,24.50%,SOX17;BAG6;SPAAR;OAS2;MYSM1;INSR;HPSE;GBX1;RAB14;DUSP6
prerank,response to interferon-beta (GO:0035456),-0.27638368928637336,-0.771072233030794,0.7982456140350878,0.932570894924868,1.0,5/22,20.17%,AIM2;NDUFA13;SHFL;BST2;IFITM3
prerank,histone H4-K16 acetylation (GO:0043984),0.2998264843674002,0.770832499203313,0.755859375,0.9666698147560531,1.0,3/19,10.66%,KMT2A;KAT8;KANSL1
prerank,striated muscle cell differentiation (GO:0051146),0.30701645867395566,0.7707396398026165,0.7604166666666666,0.9661685291166887,1.0,4/16,9.06%,CBY1;AKAP13;SIK1;KDM6B
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.282970498289845,0.7702165272689645,0.7532710280373832,0.9663506794238149,1.0,9/26,17.89%,DAB2;KANK2;STRN3;HDAC1;CNOT2;CRY1;CLOCK;SFRP1;NCOR1
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.31011040736874507,-0.7701914988241559,0.7775510204081633,0.9333054811881397,1.0,5/13,20.07%,RPL26;SPRED2;DDX5;EEF1E1;ATR
prerank,regulation of keratinocyte migration (GO:0051547),0.3316263524981095,0.7696181315824685,0.7439024390243902,0.966680164791888,1.0,3/12,7.47%,MAPRE2;MMP9;PTEN
prerank,protein transmembrane import into intracellular organelle (GO:0044743),-0.24840929169651194,-0.7694591419170347,0.8369565217391305,0.9337882649489975,1.0,11/31,30.65%,TOMM20;HSPD1;ROMO1;PEX1;PEX5;TIMM50;PEX10;PEX16;TIMM44;CHCHD4;DNLZ
prerank,cobalamin metabolic process (GO:0009235),0.31013560901758724,0.7692630924588849,0.7611940298507462,0.9665960338766698,1.0,3/17,14.18%,TCN2;TCN1;MMAB
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.29566184660692096,0.7690050222546856,0.7753479125248509,0.9663664232740148,1.0,3/22,5.20%,FANCA;DUSP10;CTLA4
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.22235045008842502,-0.7689323183442507,0.8786407766990292,0.9340177000006328,1.0,22/54,36.17%,RPL26;SOX4;PLK2;PLAGL1;CNOT6L;CHEK2;CDKN1B;TNKS1BP1;PCBP4;GADD45A;CDKN1A;E2F7;RGCC;BAX;SFN;PIDD1;AURKA;CNOT1;E2F8;CRADD;PLK3;CNOT9
prerank,defense response to symbiont (GO:0140546),0.22553654152118224,0.7688392995486106,0.8710644677661169,0.9660023550454951,1.0,11/92,9.87%,BCL2;PLA2G10;IFIT3;RNASEL;IFIT2;TRIM5;BNIP3;IL6;TRIM56;ZBP1;IRF3
prerank,cellular response to interferon-gamma (GO:0071346),0.22673418365090434,0.7687596941277088,0.8467374810318664,0.9654784724592232,1.0,11/88,10.28%,DAPK1;NCAM1;SP100;TRIM5;IRF8;CCL19;CAMK2D;SIRPA;IRF3;JAK2;CCL4
prerank,mRNA stabilization (GO:0048255),-0.23681993623331307,-0.7685751199844485,0.8446115288220551,0.9339849310125351,1.0,12/40,21.94%,TARDBP;PABPC1;YBX3;HNRNPU;YBX1;FUS;HNRNPA0;TENT5A;MYD88;TIRAP;SLC11A1;RBM24
prerank,nuclear envelope organization (GO:0006998),-0.2758085391183913,-0.7685657056781612,0.7695473251028807,0.9334412734737271,1.0,6/20,20.10%,REEP3;LEMD2;TOR1B;TMEM43;SUN1;CTDNEP1
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.2449923886457654,0.7680901214485681,0.8276450511945392,0.9658806921757926,1.0,12/58,14.16%,XRCC5;XRCC4;KDM2A;UVRAG;POLM;MDC1;PRKDC;DCLRE1A;NHEJ1;DCLRE1B;MRE11;BABAM2
prerank,regulation of cytokinesis (GO:0032465),-0.20342121460898588,-0.7680134781906937,0.9247058823529412,0.933680466002847,1.0,16/78,18.91%,PKP4;CALM1;SH3GLB1;CIT;PLK2;BCL2L1;CUL3;RHOA;GIT1;KIF13A;PIK3C3;CALM2;PRKCE;KLHL9;CETN2;ENTR1
prerank,regulation of cellular response to stress (GO:0080135),0.21651569993595168,0.7679489377135826,0.8872832369942196,0.9654712477164714,1.0,19/115,13.47%,ROCK2;PRKN;CRHBP;NDC1;NEK4;AMFR;CAMK2D;NUPR1;HSPA1L;NUP107;ABL1;MLST8;NPAS2;MAPKAPK2;AKT1S1;SLC38A2;HSF1;MAPK1;CREBBP
prerank,protein-DNA complex assembly (GO:0065004),0.2165419664539006,0.7678892339264896,0.8680659670164917,0.9649326957646073,1.0,22/116,16.27%,TCF4;CDK7;DDB2;DMC1;PSME4;PSMA2;PSMA3;RSF1;KAT6B;PSMD8;SMARCA5;NAP1L3;PSMD3;CUL4B;ORC2;NAA60;RAD23B;MNAT1;MCM2;ORC3;RAD51;NAP1L1
prerank,regulation of type I interferon production (GO:0032479),0.2266056934317378,0.7677703551495453,0.8531684698608965,0.9644982665688857,1.0,21/84,14.72%,IRF8;XRCC5;TRIM56;POLR3GL;POLR3G;RNF135;RNF216;ZBP1;ITCH;IRF3;PRKDC;UBA7;IKBKE;PCBP2;CYLD;TBK1;CREBBP;MRE11;DDX41;POLR3C;NLRX1
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.294880012208426,0.7673907475053338,0.747148288973384,0.9644985741126176,1.0,5/23,18.03%,CECR2;DICER1;DFFA;REXO4;KPNB1
prerank,apoptotic DNA fragmentation (GO:0006309),0.3230137519498316,0.7665187492732071,0.7672064777327935,0.9652200327519416,1.0,4/16,18.03%,CECR2;DICER1;DFFA;KPNB1
prerank,regulation of defense response to virus (GO:0050688),0.3285434228213664,0.7662569583272235,0.7484909456740443,0.9649938747398,1.0,5/14,19.40%,RNF216;ITCH;PCBP2;ILRUN;TRAF3IP1
prerank,acute-phase response (GO:0006953),-0.31469779879826043,-0.7657876228063679,0.7768924302788844,0.9362407049646355,1.0,4/12,29.43%,LBP;SIGIRR;CEBPB;AHSG
prerank,fatty acid metabolic process (GO:0006631),0.2157127646871581,0.7656948041786077,0.890625,0.9652386652324547,1.0,10/115,8.97%,PPARA;ACADSB;ACSL1;CEL;ACOT4;CPT2;ECHDC3;LIPC;LIPH;AASDH
prerank,regulation of exosomal secretion (GO:1903541),0.30805674617812495,0.7655396007193578,0.7535934291581109,0.9648356738288228,1.0,1/19,1.41%,PRKN
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.29017384933266654,-0.7654311635274548,0.8105263157894737,0.9362093481033814,1.0,4/17,14.36%,SLIT2;SFRP4;TMEM204;CASK
prerank,regulation of chromatin binding (GO:0035561),0.34613810077592777,0.7647274923403725,0.723175965665236,0.9655041045855864,1.0,3/10,17.42%,PARP9;DTX3L;KDM4D
prerank,myeloid cell differentiation (GO:0030099),-0.21955680622210244,-0.764562467611411,0.8970917225950783,0.9368912331827569,1.0,21/47,33.02%,RUNX1;RPS19;RPS14;IKZF1;KMT2E;TAL1;ATP5IF1;JAK3;HSPA9;INHA;SPI1;TIRAP;PRKX;CEBPA;FLVCR1;EPO;ZFPM1;MFHAS1;ALAS2;HCLS1;SNRK
prerank,protein ADP-ribosylation (GO:0006471),0.2801777845947591,0.7642110092928985,0.7886792452830189,0.9656942430261001,1.0,12/28,25.71%,PARP4;PARP10;PARP12;PARP9;SIRT3;ARF4;TIPARP;PARP14;TNKS2;SIRT5;ART4;PARP2
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.3012594417352991,0.7639969734917607,0.7726396917148363,0.9654011186351019,1.0,4/20,11.59%,SMOC2;SULF1;APLN;PRKD2
prerank,DNA damage checkpoint signaling (GO:0000077),-0.25474843894328314,-0.7639361825253491,0.825287356321839,0.9371662364380582,1.0,9/28,24.37%,TIPRL;CHEK2;DONSON;RAD17;USP28;RAD9A;ATR;DOT1L;CHEK1
prerank,microtubule-based transport (GO:0099111),-0.31705560099466,-0.763808087134208,0.7746478873239436,0.9368020407922476,1.0,6/12,38.13%,SPAG17;DYNC1I1;DNAAF2;CABYR;CCDC40;DNAAF4
prerank,chromatin disassembly (GO:0031498),0.32005401704068764,0.763778298077686,0.7415506958250497,0.964491877008519,1.0,5/14,15.56%,ARID2;SMARCE1;SMARCB1;SMARCC1;SMARCD3
prerank,nucleosome disassembly (GO:0006337),0.32005401704068764,0.763778298077686,0.7415506958250497,0.964491877008519,1.0,5/14,15.56%,ARID2;SMARCE1;SMARCB1;SMARCC1;SMARCD3
prerank,sno(s)RNA 3'-end processing (GO:0031126),-0.3198626560894108,-0.7632006980687734,0.7732558139534884,0.937093312703655,1.0,5/11,31.02%,LARP7;FBL;EXOSC10;EXOSC5;TENT4B
prerank,positive regulation of protein import (GO:1904591),-0.25235828870743443,-0.7631174936946761,0.8235294117647058,0.936660819700303,1.0,11/30,24.09%,CDH1;FLNA;TGFB1;ARHGEF5;JUP;ZC3H12A;PSEN1;PRKCD;RBM22;HYAL2;ZPR1
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.3043367401143611,0.7630651549689559,0.7555110220440882,0.9649630402839285,1.0,3/17,8.14%,ALG6;ALG2;ALG9
prerank,histone methylation (GO:0016571),0.27936378141852214,0.7622709982652881,0.818359375,0.9656087146568565,1.0,8/26,19.85%,SETD6;PRMT7;NSD1;SMYD3;CREBBP;N6AMT1;CARM1;NSD3
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.31183379336561245,0.7621586751733865,0.74373795761079,0.9651569125134085,1.0,8/17,22.23%,AKAP13;ADRA1D;ADRB3;DRD2;ADCY9;ADRA2A;GPR101;RAPGEF2
prerank,protein import (GO:0017038),0.22260967797247624,0.7620299658396068,0.8814352574102964,0.9647221897441225,1.0,11/84,13.32%,APPL2;IPO13;PXMP2;PRICKLE1;SNX33;LAMP2;NUTF2;NUP107;PXMP4;TNPO1;NXT2
prerank,positive regulation of protein targeting to membrane (GO:0090314),-0.26426730379688207,-0.7619942752661575,0.8229166666666666,0.9376530149046328,1.0,7/24,14.11%,FYN;KCNB1;CHP1;C2CD5;MIEF1;MTCL1;MIEF2
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.29094237114060184,-0.761774350894157,0.7826923076923077,0.937417525452164,1.0,6/15,26.00%,SCARB1;MFSD2A;NR1H2;CTDNEP1;NR1H3;C3
prerank,photoreceptor cell development (GO:0042461),0.3224003955918283,0.7614188158207247,0.7659137577002053,0.9650495544778886,1.0,2/14,4.32%,TULP1;ARL3
prerank,protein sumoylation (GO:0016925),0.24571610024583967,0.7613284570349255,0.8286713286713286,0.9645666556532847,1.0,4/49,10.11%,EYA1;NDC1;PIAS1;NUP107
prerank,cellular response to UV (GO:0034644),-0.20094686368920106,-0.7612583488018974,0.9135135135135135,0.937588929924687,1.0,24/76,26.44%,RPL26;CRIP1;DDB1;ATF4;MFAP4;COPS9;POLK;CARD16;USP28;N4BP1;ATR;PRKCD;MMP1;METTL3;NOC2L;BMF;CDKN1A;FMR1;HYAL2;POLD1;CHEK1;XPA;TIMP1;OPN3
prerank,protein polyglutamylation (GO:0018095),-0.32473358072446323,-0.760520411988242,0.7347328244274809,0.9380141171537434,1.0,4/11,28.20%,TTLL7;CEP41;TTLL6;TTLL2
prerank,positive regulation of ion transport (GO:0043270),0.24808445740062762,0.7602292846714284,0.8222996515679443,0.9655895702644005,1.0,13/48,18.61%,GPD1L;MYLK;ANK2;CACNA1D;DLG1;CCL4;SCN3B;ACTN2;GDNF;CHRNB2;DRD2;ANO6;CAMK2A
prerank,regulation of lymphocyte differentiation (GO:0045619),0.30971729076742505,0.759912054436451,0.7620967741935484,0.9654341027062981,1.0,3/18,10.40%,SLAMF8;ABL1;PRKDC
prerank,regulation of myeloid cell differentiation (GO:0045637),0.23826039822271083,0.7591621655261166,0.8449477351916377,0.9659520887679367,1.0,12/62,13.60%,KMT2A;MEIS1;ASH2L;TNRC6B;TNRC6A;PRKCB;SETD1A;HDAC1;KMT2B;CDC73;CREBBP;MEIS2
prerank,regulation of myoblast fusion (GO:1901739),0.3335127232761992,0.7590794222436391,0.7436974789915967,0.9654493294376572,1.0,2/11,11.35%,RIPOR2;CFLAR
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.31692648458574113,0.7589881211076034,0.76171875,0.9649448795034594,1.0,4/15,17.43%,NLGN2;ZDHHC3;USP46;DRD2
prerank,peptidyl-lysine modification (GO:0018205),0.2186306626111944,0.7583929622849312,0.8773584905660378,0.9652237437297129,1.0,8/99,10.16%,EYA1;LOXL1;LOXL3;SENP7;NDC1;PIAS1;NUP107;EEF1AKMT1
prerank,endomembrane system organization (GO:0010256),0.20094300596905915,0.7578343363348372,0.9259259259259259,0.9654372615706807,1.0,26/178,9.94%,HOOK2;TANGO2;DMPK;ALS2;A4GALT;OBSL1;DYNC2H1;LRRK2;SNX33;RAB30;FAM174B;MYO18A;OPTN;PLEKHJ1;UBXN2B;DYM;MIA3;BLZF1;CUL7;ARFGEF2;PLEKHF1;RAB22A;TRAPPC8;LEMD3;TJAP1;GOLGA2
prerank,regulation of regulated secretory pathway (GO:1903305),0.26447314406316824,0.7576359575732274,0.7909407665505227,0.9651099055833086,1.0,4/34,5.17%,DTNBP1;SYT11;SYT12;LRRK2
prerank,intracellular protein transport (GO:0006886),0.18918396012084573,0.7575235702596778,0.9758389261744966,0.964654344523524,1.0,65/304,19.06%,RANBP3L;WLS;APPL2;IPO13;KIF13B;SNX6;ARFGAP3;PRICKLE1;RAB19;SNX9;ACD;ARL5A;TBC1D9B;MAIP1;PDCD6;STX16;ARL6;LAMP2;GGA2;SLU7;RAB32;DNAJC27;TBC1D4;RAB22A;NUTF2;RIC1;NUP107;WDR11;IFT27;STX8;OXA1L;TNPO1;SAR1B;STX17;TECPR2;NXT2;TRAK1;CLTC;ARL4C;AP3B1;COPZ2;ARL5B;RAB43;CCHCR1;COPB2;TBC1D17;TRAK2;STX11;VPS26A;AP4M1;NUP214;VPS35;DESI1;RPAIN;IPO9;IFT22;USP6NL;ARF4;KPNB1;TBC1D15;FAM91A1;TBC1D9;RAB21;RAB29;CLIP3
prerank,nucleotide metabolic process (GO:0009117),0.28560251554564026,0.7560682679363094,0.7954110898661568,0.9662128802255956,1.0,5/23,12.28%,FHIT;CTPS2;NMNAT2;ENPP3;NMNAT1
prerank,negative regulation of protein catabolic process (GO:0042177),0.25459639684861274,0.7557892135481853,0.8093587521663779,0.9659866768302486,1.0,7/40,12.77%,TIMP3;AZIN2;BANP;ATRAID;RIC1;PTPN3;SNX12
prerank,leukotriene metabolic process (GO:0006691),-0.27186264737379623,-0.7557716848637751,0.8080168776371308,0.9440001025156733,1.0,11/19,40.89%,ALOX12;PLA2G4A;GGT1;LTA4H;MGST2;PLA2G5;ALOX5AP;DPEP1;GGT5;ABCC1;ABCC10
prerank,regulation of microtubule-based process (GO:0032886),0.26205616174840063,0.7556168784735784,0.8055077452667814,0.9656142965290633,1.0,9/36,14.31%,EPHA3;MACF1;PRKAA2;PHLDB2;PRKAA1;ERBB2;CYLD;BICD2;MEMO1
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.18771184336162922,-0.7536443594159259,0.9681528662420382,0.9463042149644133,1.0,35/117,28.80%,PLCG2;RAMP2;FYN;ADCY4;PLK2;RHBDF2;RAMP1;MYH9;PTHLH;CYSLTR1;ADCY7;ADCY3;FURIN;CYSLTR2;ADRB2;CD81;PRKAR1A;CALCRL;VIPR2;IAPP;GPR27;YES1;HRH2;TSHR;GGT1;GLP2R;NPSR1;MC5R;ADCYAP1;GNB1;CALCA;GPR20;CD163;KARS1;TREM2
prerank,regulation of stress-activated MAPK cascade (GO:0032872),-0.22280619294835866,-0.7522006544827111,0.8733333333333333,0.9476402000781273,1.0,15/47,23.33%,TGFB2;DAB2IP;PPIA;MID1;PDCD10;FOXO1;STK25;EPHB1;FAS;PER1;MAP2K2;GREM1;MAPK3;MAPK8IP2;AGER
prerank,neuron projection fasciculation (GO:0106030),0.35294526615253025,0.7515446003415555,0.7419354838709677,0.9710594968831927,1.0,5/10,20.34%,EPHA4;ARHGAP35;SEMA5A;EPHB2;AMIGO1
prerank,RNA splicing (GO:0008380),-0.19219724216832623,-0.7513287863426474,0.9679144385026738,0.9482065536211253,1.0,16/95,15.61%,MBNL1;PPARGC1A;TARDBP;IVNS1ABP;SRSF2;SFPQ;SF3B1;SF3B2;DDX39B;USP39;RBM8A;RNPS1;PRPF18;SRPK1;FUS;PRPF4
prerank,negative regulation of hydrolase activity (GO:0051346),0.247535633277799,0.7512551521722373,0.8324958123953099,0.9708632337659117,1.0,11/49,14.74%,GMIP;ECM1;CPEB2;LRRK2;GPATCH2;CST7;SH3RF2;GPSM1;PLIN5;FZD10;SH2D4A
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.32580133960338553,0.7512293874156949,0.7429718875502008,0.9702694357252115,1.0,2/11,8.81%,ANXA1;RC3H2
prerank,positive regulation of receptor internalization (GO:0002092),-0.2614904104234698,-0.7511880000480605,0.816414686825054,0.9478257227719538,1.0,10/22,22.10%,SFRP4;ARRB1;VEGFA;CD63;PICK1;GREM1;ARRB2;INSR;ATAD1;FMR1
prerank,cellular response to catecholamine stimulus (GO:0071870),0.28317606767518777,0.7508395962313898,0.7984790874524715,0.9702153716925763,1.0,7/23,18.48%,PRKN;LRRK2;ABL1;MAPK1;GNG2;SLC9A1;SNCA
prerank,UV-damage excision repair (GO:0070914),0.33137777772198146,0.7505802588491438,0.7644710578842315,0.9699909505401149,1.0,4/12,17.88%,DDB2;CUL4B;INO80;XPC
prerank,negative regulation of receptor internalization (GO:0002091),-0.3024193692420246,-0.7502552437092329,0.7939508506616257,0.9484274569291123,1.0,7/12,40.22%,RIN3;ANKRD13A;ANKRD13B;WDR54;ATXN2;ANKRD13D;NECAB2
prerank,positive regulation of protein ubiquitination (GO:0031398),-0.1991670897874304,-0.7502096722363736,0.9206349206349206,0.947915546182687,1.0,25/80,26.37%,CAV1;UBE3A;UBB;FAM107A;CUL3;RPS2;DERL1;BIRC3;RBX1;NDFIP2;DCUN1D1;DCUN1D2;WFS1;LAPTM5;SPRTN;UBE2D1;PINK1;NDFIP1;HUWE1;TRIB3;SPSB4;PTTG1IP;TSPYL5;PSMD10;ARRDC3
prerank,hexose transmembrane transport (GO:0008645),0.29174524049442074,0.7501272901491258,0.8003802281368821,0.9700243289244868,1.0,3/21,6.15%,SLC2A12;SLC45A3;SLC2A10
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.34949904615687477,0.7495650036934655,0.7664670658682635,0.9702383278413413,1.0,2/10,8.90%,PXYLP1;XYLT2
prerank,positive regulation of lipid storage (GO:0010884),-0.2662506538741113,-0.7495586600482542,0.8304721030042919,0.9482400913516909,1.0,3/21,6.12%,SCARB1;SREBF2;EHD1
prerank,positive regulation of cell growth (GO:0030307),0.21516376902978623,0.7494408844208316,0.9012539184952978,0.9697902382211634,1.0,21/96,19.31%,IGF1;BCL2;MACF1;SPHK1;NTN1;KLHL22;ERBB2;INO80;ADNP2;S100A9;CIB1;CDKL5;HYAL1;N6AMT1;SDCBP;SFRP1;MMP14;DDX3X;GOLGA4;TAF9B;USP47
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.31581090049943644,0.7480349787626623,0.7591522157996147,0.9712073717849462,1.0,2/13,10.99%,TPST1;SULT4A1
prerank,negative regulation of T cell proliferation (GO:0042130),-0.2534326246077107,-0.7477848009792739,0.841304347826087,0.9499600290952023,1.0,12/28,39.19%,TNFRSF21;PRKAR1A;CD274;SDC4;CEBPB;CD80;IL4I1;GPNMB;RC3H1;VTCN1;ARG1;CRTAM
prerank,glutathione metabolic process (GO:0006749),0.255725854488867,0.7475399255273506,0.818018018018018,0.9713024988443871,1.0,3/38,4.82%,GSTM2;GSTT4;GSTT1
prerank,regulation of B cell apoptotic process (GO:0002902),-0.31263043794377426,-0.7473730403041853,0.796078431372549,0.9499275334617542,1.0,1/12,0.83%,FOXP1
prerank,regulation of protein targeting to membrane (GO:0090313),-0.2500935435864575,-0.7472593435585815,0.8395833333333333,0.949516882620933,1.0,9/28,19.58%,FYN;KCNB1;CHP1;C2CD5;MIEF1;MTCL1;MIEF2;GDI1;ANK3
prerank,inositol phosphate catabolic process (GO:0071545),-0.3038414649212242,-0.7468557635653102,0.791907514450867,0.9494912353031951,1.0,2/12,5.63%,SYNJ1;NUDT3
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.30001094156038677,0.7468466852628354,0.7775510204081633,0.9716773622089713,1.0,4/18,13.22%,PDPK1;IGF2;APLN;COL4A3
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.24372929935407733,-0.7468109499276493,0.8736383442265795,0.9489968670210812,1.0,10/31,22.93%,KLF4;FHL1;FAM107A;APC;CDK6;JADE1;CDK2AP2;CDKN1A;CDKN2D;E2F7
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.2886493805040845,0.7465131475407331,0.7819253438113949,0.9715404468951231,1.0,2/21,5.17%,PRKN;LRRK2
prerank,regulation of neuroblast proliferation (GO:1902692),0.31434133941686576,0.7462862820712842,0.759765625,0.9712266334432414,1.0,6/15,17.43%,LRRK2;PTN;DCT;CX3CL1;SMARCD3;DRD2
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.2691435111496496,-0.7457227064812103,0.821501014198783,0.9487595942475103,1.0,11/20,34.79%,BUB3;APC;BUB1B;TEX14;KNTC1;TRIP13;ZWINT;IK;PLK1;CDC20;BUB1
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.2691435111496496,-0.7457227064812103,0.821501014198783,0.9487595942475103,1.0,11/20,34.79%,BUB3;APC;BUB1B;TEX14;KNTC1;TRIP13;ZWINT;IK;PLK1;CDC20;BUB1
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.2691435111496496,-0.7457227064812103,0.821501014198783,0.9487595942475103,1.0,11/20,34.79%,BUB3;APC;BUB1B;TEX14;KNTC1;TRIP13;ZWINT;IK;PLK1;CDC20;BUB1
prerank,dorsal/ventral pattern formation (GO:0009953),-0.27279934892858965,-0.7456362124229182,0.83640081799591,0.9483197135853196,1.0,5/20,18.47%,ACVRL1;PTCH1;DSCAML1;ACVR1;GREM1
prerank,regulation of embryonic development (GO:0045995),0.25531602927120156,0.745084731923867,0.8148820326678766,0.9723485679263887,1.0,7/34,12.52%,PLCB1;PHLDB2;NIBAN2;WDPCP;CDK1;CCSAP;RBM19
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.33707746054151466,0.7449913440847092,0.758985200845666,0.9712394265729802,1.0,2/11,7.47%,SYNJ2;PTEN
prerank,inositol phosphate dephosphorylation (GO:0046855),0.33707746054151466,0.7449913440847092,0.758985200845666,0.9712394265729802,1.0,2/11,7.47%,SYNJ2;PTEN
prerank,non-motile cilium assembly (GO:1905515),0.2647423977134322,0.7447962201584687,0.8198874296435272,0.9708914014789876,1.0,6/30,11.81%,TTC8;TBC1D32;ARL13A;RPGRIP1L;CEP89;IFT122
prerank,posttranscriptional regulation of gene expression (GO:0010608),-0.22467805625920398,-0.7437338029496676,0.8755656108597285,0.9501324003994776,1.0,22/45,38.38%,PUM2;APP;GCNT2;PER1;ZC3H7A;EIF2A;YTHDC1;NOLC1;EIF4E;PUM3;PCIF1;DDX25;RBM4B;RPL10;METTL18;MATR3;RC3H1;ATXN2;MAPKAPK5;MTPN;ZC3H10;TRIM71
prerank,DNA packaging (GO:0006323),0.3075084831065004,0.7436045139086591,0.7519685039370079,0.9719547258818656,1.0,3/16,18.25%,RBBP4;BANF2;AIFM1
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.3379292677139449,0.7431361997754135,0.7538461538461538,0.972020580891116,1.0,2/10,7.01%,NOS1AP;CACNA2D1
prerank,erythrocyte development (GO:0048821),-0.3180961979670889,-0.7431009589227494,0.8192534381139489,0.9503315727118515,1.0,4/10,20.26%,ABCB10;ZBTB7A;SH2B3;NCKAP1L
prerank,innate immune response in mucosa (GO:0002227),0.3412561288778661,0.7430612714717106,0.7758241758241758,0.9715160292580717,1.0,1/10,2.80%,LTF
prerank,positive regulation of TOR signaling (GO:0032008),0.25143108138750747,0.7425964098501117,0.8638838475499092,0.9715550218125173,1.0,14/40,20.12%,FNIP1;RICTOR;SLC38A9;GPR137C;FLCN;KLHL22;MLST8;SIK3;TELO2;MIOS;LARS1;CLEC16A;LAMTOR5;PIK3CA
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.2861946028220117,-0.7424909835550728,0.8264299802761341,0.9505572450812493,1.0,6/16,29.17%,CLU;CYP51A1;IFNGR1;TREM2;HMGCR;ABCA7
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),-0.2968415293985949,-0.7420263696928401,0.8045738045738046,0.9505793464805861,1.0,7/13,28.57%,APOD;CHP1;RANGAP1;MDFIC;CABP1;BARD1;NUP153
prerank,phospholipid metabolic process (GO:0006644),0.2249865682174462,0.741971428511859,0.8853288364249579,0.9718200761445114,1.0,3/71,2.75%,AGPAT4;PLPP3;PLA2G10
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.3357086767538672,0.7419649711119337,0.7572614107883817,0.9712090970962582,1.0,4/11,16.23%,ADM;GRK3;ADRB3;GRK2
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.24686231884201593,0.7419553619692538,0.8471223021582733,0.970602919653644,1.0,8/46,10.64%,TIMP3;DUSP10;FBLN1;DLG1;LMO3;PTEN;SIRPA;FLCN
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.3179948133663349,-0.7419414945366003,0.8129496402877698,0.950127964457977,1.0,4/10,23.16%,MFSD2A;MTMR9;ABCA3;MTMR1
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.24938416078253695,-0.7417582393406862,0.8591885441527446,0.9498014239744268,1.0,14/29,35.69%,LPCAT3;TMEM86B;LPCAT1;NR1H2;PLA2G4A;NR1H3;PLA2G4F;DBI;LPCAT4;MBOAT2;PLA2G5;PLAAT3;PLBD1;PLB1
prerank,nuclear pore complex assembly (GO:0051292),0.337525262705648,0.7415608049736679,0.7727272727272727,0.9705332877577687,1.0,2/10,10.11%,NDC1;NUP107
prerank,negative regulation of DNA replication (GO:0008156),-0.3003510599522402,-0.7415453446551644,0.8145315487571702,0.9495123413866703,1.0,6/13,33.63%,RAD17;S100A11;ATR;GMNC;GMNN;CDC6
prerank,histone deubiquitination (GO:0016578),0.29721154429196156,0.7410432075044406,0.7849686847599165,0.9706519777524626,1.0,5/18,21.03%,EPOP;USP7;TRRAP;UIMC1;USP21
prerank,double-strand break repair via homologous recombination (GO:0000724),0.21076934701756112,0.7405971148308207,0.9217791411042945,0.9706632690843511,1.0,19/95,16.05%,RAD51B;RNF138;RAD51AP2;HUS1B;RAD51C;HELQ;BLM;AUNIP;BRCA2;ZSWIM7;ZFYVE26;INO80;MRE11;FANCB;MCM2;NIPBL;WRN;SWI5;RAD51
prerank,heterocycle biosynthetic process (GO:0018130),-0.2973923086744539,-0.7404081662694816,0.8057851239669421,0.9503807954166308,1.0,6/14,33.25%,GCH1;GPHN;LIAS;PYCR2;PYCR1;NFS1
prerank,negative regulation of JUN kinase activity (GO:0043508),-0.32846697231141503,-0.7403396501027647,0.8081936685288641,0.9499123853028314,1.0,2/10,7.39%,DNAJA1;PDCD4
prerank,positive regulation of oxidoreductase activity (GO:0051353),-0.2785417622849528,-0.7400028543628591,0.8396793587174348,0.9497873800108159,1.0,9/18,34.83%,EDN1;RFK;AGTR1;PDP2;NOD2;AGT;POR;PDP1;PARK7
prerank,regulation of lymphocyte activation (GO:0051249),0.32046453232893907,0.7393504738138834,0.7670103092783506,0.9717744238557637,1.0,12/12,67.98%,PAG1;LAT;SIT1;CD4;CD19;LCK;CRTAM;CCL5;KAT2A;THEMIS2;IKZF3;DCAF15
prerank,protein-DNA complex disassembly (GO:0032986),-0.28208717767139124,-0.7392853354386685,0.8044806517311609,0.95011291241502,1.0,3/16,10.69%,RPL23;SET;SMARCD1
prerank,positive regulation of macrophage migration (GO:1905523),0.29310883045525243,0.7389550075505334,0.7801980198019802,0.9717139616516455,1.0,1/19,0.61%,IL34
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.28543415314340825,-0.7386238756714175,0.8026819923371648,0.9503673693087689,1.0,8/15,34.16%,APPL1;GBP5;STAT3;MYD88;TLR4;TLR6;NOD2;TICAM1
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),-0.24921309477656314,-0.7383202661250137,0.8431372549019608,0.9502215743546705,1.0,10/27,24.72%,ZC3H12C;TRIR;CPSF3;RNASE4;ZC3H12A;RPP30;PCF11;NHP2;ERN1;NUDT16
prerank,endosome organization (GO:0007032),0.2460872153824542,0.737825722192192,0.8255613126079447,0.972647303063543,1.0,10/41,14.45%,HOOK2;ALS2;SNX33;PLEKHJ1;ARFGEF2;PLEKHF1;RAB22A;EEA1;PHETA1;WASHC4
prerank,establishment of spindle localization (GO:0051293),-0.28489436119203637,-0.7376610567470736,0.8317214700193424,0.9504568857133457,1.0,10/14,37.58%,MAP4;CFL1;TLE6;CLASP2;ZBED3;ESPL1;CLASP1;NUSAP1;DYNC1H1;NLRP5
prerank,"base-excision repair, AP site formation (GO:0006285)",-0.28311396050196475,-0.7376416531029308,0.844758064516129,0.9499324334047122,1.0,7/17,24.94%,SMUG1;OGG1;TERF2IP;NEIL1;NEIL3;NTHL1;ERCC5
prerank,endodermal cell fate commitment (GO:0001711),-0.31652051007998616,-0.7375800483790357,0.7917414721723519,0.9494616505344231,1.0,2/10,17.75%,SOX17;SOX2
prerank,regulation of histone deacetylation (GO:0031063),0.32016223886423606,0.7369942229785097,0.7820773930753564,0.9732499528221271,1.0,4/13,15.49%,CAMK2D;AKAP8L;SAP30BP;NIPBL
prerank,negative regulation of DNA recombination (GO:0045910),0.24343229381091813,0.7366625902378316,0.8539741219963032,0.9730285943463335,1.0,7/43,13.99%,POLR2D;ACD;BLM;POLR2A;KLHL15;RTEL1;FANCB
prerank,regulation of B cell differentiation (GO:0045577),-0.2769821538947353,-0.7361872886109754,0.8322981366459627,0.9506140542477987,1.0,6/17,20.26%,XBP1;ZFP36L1;ID2;PPP2R3C;INHA;NCKAP1L
prerank,mitotic spindle assembly (GO:0090307),-0.22302569437979008,-0.7359261330827751,0.9075829383886256,0.9503735239256926,1.0,16/42,27.70%,SMC1A;FLNA;CHEK2;RHOA;ARHGEF10;MZT1;TOGARAM1;WRAP73;KIF3B;KIF11;CLASP2;KIFC1;KIFC2;KIF4A;SMC3;KIF23
prerank,negative regulation of double-strand break repair (GO:2000780),-0.23906946974000962,-0.7358345798081035,0.8733624454148472,0.9499323713127005,1.0,11/30,30.44%,SMCHD1;OGG1;UBQLN4;OTUB1;POLQ;RMI2;CGAS;SHLD3;TFIP11;SHLD2;RIF1
prerank,regulation of cytoplasmic translation (GO:2000765),-0.29087739506835075,-0.7356822083304743,0.83,0.9495685555112664,1.0,8/14,31.11%,PKM;YBX3;CPEB1;RBM24;FMR1;CPEB3;CNBP;DHX9
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.262718756343389,-0.7348708998566386,0.8329896907216495,0.9499839592416992,1.0,11/21,34.79%,BUB3;APC;BUB1B;TEX14;KNTC1;TRIP13;ZWINT;IK;PLK1;CDC20;BUB1
prerank,cellular response to chemokine (GO:1990869),0.244946910333046,0.7346257743120398,0.8527397260273972,0.9752505421513425,1.0,3/46,3.68%,OXSR1;CXCL13;RIPOR2
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.3048218733205098,-0.7342545248991942,0.8487084870848709,0.9501699572182665,1.0,6/12,23.79%,SERINC5;PSAT1;SEPHS2;SERINC3;GGT1;SEPHS1
prerank,embryonic axis specification (GO:0000578),0.30223927738304424,0.7336049324711921,0.7700205338809035,0.9759948524609299,1.0,5/15,19.08%,SMAD6;COBL;HOXD8;CXXC4;SMAD2
prerank,lymphocyte migration (GO:0072676),-0.23295307075997496,-0.7330491631235908,0.8713080168776371,0.9510517922086874,1.0,2/32,3.41%,MSN;S1PR1
prerank,presynaptic endocytosis (GO:0140238),0.27427418316587876,0.7325340755655336,0.8169556840077071,0.9768129700043979,1.0,3/24,5.95%,CEL;NLGN2;SYNJ2
prerank,copper ion transport (GO:0006825),-0.30749488221421445,-0.7324741742697312,0.8125,0.9511809222806752,1.0,2/11,6.91%,ATOX1;SLC31A1
prerank,cranial nerve development (GO:0021545),0.33111543531479504,0.7323285815740255,0.7626373626373626,0.9764986769345554,1.0,11/11,66.91%,SALL1;TFAP2A;CHRNB2;CHD7;ATOH7;ISL1;ERBB3;TIFAB;POU4F1;PAX2;TMEM126A
prerank,regulation of cell aging (GO:0090342),-0.3121196747082996,-0.7317512471238242,0.8067729083665338,0.951479209916037,1.0,3/11,16.37%,RSL1D1;LMNA;MIF
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),-0.25170330489906273,-0.7304171947400768,0.8832684824902723,0.9525093202644819,1.0,14/23,45.53%,PLK2;BUB1B;INTS3;CHEK1;CHMP4C;ZWINT;BUB1;PLK3;CDK5RAP3;WEE2;NABP1;AURKB;ZW10;PRCC
prerank,dendritic cell differentiation (GO:0097028),0.27908156570292003,0.7303163544997858,0.8092592592592592,0.978512207383772,1.0,8/22,19.15%,IRF8;CCL19;BATF2;AXL;BATF;PRTN3;LYN;LGALS9
prerank,regulation of endopeptidase activity (GO:0052548),0.23018971778215738,0.729732158260541,0.8794567062818336,0.9786716548541539,1.0,10/59,13.10%,TIMP3;SERPIND1;A2ML1;NRDC;PSMA3;VTN;PICALM;HDAC1;SERPINE1;PSENEN
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.18119744430350437,-0.7291622072637708,0.9779874213836478,0.9534276482436794,1.0,34/116,28.80%,PLCG2;RAMP2;FYN;ADCY4;PLK2;RHBDF2;RAMP1;MYH9;PTHLH;CYSLTR1;ADCY7;ADCY3;FURIN;CYSLTR2;ADRB2;PRKAR1A;CALCRL;VIPR2;IAPP;GPR27;YES1;HRH2;TSHR;GGT1;FCGR2B;GLP2R;NPSR1;MC5R;ADCYAP1;GNB1;CALCA;GPR20;CD163;TREM2
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.27970299175695423,0.7291606665165186,0.8076190476190476,0.9788075649537263,1.0,1/20,1.22%,IL18
prerank,histone H4 deacetylation (GO:0070933),0.3303961217081307,0.727344488343862,0.7849686847599165,0.9807128697505944,1.0,2/10,10.21%,HDAC8;HDAC1
prerank,regulation of cell cycle process (GO:0010564),0.2079991761851745,0.7272250611134853,0.9310344827586207,0.9802441944222183,1.0,25/104,18.53%,OBSL1;HORMAD1;PLK5;CCDC8;CUL9;BIRC6;RPRD1B;PIK3R4;CUL7;YTHDF2;UVRAG;SND1;FLCN;ZFYVE26;MAD1L1;CDKN2B;TXLNG;MYO19;KLHL13;SFRP1;SETD2;IHO1;USP19;RAB11FIP3;PRPF40A
prerank,lipoprotein transport (GO:0042953),0.33639767203368187,0.7269189026541666,0.8024691358024691,0.97999425751214,1.0,2/10,7.97%,PRKCB;MIA3
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.23293314064234344,0.7268049497299656,0.8667820069204152,0.9795169741567588,1.0,12/52,13.52%,TLN1;TATDN2;WIPI1;TPP1;EXTL1;CUL7;ATP6V0D1;EDEM1;FKBP14;SERP1;TSPYL2;PLA2G4B
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.2537161184378953,-0.7266998351892516,0.8601694915254238,0.955670044492818,1.0,9/25,26.82%,ETS1;ABCB10;TAL1;STAT3;ANKRD54;NCKAP1L;HSPA1B;MAPK11;STAT1
prerank,negative regulation of cell division (GO:0051782),0.3248917678772499,0.7266194978973186,0.7899343544857768,0.9791361785784655,1.0,3/11,17.01%,BLM;TXNIP;ORC6
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),-0.27067088800183453,-0.7265936919915743,0.8717948717948718,0.9552495784957036,1.0,4/18,12.95%,RAP1A;GSK3B;SLC4A8;VPS18
prerank,antibacterial humoral response (GO:0019731),0.29751226668982983,0.7257957340589415,0.8115079365079365,0.9796046907028788,1.0,1/16,2.80%,LTF
prerank,negative regulation of catabolic process (GO:0009895),0.2356312876884076,0.725618523373654,0.8682432432432432,0.979212985684457,1.0,6/47,9.19%,PPARA;AZIN2;BANP;PRKAA1;NUPR1;APOC1
prerank,negative regulation of dephosphorylation (GO:0035305),-0.27313820385747983,-0.7245487688655604,0.8586065573770492,0.9570120628842241,1.0,9/18,31.42%,PPP1R16B;YWHAB;CHP1;ZCCHC9;PPP1R15A;URI1;ARPP19;PPP1R35;MFHAS1
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.23720628860534285,0.7245289739657756,0.8805460750853242,0.9800506589620991,1.0,6/51,8.80%,IL34;PTN;IL6;CSF1;MOSPD2;VEGFB
prerank,RNA stabilization (GO:0043489),0.25728370348805807,0.724492908233016,0.835016835016835,0.9794757977340407,1.0,7/33,16.67%,PHAX;TRDMT1;AXIN2;TENT2;GDNF;PARN;LARP1
prerank,DNA catabolic process (GO:0006308),0.3220136840123031,0.7240811879302647,0.7789046653144016,0.9794010793932186,1.0,11/11,67.82%,REXO4;DFFB;MUS81;DNASE1L3;SETMAR;DNASE1L2;DNASE1;FBH1;XRN2;DNASE1L1;ISG20
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.2615469200281745,0.7237779214606122,0.833641404805915,0.979155752007239,1.0,8/31,20.42%,HSD17B1;FDXR;MOCS2;MOCS1;DHRS11;MOCS3;FDFT1;ALOX5
prerank,regulation of neutrophil migration (GO:1902622),-0.31889526162000537,-0.7225076544140355,0.8232931726907631,0.9587603357699269,1.0,4/10,21.30%,RAC1;RHOG;NCKAP1L;JAM3
prerank,protein import into peroxisome membrane (GO:0045046),-0.25320644566152745,-0.7223657122166679,0.8375,0.9583804968934301,1.0,10/22,32.24%,ABCD3;ABCD2;PEX11B;ATAD1;PEX5;RAB8B;PEX16;FIS1;PEX13;ACBD5
prerank,amino sugar biosynthetic process (GO:0046349),-0.2986170764186783,-0.7223226146767939,0.8194444444444444,0.9578716520265615,1.0,6/12,28.40%,UAP1L1;UAP1;GNPDA1;AMDHD2;GNPDA2;NANP
prerank,peptidyl-glutamic acid modification (GO:0018200),-0.25216126160704116,-0.7222522024969744,0.8725701943844493,0.9573928498863494,1.0,8/24,30.36%,TTLL7;VKORC1L1;VKORC1;TTLL8;CEP41;TTLL6;TTLL2;AGTPBP1
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.3032017820380913,-0.7218563823053266,0.8284600389863548,0.9572890339676983,1.0,5/11,24.48%,UAP1L1;UAP1;GNPDA1;AMDHD2;GNPDA2
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.24378957049820596,-0.721682849299221,0.875268817204301,0.9569224205741675,1.0,9/25,34.00%,HNRNPU;LARP7;NELFCD;NELFE;RNF168;EAF2;EAPP;RNF8;EAF1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.33455029944869796,0.7213318048846714,0.7693965517241379,0.9816894097162945,1.0,1/10,2.83%,SP100
prerank,protein kinase A signaling (GO:0010737),0.31196903759268185,0.7208926371720467,0.8044943820224719,0.9816230419047912,1.0,2/12,13.70%,RAB13;PRKACB
prerank,RNA modification (GO:0009451),-0.20496052303422566,-0.7202421098576874,0.9184210526315789,0.9580062340407083,1.0,22/54,32.22%,ADARB1;ADAR;SSB;MEPCE;QTRT1;TSR3;NSUN4;MRM2;THUMPD1;ELP5;METTL3;AARS2;METTL1;PUS7;CDKAL1;ADAT2;NOP10;QTRT2;RBM15;JMJD6;NSUN5;CTU1
prerank,regulation of DNA recombination (GO:0000018),-0.2279593018121122,-0.7201920116787806,0.8571428571428571,0.9575175869481236,1.0,15/32,34.61%,SPIDR;MSH2;TERF2IP;PPP4R2;SMARCAD1;SIRT6;CHEK1;ALYREF;SHLD2;ZCWPW1;RPA2;FIGNL1;PPP4C;KPNA2;IL7R
prerank,protein alkylation (GO:0008213),-0.25484758713793537,-0.7196059183027347,0.8813559322033898,0.9576036020178988,1.0,11/22,43.36%,PCMT1;PRMT8;PRMT3;ETFBKMT;ETF1;FAM98B;FAM98A;PRMT1;VCPKMT;METTL21C;METTL21A
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.2881143834321539,0.7192738510906027,0.8026565464895635,0.9830371634926859,1.0,3/17,7.70%,ABI2;WASF1;WASF3
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.23373232068341565,0.7191568152867417,0.8677966101694915,0.9819687519980927,1.0,6/50,10.22%,POLR2D;TNRC6A;NDC1;POLR2A;NUP107;AGO2
prerank,regulation of gene silencing by RNA (GO:0060966),0.23373232068341565,0.7191568152867417,0.8677966101694915,0.9819687519980927,1.0,6/50,10.22%,POLR2D;TNRC6A;NDC1;POLR2A;NUP107;AGO2
prerank,regulation of intracellular transport (GO:0032386),-0.22459286882094337,-0.7191506123045527,0.9247787610619469,0.9575605947354532,1.0,11/38,25.08%,REEP5;CRYAB;LAMP1;PTPN1;ATP13A2;INPP5F;NUMA1;MLC1;SPAG5;CAPN10;HAP1
prerank,intracellular cholesterol transport (GO:0032367),0.3098775869516443,0.7190957693605324,0.7935222672064778,0.9814316060368566,1.0,3/15,16.33%,ABCA1;SERAC1;RELCH
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.2656686057027162,-0.718917900946217,0.8609406952965235,0.9572784336426657,1.0,14/18,51.04%,CORO2B;CHP1;PTP4A3;CEP295;TREM2;CCT3;CCT4;CCT2;WRAP53;TNF;CCT7;CCT5;CCT8;DKC1
prerank,positive regulation of chromatin organization (GO:1905269),-0.30099587139479644,-0.7187537274608559,0.8465909090909091,0.9569315681958261,1.0,3/12,14.85%,H3-3A;TAL1;TERF2IP
prerank,cell junction maintenance (GO:0034331),0.30446943777754176,0.7184658661959116,0.7898989898989899,0.981635173187546,1.0,1/14,2.26%,NLGN2
prerank,regulation of viral genome replication (GO:0045069),0.22891914812812925,0.7183175236327886,0.8731466227347611,0.9812260125974833,1.0,8/56,11.40%,PPARA;LTF;RNASEL;SRPK2;HACD3;PKN2;PARP10;TMEM39A
prerank,gene silencing by miRNA (GO:0035195),0.2534530161335919,0.7180514925217795,0.8417132216014898,0.9809460759610881,1.0,11/32,21.97%,ZC3H7B;TNRC6B;TNRC6A;AGO2;DICER1;MOV10;CNOT7;CNOT8;RBM4;AGO1;XPO5
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.2529277879871836,0.7177950067965131,0.8297872340425532,0.9806451431232495,1.0,2/34,5.19%,LGR4;CACTIN
prerank,positive regulation of transmembrane transport (GO:0034764),0.30976823566399714,0.7175516662654511,0.7911877394636015,0.980341217076907,1.0,2/13,6.12%,ACSL1;AZIN2
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.2703742522239631,-0.7172170379593937,0.8603238866396761,0.9580715629621002,1.0,7/18,32.58%,GSK3B;HIP1R;SLC35F6;CHCHD10;BAX;BID;HSPA1A
prerank,mitotic spindle organization (GO:0007052),-0.17164377461573826,-0.7151736984944483,0.9968051118210862,0.9597362433896445,1.0,48/153,28.33%,MAP4;SMC1A;CLIP1;FLNA;BUB3;DYNLL2;PLK2;EFHC2;RPS27;CENPO;CHEK2;RHOA;CENPK;ARHGEF10;MZT1;RANGAP1;STMN1;NUP37;RCC2;TOGARAM1;NDE1;RMDN1;CENPU;WRAP73;NUP85;BUB1B;KIF3B;NUP133;CKAP5;KIF11;PPP1CC;MAPRE1;B9D2;VCP;CLASP2;NDC80;KIFC1;KNL1;KIFC2;KIF4A;KNTC1;SPDL1;CDCA8;SMC3;ZWINT;KIF23;CEP126;DYNC1I1
prerank,regulation of synapse organization (GO:0050807),0.27076716318699423,0.7150553875745559,0.8447937131630648,0.9828287319398191,1.0,9/26,18.92%,IL1RAPL1;NEDD4;EPHA4;ABL1;CDKL5;GRIPAP1;CHRNB2;PDLIM5;MDGA1
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.25886025674964697,0.7131417842324284,0.8410852713178295,0.9845859639564196,1.0,10/28,18.30%,LACC1;IRAK2;MAP2K6;ITCH;CYLD;MAP3K7;UBE2V1;IRGM;TAB1;TRAF6
prerank,establishment of spindle orientation (GO:0051294),0.2557426075217153,0.7126181095677167,0.8630393996247655,0.9846438017201297,1.0,5/28,10.96%,LLGL2;GJA1;UBXN2B;PAFAH1B1;LLGL1
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.3124494365796347,-0.7125655981480132,0.8476190476190476,0.9620360874770897,1.0,1/10,2.22%,CALM1
prerank,determination of left/right symmetry (GO:0007368),0.2480252023553304,0.7122677081505565,0.8776595744680851,0.9844585399391987,1.0,6/36,11.59%,ODAD3;DNAH11;ARL6;BBS7;OFD1;PKD2
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.26318544284629486,0.7117501564241963,0.8628571428571429,0.9844570648837111,1.0,4/30,6.02%,ACSL1;HACD1;ACOT4;HACD3
prerank,regulation of DNA replication (GO:0006275),-0.21205663411874007,-0.7110257460786193,0.9347319347319347,0.9630637391023786,1.0,25/49,41.53%,BCAR3;ACVRL1;CCDC88A;FAF1;USP37;GLI1;RAD17;EHMT2;S100A11;ATR;GMNC;SMC3;PPP2CA;DHX9;EGF;GMNN;CDC6;DNA2;ESCO2;CCNA2;PCNA;TERF1;ATAD5;CTC1;PPP2R1A
prerank,autophagosome organization (GO:1905037),0.22915557328718378,0.7104519003221904,0.8952042628774423,0.9854309696364651,1.0,12/50,16.69%,TP53INP2;RAB19;WIPI1;UBXN2B;ATG14;ATG9A;AMBRA1;ATG3;RAB43;RUFY4;IRGM;ATG16L2
prerank,ruffle organization (GO:0031529),0.2915559340376972,0.7097904670705236,0.8174904942965779,0.9855876291213642,1.0,2/16,6.80%,TPM1;LIMA1
prerank,response to interferon-gamma (GO:0034341),-0.19574131636329464,-0.7091077325390226,0.946969696969697,0.9645676318752824,1.0,21/67,27.67%,GCH1;GBP4;GAPDH;AQP4;GBP5;SLC26A6;CD74;CD47;GBP3;SHFL;RPL13A;CCL13;BST2;CD40;IFITM3;SLC11A1;CIITA;CASP1;STAT1;CCL2;TLR4
prerank,regulation of TORC1 signaling (GO:1903432),0.2504439289632322,0.708763279232752,0.8538011695906432,0.986197105093584,1.0,12/33,20.05%,SZT2;SESN1;RNF152;GPR137C;FLCN;KLHL22;SIK3;TELO2;LARS1;CLEC16A;LAMTOR5;KPTN
prerank,positive regulation of signaling receptor activity (GO:2000273),-0.22068867906522258,-0.7086635397680757,0.9035874439461884,0.9644668595714774,1.0,15/36,35.11%,SHANK3;ITGB1;EDN1;RELN;ADRB2;GREM1;HDAC6;CCR2;CCL2;BUD31;BTC;EGF;NCF1;PARK7;ADAM17
prerank,tetrapyrrole metabolic process (GO:0033013),0.28045785814401974,0.708447446270142,0.8348623853211009,0.9859868924203474,1.0,3/18,14.18%,TCN2;TCN1;MMAB
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.32716615179728314,0.7079895173476406,0.7974947807933194,0.9858924235421817,1.0,4/10,20.25%,SLC45A3;SNCA;IRS1;IRS2
prerank,positive regulation of defense response to virus by host (GO:0002230),-0.24215697957350285,-0.7077515024665122,0.8624454148471615,0.9648684681735301,1.0,10/24,33.58%,HSP90AA1;AIM2;ZC3H12A;TRIM44;STAT1;CGAS;SIN3A;MAVS;PTPN22;PQBP1
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.2603781407255862,0.7075910910342734,0.8598484848484849,0.9857406443502906,1.0,3/25,9.80%,B3GALT1;HAS1;NDST2
prerank,arachidonic acid metabolic process (GO:0019369),-0.22665085792207434,-0.7075227164157161,0.8977035490605428,0.9645556777123111,1.0,9/35,20.89%,MGLL;GPX4;PTGIS;PTGDS;PTGS2;ALOX12;PLA2G4A;CYP2U1;CYP1B1
prerank,natural killer cell mediated cytotoxicity (GO:0042267),-0.26922922055492354,-0.7066172756890972,0.8724696356275303,0.9649295073210564,1.0,9/16,47.09%,TUBB4B;ULBP1;CORO1A;KIF5B;RAET1E;SLAMF7;PLEKHM2;KLRK1;LYST
prerank,regulation of cholesterol metabolic process (GO:0090181),-0.2557390959745312,-0.7062490029437699,0.8669527896995708,0.9647577619545531,1.0,7/20,23.40%,SREBF2;LPCAT3;NR1H4;ABCA2;TTC39B;MBTPS1;DGKQ
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),-0.2799536964104494,-0.7061787883395566,0.8509803921568627,0.9642954174800398,1.0,10/13,35.32%,HES1;PTPRC;JAK3;DOT1L;PTPRT;CRLF2;MGAT5;EGF;IL7R;TSLP
prerank,selective autophagy (GO:0061912),-0.20183352523646358,-0.7059194080001533,0.9300518134715026,0.9640146857417539,1.0,22/56,35.93%,VIM;UBB;DYNLL2;UBC;RPS27A;MAP1LC3B;WDFY3;CFTR;UBA52;AUP1;PEX5;HDAC6;ULK2;RAB7A;KLHL3;DYNC1I1;STBD1;ACBD5;UFC1;PARK7;PCNT;DYNC1H1
prerank,regulation of axon guidance (GO:1902667),-0.3066277873847938,-0.7054741510561309,0.8330097087378641,0.9638975394265653,1.0,4/10,25.00%,VEGFA;ZSWIM6;ZSWIM8;TUBB2B
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.309365824137028,-0.7053305312463173,0.8465909090909091,0.9629518939142735,1.0,6/10,29.81%,AP2A2;AP2M1;AP2B1;AP2A1;VLDLR;AP2S1
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.309365824137028,-0.7053305312463173,0.8465909090909091,0.9629518939142735,1.0,6/10,29.81%,AP2A2;AP2M1;AP2B1;AP2A1;VLDLR;AP2S1
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),-0.27445598226881074,-0.7047313594515134,0.8343313373253493,0.9629928518174189,1.0,13/15,51.48%,CD55;NKAP;CCR2;SHH;SYK;IL12A;IL23A;EBI3;IHH;PNP;IL12B;IL23R;HSPH1
prerank,regulation of sensory perception of pain (GO:0051930),-0.3001245641068623,-0.7044347305273807,0.849802371541502,0.962764790838861,1.0,2/11,4.87%,MGLL;CCN3
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.26664169238651236,0.704268064633828,0.8308270676691729,0.9891155788142023,1.0,1/22,1.28%,BMP7
prerank,aromatic amino acid family metabolic process (GO:0009072),-0.3027984617692795,-0.7037529631011947,0.8633776091081594,0.9629105598844377,1.0,2/10,16.48%,KYAT1;QDPR
prerank,"DNA-templated transcription, termination (GO:0006353)",0.21410456546789908,0.7035973543100873,0.9262820512820513,0.9893000072212604,1.0,18/68,20.67%,CDK7;SSU72;MTERF2;POLR2A;SMN1;TAF1A;POLR1F;POLR1A;TAF1D;MNAT1;WDR33;FIP1L1;CSTF3;POLR1G;CPSF4;NUDT21;SNRPF;SETX
prerank,regulation of autophagosome maturation (GO:1901096),0.2979427120338589,0.7034250187243126,0.8289738430583501,0.9889148952054472,1.0,7/13,24.45%,UVRAG;TMEM39A;RUBCN;IRGM;CLEC16A;FYCO1;PHF23
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.21496275738446408,-0.7032359606264602,0.9239373601789709,0.9628732676123659,1.0,19/42,34.27%,SMCHD1;SPIDR;UBQLN4;ACTR2;FUS;TERF2IP;POLQ;PPP4R2;SIRT6;CHEK1;RMI2;CGAS;SHLD3;SHLD2;RIF1;RPA2;FIGNL1;PPP4C;HELB
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.3186113979636345,0.7025547356262919,0.7848101265822784,0.9893467151279514,1.0,1/11,2.83%,SP100
prerank,mitotic sister chromatid segregation (GO:0000070),-0.18416343281018963,-0.7022056685690851,0.9911764705882353,0.9633484703103841,1.0,32/98,27.70%,SMC1A;CHMP5;CHMP2B;PINX1;CUL3;SET;CENPK;CSNK2B;BOD1;WRAP73;CHMP1B;CHMP1A;NCAPD3;KNSTRN;NCAPH;SMC4;SPAG5;TEX14;CHMP3;NDC80;CHMP7;PDCD6IP;KIFC1;REC8;KIF14;SPDL1;CHMP4C;CDCA8;CEP55;DIS3L2;ZWINT;KIF23
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.2129336324375158,0.7018284559395694,0.9397394136807817,0.9895918005015402,1.0,22/76,19.48%,ANGPT1;PRICKLE1;SPHK1;LRRK2;UBE2L3;RWDD3;PIAS1;WDR48;FANCI;MYCBP2;FBXO4;CRY1;RCHY1;CENPX;BIRC2;AXIN1;TBC1D7;TRAF6;DCUN1D5;HDAC4;PIAS3;XIAP
prerank,negative regulation of protein-containing complex assembly (GO:0031333),-0.20648617687907464,-0.7012125395313609,0.9344660194174758,0.9638414066491987,1.0,19/49,28.80%,GSK3B;CRYAB;HSPA5;SVIP;CLU;NLRP2B;RPL13A;RAF1;IAPP;PPM1A;NOP53;PEX5;JAM3;HDAC6;SORL1;KIF14;THRA;TFIP11;TREM2
prerank,positive regulation of protein import into nucleus (GO:0042307),-0.2348790607682408,-0.7010710084438144,0.8952991452991453,0.9634170705074511,1.0,10/28,24.09%,CDH1;FLNA;TGFB1;JUP;ZC3H12A;PSEN1;PRKCD;RBM22;HYAL2;ZPR1
prerank,myeloid cell development (GO:0061515),0.2776156426590229,0.7007457446910779,0.8493150684931506,0.9902120905129042,1.0,3/18,10.09%,KIT;LYAR;MED1
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.24400394346600865,0.7002067281787882,0.8726937269372693,0.9902192953699266,1.0,10/36,17.89%,PRKN;DUSP10;DLG1;SIRPA;ITCH;SH3RF2;CYLD;TAOK3;IGBP1;NCOR1
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.29974326765236103,0.7001027985727961,0.7952755905511811,0.989724397899682,1.0,2/13,8.65%,IRAK2;PIK3R4
prerank,protein localization to microtubule organizing center (GO:1905508),-0.26948401829578317,-0.6998973802443866,0.8766603415559773,0.9640264556693359,1.0,5/15,33.01%,CEP83;SPAG5;PCM1;CEP131;STIL
prerank,DNA conformation change (GO:0071103),0.2789319797798112,0.6991859113255826,0.8320754716981132,0.9901377572505379,1.0,3/17,14.41%,TOP2B;ABL1;TOP1MT
prerank,regulation of mitochondrion organization (GO:0010821),0.2267112621537123,0.6976718345241403,0.906896551724138,0.99127428494923,1.0,8/47,15.34%,PID1;PRKN;LRRK2;FLCN;PISD;OMA1;HTRA2;MYO19
prerank,macrophage migration (GO:1905517),0.3012831942943332,0.6973050356215612,0.8370672097759674,0.9910958579171371,1.0,3/13,18.00%,TAFA4;CKLF;EDNRB
prerank,defense response to protozoan (GO:0042832),-0.2838496605890495,-0.6963640849460654,0.8699029126213592,0.9669702809341798,1.0,4/12,20.88%,GBP4;CD40;MYD88;SLC11A1
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),-0.28488110440618836,-0.6962853885194887,0.8385214007782101,0.9664883319197836,1.0,3/12,15.14%,WDTC1;CEACAM1;ERLIN2
prerank,neuromuscular synaptic transmission (GO:0007274),0.2797046300674977,0.6959698052186756,0.8554913294797688,0.9919785873808784,1.0,5/18,17.11%,DTNA;SLC5A7;FCHSD2;CHRNB2;ERC2
prerank,regulation of lipid storage (GO:0010883),0.2611696549999871,0.695367907872201,0.8515625,0.9920477342975411,1.0,4/22,14.34%,PLA2G10;IL6;IKBKE;PLIN5
prerank,regulation of viral release from host cell (GO:1902186),-0.24688920547449456,-0.6953632720842751,0.8875255623721882,0.9668267237477886,1.0,6/21,23.07%,CHMP2B;TRIM25;DDB1;TRIM13;MID2;CHMP3
prerank,somite development (GO:0061053),-0.293349160805302,-0.6925700034423515,0.8473282442748091,0.9689365169724039,1.0,2/11,7.73%,MEOX2;PTCH1
prerank,regulation of axon regeneration (GO:0048679),-0.28287529511455434,-0.6922243502821726,0.8563106796116505,0.9687303731469759,1.0,5/12,21.01%,SCARF1;RTN4RL1;GRN;INPP5F;RTN4R
prerank,entrainment of circadian clock by photoperiod (GO:0043153),-0.2308071330821681,-0.6918499700719827,0.8943965517241379,0.9685301048297413,1.0,10/27,28.55%,BHLHE40;FBXL3;PPP1CA;PER1;ID2;PPP1CB;PPP1CC;RBM4B;USP2;PER2
prerank,tryptophan catabolic process (GO:0006569),-0.29191321492664646,-0.6913830365369358,0.8566037735849057,0.9683914864682005,1.0,4/11,31.62%,KYAT1;KMO;IL4I1;HAAO
prerank,negative regulation of protein depolymerization (GO:1901880),0.2592101921545267,0.6910321604390866,0.8568702290076335,0.9962458925854171,1.0,2/24,6.80%,PLEKHH2;LIMA1
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.2825517848468729,0.6903938073456988,0.8466019417475729,0.9963327778142375,1.0,4/18,11.64%,PHF8;LYAR;RASL11A;ERBB2
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.2753148716945441,-0.6903801642942344,0.8489065606361829,0.9688161921340155,1.0,5/13,24.48%,UAP1L1;UAP1;GNPDA1;AMDHD2;GNPDA2
prerank,regulation of viral transcription (GO:0046782),0.23376775375785366,0.6894296667844598,0.8908450704225352,0.9967568773190464,1.0,5/39,8.29%,POLR2D;RSF1;CCNT1;POLR2A;GTF2F1
prerank,endocytic recycling (GO:0032456),-0.2006212976162547,-0.6893911808967933,0.9496567505720824,0.9691853264345007,1.0,15/50,26.95%,EHD4;DENND1B;EHD1;STX6;LMTK2;PTPN23;EHD3;ANKRD50;VPS51;ENTR1;RAB14;SNX27;RAB7A;MICALL2;SNX3
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),-0.238556040751501,-0.688970469734902,0.8895966029723992,0.969024047557933,1.0,14/23,35.75%,SIX1;VEGFA;PIK3CD;SIX4;BMP4;PAX8;SIRT6;FGF2;AGT;EGF;NOG;PAX2;MDK;LIF
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.2573330509255178,-0.6885397801083614,0.8757763975155279,0.968876082230483,1.0,8/18,26.95%,MSN;PTPN23;VPS11;MAP2K2;MAPK3;CHMP3;EZR;SNX3
prerank,negative regulation of bone mineralization (GO:0030502),0.29095452129224375,0.6884912217545773,0.8115942028985508,0.9971898370214934,1.0,2/13,6.54%,ECM1;BCOR
prerank,regulation of lipoprotein lipase activity (GO:0051004),-0.25942978931076444,-0.6884420708348608,0.8882113821138211,0.9684251386904154,1.0,6/17,22.02%,FURIN;NR1H2;HDAC9;PCSK5;ANGPTL4;NR1H3
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.2950653305088553,0.6881998313857162,0.8185654008438819,0.996887796588428,1.0,2/13,5.33%,GPD1L;SNX33
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.22707601392228605,0.6873214702835634,0.9202037351443124,0.9972154439112942,1.0,8/45,14.42%,BMP7;TOM1L2;SMAD3;TRIM35;PTPN3;GAS1;CHFR;CDKN1C
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.31437509531189706,0.6868333608206938,0.850597609561753,0.9959385494636649,1.0,4/10,24.28%,BLM;WRN;NBN;SMARCAL1
prerank,telomere maintenance via telomere trimming (GO:0090737),0.31437509531189706,0.6868333608206938,0.850597609561753,0.9959385494636649,1.0,4/10,24.28%,BLM;WRN;NBN;SMARCAL1
prerank,t-circle formation (GO:0090656),0.31437509531189706,0.6868333608206938,0.850597609561753,0.9959385494636649,1.0,4/10,24.28%,BLM;WRN;NBN;SMARCAL1
prerank,regulation of lipid kinase activity (GO:0043550),0.30417808175957184,0.6851978222520476,0.820040899795501,0.9971114486287082,1.0,2/11,10.32%,RBL2;PIK3R1
prerank,organophosphate biosynthetic process (GO:0090407),0.23657861539982747,0.6850441723387303,0.8892794376098418,0.9966671710855077,1.0,11/37,21.32%,AGPAT4;MOCS2;MOCS1;PPIP5K2;ITPKA;GK;MOCS3;GK5;PIP5K1A;IP6K2;PCYT2
prerank,natural killer cell mediated immunity (GO:0002228),-0.2610920812005383,-0.6849270578779424,0.875968992248062,0.9710419231058852,1.0,9/15,47.09%,TUBB4B;ULBP1;KIF5B;RAET1E;SLAMF7;PLEKHM2;KLRD1;KLRK1;LYST
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.27797161688927036,-0.6846374571048504,0.861271676300578,0.9707607187791648,1.0,6/13,27.36%,ETS1;RHOA;IRAK1;FUT9;RELA;ITGB2
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.2891173669217265,-0.6844691399112506,0.89453125,0.9703781175956853,1.0,2/11,11.67%,PLCG2;CDH13
prerank,mitotic cell cycle phase transition (GO:0044772),0.18003592793068177,0.6843763402909075,0.9958100558659218,0.9967680945307643,1.0,30/203,15.49%,NINL;ALMS1;PLCB1;PHLDA1;CDK7;EIF4EBP1;CCDC57;HAUS4;CEP152;NASP;PHF8;SDCCAG8;OPTN;PAFAH1B1;CDK1;FBXL17;LATS1;OFD1;RPS6KB1;HAUS1;SFI1;CUL4B;CCNE1;CEP57;MNAT1;CDKN2B;CEP63;CEP164;CDK4;BRSK1
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.22546125801775468,0.6841652493364606,0.9342560553633218,0.9963915107781328,1.0,12/48,18.32%,BAZ1B;ARID1B;ZMIZ1;TAF1A;SMARCA5;POLR1F;POLR1A;TAF1D;ZMIZ2;PHF2;POLR1G;ATAD2B
prerank,positive regulation of interleukin-12 production (GO:0032735),-0.2184061856173229,-0.6837299282039564,0.9245283018867925,0.9704954820397297,1.0,12/31,35.21%,PLCG2;HSPD1;LAPTM5;IRF5;CD40;TIRAP;AGER;MAPK11;TLR4;SYK;MDK;IL16
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.24706149313136716,-0.6831844130720711,0.8806818181818182,0.970438192654448,1.0,3/18,9.52%,AGRN;CHRM3;GNA11
prerank,autophagy of nucleus (GO:0044804),0.27801309347564795,0.6807616211533887,0.8598848368522073,0.9993051385274554,1.0,3/16,14.73%,WIPI1;ATG9A;ATG3
prerank,negative regulation of intracellular protein transport (GO:0090317),0.2627358651714245,0.6803624079909806,0.8522072936660269,0.999112162546051,1.0,3/22,6.04%,SP100;LRRK2;SUFU
prerank,protein import into nucleus (GO:0006606),0.20741427781227267,0.6801954107850202,0.9427662957074722,0.998677330337532,1.0,12/66,18.03%,APPL2;IPO13;PRICKLE1;NUTF2;NUP107;TNPO1;NXT2;CBLB;NUP214;RPAIN;IPO9;KPNB1
prerank,NLS-bearing protein import into nucleus (GO:0006607),-0.2731755961090837,-0.6799792615685848,0.8855421686746988,0.972695223179802,1.0,8/13,43.80%,NUP54;KPNA4;KPNA3;RGPD1;KPNA2;NUP35;KPNA1;KPNA7
prerank,kinetochore organization (GO:0051383),-0.27787112339431447,-0.67949800851533,0.8608349900596421,0.972556457095223,1.0,10/13,53.40%,NDC80;DLGAP5;CENPW;CENPF;CENPT;CENPC;CDT1;CENPH;NUF2;CENPA
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.2625476290174268,0.6791599874717306,0.8677839851024208,0.9991626317591811,1.0,7/20,21.08%,MEIS1;CDC73;MEIS2;CIB1;CTR9;LDB1;PAF1
prerank,T cell differentiation in thymus (GO:0033077),-0.26912705325445596,-0.6786305356849235,0.8862275449101796,0.9727750202961544,1.0,4/14,18.55%,PTPRC;ZFP36L1;RABL3;LIG4
prerank,indolalkylamine catabolic process (GO:0046218),-0.29615042980142253,-0.6778913486923787,0.8674242424242424,0.9728683365206473,1.0,4/10,31.62%,KYAT1;KMO;IL4I1;HAAO
prerank,regulation of protein sumoylation (GO:0033233),0.27577052708403926,0.6778636626687561,0.8689138576779026,0.9998481118548842,1.0,3/17,8.10%,ZMIZ1;RWDD3;PIAS1
prerank,positive regulation of growth (GO:0045927),0.21149703145610768,0.6766319742491316,0.9412780656303973,1.0,1.0,17/64,19.31%,BCL2;PLCB1;SPHK1;KLHL22;ERBB2;INO80;ADNP2;S100A9;CIB1;HYAL1;N6AMT1;SDCBP;SFRP1;MMP14;DDX3X;TAF9B;USP47
prerank,cellular component maintenance (GO:0043954),0.30324955757670574,0.6764894323551783,0.8641975308641975,1.0,1.0,2/12,5.86%,ITGA3;IGF1R
prerank,negative regulation of synaptic transmission (GO:0050805),-0.23415718747467512,-0.6763829910704888,0.9024390243902439,0.9735899502526597,1.0,5/23,13.34%,PLK2;ARF1;SLC24A2;SLC30A1;PICK1
prerank,DNA integrity checkpoint signaling (GO:0031570),0.2324189821788807,0.6763181802787623,0.9119170984455959,0.9995810083708422,1.0,7/36,15.05%,ATRIP;HUS1B;CLSPN;FBXO6;CLOCK;BRIP1;CEP63
prerank,synaptic vesicle recycling (GO:0036465),0.23888921468828025,0.6759941682441236,0.8813559322033898,0.9992953642793713,1.0,3/31,5.95%,CEL;NLGN2;SYNJ2
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.2607201073246588,0.6758747635936269,0.873767258382643,0.9987984523492421,1.0,5/20,16.60%,PLCB1;GNAQ;LY6G6D;GRK2;CHRNB2
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.2922634765077448,0.6755104083769458,0.841541755888651,0.9985365200553972,1.0,5/13,22.37%,LRRK2;RHOQ;RAB23;AK4;AK3
prerank,tRNA modification (GO:0006400),0.2092398460640279,0.6753360809278919,0.95260663507109,0.9981016782708584,1.0,14/62,18.89%,TRMT9B;PUS3;THADA;TRDMT1;LCMT2;OSGEP;WDR4;MTO1;THUMPD3;DTWD1;DUS2;TYW5;TPRKB;MOCS3
prerank,positive regulation of mRNA processing (GO:0050685),-0.24411813549221795,-0.6747144037747986,0.9007936507936508,0.9744492939688703,1.0,12/21,48.07%,RBMXL1;TRA2B;PRDX6;DAZAP1;CELF4;CELF3;NCBP2;LEO1;SF3B4;NCBP1;RBM3;TRA2A
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.28684971826907946,0.6741138763572814,0.8330241187384044,0.9986979251530422,1.0,1/12,1.76%,UST
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.2512462606974748,-0.6739928520379334,0.8803418803418803,0.9745197945340286,1.0,9/18,45.45%,ADAM10;PSEN1;ABCG1;ACHE;ADAM17;LDLRAP1;CLN3;NSG1;PSEN2
prerank,regulation of response to biotic stimulus (GO:0002831),0.2433189973528695,0.6739367368730956,0.896421845574388,0.9982662314660733,1.0,2/28,3.26%,APPL2;TRIM5
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.2611377876854361,0.6733265367355923,0.8803088803088803,0.9982608153060878,1.0,2/21,4.75%,PPP4R4;PTPA
prerank,necroptotic process (GO:0070266),0.27684289840512366,0.6732628749634674,0.8762677484787018,0.9977157873072166,1.0,16/16,72.34%,CYLD;CD14;PGAM5;ITPK1;FASLG;TRPM7;LY96;IPMK;MLKL;TLR3;RIPK3;TICAM2;RIPK1;DNM1L;TICAM1;TLR4
prerank,sensory perception of taste (GO:0050909),0.3058624152648759,0.6702251157776157,0.841995841995842,0.9999900782122793,1.0,10/10,69.43%,ASIC3;TAS1R2;PKD2L1;ASIC2;TAS1R3;PKD1L3;GNAT3;TAS1R1;CD36;ASIC1
prerank,ureteric bud morphogenesis (GO:0060675),-0.26033812903741466,-0.6702009786262948,0.9163090128755365,0.9770344815877712,1.0,8/16,33.68%,SIX1;NPNT;BMP2;BMP4;PAX8;FGF2;SHH;PAX2
prerank,cellular response to interferon-beta (GO:0035458),-0.26463550477002407,-0.6701027713357415,0.8758029978586723,0.9765725916864847,1.0,2/14,10.67%,AIM2;NDUFA13
prerank,programmed necrotic cell death (GO:0097300),0.26657874905802575,0.6697190451560298,0.8757396449704142,0.9998805075340971,1.0,18/18,73.37%,CYLD;CD14;PGAM5;ITPK1;PPIF;FASLG;TRPM7;LY96;IPMK;MLKL;TLR3;RIPK3;TICAM2;RIPK1;DNM1L;TICAM1;TLR4;ALKBH7
prerank,positive regulation of secretion (GO:0051047),-0.28003916179581173,-0.6692047276798558,0.8782771535580525,0.9767403527847266,1.0,2/11,17.17%,XBP1;ACSL3
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.2439999122278484,0.6691930259393161,0.9092627599243857,0.9997558804460267,1.0,7/28,17.42%,MRNIP;AUNIP;PRKDC;PARP9;HSF1;DTX3L;KDM4D
prerank,mitochondrial protein processing (GO:0034982),0.29931555171581337,0.6686929870952685,0.8498942917547568,0.9996379087038197,1.0,3/11,17.14%,YME1L1;OMA1;IMMP1L
prerank,negative regulation of viral genome replication (GO:0045071),0.22746919367273608,0.6669288625447382,0.9191176470588235,1.0,1.0,3/40,3.90%,LTF;RNASEL;SRPK2
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.2630061907349934,-0.6667374932517183,0.8904109589041096,0.9781605527609496,1.0,5/15,22.36%,ZC3H12A;GSTO2;ATF3;MKNK2;VCP
prerank,positive regulation of RNA splicing (GO:0033120),-0.22111193673626786,-0.6656786540901353,0.9240780911062907,0.9784547947133172,1.0,11/29,32.58%,RBMXL1;HNRNPLL;RBM22;TRA2B;RBM20;ZPR1;ERN1;PRDX6;DAZAP1;CELF4;HSPA1A
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),-0.27339137980824246,-0.6655703727806844,0.8841698841698842,0.9780011858108179,1.0,1/11,2.07%,GAS6
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.2729340409646774,-0.6654126484504836,0.890020366598778,0.9775845684166935,1.0,5/13,22.52%,SMUG1;NT5C;OGG1;NEIL1;NTHL1
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.25392916497810203,0.6646812065458347,0.9108910891089109,1.0,1.0,2/22,6.85%,KIT;IL6
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.2479057165399979,-0.6641894875461372,0.8993839835728953,0.9780041208075114,1.0,1/17,1.60%,SLC7A5
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.23635041054216022,0.6641868852869287,0.8843283582089553,1.0,1.0,15/31,25.49%,EXOSC8;DCP2;LSM5;CNOT7;CNOT8;EXOSC3;LSM3;LSM1;DDX6;LSM4;EXOSC4;LSM6;DCP1B;DIS3;NT5C3B
prerank,termination of RNA polymerase I transcription (GO:0006363),0.2376576566137894,0.6639723394748198,0.9122486288848263,1.0,1.0,7/30,17.11%,CDK7;TAF1A;POLR1F;POLR1A;TAF1D;MNAT1;POLR1G
prerank,acyl-CoA metabolic process (GO:0006637),0.22983290046838106,0.6636547736590156,0.902803738317757,1.0,1.0,2/35,4.11%,SUCLG2;ACOT4
prerank,mitotic nuclear division (GO:0140014),-0.18203885873363404,-0.6633137019287579,0.9869109947643979,0.9781408811355022,1.0,25/71,27.61%,SMC1A;FLNA;CHEK2;EPS8;RHOA;CENPK;ARHGEF10;MZT1;TOGARAM1;PPP2R2D;NDE1;WRAP73;KIF3B;KIF11;KNSTRN;SMC4;SPAG5;CLASP2;NDC80;CHMP7;KIFC1;KIFC2;CDCA8;SMC3;ZWINT
prerank,nucleoside phosphate biosynthetic process (GO:1901293),-0.26008627312219235,-0.6630982597399201,0.869120654396728,0.977774272385367,1.0,2/14,5.14%,ME1;CMPK1
prerank,positive regulation of protein sumoylation (GO:0033235),0.3042798197202417,0.6628024648763874,0.8412371134020619,1.0,1.0,4/10,19.35%,RWDD3;PIAS1;HDAC4;PIAS3
prerank,regulation of defense response to virus by host (GO:0050691),-0.2162177191508006,-0.6620550903619864,0.9065420560747663,0.9780171506201959,1.0,13/30,34.96%,HSP90AA1;AIM2;ZC3H12A;TRIM44;TNFAIP3;STAT1;CGAS;SIN3A;MAVS;DHX9;PTPN22;PQBP1;IFNLR1
prerank,gluconeogenesis (GO:0006094),0.22345180750820412,0.6610266237541979,0.9204339963833634,1.0,1.0,6/39,14.25%,RBP4;SLC25A11;CRY1;ENO2;PFKFB1;GPI
prerank,regulation of protein acetylation (GO:1901983),-0.26779543492601127,-0.6609035978943816,0.8942115768463074,0.9783343894084487,1.0,3/12,24.11%,GSK3B;TERF2IP;CEP295
prerank,regulation of integrin activation (GO:0033623),0.2723202797470075,0.6600412985244473,0.8785425101214575,1.0,1.0,5/15,17.58%,CXCL13;FERMT1;PTGER4;FBLIM1;RAP1B
prerank,amyloid precursor protein catabolic process (GO:0042987),-0.26775567238773657,-0.6599861282887749,0.9006211180124224,0.978491008106212,1.0,1/14,1.80%,ADAM10
prerank,regulation of response to stress (GO:0080134),-0.28915274500076116,-0.6594286734267357,0.9053030303030303,0.9783535818228829,1.0,2/10,9.97%,CORO2B;EIF4G1
prerank,axoneme assembly (GO:0035082),0.23340485314713066,0.6590415568578846,0.9064220183486239,1.0,1.0,6/30,15.17%,DNAI4;SPAG1;TTC12;CFAP74;CCDC65;DNAAF3
prerank,spindle assembly (GO:0051225),0.20201845153921305,0.6590001765615152,0.9626016260162602,1.0,1.0,10/67,12.08%,SPICE1;KIF2A;MAPRE2;HAUS4;TUBGCP6;TUBGCP2;GOLGA2;OFD1;HAUS1;INO80
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.24986577868731008,0.658741976798341,0.8827977315689981,1.0,1.0,2/23,5.73%,GSTM2;EPHX2
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.27922386797319526,0.6580868583531279,0.880859375,1.0,1.0,3/13,10.22%,TNRC6B;TNRC6A;AGO2
prerank,heterochromatin assembly (GO:0031507),-0.2333481218498036,-0.657520480485254,0.9049586776859504,0.9792692315911141,1.0,4/20,19.01%,SMCHD1;H3-3A;BAHD1;NRDE2
prerank,purine-containing compound salvage (GO:0043101),0.2860091948563527,0.6556918310121064,0.8620689655172413,1.0,1.0,4/12,18.11%,AMPD3;ADK;APRT;GMPR2
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.262587783469601,0.6551719914688251,0.8869047619047619,1.0,1.0,7/19,21.27%,GFPT2;PMM2;RENBP;UGDH;PGM3;GMPPB;MPI
prerank,positive regulation of chemokine production (GO:0032722),-0.19399975942625322,-0.654179277716579,0.9578454332552693,0.9811839091477524,1.0,16/44,35.32%,IL33;MBP;APP;CD74;CSF1R;TIRAP;AGER;ADCYAP1;TLR4;TLR7;MAVS;LPL;SYK;IL7;ADAM17;TSLP
prerank,cell-cell junction maintenance (GO:0045217),0.28824924189659973,0.6538013617141172,0.8685831622176592,1.0,1.0,1/11,2.26%,NLGN2
prerank,Golgi inheritance (GO:0048313),0.28373684718491365,0.653585012312875,0.8807531380753139,1.0,1.0,3/11,9.94%,PLK5;CDK1;GOLGA2
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.30055938317653014,0.6535823870188936,0.8898128898128899,1.0,1.0,1/10,6.15%,PDE6G
prerank,sister chromatid segregation (GO:0000819),0.2305183168121527,0.6522681316495935,0.9148936170212766,1.0,1.0,11/31,20.14%,TOP2B;LATS1;NSL1;KLHL22;INO80;DSN1;MIS12;TUBG1;KIF18A;KIF18B;NCAPG2
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.24333712459485007,0.6514043720542273,0.9179389312977099,1.0,1.0,3/23,10.25%,KIT;IL6;JAK2
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.17817950619675899,0.6505784031642345,0.986784140969163,1.0,1.0,17/145,11.55%,NINL;ALMS1;RAD51B;RAD51C;HAUS4;CEP152;PSME4;PSMA2;SDCCAG8;PSMA3;PAFAH1B1;CDK1;PSMD8;OFD1;HAUS1;SFI1;PSMD3
prerank,phasic smooth muscle contraction (GO:0014821),-0.2832200050025997,-0.6501823077161287,0.878003696857671,0.9834895088333359,1.0,2/10,13.38%,EDN1;PTGER3
prerank,RNA methylation (GO:0001510),-0.18299073635298557,-0.6496520898391218,0.9729064039408867,0.9832967700402181,1.0,15/60,23.81%,TFB2M;TRMT61B;MEPCE;BUD23;FBL;ALKBH8;TRMT44;NSUN4;MRM2;TRMT12;METTL3;TYW3;TRMT10C;PCIF1;METTL1
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.25224748950032216,-0.6496342312342699,0.8895463510848126,0.9827675561483918,1.0,5/14,33.23%,CMPK1;AK5;NME2;ITPA;DCTPP1
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.24811997970101454,0.6494016382907268,0.9054325955734407,1.0,1.0,4/21,14.36%,MITF;MED13;MED1;SRF
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.19307568786929563,0.6491327893795195,0.9603174603174603,1.0,1.0,13/78,14.79%,NR2F2;CDK7;BLM;PTEN;CCNT2;CCNT1;CDK5RAP1;LATS1;PKD2;CCNE1;MNAT1;CDKN1C;CDKN2B
prerank,prostanoid metabolic process (GO:0006692),0.2682325605017366,0.6470117400550689,0.8961303462321792,1.0,1.0,3/13,18.54%,PTGR1;ACOX1;PTGR2
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.29194651936476046,0.6460040988701958,0.869215291750503,1.0,1.0,11/11,70.83%,CCT6A;TCP1;DKC1;CCT8;CCT5;CCT7;TERF1;WRAP53;CCT2;CCT4;CCT3
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),-0.26853574725006973,-0.6452811473786938,0.8895833333333333,0.9841674970306435,1.0,3/11,29.14%,PPCDC;PANK2;PANK3
prerank,coenzyme A biosynthetic process (GO:0015937),-0.26853574725006973,-0.6452811473786938,0.8895833333333333,0.9841674970306435,1.0,3/11,29.14%,PPCDC;PANK2;PANK3
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),-0.26853574725006973,-0.6452811473786938,0.8895833333333333,0.9841674970306435,1.0,3/11,29.14%,PPCDC;PANK2;PANK3
prerank,protein lipidation (GO:0006497),0.20550046048827234,0.6449980937261899,0.9714285714285714,1.0,1.0,9/59,13.27%,PIGU;ZDHHC1;ATG10;WIPI1;PIGG;ZDHHC3;PIGV;PIGC;PIGQ
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.28206969291601036,0.6435177859482452,0.8757637474541752,1.0,1.0,2/12,7.37%,CLCN2;H6PD
prerank,DNA duplex unwinding (GO:0032508),0.20497824048751037,0.6433919423088358,0.9525483304042179,1.0,1.0,21/50,24.43%,ANXA1;DDB2;BLM;SSBP1;RTEL1;CUL4B;MRE11;RAD23B;MCM2;WRN;RAD51;XPC;PURA;MCM7;RECQL5;RAD50;NBN;GTF2H1;MCM9;CUL4A;ERCC2
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.293748430831032,0.6418367104654806,0.8742138364779874,1.0,1.0,10/10,70.64%,TGFA;AREG;HBEGF;ADRA2A;EPGN;FBXW7;ADAM17;NCF1;EGF;BTC
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.2294515805322128,0.6413553474688589,0.9172932330827067,1.0,1.0,1/26,1.05%,PPARA
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.28525304177368427,0.641133222765987,0.856858846918489,1.0,1.0,5/10,22.23%,CCL19;AXL;LYN;LGALS9;RAPGEF2
prerank,dermatan sulfate metabolic process (GO:0030205),0.2718994917146555,0.6408242982310574,0.8641509433962264,1.0,1.0,1/13,1.76%,UST
prerank,GTP metabolic process (GO:0046039),-0.25122975166068373,-0.6405834566263299,0.9253731343283582,0.9867703991684174,1.0,3/15,14.16%,ENTPD7;IMPDH1;IMPDH2
prerank,protein processing (GO:0016485),0.18350299737212597,0.6392428475784515,0.9858712715855573,1.0,1.0,5/102,4.16%,AEBP1;KLK2;CTSH;PCSK9;MYRFL
prerank,defense response to fungus (GO:0050832),-0.2387171167744485,-0.6381728103634625,0.9213051823416507,0.9877890471750365,1.0,3/17,15.51%,PLCG2;GAPDH;CX3CR1
prerank,regulation of pH (GO:0006885),0.28601730989359886,0.6374716189132777,0.878,1.0,1.0,1/11,3.44%,LACC1
prerank,secondary alcohol biosynthetic process (GO:1902653),0.2271398342935859,0.6366540975958542,0.9177330895795247,1.0,1.0,5/30,11.77%,INSIG2;PMVK;ACAA2;ACAT2;FDPS
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.25547300239170384,-0.6358707001119344,0.9104477611940298,0.9887171729588843,1.0,4/14,17.32%,RTCB;CLP1;RTRAF;CSTF2
prerank,eye photoreceptor cell development (GO:0042462),-0.24479184683630517,-0.6350006041917705,0.9134615384615384,0.9887054161952009,1.0,4/15,20.93%,RP1;VEGFA;RORB;THY1
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.26782197140652697,0.6345615292394472,0.8985200845665962,1.0,1.0,1/17,2.87%,NOS1AP
prerank,membrane protein ectodomain proteolysis (GO:0006509),-0.22632129217918412,-0.6345457436799441,0.9316770186335404,0.988453272879284,1.0,4/21,20.09%,ADAM10;MYH9;ADAM9;PSEN1
prerank,photoperiodism (GO:0009648),-0.21082061650701633,-0.6345035715369108,0.9472527472527472,0.987941573498118,1.0,10/28,28.55%,BHLHE40;FBXL3;PPP1CA;PER1;ID2;PPP1CB;PPP1CC;RBM4B;USP2;PER2
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.2919281948280191,0.6343823080126448,0.8688524590163934,1.0,1.0,10/10,70.83%,CCT6A;TCP1;DKC1;CCT8;CCT5;CCT7;WRAP53;CCT2;CCT4;CCT3
prerank,tRNA methylation (GO:0030488),0.22231197908815162,0.633868167372258,0.9442379182156134,1.0,1.0,6/34,14.72%,HSD17B10;THADA;TRDMT1;LCMT2;MTO1;THUMPD3
prerank,regulation of mRNA polyadenylation (GO:1900363),0.2580674531604789,0.6322227690901602,0.8808080808080808,1.0,1.0,7/17,18.69%,CCNT1;RNF20;HSF1;ZC3H14;CTR9;CDK9;NUDT21
prerank,homologous chromosome segregation (GO:0045143),0.2488169803640065,0.6307692296793136,0.890020366598778,1.0,1.0,2/20,8.85%,TERB2;MAJIN
prerank,interleukin-2-mediated signaling pathway (GO:0038110),-0.2659116582614027,-0.6304463914258666,0.9097888675623801,0.9893199068528734,1.0,6/11,33.05%,PTK2B;JAK3;JAK1;IL2RA;IL2RG;SYK
prerank,cellular response to interleukin-2 (GO:0071352),-0.2659116582614027,-0.6304463914258666,0.9097888675623801,0.9893199068528734,1.0,6/11,33.05%,PTK2B;JAK3;JAK1;IL2RA;IL2RG;SYK
prerank,glycogen catabolic process (GO:0005980),0.26105674993173106,0.6293945407881394,0.9096267190569745,1.0,1.0,1/15,1.73%,PHKB
prerank,regulation of telomere capping (GO:1904353),-0.22342623102021308,-0.6273198151655894,0.9399141630901288,0.9906524933259582,1.0,1/23,0.71%,NEK7
prerank,transcription by RNA polymerase I (GO:0006360),0.21764019665248902,0.6266045017956345,0.9324817518248175,1.0,1.0,8/34,17.11%,CDK7;TAF1A;POLR1F;POLR1A;TAF1D;MNAT1;TCOF1;POLR1G
prerank,coenzyme A metabolic process (GO:0015936),-0.2455909104508333,-0.6262955514710989,0.9305263157894736,0.9907092631874899,1.0,4/14,29.14%,PPCDC;ACLY;PANK2;PANK3
prerank,mucosal immune response (GO:0002385),0.2609447172998589,0.6260361887594589,0.9117647058823529,1.0,1.0,1/15,2.80%,LTF
prerank,fatty acid transport (GO:0015908),0.2549143795851142,0.6248644660959186,0.8932806324110671,1.0,1.0,2/17,10.08%,ACSL1;SLC27A1
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.26587792391731413,-0.6245206209868925,0.9398797595190381,0.9905880098857912,1.0,2/11,10.30%,LARP7;MEPCE
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.26587792391731413,-0.6245206209868925,0.9398797595190381,0.9905880098857912,1.0,2/11,10.30%,LARP7;MEPCE
prerank,positive regulation of organelle assembly (GO:1902117),0.2053012443184586,0.6242941475165888,0.9553571428571429,1.0,1.0,8/44,16.64%,ASAP1;ARHGAP35;STX18;CNOT2;CROCC;RAB3GAP1;CEP120;SDCBP
prerank,insulin secretion (GO:0030073),0.24580623482673733,0.6238189334293484,0.9139579349904398,1.0,1.0,5/19,18.16%,ANXA1;SLC30A8;RAB11FIP2;RAB11B;CYB5R4
prerank,response to light stimulus (GO:0009416),-0.1760534280383727,-0.6232281547634816,0.9874686716791979,0.990776883347852,1.0,17/55,28.61%,UVSSA;MAPK8;UBE2B;MEN1;MAP2K7;ERCC8;SPRTN;CDKN2D;POLD1;GTF2H2;MAPK10;FECH;DTL;ERCC5;OPN3;ERCC3;GPR52
prerank,covalent chromatin modification (GO:0016569),0.2617669127703872,0.6230270295306078,0.9007633587786259,1.0,1.0,2/14,10.21%,UFL1;HDAC1
prerank,axonal transport of mitochondrion (GO:0019896),-0.2640048522359134,-0.6228198758416562,0.9107806691449815,0.9904475420028428,1.0,3/11,25.08%,ACTR10;NEFL;HAP1
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.23114716099292,-0.6227273013754859,0.9399585921325052,0.9899713322155239,1.0,10/18,38.13%,AQP4;CFAP53;SPAG17;RFX3;DNAAF2;ODAD4;CABYR;CCDC40;CCDC39;DNAAF4
prerank,regulation of interferon-alpha production (GO:0032647),-0.21565879715012778,-0.6226372601175165,0.9535864978902954,0.9894828713958538,1.0,9/23,31.11%,CHUK;HSPD1;IFIH1;IRF5;STAT1;TLR4;TLR7;MAVS;DHX9
prerank,cellular response to hydroxyurea (GO:0072711),-0.26719242443218466,-0.6200376259453935,0.9285714285714286,0.9904504164866456,1.0,3/10,22.10%,SPIDR;RTF2;FMR1
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.24872329743242352,0.6193971715579025,0.9005964214711729,1.0,1.0,7/18,20.84%,FER;IL6;JAK2;SMAD4;PTPN11;CTR9;IL6R
prerank,cellular response to light stimulus (GO:0071482),-0.17112455789931694,-0.6190488650269615,0.9869791666666666,0.9904870057535368,1.0,26/66,39.34%,RPL26;ATF4;COPS9;POLK;USP28;N4BP1;ATR;PRKCD;METTL3;NOC2L;BMF;FMR1;POLD1;OPN3;GNB1;GPR52;SAG;TMEM161A;NPM1;PTPRK;YY1;CASP9;CDC25A;PDE6A;SMPD1;PCNA
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),-0.19783260263666116,-0.6186554983178867,0.9573033707865168,0.9901744991647582,1.0,14/29,38.72%,RPS2;FEM1A;DCUN1D1;DCUN1D2;PINK1;TRIB3;ARRDC3;SMAD7;PLK1;DCUN1D3;PARK7;DCUN1D4;FBXW7;LIMK1
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.1798133960701087,-0.6185880529155671,0.9682926829268292,0.9896833479023444,1.0,12/50,25.07%,ACTB;HSP90AB1;CDC37;CDKN1B;CCNF;CAMK2N1;CCNG2;GADD45A;CDKN1A;CDKN2D;CCNB2;CDKN3
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.24032543498831024,0.6183725533141498,0.8970873786407767,1.0,1.0,6/19,19.11%,AMPD3;TYMS;ADK;APRT;GMPR2;POLD2
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.245632608427177,-0.6179916966832334,0.942,0.9894631818354659,1.0,5/15,35.94%,PTTG1;ANAPC7;PLK1;CDC6;UBE2C
prerank,aromatic amino acid family catabolic process (GO:0009074),0.25397360627450916,0.6162342751286096,0.9153225806451613,1.0,1.0,3/15,15.78%,FAH;AADAT;GSTZ1
prerank,regulation of lipid catabolic process (GO:0050994),0.24212017685578185,0.615026241544442,0.9069767441860465,1.0,1.0,5/19,21.36%,PRKAA1;APOC1;RARRES2;ADRA2A;LONP2
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.21268006245001925,0.61430831066703,0.9657039711191335,1.0,1.0,5/36,10.73%,PRKN;CSF1;ZBP1;AXL;PARP9
prerank,cardiolipin metabolic process (GO:0032048),-0.25135185620747363,-0.6129111006394214,0.914,0.9916596437816695,1.0,2/13,15.57%,CRLS1;PLA2G4A
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),-0.21970587096572244,-0.6127882846917916,0.9390962671905697,0.9911751493123564,1.0,6/20,21.10%,PUM2;ZC3H7A;AGO3;TSN;SNIP1;TSNAX
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.24299382315442997,0.6120574781174416,0.9182879377431906,1.0,1.0,4/18,13.07%,COX19;COX17;OXA1L;COX20
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.26396445594407525,-0.611236431674429,0.9224952741020794,0.9914757918473346,1.0,7/10,49.86%,NFKBIZ;ZC3H12A;SMAD7;RC3H1;IL4;FOXP3;TBX21
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.23904610086905537,0.6112110741373707,0.9236641221374046,1.0,1.0,3/22,7.28%,PSME4;PSMA2;PSMA3
prerank,miRNA metabolic process (GO:0010586),0.2417687467165663,0.6109927036511701,0.9232323232323232,1.0,1.0,8/20,23.13%,SND1;AGO2;DICER1;PARN;TUT4;TUT7;XPO5;KHSRP
prerank,tricarboxylic acid metabolic process (GO:0072350),-0.2539262272834073,-0.6109515719099682,0.9324577861163227,0.9910857091026418,1.0,5/12,29.61%,IREB2;SIRT4;ACLY;IDH3A;GLUD1
prerank,icosanoid metabolic process (GO:0006690),-0.18706565485247056,-0.6106532093567274,0.9887387387387387,0.9906881864699884,1.0,7/40,15.57%,MGLL;GPX4;PTGIS;PTGS2;PON2;ALOX12;PLA2G4A
prerank,regulation of lysosomal lumen pH (GO:0035751),0.26716620003053587,0.6101411380399787,0.9226415094339623,1.0,1.0,2/12,9.30%,LRRK2;TMEM199
prerank,ncRNA 3'-end processing (GO:0043628),0.2529467839854322,0.6088381346141344,0.89,1.0,1.0,4/14,17.68%,TRNT1;INTS8;ERI1;INTS14
prerank,protein localization to condensed chromosome (GO:1903083),0.26204280714324324,0.6083843170603629,0.9068825910931174,1.0,1.0,3/12,15.99%,TTK;CDK1;MIS12
prerank,positive regulation of monocyte chemotaxis (GO:0090026),-0.2234612566222267,-0.6082068867301632,0.961864406779661,0.9913790658572887,1.0,7/17,36.86%,LGMN;CXCL12;CCR2;CXCL10;CREB3;CXCL17;CCL5
prerank,peptide hormone secretion (GO:0030072),0.22093204532756944,0.6081568968285692,0.9383177570093458,1.0,1.0,3/26,8.15%,ANXA1;IL6;SLC30A8
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.16748671209205548,0.6079583126471931,0.9969040247678018,1.0,1.0,16/125,13.30%,EML4;KIF2A;ITGB3BP;PTPA;CENPI;TTK;BIRC5;PAFAH1B1;SKA2;NUP107;CENPQ;NSL1;MAD1L1;DSN1;DCTN6;SUN2
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.2514598854739988,0.6078629214788621,0.9266409266409267,1.0,1.0,3/15,10.22%,TNRC6B;TNRC6A;AGO2
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.2478890076618126,0.6073923051842781,0.9032882011605415,1.0,1.0,1/16,3.98%,TOP2B
prerank,androgen metabolic process (GO:0008209),0.24309622460141908,0.6069298634554484,0.9110671936758893,1.0,1.0,2/18,10.09%,HSD17B10;MED1
prerank,epithelial cell development (GO:0002064),-0.22089671322173665,-0.606459885882483,0.9438877755511023,0.9916952593072804,1.0,2/20,6.79%,SIPA1L3;ACTA2
prerank,mRNA methylation (GO:0080009),-0.23388221408994186,-0.6061969114436893,0.9402390438247012,0.991290202387027,1.0,4/15,23.63%,TRMT61B;METTL3;TRMT10C;PCIF1
prerank,DNA replication (GO:0006260),0.1731416202118697,0.6061661175574268,0.9908536585365854,1.0,1.0,29/105,21.35%,RBMS1;ATRIP;BAZ1A;NT5M;BLM;CDK1;CLSPN;REV1;RFC1;ORC2;CDK2AP1;MRE11;TOP1MT;MCM2;BRIP1;WRN;ORC3;NAP1L1;ORC6;RNASEH2A;RPAIN;MCM7;POLD2;POLG2;RECQL5;RAD9B;RAD50;KAT5;NBN
prerank,microtubule depolymerization (GO:0007019),0.24445581109847833,0.6060939624094779,0.9106796116504854,1.0,1.0,1/17,1.89%,KIF2A
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.23863935990863902,0.6055777444832035,0.9184466019417475,1.0,1.0,6/19,21.72%,HNRNPC;ACD;DCP2;STN1;XRN1;TERF2
prerank,regulation of RNA export from nucleus (GO:0046831),-0.2558397997990986,-0.6049776521973644,0.9292730844793713,0.9913544636709842,1.0,6/11,37.20%,CPSF6;NRDE2;NUP153;DHX9;IWS1;NCBP2
prerank,DNA strand elongation (GO:0022616),0.24361105253496118,0.6045592207490477,0.9207317073170732,1.0,1.0,8/18,23.74%,DCLRE1B;MRE11;MCM7;POLD2;RAD50;NBN;GINS3;RFC4
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.2518700007998923,0.6044524699806857,0.9176954732510288,1.0,1.0,3/15,13.79%,HUS1B;MDC1;MRE11
prerank,snRNA processing (GO:0016180),-0.23090757169296466,-0.6029038566718757,0.9341085271317829,0.9918227493714532,1.0,5/16,22.80%,INTS6L;INTS11;INTS6;INTS1;INTS3
prerank,replicative senescence (GO:0090399),0.26087779136570494,0.6026739125909735,0.9012605042016807,1.0,1.0,1/12,2.44%,PLA2R1
prerank,spliceosomal snRNP assembly (GO:0000387),0.20867580149247292,0.6024301404005266,0.9567474048442907,1.0,1.0,9/38,20.37%,PRMT7;SMN1;COIL;PRPF3;USP4;GEMIN5;PRPF6;LSM4;SNRPF
prerank,response to hydroxyurea (GO:0072710),-0.25146646898563163,-0.6022491785847635,0.9309090909090909,0.9916069551543264,1.0,3/11,22.10%,SPIDR;RTF2;FMR1
prerank,mRNA modification (GO:0016556),0.22829519063655104,0.6014565818397004,0.9262759924385633,1.0,1.0,3/22,10.76%,PUS3;METTL8;METTL14
prerank,cholesterol biosynthetic process (GO:0006695),0.21400726831988598,0.6011027934670744,0.9414990859232175,1.0,1.0,5/31,11.77%,INSIG2;PMVK;ACAA2;ACAT2;FDPS
prerank,pigment granule transport (GO:0051904),0.24095330315283836,0.6000431131207301,0.9487704918032787,1.0,1.0,4/18,15.10%,ARL6;GPR143;BBS7;RAB11B
prerank,melanosome transport (GO:0032402),0.24095330315283836,0.6000431131207301,0.9487704918032787,1.0,1.0,4/18,15.10%,ARL6;GPR143;BBS7;RAB11B
prerank,tryptophan metabolic process (GO:0006568),-0.2549313353502952,-0.5995275649537788,0.9269662921348315,0.9923692105018933,1.0,4/11,31.62%,KYAT1;KMO;IL4I1;HAAO
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.20830500800593768,0.5989275275187124,0.9585585585585585,1.0,1.0,7/32,17.11%,CDK7;TAF1A;POLR1F;POLR1A;TAF1D;MNAT1;POLR1G
prerank,positive regulation of immunoglobulin production (GO:0002639),0.20968675408508888,0.5982277640790133,0.9656488549618321,1.0,1.0,2/31,6.85%,RBP4;IL6
prerank,neuron fate commitment (GO:0048663),0.25166641451221794,0.5977437314173044,0.9144602851323829,1.0,1.0,1/14,3.27%,EPOP
prerank,respiratory chain complex IV assembly (GO:0008535),-0.20841999847730172,-0.5976998435851626,0.9600840336134454,0.9927217846190164,1.0,9/21,29.00%,SMIM20;COA6;FASTKD3;BCS1L;COA3;COX15;COX16;COA8;COA5
prerank,positive regulation of T cell differentiation (GO:0045582),-0.18853954507176654,-0.5976229265500037,0.9807692307692307,0.9922260056164901,1.0,17/36,39.96%,LEF1;SOX4;XBP1;NCKAP1L;NKAP;VSIR;SOCS1;IL4I1;VNN1;SHH;MDK;IL7;ZAP70;GATA3;TESPA1;IL12RB1;IL4
prerank,gastrulation (GO:0007369),0.24510854247864766,0.5973955331594174,0.904296875,1.0,1.0,5/15,23.02%,GPC3;UGDH;SMAD2;LMBRD1;NPHP3
prerank,amyloid-beta metabolic process (GO:0050435),0.24443494800819177,0.5972707403216685,0.9371196754563894,1.0,1.0,5/16,20.61%,ACE;PSENEN;NAT8;BACE1;MGAT3
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.21304404801800986,0.5972069663015634,0.9523809523809523,1.0,1.0,9/29,21.63%,ZC3H7B;SMAD3;AGO2;DICER1;HNRNPA2B1;SMAD2;TUT4;AGO1;TUT7
prerank,zymogen activation (GO:0031638),0.20490093915644966,0.5965640047564427,0.964406779661017,1.0,1.0,2/39,3.29%,KLK2;CTSH
prerank,regulation of endocytic recycling (GO:2001135),-0.25169369245087503,-0.5962097433987193,0.950381679389313,0.9923551199097446,1.0,6/11,41.40%,EHD1;INPP5F;SORL1;EIPR1;EHD2;PLA2G3
prerank,neuromuscular process controlling balance (GO:0050885),0.2631127578699376,0.5961003090828246,0.9087136929460581,1.0,1.0,2/12,8.78%,TPP1;PAFAH1B1
prerank,RNA biosynthetic process (GO:0032774),0.21088392968522687,0.5944626970309383,0.9543795620437956,1.0,1.0,4/31,11.10%,RSF1;POLR2A;SMN1;SMARCA5
prerank,ncRNA metabolic process (GO:0034660),0.206065045647849,0.5941448244157808,0.9662522202486679,1.0,1.0,12/37,23.13%,DTD2;AGO2;DICER1;NIFK;PARN;DTD1;TUT4;DDX4;TUT7;XPO5;PIWIL4;KHSRP
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.20896152941623275,0.5938998843807498,0.959409594095941,1.0,1.0,8/35,15.46%,ACD;XRCC5;CCT6A;FBXO4;RTEL1;MAPK1;TCP1;PARN
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.2580696196987155,-0.5934056901053124,0.9437984496124031,0.9931147325799654,1.0,3/10,24.18%,PIH1D1;RUVBL1;PIH1D2
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.2165291272233434,0.5928649482155781,0.9480286738351255,1.0,1.0,6/27,19.29%,LPAR1;F2RL2;F2RL3;GPR157;DRD2;GPR35
prerank,DNA modification (GO:0006304),-0.20924544440150722,-0.5921777977309168,0.9650924024640657,0.993118853291764,1.0,5/22,16.82%,SMUG1;OGG1;TERF2IP;NEIL1;NEIL3
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.22292434570793151,0.5920232920645073,0.9410681399631676,1.0,1.0,4/23,14.96%,PLA2G10;PLA2G4B;PLA2G4C;PLA2G12A
prerank,ncRNA export from nucleus (GO:0097064),0.20575401153946077,0.5906145970477307,0.9555160142348754,1.0,1.0,3/36,10.11%,PHAX;NDC1;NUP107
prerank,rRNA methylation (GO:0031167),-0.2108399433678255,-0.5905482723753036,0.9642857142857143,0.9932971243454931,1.0,6/22,23.09%,TFB2M;BUD23;FBL;NSUN4;MRM2;MRM3
prerank,alpha-amino acid metabolic process (GO:1901605),0.19702269703388545,0.5900980946000837,0.9772329246935202,1.0,1.0,7/45,15.41%,CBS;MTHFR;SRR;RIMKLB;KYAT3;AADAT;ASPA
prerank,glycogen biosynthetic process (GO:0005978),0.2576362848925143,0.5898208667383312,0.9204301075268817,1.0,1.0,2/12,9.65%,GYS1;NHLRC1
prerank,glucan biosynthetic process (GO:0009250),0.2576362848925143,0.5898208667383312,0.9204301075268817,1.0,1.0,2/12,9.65%,GYS1;NHLRC1
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.21780220019923457,0.5895018205352939,0.9616858237547893,1.0,1.0,3/28,8.78%,PRKN;PTEN;NUPR1
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.26482957755319825,0.5886581363423009,0.9194499017681729,1.0,1.0,11/11,73.54%,TAS1R2;PKD2L1;RTP2;TAS1R3;PIGR;GNAT2;PKD1L3;GNAT3;RTP3;LPO;RTP4
prerank,regulation of biosynthetic process (GO:0009889),0.25698324022346375,0.5883078486479144,0.9303370786516854,1.0,1.0,11/11,74.32%,SNCA;ALOX5;PIKFYVE;PCK1;UCP1;MID1IP1;CCN6;GSTP1;SLC25A33;THRSP;SPHK2
prerank,mitochondrial transcription (GO:0006390),0.2606602144297797,0.5858404789543394,0.9002169197396963,1.0,1.0,4/10,24.32%,MTERF2;MRPL12;POLRMT;TFB1M
prerank,positive regulation of cytokinesis (GO:0032467),0.20737631295593015,0.5855130951951202,0.9509433962264151,1.0,1.0,3/32,8.76%,CXCR5;CDC14B;PKN2
prerank,calcium-ion regulated exocytosis (GO:0017156),0.21289490210693754,0.5847151055459959,0.96875,1.0,1.0,2/27,4.23%,SYT11;SYT12
prerank,tRNA processing (GO:0008033),0.18465136882851013,0.5841993356750922,0.9834162520729685,1.0,1.0,13/61,17.65%,TRMT9B;PUS3;TSEN34;TRNT1;TRDMT1;ZBTB8OS;LCMT2;WDR4;TSEN2;FARS2;DTWD1;CPSF4;TYW5
prerank,negative regulation of B cell proliferation (GO:0030889),-0.24838195937667945,-0.5841875331417589,0.9475728155339805,0.9954853117803698,1.0,4/11,23.77%,TNFRSF21;TYROBP;CD300A;FCGR2B
prerank,eosinophil chemotaxis (GO:0048245),-0.2286459070727032,-0.5834376314681045,0.9421641791044776,0.9947295424021299,1.0,10/14,50.41%,SCG2;CCL13;CCL2;CCL5;CCL8;CCL7;CCL1;CCL3;CCL11;LGALS3
prerank,eosinophil migration (GO:0072677),-0.2286459070727032,-0.5834376314681045,0.9421641791044776,0.9947295424021299,1.0,10/14,50.41%,SCG2;CCL13;CCL2;CCL5;CCL8;CCL7;CCL1;CCL3;CCL11;LGALS3
prerank,purine ribonucleotide metabolic process (GO:0009150),0.17582369544669493,0.5829265246058537,0.9931740614334471,1.0,1.0,4/68,5.17%,TPST1;AMPD3;ACOT4;LRRK2
prerank,neuropeptide signaling pathway (GO:0007218),-0.1635873850091961,-0.5813773754208664,0.9949748743718593,0.9950360053474308,1.0,12/58,25.22%,SORCS2;CYSLTR1;CYSLTR2;NXPH2;SORCS1;GPR149;GLRA3;NPY;PNOC;SORL1;ADCYAP1;GLRA1
prerank,protein targeting to membrane (GO:0006612),0.17227744096779635,0.5807797351499228,0.9968847352024922,1.0,1.0,10/83,11.69%,PARD3;RAB3IP;PXMP2;ZDHHC1;ARL6;ZDHHC3;MICALL1;PXMP4;VPS37C;VPS37A
prerank,nuclear transport (GO:0051169),0.24282008710142972,0.580590046601854,0.9267782426778243,1.0,1.0,4/16,18.81%,NUTF2;NXT2;PSIP1;RSRC1
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.22806922751855735,-0.5777209652164842,0.9550321199143469,0.9959308836641797,1.0,4/15,17.32%,RTCB;CLP1;RTRAF;CSTF2
prerank,smoothened signaling pathway (GO:0007224),-0.1806865108082446,-0.5758550093946999,0.9806451612903225,0.9961274293055443,1.0,9/32,23.70%,PTCH1;DISP2;GLI1;STK36;PTCHD1;DISP3;TTBK2;PTCH2;TCTN3
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.22607633961803184,0.5743994786917075,0.9543726235741445,1.0,1.0,8/21,21.63%,SAMD4A;CNOT2;PARN;CNOT7;CNOT8;CNOT10;TUT4;TUT7
prerank,regulation of cholesterol transport (GO:0032374),0.22080616549289833,0.5739900908609485,0.9513184584178499,1.0,1.0,3/20,9.19%,ABCA13;ABCA5;APOC1
prerank,extracellular transport (GO:0006858),0.25291902071563077,0.573740110381644,0.9321357285429142,1.0,1.0,12/12,74.73%,WWP2;SPA17;SPEF2;ADCY10;ROPN1L;ARRDC1;TSG101;DNAAF4;CCDC40;CABYR;DNAAF2;SPAG17
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.22179645128051673,0.5735044323499762,0.9401544401544402,1.0,1.0,7/19,22.93%,POLR3G;ICE2;AR;POLR3C;ELL;NAB2;ICE1
prerank,apoptotic nuclear changes (GO:0030262),0.21741806835609084,0.573487224530041,0.951310861423221,1.0,1.0,5/24,18.03%,ACIN1;CECR2;DICER1;DFFA;KPNB1
prerank,positive regulation of glucose metabolic process (GO:0010907),-0.2284499555202794,-0.5722515052884408,0.97,0.996934014808146,1.0,6/14,33.43%,PPARGC1A;DDB1;AKT1;ARPP19;PMAIP1;AKT2
prerank,sensory perception of pain (GO:0019233),-0.20002546215078532,-0.5716935228401133,0.9628099173553719,0.9965826762388075,1.0,9/21,36.11%,TRPA1;CCR2;CCL2;ALOXE3;NIPSNAP1;P2RX7;KCNA2;PROK2;OPRM1
prerank,regulation of lymphocyte proliferation (GO:0050670),-0.21839290501862405,-0.5714227376736201,0.9681647940074907,0.9961498358724782,1.0,2/16,7.55%,TNFRSF1B;AHR
prerank,membrane protein proteolysis (GO:0033619),-0.17968697532178407,-0.5712668045245254,0.9869281045751634,0.9956702692118343,1.0,8/37,23.64%,ADAM10;TGFB1;MYH9;RET;ADAM9;PSEN1;MBTPS1;RELA
prerank,placenta development (GO:0001890),0.25048375268222767,0.5711994539803211,0.941908713692946,1.0,1.0,2/12,8.66%,ASCL2;CUL7
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.2601892812030621,0.5707831354612668,0.9279661016949152,1.0,1.0,4/10,21.08%,CDC73;HSF1;NUDT21;PAF1
prerank,regulation of oxidative phosphorylation (GO:0002082),0.23121519926436193,0.5696988980665194,0.9337231968810916,1.0,1.0,6/16,22.36%,NUPR1;COX7A2L;PDE12;COX7A2;ATP7A;AK4
prerank,tRNA wobble uridine modification (GO:0002098),0.24413329831969893,0.5696727077440957,0.9402061855670103,1.0,1.0,2/14,12.68%,TRMT9B;MTO1
prerank,defense response to Gram-negative bacterium (GO:0050829),0.189500584936207,0.5684591376097818,0.977112676056338,1.0,1.0,6/42,12.57%,LTF;IL6;OPTN;GSDMD;MR1;SERPINE1
prerank,negative regulation of telomere maintenance (GO:0032205),-0.22271411713390044,-0.5683338330939409,0.9494949494949495,0.9961923950219367,1.0,2/15,14.85%,PINX1;TERF2IP
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.22024593079883067,-0.5681798467899531,0.957983193277311,0.995724654537817,1.0,4/15,25.69%,RACK1;ORMDL2;PRKCD;SPHK2
prerank,regulation of mRNA 3'-end processing (GO:0031440),-0.24380956362203424,-0.5672532004073894,0.9488188976377953,0.9955239903591518,1.0,6/11,42.66%,ZFP36L1;AHCYL1;BARD1;NCBP2;LEO1;PAPOLA
prerank,cell proliferation in forebrain (GO:0021846),0.2574692442882251,0.5670621949572996,0.912472647702407,1.0,1.0,10/10,74.27%,CEP120;AKNA;NUMBL;DOCK7;NUMB;HOOK3;WNT3A;WNT7A;PCM1;KIF14
prerank,production of siRNA involved in RNA interference (GO:0030422),0.2542824792051901,0.5659206927709134,0.9199134199134199,1.0,1.0,2/10,13.35%,AGO2;DICER1
prerank,snRNA 3'-end processing (GO:0034472),0.22150005561059138,0.5654049274875879,0.9555984555984556,1.0,1.0,5/19,18.02%,INTS8;EXOSC8;TUT1;INTS14;EXOSC3
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.20007073992421254,0.5641040411663314,0.9762773722627737,1.0,1.0,3/31,7.09%,CTLA4;LST1;PDCD1LG2
prerank,regulation of gene silencing by miRNA (GO:0060964),0.17805008833335897,0.5640123008525745,0.9934102141680395,1.0,1.0,7/62,11.68%,POLR2D;TNRC6A;NDC1;POLR2A;NUP107;AGO2;FXR1
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.17890526902803533,-0.5640073729678693,0.9819819819819819,0.9955540195100182,1.0,13/32,40.01%,SSB;NUP37;NUP54;NUP85;NUP133;POM121;NUP153;NUP42;NUP93;NOL6;NUP35;RAN;SEH1L
prerank,tRNA export from nucleus (GO:0006409),-0.17890526902803533,-0.5640073729678693,0.9819819819819819,0.9955540195100182,1.0,13/32,40.01%,SSB;NUP37;NUP54;NUP85;NUP133;POM121;NUP153;NUP42;NUP93;NOL6;NUP35;RAN;SEH1L
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.22062617048244032,-0.564007097703027,0.9524793388429752,0.9950239055486177,1.0,3/15,11.89%,NLRC5;ISG15;YTHDF3
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.213125991366772,0.5636453043650268,0.9600760456273765,1.0,1.0,7/24,23.69%,HNRNPC;ACD;DCP2;STN1;XRN1;TERF2;TNKS2
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.17782939172237427,-0.5633938028570209,0.9838709677419355,0.9946901438815269,1.0,17/35,42.06%,CDH11;ATP2C1;CDH13;PCDHB14;CDH12;CDH10;SELP;CDH8;PCDHB9;PCDHB13;PCDHB5;PCDHB3;CDH7;CDH20;CDH19;DCHS1;PCDHB4
prerank,protein localization to centrosome (GO:0071539),-0.2108342903061159,-0.5630619355633306,0.9703557312252964,0.9942681144800818,1.0,5/17,33.01%,CEP83;SPAG5;PCM1;CEP131;STIL
prerank,negative regulation of hormone secretion (GO:0046888),0.26110125763364955,0.5628961751453115,0.9393305439330544,1.0,1.0,3/10,18.22%,GJA1;IL11;RAB11FIP3
prerank,tRNA wobble base modification (GO:0002097),0.234737226620364,0.5619602482474397,0.9268774703557312,1.0,1.0,2/14,12.68%,TRMT9B;MTO1
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),-0.23668480294295519,-0.5601009839447506,0.9611111111111111,0.9946799775033334,1.0,2/11,16.23%,CTNNB1;NR4A2
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.2520479971733289,0.5587374382014771,0.946058091286307,1.0,1.0,2/11,11.59%,GSTM2;PKD2
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.2520479971733289,0.5587374382014771,0.946058091286307,1.0,1.0,2/11,11.59%,GSTM2;PKD2
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.22119630150373668,-0.5576093713115654,0.9509803921568627,0.9949505888596806,1.0,5/13,39.36%,DUSP1;GEN1;NDC80;XRCC3;CCNB1
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.25128265624435214,0.555562590188446,0.9426229508196722,1.0,1.0,1/10,2.80%,LTF
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.16216337449318458,0.5507352554597541,0.9968354430379747,1.0,1.0,14/83,15.36%,CDK7;EIF4EBP1;NASP;PHF8;TYMS;LATS1;RPS6KB1;CUL4B;CCNE1;MNAT1;TFDP2;CDK15;BACH1;CDK4
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.2381192830346519,-0.5506158222667324,0.9473684210526315,0.9965326971355328,1.0,1/10,3.18%,PDE8A
prerank,positive regulation of chromosome organization (GO:2001252),-0.21071612517976468,-0.5503686588054799,0.9717171717171718,0.996079129144555,1.0,4/15,23.25%,GNL3;PPP1R10;LIG4;SIRT6
prerank,regulation of mast cell activation (GO:0033003),0.24297012302284698,0.5502831216434044,0.9360824742268041,1.0,1.0,10/10,75.72%,NECTIN2;LYN;CD84;CD300LF;PLSCR1;HAVCR1;CD226;TSLP;MILR1;CRLF2
prerank,regulation of spindle organization (GO:0090224),-0.20015089947698872,-0.5495296897117729,0.9776876267748479,0.9957796828028268,1.0,3/18,21.39%,GNAI1;DCTN1;NUMA1
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.25254241703085234,0.5486573452661864,0.9445628997867804,1.0,1.0,2/10,12.08%,SSBP1;INO80
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.24316938128762147,0.546638257528531,0.9448818897637795,1.0,1.0,2/12,9.37%,HUS1B;CLSPN
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.2327768810200862,-0.5454157406824897,0.9641509433962264,0.9959491300994024,1.0,4/11,21.43%,NOTCH4;TNRC6C;AGO3;EIF6
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.2327768810200862,-0.5454157406824897,0.9641509433962264,0.9959491300994024,1.0,4/11,21.43%,NOTCH4;TNRC6C;AGO3;EIF6
prerank,regulation of microtubule-based movement (GO:0060632),-0.22638783777940572,-0.5452804776163175,0.9657794676806084,0.9954642576510795,1.0,4/11,29.96%,LAMP1;HDAC6;HAP1;DYNLT2B
prerank,C21-steroid hormone biosynthetic process (GO:0006700),-0.2263130420817667,-0.5437313143024397,0.9701492537313433,0.9953824246272422,1.0,5/12,31.70%,STARD3NL;CACNA1H;TSPOAP1;TSPO;FDX2
prerank,ribosomal subunit export from nucleus (GO:0000054),-0.21460634004952794,-0.5411110932967662,0.9668615984405458,0.995589397000351,1.0,1/13,2.97%,RPS15
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.1920180459321844,0.5402571702171822,0.9872029250457038,1.0,1.0,7/32,15.46%,ACD;XRCC5;CCT6A;FBXO4;MAPK1;TCP1;PARN
prerank,pre-miRNA processing (GO:0031054),0.2264654426798473,0.5396040430882013,0.9585062240663901,1.0,1.0,5/14,21.63%,AGO2;DICER1;TUT4;AGO1;TUT7
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.23577507003475684,-0.5394234926926557,0.967032967032967,0.9955336026070118,1.0,1/10,6.03%,CTNNB1
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.21789879329819573,-0.5363273802283525,0.9753593429158111,0.9957940583340181,1.0,10/12,51.04%,GNL3;CCT3;GNL3L;CCT4;CCT2;WRAP53;CCT7;CCT5;CCT8;DKC1
prerank,mitochondrial RNA metabolic process (GO:0000959),0.22157455485168048,0.5359113477989708,0.9478079331941545,1.0,1.0,4/14,24.32%,MTERF2;MRPL12;POLRMT;TFB1M
prerank,dendritic cell migration (GO:0036336),-0.20361875974638383,-0.5356257431201349,0.9725158562367865,0.995450544229633,1.0,9/16,47.20%,EPS8;TRPM4;CCR2;TRPM2;PIK3CG;CCL5;CCR1;CCR5;CXCR2
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.21647499015065746,0.5349273739817605,0.9585798816568047,1.0,1.0,6/18,20.42%,CCT6A;DCP2;TCP1;PARN;SHQ1;RUVBL2
prerank,cell cycle G1/S phase transition (GO:0044843),0.16614939367716158,0.5345930208310727,0.9983136593591906,1.0,1.0,10/61,15.36%,CDK7;EIF4EBP1;NASP;PHF8;LATS1;RPS6KB1;CUL4B;CCNE1;MNAT1;CDK4
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.2255559231884371,0.5337608762819305,0.974757281553398,1.0,1.0,3/15,15.12%,ZC3H12B;DICER1;NYNRIN
prerank,mitochondrial genome maintenance (GO:0000002),-0.22562704281538687,-0.5321603737490425,0.9788461538461538,0.9957668555797088,1.0,3/11,26.94%,TOP3A;SLC25A4;MEF2A
prerank,peptidyl-lysine acetylation (GO:0018394),0.24346353416454247,0.5312822723252543,0.9584245076586433,1.0,1.0,4/10,21.31%,CREBBP;ESCO1;KAT2B;KAT5
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.19152161084233865,0.5311465566316348,0.9909420289855072,1.0,1.0,4/31,9.94%,CDC14B;UBE2L3;PTEN;GOLGA2
prerank,mitochondrion distribution (GO:0048311),0.2325954386963886,0.530976185414529,0.9490835030549898,1.0,1.0,3/12,15.88%,LRRK2;TRAK1;TRAK2
prerank,chromosome condensation (GO:0030261),0.18343186881674114,0.5298190308487921,0.9861830742659758,1.0,1.0,9/36,20.14%,ACIN1;PHF8;CDK1;AKAP8L;BANF2;MCPH1;AIFM1;SMC2;NCAPG2
prerank,histone mRNA metabolic process (GO:0008334),0.19312909312740006,0.528062933077758,0.9818511796733213,1.0,1.0,10/27,22.48%,TENT2;DCP2;TUT1;ERI1;TUT4;LSM1;SNRPF;XRN1;TUT7;EXOSC4
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.2292042366894938,0.527544350578965,0.9612068965517241,1.0,1.0,2/12,10.40%,PLK5;PRKDC
prerank,acetyl-CoA metabolic process (GO:0006084),-0.20512248001664152,-0.5251014150883644,0.9754601226993865,0.9969030385101223,1.0,3/15,18.71%,ACACA;HMGCS1;ACLY
prerank,protein targeting to peroxisome (GO:0006625),0.1909991797142148,0.5231659388425796,0.988929889298893,1.0,1.0,5/29,15.21%,PXMP2;ZFAND6;PXMP4;HACL1;PEX7
prerank,regulation of MHC class II biosynthetic process (GO:0045346),-0.22016099452552437,-0.5201843105913362,0.9640151515151515,0.997442360670167,1.0,5/11,39.96%,XBP1;CIITA;TAF7;PF4;IL4
prerank,mesenchymal to epithelial transition (GO:0060231),0.23890244873164115,0.5186130355222129,0.9478957915831663,1.0,1.0,2/10,15.86%,SALL1;FZD7
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.16607899525594294,0.5180160380961248,0.9982638888888888,1.0,1.0,5/53,11.02%,ANXA1;SSTR2;HTR5A;PTGIR;ADRB3
prerank,COPII-coated vesicle cargo loading (GO:0090110),-0.2039693494970365,-0.5179709857657936,0.9783889980353635,0.997399912851373,1.0,5/14,32.67%,RAB1A;SEC23A;SEC23B;SEC31A;SEC31B
prerank,positive regulation of lymphocyte differentiation (GO:0045621),-0.18756444100083736,-0.517664806523856,0.9736842105263158,0.9969439312632925,1.0,10/19,39.96%,GAS6;XBP1;PPP2R3C;NCKAP1L;SYK;MDK;IL7;ZAP70;GATA3;IL4
prerank,dopaminergic neuron differentiation (GO:0071542),-0.18735752051575877,-0.5154691601160889,0.9878542510121457,0.9968670494769931,1.0,7/19,35.13%,CTNNB1;VEGFA;NR4A2;LMX1A;MANF;SHH;LMX1B
prerank,regulation of platelet activation (GO:0010543),-0.18259758444917792,-0.511849178406984,0.9916839916839917,0.9970856871695353,1.0,6/21,27.67%,NOS3;THBD;PLA2G4A;TXK;SELP;TLR4
prerank,positive regulation of DNA recombination (GO:0045911),0.18548095890164867,0.5102835999155328,0.9844961240310077,1.0,1.0,3/27,8.42%,MRNIP;WDR48;ARID2
prerank,positive regulation of interferon-beta production (GO:0032728),0.17955521669501684,0.5096472883314801,0.9929453262786596,1.0,1.0,8/33,18.91%,TRIM56;POLR3G;RNF135;IRF3;TBK1;POLR3C;PTPN11;DDX3X
prerank,mRNA catabolic process (GO:0006402),0.17316543747412097,0.5076874608275481,0.9915397631133672,1.0,1.0,15/44,23.31%,YTHDF2;NBDY;DHX34;DCP2;NUDT12;LSM5;CNOT10;TUT4;XRN1;AGO1;PDE12;TUT7;THRAP3;EXOSC4;LSM6
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.21106759754841206,-0.5037651657024826,0.9718574108818011,0.9980652430078782,1.0,7/12,44.89%,RMDN1;BOD1;NDC80;KIF2C;SEH1L;CENPC;CDT1
prerank,DNA replication checkpoint signaling (GO:0000076),0.20564096593151845,0.503161899543024,0.981203007518797,1.0,1.0,2/16,9.37%,HUS1B;CLSPN
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.21154004375105134,0.4989945376512665,0.9721030042918455,1.0,1.0,4/11,21.68%,PRKCA;LYN;RDX;PRKCQ
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.17493601358901045,0.4988990980549178,0.9965576592082617,1.0,1.0,7/40,14.57%,NEK4;FEM1B;ABL1;NPAS2;FXR1;CRY1;UBE2V1
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.20498992572060074,0.49825979863555997,0.971252566735113,1.0,1.0,1/15,3.68%,RIPOR2
prerank,regulation of double-strand break repair (GO:2000779),0.16854841737733048,0.49806904337731617,0.9964788732394366,1.0,1.0,10/39,21.73%,MRNIP;SPIRE2;SLF1;RTEL1;RAD51;PML;SETD2;TRIP12;RNF169;SLF2
prerank,peptidyl-amino acid modification (GO:0018193),-0.21503891539040923,-0.49765647267001656,0.9716446124763705,0.9985399349515601,1.0,10/10,78.52%,FKBP10;PDF;APOA1;METAP1D;APOA2;METAP2;METAP1;TTLL4;FKBP7;ATP7A
prerank,positive regulation of leukocyte degranulation (GO:0043302),-0.2049031829561424,-0.4975107562155845,0.988,0.9980375447394301,1.0,4/13,33.05%,LAMP1;SPHK2;ITGB2;SYK
prerank,regulation of rRNA processing (GO:2000232),0.20476465404852665,0.49702493852523344,0.9802371541501976,1.0,1.0,5/16,20.68%,YTHDF2;DIMT1;SHQ1;KAT2B;RIOK1
prerank,protein methylation (GO:0006479),0.1700974045160844,0.4960111090533281,0.9927797833935018,1.0,1.0,4/40,10.16%,CAMKMT;PRMT7;NSD1;EEF1AKMT1
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.18012768009948105,0.49341938864090634,0.9943074003795066,1.0,1.0,6/25,23.46%,CCNT2;CCNT1;ELL;LDB1;SUPT4H1;THOC1
prerank,negative regulation of lipid catabolic process (GO:0050995),0.19688757379672472,0.4925199292095331,0.9775051124744376,1.0,1.0,3/17,14.34%,PRKAA1;APOC1;PLIN5
prerank,nuclear pore organization (GO:0006999),0.21054761580251932,0.49046067920869096,0.9792099792099792,1.0,1.0,2/14,10.11%,NDC1;NUP107
prerank,primary miRNA processing (GO:0031053),0.22103576980998138,0.48980628744062615,0.9708333333333333,1.0,1.0,3/10,19.08%,SMAD3;HNRNPA2B1;SMAD2
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.217481699368538,0.4895966429369307,0.9734513274336283,1.0,1.0,2/12,15.05%,TET1;ATF7IP
prerank,DNA methylation (GO:0006306),-0.16968543998141827,-0.4875215329935776,0.9935760171306209,0.9989880420504129,1.0,6/23,26.46%,KMT2E;PICK1;EHMT2;ZFP57;DNMT1;HELLS
prerank,DNA methylation or demethylation (GO:0044728),-0.17645601201009922,-0.4862264963783899,0.9787685774946921,0.9981339738638542,1.0,7/19,42.01%,KMT2E;EHMT2;DNMT1;HELLS;TEX15;SPOCD1;DNMT3B
prerank,DNA alkylation (GO:0006305),-0.17645601201009922,-0.4862264963783899,0.9787685774946921,0.9981339738638542,1.0,7/19,42.01%,KMT2E;EHMT2;DNMT1;HELLS;TEX15;SPOCD1;DNMT3B
prerank,vitamin D metabolic process (GO:0042359),-0.19286438220240482,-0.4849442267526743,0.9884615384615385,0.9977812000819731,1.0,1/13,4.56%,LGMN
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.1564275450867464,0.48439186970773984,1.0,1.0,1.0,10/51,16.56%,HNRNPC;ACD;XRCC5;CCT6A;FBXO4;DCP2;MAPK1;TCP1;PARN;STN1
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.1928497608459362,0.48431838744857836,0.988527724665392,1.0,1.0,2/17,8.93%,TTK;CDK1
prerank,regulation of lipase activity (GO:0060191),0.20567942375386766,0.4830140644127581,0.9878542510121457,1.0,1.0,4/13,18.48%,LIPC;PLIN5;LMF1;SNCA
prerank,protein localization to kinetochore (GO:0034501),0.20201661334412274,0.48069370286653806,0.983640081799591,1.0,1.0,2/14,8.93%,TTK;CDK1
prerank,cellular response to pH (GO:0071467),-0.17734538628793062,-0.4791329555264607,0.9938900203665988,0.9979949256076123,1.0,2/17,13.42%,CHP1;RAB11FIP5
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.20208192991104904,0.4783058375929382,0.9734151329243353,1.0,1.0,1/14,5.72%,DDX60
prerank,long-term memory (GO:0007616),0.18673744242821463,0.47794990379264696,0.9879518072289156,1.0,1.0,5/19,21.59%,ARC;NFATC4;SLC2A4;CALB1;RASGRF1
prerank,regulation of DNA metabolic process (GO:0051052),-0.14410093552872405,-0.47794647117903827,1.0,0.9976326365311378,1.0,17/44,34.61%,WDR70;WRNIP1;TERF2IP;UBE2V2;SMG5;SMARCAD1;SIRT7;HNRNPD;ALYREF;TOM1L1;SMG6;PIF1;SUB1;TICRR;HELB;KPNA2;IL7R
prerank,autophagy of peroxisome (GO:0030242),0.20777931467806354,0.4745582567655189,0.979381443298969,1.0,1.0,2/12,9.70%,PIK3R4;TRAPPC8
prerank,fibrinolysis (GO:0042730),0.2064834555442875,0.47406895971958535,0.9771309771309772,1.0,1.0,12/13,60.16%,SERPINE1;PLAU;HRG;PLG;SERPINF2;FGG;PLAT;KRT1;F2;GP1BA;CPB2;SERPINB2
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.1960698141637367,0.47278972377942324,0.9798387096774194,1.0,1.0,14/14,80.41%,CSF1;TRAF6;POU4F2;IFNG;IL23R;IL12B;TNFSF11;TNF;IL23A;OCSTAMP;CCR1;POU4F1;ATP6AP1;TYROBP
prerank,peptidyl-methionine modification (GO:0018206),0.2059635907093534,0.47274641466884704,0.9789473684210527,1.0,1.0,12/12,79.42%,NAA60;NAA20;NAA15;METAP1;NAA25;METAP2;APOA2;METAP1D;APOA1;PDF;NAA16;NAA30
prerank,regulation of DNA damage checkpoint (GO:2000001),0.21674262520428986,0.4686994006458003,0.9813664596273292,1.0,1.0,4/10,23.46%,FEM1B;CRY1;ETAA1;THOC1
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.18647066986471386,-0.4675040613390936,0.9960238568588469,0.9983286200336293,1.0,2/14,13.38%,PTGS2;PTGER3
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.1961854093165013,0.46421167222401927,0.982421875,1.0,1.0,3/13,19.16%,PRPF3;USP4;PRPF6
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.17604404536355575,-0.46108415051551715,0.9960707269155207,0.9984756032847446,1.0,1/16,5.38%,PINX1
prerank,protein import into mitochondrial matrix (GO:0030150),-0.1724995321404726,-0.46060123767258765,0.9941060903732809,0.9980019288471267,1.0,5/18,30.65%,TOMM20;ROMO1;TIMM50;TIMM44;DNLZ
prerank,membrane lipid catabolic process (GO:0046466),0.2085907346495388,0.45872000087519654,0.9719827586206896,1.0,1.0,1/10,6.84%,ENPP2
prerank,dendritic cell chemotaxis (GO:0002407),0.1935585133098942,0.4558319032176046,0.9918367346938776,1.0,1.0,14/14,80.66%,CCL19;CCR6;GPR183;HMGB1;CXCR4;CCR7;CXCR2;CCR5;CCR1;CCL5;PIK3CG;TRPM2;CCR2;TRPM4
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.1440353317632971,-0.4512360678254926,1.0,0.9983313005794598,1.0,15/32,44.89%,CDK17;POLA1;ID2;CDK5;E2F7;ZPR1;ORC1;CDC6;ESRRB;PCNA;RRM2;CDK18;CDC45;TFDP1;CDT1
prerank,mitotic DNA replication (GO:1902969),-0.1978970250464662,-0.4507000592863014,0.9885931558935361,0.9978581964927201,1.0,2/10,17.35%,MCM4;POLA1
prerank,activin receptor signaling pathway (GO:0032924),0.18689960213730866,0.44872325580607536,0.9874739039665971,1.0,1.0,4/15,25.24%,SMAD3;SMAD2;INHBA;ACVR1B
prerank,rRNA catabolic process (GO:0016075),-0.16879219130762413,-0.4405128954957147,0.9957173447537473,0.9980985444881433,1.0,8/16,42.18%,TRIR;PELO;EXOSC10;EXOSC5;DEDD2;EXOSC9;EXOSC2;ERN2
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.1949267029226916,0.4391017434046791,0.9899193548387096,1.0,1.0,1/11,7.32%,BLM
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.1795887039604465,0.4360362086549695,0.9918367346938776,1.0,1.0,4/16,17.42%,PRKDC;PARP9;DTX3L;KDM4D
prerank,mitotic chromosome condensation (GO:0007076),0.1600156691089746,0.4323829498306568,0.9928057553956835,1.0,1.0,6/26,20.14%,PHF8;CDK1;AKAP8L;MCPH1;SMC2;NCAPG2
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.14458159451603167,0.4306939088552784,1.0,1.0,1.0,13/40,25.38%,BLM;RTEL1;BOD1L1;PRIMPOL;CENPX;WRN;RAD51;CDK9;ETAA1;THOC1;MCM9;SMARCAL1;ATRX
prerank,mismatch repair (GO:0006298),0.15697386196148114,0.4304751015191022,0.998211091234347,0.9998367690928596,1.0,7/27,19.11%,ABL1;LIG1;MLH1;SETD2;RNASEH2A;XPC;POLD2
prerank,cilium-dependent cell motility (GO:0060285),0.16252101945543548,0.4260252090309131,0.9941860465116279,0.9996869119570492,1.0,3/22,14.38%,DNAH2;TEKT2;CCDC65
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.14915190773667078,0.42165654406700365,0.9980879541108987,0.9989626521197837,1.0,7/29,23.93%,ACOT4;ACOT1;ACOT13;ACOT11;ACBD6;ACOT6;ACAT1
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.14915190773667078,0.42165654406700365,0.9980879541108987,0.9989626521197837,1.0,7/29,23.93%,ACOT4;ACOT1;ACOT13;ACOT11;ACBD6;ACOT6;ACAT1
prerank,regulation of chromosome segregation (GO:0051983),0.17202821376178104,0.41591462912056065,0.9941291585127201,0.9988252597040591,1.0,3/16,17.34%,HORMAD1;RAD18;IHO1
prerank,ncRNA catabolic process (GO:0034661),-0.13394743941990594,-0.407215360665633,0.9976744186046511,0.9992601592810991,1.0,13/28,42.18%,TRIR;LIN28B;EXOSC10;MTREX;NUDT16;EXOSC5;DIS3L2;TENT4B;NUDT16L1;DEDD2;EXOSC9;EXOSC2;ERN2
prerank,glycine metabolic process (GO:0006544),-0.16408360980372644,-0.4047295593060257,1.0,0.9988240591890208,1.0,3/12,29.90%,RIDA;GCAT;GLDC
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.18000037249264328,0.4026819624328642,1.0,0.9991218828467633,1.0,1/10,7.09%,PDCD1LG2
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.16801657562629496,0.40235956020102964,0.9979633401221996,0.9985963874157586,1.0,15/15,83.21%,CCT6A;TCP1;SHQ1;RUVBL2;DKC1;CCT8;CCT5;CCT7;NAF1;CCT2;CCT4;CCT3;NOP10;NHP2;RUVBL1
prerank,inositol phosphate biosynthetic process (GO:0032958),0.1661691765369695,0.36811240870487644,1.0,0.9993369581575157,1.0,3/11,20.49%,PPIP5K2;ITPKA;IP6K2
